
<html lang="en"     class="pb-page"  data-request-id="71ec4f6e-2345-433f-81c8-0c7887b756e6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2020.63.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b00924;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases" /></meta><meta name="dc.Creator" content="Margherita  Brindisi" /></meta><meta name="dc.Creator" content="A. Prasanth  Saraswati" /></meta><meta name="dc.Creator" content="Simone  Brogi" /></meta><meta name="dc.Creator" content="Sandra  Gemma" /></meta><meta name="dc.Creator" content="Stefania  Butini" /></meta><meta name="dc.Creator" content="Giuseppe  Campiani" /></meta><meta name="dc.Description" content="Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms. Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic ..." /></meta><meta name="Description" content="Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms. Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 15, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00924" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00924" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00924" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00924" /></link>
        
    
    

<title>Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00924" /></meta><meta property="og:title" content="Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0008.jpeg" /></meta><meta property="og:description" content="Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms. Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic targets owing to their involvement in specific pathophysiological pathways. Beyond their well-characterized role as histone modifiers, HDACs also interact with several nonhistone substrates and their increased expression has been highlighted in specific diseases. The HDAC6 isoform, due to its unique cytoplasmic localization, modulates the acetylation status of tubulin, HSP90, TGF-β, and peroxiredoxins. HDAC6 also exerts noncatalytic activities through its interaction with ubiquitin. Both catalytic and noncatalytic functions of HDACs are being actively studied in the field of specific rare disorders beyond the well-established role in carcinogenesis. This Perspective outlines the application of HDAC(6) inhibitors in rare diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis, and Charcot–Marie–Tooth disease, highlighting their therapeutic potential as innovative and targeted disease-modifying agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00924"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00924">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00924&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00924&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00924&amp;href=/doi/10.1021/acs.jmedchem.9b00924" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 23-39</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00803" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00964" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Margherita Brindisi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Margherita Brindisi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Department of Excellence 2018−2022, University of Naples Federico II, Via D. Montesano 49, I-80131 Naples, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Margherita++Brindisi">Margherita Brindisi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9119-3773" title="Orcid link">http://orcid.org/0000-0001-9119-3773</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">A. Prasanth Saraswati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">A. Prasanth Saraswati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=A.+Prasanth++Saraswati">A. Prasanth Saraswati</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simone Brogi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simone Brogi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, University of Pisa, via Bonanno 6, 56126, Pisa, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Brogi">Simone Brogi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9375-6242" title="Orcid link">http://orcid.org/0000-0001-9375-6242</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandra Gemma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandra Gemma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Gemma">Sandra Gemma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8313-2417" title="Orcid link">http://orcid.org/0000-0002-8313-2417</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefania Butini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefania Butini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Butini">Stefania Butini</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8471-0880" title="Orcid link">http://orcid.org/0000-0002-8471-0880</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Giuseppe Campiani</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuseppe Campiani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +39 0577 232239. Fax: +39 0577 234333. E-mail: <a href="/cdn-cgi/l/email-protection#b4d7d5d9c4ddd5daddf4c1daddc7dd9addc0"><span class="__cf_email__" data-cfemail="4023212d3029212e2900352e2933296e2934">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Campiani">Giuseppe Campiani</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5295-9529" title="Orcid link">http://orcid.org/0000-0001-5295-9529</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00924&amp;href=/doi/10.1021%2Facs.jmedchem.9b00924" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 23–39</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 15, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 June 2019</li><li><span class="item_label"><b>Published</b> online</span>15 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00924" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00924</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D23%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMargherita%2BBrindisi%252C%2BA.%2BPrasanth%2BSaraswati%252C%2BSimone%2BBrogi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D1%26contentID%3Dacs.jmedchem.9b00924%26title%3DOld%2Bbut%2BGold%253A%2BTracking%2Bthe%2BNew%2BGuise%2Bof%2BHistone%2BDeacetylase%2B6%2B%2528HDAC6%2529%2BEnzyme%2Bas%2Ba%2BBiomarker%2Band%2BTherapeutic%2BTarget%2Bin%2BRare%2BDiseases%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D39%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00924"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2744</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00924" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Margherita&quot;,&quot;last_name&quot;:&quot;Brindisi&quot;},{&quot;first_name&quot;:&quot;A.&quot;,&quot;last_name&quot;:&quot;Prasanth Saraswati&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Brogi&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Gemma&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Butini&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Campiani&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;23-39&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00924&quot;},&quot;abstract&quot;:&quot;Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms. Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic targets owing to their involvement in specific pathophysiological pathways. Beyond their well-characterized role as histone modifiers, HDACs also interact with several nonhistone substrates and their increased expression has been highlighted in specific diseases. The HDAC6 isoform, due to its unique cytoplasmic localization, modulates the acetylation status of tubulin, HSP90, TGF-β, and peroxiredoxins. HDAC6 also exerts noncatalytic activities through its interaction with ubiquitin. Both catalytic and noncatalytic functions of HDACs are being actively studied in the field of specific rare disorders beyond the well-established role in carcinogenesis. This Perspective outlines the application of HDAC(6) inhibitors in rare diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis, and &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00924&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00924" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00924&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00924" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00924&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00924" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00924&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00924&amp;href=/doi/10.1021/acs.jmedchem.9b00924" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00924" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00924" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00924%26sid%3Dliteratum%253Aachs%26pmid%3D31415174%26genre%3Darticle%26aulast%3DBrindisi%26date%3D2020%26atitle%3DOld%2Bbut%2BGold%253A%2BTracking%2Bthe%2BNew%2BGuise%2Bof%2BHistone%2BDeacetylase%2B6%2B%2528HDAC6%2529%2BEnzyme%2Bas%2Ba%2BBiomarker%2Band%2BTherapeutic%2BTarget%2Bin%2BRare%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D1%26spage%3D23%26epage%3D39%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290982" title="Diseases and disorders">Diseases and disorders</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/jmcmar.2020.63.issue-1/20200109/jmcmar.2020.63.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0008.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms. Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic targets owing to their involvement in specific pathophysiological pathways. Beyond their well-characterized role as histone modifiers, HDACs also interact with several nonhistone substrates and their increased expression has been highlighted in specific diseases. The HDAC6 isoform, due to its unique cytoplasmic localization, modulates the acetylation status of tubulin, HSP90, TGF-β, and peroxiredoxins. HDAC6 also exerts noncatalytic activities through its interaction with ubiquitin. Both catalytic and noncatalytic functions of HDACs are being actively studied in the field of specific rare disorders beyond the well-established role in carcinogenesis. This Perspective outlines the application of HDAC(6) inhibitors in rare diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis, and Charcot–Marie–Tooth disease, highlighting their therapeutic potential as innovative and targeted disease-modifying agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Epigenetics is a natural progression of genetics and represents one of the most attractive research areas in medicine and modern biology; it describes the influence of genetic processes on development and studies the inherited modifications in gene expression which do not encompass alterations in the original DNA sequence, namely the changes in the phenotype not involving any corresponding changes in genotype.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> Epigenetic modifications occur naturally but they could also be favored by environment, age, nutrients, disease states, and lifestyle. Epigenomic profiling has allowed defining the critical DNA control elements, such as gene promoters and enhancers. In combination with DNA sequence analysis, epigenetic research has provided deep insights into disease pathways. Also, the successful completion of the Human Genome Project prompted an effective investigation of epigenetic mechanisms involving scientists from various disciplines.</div><div class="NLM_p last">Epigenetics comprises a series of mechanisms by which DNA and its associated proteins, or other crucial protein substrates, get chemically or structurally altered. Chemical alteration includes modifications of DNA and histones, whereas structural changes occur via chromatin remodelling and inter/intrachromosomal DNA–DNA interactions. The typical epigenetic modifications include three main processes, such as histone modifications, DNA methylation, and gene silencing related to noncoding RNA (ncRNA). DNA methylation involves the enzymatic insertion of a methyl (−CH<sub>3</sub>) group on the cytosine rings with both spatial and temporal precision, while histone post-translational modifications (PTMs) include specific methylation, acetylation, phosphorylation, sumoylation, and ubiquitination.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Epigenetics in Rare Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While genetic mutations are irreversible, epigenetic modifications are reversible in nature and can be modulated by targeting enzymes or other factors involved in their regulation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Many of these enzymes mediating epigenetic processes, such as histone deacetylase (HDAC) and DNA methyltransferase (DNMT), are usually deregulated in a variety of disease conditions.</div><div class="NLM_p">Approval of anticancer epigenetic drugs, such as the potent HDAC inhibitors vorinostat (SAHA, <b>1</b>) and romidepsin (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) has inspired the development of drugs targeting the epigenetic machinery for other disorders, especially neurodegenerative disorders and rare diseases.</div><div class="NLM_p last">Rare diseases, often termed as orphan diseases, are health conditions which affect a small number of individuals. However, the cutoff number for a disease to be defined as rare differs from region to region.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To date, 5000–8000 distinct rare diseases have been documented, and new rare disorders constantly appear in the scientific literature.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The vast majority of rare diseases still lack therapeutic solutions partially due to the limited understanding of their pathological mechanisms but also due to the lack of druggable targets. Owing to the low incidence of rare disorders, the quest for potential therapeutic options from both academia and industry is relatively slow and unfruitful. Most rare diseases are genetic in nature which could be either life-threatening or debilitating. Notably, some rare disorders are characterized by an epigenetic basis. In particular, the nervous system due to its highly complex structure is vulnerable to epigenetic changes; accordingly, several aberrations in the epigenetic machinery have been associated with the insurgence of a number of mental disorders. For example, Rett syndrome (RTT) involves mutations of genes associated with DNA methylation in the methyl-binding domain protein such as the methyl-CpG binding protein 2 (MeCP2).<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Besides cancerous and central nervous system (CNS)-related disorders, epigenetic changes are crucial factors also in the progress of immunological and inflammatory disorders. Among them, idiopathic pulmonary fibrosis (IPF) is one such case characterized by progressive lung damage, causing the loss of pulmonary function, respiratory failure, and death. Epigenetic mechanisms have been associated with the pathogenesis of IPF, thus playing a key role for the identification of either crucial biomarkers or potential therapeutic targets.<a onclick="showRef(event, 'ref9 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref12 ref13">(9,12,13)</a> Moreover, the contribution of epigenetic mechanisms has been recently unveiled in other rare disorders with limited therapeutic options so far, namely inherited retinal disorders (IRDs)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and Charcot–Marie–Tooth (CMT) disease.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3.  HDAC Enzymes and HDAC6 Isoform</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acetylation of the ε-amino group of lysine residues is a dynamic PTM finely tuned by the opposite action of lysine acetyltransferases (KATs) and HDACs.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Hyperacetylation is associated with transcriptionally active genes and to the decondensed chromatin status, therefore maintaining the unfolded structure of transcribed nucleosome.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> HDACs remove the acetyl groups from histones, resulting in decreased gene transcription. Currently, 18 HDAC isoforms have been recognized in mammalian cells, and they are clustered based on their homology to yeast HDACs into four classes. HDACs belonging to classes I, II, and IV are zinc-dependent, while class III HDACs are NAD<sup>+</sup> dependent. HDAC isoforms 1, 2, 3, and 8 (class I) are expressed in the nucleus of the cells of all tissues and share homology with yeast HDAC RDP3. While HDAC isoforms 1 and 2 are mostly nuclear, isoforms 3 and 8 are able to shuttle in and out of the cell nucleus.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Some of their key substrates include steroid receptors, tumor suppressors, and transcription factors. Class II HDACs show homology to yeast HDAC HDA1 and perform tissue-specific functions, including deacetylation of nonhistone substrates. Class II HDACs are further clustered into class IIA (HDAC isoforms 4, 5, 7, and 9) and class IIB (HDAC isoforms 6 and HDAC10). Class IV HDACs, only composed by HDAC isoform 11, shares homology with class I and II enzymes. Class III HDACs, named sirtuins (SIRT isoforms 1–7), are homologous to yeast sirtuin protein Sir2. They are broadly expressed in human tissues and are involved in the regulation of DNA repair, metabolism, oxidative stress, and aging.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a></div><div class="NLM_p">Among epigenetic regulation processes, HDAC inhibition holds an enormous therapeutic potential,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and it is known to exert pleiotropic effects at both cellular as well as systemic levels. Mounting evidence shows that HDAC inhibition also possesses anti-inflammatory properties.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> HDAC inhibitors can be clustered based on their structure into four large classes: hydroxamates, benzamides, cyclic peptides, and short-chain fatty acids. The three hydroxamate-based HDAC inhibitors approved by the FDA, namely SAHA, belinostat (<b>3</b>), and panobinostat (<b>4</b>), behave as pan-inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The fourth HDAC inhibitor, FK228 (romidepsin, <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), is a class I selective cyclic peptide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). All of them have been approved to treat cancers.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. FDA approved HDAC inhibitors <b>1</b>–<b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the successful approvals of the four HDAC inhibitors by the FDA, their nonselective HDAC inhibition profile represents a significant drawback, being associated with the occurrence of several side effects. In this regard, increasing investigations are being focused on the identification of isoform-selective HDAC inhibitors as drugs for epigenetic therapy.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Because of the unique cytoplasmic localization of HDAC6, and its diverse protein substrates, selective HDAC6 inhibitors are increasingly emerging as potential therapeutic agents for cancer, neurodegenerative diseases, and immunological disorders.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.1.  Structure of HDAC6</h3><div class="NLM_p">HDAC6 isoform was identified in 1999 and displays a unique full duplication of the class I/II homology domain. The human isoform (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is composed by 1255 amino acids and displays two deacetylase binding domains, namely DD1 and DD2.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Besides this, it also has SE14 (Ser-Glu tetra decapeptide repeat domain) and C-terminus hydrolase-like zinc finger domain for ubiquitin binding (ZnF-UBP). At the <i>N</i>-terminal, it has a conserved nuclear export signal (NES) sequence.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Experimental data using purified HDAC6 indicated that DD2 is responsible for its deacetylation activity on histones and α-tubulin.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Moreover, HDAC6 enzyme also displays peptide moieties which are necessary for its cytoplasmic localization. In response to cellular signals, HDAC6 shuttles between the cytoplasm and the nucleus, wherein, NES and SE14 are responsible for the stability and cytoplasmic localization of the enzyme. HDAC6 also contains a unique zinc finger motif in its <i>C</i>-terminus end, with conserved cysteine- and histidine-rich regions. ZnF-UBP specifically binds to both mono- and poly ubiquitin chains.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HDAC6 structure: domain organization and functions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Not only HDAC6 displays a variety of nonhistone substrates, but it also interacts with several proteins regulating its deacetylase activity through protein–protein interaction.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> summarizes HDAC6 substrates and interacting proteins, while next subparagraphs will analyze in detail substrates or interactions specifically involved in the pathomechanisms of the rare disorders herein discussed.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HDAC6 Substrates and Proteins Regulating HDAC6 Deacetylase Activity through Protein–protein Interactions</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>protein</b></th><th class="colsep0 rowsep0" align="center"><b>type of interaction with HDAC6</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-tubulin<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cortactin<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSP90<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-catenin<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peroxiredoxin<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">survivin<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></td><td class="colsep0 rowsep0" align="center">substrate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ubiquitin<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></td><td class="colsep0 rowsep0" align="center">protein–protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tau<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="center">protein–protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IIp45<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></td><td class="colsep0 rowsep0" align="center">protein–protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td><td class="colsep0 rowsep0" align="center">protein–protein</td></tr></tbody></table></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.2.  HDAC6 and α-Tubulin</h3><div class="NLM_p">Tubulin was the first acknowledged HDAC6 protein substrate. The acetylation of α-tubulin at lysine 40 is a common process in the microtubules. Regulation of microtubule function and stability is strongly dependent upon acetylation status of α-tubulin.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Chemotactic cell movement and tubulin hypoacetylation are promoted by increased expression of HDAC6 in cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Acetylated α-tubulin regulates motor-based trafficking and tubulin binding to kinesin-1, which is required for transporting cargos along with the microtubule network.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Interaction of HDAC6 with α-tubulin and HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.3.  HDAC6 and HSP90</h3><div class="NLM_p last">Heat shock protein 90 (HSP90) was identified as the second substrate for HDAC6.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> HDAC6 inhibition or knockdown increase acetylated HSP90 levels and lead to loss of its chaperone activity by dissociation from cochaperone p23. This event halts the maturation of the glucocorticoid receptor (GR). HDAC6 has been found to exist in a complex with HSP90 and was seen to be capable of detecting ubiquitinated cell aggregates (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The dissociation of HDAC6–heat shock transcription factor 1-(HSF1)–HSP90 complex causes the activation of HSF1, thus prompting the expression of important cellular chaperones.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> These evidences highlight the crucial regulatory role of HDAC6 in the cellular response to the event of cytotoxic protein aggregate formation.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.4.  HDAC6 and Ubiquitin</h3><div class="NLM_p">The fact that HDAC6 binds ubiquitin and colocalizes with ubiquitinated aggresomes supports the existence of ubiquitin-dependent activities for this enzyme.<a onclick="showRef(event, 'ref31 ref32 ref47'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref47">(31,32,47)</a> The ubiquitin binding-activity mediates the shuttling of ubiquitinated aggregates to the aggresomes along microtubules.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Aggresomes represent the end point of microtubule-mediated transport of misfolded polyubiquitinated proteins and HDAC6 plays a vital role in their degradation.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> HDAC6 binds to ubiquitin with a high affinity (<i>K</i><sub>d</sub> = 60 nM), thus stabilizing polyubiquitin chains and inhibiting degradation of ubiquitinated proteins via ubiquitin–proteasome system. Moreover, HDAC6 binds phospholipase A2 inactivating protein (PLAP) and p97/valosin containing protein (p97/VCP), two proteins involved in the control of ubiquitinated substrates.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> p97/VCP is an AAA-ATPase chaperone with a crucial role in the control of ubiquitin-dependent endoplasmic reticulum-associated degradation. Besides this, it is able to dissociate the complex between HDAC6 and ubiquitin and to counteract the accumulation of polyubiquitinated proteins promoted by HDAC6.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> The equilibrium between the cellular levels of HDAC6 and p97/VCP is, therefore, a key aspect influencing the fate of polyubiquitinated proteins, which could either undergo proteasomal degradation by p97/VCP or be sequestered into the aggresome (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interaction of HDAC6 with ubiquitin and tau protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.5.  HDAC6 and Tau</h3><div class="NLM_p last">Tau proteins, comprising six distinct tau forms located in the brain, normally act by binding and stabilizing neural microtubules. Binding of tau to microtubules is regulated by the serine/threonine phosphorylation status, mostly in the proline-rich regions of tau, and also by lysine acetylation directly in the microtubule-binding repeat region. HDAC6 binds tau in in vitro settings and in tissues derived from human brain. In healthy tissues, HDAC6 actively binds to tau and shuttles it for targeted sequestration or degradation. Moreover, HDAC6 is also seen to play a role in the tau hyperphosphorylation process. Tau phosphorylation impairs the binding and stabilizing the function of tau, resulting in self-assembly and aggregation, an important feature in neurodegenerative disorders. HDAC6 inhibitory activity leads to increased acetylated HSP90 levels, thus prompting dissociation of HSP90-HDAC6 complex and triggering ubiquitination of phosphorylated tau proteins (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.6.  HDAC6 and TGF-β</h3><div class="NLM_p">Epithelial–mesenchymal transition (EMT) encompasses loss of cell–cell junctions and polarization of cell-surface molecules of epithelial cells, wherein they acquire the typical features of mesenchymal cells, including metastasis formation.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Transforming growth factor-β (TGF-β) family and its members are well-known to be potent inducers of EMT. In particular, abnormal expression of TGF-β1 has been widely documented in the tumor microenvironment and fibrotic lesions.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Studies performed on human lung epithelial cells demonstrated that TGF-β1 causes HDAC6-associated deacetylation of α-tubulin accompanied by increased cell motility and expression of EMT markers (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Upregulation of HDAC6 by TGF-β1 occurs via post-translational mechanisms because TGF-β1 does not alter mRNA or protein levels of HDAC6. SMAD3 represents a vital element for TGF-β1-induced EMT through the canonical pathway and increasing data demonstrate that the microtubule structure controls SMAD activity.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> HDAC6 was found to regulate EMT through an interplay with SMAD3 signaling process, as demonstrated by the observation that TGF-β1-mediated phosphorylation of SMAD3 was impaired in the presence of HDAC6-specific siRNA. Also, TGF-β1-dependent nuclear accumulation of SMAD3 was found to be regulated by HDAC6.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. HDAC6-dependent and independent activation of EMT by TGF-β1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.7.  HDAC6 and Peroxiredoxins</h3><div class="NLM_p">Peroxiredoxin I (Prx I) and II (Prx II) are proteins involved in redox regulation; they are HDAC6 substrates and their acetylated forms are accumulated in the cells lacking HDAC6 activity.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> They belong to the Prx protein family, and specifically they represent the 2-cysteine members of the family, behaving as antioxidants at low H<sub>2</sub>O<sub>2</sub> concentrations,<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> while at high concentrations of H<sub>2</sub>O<sub>2</sub>, oxidation of the cysteine residue to sulfonic acid occurs, leading to the formation of high molecular-mass protein complexes. It has been observed that the acetylated Prx protein more actively reduces H<sub>2</sub>O<sub>2</sub> than the nonacetylated form. Therefore, increased levels of acetylated Prx upon HDAC6 inhibition may result in a valuable enhancement of the antioxidant activity. In this regard, several HDAC inhibitors such as trichostatin A (TSA, <b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), SAHA, and sodium butyrate demonstrated efficacy in animal models of Huntington’s disease (HD)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and amyotrophic lateral sclerosis.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> However, detailed mechanistic reasons for this beneficial effect are not clearly understood yet.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of HDAC inhibitors <b>5</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for HDAC Inhibitors <b>1</b>–<b>18</b> on HDAC6 and Other Isoforms Belonging to Class I</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> HDAC6 (nM)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> class I HDACs (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>, SAHA</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">HDAC1 = 33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC2 = 96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 540</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>, romidepsin</td><td class="colsep0 rowsep0" align="center">790</td><td class="colsep0 rowsep0" align="center">HDAC1 = 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC2 = 3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b>, belinostat</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b>, panobinostat</td><td class="colsep0 rowsep0" align="center"><15</td><td class="colsep0 rowsep0" align="center">HDAC1 = <15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = <15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 550</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b>, trichostatin A</td><td class="colsep0 rowsep0" align="center">8.6</td><td class="colsep0 rowsep0" align="center">HDAC1 = 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b>, ricolinostat</td><td class="colsep0 rowsep0" align="center">4.7</td><td class="colsep0 rowsep0" align="center">HDAC1 = 58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC2 = 48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = 51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b>, tubastatin A</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">HDAC1 = 16400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC2 = >30000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = >30000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 854</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">56</td><td class="colsep0 rowsep0" align="center">HDAC1 = 2570</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b>, valproic acid</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC1 = 40000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b>, tubacin</td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">HDAC1 = 1400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC2 = 6270</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = 1270</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 1270</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">3.0</td><td class="colsep0 rowsep0" align="center">HDAC1 = 4320</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b>, ACY738</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">HDAC1 = 94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b>, ACY775</td><td class="colsep0 rowsep0" align="center">7.5</td><td class="colsep0 rowsep0" align="center">HDAC1 = 2123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b>, scriptaid</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC1 = 600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = 600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC8 = 1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b>, spiruchostatin A</td><td class="colsep0 rowsep0" align="center">1600</td><td class="colsep0 rowsep0" align="center">HDAC1 = 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b>, entinostat</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC1 = 510</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC3 = 1700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b>, MC1568</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC = 100 nM (maize HD1-A)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b>, M344</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">HDAC = 100 nM (maize HD-2)</td></tr></tbody></table></div></div><div class="NLM_p last">Considering the unique place occupied by HDAC6 in the therapeutic spectrum, owing to its structural and functional features, several research groups have developed novel, potent, and selective HDAC6 inhibitors for various disease profiles.<a onclick="showRef(event, 'ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64">(61−64)</a> In this aspect, the recently reported crystal structures of HDAC6 have helped advance newer drug design and discovery strategies toward partially selective HDAC6 inhibitors<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> to be used in cancer therapy (e.g., ACY-1215, ricolinostat, <b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> Moreover, there has also been a recent surge in reports regarding the therapeutic application of novel selective HDAC6 inhibitors in noncancerous conditions. This perspective article highlights the new guise of HDAC6 inhibitors as a therapeutic option for the treatment of diverse rare diseases.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">4.  HDAC6 Inhibitors in Rare Disorders Related to Impaired Axonal Transport</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As mentioned above, HDAC6 catalyzes the deacetylation of substrates with cytoplasmic localization, such as HSP90, α-tubulin, and cortactin.<a onclick="showRef(event, 'ref35 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref35 ref68 ref69 ref70">(35,68−70)</a> Therefore, HDAC6 deficiency in cells leads to increased acetylation within the entire microtubule network.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">A number of evidence demonstrates that in neuronal cells the motor-based cellular trafficking is strongly dependent on the tubulin acetylation status, through the control of microtubule association with dynein and kinesin, which prompts amplified motor processivity and secretory vesicle flux.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> These data also support the role of HDAC6 as a key regulator of endocytic cargo transport due to its crucial role in modulating α-tubulin acetylation status.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> More in detail, the tubulin binding ability and motility of kinesin-1 (a motor protein responsible for the transport of cargos along microtubules) is regulated by the acetylation of α-tubulin at lysine residue 40. Inhibition of HDAC6 mediates, through augmented acetylated α-tubulin levels, the transport and accumulation to neurites of a kinesin-1 cargo protein, namely the JNK-interacting protein 1 (JIP1).<a onclick="showRef(event, 'ref73 ref75'); return false;" href="javascript:void(0);" class="ref ref73 ref75">(73,75)</a> Moreover, it was demonstrated that pharmacological inhibition of HDAC6 with the pan-inhibitor TSA, beyond promoting in vivo dynein and kinesin-1 binding to microtubules, was able to boost the intracellular shuttling of the brain-derived neurotrophic factor (BDNF), another kinesin-1 cargo protein.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> On the contrary, defective α-tubulin acetylation reduces both recruitment of motor complexes and BDNF shuttling.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Taken together, these evidences provide a clear-cut picture of the key role of HDAC6 in the control of microtubule-mediated intracellular trafficking through its tubulin deacetylase activity.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Therefore, HDAC6 is increasingly emerging as a valuable therapeutic target for the treatment of neurodegenerative diseases, including rare disorders.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Already more than a decade ago, the neuroprotective effects associated to HDAC inhibitors (i.e., TSA and SAHA) have been highlighted in cell-based models of HD, in which they corrected the mutant huntingtin-induced deficits in vesicular BDNF transport.<a onclick="showRef(event, 'ref72 ref77'); return false;" href="javascript:void(0);" class="ref ref72 ref77">(72,77)</a> More recently, neuroprotective effects upon genetic ablation of HDAC6 have been demonstrated in vivo.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Several pieces of evidence have also shown the protective effect of HDAC6 inhibition by enhancement of the axonal transportation of neurotrophic factors in in vivo models of brain disorders characterized by cognitive deficits.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> This impaired BDNF transport has been related to rare disorders such as RTT.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Moreover, defective mitochondrial transportation and degradation of protein aggregates are abnormalities encountered in neurodegenerative disorders which are related to both catalytic and noncatalytic functions of HDAC6<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> such as CMT disease.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Accordingly, it has been demonstrated that HDAC6 silencing improved associative and spatial memory formation, which are impaired due to defective mitochondrial trafficking associated to neurodegenerative disorders.<a onclick="showRef(event, 'ref75 ref83'); return false;" href="javascript:void(0);" class="ref ref75 ref83">(75,83)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.1.  HDAC6 and Rett Syndrome (RTT)</h3><div class="NLM_p">RTT is a rare neurodevelopmental disorder, mainly ascribable to the loss of functional mutations in the X-linked MeCP2 gene.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> RTT patients are characterized by severe neurological, motor, and behavioral defects. RTT clinical course entails the increasing impairment of intellectual functioning and motor skills and defective head growth. Also, between 6 and 18 months after birth, RTT patients display stereotypic hand movements.<a onclick="showRef(event, 'ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88">(86−88)</a></div><div class="NLM_p">MeCP2 interacts with DNA in the context of CpG islands behaving as a transcriptional repressor.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89−91)</a> A series of evidence correlate the MeCP2 abnormalities with defective BDNF trafficking and microtubule dynamics, thus highlighting a crucial role of HDAC6 in RTT neurobiology and its potential as a valuable disease-modifying target.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">MeCP2 controls <i>Bdnf</i> expression through its binding to the <i>Bdnf</i> promoter.<a onclick="showRef(event, 'ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95">(93−95)</a> Accordingly, reduced BDNF mRNA and protein levels were detected in <i>MeCP2</i> deficient mice and patients affected by RTT.<a onclick="showRef(event, 'ref96 ref97 ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref96 ref97 ref98 ref99">(96−99)</a> Moreover, <i>Bdnf</i> mutant mice and <i>MeCP2</i> knockout mice exhibited comparable RTT phenotypes. Interestingly, <i>Bdnf</i> overexpression corrected several functional defects encountered in <i>MeCP2</i> mutants, thus allowing to increase their lifespan.<a onclick="showRef(event, 'ref84 ref96'); return false;" href="javascript:void(0);" class="ref ref84 ref96">(84,96)</a> Taken together, these findings strongly suggest a key role for BDNF in neurological dysfunctions in RTT.</div><div class="NLM_p">As mentioned above, the acetylation levels of microtubules regulate the efficacy of a series of key processes in neuronal cells, namely differentiation and migration, and trafficking of mRNA, mitochondria, and BDNF-containing vesicles.<a onclick="showRef(event, 'ref72 ref100'); return false;" href="javascript:void(0);" class="ref ref72 ref100">(72,100)</a> Furthermore, HDAC6 inhibition increased fast axonal transport of BDNF and mitochondria in both the anterograde and retrograde directions,<a onclick="showRef(event, 'ref72 ref73 ref101'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref101">(72,73,101)</a> thus enhancing synaptic activity.</div><div class="NLM_p"><i>MeCP2</i>-mutated fibroblasts show a significant impairment in microtubule dynamics, displaying higher sensitivity toward cold-induced microtubule depolymerization with the concomitant defective ability to recover.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Similarly, defective microtubule dynamics were detected in astrocytes from RTT mouse models.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Most importantly, impaired microtubule-mediated transportation of BDNF vesicles was described in a rodent model of RTT.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The essential role of these processes for synaptic function and plasticity can help shedding light on the pathways contributing to the neuropathology of RTT.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">In the context of RTT and HDAC6, reduced acetylated α-tubulin levels in cells from two male patients displaying different MeCP2 mutations when compared to control fibroblasts were recently demonstrated.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> HDAC6 but not SIRT2 was shown to be a RTT biomarker in MeCP2 cells and in a MeCP2<sup>T158A</sup> RTT murine model. Tubastatin A (TubA, <b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) is a partially selective HDAC6 inhibitor able to cross the blood–brain barrier.<a onclick="showRef(event, 'ref77 ref105'); return false;" href="javascript:void(0);" class="ref ref77 ref105">(77,105)</a> It was also shown to stabilize the microtubule network by counteracting depolymerization induced by either cold or nocodazole.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Moreover, TubA induces a strong increase of acetylated tubulin levels, consequently ameliorating microtubule instability in RTT patient fibroblasts.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> These observations strongly suggest that augmented levels of acetylated tubulin in MeCP2/<i>MeCP2-</i>deficient cells could be a direct effect of the HDAC6 overexpression and that treatment with a HDAC6 inhibitor could potentially lead to improved efficacy of molecular motors and motor-based trafficking of BDNF-containing vesicles, eventually enhancing synaptic activity.<a onclick="showRef(event, 'ref92 ref107'); return false;" href="javascript:void(0);" class="ref ref92 ref107">(92,107)</a> TubA also stabilized the microtubule network of MeCP2-mutated fibroblasts, effectively counteracting nocodazole-induced depolymerization, thus restoring polymerization levels to that of control fibroblasts.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">Moreover, employing a novel method to detect BDNF secretion, using surface immunostaining of BDNF tagged with a yellow fluorescent protein (BDNG-YFP) in live neurons after neuronal depolarization,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> the defective BDNF release was confirmed in hippocampal neuronal cells derived from <i>MeCP2</i>-null mice.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Because increased acetylated α-tubulin levels improve microtubule stability, and BDNF vesicles are shuttled through the microtubule network,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> the use of selective HDAC6 inhibitors could represent an innovative targeted strategy for ameliorating cellular and synaptic defects in RTT.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><div class="NLM_p">Despite the growing insights on MeCP2 function and the evidence of the efficacy of HDAC6 inhibitors in the frame of RTT in cells and animal models, the pathomechanisms underlying RTT are still not fully understood. Most importantly, animal models may not entirely recapitulate the features of the human disease, thus rendering difficult the identification of effective disease-modifying therapies.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> A new frontier in this field was represented by the genetic reprogramming approach, which allowed the development of induced pluripotent stem cells (iPSCs) from human fibroblasts.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Neurons deriving from iPSCs are mostly superimposable to neurons from human fetal brain<a onclick="showRef(event, 'ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114">(112−114)</a> and display a significant transcriptome resemblance to fetal neurons.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">It was demonstrated that iPSCs can be established from <i>MeCP2</i>-mutated patients,<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> thus supporting the validity of iPSCs technology for recapitulating RTT features in vitro.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118,119)</a><i>MeCP2</i>-iPSCs neurons show a reduced number of synapses, impaired spine density, and defective calcium signaling when compared to controls. These phenotypic alterations are completely superimposable to those observed in RTT mice and post-mortem brain tissues derived from patients’.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div><div class="NLM_p">A transcriptome profiling of <i>MeCP2</i>-iPSCs neurons was performed in order to unveil the specific signature of RTT neurons responsible for the observed phenotypic changes. This analysis highlighted a significant GABAergic neurons impairment in RTT pathogenesis.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Most importantly, RNA-sequencing results highlighted an abnormal expression of the <i>HDAC6</i> gene, further confirmed by Western blot analysis evidencing a relevant reduction of acetylated α-tubulin levels in <i>MeCP2</i>-iPSCs neurons, likely as the direct result of the increased HDAC6 activity. In support of the hypothesized connection between HDAC6 overexpression and decreased acetylated tubulin levels, treatment of <i>MeCP2</i>-iPSCs neurons with a new class of selective HDAC6 inhibitors (general structure <b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) effectively increased the levels of acetylated α-tubulin, as determined by Western blot analysis on mutated and control neurons.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Consequently, scientists very recently proposed the repositioning of ricolinostat, currently in clinical trials for the therapy of multiple myeloma in association with proteasome inhibitors such as bortezomib.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120,121)</a> Accordingly, the treatment with ricolinostat led to increased levels of acetylated α-tubulin, thus further supporting the close connection between HDAC6 deacetylase activity and the status of the entire microtubule network.</div><div class="NLM_p last">In conclusion, a significant number of experimental findings point out that microtubule-based trafficking is strongly related to the acetylation status of tubulin and impairments in its fine-tuning are strongly implied in defective bidirectional trafficking of BDNF, vesicle transportation, neuronal cell migration, and axon elongation. The impact of HDAC6 expression on these pathways, through its unique tubulin deacetylase activity, strongly supports its role as a potential therapeutic option to counteract cellular and synaptic defects in RTT.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.2.  HDAC6 and Charcot–Marie–Tooth Disease (CMT)</h3><div class="NLM_p">CMT can be classified as a heterogeneous group of hereditary motor and sensory peripheral neuropathies (HMN) affecting 17–40 per 100000 individuals. Nearly 40 genes have been related with CMT pathogenesis.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> The vast majority of affected individuals exhibit progressive muscle weakness and atrophy. At the later CMT stages, muscles of hands and forearms are involved. In 90% of cases, CMT shows an autosomal dominant pattern of inheritance.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a></div><div class="NLM_p">On the basis of electrophysiological features, CMT can be clustered into three main groups: type 1 CMT (CMT1), mainly characterized by demyelination, type 2 CMT (CMT2), mainly featuring axonal loss, and intermediate forms displaying both axonal loss and demyelination.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Although CMT displays genetic and clinical heterogeneity, a number of studies highlighted common features. Therefore, despite the variety of primary causes which may be involved, the mechanisms underlying the disease seem to be mostly related to abnormalities in the cytoskeleton of peripheral axons and to defective axonal transport.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Currently, the few drugs available for the treatment of CMT act by halting/slowing down disease symptoms, while a disease-modifying approach is still missing.</div><div class="NLM_p">In 2010, Yamauchi and collaborators showed that valproic acid (VPA, <b>9</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), an antiepileptic drug also known for its activity as a pan-HDAC inhibitor, was able to restore neurite formation events in the CMT2B mutant Rab7. However, the authors correlated this protective effect to the modulation of the JNK signaling pathway rather than to the inhibition of HDAC activity.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><div class="NLM_p">One year later, Van Den Bosch and co-workers characterized two mutant murine models expressing mutant small heat-shock protein B1 (HSPB1), a 27 kDa small HSP, accurately recapitulating human CMT2 and distal HMN.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The authors investigated the outcome of mutant HSPB1 on mitochondria axonal transport in dorsal root ganglion (DRG) neurons isolated from transgenic mice. The authors were able to measure the number of mitochondria and to distinguish bidirectionally moving mitochondria from the motionless ones. DRG neurons of HSPB1<sup>S135F</sup> mutant showed a reduced number of mitochondria compared to their wild-type littermates, accompanied by significantly reduced moving mitochondria in their neurites.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In agreement with impaired mitochondrial transport, they also registered a significant reduction of acetylated α-tubulin levels in the mutated mice peripheral nerves. Because HDAC6 has a key role in controlling the axonal transport of mitochondria in cultured hippocampal neurons<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and in order to understand the mechanisms underlying CMT2 induction by HSPB1 mutants, the authors incubated DRG neurons from HSPB1<sup>S135F</sup> mutant with diverse HDAC6 inhibitors. In particular, the pan-inhibitor TSA and the selective HDAC6 inhibitors TubA and tubacin (<b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were investigated. The three inhibitors were able to nicely increase the total number of mitochondria; interestingly, TubA and tubacin were more effective in restoring the number of moving mitochondria, thus highlighting the key role of HDAC6 isoform in the microtubule network impairment associated to CMT disease.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">As the following advancement, evaluation of the best-performing inhibitors was translated to animal models. Symptomatic treatment of mutant mice with TSA and TubA for 21 days provided a robust increase of acetylated α-tubulin levels in peripheral nerves and led to significantly improved motor performance. Taken together, these results strongly pointed out to HDAC6 as a novel potential therapeutic option for an effective disease-modifying approach for CMT and other peripheral nerve disorders.<a onclick="showRef(event, 'ref82 ref83 ref125 ref128'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref125 ref128">(82,83,125,128)</a></div><div class="NLM_p">Recently, a novel HDAC6 inhibitor characterized by improved selectivity (<b>11</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) was evaluated in cell-based settings, namely the Neuro-2a (N2a) cells, in which the effects on the acetylation levels of histone H3 and α-tubulin (as markers of inhibition of class I HDACs and HDAC6, respectively) were evaluated.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Compound <b>11</b> effectively increased the levels of acetylated α-tubulin, while not altering the acetylation levels of histone H3. The compound was further investigated in vitro in cultured DRG neurons from a mouse model of CMT2 induced by mutant HSPB1. In this model, compound <b>11</b> was able to improve mitochondrial transport, thus correcting the CMT-associated mitochondrial axonal transport more effectively than other unselective HDAC6 inhibitors.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of HDAC inhibitors <b>11</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another recent study was engaged on three potent HDAC6 inhibitors under preclinical evaluation or in clinical trials, namely ACY738 (<b>12</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), ACY775 (<b>13</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and ricolinostat.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> The advantage of these three molecules is their drug-like profile, suitable for the transition into clinical use as a potential targeted therapy for CMT disease. The more selective HDAC6 inhibitors <b>12</b> and <b>13</b> were investigated in cultured DRG neurons from HSPB1<sup>S135F</sup> mice and from adult nontransgenic mice (NTG) for their ability to improve mitochondrial axonal transport. Immunofluorescence analysis highlighted a relevant increase of acetylated α-tubulin induced by treatment with either <b>12</b> and <b>13</b>. DRG neurons cultured from symptomatic HSPB1<sup>S135F</sup> were treated with the two inhibitors (2.5 μM dose) to assess their ability to counteract CMT-related mitochondrial axonal transport defects. Both compounds were able to significantly increase the motility and the total number of mitochondria in comparison with nontreated DRG neurons.</div><div class="NLM_p">In vivo transition of these molecules in the HSPB1<sup>S135F</sup>-induced CMT2 mouse model gave the opportunity to evaluate their effects on motor and sensory deficits. After daily intraperitoneal administration of <b>12</b> and <b>13</b> (3 mg/kg) or ricolinostat (30 mg/kg) for 21 days, motor and sensory nerves were submitted to nerve-conduction studies, which showed that all tested inhibitors were able to increase the action potential amplitudes. To visualize reinnervation of the neuromuscular junctions, the mice were sacrificed and the gastrocnemius muscle was dissected. Quantification of the number of double-labeled neuromuscular junctions highlighted significant reinnervation following treatment with the three HDAC6 inhibitors, thus confirming the potential of the compounds to improve motor and sensory deficits in a CMT2 animal model.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><div class="NLM_p">Because of the phenotypic similarities encountered in CMT individuals and those with vincristine-induced peripheral neuropathies (VIPN), it was also recently assumed that vincristine could cause axonal deficits by altering microtubule dynamics. Therefore, HDAC6 inhibitors were investigated as a potential treatment of VIPN. Beyond the reduced proliferation of lymphoblastic T cells associated to HDAC6 inhibition, the significant therapeutic effects registered in VIPN rodent models were related to the augmented acetylated α-tubulin levels, responsible of restoring the axonal transport.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">Very recently, Mo and co-workers added a further advance to the study of the pathomechanisms in CMT disorder, analyzing the interaction of Glycyl-tRNA synthetase (GlyRS) and HDAC6.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> GlyRS was the first member identified among the dominant mutations associated with CMT2D. However, it was demonstrated that CMT2D phenotype could not be recapitulated by loss of wild-type protein function, but it could rather be associated with abnormal activities of mutant GlyRS<sup>CMT2D</sup>. The authors identified HDAC6 as an intracellular element abnormally interacting with GlyRS<sup>CMT2D</sup>. This abnormal interaction fuels HDAC6 catalytic activity, thus negatively impacting on α-tubulin acetylation levels. A HDAC6 inhibitor (administered ip for 2 weeks at 50 mg/kg) was able to restore axonal transportation and to rescue motor functions in CMT2D mice, thus further highlighting HDAC6 role as a pathogenic factor and therapeutic target in CMT disease.</div><div class="NLM_p">Almost in parallel, Van Den Bosch and collaborators provided proof for the interaction of GlyRS and HDAC6 through a coimmunoprecipitation assay in N2a cells.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In line with the previous evidence, GlyRS-HDAC6 interaction was disrupted in cells incubated with TubA prior to coimmunoprecipitation. Also, an increased level of acetylated α-tubulin was detected in cell lysate in response to treatment with TubA. Moreover, the study demonstrated that acetylation tissue levels from Gars<sup>C201R/+</sup> mice were significantly decreased relative to sciatic nerve tissues. Also, mitochondrial transport was impaired in DRG cultures from Gars<sup>C201R/+</sup> mice. TubA was intraperitoneally administered to Gars<sup>C201R/+</sup> mice; subsequently, motor behavior and parameters related to nerve conduction were assessed, thus demonstrating the beneficial effects of drug treatment in mutant mice.</div><div class="NLM_p last">Analogously to what described for RTT, ex vivo cellular models of disease based on patient-derived iPSCs provide powerful approaches for the dissection of the molecular underpinnings of CMT disease biology. In a study conducted by Kim and collaborators with iPSCs from CMT disease 2F (CMT2F) and distal hereditary motor neuropathy 2B (dHMN2B) carrying heat shock 27 kDa protein 1 (HSPB1).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The mutant cell lines showed decreased levels of acetylated α-tubulin and relevant deficits in the axonal movement of mitochondria. Two novel HDAC6 inhibitors were employed in the study. Both the assayed inhibitors were able to increase the acetylation level of α-tubulin and to rescue the impairment of axonal mitochondrial trafficking.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">5.  HDAC6 and Inherited Retinal Diseases (IRDs)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">IRDs are a group of pathologies featuring a progressive retinal degeneration.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In most cases, mutations of genes expressed either in the photoreceptor cells (rod or cones) or in retinal pigment epithelium are involved.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> These mutations cause alterations in the correct functioning of photoreceptors leading to slow and progressive degeneration of the retina with consequent blindness. In retinitis pigmentosa (RP), mutations mainly occur at rod photoreceptors, followed by secondary cone photoreceptors damage. In diseases such as Best’s and Stargardt’s disease, dystrophies of the cone photoreceptors are involved.</div><div class="NLM_p">Activation of HDACs in animal models of IRDs was documented.<a onclick="showRef(event, 'ref137 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref137 ref138 ref139">(137−139)</a> In preclinical rodent models of both rod and cone photoreceptors degeneration, class I/II HDAC inhibition was demonstrated to have a protective effect against photoreceptors degeneration even though no data were initially presented regarding specific HDAC subtype involvement.<a onclick="showRef(event, 'ref138 ref140'); return false;" href="javascript:void(0);" class="ref ref138 ref140">(138,140)</a> Among the RP murine models available, the <i>retinal degeneration 1</i>-(<i>rd1</i>) mouse model, the first mouse model of retinal degeneration initially referred to as the rodless mouse, carries a mutation in the gene encoding for the rod photoreceptor cGMP phosphodiesterase-6 (<i>pde6</i>), causing an increase in cGMP levels and oxidative stress.<a onclick="showRef(event, 'ref141 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref141 ref142 ref143">(141−143)</a> An increased HDAC activity in <i>rd1</i> mutated photoreceptors, with resulting acetylation/deacetylation imbalance could be involved in their degeneration.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Inhibition of HDAC activity by TSA or scriptaid (<b>14</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) resulted in a neuroprotective effect to <i>rd1</i> mutated photoreceptors and retinal explant cultures. Using the <i>rd10</i> mouse model in which rod cell death is ascribable to a mutation in the rod-specific <i>Pde6b</i> gene, Trifunovic et al.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> demonstrated that <i>rd10</i> cultures treated with 10 μM SAHA every other day for 14 days showed a 5-fold increase of surviving <i>rd10</i> mutant photoreceptors. The cone-photoreceptor-function-loss-1 (<i>cpfl1</i>) mouse model presents a mutation in the cone-specific <i>Pde6c</i> gene causing an early onset (postnatal day 14, PN14) and fast (peak of cell death at PN24) loss of cones. Using this model, Trifunovic et al. demonstrated that both at PN14 and at PN24 <i>cpfl1</i> cone photoreceptors show increased HDAC activity.<a onclick="showRef(event, 'ref137 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref137 ref144 ref145">(137,144,145)</a> Treatment of cultured <i>cpfl1</i> retina cells explanted at PN14 with TSA (10 nM) every second day until PN24 resulted in an increase of surviving cones with respect to untreated control.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Also, in vivo intravitreal injection of TSA was shown to protect degenerating cones. Because <i>cpfl1</i> retina displays an aberrant cone positioning, treatment with TSA improved the altered cone migration.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> In 2011, Clemson et al.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> reported a study on the off-label use of VPA<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> for the treatment of RP. Enhanced visual field and acuity and deferred vision loss were reported, posing the basis for subsequent approval of a randomized, placebo-controlled trial for the treatment of autosomal dominant RP. However, the original study was subject to criticism due to problems related to experimental design and results analysis.<a onclick="showRef(event, 'ref146 ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref146 ref148 ref149 ref150">(146,148−150)</a> Another study with longer patient follow up, involving patients with several retinal dystrophies, showed no benefits of VPA treatment and highlighted adverse effects of the drug.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Moreover, VPA was demonstrated to have a beneficial effect in an in vitro model characterized by P23H mutation of rhodopsin, while it had a detrimental effect on the degeneration of the retina in the T17 M model of RP, this latter effect seemingly due to inhibition of HDAC.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">The role of HDAC6 in retinal degeneration was specifically investigated by Leyk et al.,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> who demonstrated that mouse-derived cone-like 661W cells do express HDAC6 and that the enzyme is active in that model because treatment with specific inhibitors led to α-tubulin hyperacetylation. Inhibition of HDAC6 protected the cells from oxidative stress induced by H<sub>2</sub>O<sub>2</sub>. In vivo studies were conducted on the dye<sup><i>ucd6</i></sup> zebrafish model, displaying defective visual behavior and retinal morphology. HDAC6 inhibitors induced an increase in eye saccades on treated dye larvae and enhanced locomotor activity in response to light as assessed in the visual-motor response assay. Investigation of the molecular basis of the observed protection highlighted a significant upregulation of HSP25 and HSP70 in 661W cells upon treatment. However, other experiments highlighted that this effect alone could not fully explain the protective effect of TubA. Further investigations were performed on Prx1, an enzyme involved in the detoxification of H<sub>2</sub>O<sub>2</sub>, which is overoxidized and inactivated under oxidative stress conditions and a known substrate of HDAC6. Pretreatment with an HDAC6 inhibitor reduced the levels of PrxSO2/3 (the inactivated form of Prx1) with respect to H<sub>2</sub>O<sub>2</sub>-treated controls, so its effect could be mediated by regulation of Prx1 activity. Actually, it is known that Prx1 reducing activity is also controlled by HDAC6-mediated post-translational acetylation.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">Consequently, HDAC6 inhibition has a significant protective role from oxidative stress-induced injuries and this is particularly important for photoreceptors and retinal cells which are exposed to high concentrations of reactive oxygen species (ROS).</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">6.  HDAC6 and Idiopathic Pulmonary Fibrosis (IPF)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">IPF is a chronic, progressive interstitial lung disease (ILD) with indefinite etiology and characterized with a poor prognosis. Pathological hallmarks of IPF are fibroblast activation which implies aberrant proliferation, myofibroblast transformation, tissue invasiveness, and extracellular matrix production.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Epidemiological data indicate that the incidence of IPF in Europe and North America ranges between 2.8 and 18 cases per 100000 people per year with possibly lower numbers in Asia and South America (from 0.5 to 4.2 cases per 100000 individuals per year) with an average life expectancy from diagnosis of 2–4 years (the median age at diagnosis is usually around 65 years).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div><div class="NLM_p">Despite the recent introduction in the therapy of nintedanib<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> (a tyrosine kinase inhibitor) and pirfenidone<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> (an antifibrotic and anti-inflammatory agent acting, with a not fully elucidated mechanism of action yet), the IPF medical need is high. Hence, research is ongoing in the quest for new therapeutic options and to glean novel insights toward innovative and druggable targets for the therapy of this life-threatening disease. The mechanisms relevant for IPF pathogenesis have not been fully elucidated, however, they may offer a glimpse in the therapeutic targeting of the disease.</div><div class="NLM_p">In the context of epigenetic targets, the involvement of HDACs in IPF has been proved by a limited number of seminal studies. Deacetylation of nonhistone proteins controls several key cellular processes (cell signaling, motility, survival, protein degradation, and inflammation) and, as pointed out by some recent research reports, also plays a pivotal role in fibrotic degeneration.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><div class="NLM_p">Fibrosis results from an overgrowth of various tissues, an increased number of myofibroblasts, and is accompanied by an abnormal deposition of extracellular matrix components. EMT is a key process in IPF. It is known that in lung fibrogenesis a relevant number of myofibroblasts can generate via EMT, starting from the resident epithelial cells. EMT is highly stimulated by TGF-β1. In 2008, Shan and colleagues explored the molecular pathways underlying TGF-β1-induced EMT and proposed HDAC6 as a novel regulating factor for TGF-β1-induced EMT.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Accordingly, the HDAC6 inhibitor tubacin decreased the expression and generation of TGF-β1-induced EMT markers (namely epithelial and mesenchymal peptides, and stress fibers) to the same extent as that produced by small interfering RNA. A cross-talk between HDAC6 and SMAD3 was also evidenced in TGF-β1-induced EMT. Shortly after, Wang and co-workers confirmed the therapeutic benefits associated to the use of HDAC inhibitors in IPF by applying the HDAC pan-inhibitor SAHA.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> This latter compound impaired TGF-β1-induced fibroblast-myofibroblast differentiation and inhibited fibroblast proliferation. Later, a crucial role of HDAC4 in TGF-β1-stimulated trans-differentiation of lung fibroblasts via a mechanism regulating Akt phosphorylation was demonstrated. However, in this mechanism, a possible cooperation of HDAC4 with other HDACs could not be ruled out.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">As opposed to the role of TGF-β1, that acts as a profibrotic mediator, the prostaglandin E2 (PGE<sub>2</sub>) acts as antifibrotic mediator in IPF. PGE<sub>2</sub> is produced via the cyclooxygenase (COX) pathway. Of the two COX isoforms (COX-1 and COX-2), COX-2 is inducible by inflammatory stimuli including TGF-β1. Interestingly, Coward and colleagues found lower COX-2 mRNA levels in fibroblasts from IPF patients and described an epigenetic aberration leading to deregulated gene expression in IPF.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> They demonstrated that reduced COX-2 expression in IPF is due to histone hypoacetylation. Accordingly, when fibroblasts from IPF patients underwent treatment with SAHA or panobinostat, histone H3 and H4 acetylation levels were increased, thus ultimately restoring cytokine-induced COX-2 mRNA and protein expression. In 2010, the same team, by capitalizing the data from the previous study, completed a new investigation focusing on angiogenesis in IPF.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Their working hypothesis was that an aberrant angiogenesis supporting tissue remodelling might contribute to IPF pathogenesis in similar fashion to that observed in tumorigenesis. In particular, the authors observed that the angiostatic chemokine gamma interferon (IFN-γ)-inducible protein of 10 kDa (IP-10), that acts as an antifibrotic by modulating fibroblast migration and proliferation, is repressed in IPF fibroblasts. They observed that interplay between histone deacetylation and hypermethylation is accountable for the decreased expression of IP-10. To confirm this hypothesis, treatment with the pan-HDAC inhibitor panobinostat, or with a G9a inhibitor, restored IP-10 mRNA and protein expression in fibroblasts from IPF patients. However, the detailed mechanisms underlying restoration of IP-10 gene expression induced by HDAC inhibitors require further investigation.</div><div class="NLM_p">More recently, SAHA has been shown to induce apoptosis of IPF myofibroblasts through upregulation of the pro-apoptotic gene Bak and parallel downregulation of the antiapoptotic gene Bcl-xL.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Because in fibroproliferative diseases, such as IPF, are characterized by resistance to apoptosis, the epigenetic pathways accountable for the reduced expression of Fas, a cell surface death receptor decreased in IPF, were further explored.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Reduced Fas expression and resistance to Fas-mediated apoptosis were registered in fibroblasts deriving from bleomycin-treated mice. Also, reduced histone acetylation and augmented histone H3 lysine 9 trimethylation (H3K9Me3) levels were detected in the Fas promoter in the same cell type. These events were related to HDAC2 and HDAC4 overexpression. Accordingly, treatment with HDAC pan-inhibitors enhanced Fas expression and reestablished susceptibility to Fas-mediated apoptosis.</div><div class="NLM_p">Further insights on the role of HDACs in IPF were recently provided. Korfei demonstrated an abnormal overexpression of HDAC enzymes in basal cells of IPF lungs and how it contributes to the bronchodilation process.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> These studies led to the conclusion that the enhanced activity of HDACs mediates the formation and apoptosis resistance of IPF fibroblasts.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> This pioneering study also provided evidence that panobinostat was able to downregulate the biosynthesis of collagen I and antiapoptotic genes in IPF fibroblasts, thus correcting their profibrotic and “malignant” phenotype. Although no hints on differential involvement of HDAC isoforms in IPF were provided, it was ascertained that pan-HDAC inhibition may represent a valuable treatment option for IPF patients. In fact, by a comparative analysis with pirfenidone, they observed a higher efficacy of panobinostat in reducing the profibrotic phenotypes of the IPF fibroblasts while inducing cell cycle arrest and apoptosis.</div><div class="NLM_p">On these premises, a series of pan-HDAC inhibitors were then tested on a variety of cell and animal models by other research groups. Recently, Davies tested Spiruchostatin A (<b>15</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), a cysteine-containing depsipeptide binding HDAC6, in primary fibroblasts from lung biopsy explants of IPF patients.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> The compound was able to decrease the aberrant cell proliferation of IPF already in the nanomolar range. Notably, the effective dose of <b>15</b> was significantly lower than that of either inhibitor TSA<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> or SAHA<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> as seen from previous studies, with a markedly longer duration of action.</div><div class="NLM_p">The antifibrotic efficacy of romidepsin was investigated in vitro and in vivo.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The efficacy of the tested compound in inhibiting fibroblast proliferation was established with no adverse effects on alveolar type II cells, where HDAC6 is predominantly overexpressed in IPF.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> When tested in vivo, in a rodent bleomycin model of IPF, romidepsin inhibited fibrosis. Notably, this effect was paralleled by suppression of lysyl oxidase (LOX) expression, taken as a companion biomarker of the activity of the inhibitor. LOX was identified as a valuable biomarker as its activity has strong connections with organ fibrosis. In fact, LOX is induced by the profibrotic factor TGF-β1, which is in turn strongly related to HDAC6-mediated α-tubulin deacetylation responsible for the increase of EMT markers in lung epithelial cells. Therefore, romidepsin may counteract IPF fibrosis targeting multiple pathways.</div><div class="NLM_p">More recently, it was proved that HDAC inhibitors modulate exchange factor found in platelets, leukemic, and neuronal tissues (XPLN) expression and affects secreted protein acidic and rich in cysteine (SPARC) expression in human lung fibroblasts.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> SPARC contributes to the deposition and turnover of the extracellular matrix, controlled by TGF-β1 by activation of mammalian target of rapamycin complex 2 (mTORC2) which is modulated by XPLN. Fibroblasts were treated with TGF-β1 and HDAC inhibitors entinostat (<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), or SAHA, to evaluate their influence on XPLN expression and demonstrated that (i) the HDAC inhibitors dose-dependently up-regulated XPLN mRNA, and (ii) TGF-β1-induced SPARC expression was counteracted upon exposure to entinostat. By seminal studies, the role of XPLN in the regulation of SPARC was demonstrated, indicating that the up-regulation of XPLN induced by HDAC inhibitors may represent a useful therapeutic strategy for IPF patients. Once the role of HDACs was established in IPF, the involvement of specific HDAC isoforms was further and widely investigated in the very recent years.</div><div class="NLM_p">Saito and colleagues addressed the relevance of selectively targeting HDAC6 for the treatment of IPF.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Interestingly, HDAC6 expression in lung tissue homogenates derived from patients affected or not from IPF was examined and an aberrant HDAC6 expression in IPF lungs was observed. In fact, inhibition of HDAC6 can alter the activity and fate of several proteins and implication of HDAC6 in TGF-β1-induced EMT and Akt signaling pathways (in fact TGF-β1 prompts myofibroblast differentiation by activation of SMAD3 and Akt signaling pathways) was confirmed. In these studies, HDAC6 inhibitors ricolinostat, TubA, tubacin, and <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were tested. TubA was the only inhibitor that, when tested in the bleomycin murine model of IPF, significantly inhibited TGF-β1-mediated type-1 collagen expression by reduction of Akt phosphorylation and regulation of downstream pathways such as HIF-1α-VEGF axis and autophagy (as noted by the decreased levels of the marker LC3B-II). These data indicate HDAC6 inhibitor-treated wild-type mice were protected against bleomycin-induced fibrosis, but HDAC6 knockout mice were not.</div><div class="NLM_p">Further support to the role of acetylated α-tubulin in fibrotic degeneration as a marker of EMT and of HDAC6 as a key regulator of the EMT process in IPF has been provided.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> The effectiveness of tubacin was demonstrated in restoring acetylated α-tubulin levels and consequently blocking EMT. In particular, it was confirmed that (i) acetylated α-tubulin levels are reduced during TGF-β-induced EMT, (ii) loss of acetylated α-tubulin is a common feature in fibrotic cells during EMT, (iii) high levels of acetylated α-tubulin block EMT, (iv) TGF-β1 prompts HDAC6 activity, and (v) increased expression of HDAC6 induces EMT in fibrotic cells.</div><div class="NLM_p">Beyond the traditional bleomycin mouse model for the in vivo validation of antifibrotic approaches in IPF, a very recent ex vivo model of human lung fibrogenesis has emerged. This model recapitulates TGF-β1-mediated events stimulating fibrosis in IPF. By preserving the multifaceted cell–cell and cell–matrix interplay found in human tissues, this model may be of extreme utility to accurately predict drug efficacy, thus accelerating drug discovery track in IPF, also with reference to HDAC inhibitors.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></div><div class="NLM_p">In a very recent report, Lou and colleagues applied a drug repurposing approach to HDAC inhibitors to treat IPF and acute lung injury (ALI).<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Their working hypothesis was based on the evidence that both diseases are characterized by neutrophilic inflammation and that blockade of this event might represent a valuable treatment strategy for both ALI and IPF. In this context, among several chemotactic agents, leukotriene B4 (LTB4) represents the main player. In fact, it was noted that levels of this lipid mediator were persistently elevated in broncho-alveolar lavage fluid (BALF) in ALI models and in BALF from IPF patients. Furthermore, the levels of LTB4 well correlate with the degree of fibrotic degeneration in tissues. On this basis, the authors propose that blockade of LTB4 biosynthesis by inhibiting leukotriene A4 hydrolase (LTA4H) would lower inflammation, thus providing an alternative therapeutic approach in IPF or ALI. In their repurposing approach, the authors involved 18 HDAC pan-inhibitors. After enzymatic tests, thermofluor assays, and X-ray analysis, they selected SAHA and its analogue <b>18</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) as effective inhibitors of LTA4H. They observed that SAHA repressed neutrophils infiltration and LTB4 biosynthesis in murine models of both ALI and IPF. Compound <b>18</b> performed better than SAHA in the same models. Although they concluded that HDAC and LTA4H dual inhibitors display higher efficacy with respect to an inhibitor specifically targeting HDACs, we may argue that the engaged compounds hit too many targets for being used as useful pharmacological tools for the study of an innovative mechanism of action.</div><div class="NLM_p last">In general, pan-HDAC inhibitors proved their effectiveness for the potential treatment of IPF. However, as isoform selectivity may imply a low attrition rate in the process of drug development, the identification of subtype-selective compounds may be preferred. In this context, the above literature reports support the predominant role of HDAC6 in EMT and validate this enzyme isoform as an innovative target for a ground-breaking targeted approach in IPF therapy.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">7.  Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many research efforts in the past two decades have been devoted to the identification of relevant epigenetic therapeutic targets in cancer and to the design of epigenetic therapies effective in tackling crucial oncological pathways. More recently, growing evidence indicates that epigenetic pathways are pertinent to many other nononcological diseases, particularly rare diseases.</div><div class="NLM_p">Rare diseases represent an unmet medical need due to their low prevalence, which in turn leads to poor interest from both academia and industry in the development of specific therapies. Moreover, the patients diagnosed with rare diseases encounter unique challenges that initiate with lengthy diagnosis times, as many health care experts have limited experience in identifying rare diseases and may miss the initial symptoms. In addition, the scarce availability of suitable disease models has dissuaded focused efforts to address this imminent challenge. The past few years have represented a phase of hope for patients, with increased scientific awareness toward rare disease therapeutics. Accordingly, researchers in academia and pharma are actively collaborating to leverage new technologies and scientific knowledge on these diseases for developing therapies. Such efforts have received impetus from the successful completion of the Human Genome Project in 2003 and from the progress in proteomics and next-generation sequencing. However, the identified targets from such techniques have yet to be validated as “druggable”. Unfortunately, this process usually narrows down the availability of suitable drug targets to an abysmally low number. Besides this, a continuous struggle in the quest for highly specific disease biomarkers for effective targeted therapy approaches has proved to be an existential issue.</div><div class="NLM_p">The recent progress in (epi)genomics and proteomics has enabled to clearly unveil the molecular underpinnings responsible for disease initiation and progress. A number of rare diseases involve epigenetically regulated genes or other epigenetic components. While genetic mutations are infrequent, epigenetic modifications are very common. Therefore, the interplay between genetics and epigenetics plays a crucial role when considering the etiologic factors in some of these diseases. A very representative example is the RTT, which is caused by mutations of genes related to DNA methylation (namely mutations in the methyl-binding domain protein MeCP2). This genetic mutation is flanked by a series of epigenetic changes which strongly contribute to the disease phenotypic manifestations. In this context, HDAC enzymes have emerged as a central player in regulating pathophysiological mechanisms involved in specific rare diseases. HDAC6 stands out as a unique deacetylase isoform owing to its distinctive structure, domain organization, and its cytoplasmic localization. The upregulation of HDAC6 levels has been confirmed in rare diseases such as RTT and IPF among others. This evidence, coupled with the direct involvement of HDAC6 substrates found in disease models, strongly supports the investigation of HDAC6 as an innovative and disease-modifying target in the treatment of such disorders. Both HDAC pan-inhibitors and HDAC6 partially selective modulators have been investigated in recent years in cell- and animal-based models of rare diseases such as RTT, IPF, CMT, and IRDs. We have herein described these approaches and showed that HDAC6 inhibition provided in many cases a robust proof-of-concept as a novel therapeutic option for these pathologies.</div><div class="NLM_p">Another recent advancement has been represented by the advent of novel and more reliable disease models (also with respect to rare diseases) employing the technology associated with iPSCs. These cells have a special resemblance with human tissues, thus providing highly reliable results and enhancing the successful translation of preclinical candidates into clinical studies. On the other hand, most of the approved HDAC inhibitors possess a low degree of selectivity for HDAC6 and are not useful to dissect the role of this specific isoform in these rare diseases and cannot be considered therapeutic options for treating these patients.</div><div class="NLM_p">The X-ray cocrystal structures with several HDAC6 inhibitors allowed more powerful and reliable structure-based design strategies, which led to conceiving selective HDAC6 inhibitors. However, medicinal chemists are still called to invest more efforts in the fine-tuning of the drug discovery trajectory toward selective HDAC6 inhibitors, also endowed with a favorable drug-like profile.</div><div class="NLM_p last">In conclusion, it is conceivable that, in the new era of personalized medicine, epigenetic research involving HDAC(6) modulators, as well as modulators of other specific epigenetic targets, will lead scientists in the direction of developing individualized therapies in the area of rare diseases, in resemblance to what is being promised by personalized genomic-based medicine in other diseases such as cancer.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00924" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Campiani</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, Department of Excellence
2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5295-9529" title="Orcid link">http://orcid.org/0000-0001-5295-9529</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cdaeaca0bda4aca3a48db8a3a4bea4e3a4b9"><span class="__cf_email__" data-cfemail="c1a2a0acb1a8a0afa881b4afa8b2a8efa8b5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margherita Brindisi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Department of Excellence 2018−2022, University of Naples Federico II, Via D. Montesano 49, I-80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9119-3773" title="Orcid link">http://orcid.org/0000-0001-9119-3773</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">A. Prasanth Saraswati</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, Department of Excellence
2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Brogi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Pisa, via Bonanno 6, 56126, Pisa, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9375-6242" title="Orcid link">http://orcid.org/0000-0001-9375-6242</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Gemma</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, Department of Excellence
2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8313-2417" title="Orcid link">http://orcid.org/0000-0002-8313-2417</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Butini</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, Department of Excellence
2018−2022, University of Siena, via Aldo Moro 2, 53100, Siena, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8471-0880" title="Orcid link">http://orcid.org/0000-0002-8471-0880</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Margherita Brindisi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1845-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Margherita Brindisi</b> graduated cum laude from the University of Siena, where she also received her Ph.D. in Pharmaceutical Sciences in 2008. In 2010–2011, she worked as a postdoctoral fellow at Purdue University on the development of aspartyl protease inhibitors under the supervision of Prof. Arun Ghosh. From 2012 to 2015. she was appointed as fixed-term Researcher at the Department of Biotechnology, Chemistry. and Pharmacy, University of Siena, where she worked in the group of Prof. Giuseppe Campiani on the development of novel treatments for cancer, parasitic diseases, and brain disorders. In 2016–2017. she again moved to Purdue University as a Temporary Researcher. Dr Brindisi currently holds a position as Assistant Professor at the Department of Excellence of Pharmacy at the University of Naples Federico II.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">A. Prasanth Saraswati</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1850-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>A. Prasanth Saraswati</b> obtained his Bachelor in Pharmacy from M.S. Ramaiah College of Pharmacy, Bengaluru, in 2009, and later on obtained his Master’s in Medicinal Chemistry in 2013 from the National Institute of Pharmaceutical Education and Research, Hyderabad, under the supervision of Ahmed Kamal. He is presently pursuing his Ph.D. in Pharmaceutical Sciences at the University of Siena, Italy, as a Marie Curie Early Stage Researcher, mentored by Giuseppe Campiani and Stefania Butini. His research activities encompass the development of novel anticancer agents, including compounds acting through epigenetic mechanism of action, with a special focus on novel therapeutic options for oral squamous cell carcinoma.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Simone Brogi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1855-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Simone Brogi</b> is an Assistant Professor at the Department of Pharmacy at University of Pisa. He graduated in 2005 in Biological Sciences from the University of Siena, where he also received his Ph.D. in Pharmaceutical Sciences in 2010. From 2011–2019 he has directed the Molecular Modeling Unit at the Department of Biotechnology, Chemistry and Pharmacy (University of Siena) in the research group of Prof. Giuseppe Campiani. His research activity, described in over 65 papers, is focused on computational approaches for the discovery and optimization of small molecules with therapeutic potential for treating cancer and pain, neurodegenerative, cardiovascular, and parasitic diseases. Actually, he is the head of in silico pharmacology and toxicology unit at University of Pisa in the research group of Prof. Vincenzo Calderone.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Sandra Gemma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1860-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sandra Gemma</b> is an Associate Professor of Medicinal Chemistry at the University of Siena. She graduated in Chemical and Pharmaceutical Sciences at the University of Siena in 1998, where she also received her Ph.D. degree (2003). She was a postdoctoral fellow at the Department of Chemistry at the University of Illinois at Chicago in the research group of Prof. Arun K. Ghosh. She also visited the Department of Chemistry at Purdue University as a research assistant in the Ghosh group. Her research activity is currently focused on the structure- and ligand-based design and synthesis of therapeutic agents, comprising anti-infective and antiparasitic compounds, anticancer agents, and compounds active at the central nervous system. She has authored more than 100 papers in these fields.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Stefania Butini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1865-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stefania Butini</b> is an Associate Professor of Medicinal Chemistry at the University of Siena. She graduated from the University of Siena in 1997 and obtained her Ph.D. in pharmaceutical sciences in 2000. From 1999 to 2000, she interned at the University of Groningen, Netherlands, working on the development of novel agents for the treatment of Parkinson’s disease under the supervision of H. W. Wikström. In 2004, she was appointed as senior researcher at the University of Siena. Her research activity (reported in more than 110 manuscripts) includes target selection, rational design of innovative drugs, the development of new synthetic methodologies, and structure–activity relationship studies, with a main focus on CNS diseases, and antiparasitic and antitumor agents.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Giuseppe Campiani</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=BIO-d7e1870-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giuseppe Campiani</b> is a full professor of Medicinal Chemistry at Siena University. After his Ph.D. in Pharmaceutical Sciences, Giuseppe Campiani carried out postdoctoral research at Mayo Clinic Jacksonville in the group directed by Prof. Alan Kozikowski and at Columbia University in New York City working in the Koji Nakanishi’s research group. He was also appointed as visiting professor at Trinity College Dublin. Giuseppe Campiani is presently leading a drug discovery research group at the Department of Excellence of Biotechnology, Chemistry, and Pharmacy of Siena University. His broad interest in medicinal chemistry and drug discovery encompasses the development of modulators of epigenetic targets and the discovery of biologically active compounds to combat rare diseases, cancer, neuropsychiatric and neurodegenerative disorders, and infectious diseases.</p></figure></div><div class="ack" id="ACK-d7e1841-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge MIUR Grant Dipartimento di Eccellenza 2018–2022 (l. 232/2016) to the Department of Biotechnology, Chemistry and Pharmacy, University of Siena, and the Department of Pharmacy, University of Naples Federico II.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ALI</td><td class="NLM_def"><p class="first last">acute lung injury</p></td></tr><tr><td class="NLM_term">BALF</td><td class="NLM_def"><p class="first last">broncho-alveolar lavage fluid</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">BDNG-YFP</td><td class="NLM_def"><p class="first last">BDNF tagged with a yellow fluorescent protein</p></td></tr><tr><td class="NLM_term">CMT</td><td class="NLM_def"><p class="first last">Charcot–Marie–Tooth disease</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COX</td><td class="NLM_def"><p class="first last">cyclooxygenase</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribnucleic acid</p></td></tr><tr><td class="NLM_term">dHMN2B</td><td class="NLM_def"><p class="first last">distal hereditary motor neuropathy 2B</p></td></tr><tr><td class="NLM_term">DNMT</td><td class="NLM_def"><p class="first last">DNA methyltransferase</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial–mesenchymal transition</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">GlyRS</td><td class="NLM_def"><p class="first last">glycyl-tRNA synthetase</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glucocorticoid receptor</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HMN</td><td class="NLM_def"><p class="first last">hereditary motor neuropathies</p></td></tr><tr><td class="NLM_term">HSF1</td><td class="NLM_def"><p class="first last">heat shock transcription factor 1</p></td></tr><tr><td class="NLM_term">HSPB1</td><td class="NLM_def"><p class="first last">heat-shock protein B1</p></td></tr><tr><td class="NLM_term">HSP90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">IFN-γ</td><td class="NLM_def"><p class="first last">gamma interferon</p></td></tr><tr><td class="NLM_term">ILD</td><td class="NLM_def"><p class="first last">interstitial lung disease</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">iPSCs</td><td class="NLM_def"><p class="first last">pluripotent stem cells</p></td></tr><tr><td class="NLM_term">IRDs</td><td class="NLM_def"><p class="first last">inherited retinal disorders</p></td></tr><tr><td class="NLM_term">JIP1</td><td class="NLM_def"><p class="first last">JNK-interacting protein 1</p></td></tr><tr><td class="NLM_term">KATs</td><td class="NLM_def"><p class="first last">lysine acetyltransferases</p></td></tr><tr><td class="NLM_term">LOX</td><td class="NLM_def"><p class="first last">lysyl oxidase</p></td></tr><tr><td class="NLM_term">LTB4</td><td class="NLM_def"><p class="first last">leukotriene B4</p></td></tr><tr><td class="NLM_term">MeCP2</td><td class="NLM_def"><p class="first last">X-linked methyl-CpG-binding protein 2</p></td></tr><tr><td class="NLM_term">ncRNA</td><td class="NLM_def"><p class="first last">noncoding RNA</p></td></tr><tr><td class="NLM_term">NES</td><td class="NLM_def"><p class="first last">nuclear export signal</p></td></tr><tr><td class="NLM_term">NTG</td><td class="NLM_def"><p class="first last">nontransgenic mice</p></td></tr><tr><td class="NLM_term">PLAP</td><td class="NLM_def"><p class="first last">phospholipase A2 inactivating protein</p></td></tr><tr><td class="NLM_term">PTMs</td><td class="NLM_def"><p class="first last">post-translational modifications</p></td></tr><tr><td class="NLM_term">Prx</td><td class="NLM_def"><p class="first last">peroxiredoxin I</p></td></tr><tr><td class="NLM_term">p97/VCP</td><td class="NLM_def"><p class="first last">p97/valosin containing protein</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">retinitis pigmentosa</p></td></tr><tr><td class="NLM_term">RTT</td><td class="NLM_def"><p class="first last">Rett syndrome</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr><tr><td class="NLM_term">SIRT</td><td class="NLM_def"><p class="first last">sirtuin</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">transforming growth factor-β</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">trichostatin A</p></td></tr><tr><td class="NLM_term">Tub A</td><td class="NLM_def"><p class="first last">tubastatin A</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">VIPN</td><td class="NLM_def"><p class="first last">vincristine-induced peripheral neuropathies</p></td></tr><tr><td class="NLM_term">VPA</td><td class="NLM_def"><p class="first last">valproic acid</p></td></tr><tr><td class="NLM_term">UBPs</td><td class="NLM_def"><p class="first last">ubiquitin-specific proteases</p></td></tr><tr><td class="NLM_term">ZnF-UBP</td><td class="NLM_def"><p class="first last">ubiquitin C-terminus hydrolase-like zinc finger</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 175 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crick, F. H.</span></span> <span> </span><span class="NLM_article-title">Molecular structure of nucleic acids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/171737a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F171737a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=13054692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaG2cXivVGktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=737-738&author=J.+D.+Watsonauthor=F.+H.+Crick&title=Molecular+structure+of+nucleic+acids&doi=10.1038%2F171737a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure of nucleic acids. A structure for deoxyribose nucleic acid</span></div><div class="casAuthors">Watson, J. D.; Crick, F. H. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">737-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">W. and C. propose a new structure for the Na salt of deoxyribose nucleic acid.  This structure, which loosely resembles Furberg's model No. 1 (C.A. 47, 9924g), has 2 helical polynucleotide chains each coiled around the same axis but whose sequence of atoms runs in opposite directions.  The chains are held together by H-bonding between purine and pyrimidine bases, a purine of 1 chain bonded to a pyrimidine of the other.  Full details will be published elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphu-DopoWzBrVg90H21EOLACvtfcHk0lh1mhJfqChCZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXivVGktA%253D%253D&md5=66b78cf4b12c8c5ced56ff75a9468f35</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F171737a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F171737a0%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DCrick%26aufirst%3DF.%2BH.%26atitle%3DMolecular%2520structure%2520of%2520nucleic%2520acids%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D737%26epage%3D738%26doi%3D10.1038%2F171737a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crick, F.</span></span> <span> </span><span class="NLM_article-title">Central dogma of molecular biology</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">561</span>, <span class="refDoi"> DOI: 10.1038/227561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F227561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=4913914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaE3cXltVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1970&pages=561&author=F.+Crick&title=Central+dogma+of+molecular+biology&doi=10.1038%2F227561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Central dogma of molecular biology</span></div><div class="casAuthors">Crick, Francis H. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">5258</span>),
    <span class="NLM_cas:pages">561-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The history of the central dogma of mol. biol., which states that residue-by-residue transfer of sequential information cannot occur from protein to protein or to nucleic acid, is presented; and the 9 possible transfers are tentatively regrouped into 3 classes:  general, special, and unknown transfers (those postulated by the central dogma).  The general transfers, DNA → DNA (the arrow represents directional flow of detailed sequence information), DNA → RNA, and RNA → protein, are those that can occur in all cells.  Special transfers, RNA → RNA, RNA → DNA, and DNA → protein, may occur in special circumstances.  Unknown transfers, protein → protein, protein → DNA, protein → RNA, the central dogma postulates, never occur.  The current validity of the central dogma is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyCHO3CXZWbVg90H21EOLACvtfcHk0liRW6qqkBZbJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXltVGgtLw%253D&md5=ed1c1371c5593a29eaab6937a9338f96</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F227561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F227561a0%26sid%3Dliteratum%253Aachs%26aulast%3DCrick%26aufirst%3DF.%26atitle%3DCentral%2520dogma%2520of%2520molecular%2520biology%26jtitle%3DNature%26date%3D1970%26volume%3D227%26spage%3D561%26doi%3D10.1038%2F227561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waddington, C. H.</span></span> <span> </span><span class="NLM_article-title">The epigenotype</span>. <i>Endeavour</i> <span class="NLM_year" style="font-weight: bold;">1942</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1942&pages=18-20&author=C.+H.+Waddington&title=The+epigenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaddington%26aufirst%3DC.%2BH.%26atitle%3DThe%2520epigenotype%26jtitle%3DEndeavour%26date%3D1942%26volume%3D1%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenuwein, T.</span></span> <span> </span><span class="NLM_article-title">The molecular hallmarks of epigenetic control</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">487</span>, <span class="refDoi"> DOI: 10.1038/nrg.2016.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrg.2016.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27346641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGiur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=487&author=C.+D.+Allisauthor=T.+Jenuwein&title=The+molecular+hallmarks+of+epigenetic+control&doi=10.1038%2Fnrg.2016.59"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular hallmarks of epigenetic control</span></div><div class="casAuthors">Allis, C. David; Jenuwein, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">487-500</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Over the past 20 years, breakthrough discoveries of chromatin-modifying enzymes and assocd. mechanisms that alter chromatin in response to physiol. or pathol. signals have transformed our knowledge of epigenetics from a collection of curious biol. phenomena to a functionally dissected research field.  Here, we provide a personal perspective on the development of epigenetics, from its historical origins to what we define as 'the modern era of epigenetic research'.  We primarily highlight key mol. mechanisms of and conceptual advances in epigenetic control that have changed our understanding of normal and perturbed development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Q3sD-IHiK7Vg90H21EOLACvtfcHk0liRW6qqkBZbJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGiur%252FJ&md5=dbbff4b5de8a0316f16664f73f3ad16d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrg.2016.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg.2016.59%26sid%3Dliteratum%253Aachs%26aulast%3DAllis%26aufirst%3DC.%2BD.%26aulast%3DJenuwein%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520hallmarks%2520of%2520epigenetic%2520control%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2016%26volume%3D17%26spage%3D487%26doi%3D10.1038%2Fnrg.2016.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span> <span> </span><span class="NLM_article-title">Mapping human epigenomes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24074860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFenu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=39-55&author=C.+M.+Riveraauthor=B.+Ren&title=Mapping+human+epigenomes&doi=10.1016%2Fj.cell.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping human epigenomes</span></div><div class="casAuthors">Rivera, Chloe M.; Ren, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  As the second dimension to the genome, the epigenome contains key information specific to every type of cells.  Thousands of human epigenome maps have been produced in recent years thanks to rapid development of high throughput epigenome mapping technologies.  In this review, we discuss the current epigenome mapping toolkit and utilities of epigenome maps.  We focus particularly on mapping of DNA methylation, chromatin modification state, and chromatin structures, and emphasize the use of epigenome maps to delineate human gene regulatory sequences and developmental programs.  We also provide a perspective on the progress of the epigenomics field and challenges ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriI0hyLI1-SLVg90H21EOLACvtfcHk0liRW6qqkBZbJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFenu7zM&md5=3bc3da71a7f0e29af650bed05c55151c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DC.%2BM.%26aulast%3DRen%26aufirst%3DB.%26atitle%3DMapping%2520human%2520epigenomes%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D39%26epage%3D55%26doi%3D10.1016%2Fj.cell.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mill, J.</span></span> <span> </span><span class="NLM_article-title">Toward an integrated genetic and epigenetic approach to Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2010.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neurobiolaging.2010.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21497948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlGjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1188-1191&author=J.+Mill&title=Toward+an+integrated+genetic+and+epigenetic+approach+to+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2010.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toward an integrated genetic and epigenetic approach to Alzheimer's disease</span></div><div class="casAuthors">Mill, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1188-1191</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Epigenetics is the study of mitotically heritable, but reversible, changes in gene expression brought about principally through alterations in DNA methylation and chromatin structure.  The comprehensive review by Mastroeni et al. (Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P., Rogers, J., 2010.  Epigenetic mechanisms in Alzheimer's disease.  Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.08.017) in this issue describes mounting evidence for an involvement of epigenetic alterations in the etiol. of Alzheimer's disease (AD), highlighting the potential of epigenomic approaches for uncovering novel mol. pathways involved in pathol.  Here, we briefly describe some methodol. issues related to epigenomic studies using postmortem brain tissue in Alzheimer's disease, and argue for an integrated genetic-epigenetic approach to disease etiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeRo28Vn9PtbVg90H21EOLACvtfcHk0lg_MspswWo1Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlGjt78%253D&md5=bc695601b1b18a9b90e0dce57ef6a309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMill%26aufirst%3DJ.%26atitle%3DToward%2520an%2520integrated%2520genetic%2520and%2520epigenetic%2520approach%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D1188%26epage%3D1191%26doi%3D10.1016%2Fj.neurobiolaging.2010.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestler-Parr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesoro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molsen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. A.</span></span> <span> </span><span class="NLM_article-title">Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group</span>. <i>Value Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1016/j.jval.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.jval.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26409619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283msVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=906-914&author=T.+Richterauthor=S.+Nestler-Parrauthor=R.+Babelaauthor=Z.+M.+Khanauthor=T.+Tesoroauthor=E.+Molsenauthor=D.+A.+Hughes&title=Rare+disease+terminology+and+definitions%E2%80%94a+systematic+global+review%3A+report+of+the+ISPOR+rare+disease+special+interest+group&doi=10.1016%2Fj.jval.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group</span></div><div class="casAuthors">Richter Trevor; Nestler-Parr Sandra; Babela Robert; Khan Zeba M; Tesoro Theresa; Molsen Elizabeth; Hughes Dyfrig A</div><div class="citationInfo"><span class="NLM_cas:title">Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">906-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  At present, there is no universal definition of rare disease.  OBJECTIVE:  To provide an overview of rare disease definitions currently used globally.  METHODS:  We systematically searched for definitions related to rare disease from organizations in 32 international jurisdictions.  Descriptive statistics of definitions were generated and prevalence thresholds were calculated.  RESULTS:  We identified 296 definitions from 1109 organizations.  The terms "rare disease(s)" and "orphan drug(s)" were used most frequently (38% and 27% of the definitions, respectively).  Qualitative descriptors such as "life-threatening" were used infrequently.  A prevalence threshold was specified in at least one definition in 88% of the jurisdictions.  The average prevalence threshold across organizations within individual jurisdictions ranged from 5 to 76 cases/100,000 people.  Most jurisdictions (66%) had an average prevalence threshold between 40 and 50 cases/100,000 people, with a global average of 40 cases/100,000 people.  Prevalence thresholds used by different organizations within individual jurisdictions varied substantially.  Across jurisdictions, umbrella patient organizations had the highest (most liberal) average prevalence threshold (47 cases/100,000 people), whereas private payers had the lowest threshold (18 cases/100,000 people).  CONCLUSIONS:  Despite variation in the terminology and prevalence thresholds used to define rare diseases among different jurisdictions and organizations, the terms "rare disease" and "orphan drug" are used most widely and the average prevalence threshold is between 40 and 50 cases/100,000 people.  These findings highlight the existing diversity among definitions of rare diseases, but suggest that any attempts to harmonize rare disease definitions should focus on standardizing objective criteria such as prevalence thresholds and avoid qualitative descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGgRGZSIdH-bGbPKh4T9eAfW6udTcc2eYB-_ZdyOZeG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283msVWltg%253D%253D&md5=cf6307a9e73556b7f8399c81e18fb6bf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jval.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jval.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DT.%26aulast%3DNestler-Parr%26aufirst%3DS.%26aulast%3DBabela%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DZ.%2BM.%26aulast%3DTesoro%26aufirst%3DT.%26aulast%3DMolsen%26aufirst%3DE.%26aulast%3DHughes%26aufirst%3DD.%2BA.%26atitle%3DRare%2520disease%2520terminology%2520and%2520definitions%25E2%2580%2594a%2520systematic%2520global%2520review%253A%2520report%2520of%2520the%2520ISPOR%2520rare%2520disease%2520special%2520interest%2520group%26jtitle%3DValue%2520Health%26date%3D2015%26volume%3D18%26spage%3D906%26epage%3D914%26doi%3D10.1016%2Fj.jval.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Institute of Medicine</span>.  <i>Rare
Diseases and Orphan Products: Accelerating Research and Development</i>; <span class="NLM_publisher-name">The National Academies Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2010</span>; p  <span class="NLM_fpage">442</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=442&author=Institute+of+Medicine&title=Rare%0ADiseases+and+Orphan+Products%3A+Accelerating+Research+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DRare%250ADiseases%2520and%2520Orphan%2520Products%253A%2520Accelerating%2520Research%2520and%2520Development%26pub%3DThe%2520National%2520Academies%2520Press%26date%3D2010%26spage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3389%2Ffncel.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24639629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=68&author=X.+Xuauthor=A.+Kozikowskiauthor=L.+Pozzo-Miller&title=A+selective+histone+deacetylase-6+inhibitor+improves+BDNF+trafficking+in+hippocampal+neurons+from+Mecp2+knockout+mice%3A+implications+for+Rett+syndrome&doi=10.3389%2Ffncel.2014.00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span></div><div class="casAuthors">Xu, Xin; Kozikowski, Alan P.; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/9</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by loss-of-function mutations in the transcriptional modulator methyl-CpG-binding protein 2 (MECP2).  One of the most prominent gene targets of MeCP2 is brain-derived neurotrophic factor (Bdnf), a potent modulator of activity-dependent synaptic development, function and plasticity.  Dysfunctional BDNF signaling has been demonstrated in several pathophysiol. mechanisms of RTT disease progression.  To evaluate whether the dynamics of BDNF trafficking is affected by Mecp2 deletion, we analyzed movements of BDNF tagged with yellow fluorescent protein (YFP) in cultured hippocampal neurons by time-lapse fluorescence imaging.  We found that both anterograde and retrograde vesicular trafficking of BDNF-YFP are significantly impaired in Mecp2 knockout hippocampal neurons.  Selective inhibitors of histone deacetylase 6 (HDAC6) show neuroprotective effects in neurodegenerative diseases and stimulate microtubule-dependent vesicular trafficking of BDNF-contg. dense core vesicles.  Here, we show that the selective HDAC6 inhibitor Tubastatin-A increased the velocity of BDNF-YFP vesicles in Mecp2 knockout neurons in both directions by increasing α-tubulin acetylation.  Tubastatin-A also restored activity-dependent BDNF release from Mecp2 knockout neurons to levels comparable to those shown by wildtype neurons.  These findings demonstrate that a selective HDAC6 inhibitor is a potential pharmacol. strategy to reverse cellular and synaptic impairments in RTT resulting from impaired BDNF signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTWjdzmjqurVg90H21EOLACvtfcHk0lg_MspswWo1Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM&md5=ead557e0e05455dd86fa959e7edeb5bc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DA%2520selective%2520histone%2520deacetylase-6%2520inhibitor%2520improves%2520BDNF%2520trafficking%2520in%2520hippocampal%2520neurons%2520from%2520Mecp2%2520knockout%2520mice%253A%2520implications%2520for%2520Rett%2520syndrome%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D68%26doi%3D10.3389%2Ffncel.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amir, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Veyver, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1038/13810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F13810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10508514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=185-188&author=R.+E.+Amirauthor=I.+B.+Van+den+Veyverauthor=M.+Wanauthor=C.+Q.+Tranauthor=U.+Franckeauthor=H.+Y.+Zoghbi&title=Rett+syndrome+is+caused+by+mutations+in+X-linked+MECP2%2C+encoding+methyl-CpG-binding+protein+2&doi=10.1038%2F13810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span></div><div class="casAuthors">Amir, Ruthie E.; Van den Veyver, Ignatia B.; Wan, Mimi; Tran, Charles Q.; Francke, Uta; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-188</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Rett syndrome (RTT, MIM 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females, with an incidence of 1 in 10,000-15,000.  Patients with classic RTT appear to develop normally until 6-18 mo of age, then gradually lose speech and purposeful hand use, and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements.  After initial regression, the condition stabilizes and patients usually survive into adulthood.  As RTT occurs almost exclusively in females, it has been proposed that RTT is caused by an X-linked dominant mutation with lethality in hemizygous males.  Previous exclusion mapping studies using RTT families mapped the locus to Xq28.  Using a systematic gene screening approach, the authors have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT.  MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A.  In 5 of 21 sporadic patients, the authors found 3 de novo missense mutations in the region encoding the highly conserved methyl-binding domain (MBD) as well as a de novo frameshift and a de novo nonsense mutation, both of which disrupt the transcription repression domain (TRD).  In two affected half-sisters of a RTT family, the authors found segregation of an addnl. missense mutation not detected in their obligate carrier mother.  This suggests that the mother is a germline mosaic for this mutation.  The authors' study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yw7uglP4ErVg90H21EOLACvtfcHk0lguRHd5RxoU0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D&md5=ca0a168eb91cd1514c38058a1955c289</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F13810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13810%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DR.%2BE.%26aulast%3DVan%2Bden%2BVeyver%26aufirst%3DI.%2BB.%26aulast%3DWan%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DC.%2BQ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DRett%2520syndrome%2520is%2520caused%2520by%2520mutations%2520in%2520X-linked%2520MECP2%252C%2520encoding%2520methyl-CpG-binding%2520protein%25202%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D185%26epage%3D188%26doi%3D10.1038%2F13810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteller, M.</span></span> <span> </span><span class="NLM_article-title">Genetic syndromes caused by mutations in epigenetic genes</span>. <i>Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1007/s00439-013-1271-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00439-013-1271-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23370504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12ksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=359-383&author=M.+Berdascoauthor=M.+Esteller&title=Genetic+syndromes+caused+by+mutations+in+epigenetic+genes&doi=10.1007%2Fs00439-013-1271-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic syndromes caused by mutations in epigenetic genes</span></div><div class="casAuthors">Berdasco, Maria; Esteller, Manel</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-383</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The orchestrated organization of epigenetic factors that control chromatin dynamism, including DNA methylation, histone marks, non-coding RNAs (ncRNAs) and chromatin-remodeling proteins, is essential for the proper function of tissue homeostasis, cell identity and development.  Indeed, deregulation of epigenetic profiles has been described in several human pathologies, including complex diseases (such as cancer, cardiovascular and neurol. diseases), metabolic pathologies (type 2 diabetes and obesity) and imprinting disorders.  Over the last decade it has become increasingly clear that mutations of genes involved in epigenetic mechanism, such as DNA methyltransferases, methyl-binding domain proteins, histone deacetylases, histone methylases and members of the SWI/SNF family of chromatin remodelers are linked to human disorders, including Immunodeficiency Centromeric instability Facial syndrome 1, Rett syndrome, Rubinstein-Taybi syndrome, Sotos syndrome or alpha-thalassemia/mental retardation X-linked syndrome, among others.  As new members of the epigenetic machinery are described, the no. of human syndromes assocd. with epigenetic alterations increases.  As recent examples, mutations of histone demethylases and members of the non-coding RNA machinery have recently been assocd. with Kabuki syndrome, Claes-Jensen X-linked mental retardation syndrome and Goiter syndrome.  In this review, we describe the variety of germline mutations of epigenetic modifiers that are known to be assocd. with human disorders, and discuss the therapeutic potential of epigenetic drugs as palliative care strategies in the treatment of such disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobmk0XWyUOd7Vg90H21EOLACvtfcHk0lguRHd5RxoU0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12ksbk%253D&md5=2c80c7b4c0a2a5c18f18dc5426c9cbbd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00439-013-1271-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-013-1271-x%26sid%3Dliteratum%253Aachs%26aulast%3DBerdasco%26aufirst%3DM.%26aulast%3DEsteller%26aufirst%3DM.%26atitle%3DGenetic%2520syndromes%2520caused%2520by%2520mutations%2520in%2520epigenetic%2520genes%26jtitle%3DHum.%2520Genet.%26date%3D2013%26volume%3D132%26spage%3D359%26epage%3D383%26doi%3D10.1007%2Fs00439-013-1271-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186615</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0186615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0186615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29045477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186615&author=S.+Saitoauthor=Y.+Zhuangauthor=B.+Shanauthor=S.+Danchukauthor=F.+Luoauthor=M.+Korfeiauthor=A.+Guentherauthor=J.+A.+Lasky&title=Tubastatin+ameliorates+pulmonary+fibrosis+by+targeting+the+TGF%CE%B2-PI3K-Akt+pathway&doi=10.1371%2Fjournal.pone.0186615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span></div><div class="casAuthors">Saito, Shigeki; Zhuang, Yan; Shan, Bin; Danchuk, Svitlana; Luo, Fayong; Korfei, Martina; Guenther, Andreas; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186615/1-e0186615/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease.  Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition).  However, the role of HDAC6 in pulmonary fibrosis is unknown.  Methods HDAC6 expression in IPF and control lungs was assessed by quant. real-time PCR (qRT-PCR) and immunoblots.  Lung fibroblasts were treated with TGF-β1 ± HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots.  Mice were treated with bleomycin (oropharyngeal aspiration; single dose) ± Tubastatin (i.p. injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining.  In a sep. expt., HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner.  Results HDAC6 expression was deregulated in IPF lungs.  Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-β1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) assocn.  Tubastatin repressed TGF-β1-induced S6K phosphorylation, HIF-1α expression, and VEGF expression.  Tubastatin also repressed TGF-β1-induced inhibition of LC3B-II (a marker of autophagosome formation).  In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression.  However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice.  Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-β1-induced collagen expression in lung fibroblasts.  Conclusions HDAC6 expression is altered during lung fibrogenesis.  Tubastatin represses TGF-β1-induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1α-VEGF axis and autophagy.  Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not.  Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGFβ-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorEUu1wcAKXLVg90H21EOLACvtfcHk0lguRHd5RxoU0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO&md5=67dfcd8dfe9baac9d5273163c2cf3543</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186615%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DDanchuk%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DTubastatin%2520ameliorates%2520pulmonary%2520fibrosis%2520by%2520targeting%2520the%2520TGF%25CE%25B2-PI3K-Akt%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186615%26doi%3D10.1371%2Fjournal.pone.0186615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. A.</span></span> <span> </span><span class="NLM_article-title">Epigenetics of idiopathic pulmonary fibrosis</span>. <i>Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.trsl.2014.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.trsl.2014.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24746870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1eht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2015&pages=48-60&author=I.+V.+Yangauthor=D.+A.+Schwartz&title=Epigenetics+of+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.trsl.2014.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetics of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Yang, Ivana V.; Schwartz, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1878-1810</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a complex lung disease of unknown etiol.  Development of IPF is influenced by both genetic and environmental factors.  Recent work by our and other groups has identified strong genetic predisposition factors for the development of pulmonary fibrosis, and cigarette smoke remains the most strongly assocd. environmental exposure risk factor.  Gene expression profiling studies of IPF lung have taught us quite a bit about the biol. of this fatal disease, and those of peripheral blood have provided important biomarkers.  However, epigenetic marks may be the missing link that connects the environmental exposure in genetically predisposed individuals to transcriptional changes assocd. with disease development.  Moreover, epigenetic marks represent a promising therapeutic target for IPF.  In this review, the disease is introduced, genetic and gene expression studies in IPF are summarized, exposures relevant to IPF and known epigenetic changes assocd. with cigarette smoke exposure are discussed, and epigenetic studies conducted so far in IPF are summarized.  Limitations, challenges, and future opportunities in this field are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrucclb9qMiKbVg90H21EOLACvtfcHk0liA7dE82c9Ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1eht74%253D&md5=f239cc89ca03fb73326c6a285711750d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2014.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2014.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DI.%2BV.%26aulast%3DSchwartz%26aufirst%3DD.%2BA.%26atitle%3DEpigenetics%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DTransl.%2520Res.%26date%3D2015%26volume%3D165%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.trsl.2014.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter-Landsberg, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3028</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2017.415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29048427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e3028&author=J.+Leykauthor=C.+Dalyauthor=U.+Janssen-Bienholdauthor=B.+N.+Kennedyauthor=C.+Richter-Landsberg&title=HDAC6+inhibition+by+tubastatin+A+is+protective+against+oxidative+stress+in+a+photoreceptor+cell+line+and+restores+visual+function+in+a+zebrafish+model+of+inherited+blindness&doi=10.1038%2Fcddis.2017.415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span></div><div class="casAuthors">Leyk, Janina; Daly, Conor; Janssen-Bienhold, Ulrike; Kennedy, Breandan N.; Richter-Landsberg, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e3028</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinal diseases, such as hereditary retinitis pigmentosa and age-related macular degeneration, are characterized by the progressive loss of photoreceptors.  Histone deacetylase 6 (HDAC6) is considered as a stress surveillance factor and a potential target for neuroprotection and regeneration.  Overexpression of HDAC6 has been connected to neurodegenerative disorders, and its suppression may provide protection.  Here we show that HDAC6 is constitutively present in the mouse retina, and in the cone-like mouse cell line 661W.  In 661W cells HDAC6 inhibition by the specific inhibitor tubastatin A (TST) led to the acetylation of α-tubulin, which is a major substrate for HDAC6.  After oxidative stress, exerted by hydrogen peroxide, TST promoted cell survival and the upregulation of heat-shock proteins HSP70 and HSP25 by activation of heat-shock transcription factor 1.  Furthermore, in response to oxidative stress the redox regulatory protein peroxiredoxin 1 (Prx1) was modulated in 661W cells by HDAC6 inhibition.  The peroxide reducing activity of Prx1 is dependent on its acetylation, which is mediated by HDAC6.  Pre-incubation with TST prevented the inactivation of Prx1 and its preserved activity may exert protective effects in photoreceptor cells.  To det. whether TST treatment has a therapeutic effect on visual function, the dyeucd6 zebrafish model of inherited sight loss was utilized.  Zebrafish have developed as a suitable model system for pharmacol. testing.  In vivo application of TST caused the hyperacetylation of α-tubulin, indicating that HDAC6 is active in this model.  Furthermore, TST was sufficient to rescue visual function and retinal morphol.  Hence, HDAC6 inhibition and the regulation of peroxiredoxin activity may play a significant role in protecting retinal cells and in particular photoreceptors, which are exposed to high levels of reactive oxygen species derived from oxidative stress-induced injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltlSmCwk0BrVg90H21EOLACvtfcHk0liA7dE82c9Ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL&md5=d6a6315da7b623e42cc3784dd76cd444</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.415%26sid%3Dliteratum%253Aachs%26aulast%3DLeyk%26aufirst%3DJ.%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26atitle%3DHDAC6%2520inhibition%2520by%2520tubastatin%2520A%2520is%2520protective%2520against%2520oxidative%2520stress%2520in%2520a%2520photoreceptor%2520cell%2520line%2520and%2520restores%2520visual%2520function%2520in%2520a%2520zebrafish%2520model%2520of%2520inherited%2520blindness%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De3028%26doi%3D10.1038%2Fcddis.2017.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot–Marie–Tooth disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs13311-016-0501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27957719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=417-428&author=V.+Benoyauthor=P.+Vanden+Bergheauthor=M.+Jarpeauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=Development+of+improved+HDAC6+inhibitors+as+pharmacological+therapy+for+axonal+Charcot%E2%80%93Marie%E2%80%93Tooth+disease&doi=10.1007%2Fs13311-016-0501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Benoy, Veronick; Vanden Berghe, Pieter; Jarpe, Matthew; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recently, we identified histone deacetylase 6, which deacetylates α-tubulin, as a potential therapeutic target in axonal CMT.  Pharmacol. inhibition of the deacetylating function of HDAC6 reversed the motor and sensory deficits in a mouse model for mutant "small heat shock protein B1"-induced CMT2 at the behavioral and electrophysiol. level.  In order to translate this potential therapeutic strategy into a clin. application, small drug-like mols. that are potent and selective HDAC6 inhibitors are essential.  To screen for these, we developed a method that consisted of 3 distinct phases and that was based on the pathol. findings in the mutant HSPB1-induced CMT2 mouse model.  Three different inhibitors (ACY-738, ACY-775, and ACY-1215) were tested and demonstrated to be both potent and selective HDAC6 inhibitors.  Moreover, these inhibitors increased the innervation of the neuromuscular junctions in the gastrocnemius muscle and improved the motor and sensory nerve conduction, confirming that HDAC6 inhibition is a potential therapeutic strategy in CMT2.  Furthermore, ACY-1215 is an interesting lead mol. as it is currently tested in clin. trials for cancer.  Taken together, these results may speed up the translation of pharmacol. inhibition of HDAC6 into a therapy against CMT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJr47ap41l7Vg90H21EOLACvtfcHk0liA7dE82c9Ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO&md5=cb382132da19455955c1b432cf59aa5e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0501-z%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520improved%2520HDAC6%2520inhibitors%2520as%2520pharmacological%2520therapy%2520for%2520axonal%2520Charcot%25E2%2580%2593Marie%25E2%2580%2593Tooth%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D417%26epage%3D428%26doi%3D10.1007%2Fs13311-016-0501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verreault, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almouzni, G.</span></span> <span> </span><span class="NLM_article-title">Chromatin challenges during DNA replication and repair</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2007.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17320509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=721-733&author=A.+Grothauthor=W.+Rochaauthor=A.+Verreaultauthor=G.+Almouzni&title=Chromatin+challenges+during+DNA+replication+and+repair&doi=10.1016%2Fj.cell.2007.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin challenges during DNA replication and repair</span></div><div class="casAuthors">Groth, Anja; Rocha, Walter; Verreault, Alain; Almouzni, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-733</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inheritance and maintenance of the DNA sequence and its organization into chromatin are central for eukaryotic life.  To orchestrate DNA-replication and -repair processes in the context of chromatin is a challenge, both in terms of accessibility and maintenance of chromatin organization.  To meet the challenge of maintenance, cells have evolved efficient nucleosome-assembly pathways and chromatin-maturation mechanisms that reproduce chromatin organization in the wake of DNA replication and repair.  The aim of this Review is to describe how these pathways operate and to highlight how the epigenetic landscape may be stably maintained even in the face of dramatic changes in chromatin structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdiwkoydTZ7Vg90H21EOLACvtfcHk0liA7dE82c9Ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12isr4%253D&md5=d10072a37109161edccac5ba24ef88f5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DGroth%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DW.%26aulast%3DVerreault%26aufirst%3DA.%26aulast%3DAlmouzni%26aufirst%3DG.%26atitle%3DChromatin%2520challenges%2520during%2520DNA%2520replication%2520and%2520repair%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D721%26epage%3D733%26doi%3D10.1016%2Fj.cell.2007.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shahbazian, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunstein, M.</span></span> <span> </span><span class="NLM_article-title">Functions of site-specific histone acetylation and deacetylation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.052705.162114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1146%2Fannurev.biochem.76.052705.162114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17362198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=75-100&author=M.+D.+Shahbazianauthor=M.+Grunstein&title=Functions+of+site-specific+histone+acetylation+and+deacetylation&doi=10.1146%2Fannurev.biochem.76.052705.162114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functions of site-specific histone acetylation and deacetylation</span></div><div class="casAuthors">Shahbazian, Mona D.; Grunstein, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-100</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Histone acetylation regulates many cellular processes, and specific acetylation marks, either singly or in combination, produce distinct outcomes.  For example, the acetylation pattern on newly synthesized histones is important for their assembly into nucleosomes by histone chaperones.  Addnl., the degree of chromatin compaction and folding may be regulated by acetylation of histone H4 at Lys-16.  Histone acetylation also regulates the formation of heterochromatin; deacetylation of H4 Lys-16 is important for the spreading of heterochromatin components, whereas acetylation of this site serves as a barrier to this spreading.  Finally, histone acetylation is crit. for gene transcription, but recent results suggest that deacetylation of certain sites also plays an important role.  There are many histone acetyltransferases (HATs) and deacetylases, with differing preferences for the various histone proteins and for specific sites on individual histones.  Detg. how these enzymes create distinct acetylation patterns and regulate the functional outcome is an important challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2iL3QDzZh-7Vg90H21EOLACvtfcHk0lj-t6wKNAu4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7O&md5=51fb46ba44a7f0c614c812baddb4e65e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.052705.162114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.052705.162114%26sid%3Dliteratum%253Aachs%26aulast%3DShahbazian%26aufirst%3DM.%2BD.%26aulast%3DGrunstein%26aufirst%3DM.%26atitle%3DFunctions%2520of%2520site-specific%2520histone%2520acetylation%2520and%2520deacetylation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D75%26epage%3D100%26doi%3D10.1146%2Fannurev.biochem.76.052705.162114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ausió, J.</span></span> <span> </span><span class="NLM_article-title">Effects of histone acetylation on the solubility and folding of the chromatin fiber</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">12764</span>– <span class="NLM_lpage">12768</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100501200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M100501200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11279082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=12764-12768&author=X.+Wangauthor=C.+Heauthor=S.+C.+Mooreauthor=J.+Ausi%C3%B3&title=Effects+of+histone+acetylation+on+the+solubility+and+folding+of+the+chromatin+fiber&doi=10.1074%2Fjbc.M100501200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of histone acetylation on the solubility and folding of the chromatin fiber</span></div><div class="casAuthors">Wang, Xiaoying; He, Cheng; Moore, Susan C.; Ausio, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12764-12768</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The folding ability of chromatin fractions contg. approx. identical nucleosome nos. and the same linker histone compn., but with different extents of core histone acetylation, were analyzed by anal. ultracentrifugation.  It was found that the acetylated fractions consistently exhibited a relatively small but significantly lower extent of compaction than that of their native nonacetylated counterparts.  This was regardless of the extent of the size distribution heterogeneity of the fractions analyzed.  Furthermore the acetylated chromatin fibers exhibited an enhanced soly. in both NaCl and MgCl2, which is neither the result of a differential binding affinity of the linker histones to chromatin nor of an alteration in the relative amts. of the histone H1 variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkairv1oZy6LVg90H21EOLACvtfcHk0lj-t6wKNAu4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyntbg%253D&md5=e720255bfeebeb905aa097940fa10e0a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100501200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100501200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DS.%2BC.%26aulast%3DAusi%25C3%25B3%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520histone%2520acetylation%2520on%2520the%2520solubility%2520and%2520folding%2520of%2520the%2520chromatin%2520fiber%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D12764%26epage%3D12768%26doi%3D10.1074%2Fjbc.M100501200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shogren-Knaak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C. L.</span></span> <span> </span><span class="NLM_article-title">Histone H4-K16 acetylation controls chromatin structure and protein interactions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1126/science.1124000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1124000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16469925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2006&pages=844-847&author=M.+Shogren-Knaakauthor=H.+Ishiiauthor=J.-M.+Sunauthor=M.+J.+Pazinauthor=J.+R.+Davieauthor=C.+L.+Peterson&title=Histone+H4-K16+acetylation+controls+chromatin+structure+and+protein+interactions&doi=10.1126%2Fscience.1124000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions</span></div><div class="casAuthors">Shogren-Knaak, Michael; Ishii, Haruhiko; Sun, Jian-Min; Pazin, Michael J.; Davie, James R.; Peterson, Craig L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">5762</span>),
    <span class="NLM_cas:pages">844-847</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Acetylation of histone H4 on lysine 16 (H4-K16Ac) is a prevalent and reversible posttranslational chromatin modification in eukaryotes.  To characterize the structural and functional role of this mark, we used a native chem. ligation strategy to generate histone H4 that was homogeneously acetylated at K16.  The incorporation of this modified histone into nucleosomal arrays inhibits the formation of compact 30-nm-like fibers and impedes the ability of chromatin to form cross-fiber interactions.  H4-K16Ac also inhibits the ability of the ATP-utilizing chromatin assembly and remodeling enzyme ACF to mobilize a mononucleosome, indicating that this single histone modification modulates both higher order chromatin structure and functional interactions between a nonhistone protein and the chromatin fiber.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqawsTg7m9LQLVg90H21EOLACvtfcHk0lj-t6wKNAu4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFylsLY%253D&md5=c82b2fe14098f9e30a0aba389d11fb67</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1124000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1124000%26sid%3Dliteratum%253Aachs%26aulast%3DShogren-Knaak%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DJ.-M.%26aulast%3DPazin%26aufirst%3DM.%2BJ.%26aulast%3DDavie%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DC.%2BL.%26atitle%3DHistone%2520H4-K16%2520acetylation%2520controls%2520chromatin%2520structure%2520and%2520protein%2520interactions%26jtitle%3DScience%26date%3D2006%26volume%3D311%26spage%3D844%26epage%3D847%26doi%3D10.1126%2Fscience.1124000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldog, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khramtsov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghs, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichenstein, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehested, M.</span></span> <span> </span><span class="NLM_article-title">Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1042/BJ20070779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1042%2FBJ20070779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17868033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2008&pages=581-589&author=N.+Khanauthor=M.+Jeffersauthor=S.+Kumarauthor=C.+Hackettauthor=F.+Boldogauthor=N.+Khramtsovauthor=X.+Qianauthor=E.+Millsauthor=S.+C.+Berghsauthor=N.+Careyauthor=P.+W.+Finnauthor=L.+S.+Collinsauthor=A.+Tumberauthor=J.+W.+Ritchieauthor=P.+B.+Jensenauthor=H.+S.+Lichensteinauthor=M.+Sehested&title=Determination+of+the+class+and+isoform+selectivity+of+small-molecule+histone+deacetylase+inhibitors&doi=10.1042%2FBJ20070779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors</span></div><div class="casAuthors">Khan, Nagma; Jeffers, Michael; Kumar, Sampath; Hackett, Craig; Boldog, Ferenc; Khramtsov, Nicholai; Qian, Xiaozhong; Mills, Evan; Berghs, Stanny C.; Carey, Nessa; Finn, Paul W.; Collins, Laura S.; Tumber, Anthony; Ritchie, James W.; Jensen, Peter Buhl; Lichenstein, Henri S.; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The human HDAC (histone deacetylase) family, a well-validated anticancer target, plays a key role in the control of gene expression through regulation of transcription.  While HDACs can be subdivided into three main classes, the class I, class II and class III HDACs (sirtuins), it is presently unclear whether inhibiting multiple HDACs using pan-HDAC inhibitors, or targeting specific isoforms that show aberrant levels in tumors, will prove more effective as an anticancer strategy in the clinic.  To address the above issues, we have tested a no. of clin. relevant HDACis (HDAC inhibitors) against a panel of rhHDAC (recombinant human HDAC) isoforms.  Eight rhHDACs were expressed using a baculoviral system, and a Fluor de Lys (Biomol International) HDAC assay was optimized for each purified isoform.  The potency and selectivity of ten HDACs on class I isoforms (rhHDAC1, rhHDAC2, rhHDAC3 and rhHDAC8) and class II HDAC isoforms (rhHDAC4, rhHDAC6, rhHDAC7 and rhHDAC9) was detd.  MS-275 was HDAC1-selective, MGCD0103 was HDAC1- and HDAC2-selective, apicidin was HDAC2- and HDAC3-selective and valproic acid was a specific inhibitor of class I HDACs.  The hydroxamic acid-derived compds. (trichostatin A, NVP-LAQ824, panobinostat, ITF2357, vorinostat and belinostat) were potent pan-HDAC inhibitors.  The growth-inhibitory effect of the HDACis on HeLa cells showed that both pan-HDAC and class-I-specific inhibitors inhibited cell growth.  The results also showed that both pan-HDAC and class-I-specific inhibitor treatment resulted in increased acetylation of histones, but only pan-HDAC inhibitor treatment resulted in increased tubulin acetylation, which is in agreement with their activity towards the HDAC6 isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHb1RAVCAf77Vg90H21EOLACvtfcHk0lgkqI4xROfvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSru7o%253D&md5=6d268ef4776d3165c6b0a61179642969</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1042%2FBJ20070779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070779%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJeffers%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHackett%26aufirst%3DC.%26aulast%3DBoldog%26aufirst%3DF.%26aulast%3DKhramtsov%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DBerghs%26aufirst%3DS.%2BC.%26aulast%3DCarey%26aufirst%3DN.%26aulast%3DFinn%26aufirst%3DP.%2BW.%26aulast%3DCollins%26aufirst%3DL.%2BS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DJ.%2BW.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DLichenstein%26aufirst%3DH.%2BS.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520the%2520class%2520and%2520isoform%2520selectivity%2520of%2520small-molecule%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D409%26spage%3D581%26epage%3D589%26doi%3D10.1042%2FBJ20070779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Presegué, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaquero, A.</span></span> <span> </span><span class="NLM_article-title">The dual role of sirtuins in cancer</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1177/1947601911417862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1177%2F1947601911417862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21941620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCgu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=648-662&author=L.+Bosch-Presegu%C3%A9author=A.+Vaquero&title=The+dual+role+of+sirtuins+in+cancer&doi=10.1177%2F1947601911417862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The dual role of sirtuins in cancer</span></div><div class="casAuthors">Bosch-Presegue, Laia; Vaquero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">648-662</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Among the greatest challenges facing organisms is that of detecting and effectively responding to life-threatening environmental changes that are intimately assocd. with metabolic fluctuations and certain forms of stress.  These conditions have been linked to the onset of many human pathologies, including cancer.  Over the past decade, members of the Sir2 family, or sirtuins, have been described as major players in sensing and coordinating stress response.  Evidence has imputed mammalian sirtuins in carcinogenesis, although the mechanisms involved seem to be more diverse and complex than previously anticipated.  Some sirtuins, such as SirT2 and SirT6, seem to work as tumor suppressors, but others, such as SirT1, are apparently bifunctional: operating as both tumor suppressors and oncogenic factors depending on the context and the study conditions.  The mechanisms underlying these apparently contradictory activities are not well understood, although recent findings suggest that they might actually be two sides of the same coin.  In this review, the authors summarize current knowledge on the functional implications of sirtuins in cancer and discuss possible explanations for their functional duality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuaHytg5hPbVg90H21EOLACvtfcHk0lgkqI4xROfvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCgu7jP&md5=1ec812b225a9204016a2d10e2b30a949</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1947601911417862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911417862%26sid%3Dliteratum%253Aachs%26aulast%3DBosch-Presegu%25C3%25A9%26aufirst%3DL.%26aulast%3DVaquero%26aufirst%3DA.%26atitle%3DThe%2520dual%2520role%2520of%2520sirtuins%2520in%2520cancer%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D648%26epage%3D662%26doi%3D10.1177%2F1947601911417862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span> <span> </span><span class="NLM_article-title">Sirtuins: critical regulators at the crossroads between cancer and aging</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5489</span>– <span class="NLM_lpage">5504</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.onc.1210616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17694089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFersro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5489-5504&author=L.+Saundersauthor=E.+Verdin&title=Sirtuins%3A+critical+regulators+at+the+crossroads+between+cancer+and+aging&doi=10.1038%2Fsj.onc.1210616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins: critical regulators at the crossroads between cancer and aging</span></div><div class="casAuthors">Saunders, L. R.; Verdin, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5489-5504</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sirtuins (SIRTs 1-7), or class III histone deacetylases (HDACs), are protein deacetylases/ADP ribosyltransferases that target a wide range of cellular proteins in the nucleus, cytoplasm, and mitochondria for post-translational modification by acetylation (SIRT1, -2, -3 and -5) or ADP ribosylation (SIRT4 and -6).  The orthologs of sirtuins in lower organisms play a crit. role in regulating lifespan.  As cancer is a disease of aging, we discuss the growing implications of the sirtuins in protecting against cancer development.  Sirtuins regulate the cellular responses to stress and ensure that damaged DNA is not propagated and that mutations do not accumulate.  SIRT1 also promotes replicative senescence under conditions of chronic stress.  By participating in the stress response to genomic insults, sirtuins are thought to protect against cancer, but they are also emerging as direct participants in the growth of some cancers.  Here, we review the growing implications of sirtuins both in cancer prevention and as specific and novel cancer therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTDJ1i__5BHrVg90H21EOLACvtfcHk0lgkqI4xROfvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFersro%253D&md5=d9d7e96428e124991c6fe9bcb9fe55d2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210616%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DSirtuins%253A%2520critical%2520regulators%2520at%2520the%2520crossroads%2520between%2520cancer%2520and%2520aging%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5489%26epage%3D5504%26doi%3D10.1038%2Fsj.onc.1210616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delcuve, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, J. R.</span></span> <span> </span><span class="NLM_article-title">Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/1868-7083-4-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1186%2F1868-7083-4-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22414492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlyqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=5&author=G.+P.+Delcuveauthor=D.+H.+Khanauthor=J.+R.+Davie&title=Roles+of+histone+deacetylases+in+epigenetic+regulation%3A+emerging+paradigms+from+studies+with+inhibitors&doi=10.1186%2F1868-7083-4-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors</span></div><div class="casAuthors">Delcuve, Genevieve P.; Khan, Dilshad H.; Davie, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The zinc-dependent mammalian histone deacetylase (HDAC) family comprises 11 enzymes, which have specific and crit. functions in development and tissue homeostasis.  Mounting evidence points to a link between misregulated HDAC activity and many oncol. and nononcol. diseases.  Thus the development of HDAC inhibitors for therapeutic treatment garners a lot of interest from academic researchers and biotechnol. entrepreneurs.  Numerous studies of HDAC inhibitor specificities and mol. mechanisms of action are ongoing.  In one of these studies, mass spectrometry was used to characterize the affinities and selectivities of HDAC inhibitors toward native HDAC multiprotein complexes in cell exts.  Such a novel approach reproduces in vivo mol. interactions more accurately than std. studies using purified proteins or protein domains as targets and could be very useful in the isolation of inhibitors with superior clin. efficacy and decreased toxicity compared to the ones presently tested or approved.  HDAC inhibitor induced-transcriptional reprogramming, believed to contribute largely to their therapeutic benefits, is achieved through various and complex mechanisms not fully understood, including histone deacetylation, transcription factor or regulator (including HDAC1) deacetylation followed by chromatin remodeling and pos. or neg. outcome regarding transcription initiation.  Although only a very low percentage of protein-coding genes are affected by the action of HDAC inhibitors, about 40% of noncoding microRNAs are upregulated or downregulated.  Moreover, a whole new world of long noncoding RNAs is emerging, revealing a new class of potential targets for HDAC inhibition.  HDAC inhibitors might also regulate transcription elongation and have been shown to impinge on alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobz_EWcDenLbVg90H21EOLACvtfcHk0lgfxZ4-W85GVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlyqtbY%253D&md5=6a9242d0f759866a231a22803dcf46b8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1868-7083-4-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1868-7083-4-5%26sid%3Dliteratum%253Aachs%26aulast%3DDelcuve%26aufirst%3DG.%2BP.%26aulast%3DKhan%26aufirst%3DD.%2BH.%26aulast%3DDavie%26aufirst%3DJ.%2BR.%26atitle%3DRoles%2520of%2520histone%2520deacetylases%2520in%2520epigenetic%2520regulation%253A%2520emerging%2520paradigms%2520from%2520studies%2520with%2520inhibitors%26jtitle%3DClin.%2520Epigenet.%26date%3D2012%26volume%3D4%26spage%3D5%26doi%3D10.1186%2F1868-7083-4-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, I.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibitors as anti-inflammatory agents</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.bjp.0707166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17325655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=829-831&author=I.+Adcock&title=HDAC+inhibitors+as+anti-inflammatory+agents&doi=10.1038%2Fsj.bjp.0707166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitors as anti-inflammatory agents</span></div><div class="casAuthors">Adcock, I. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Diverse cellular functions including the regulation of inflammatory gene expression, DNA repair and cell proliferation are regulated by changes in the acetylation status of histones and non-histone proteins.  Many human diseases, particularly cancer, have been assocd. with altered patterns of histone acetylation.  Furthermore, abnormal expression and activation of histone acetyltransferases, which act as transcriptional co-activators, has been reported in inflammatory diseases.  Histone deacetylase (HDAC) inhibitors have been developed clin. for malignancies due to their effects on apoptosis.  More recently, in vitro and in vivo data indicates that HDAC inhibitors may be anti-inflammatory due to their effects on cell death acting through acetylation of non-histone proteins.  Although there are concerns over the long-term safety of these agents, they may prove useful particularly in situations where current anti-inflammatory therapies are suboptimal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgMCgv5sxZbVg90H21EOLACvtfcHk0lgfxZ4-W85GVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ntL8%253D&md5=9efe612e1b0e8fd5a4d166248e4da8f2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707166%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DI.%26atitle%3DHDAC%2520inhibitors%2520as%2520anti-inflammatory%2520agents%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D829%26epage%3D831%26doi%3D10.1038%2Fsj.bjp.0707166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, P.</span></span> <span> </span><span class="NLM_article-title">Inside HDACs with more selective HDAC inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2016.05.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27318122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWns7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=451-483&author=J.+Rocheauthor=P.+Bertrand&title=Inside+HDACs+with+more+selective+HDAC+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inside HDACs with more selective HDAC inhibitors</span></div><div class="casAuthors">Roche, Joelle; Bertrand, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-483</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Inhibitors of histone deacetylases (HDACs) are nowadays part of the therapeutic arsenal mainly against cancers, with four compds. approved by the Food and Drug Administration.  During the last five years, several groups have made continuous efforts to improve this class of compds., designing more selective compds. or compds. with multiple capacities.  After a survey of the HDAC biol. and structures, this review summarizes the results of the chemists working in this field, and highlights when possible the behavior of the mols. inside their targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHO5YBuaN7c7Vg90H21EOLACvtfcHk0lgfxZ4-W85GVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWns7%252FI&md5=3bbd062c1fb8a402c039e20bacd4af14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DJ.%26aulast%3DBertrand%26aufirst%3DP.%26atitle%3DInside%2520HDACs%2520with%2520more%2520selective%2520HDAC%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483%26doi%3D10.1016%2Fj.ejmech.2016.05.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1111/febs.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Ffebs.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23181831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2012&pages=775-793&author=Y.+Liauthor=D.+Shinauthor=S.+H.+Kwon&title=Histone+deacetylase+6+plays+a+role+as+a+distinct+regulator+of+diverse+cellular+processes&doi=10.1111%2Ffebs.12079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12079%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26atitle%3DHistone%2520deacetylase%25206%2520plays%2520a%2520role%2520as%2520a%2520distinct%2520regulator%2520of%2520diverse%2520cellular%2520processes%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D280%26spage%3D775%26epage%3D793%26doi%3D10.1111%2Ffebs.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, C. A. M.</span></span> <span> </span><span class="NLM_article-title">Beyond the selective inhibition of histone deacetylase 6</span>. <i>Mini. Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160428115959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.2174%2F1389557516666160428115959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27121714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1175-1184&author=D.+A.+Rodriguesauthor=S.+Thotaauthor=C.+A.+M.+Fraga&title=Beyond+the+selective+inhibition+of+histone+deacetylase+6&doi=10.2174%2F1389557516666160428115959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Selective Inhibition of Histone Deacetylase 6</span></div><div class="casAuthors">Rodrigues, Daniel A.; Thota, Sreekanth; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) catalyzes the removal of acetyl groups from the lysine residues of a series of non-histone proteins, e.g., -tubulin, Hsp90 and cortactin.  HDAC6 is a unique deacetylase enzyme that is related to various processes that may be important in oncol., immunol. and neurol. fields, which makes the study of selective inhibitors extremely important to understand the function of this enzyme and to validate HDAC6 as a drug target through the development of clin. candidates.  Therefore, this review describes the structure-activity and structureselectivity relationships of HDAC6 inhibitors, which were divided into two main classes, bulky and lipophilic cap groups and inhibitors with Ph linkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbHYjlHhuAC7Vg90H21EOLACvtfcHk0lgOg-lNSUXAfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnM&md5=fe940915b5ff69c061d09fd7ad129d87</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160428115959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160428115959%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DBeyond%2520the%2520selective%2520inhibition%2520of%2520histone%2520deacetylase%25206%26jtitle%3DMini.%2520Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1175%26epage%3D1184%26doi%3D10.2174%2F1389557516666160428115959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span> <span> </span><span class="NLM_article-title">Two catalytic domains are required for protein deacetylation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">2401</span>– <span class="NLM_lpage">2404</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500241200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C500241200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16272578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=2401-2404&author=Y.+Zhangauthor=B.+Gilquinauthor=S.+Khochbinauthor=P.+Matthias&title=Two+catalytic+domains+are+required+for+protein+deacetylation&doi=10.1074%2Fjbc.C500241200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two Catalytic Domains Are Required for Protein Deacetylation</span></div><div class="casAuthors">Zhang, Yu; Gilquin, Benoit; Khochbin, Saadi; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2401-2404</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC)-6 was recently identified as a dual substrate, possibly multisubstrate, deacetylase that can act both on acetylated histone tails and on α-tubulin acetylated on Lys40.  HDAC-6 is unique among deacetylases in having two hdac domains, and we have used this enzyme as a useful model to dissect the structural requirements for the deacetylation reaction.  In this report, we show that both hdac domains are required for the intact deacetylase activity of HDAC-6 in vitro and in vivo.  The spatial arrangement of these two domains in HDAC-6 is essential and alteration of the linker region between the two domains severely affects the catalytic activity.  Artificial chimeric HDACs, made by replacing the hdac domains in HDAC-6 with corresponding domains from other class II HDACs, show de novo deacetylase activity.  Taken together, our results demonstrate for the first time that the spatial arrangement of hdac domains is crit. for in vivo deacetylation reaction and may provide a useful model for the development of novel HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwsRUedc-X1LVg90H21EOLACvtfcHk0lgOg-lNSUXAfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVaruw%253D%253D&md5=7d7a32194709c18c0870e93022585624</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500241200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500241200%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DKhochbin%26aufirst%3DS.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DTwo%2520catalytic%2520domains%2520are%2520required%2520for%2520protein%2520deacetylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D2401%26epage%3D2404%26doi%3D10.1074%2Fjbc.C500241200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozinger, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Three proteins define a class of human histone deacetylases related to yeast Hda1p</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">4868</span>– <span class="NLM_lpage">4873</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.9.4868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.96.9.4868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10220385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4868-4873&author=C.+M.+Grozingerauthor=C.+A.+Hassigauthor=S.+L.+Schreiber&title=Three+proteins+define+a+class+of+human+histone+deacetylases+related+to+yeast+Hda1p&doi=10.1073%2Fpnas.96.9.4868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Three proteins define a class of human histone deacetylases related to yeast Hda1p</span></div><div class="casAuthors">Grozinger, Christina M.; Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4868-4873</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene expression is in part controlled by chromatin remodeling factors and the acetylation state of nucleosomal histones.  The latter process is regulated by histone acetyltransferases and histone deacetylases (HDACs).  Previously, three human and five yeast HDAC enzymes had been identified.  These can be categorized into two classes: the first class represented by yeast Rpd3-like proteins and the second by yeast Hda1-like proteins.  Human HDAC1, HDAC2, and HDAC3 proteins are members of the first class, whereas no class II human HDAC proteins had been identified.  The amino acid sequence of Hda1p was used to search the GenBank/expressed sequence tag databases to identify partial sequences from three putative class II human HDAC proteins.  The corresponding full-length cDNAs were cloned and defined as HDAC4, HDAC5, and HDAC6.  These proteins possess certain features present in the conserved catalytic domains of class I human HDACs, but also contain addnl. sequence domains.  Interestingly, HDAC6 contains an internal duplication of two catalytic domains, which appear to function independently of each other.  These class II HDAC proteins have differential mRNA expression in human tissues and possess in vitro HDAC activity that is inhibited by trichostatin A.  Coimmunopptn. expts. indicate that these HDAC proteins are not components of the previously identified HDAC1 and HDAC2 NRD and mSin3A complexes.  However, HDAC4 and HDAC5 assoc. with HDAC3 in vivo.  This finding suggests that the human class II HDAC enzymes may function in cellular processes distinct from those of HDAC1 and HDAC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcejIcOOdQtrVg90H21EOLACvtfcHk0lgOg-lNSUXAfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVKms7s%253D&md5=923a1617e1ed850f39fb5247e6baf14f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.9.4868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.9.4868%26sid%3Dliteratum%253Aachs%26aulast%3DGrozinger%26aufirst%3DC.%2BM.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DThree%2520proteins%2520define%2520a%2520class%2520of%2520human%2520histone%2520deacetylases%2520related%2520to%2520yeast%2520Hda1p%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D4868%26epage%3D4873%26doi%3D10.1073%2Fpnas.96.9.4868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span> <span> </span><span class="NLM_article-title">Characterization of the two catalytic domains in histone deacetylase 6</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.12.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.bbrc.2005.12.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16412385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2006&pages=45-50&author=H.+Zouauthor=Y.+Wuauthor=M.+Navreauthor=B.-C.+Sang&title=Characterization+of+the+two+catalytic+domains+in+histone+deacetylase+6&doi=10.1016%2Fj.bbrc.2005.12.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the two catalytic domains in histone deacetylase 6</span></div><div class="casAuthors">Zou, Hua; Wu, Yiqin; Navre, Marc; Sang, Bi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-50</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is the only known HDAC with two potentially functional catalytic domains, yet the role towards substrate played by these two domains remains ambiguous.  Most studies report HDAC6 activities measured using either immune complexes or in vitro translated products.  Here, we characterize the activity of highly purified recombinant HDAC6, mutants with active site histidine mutations in each domain (H216A and H611A), and individual catalytic domains.  The deacetylase activities of these proteins, as well as their kinetic parameters, were measured using histone, α-tubulin, and fluorogenic acetylated lysine as substrates.  Mutant H216A only slightly lowers the catalytic rate.  However, mutant H611A decreases the catalytic rate more than 5000-fold.  The first domain expressed alone is not catalytically active.  In contrast, the second domain shows only a modest decrease in substrate binding and product formation rate.  Our results indicate that the in vitro deacetylase activity of HDAC6 resides in the C-terminal second catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ljQmtqSmN7Vg90H21EOLACvtfcHk0ljpj8DLa9cIJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D&md5=160f566a8fdd2756e398869647e54fe7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.12.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.12.144%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DSang%26aufirst%3DB.-C.%26atitle%3DCharacterization%2520of%2520the%2520two%2520catalytic%2520domains%2520in%2520histone%2520deacetylase%25206%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D341%26spage%3D45%26epage%3D50%26doi%3D10.1016%2Fj.bbrc.2005.12.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seigneurin-Berny, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8035</span>– <span class="NLM_lpage">8044</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.23.8035-8044.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.21.23.8035-8044.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11689694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotl2gtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=8035-8044&author=D.+Seigneurin-Bernyauthor=A.+Verdelauthor=S.+Curtetauthor=C.+Lemercierauthor=J.+Garinauthor=S.+Rousseauxauthor=S.+Khochbin&title=Identification+of+components+of+the+murine+histone+deacetylase+6+complex%3A+link+between+acetylation+and+ubiquitination+signaling+pathways&doi=10.1128%2FMCB.21.23.8035-8044.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways</span></div><div class="casAuthors">Seigneurin-Berny, Daphne; Verdel, Andre; Curtet, Sandrine; Lemercier, Claudie; Garin, Jerome; Rousseaux, Sophie; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8035-8044</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The immunopurifn. of the endogenous cytoplasmic murine histone deacetylase 6 (mHDAC6), a member of the class II HDACs, from mouse testis cytosolic exts. allowed the identification of two assocd. proteins.  Both were mammalian homologues of yeast proteins known to interact with each other and involved in the ubiquitin signaling pathway: p97/VCP/Cdc48p, a homolog of yeast Cdc48p, and phospholipase A2-activating protein, a homolog of yeast UFD3 (ubiquitin fusion degrdn. protein 3).  Moreover, in the C-terminal region of mHDAC6, a conserved zinc finger-contg. domain named ZnF-UBP, also present in several ubiquitin-specific proteases, was discovered and was shown to mediate the specific binding of ubiquitin by mHDAC6.  By using a ubiquitin pull-down approach, nine major ubiquitin-binding proteins were identified in mouse testis cytosolic exts., and mHDAC6 was found to be one of them.  All of these findings strongly suggest that mHDAC6 could be involved in the control of protein ubiquitination.  The investigation of biochem. properties of the mHDAC6 complex in vitro further supported this hypothesis and clearly established a link between protein acetylation and protein ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr46PPvjekckbVg90H21EOLACvtfcHk0ljpj8DLa9cIJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotl2gtLs%253D&md5=82eccf722f2702e987e74d2fb5138c2b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.23.8035-8044.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.23.8035-8044.2001%26sid%3Dliteratum%253Aachs%26aulast%3DSeigneurin-Berny%26aufirst%3DD.%26aulast%3DVerdel%26aufirst%3DA.%26aulast%3DCurtet%26aufirst%3DS.%26aulast%3DLemercier%26aufirst%3DC.%26aulast%3DGarin%26aufirst%3DJ.%26aulast%3DRousseaux%26aufirst%3DS.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520components%2520of%2520the%2520murine%2520histone%2520deacetylase%25206%2520complex%253A%2520link%2520between%2520acetylation%2520and%2520ubiquitination%2520signaling%2520pathways%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D8035%26epage%3D8044%26doi%3D10.1128%2FMCB.21.23.8035-8044.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hook, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, R. N.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">13425</span>– <span class="NLM_lpage">13430</span>, <span class="refDoi"> DOI: 10.1073/pnas.172511699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.172511699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12354939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13425-13430&author=S.+S.+Hookauthor=A.+Orianauthor=S.+M.+Cowleyauthor=R.+N.+Eisenman&title=Histone+deacetylase+6+binds+polyubiquitin+through+its+zinc+finger+%28PAZ+domain%29+and+copurifies+with+deubiquitinating+enzymes&doi=10.1073%2Fpnas.172511699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes</span></div><div class="casAuthors">Hook, Sara S.; Orian, Amir; Cowley, Shaun M.; Eisenman, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13425-13430</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are thought to function as crit. mediators of transcriptional repression.  However, the physiol. targets and posttranslational modifications of the class II HDACs are largely unknown.  Here we show that the C terminus of HDAC 6 is both necessary and sufficient for specific assocn. with polyubiquitin.  This region contains a putative zinc finger but lacks significant similarity to other known ubiquitin binding domains.  Thus, we have designated this region as a PAZ domain, for Polyubiquitin Assocd. Zinc finger.  Although the PAZ domain possesses homol. with the zinc finger of deubiquitinating enzymes, it is dispensable for the deubiquitinating activity we find assocd. with HDAC6 following immunopurifn.  We also show that both HDAC 5 and HDAC 6 are ubiquitinated in vitro and in vivo.  However, both of these proteins are stable in vivo and do not appear to be targeted for rapid degrdn. by the proteasome.  Thus, HDAC6 is linked to the ubiquitin system via ubiquitin conjugation, polyubiquitin binding, and copurifn. with deubiquitinating enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo98Vuze3Eua7Vg90H21EOLACvtfcHk0ljpj8DLa9cIJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKmsrw%253D&md5=1000bc2fc966f1d66c7198364691bc80</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172511699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172511699%26sid%3Dliteratum%253Aachs%26aulast%3DHook%26aufirst%3DS.%2BS.%26aulast%3DOrian%26aufirst%3DA.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DEisenman%26aufirst%3DR.%2BN.%26atitle%3DHistone%2520deacetylase%25206%2520binds%2520polyubiquitin%2520through%2520its%2520zinc%2520finger%2520%2528PAZ%2520domain%2529%2520and%2520copurifies%2520with%2520deubiquitinating%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13425%26epage%3D13430%26doi%3D10.1073%2Fpnas.172511699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. M.</span></span> <span> </span><span class="NLM_article-title">Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">146493</span>, <span class="refDoi"> DOI: 10.1155/2011/146493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2011%2F146493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21234400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M7hsFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=146493&author=Y.+L.+Yaoauthor=W.+M.+Yang&title=Beyond+histone+and+deacetylase%3A+an+overview+of+cytoplasmic+histone+deacetylases+and+their+nonhistone+substrates&doi=10.1155%2F2011%2F146493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates</span></div><div class="casAuthors">Yao Ya-Li; Yang Wen-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146493</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylation of lysines is a prominent form of modification in mammalian proteins.  Deacetylation of proteins is catalyzed by histone deacetylases, traditionally named after their role in histone deacetylation, transcriptional modulation, and epigenetic regulation.  Despite the link between histone deacetylases and chromatin structure, some of the histone deacetylases reside in various compartments in the cytoplasm.  Here, we review how these cytoplasmic histone deacetylases are regulated, the identification of nonhistone substrates, and the functional implications of their nondeacetylase enzymatic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4UMp7VaIC6qx48Rj5GnGofW6udTcc2eb2sZCXGtmv-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7hsFajtQ%253D%253D&md5=bedcf26e85122904932428ec42166e3d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1155%2F2011%2F146493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F146493%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DW.%2BM.%26atitle%3DBeyond%2520histone%2520and%2520deacetylase%253A%2520an%2520overview%2520of%2520cytoplasmic%2520histone%2520deacetylases%2520and%2520their%2520nonhistone%2520substrates%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2011%26volume%3D2011%26spage%3D146493%26doi%3D10.1155%2F2011%2F146493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin</span>. <i>Protein Pept. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.2174/092986610791112620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.2174%2F092986610791112620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19961433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=555-558&author=Z.+Zhaoauthor=H.+Xuauthor=W.+Gong&title=Histone+deacetylase+6+%28HDAC6%29+is+an+independent+deacetylase+for+alpha-tubulin&doi=10.2174%2F092986610791112620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 (HDAC6) is an independent deacetylase for α-tubulin</span></div><div class="casAuthors">Zhao, Zhiqiang; Xu, Hang; Gong, Weimin</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-558</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a cytosolic enzyme that catalyzes the deacetylation of several proteins.  Acetylated tubulin was recently identified as a physiol. substrate of HDAC6.  However in previous reports, all in vitro binding and enzymic assays were accomplished with only partially purified protein samples.  Therefore, it still remained unclear whether HDAC6 alone could interact with tubulin and catalyze deacetylation.  Here, both binding and enzymic assays were conducted using recombinant-derived HDAC6 and purified α/β tubulin to eliminate possible contamination.  The results clearly demonstrated that the interaction between HDAC6 and tubulin was independent of other proteins.  In addn., HDAC6 could independently catalyze the deacetylation of both the tubulin dimer and microtubule polymer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYmCtVND6snrVg90H21EOLACvtfcHk0lhiyN4lO-S-eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVahtLc%253D&md5=833f3282749b11d7080c45da2941ba95</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F092986610791112620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986610791112620%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26atitle%3DHistone%2520deacetylase%25206%2520%2528HDAC6%2529%2520is%2520an%2520independent%2520deacetylase%2520for%2520alpha-tubulin%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2010%26volume%3D17%26spage%3D555%26epage%3D558%26doi%3D10.2174%2F092986610791112620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas-Burgos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olashaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dent, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17643370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=197-213&author=X.+Zhangauthor=Z.+Yuanauthor=Y.+Zhangauthor=S.+Yongauthor=A.+Salas-Burgosauthor=J.+Koomenauthor=N.+Olashawauthor=J.+T.+Parsonsauthor=X.+J.+Yangauthor=S.+R.+Dentauthor=T.+P.+Yaoauthor=W.+S.+Laneauthor=E.+Seto&title=HDAC6+modulates+cell+motility+by+altering+the+acetylation+level+of+cortactin&doi=10.1016%2Fj.molcel.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span></div><div class="casAuthors">Zhang, Xiaohong; Yuan, Zhigang; Zhang, Yingtao; Yong, Sarah; Salas-Burgos, Alexis; Koomen, John; Olashaw, Nancy; Parsons, J. Thomas; Yang, Xiang-Jiao; Dent, Sharon R.; Yao, Tso-Pang; Lane, William S.; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-213</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a tubulin-specific deacetylase that regulates microtubule-dependent cell movement.  In this study, we identify the F-actin-binding protein cortactin as a HDAC6 substrate.  We demonstrate that HDAC6 binds cortactin and that overexpression of HDAC6 leads to hypoacetylation of cortactin, whereas inhibition of HDAC6 activity leads to cortactin hyperacetylation.  HDAC6 alters the ability of cortactin to bind F-actin by modulating a "charge patch" in its repeat region.  Introduction of charge-preserving or charge-neutralizing mutations in this cortactin repeat region correlates with the gain or loss of F-actin binding ability, resp.  Cells expressing a charge-neutralizing cortactin mutant were less motile than control cells or cells expressing a charge-preserving mutant.  These findings suggest that, in addn. to its role in microtubule-dependent cell motility, HDAC6 influences actin-dependent cell motility by altering the acetylation status of cortactin, which, in turn, changes the F-actin binding activity of cortactin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSM-mAzzZOrVg90H21EOLACvtfcHk0lhiyN4lO-S-eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D&md5=752a0203b7cde321c9c5de07fba79ca7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYong%26aufirst%3DS.%26aulast%3DSalas-Burgos%26aufirst%3DA.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DOlashaw%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DDent%26aufirst%3DS.%2BR.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHDAC6%2520modulates%2520cell%2520motility%2520by%2520altering%2520the%2520acetylation%2520level%2520of%2520cortactin%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D197%26epage%3D213%26doi%3D10.1016%2Fj.molcel.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">An acetylation site in the middle domain of Hsp90 regulates chaperone function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2006.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17218278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=151-159&author=B.+T.+Scrogginsauthor=K.+Robzykauthor=D.+Wangauthor=M.+G.+Marcuauthor=S.+Tsutsumiauthor=K.+Beebeauthor=R.+J.+Cotterauthor=S.+Feltsauthor=D.+Toftauthor=L.+Karnitzauthor=N.+Rosenauthor=L.+Neckers&title=An+acetylation+site+in+the+middle+domain+of+Hsp90+regulates+chaperone+function&doi=10.1016%2Fj.molcel.2006.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An acetylation site in the middle domain of Hsp90 regulates chaperone function</span></div><div class="casAuthors">Scroggins, Bradley T.; Robzyk, Kenneth; Wang, Dongxia; Marcu, Monica G.; Tsutsumi, Shinji; Beebe, Kristin; Cotter, Robert J.; Felts, Sara; Toft, David; Karnitz, Larry; Rosen, Neal; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-159</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) chaperones represent a key subset of signaling proteins necessary for malignant transformation.  Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation.  Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity.  However, direct detn. of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites.  We now demonstrate that Hsp90 K294 is acetylated.  Mutational anal. of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding.  In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation.  These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposaZEwc5nC7Vg90H21EOLACvtfcHk0lheWprRb8A_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurk%253D&md5=abcc378115fc49ffcf3bf4a96289b18a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26aulast%3DRobzyk%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DKarnitz%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DAn%2520acetylation%2520site%2520in%2520the%2520middle%2520domain%2520of%2520Hsp90%2520regulates%2520chaperone%2520function%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D25%26spage%3D151%26epage%3D159%26doi%3D10.1016%2Fj.molcel.2006.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakiewicz, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comb, M. J.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">12686</span>– <span class="NLM_lpage">12690</span>, <span class="refDoi"> DOI: 10.1074/jbc.C700185200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C700185200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18356165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlGkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=12686-12690&author=Y.+Liauthor=X.+Zhangauthor=R.+D.+Polakiewiczauthor=T.+P.+Yaoauthor=M.+J.+Comb&title=HDAC6+is+required+for+epidermal+growth+factor-induced+beta-catenin+nuclear+localization&doi=10.1074%2Fjbc.C700185200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization</span></div><div class="casAuthors">Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Yao, Tso-Pang; Comb, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12686-12690</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nuclear translocation of β-catenin is a hallmark of Wnt signaling and is assocd. with various cancers.  In addn. to the canonical Wnt pathway activated by Wnt ligands, growth factors such as epidermal growth factor (EGF) also induce β-catenin dissocn. from the adherens junction complex, translocation into the nucleus, and activation of target genes such as c-myc.  Here we report that EGF-induced β-catenin nuclear localization and activation of c-myc are dependent on the deacetylase HDAC6.  We show that EGF induces HDAC6 translocation to the caveolae membrane and assocn. with β-catenin.  HDAC6 deacetylates β-catenin at lysine 49, a site frequently mutated in anaplastic thyroid cancer, and inhibits β-catenin phosphorylation at serine 45.  HDAC6 inactivation blocks EGF-induced β-catenin nuclear localization and decreases c-Myc expression, leading to inhibition of tumor cell proliferation.  These results suggest that EGF-induced nuclear localization of β-catenin is regulated by HDAC6-dependent deacetylation and provide a new mechanism by which HDAC inhibitors prevent tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgCOcF77MEkLVg90H21EOLACvtfcHk0lheWprRb8A_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlGkur8%253D&md5=96cf7599f54ca2c3713bb1dc71708db5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C700185200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C700185200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DHDAC6%2520is%2520required%2520for%2520epidermal%2520growth%2520factor-induced%2520beta-catenin%2520nuclear%2520localization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D12686%26epage%3D12690%26doi%3D10.1074%2Fjbc.C700185200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+B.+Parmigianiauthor=W.+S.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+A.+Marks&title=HDAC6+is+a+specific+deacetylase+of+peroxiredoxins+and+is+involved+in+redox+regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0lheWprRb8A_1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%2BB.%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHDAC6%2520is%2520a%2520specific%2520deacetylase%2520of%2520peroxiredoxins%2520and%2520is%2520involved%2520in%2520redox%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riolo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakirevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altura, R. A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">10885</span>– <span class="NLM_lpage">10893</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.308791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M111.308791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22334690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10885-10893&author=M.+T.+Rioloauthor=Z.+A.+Cooperauthor=M.+P.+Hollowayauthor=Y.+Chengauthor=C.+Bianchiauthor=E.+Yakirevichauthor=L.+Maauthor=Y.+E.+Chinauthor=R.+A.+Altura&title=Histone+deacetylase+6+%28HDAC6%29+deacetylates+survivin+for+its+nuclear+export+in+breast+cancer&doi=10.1074%2Fjbc.M111.308791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer</span></div><div class="casAuthors">Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Bianchi, Cesario; Yakirevich, Evgeny; Ma, Li; Chin, Y. Eugene; Altura, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10885-10893</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Survivin is an oncogenic protein that is highly expressed in breast cancer and has a dual function that is dependent on its subcellular localization.  In the cytosol, survivin blocks programmed cell death by inactivating caspase proteins; however, in the nucleus it facilitates cell division by regulating chromosomal movement and cytokinesis.  In prior work, we showed that survivin is acetylated by CREB-binding protein (CBP), which restricts its localization to the nuclear compartment and thereby inhibits its anti-apoptotic function.  Here, we identify histone deacetylase 6 (HDAC6) as responsible for abrogating CBP-mediated survivin acetylation in the estrogen receptor (ER)-pos. breast cancer cell line, MCF-7.  HDAC6 directly binds survivin, an interaction that is enhanced by CBP.  In quiescent breast cancer cells in culture and in malignant tissue sections from ER+ breast tumors, HDAC6 localizes to a perinuclear region of the cell, undergoing transport to the nucleus following CBP activation where it then deacetylates survivin.  Genetically modified mouse embryonic fibroblasts that lack mhdac6 localize survivin predominantly to the nuclear compartment, whereas wild-type mouse embryonic fibroblasts localize survivin to distinct cytoplasmic structures.  Together, these data imply that HDAC6 deacetylates survivin to regulate its nuclear export, a feature that may provide a novel target for patients with ER+ breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Ddc8wIGMMbVg90H21EOLACvtfcHk0liQb2ZRx8t9lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVWmu7Y%253D&md5=89d158f33f2717499a93c1dfb21d9813</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.308791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.308791%26sid%3Dliteratum%253Aachs%26aulast%3DRiolo%26aufirst%3DM.%2BT.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BP.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DYakirevich%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChin%26aufirst%3DY.%2BE.%26aulast%3DAltura%26aufirst%3DR.%2BA.%26atitle%3DHistone%2520deacetylase%25206%2520%2528HDAC6%2529%2520deacetylates%2520survivin%2520for%2520its%2520nuclear%2520export%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10885%26epage%3D10893%26doi%3D10.1074%2Fjbc.M111.308791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. V.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05564.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1471-4159.2008.05564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18636984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=2119-2130&author=H.+Dingauthor=P.+J.+Dolanauthor=G.+V.+Johnson&title=Histone+deacetylase+6+interacts+with+the+microtubule-associated+protein+tau&doi=10.1111%2Fj.1471-4159.2008.05564.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span></div><div class="casAuthors">Ding, Huiping; Dolan, Philip J.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2130</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6), a unique cytoplasmic deacetylase, likely plays a role in neurodegeneration by coordinating cell responses to abnormal protein aggregation.  Here, we provide in vitro and in vivo evidence that HDAC6 interacts with tau, a microtubule-assocd. protein that forms neurofibrillary tangles in Alzheimer's disease.  This interaction is mediated by the microtubule-binding domain on tau and the Ser/Glu tetradecapeptide domain on HDAC6.  Treatment with tubacin, a selective inhibitor of tubulin deacetylation activity of HDAC6, did not disrupt HDAC6-tau interaction.  Nonetheless tubacin treatment attenuated site-specific tau phosphorylation, as did shRNA-mediated knockdown of HDAC6.  Proteasome inhibition potentiated HDAC6-tau interactions and facilitated the concn. and co-localization of HDAC6 and tau in a perinuclear aggresome-like compartment, independent of HDAC6 tubulin deacetylase activity.  Furthermore, we obsd. that in Alzheimer's disease brains the protein level of HDAC6 was significantly increased.  These findings establish HDAC6 as a tau-interacting protein and as a potential modulator of tau phosphorylation and accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OtxbhpBU9LVg90H21EOLACvtfcHk0liQb2ZRx8t9lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM&md5=cf63da19f8f887459227b620d9a0898b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05564.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DDolan%26aufirst%3DP.%2BJ.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DHistone%2520deacetylase%25206%2520interacts%2520with%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D2119%26epage%3D2130%26doi%3D10.1111%2Fj.1471-4159.2008.05564.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">IIp45 inhibits cell migration through inhibition of HDAC6</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3560</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.063354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M109.063354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20008322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=3554-3560&author=Y.+Wuauthor=S.+W.+Songauthor=J.+Sunauthor=J.+M.+Brunerauthor=G.+N.+Fullerauthor=W.+Zhang&title=IIp45+inhibits+cell+migration+through+inhibition+of+HDAC6&doi=10.1074%2Fjbc.M109.063354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">IIp45 inhibits cell migration through inhibition of HDAC6</span></div><div class="casAuthors">Wu, Ying; Song, Sonya W.; Sun, Ji-Yuan; Bruner, Janet M.; Fuller, Gregory N.; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3554-3560</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">IIp45 (aka MIIP) is a newly discovered gene whose protein product inhibits cell migration.  HDAC6 is a class IIb deacetylase that specifically deacetylates α-tubulin, modulates microtubule dynamics, and promotes cell migration.  A yeast two-hybrid assay using IIp45 as bait identified HDAC6 protein as a binding partner of IIp45.  This phys. interaction of the two functionally antagonistic proteins was confirmed by glutathione S-transferase pulldown assay and co-immunopptn. assay in human cells.  Serial deletion constructs of HDAC6 were used to characterize the interaction of HDAC6 and IIp45, and this anal. found that the two catalytic domains of HDAC6 protein are required for IIp45 binding.  We examd. the protein expression patterns of IIp45 and HDAC6 in glioma tissues.  Elevated protein levels of HDAC6 were found in high grade glioma samples, in contrast to the decreased protein expression of IIp45.  The potential neg. regulation of HDAC6 expression by IIp45 was confirmed in cell lines with altered IIp45 expression by constitutive overexpression or small interfering RNA knockdown.  Protein turnover study revealed that overexpression of IIp45 significantly reduces the intracellular protein stability of endogenous HDAC6, indicating a possible mechanism for the neg. regulation of HDAC6 by IIp45.  Results from the HDAC activity assay demonstrated that overexpressed IIp45 effectively decreases HDAC6 activity, increases acetylated α-tubulin, and reduces cell migration.  The increased cell migration resulting from siIIp45 knockdown was significantly reversed by co-transfection of siHDAC6.  Thus, we report here for the first time a novel mechanism by which IIp45 inhibits cell motility through inhibition of HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_QSPx5PoB7Vg90H21EOLACvtfcHk0liQb2ZRx8t9lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmsb8%253D&md5=1869f13661eaf0871d99c51ccf3fceb2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.063354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.063354%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DBruner%26aufirst%3DJ.%2BM.%26aulast%3DFuller%26aufirst%3DG.%2BN.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DIIp45%2520inhibits%2520cell%2520migration%2520through%2520inhibition%2520of%2520HDAC6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D3554%26epage%3D3560%26doi%3D10.1074%2Fjbc.M109.063354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lissanu
Deribe, Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashaker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaidzidis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milutinovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratchmarova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buerkle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetchko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittanakom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurisica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagoev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerial, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagljar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6</span>. <i>Sci. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">ra84</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2000576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscisignal.2000576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20029029" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=ra84&author=Y+Lissanu%0ADeribeauthor=P.+Wildauthor=A.+Chandrashakerauthor=J.+Curakauthor=M.+H.+H.+Schmidtauthor=Y.+Kalaidzidisauthor=N.+Milutinovicauthor=I.+Kratchmarovaauthor=L.+Buerkleauthor=M.+J.+Fetchkoauthor=P.+Schmidtauthor=S.+Kittanakomauthor=K.+R.+Brownauthor=I.+Jurisicaauthor=B.+Blagoevauthor=M.+Zerialauthor=I.+Stagljarauthor=I.+Dikic&title=Regulation+of+epidermal+growth+factor+receptor+trafficking+by+lysine+deacetylase+HDAC6&doi=10.1126%2Fscisignal.2000576"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000576%26sid%3Dliteratum%253Aachs%26aulast%3DLissanu%2BDeribe%26aufirst%3DY%26aulast%3DWild%26aufirst%3DP.%26aulast%3DChandrashaker%26aufirst%3DA.%26aulast%3DCurak%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%2BH.%2BH.%26aulast%3DKalaidzidis%26aufirst%3DY.%26aulast%3DMilutinovic%26aufirst%3DN.%26aulast%3DKratchmarova%26aufirst%3DI.%26aulast%3DBuerkle%26aufirst%3DL.%26aulast%3DFetchko%26aufirst%3DM.%2BJ.%26aulast%3DSchmidt%26aufirst%3DP.%26aulast%3DKittanakom%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DK.%2BR.%26aulast%3DJurisica%26aufirst%3DI.%26aulast%3DBlagoev%26aufirst%3DB.%26aulast%3DZerial%26aufirst%3DM.%26aulast%3DStagljar%26aufirst%3DI.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DRegulation%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520trafficking%2520by%2520lysine%2520deacetylase%2520HDAC6%26jtitle%3DSci.%2520Signal.%26date%3D2009%26volume%3D2%26spage%3Dra84%26doi%3D10.1126%2Fscisignal.2000576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardiola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">455</span>, <span class="refDoi"> DOI: 10.1038/417455a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F417455a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12024216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.-F.+Wangauthor=T.-P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase&doi=10.1038%2F417455a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a microtubule-associated deacetylase</span></div><div class="casAuthors">Hubbert, Charlotte; Guardiola, Amaris; Shao, Rong; Kawaguchi, Yoshiharu; Ito, Akihiro; Nixon, Andrew; Yoshida, Minoru; Wang, Xiao-Fan; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6887</span>),
    <span class="NLM_cas:pages">455-458</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reversible acetylation of α-tubulin has been implicated in regulating microtubule stability and function.  The distribution of acetylated α-tubulin is tightly controlled and stereotypic.  Acetylated α-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts.  However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known.  Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase.  HDAC6 is localized exclusively in the cytoplasm, where it assocs. with microtubules and localizes with the microtubule motor complex contg. p150glued.  In vivo, the overexpression of HDAC6 leads to a global deacetylation of α-tubulin, whereas a decrease in HDAC6 increases α-tubulin acetylation.  In vitro, purified HDAC6 potently deacetylates α-tubulin in assembled microtubules.  Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility.  Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biol. processes beyond histone metab. and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76Er3MrWtO7Vg90H21EOLACvtfcHk0lgC1jUzgYkZww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D&md5=f18cbb0af388925c606e822358ba3da6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2F417455a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417455a%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26doi%3D10.1038%2F417455a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrador, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbrunn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranjo-Suárez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Cófreces, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente-Manzanares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ávila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Madrid, F.</span></span> <span> </span><span class="NLM_article-title">Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3445</span>, <span class="refDoi"> DOI: 10.1091/mbc.e06-01-0008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1091%2Fmbc.e06-01-0008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16738306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1ynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=3435-3445&author=J.+R.+Cabreroauthor=J.+M.+Serradorauthor=O.+Barreiroauthor=M.+Mittelbrunnauthor=S.+Naranjo-Su%C3%A1rezauthor=N.+Mart%C3%ADn-C%C3%B3frecesauthor=M.+Vicente-Manzanaresauthor=R.+Mazitschekauthor=J.+E.+Bradnerauthor=J.+%C3%81vilaauthor=A.+Valenzuela-Fern%C3%A1ndezauthor=F.+S%C3%A1nchez-Madrid&title=Lymphocyte+chemotaxis+is+regulated+by+histone+deacetylase+6%2C+independently+of+its+deacetylase+activity&doi=10.1091%2Fmbc.e06-01-0008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity</span></div><div class="casAuthors">Cabrero, J. Roman; Serrador, Juan M.; Barreiro, Olga; Mittelbrunn, Maria; Naranjo-Suarez, Salvador; Martin-Cofreces, Noa; Vicente-Manzanares, Miguel; Mazitschek, Ralph; Bradner, James E.; Avila, Jesus; Valenzuela-Fernandez, Agustin; Sanchez-Madrid, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3435-3445</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">In this work, the role of HDAC6, a type II histone deacetylase with tubulin deacetylase activity, in lymphocyte polarity, motility, and transmigration was explored.  HDAC6 was localized at dynamic subcellular structures as leading lamellipodia and the uropod in migrating T-cells.  However, HDAC6 activity did not appear to be involved in the polarity of migrating lymphocytes.  Overexpression of HDAC6 in freshly isolated lymphocytes and T-cell lines increased the lymphocyte migration mediated by chemokines and their transendothelial migration under shear flow.  Accordingly, the knockdown of HDAC6 expression in T-cells diminished their chemotactic capability.  Addnl. expts. with HDAC6 inhibitors (trichostatin, tubacin), other structural related mols. (niltubacin, MAZ-1391), and HDAC6 dead mutants showed that the deacetylase activity of HDAC6 was not involved in the modulatory effect of this mol. on cell migration.  Our results indicate that HDAC6 has an important role in the chemotaxis of T-lymphocytes, which is independent of its tubulin deacetylase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBwf0ZB--02rVg90H21EOLACvtfcHk0lgC1jUzgYkZww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1ynt70%253D&md5=1b1889ad68cbcd1d6fa1e24f8ab40704</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e06-01-0008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e06-01-0008%26sid%3Dliteratum%253Aachs%26aulast%3DCabrero%26aufirst%3DJ.%2BR.%26aulast%3DSerrador%26aufirst%3DJ.%2BM.%26aulast%3DBarreiro%26aufirst%3DO.%26aulast%3DMittelbrunn%26aufirst%3DM.%26aulast%3DNaranjo-Su%25C3%25A1rez%26aufirst%3DS.%26aulast%3DMart%25C3%25ADn-C%25C3%25B3freces%26aufirst%3DN.%26aulast%3DVicente-Manzanares%26aufirst%3DM.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3D%25C3%2581vila%26aufirst%3DJ.%26aulast%3DValenzuela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez-Madrid%26aufirst%3DF.%26atitle%3DLymphocyte%2520chemotaxis%2520is%2520regulated%2520by%2520histone%2520deacetylase%25206%252C%2520independently%2520of%2520its%2520deacetylase%2520activity%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2006%26volume%3D17%26spage%3D3435%26epage%3D3445%26doi%3D10.1091%2Fmbc.e06-01-0008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2005.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15916966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.-T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.-P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span></div><div class="casAuthors">Kovacs, Jeffrey J.; Murphy, Patrick J. M.; Gaillard, Stephanie; Zhao, Xuan; Wu, June-Tai; Nicchitta, Christopher V.; Yoshida, Minoru; Toft, David O.; Pratt, William B.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) and its accessory cochaperones function by facilitating the structural maturation and complex assembly of client proteins, including steroid hormone receptors and selected kinases.  By promoting the activity and stability of these signaling proteins, Hsp90 has emerged as a crit. modulator in cell signaling.  Here, we present evidence that Hsp90 chaperone activity is regulated by reversible acetylation and controlled by the deacetylase HDAC6.  We show that HDAC6 functions as an Hsp90 deacetylase.  Inactivation of HDAC6 leads to Hsp90 hyperacetylation, its dissocn. from an essential cochaperone, p23, and a loss of chaperone activity.  In HDAC6-deficient cells, Hsp90-dependent maturation of the glucocorticoid receptor (GR) is compromised, resulting in GR defective in ligand binding, nuclear translocation, and transcriptional activation.  Our results identify Hsp90 as a target of HDAC6 and suggest reversible acetylation as a unique mechanism that regulates Hsp90 chaperone complex activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rzQe2Zsw_7Vg90H21EOLACvtfcHk0lhDFm9o6wAJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D&md5=338a8456c56a74d82ad3d28cbccae33f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.-T.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.molcel.2005.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vourc’h, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1101/gad.436407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1101%2Fgad.436407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17785525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVaks73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2172-2181&author=C.+Boyaultauthor=Y.+Zhangauthor=S.+Fritahauthor=C.+Caronauthor=B.+Gilquinauthor=S.+H.+Kwonauthor=C.+Garridoauthor=T.-P.+Yaoauthor=C.+Vourc%E2%80%99hauthor=P.+Matthiasauthor=S.+Khochbin&title=HDAC6+controls+major+cell+response+pathways+to+cytotoxic+accumulation+of+protein+aggregates&doi=10.1101%2Fgad.436407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates</span></div><div class="casAuthors">Boyault, Cyril; Zhang, Yu; Fritah, Sabrina; Caron, Cecile; Gilquin, Benoit; Kwon, So Hee; Garrido, Carmen; Yao, Tso-Pang; Vourc'h, Claire; Matthias, Patrick; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A cellular defense mechanism counteracts the deleterious effects of misfolded protein accumulation by eliciting a stress response.  The cytoplasmic deacetylase HDAC6 (histone deacetylase 6) was previously shown to be a key element in this response by coordinating the clearance of protein aggregates through aggresome formation and their autophagic degrdn.  Here, for the first time, we demonstrate that HDAC6 is involved in another crucial cell response to the accumulation of ubiquitinated protein aggregates, and unravel its mol. basis.  Indeed, our data show that HDAC6 senses ubiquitinated cellular aggregates and consequently induces the expression of major cellular chaperones by triggering the dissocn. of a repressive HDAC6/HSP1 (heat-shock factor 1)/HSP90 (heat-shock protein 90) complex and a subsequent HSF1 activation.  HDAC6 therefore appears as a master regulator of the cell protective response to cytotoxic protein aggregate formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-1tZncylbbVg90H21EOLACvtfcHk0lhDFm9o6wAJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVaks73M&md5=b136e00ef15ffbb770f40f9d708e63be</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1101%2Fgad.436407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.436407%26sid%3Dliteratum%253Aachs%26aulast%3DBoyault%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFritah%26aufirst%3DS.%26aulast%3DCaron%26aufirst%3DC.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DT.-P.%26aulast%3DVourc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DMatthias%26aufirst%3DP.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DHDAC6%2520controls%2520major%2520cell%2520response%2520pathways%2520to%2520cytotoxic%2520accumulation%2520of%2520protein%2520aggregates%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D2172%26epage%3D2181%26doi%3D10.1101%2Fgad.436407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaurin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00939-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0092-8674%2803%2900939-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14675537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWgurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2003&pages=727-738&author=Y.+Kawaguchiauthor=J.+J.+Kovacsauthor=A.+McLaurinauthor=J.+M.+Vanceauthor=A.+Itoauthor=T.-P.+Yao&title=The+deacetylase+HDAC6+regulates+aggresome+formation+and+cell+viability+in+response+to+misfolded+protein+stress&doi=10.1016%2FS0092-8674%2803%2900939-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</span></div><div class="casAuthors">Kawaguchi, Yoshiharu; Kovacs, Jeffrey J.; McLaurin, Adam; Vance, Jeffery M.; Ito, Akihiro; Yao, Tso-pang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The efficient clearance of cytotoxic misfolded protein aggregates is crit. for cell survival.  Misfolded protein aggregates are transported and removed from the cytoplasm by dynein motors via the microtubule network to a novel organelle termed the aggresome where they are processed.  However, the means by which dynein motors recognize misfolded protein cargo, and the cellular factors that regulate aggresome formation, remain unknown.  We have discovered that HDAC6, a microtubule-assocd. deacetylase, is a component of the aggresome.  We demonstrate that HDAC6 has the capacity to bind both polyubiquitinated misfolded proteins and dynein motors, thereby acting to recruit misfolded protein cargo to dynein motors for transport to aggresomes.  Indeed, cells deficient in HDAC6 fail to clear misfolded protein aggregates from the cytoplasm, cannot form aggresomes properly, and are hypersensitive to the accumulation of misfolded proteins.  These findings identify HDAC6 as a crucial player in the cellular management of misfolded protein-induced stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnh-j9NJeDLrVg90H21EOLACvtfcHk0lhDFm9o6wAJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWgurfL&md5=4bb225e89efa841c73b6ca12284cbb06</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900939-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900939-5%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMcLaurin%26aufirst%3DA.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520deacetylase%2520HDAC6%2520regulates%2520aggresome%2520formation%2520and%2520cell%2520viability%2520in%2520response%2520to%2520misfolded%2520protein%2520stress%26jtitle%3DCell%26date%3D2003%26volume%3D115%26spage%3D727%26epage%3D738%26doi%3D10.1016%2FS0092-8674%2803%2900939-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopito, R. R.</span></span> <span> </span><span class="NLM_article-title">Aggresomes, inclusion bodies and protein aggregation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/S0962-8924(00)01852-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0962-8924%2800%2901852-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11121744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot12ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=524-530&author=R.+R.+Kopito&title=Aggresomes%2C+inclusion+bodies+and+protein+aggregation&doi=10.1016%2FS0962-8924%2800%2901852-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Aggresomes, inclusion bodies and protein aggregation</span></div><div class="casAuthors">Kopito, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">524-530</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 49 refs.  Intracellular and extracellular accumulation of aggregated protein are linked to many diseases, including ageing-related neurodegeneration and systemic amyloidosis.  Cells avoid accumulating potentially toxic aggregates by mechanisms including the suppression of aggregate formation by mol. chaperones and the degrdn. of misfolded proteins by proteasomes.  Once formed, aggregates tend to be refractory to proteolysis and to accumulate in inclusion bodies.  This accumulation has been assumed to be a diffusion-limited process, but recent studies suggest that, in animal cells, aggregated proteins are specifically delivered to inclusion bodies by dynein-dependent retrograde transport on microtubules.  This microtubule-dependent inclusion body is called an aggresome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAaQXcIeg9hLVg90H21EOLACvtfcHk0liqehjM2G1dGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot12ltL0%253D&md5=333f16b97bbb712f16cb887462323546</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2800%2901852-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252800%252901852-3%26sid%3Dliteratum%253Aachs%26aulast%3DKopito%26aufirst%3DR.%2BR.%26atitle%3DAggresomes%252C%2520inclusion%2520bodies%2520and%2520protein%2520aggregation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D524%26epage%3D530%26doi%3D10.1016%2FS0962-8924%2800%2901852-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Klaucke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">HDAC6–p97/VCP controlled polyubiquitin chain turnover</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3357</span>– <span class="NLM_lpage">3366</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.emboj.7601210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16810319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1yqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3357-3366&author=C.+Boyaultauthor=B.+Gilquinauthor=Y.+Zhangauthor=V.+Rybinauthor=E.+Garmanauthor=W.+Meyer-Klauckeauthor=P.+Matthiasauthor=C.+W.+M%C3%BCllerauthor=S.+Khochbin&title=HDAC6%E2%80%93p97%2FVCP+controlled+polyubiquitin+chain+turnover&doi=10.1038%2Fsj.emboj.7601210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6-p97/VCP controlled polyubiquitin chain turnover</span></div><div class="casAuthors">Boyault, Cyril; Gilquin, Benoit; Zhang, Yu; Rybin, Vladimir; Garman, Elspeth; Meyer-Klaucke, Wolfram; Matthias, Patrick; Mueller, Christoph W.; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3357-3366</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HDAC6 is a unique cytoplasmic deacetylase capable of interacting with ubiquitin.  Using a combination of biophys., biochem. and biol. approaches, we have characterized the ubiquitin-binding domain of HDAC6, named ZnF-UBP, and investigated its biol. functions.  These studies show that the three Zn ion-contg. HDAC6 ZnF-UBP domain presents the highest known affinity for ubiquitin monomers and mediates the ability of HDAC6 to neg. control the cellular polyubiquitin chain turnover.  We further show that HDAC6-interacting chaperone, p97/VCP, dissocs. the HDAC6-ubiquitin complexes and counteracts the ability of HDAC6 to promote the accumulation of polyubiquitinated proteins.  We propose that a finely tuned balance of HDAC6 and p97/VCP concns. dets. the fate of ubiquitinated misfolded proteins: p97/VCP would promote protein degrdn. and ubiquitin turnover, whereas HDAC6 would favor the accumulation of ubiquitinated protein aggregates and inclusion body formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCcS1_T95D37Vg90H21EOLACvtfcHk0liqehjM2G1dGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1yqtbc%253D&md5=a44c580c374cef04665f889f991bc7c1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601210%26sid%3Dliteratum%253Aachs%26aulast%3DBoyault%26aufirst%3DC.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRybin%26aufirst%3DV.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DMeyer-Klaucke%26aufirst%3DW.%26aulast%3DMatthias%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BW.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DHDAC6%25E2%2580%2593p97%252FVCP%2520controlled%2520polyubiquitin%2520chain%2520turnover%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3357%26epage%3D3366%26doi%3D10.1038%2Fsj.emboj.7601210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vij, N.</span></span> <span> </span><span class="NLM_article-title">AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00462.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1582-4934.2008.00462.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18798739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Whu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=2511-2518&author=N.+Vij&title=AAA+ATPase+p97%2FVCP%3A+cellular+functions%2C+disease+and+therapeutic+potential&doi=10.1111%2Fj.1582-4934.2008.00462.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential</span></div><div class="casAuthors">Vij, Neeraj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6A</span>),
    <span class="NLM_cas:pages">2511-2518</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  P97/VCP, a member of the AAA-ATPase super family, has been assocd. with a wide variety of essential cellular protein pathways com prising: (i) nuclear envelope reconstruction, (ii) cell cycle, (iii) Golgi reassembly, (iv) suppression of apoptosis and (v) DNA-damage response [1-6].  In addn., vasolin-contg. protein (VCP) dislodges the ubiquitinated proteins from the endoplasmic reticulum (ER) and chaperones them to the cytosol for proteasomal degrdn. by endoplasmic reticulum-assocd. degrdn. (ERAD) [7].  The interactions of VCP in the endoplasmic reticulum-assocd. degrdn. (ERAD) pathway det. the substrate selection for proteasomal degrdn.  Moreover, the interaction with VCP is also required for the ubiquitination of substrate.  VCP is phosphorylated by the master cellular kinase, Akt as a mechanism to regulate ERAD [8].  These multiple interactions in protein degrdn. pathways points to central role of VCP in misfolded protein degrdn.  VCP has a poly-glutamine and ubiquitin-binding capacity and is involved in proteasomal degrdn., cytosolic aggregation and processing of polyQ and polyUb aggregates in neurodegenerative and other misfolded protein diseases [9, 10].  Mutations in VCP gene are also linked to a protein deposition disorder, IBMFD [11].  We propose VCP as a therapeutic target for diseases caused by cytosolic protein aggregation or degrdn. of misfolded protein.  We predict that selective interference of VCP interaction(s) with aberrant protein or its ERAD function will be an effective therapeutic site to rescue functional misfolded protein in diseases like cystic fibrosis and alpha-1-trypsin deficiency.  The control of VCP expression is also proposed to be a potential therapeutic target in ex-polyQ-induced neurodegenerative diseases [12].  The further functional characterization of VCP and assocd. proteins in these diseases will help in designing of selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB8IsWhgUyobVg90H21EOLACvtfcHk0liqehjM2G1dGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Whu74%253D&md5=aa87bb41523de02cf3165f0ddee33bd7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00462.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00462.x%26sid%3Dliteratum%253Aachs%26aulast%3DVij%26aufirst%3DN.%26atitle%3DAAA%2520ATPase%2520p97%252FVCP%253A%2520cellular%2520functions%252C%2520disease%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D2511%26epage%3D2518%26doi%3D10.1111%2Fj.1582-4934.2008.00462.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span> <span> </span><span class="NLM_article-title">The novel histone deacetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">655</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0688-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41419-018-0688-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29844403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=655&author=S.-J.+Fanauthor=F.-I.+Huangauthor=J.-P.+Liouauthor=C.-R.+Yang&title=The+novel+histone+deacetylase+6+inhibitor%2C+MPT0G211%2C+ameliorates+tau+phosphorylation+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41419-018-0688-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Fan Sheng-Jun; Huang Fang-I; Yang Chia-Ron; Liou Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">655</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a dreadful neurodegenerative disease that leads to severe impairment of cognitive function, leading to a drastic decline in the quality of life.  The primary pathological features of AD include senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs), comprising aggregated amyloid β (Aβ) and hyperphosphorylated tau protein, respectively, in the hippocampus of AD patients.  Histone deacetylase 6 (HDAC6) is a key enzyme in this neurodegenerative disease, in particular, as it relates to tau hyperphosphorylation.  This study aimed to investigate the protective effects and mechanism of the novel HDAC6 inhibitor, MPT0G211, using an AD model.  Our results indicated that MPT0G211 significantly reduced tau phosphorylation and aggregation, the processes highly correlated with the formation of NFTs.  This HDAC6 inhibitory activity resulted in an increase in acetylated Hsp90, which decreased Hsp90 and HDAC6 binding, causing ubiquitination of phosphorylated tau proteins.  In addition, a significant increase of phospho-glycogen synthase kinase-3β (phospho-GSK3β) on Ser9 (the inactive form) through Akt phosphorylation was associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment.  In AD in vivo models, MPT0G211 appeared to ameliorate learning and memory impairment in animals.  Furthermore, MPT0G211 treatment reduced the amount of phosphorylated tau in the hippocampal CA1 region.  In summary, MPT0G211 treatment appears to be a promising strategy for improving the AD phenotypes, including tau hyperphosphorylation and aggregation, neurodegeneration, and learning and memory impairment, making it a valuable agent for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThODJPxWFHy0EgZCMqtRBifW6udTcc2ebD_fR5830tgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D&md5=5b9b227e4df99bd8150004e7342c214c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0688-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0688-5%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.-J.%26aulast%3DHuang%26aufirst%3DF.-I.%26aulast%3DLiou%26aufirst%3DJ.-P.%26aulast%3DYang%26aufirst%3DC.-R.%26atitle%3DThe%2520novel%2520histone%2520deacetylase%25206%2520inhibitor%252C%2520MPT0G211%252C%2520ameliorates%2520tau%2520phosphorylation%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D655%26doi%3D10.1038%2Fs41419-018-0688-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiery, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeman, J. P.</span></span> <span> </span><span class="NLM_article-title">Complex networks orchestrate epithelial–mesenchymal transitions</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1038/nrm1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrm1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16493418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=131-142&author=J.+P.+Thieryauthor=J.+P.+Sleeman&title=Complex+networks+orchestrate+epithelial%E2%80%93mesenchymal+transitions&doi=10.1038%2Fnrm1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Complex networks orchestrate epithelial-mesenchymal transitions</span></div><div class="casAuthors">Thiery, Jean Paul; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epithelial-mesenchymal transition is an indispensable mechanism during morphogenesis, as without mesenchymal cells, tissues and organs will never be formed.  However, epithelial-cell plasticity, coupled to the transient or permanent formation of mesenchyme, goes far beyond the problem of cell-lineage segregation.  Understanding how mesenchymal cells arise from an epithelial default status will also have a strong impact in unraveling the mechanisms that control fibrosis and cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi1bapHui8_rVg90H21EOLACvtfcHk0ljZnRZD-GpODg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWltLg%253D&md5=e336d638cb16ff351ef77b2c3ac09d06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrm1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1835%26sid%3Dliteratum%253Aachs%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DComplex%2520networks%2520orchestrate%2520epithelial%25E2%2580%2593mesenchymal%2520transitions%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D131%26epage%3D142%26doi%3D10.1038%2Fnrm1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavadil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttinger, E. P.</span></span> <span> </span><span class="NLM_article-title">TGF-β and epithelial-to-mesenchymal transitions</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5764</span>– <span class="NLM_lpage">5774</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1208927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.onc.1208927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16123809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=5764-5774&author=J.+Zavadilauthor=E.+P.+B%C3%B6ttinger&title=TGF-%CE%B2+and+epithelial-to-mesenchymal+transitions&doi=10.1038%2Fsj.onc.1208927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">TGF-β and epithelial-to-mesenchymal transitions</span></div><div class="casAuthors">Zavadil, Jiri; Boettinger, Erwin P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5764-5774</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Remarkable phenotype plasticity of epithelial cells underlies morphogenesis, epithelial repair and tumor invasiveness.  Detailed understanding of the contextual cues and mol. mediators that control epithelial plasticity will be required in order to develop viable therapeutic approaches targeting epithelial-to-mesenchymal transition (EMT), an advanced manifestation of epithelial plasticity.  Members of the transforming growth factor (TGF-β) family of growth factors can initiate and maintain EMT in a variety of biol. systems and pathophysiol. context by activating major signaling pathways and transcriptional regulators integrated in extensive signaling networks.  Here we will review the distinct physiol. contexts of EMT and the underlying mol. signaling networks controlled by TGF-β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPUSiLxo47c7Vg90H21EOLACvtfcHk0ljZnRZD-GpODg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVertbw%253D&md5=7c08c348502658fd0e79543670c6c30d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208927%26sid%3Dliteratum%253Aachs%26aulast%3DZavadil%26aufirst%3DJ.%26aulast%3DB%25C3%25B6ttinger%26aufirst%3DE.%2BP.%26atitle%3DTGF-%25CE%25B2%2520and%2520epithelial-to-mesenchymal%2520transitions%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D5764%26epage%3D5774%26doi%3D10.1038%2Fsj.onc.1208927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldschmidt-Clermont, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">Transforming growth factor-β–induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000118599.25944.D5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1161%2F01.RES.0000118599.25944.D5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14739161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVGlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=617-625&author=S.+Zhuauthor=P.+J.+Goldschmidt-Clermontauthor=C.+Dong&title=Transforming+growth+factor-%CE%B2%E2%80%93induced+inhibition+of+myogenesis+is+mediated+through+Smad+pathway+and+is+modulated+by+microtubule+dynamic+stability&doi=10.1161%2F01.RES.0000118599.25944.D5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming Growth Factor-β-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability</span></div><div class="casAuthors">Zhu, Shoukang; Goldschmidt-Clermont, Pascal J.; Dong, Chunming</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-625</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The expression of muscle-specific genes assocd. with myogenesis is controlled by several myogenic transcription factors, including myogenin and MEF2D.  Transforming growth factor-β (TGF-β) has been shown to inhibit myogenesis, yet the mol. mechanisms underlying such inhibition are not known.  In the present study, TGF-β was shown to inhibit myogenin and MEF2D expression and myotube formation in C2C12 myoblasts cultured in differentiation medium in a cell d.-dependent manner.  Transfection of C2C12 cells with Smad7, an antagonist for TGF-β/Smad signaling, restored the capacity of these cells to differentiate in the presence of TGF-β or when cultured in growth medium at low confluence, conditions that hinder muscle differentiation.  Moreover, nocodazole, a microtubule-destabilizing agent, enhanced the inhibition of myogenesis exerted by TGF-β, an effect that could be restored by tubulin-polymg. agent taxol, both of which have been shown to affect Smad-microtubule interaction and regulate TGF-β/Smad signaling.  The authors' results indicate that TGF-β inhibits myogenesis, at least in part, via Smad pathway, and provide evidence that low-dose pharmacol. agents taxol and nocodazole can be used as a means to modulate myogenesis without affecting cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4lzd3-EYPbVg90H21EOLACvtfcHk0lg-cgHoK8N4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVGlu7Y%253D&md5=cc2a87fd5c31ccc8c7fa4d1fbd780872</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000118599.25944.D5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000118599.25944.D5%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DGoldschmidt-Clermont%26aufirst%3DP.%2BJ.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%25E2%2580%2593induced%2520inhibition%2520of%2520myogenesis%2520is%2520mediated%2520through%2520Smad%2520pathway%2520and%2520is%2520modulated%2520by%2520microtubule%2520dynamic%2520stability%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D94%26spage%3D617%26epage%3D625%26doi%3D10.1161%2F01.RES.0000118599.25944.D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">21065</span>– <span class="NLM_lpage">21073</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802786200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M802786200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18499657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21065-21073&author=B.+Shanauthor=T.-p.+Yaoauthor=H.+T.+Nguyenauthor=Y.+Zhuoauthor=D.+R.+Levyauthor=R.+C.+Klingsbergauthor=H.+Taoauthor=M.+L.+Palmerauthor=K.+N.+Holderauthor=J.+A.+Lasky&title=Requirement+of+HDAC6+for+transforming+growth+factor-%CE%B21-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M802786200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span></div><div class="casAuthors">Shan, Bin; Yao, Tso-pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21065-21073</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aberrant expression of transforming growth factor (TGF)-β1 in the tumor microenvironment and fibrotic lesions plays a crit. role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT).  EMT promotes tumor cell motility and invasiveness.  How EMT affects motility and invasion is not well understood.  Here we report that HDAC6 is a novel modulator of TGF-β1-induced EMT.  HDAC6 is a microtubule-assocd. deacetylase that predominantly deacetylates nonhistone proteins, including α-tubulin, and regulates cell motility.  We showed that TGF-β1-induced EMT is accompanied by HDAC6-dependent deacetylation of α-tubulin.  Importantly, inhibition of HDAC6 by small interfering RNA or the small mol. inhibitor tubacin attenuated the TGF-β1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers.  Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-β1.  Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of α-tubulin as well as the expression of EMT markers.  These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-β-SMAD3 signaling cascade.  Our results identify HDAC6 as a crit. regulator of EMT and a potential therapeutic target against pathol. EMT, a key event for tumor progression and fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcx6lyo8vYbVg90H21EOLACvtfcHk0lg-cgHoK8N4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D&md5=41e37f298b484fc259266bdc4aa2eff5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802786200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802786200%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DT.-p.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLevy%26aufirst%3DD.%2BR.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPalmer%26aufirst%3DM.%2BL.%26aulast%3DHolder%26aufirst%3DK.%2BN.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DRequirement%2520of%2520HDAC6%2520for%2520transforming%2520growth%2520factor-%25CE%25B21-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21065%26epage%3D21073%26doi%3D10.1074%2Fjbc.M802786200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+Parmigianiauthor=W.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+Marks&title=HDAC6+is+a+specific+deacetylase+of+peroxiredoxins+and+is+involved+in+redox+regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0lg-cgHoK8N4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%26atitle%3DHDAC6%2520is%2520a%2520specific%2520deacetylase%2520of%2520peroxiredoxins%2520and%2520is%2520involved%2520in%2520redox%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hah, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">28775</span>– <span class="NLM_lpage">28784</span>, <span class="refDoi"> DOI: 10.1074/jbc.M505362200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M505362200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15941719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFSnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=28775-28784&author=J.+C.+Moonauthor=Y.-S.+Hahauthor=W.+Y.+Kimauthor=B.+G.+Jungauthor=H.+H.+Jangauthor=J.+R.+Leeauthor=S.+Y.+Kimauthor=Y.+M.+Leeauthor=M.+G.+Jeonauthor=C.+W.+Kimauthor=M.+J.+Choauthor=S.+Y.+Lee&title=Oxidative+stress-dependent+structural+and+functional+switching+of+a+human+2-Cys+peroxiredoxin+isotype+II+that+enhances+HeLa+cell+resistance+to+H2O2-induced+cell+death&doi=10.1074%2Fjbc.M505362200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress-dependent Structural and Functional Switching of a Human 2-Cys Peroxiredoxin Isotype II That Enhances HeLa Cell Resistance to H2O2-induced Cell Death</span></div><div class="casAuthors">Moon, Jeong Chan; Hah, Young-Sool; Kim, Woe Yeon; Jung, Bae Gyo; Jang, Ho Hee; Lee, Jung Ro; Kim, Sun Young; Lee, Young Mee; Jeon, Min Gyu; Kim, Choong Won; Cho, Moo Je; Lee, Sang Yeol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">28775-28784</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although biochem. properties of 2-Cys peroxiredoxins (Prxs) have been extensively studied, their real physiol. functions in higher eukaryotic cells remain obscure and certainly warrant further study.  Here we demonstrated that human (h) PrxII, a cytosolic isotype of human 2-Cys Prx, has dual functions as a peroxidase and a mol. chaperone, and that these different functions are closely assocd. with its adoption of distinct protein structures.  Upon exposure to oxidative stress, hPrxII assumes a high mol. wt. complex structure that has a highly efficient chaperone function.  However, the subsequent removal of stressors induces the dissocn. of this protein structure into low mol. wt. proteins and triggers a chaperone-to-peroxidase functional switch.  The formation of a high mol. wt. hPrxII complex depends on the hyperoxidn. of its N-terminal peroxidatizable Cys residue as well as on its C-terminal domain, which contains a "YF motif" that is exclusively found in eukaryotic 2-Cys Prxs.  A C-terminally truncated hPrxII exists as low and oligomeric protein species and does not respond to oxidative stress.  Moreover, this C-terminal deletion of hPrxII converted it from an oxidn.-sensitive to a hyperoxidn.-resistant form of peroxidase.  When functioning as a chaperone, hPrxII protects HeLa cells from H2O2-induced cell death, as measured by a terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling assay and fluorescence-activated cell sorting anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqugN3_X8eFy7Vg90H21EOLACvtfcHk0ljpdE8TKJunvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFSnt70%253D&md5=980903047d1ca308ece4cfb62f0fed64</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505362200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505362200%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.%2BC.%26aulast%3DHah%26aufirst%3DY.-S.%26aulast%3DKim%26aufirst%3DW.%2BY.%26aulast%3DJung%26aufirst%3DB.%2BG.%26aulast%3DJang%26aufirst%3DH.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DJeon%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DC.%2BW.%26aulast%3DCho%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26atitle%3DOxidative%2520stress-dependent%2520structural%2520and%2520functional%2520switching%2520of%2520a%2520human%25202-Cys%2520peroxiredoxin%2520isotype%2520II%2520that%2520enhances%2520HeLa%2520cell%2520resistance%2520to%2520H2O2-induced%2520cell%2520death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D28775%26epage%3D28784%26doi%3D10.1074%2Fjbc.M505362200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, L. B.</span></span> <span> </span><span class="NLM_article-title">Structure, mechanism and regulation of peroxiredoxins</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/S0968-0004(02)00003-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0968-0004%2802%2900003-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12517450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=32-40&author=Z.+A.+Woodauthor=E.+Schr%C3%B6derauthor=J.+R.+Harrisauthor=L.+B.+Poole&title=Structure%2C+mechanism+and+regulation+of+peroxiredoxins&doi=10.1016%2FS0968-0004%2802%2900003-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, mechanism and regulation of peroxiredoxins</span></div><div class="casAuthors">Wood, Zachary A.; Schroder, Ewald; Robin Harris, J.; Poole, Leslie B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-40</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxiredoxins (Prxs) are a ubiquitous family of antioxidant enzymes that also control cytokine-induced peroxide levels which mediate signal transduction in mammalian cells.  Prxs can be regulated by changes to phosphorylation, redox and possibly oligomerization states.  Prxs are divided into 3 classes: (1) typical 2-Cys Prxs; (2) atypical 2-Cys Prxs; and (3) 1-Cys Prxs.  All Prxs share the same basic catalytic mechanism, in which an active site Cys (the peroxidatic Cys) residue is oxidized to a sulfenic acid by the peroxide substrate.  The recycling of the sulfenic acid back to a thiol is what distinguishes the 3 enzyme classes.  Using crystal structures, a detailed catalytic cycle has been derived for typical 2-Cys Prxs, including a model for the redox-regulated oligomeric state proposed to control enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5HZUm7rTYLVg90H21EOLACvtfcHk0ljpdE8TKJunvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFGh&md5=3d4017f1989545b079330ec73929352f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2802%2900003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252802%252900003-8%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DZ.%2BA.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DJ.%2BR.%26aulast%3DPoole%26aufirst%3DL.%2BB.%26atitle%3DStructure%252C%2520mechanism%2520and%2520regulation%2520of%2520peroxiredoxins%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D32%26epage%3D40%26doi%3D10.1016%2FS0968-0004%2802%2900003-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hockly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathasivam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazi-Noori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowden, P. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, G. P.</span></span> <span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2046</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437870100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0437870100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12576549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=2041-2046&author=E.+Hocklyauthor=V.+M.+Richonauthor=B.+Woodmanauthor=D.+L.+Smithauthor=X.+Zhouauthor=E.+Rosaauthor=K.+Sathasivamauthor=S.+Ghazi-Nooriauthor=A.+Mahalauthor=P.+A.+S.+Lowdenauthor=J.+S.+Steffanauthor=J.+L.+Marshauthor=L.+M.+Thompsonauthor=C.+M.+Lewisauthor=P.+A.+Marksauthor=G.+P.+Bates&title=Suberoylanilide+hydroxamic+acid%2C+a+histone+deacetylase+inhibitor%2C+ameliorates+motor+deficits+in+a+mouse+model+of+Huntington%E2%80%99s+disease&doi=10.1073%2Fpnas.0437870100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease</span></div><div class="casAuthors">Hockly, Emma; Richon, Victoria M.; Woodman, Benjamin; Smith, Donna L.; Zhou, Xianbo; Rosa, Eddie; Sathasivam, Kirupa; Ghazi-Noori, Shabnam; Mahal, Amarbirpal; Lowden, Philip A. S.; Steffan, Joan S.; Marsh, J. Lawrence; Thompson, Leslie M.; Lewis, Cathryn M.; Marks, Paul A.; Bates, Gillian P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2041-2046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is an inherited, progressive neurol. disorder that is caused by a CAG/polyglutamine repeat expansion and for which there is no effective therapy.  Recent evidence indicates that transcriptional dysregulation may contribute to the mol. pathogenesis of this disease.  Supporting this view, administration of histone deacetylase (HDAC) inhibitors has been shown to rescue lethality and photoreceptor neurodegeneration in a Drosophila model of polyglutamine disease.  To further explore the therapeutic potential of HDAC inhibitors, we have conducted preclin. trials with suberoylanilide hydroxamic acid (SAHA), a potent HDAC inhibitor, in the R6/2 HD mouse model.  We show that SAHA crosses the blood-brain barrier and increases histone acetylation in the brain.  We found that SAHA could be administered orally in drinking water when complexed with cyclodextrins.  SAHA dramatically improved the motor impairment in R6/2 mice, clearly validating the pursuit of this class of compds. as HD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpy-3Y7VV7UbVg90H21EOLACvtfcHk0ljpdE8TKJunvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGrsbs%253D&md5=4096dcbfeeeafd00c51ccb01e4ee29a5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437870100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437870100%26sid%3Dliteratum%253Aachs%26aulast%3DHockly%26aufirst%3DE.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DRosa%26aufirst%3DE.%26aulast%3DSathasivam%26aufirst%3DK.%26aulast%3DGhazi-Noori%26aufirst%3DS.%26aulast%3DMahal%26aufirst%3DA.%26aulast%3DLowden%26aufirst%3DP.%2BA.%2BS.%26aulast%3DSteffan%26aufirst%3DJ.%2BS.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DLewis%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%252C%2520a%2520histone%2520deacetylase%2520inhibitor%252C%2520ameliorates%2520motor%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D2041%26epage%3D2046%26doi%3D10.1073%2Fpnas.0437870100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipiani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calingasan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2005.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2005.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16289867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=40-49&author=S.+Petriauthor=M.+Kiaeiauthor=K.+Kipianiauthor=J.+Chenauthor=N.+Y.+Calingasanauthor=J.+P.+Crowauthor=M.+F.+Beal&title=Additive+neuroprotective+effects+of+a+histone+deacetylase+inhibitor+and+a+catalytic+antioxidant+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis&doi=10.1016%2Fj.nbd.2005.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Petri, Susanne; Kiaei, Mahmoud; Kipiani, Khatuna; Chen, Junyu; Calingasan, Noel Y.; Crow, John P.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">ALS is a devastating neurodegenerative disorder for which no effective treatment exists.  Multiple mol. mechanisms are involved in the pathogenesis.  We tested the catalytic antioxidant AEOL 10150, the histone deacetylase inhibitor phenylbutyrate (PBA), and the combination of PBA and AEOL 10150 in the G93A transgenic mouse model, administered from disease onset.  AEOL 10150 alone improved motor function and extended survival by 11%, PBA alone significantly improved motor function and extended survival by 13%.  PBA and AEOL 10150 together increased survival by 19%.  Increased histone acetylation was confirmed by Western blot.  Quant. real-time RT-PCR anal. revealed upregulation of compds. capable of protecting cells against oxidative stress and apoptosis.  Markers of oxidative damage were reduced in the lumbar spinal cord as compared to vehicle administration.  These results suggest that agents inhibiting apoptosis and blocking oxidative stress show efficacy in treating mutant-SOD1-assocd. ALS and that a combination of agents targeting different disease mechanisms may exert additive therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcg3A_6aRI8rVg90H21EOLACvtfcHk0liYY--Tx6svaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOjtb4%253D&md5=a29246feff52c648ede9a267a595dc14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2005.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2005.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DPetri%26aufirst%3DS.%26aulast%3DKiaei%26aufirst%3DM.%26aulast%3DKipiani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DCrow%26aufirst%3DJ.%2BP.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAdditive%2520neuroprotective%2520effects%2520of%2520a%2520histone%2520deacetylase%2520inhibitor%2520and%2520a%2520catalytic%2520antioxidant%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D22%26spage%3D40%26epage%3D49%26doi%3D10.1016%2Fj.nbd.2005.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of potent and selective HDAC6 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2017.10.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29133060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2ntbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1406-1418&author=X.-X.+Wangauthor=R.-Z.+Wanauthor=Z.-P.+Liu&title=Recent+advances+in+the+discovery+of+potent+and+selective+HDAC6+inhibitors&doi=10.1016%2Fj.ejmech.2017.10.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of potent and selective HDAC6 inhibitors</span></div><div class="casAuthors">Wang, Xiu-Xiu; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1406-1418</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase HDAC6, a member of the class IIb HDAC family, is unique among HDAC enzymes in having two active catalytic domains, and has unique physiol. function.  In addn. to the modification of histone, HDAC6 targets specific substrates including α-tubulin and HSP90, and are involved in protein trafficking and degrdn., cell shape and migration.  Selective HDAC6 inhibitors are an emerging class of pharmaceuticals due to the involvement of HDAC6 in different pathways related to neurodegenerative diseases, cancer, and immunol.  Therefore, extensive investigations have been made in the discovery of selective HDAC6 inhibitors.  Based on their different zinc binding groups (ZBGs), in this review, HDAC6 inhibitors are grouped as hydroxamic acids, a sulfur contg. ZBG based derivs. and other ZBG-derived compds., and their enzymic inhibitory activity, selectivity and other biol. activities are introduced and summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdsNBEWGhpCrVg90H21EOLACvtfcHk0liYY--Tx6svaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2ntbrM&md5=f24fea971dbed247e1bb2568f85d1703</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.040%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-X.%26aulast%3DWan%26aufirst%3DR.-Z.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520potent%2520and%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1406%26epage%3D1418%26doi%3D10.1016%2Fj.ejmech.2017.10.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, S.</span></span> <span> </span><span class="NLM_article-title">The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2337</span>, <span class="refDoi"> DOI: 10.3390/ijms19082337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3390%2Fijms19082337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2337&author=M.+Cosenzaauthor=S.+Pozzi&title=The+therapeutic+strategy+of+HDAC6+inhibitors+in+lymphoproliferative+disease&doi=10.3390%2Fijms19082337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease</span></div><div class="casAuthors">Cosenza, Maria; Pozzi, Samantha</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2337/1-2337/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are master regulators of chromatin remodeling, acting as epigenetic regulators of gene expression.  In the last decade, inhibition of HDACs has become a target for specific epigenetic modifications related to cancer development.  Overexpression of HDAC has been obsd. in several hematol. malignancies.  Therefore, the observation that HDACs might play a role in various hematol. malignancies has brought to the development of HDAC inhibitors as potential antitumor agents.  Recently, the class IIb, HDAC6, has emerged as one potential selective HDACi.  This isoenzyme represents an important pharmacol. target for selective inhibition.  Its selectivity may reduce the toxicity related to the off-target effects of pan-HDAC inhibitors.  HDAC6 has also been studied in cancer esp. for its ability to coordinate a variety of cellular processes that are important for cancer pathogenesis.  HDAC6 has been reported to be overexpressed in lymphoid cells and its inhibition has demonstrated activity in preclin. and clin. study of lymphoproliferative disease.  Various studies of HDAC6 inhibitors alone and in combination with other agents provide strong scientific rationale for the evaluation of these new agents in the clin. setting of hematol. malignancies.  In this review, we describe the HDACs, their inhibitors, and the recent advances of HDAC6 inhibitors, their mechanisms of action and role in lymphoproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40AmGWIhm0rVg90H21EOLACvtfcHk0lj3ab6LqHRmuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVGhtrY%253D&md5=e2f63affb8a194d516a2465e772f46c1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3390%2Fijms19082337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19082337%26sid%3Dliteratum%253Aachs%26aulast%3DCosenza%26aufirst%3DM.%26aulast%3DPozzi%26aufirst%3DS.%26atitle%3DThe%2520therapeutic%2520strategy%2520of%2520HDAC6%2520inhibitors%2520in%2520lymphoproliferative%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2337%26doi%3D10.3390%2Fijms19082337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucinella, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iside, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span> <span> </span><span class="NLM_article-title">Novel spiroindoline HDAC inhibitors: synthesis, molecular modelling and biological studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2018.07.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30092367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOntbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=127-138&author=M.+Brindisiauthor=J.+Sengerauthor=C.+Cavellaauthor=A.+Grilloauthor=G.+Chemiauthor=S.+Gemmaauthor=D.+M.+Cucinellaauthor=S.+Lamponiauthor=F.+Sarnoauthor=C.+Isideauthor=A.+Nebbiosoauthor=E.+Novellinoauthor=T.+B.+Shaikauthor=C.+Romierauthor=D.+Herpauthor=M.+Jungauthor=S.+Butiniauthor=G.+Campianiauthor=L.+Altucciauthor=S.+Brogi&title=Novel+spiroindoline+HDAC+inhibitors%3A+synthesis%2C+molecular+modelling+and+biological+studies&doi=10.1016%2Fj.ejmech.2018.07.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies</span></div><div class="casAuthors">Brindisi, Margherita; Senger, Johanna; Cavella, Caterina; Grillo, Alessandro; Chemi, Giulia; Gemma, Sandra; Cucinella, Dora Mariagrazia; Lamponi, Stefania; Sarno, Federica; Iside, Concetta; Nebbioso, Angela; Novellino, Ettore; Shaik, Tajith Baba; Romier, Christophe; Herp, Daniel; Jung, Manfred; Butini, Stefania; Campiani, Giuseppe; Altucci, Lucia; Brogi, Simone</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Spiroindolinylmethyl arylhydroxamates such as I (R = t-BuOCO, Me, MeCO, t-BuCO) were prepd. as selective inhibitors of histone deacetylase 6 (HDAC6) for potential use as antitumor agents.  The spiroindolinylmethyl arylhydroxamates were prepd. using a one-pot Fischer indole synthesis of cyclohexane- or piperidinecarboxaldehydes and phenylhydrazine followed by indolenine redn. and reductive amination with formylarylcarboxylates as the key step.  The inhibition of HDAC1 and HDAC6 by the spiroindolinylmethyl arylhydroxamates was detd. and mol. docking calcns. of their binding to HDAC1 and HDAC6 performed; in addn., their calcd. lipophilicities, biol. permeabilities, polar mol. surface areas, and hERG inhibition were detd.  The inhibition of HDAC8 by I (R = t-BuOCO), its effect on metastasis and its toxicity to mouse fibroblasts, and the effect of I (R = t-BuOCO, t-BuCO) on HDAC acetylation in cells were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBNiJdoIAsrVg90H21EOLACvtfcHk0lj3ab6LqHRmuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOntbnJ&md5=e12eadf2c73e321b1a733c1cbfdfc822</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DCavella%26aufirst%3DC.%26aulast%3DGrillo%26aufirst%3DA.%26aulast%3DChemi%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCucinella%26aufirst%3DD.%2BM.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DSarno%26aufirst%3DF.%26aulast%3DIside%26aufirst%3DC.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DHerp%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DBrogi%26aufirst%3DS.%26atitle%3DNovel%2520spiroindoline%2520HDAC%2520inhibitors%253A%2520synthesis%252C%2520molecular%2520modelling%2520and%2520biological%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.ejmech.2018.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iside, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span> <span> </span><span class="NLM_article-title">Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1573</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.4155%2Ffmc-2016-0068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27556815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1573-1587&author=M.+Brindisiauthor=C.+Cavellaauthor=S.+Brogiauthor=A.+Nebbiosoauthor=J.+Sengerauthor=S.+Maramaiauthor=A.+Ciottaauthor=C.+Isideauthor=S.+Butiniauthor=S.+Lamponiauthor=E.+Novellinoauthor=L.+Altucciauthor=M.+Jungauthor=G.+Campianiauthor=S.+Gemma&title=Phenylpyrrole-based+HDAC+inhibitors%3A+synthesis%2C+molecular+modeling+and+biological+studies&doi=10.4155%2Ffmc-2016-0068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies</span></div><div class="casAuthors">Brindisi, Margherita; Cavella, Caterina; Brogi, Simone; Nebbioso, Angela; Senger, Johanna; Maramai, Samuele; Ciotta, Alfonso; Iside, Concetta; Butini, Stefania; Lamponi, Stefania; Novellino, Ettore; Altucci, Lucia; Jung, Manfred; Campiani, Giuseppe; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1573-1587</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Histone deacetylases (HDACs) regulate the expression and activity of numerous proteins involved in the initiation and progression of cancer.  Currently, three hydroxamate-contg. HDAC pan-inhibitors have been approved as antitumor agents.  Results: We herein present the development of a series of novel phenylpyrrole-based derivs. stemmed from combined computational and medicinal chem. efforts to rationally modulate HDAC1/6 isoform selectivity.  In vitro activity on HDAC1 and HDAC6 isoforms and the effects of selected analogs on histone H3 and α-tubulin acetylation levels were detd.  Cell-based data evidenced, for selected compds., a promising antitumor potential and low toxicity on normal cells.  Conclusion: The newly developed compds. represent a valuable starting point for the development of novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqELfTrUoFLVg90H21EOLACvtfcHk0lj3ab6LqHRmuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3E&md5=c96f8bfe2d30f2c2a90766531d9853ad</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0068%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DCavella%26aufirst%3DC.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DCiotta%26aufirst%3DA.%26aulast%3DIside%26aufirst%3DC.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DPhenylpyrrole-based%2520HDAC%2520inhibitors%253A%2520synthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520studies%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1573%26epage%3D1587%26doi%3D10.4155%2Ffmc-2016-0068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnchembio.2134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27454933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=741-747&author=Y.+Haiauthor=D.+W.+Christianson&title=Histone+deacetylase+6+structure+and+molecular+basis+of+catalysis+and+inhibition&doi=10.1038%2Fnchembio.2134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span></div><div class="casAuthors">Hai, Yang; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">741-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a crit. target for drug design because of its role in oncogenic transformation and cancer metastasis, and is unique among all histone deacetylases in that it contains tandem catalytic domains designated CD1 and CD2.  We now report the crystal structures of CD2 from Homo sapiens HDAC6 and of CD1 and CD2 from Danio rerio HDAC6.  We correlated these structures with activity measurements using 13 different substrates.  The catalytic activity of CD2 from both species exhibited broad substrate specificity, whereas that of CD1 was highly specific for substrates bearing C-terminal acetyllysine residues.  Crystal structures of substrate complexes yielded unprecedented snapshots of the catalytic mechanism.  Addnl., crystal structures of complexes with eight different inhibitors, including belinostat and panobinostat (currently used in cancer chemotherapy), the macrocyclic tetrapeptide HC toxin, and the HDAC6-specific inhibitor N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide, revealed surprising new insight regarding changes in Zn2+ coordination and isoenzyme-specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCfziGBHBRLVg90H21EOLACvtfcHk0ljDbj_Cu8wQ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ&md5=e167bc6f66e00923da4f2bced2b306b9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2134%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DY.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520structure%2520and%2520molecular%2520basis%2520of%2520catalysis%2520and%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D741%26epage%3D747%26doi%3D10.1038%2Fnchembio.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogl, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span> <span> </span><span class="NLM_article-title">Rocilinostat (ACY-1215), a selective HDAC6 inhibitor, alone and in combination with bortezomib in multiple myeloma: preliminary results from the first-in-humans phase I/II study</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4061</span>– <span class="NLM_lpage">4061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1182%2Fblood.V120.21.4061.4061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4061-4061&author=N.+Rajeauthor=P.+N.+Hariauthor=D.+T.+Voglauthor=S.+Jagannathauthor=R.+Z.+Orlowskiauthor=J.+G.+Supkoauthor=P.+Stephensonauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=S.+Lonial&title=Rocilinostat+%28ACY-1215%29%2C+a+selective+HDAC6+inhibitor%2C+alone+and+in+combination+with+bortezomib+in+multiple+myeloma%3A+preliminary+results+from+the+first-in-humans+phase+I%2FII+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1182%2Fblood.V120.21.4061.4061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V120.21.4061.4061%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DHari%26aufirst%3DP.%2BN.%26aulast%3DVogl%26aufirst%3DD.%2BT.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DStephenson%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DLonial%26aufirst%3DS.%26atitle%3DRocilinostat%2520%2528ACY-1215%2529%252C%2520a%2520selective%2520HDAC6%2520inhibitor%252C%2520alone%2520and%2520in%2520combination%2520with%2520bortezomib%2520in%2520multiple%2520myeloma%253A%2520preliminary%2520results%2520from%2520the%2520first-in-humans%2520phase%2520I%252FII%2520study%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4061%26epage%3D4061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce-Lara, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosko, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahlis, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reece, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat (ACY-1215), the first selective HDAC6 inhibitor, combines safely with pomalidomide and dexamethasone and shows promising early results in relapsed-and-refractory myeloma (ACE-MM-102 study)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4228</span>– <span class="NLM_lpage">4228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1182%2Fblood.V126.23.4228.4228" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=4228-4228&author=N.+S.+Rajeauthor=W.+Bensingerauthor=C.+E.+Coleauthor=S.+Lonialauthor=S.+Jagannathauthor=C.+E.+Arce-Laraauthor=J.+Valentauthor=A.+E.+Roskoauthor=W.+A.+Harbauthor=I.+Sandhuauthor=N.+J.+Bahlisauthor=D.+Reeceauthor=E.+Terposauthor=J.+Supkoauthor=D.+Tamangauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=R.+J.+Markelewiczauthor=P.+G.+Richardson&title=Ricolinostat+%28ACY-1215%29%2C+the+first+selective+HDAC6+inhibitor%2C+combines+safely+with+pomalidomide+and+dexamethasone+and+shows+promising+early+results+in+relapsed-and-refractory+myeloma+%28ACE-MM-102+study%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1182%2Fblood.V126.23.4228.4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V126.23.4228.4228%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%2BS.%26aulast%3DBensinger%26aufirst%3DW.%26aulast%3DCole%26aufirst%3DC.%2BE.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DArce-Lara%26aufirst%3DC.%2BE.%26aulast%3DValent%26aufirst%3DJ.%26aulast%3DRosko%26aufirst%3DA.%2BE.%26aulast%3DHarb%26aufirst%3DW.%2BA.%26aulast%3DSandhu%26aufirst%3DI.%26aulast%3DBahlis%26aufirst%3DN.%2BJ.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26atitle%3DRicolinostat%2520%2528ACY-1215%2529%252C%2520the%2520first%2520selective%2520HDAC6%2520inhibitor%252C%2520combines%2520safely%2520with%2520pomalidomide%2520and%2520dexamethasone%2520and%2520shows%2520promising%2520early%2520results%2520in%2520relapsed-and-refractory%2520myeloma%2520%2528ACE-MM-102%2520study%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D4228%26epage%3D4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardiola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1038/417455a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F417455a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12024216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455-458&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.+F.+Wangauthor=T.+P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase&doi=10.1038%2F417455a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a microtubule-associated deacetylase</span></div><div class="casAuthors">Hubbert, Charlotte; Guardiola, Amaris; Shao, Rong; Kawaguchi, Yoshiharu; Ito, Akihiro; Nixon, Andrew; Yoshida, Minoru; Wang, Xiao-Fan; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6887</span>),
    <span class="NLM_cas:pages">455-458</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reversible acetylation of α-tubulin has been implicated in regulating microtubule stability and function.  The distribution of acetylated α-tubulin is tightly controlled and stereotypic.  Acetylated α-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts.  However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known.  Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase.  HDAC6 is localized exclusively in the cytoplasm, where it assocs. with microtubules and localizes with the microtubule motor complex contg. p150glued.  In vivo, the overexpression of HDAC6 leads to a global deacetylation of α-tubulin, whereas a decrease in HDAC6 increases α-tubulin acetylation.  In vitro, purified HDAC6 potently deacetylates α-tubulin in assembled microtubules.  Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility.  Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biol. processes beyond histone metab. and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76Er3MrWtO7Vg90H21EOLACvtfcHk0ljDbj_Cu8wQ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D&md5=f18cbb0af388925c606e822358ba3da6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2F417455a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417455a%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26epage%3D458%26doi%3D10.1038%2F417455a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2005.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15916966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.+T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.+P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span></div><div class="casAuthors">Kovacs, Jeffrey J.; Murphy, Patrick J. M.; Gaillard, Stephanie; Zhao, Xuan; Wu, June-Tai; Nicchitta, Christopher V.; Yoshida, Minoru; Toft, David O.; Pratt, William B.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) and its accessory cochaperones function by facilitating the structural maturation and complex assembly of client proteins, including steroid hormone receptors and selected kinases.  By promoting the activity and stability of these signaling proteins, Hsp90 has emerged as a crit. modulator in cell signaling.  Here, we present evidence that Hsp90 chaperone activity is regulated by reversible acetylation and controlled by the deacetylase HDAC6.  We show that HDAC6 functions as an Hsp90 deacetylase.  Inactivation of HDAC6 leads to Hsp90 hyperacetylation, its dissocn. from an essential cochaperone, p23, and a loss of chaperone activity.  In HDAC6-deficient cells, Hsp90-dependent maturation of the glucocorticoid receptor (GR) is compromised, resulting in GR defective in ligand binding, nuclear translocation, and transcriptional activation.  Our results identify Hsp90 as a target of HDAC6 and suggest reversible acetylation as a unique mechanism that regulates Hsp90 chaperone complex activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rzQe2Zsw_7Vg90H21EOLACvtfcHk0lhbNXUNjp8lRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D&md5=338a8456c56a74d82ad3d28cbccae33f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.molcel.2005.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bali, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pranpat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaraswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyapalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">26729</span>– <span class="NLM_lpage">26734</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500186200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C500186200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15937340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Ggs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26729-26734&author=P.+Baliauthor=M.+Pranpatauthor=J.+Bradnerauthor=M.+Balasisauthor=W.+Fiskusauthor=F.+Guoauthor=K.+Rochaauthor=S.+Kumaraswamyauthor=S.+Boyapalleauthor=P.+Atadjaauthor=E.+Setoauthor=K.+Bhalla&title=Inhibition+of+histone+deacetylase+6+acetylates+and+disrupts+the+chaperone+function+of+heat+shock+protein+90%3A+a+novel+basis+for+antileukemia+activity+of+histone+deacetylase+inhibitors&doi=10.1074%2Fjbc.C500186200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors</span></div><div class="casAuthors">Bali, Purva; Pranpat, Michael; Bradner, James; Balasis, Maria; Fiskus, Warren; Guo, Fei; Rocha, Kathy; Kumaraswamy, Sandhya; Boyapalle, Sandhya; Atadja, Peter; Seto, Edward; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">26729-26734</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hydroxamic acid (HAA) analog pan-histone deacetylase (HDAC) inhibitors (HDIs) LAQ824 and LBH589 have been shown to induce acetylation and inhibit the ATP binding and chaperone function of heat shock protein (HSP) 90.  This promotes the polyubiquitylation and degrdn. of the pro-growth and pro-survival client proteins Bcr-Abl, mutant FLT-3, c-Raf, and AKT in human leukemia cells.  HDAC6 is a member of the class IIB HDACs.  It is predominantly cytosolic, microtubule-assocd. α-tubulin deacetylase that is also known to promote aggresome inclusion of the misfolded polyubiquitylated proteins.  Here the authors demonstrate that in the Bcr-abl oncogene expressing human leukemia K562 cells, HDAC6 can be coimmunopptd. with HSP90, and the knock-down of HDAC6 by its siRNA induced the acetylation of HSP90 and α-tubulin.  Depletion of HDAC6 levels also inhibited the binding of HSP90 to ATP, reduced the chaperone assocn. of HSP90 with its client proteins, e.g.  Bcr-Abl, and induced polyubiquitylation and partial depletion of Bcr-Abl.  Conversely, the ectopic overexpression of HDAC6 inhibited LAQ824-induced acetylation of HSP90 and α-tubulin and reduced LAQ824-mediated depletion of Bcr-Abl, AKT, and c-Raf.  Collectively, these findings indicate that HDAC6 is also an HSP90 deacetylase.  Targeted inhibition of HDAC6 leads to acetylation of HSP90 and disruption of its chaperone function, resulting in polyubiquitylation and depletion of pro-growth and pro-survival HSP90 client proteins including Bcr-Abl.  Depletion of HDAC6 sensitized human leukemia cells to HAA-HDIs and proteasome inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzNG3KM62J7Vg90H21EOLACvtfcHk0lhbNXUNjp8lRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Ggs7w%253D&md5=0d634a576233827dc91d6b3044e56546</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500186200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500186200%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DP.%26aulast%3DPranpat%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DBalasis%26aufirst%3DM.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DK.%26aulast%3DKumaraswamy%26aufirst%3DS.%26aulast%3DBoyapalle%26aufirst%3DS.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520acetylates%2520and%2520disrupts%2520the%2520chaperone%2520function%2520of%2520heat%2520shock%2520protein%252090%253A%2520a%2520novel%2520basis%2520for%2520antileukemia%2520activity%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26729%26epage%3D26734%26doi%3D10.1074%2Fjbc.C500186200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">8637</span>– <span class="NLM_lpage">8647</span>, <span class="refDoi"> DOI: 10.1128/MCB.00393-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.00393-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17938201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=8637-8647&author=Y.+S.+Gaoauthor=C.+C.+Hubbertauthor=J.+Luauthor=Y.+S.+Leeauthor=J.+Y.+Leeauthor=T.+P.+Yao&title=Histone+deacetylase+6+regulates+growth+factor-induced+actin+remodeling+and+endocytosis&doi=10.1128%2FMCB.00393-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis</span></div><div class="casAuthors">Gao, Ya-sheng; Hubbert, Charlotte C.; Lu, Jianrong; Lee, Yi-Shan; Lee, Joo-Yong; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8637-8647</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a cytoplasmic deacetylase that uniquely catalyzes α-tubulin deacetylation and promotes cell motility.  However, the mechanism underlying HDAC6-dependent cell migration and the role for microtubule acetylation in motility are not known.  Here we show that HDAC6-induced global microtubule deacetylation was not sufficient to stimulate cell migration.  Unexpectedly, in response to growth factor stimulation, HDAC6 underwent rapid translocation to actin-enriched membrane ruffles and subsequently became assocd. with macropinosomes, the vesicles for fluid-phase endocytosis.  Supporting the importance of these assocns., membrane ruffle formation, macropinocytosis, and cell migration were all impaired in HDAC6-deficient cells.  Conversely, elevated HDAC6 levels promoted membrane ruffle formation with a concomitant increase in macropinocytosis and motility.  In search for an HDAC6 target, we found that heat shock protein 90 (Hsp90), another prominent substrate of HDAC6, was also recruited to membrane ruffles and macropinosomes.  Significantly, inhibition of Hsp90 activity suppressed membrane ruffling and cell migration, while expression of an acetylation-resistant Hsp90 mutant promoted ruffle formation.  Our results uncover a surprising role for HDAC6 in actin remodeling-dependent processes and identify the actin cytoskeleton as an important target of HDAC6-regulated protein deacetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxVaghZhsYZ7Vg90H21EOLACvtfcHk0lhbNXUNjp8lRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Cjug%253D%253D&md5=549e4ce46d614fea654bd69603c650c5</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1128%2FMCB.00393-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00393-07%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BS.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHistone%2520deacetylase%25206%2520regulates%2520growth%2520factor-induced%2520actin%2520remodeling%2520and%2520endocytosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D8637%26epage%3D8647%26doi%3D10.1128%2FMCB.00393-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dompierre, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrin, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordelieres, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3571</span>– <span class="NLM_lpage">3583</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0037-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.0037-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17392473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3571-3583&author=J.+P.+Dompierreauthor=J.+D.+Godinauthor=B.+C.+Charrinauthor=F.+P.+Cordelieresauthor=S.+J.+Kingauthor=S.+Humbertauthor=F.+Saudou&title=Histone+deacetylase+6+inhibition+compensates+for+the+transport+deficit+in+Huntington%E2%80%99s+disease+by+increasing+tubulin+acetylation&doi=10.1523%2FJNEUROSCI.0037-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation</span></div><div class="casAuthors">Dompierre, Jim P.; Godin, Juliette D.; Charrin, Benedicte C.; Cordelieres, Fabrice P.; King, Stephen J.; Humbert, Sandrine; Saudou, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3571-3583</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A defect in microtubule (MT)-based transport contributes to the neuronal toxicity obsd. in Huntington's disease (HD).  Histone deacetylase (HDAC) inhibitors show neuroprotective effects in this devastating neurodegenerative disorder.  We report here that HDAC inhibitors, including trichostatin A (TSA), increase vesicular transport of brain-derived neurotrophic factor (BDNF) by inhibiting HDAC6, thereby increasing acetylation at lysine 40 of α-tubulin.  MT acetylation in vitro and in cells causes the recruitment of the mol. motors dynein and kinesin-1 to MTs.  In neurons, acetylation at lysine 40 of α-tubulin increases the flux of vesicles and the subsequent release of BDNF.  We show that tubulin acetylation is reduced in HD brains and that TSA compensates for the transport- and release-defect phenotypes that are obsd. in disease.  Our findings reveal that HDAC6 inhibition and acetylation at lysine 40 of α-tubulin may be therapeutic targets of interest in disorders such as HD in which intracellular transport is altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHOlSuVjT9a7Vg90H21EOLACvtfcHk0lgnyYpRH5zLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOjsLg%253D&md5=eda05dd830c0e02e621466563092900e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0037-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0037-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DDompierre%26aufirst%3DJ.%2BP.%26aulast%3DGodin%26aufirst%3DJ.%2BD.%26aulast%3DCharrin%26aufirst%3DB.%2BC.%26aulast%3DCordelieres%26aufirst%3DF.%2BP.%26aulast%3DKing%26aufirst%3DS.%2BJ.%26aulast%3DHumbert%26aufirst%3DS.%26aulast%3DSaudou%26aufirst%3DF.%26atitle%3DHistone%2520deacetylase%25206%2520inhibition%2520compensates%2520for%2520the%2520transport%2520deficit%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520increasing%2520tubulin%2520acetylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D3571%26epage%3D3583%26doi%3D10.1523%2FJNEUROSCI.0037-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reed, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jih, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaertig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhey, K. J.</span></span> <span> </span><span class="NLM_article-title">Microtubule acetylation promotes kinesin-1 binding and transport</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2166</span>– <span class="NLM_lpage">2172</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2006.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cub.2006.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17084703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2166-2172&author=N.+A.+Reedauthor=D.+Caiauthor=T.+L.+Blasiusauthor=G.+T.+Jihauthor=E.+Meyhoferauthor=J.+Gaertigauthor=K.+J.+Verhey&title=Microtubule+acetylation+promotes+kinesin-1+binding+and+transport&doi=10.1016%2Fj.cub.2006.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Acetylation Promotes Kinesin-1 Binding and Transport</span></div><div class="casAuthors">Reed, Nathan A.; Cai, Dawen; Blasius, T. Lynne; Jih, Gloria T.; Meyhofer, Edgar; Gaertig, Jacek; Verhey, Kristen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2166-2172</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Long-distance intracellular delivery is driven by kinesin and dynein motor proteins that ferry cargoes along microtubule tracks.  Current models postulate that directional trafficking is governed by known biophys. properties of these motors-kinesins generally move to the plus ends of microtubules in the cell periphery, whereas cytoplasmic dynein moves to the minus ends in the cell center.  However, these models are insufficient to explain how polarized protein trafficking to subcellular domains is accomplished.  We show that the kinesin-1 cargo protein JNK-interacting protein 1 (JIP1) is localized to only a subset of neurites in cultured neuronal cells.  The mechanism of polarized trafficking appears to involve the preferential recognition of microtubules contg. specific posttranslational modifications (PTMs) by the kinesin-1 motor domain.  Using a genetic approach to eliminate specific PTMs, we show that the loss of a single modification, α-tubulin acetylation at Lys-40, influences the binding and motility of kinesin-1 in vitro.  In addn., pharmacol. treatments that increase microtubule acetylation cause a redirection of kinesin-1 transport of JIP1 to nearly all neurite tips in vivo.  These results suggest that microtubule PTMs are important markers of distinct microtubule populations and that they act to control motor protein trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LH6Ksw7IYLVg90H21EOLACvtfcHk0lgnyYpRH5zLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjtLzN&md5=912493542c364849cc77b29aafbc3a01</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DN.%2BA.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DBlasius%26aufirst%3DT.%2BL.%26aulast%3DJih%26aufirst%3DG.%2BT.%26aulast%3DMeyhofer%26aufirst%3DE.%26aulast%3DGaertig%26aufirst%3DJ.%26aulast%3DVerhey%26aufirst%3DK.%2BJ.%26atitle%3DMicrotubule%2520acetylation%2520promotes%2520kinesin-1%2520binding%2520and%2520transport%26jtitle%3DCurr.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D2166%26epage%3D2172%26doi%3D10.1016%2Fj.cub.2006.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">11219</span>– <span class="NLM_lpage">11226</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.042754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M109.042754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20133936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11219-11226&author=Y.+S.+Gaoauthor=C.+C.+Hubbertauthor=T.+P.+Yao&title=The+microtubule-associated+histone+deacetylase+6+%28HDAC6%29+regulates+epidermal+growth+factor+receptor+%28EGFR%29+endocytic+trafficking+and+degradation&doi=10.1074%2Fjbc.M109.042754"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation</span></div><div class="casAuthors">Gao, Ya-sheng; Hubbert, Charlotte C.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">11219-11226</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a microtubule-assocd. deacetylase with tubulin deacetylase activity, and it binds dynein motors.  Recent studies revealed that microtubule acetylation affects the affinity and processivity of microtubule motors.  These unique properties implicate a role for HDAC6 in intracellular organelle transport.  Here, we show that HDAC6 assocs. with the endosomal compartments and controls epidermal growth factor receptor (EGFR) trafficking and degrdn.  We found that loss of HDAC6 promoted EGFR degrdn.  Mechanistically, HDAC6 deficiency did not cause aberrant EGFR internalization and recycling.  Rather, it resulted in accelerated segregation of EGFR from early endosomes and premature delivery of EGFR to the late endosomal and lysosomal compartments.  The deregulated EGFR endocytic trafficking was accompanied by an increase in microtubule-dependent movement of EGFR-bearing vesicles, revealing a novel regulation of EGFR vesicular trafficking and degrdn. by the microtubule deacetylase HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1BxF_ZY-3ULVg90H21EOLACvtfcHk0lhzDUq8RAfvOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFGlsLs%253D&md5=57eb3c30f45b2fa74ca64c741eb478c8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.042754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.042754%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BS.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DThe%2520microtubule-associated%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520regulates%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520endocytic%2520trafficking%2520and%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11219%26epage%3D11226%26doi%3D10.1074%2Fjbc.M109.042754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 alpha-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.jns.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21377170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFKmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2011&pages=1-8&author=G.+Liauthor=H.+Jiangauthor=M.+Changauthor=H.+Xieauthor=L.+Hu&title=HDAC6+alpha-tubulin+deacetylase%3A+a+potential+therapeutic+target+in+neurodegenerative+diseases&doi=10.1016%2Fj.jns.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases</span></div><div class="casAuthors">Li, Guoyi; Jiang, Huiyi; Chang, Ming; Xie, Hongrong; Hu, Linsen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs), or lysine deacetylases (KDAC), are epigenetic regulators that catalyze the removal of acetyl moieties from the tails of lysine residues of histones and other proteins.  To date, eighteen HDAC family members (HDAC1-11 and SIRT1-7) have been identified and grouped into four classes according to their homol. to yeast histone deacetylases.  HDACs play an important role in regulating gene transcription as well as a variety of cellular functions.  Recent studies have found that HDAC6 (α-tubulin deacetylase) has the novel ability to capture α-tubulin as a substrate and regulate the physiol. level of its acetylated form.  In addn., a growing body of evidence suggests that α-tubulin deacetylase plays a crit. role in the cellular response to the accumulation of misfolded and aggregated proteins, which are a prominent pathol. feature common to many age-related neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases.  Therefore, the role of α-tubulin deacetylase and its potential as a therapeutic target for neurodegenerative diseases are areas of rapidly expanding investigation.  Here we review the research of the role played by HDAC6 in the regulation of tubulin modification and aggresome formation.  We also summarize the specific inhibitors of HDAC6 and address reports that implicate HDAC6 in various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVloOrNKWBLVg90H21EOLACvtfcHk0lhzDUq8RAfvOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFKmt7k%253D&md5=983e14b8e7fe8ef1cbb1005cfb677e06</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DHDAC6%2520alpha-tubulin%2520deacetylase%253A%2520a%2520potential%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2011%26volume%3D304%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.jns.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieland, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fass, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samiei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. H.</span></span> <span> </span><span class="NLM_article-title">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1038/nature10849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnature10849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22388814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=222-226&author=J.+Graffauthor=D.+Reiauthor=J.+S.+Guanauthor=W.+Y.+Wangauthor=J.+Seoauthor=K.+M.+Hennigauthor=T.+J.+Nielandauthor=D.+M.+Fassauthor=P.+F.+Kaoauthor=M.+Kahnauthor=S.+C.+Suauthor=A.+Samieiauthor=N.+Josephauthor=S.+J.+Haggartyauthor=I.+Delalleauthor=L.+H.+Tsai&title=An+epigenetic+blockade+of+cognitive+functions+in+the+neurodegenerating+brain&doi=10.1038%2Fnature10849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span></div><div class="casAuthors">Graff Johannes; Rei Damien; Guan Ji-Song; Wang Wen-Yuan; Seo Jinsoo; Hennig Krista M; Nieland Thomas J F; Fass Daniel M; Kao Patricia F; Kahn Martin; Su Susan C; Samiei Alireza; Joseph Nadine; Haggarty Stephen J; Delalle Ivana; Tsai Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7388</span>),
    <span class="NLM_cas:pages">222-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease.  The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge.  Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible.  This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease.  Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression.  Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments.  These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_TBTrhihJh3WEEzDrymxmfW6udTcc2eYWsEEl6Kj7Brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D&md5=6e567f82c587972acbdf75fbb06d2954</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnature10849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10849%26sid%3Dliteratum%253Aachs%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRei%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DNieland%26aufirst%3DT.%2BJ.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DKao%26aufirst%3DP.%2BF.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BC.%26aulast%3DSamiei%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DDelalle%26aufirst%3DI.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DAn%2520epigenetic%2520blockade%2520of%2520cognitive%2520functions%2520in%2520the%2520neurodegenerating%2520brain%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D222%26epage%3D226%26doi%3D10.1038%2Fnature10849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrin, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrell-Pages, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dompierre, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordelieres, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span> <span> </span><span class="NLM_article-title">Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2004.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15242649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFejtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=127-138&author=L.+R.+Gauthierauthor=B.+C.+Charrinauthor=M.+Borrell-Pagesauthor=J.+P.+Dompierreauthor=H.+Rangoneauthor=F.+P.+Cordelieresauthor=J.+De+Meyauthor=M.+E.+MacDonaldauthor=V.+Lessmannauthor=S.+Humbertauthor=F.+Saudou&title=Huntingtin+controls+neurotrophic+support+and+survival+of+neurons+by+enhancing+BDNF+vesicular+transport+along+microtubules&doi=10.1016%2Fj.cell.2004.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules</span></div><div class="casAuthors">Gauthier, Laurent R.; Charrin, Benedicte C.; Borrell-Pages, Maria; Dompierre, Jim P.; Rangone, Helene; Cordelieres, Fabrice P.; De Mey, Jan; MacDonald, Marcy E.; Lessmann, Volkmar; Humbert, Sandrine; Saudou, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polyglutamine expansion (polyQ) in the protein huntingtin is pathogenic and responsible for the neuronal toxicity assocd. with Huntington's disease (HD).  Although wild-type huntingtin possesses antiapoptotic properties, the relationship between the neuroprotective functions of huntingtin and pathogenesis of HD remains unclear.  Here, we show that huntingtin specifically enhances vesicular transport of brain-derived neurotrophic factor (BDNF) along microtubules.  Huntingtin-mediated transport involves huntingtin-assocd. protein-1 (HAP1) and the p150Glued subunit of dynactin, an essential component of mol. motors.  BDNF transport is attenuated both in the disease context and by reducing the levels of wild-type huntingtin.  The alteration of the huntingtin/HAP1/p150Glued complex correlates with reduced assocn. of motor proteins with microtubules.  Finally, we find that the polyQ-huntingtin-induced transport deficit results in the loss of neurotrophic support and neuronal toxicity.  Our findings indicate that a key role of huntingtin is to promote BDNF transport and suggest that loss of this function might contribute to pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpItkddoAVvnrVg90H21EOLACvtfcHk0ljkYvVCbmzd7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFejtbc%253D&md5=99f2a8c0a66ae1a2168c2454c60bf682</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DL.%2BR.%26aulast%3DCharrin%26aufirst%3DB.%2BC.%26aulast%3DBorrell-Pages%26aufirst%3DM.%26aulast%3DDompierre%26aufirst%3DJ.%2BP.%26aulast%3DRangone%26aufirst%3DH.%26aulast%3DCordelieres%26aufirst%3DF.%2BP.%26aulast%3DDe%2BMey%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DLessmann%26aufirst%3DV.%26aulast%3DHumbert%26aufirst%3DS.%26aulast%3DSaudou%26aufirst%3DF.%26atitle%3DHuntingtin%2520controls%2520neurotrophic%2520support%2520and%2520survival%2520of%2520neurons%2520by%2520enhancing%2520BDNF%2520vesicular%2520transport%2520along%2520microtubules%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.cell.2004.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietropaolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinquant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinekugel, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. H.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington’s disease</span>. <i>Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00361</span>, <span class="refDoi"> DOI: 10.1002/brb3.361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fbrb3.361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26445700" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e00361&author=A.+Ragotauthor=S.+Pietropaoloauthor=J.+Vincentauthor=P.+Delageauthor=H.+Zhangauthor=B.+Allinquantauthor=X.+Leinekugelauthor=A.+Fischerauthor=Y.+H.+Cho&title=Genetic+deletion+of+the+Histone+Deacetylase+6+exacerbates+selected+behavioral+deficits+in+the+R6%2F1+mouse+model+for+Huntington%E2%80%99s+disease&doi=10.1002%2Fbrb3.361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fbrb3.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbrb3.361%26sid%3Dliteratum%253Aachs%26aulast%3DRagot%26aufirst%3DA.%26aulast%3DPietropaolo%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DJ.%26aulast%3DDelage%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAllinquant%26aufirst%3DB.%26aulast%3DLeinekugel%26aufirst%3DX.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DCho%26aufirst%3DY.%2BH.%26atitle%3DGenetic%2520deletion%2520of%2520the%2520Histone%2520Deacetylase%25206%2520exacerbates%2520selected%2520behavioral%2520deficits%2520in%2520the%2520R6%252F1%2520mouse%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Behav.%26date%3D2015%26volume%3D5%26spage%3De00361%26doi%3D10.1002%2Fbrb3.361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govindarajan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sananbenesi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluter, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span> <span> </span><span class="NLM_article-title">Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Femmm.201201923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23184605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFeh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=52-63&author=N.+Govindarajanauthor=P.+Raoauthor=S.+Burkhardtauthor=F.+Sananbenesiauthor=O.+M.+Schluterauthor=F.+Bradkeauthor=J.+Luauthor=A.+Fischer&title=Reducing+HDAC6+ameliorates+cognitive+deficits+in+a+mouse+model+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Femmm.201201923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease</span></div><div class="casAuthors">Govindarajan, Nambirajan; Rao, Pooja; Burkhardt, Susanne; Sananbenesi, Farahnaz; Schlueter, Oliver M.; Bradke, Frank; Lu, Jianrong; Fischer, Andre</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are currently being discussed as promising therapeutic targets to treat neurodegenerative diseases.  However, the role of specific HDACs in cognition and neurodegeneration remains poorly understood.  Here, we investigate the function of HDAC6, a class II member of the HDAC superfamily, in the adult mouse brain.  We report that mice lacking HDAC6 are cognitively normal but reducing endogenous HDAC6 levels restores learning and memory and α-tubulin acetylation in a mouse model for Alzheimer's disease (AD).  Our data suggest that this therapeutic effect is, at least in part, linked to the observation that loss of HDAC6 renders neurons resistant to amyloid-β-mediated impairment of mitochondrial trafficking.  Thus, our study suggests that targeting HDAC6 could be a suitable strategy to ameliorate cognitive decline obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogV6jnfwqJarVg90H21EOLACvtfcHk0ljxkklMjImwhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFeh&md5=07ebf0d298c0927f3d736ab881118da5</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201923%26sid%3Dliteratum%253Aachs%26aulast%3DGovindarajan%26aufirst%3DN.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DBurkhardt%26aufirst%3DS.%26aulast%3DSananbenesi%26aufirst%3DF.%26aulast%3DSchluter%26aufirst%3DO.%2BM.%26aulast%3DBradke%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DReducing%2520HDAC6%2520ameliorates%2520cognitive%2520deficits%2520in%2520a%2520mouse%2520model%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D52%26epage%3D63%26doi%3D10.1002%2Femmm.201201923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoes-Pires, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwick, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurisso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span> <span> </span><span class="NLM_article-title">HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-8-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1186%2F1750-1326-8-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23356410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVCjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=7&author=C.+Simoes-Piresauthor=V.+Zwickauthor=A.+Nurissoauthor=E.+Schenkerauthor=P.+A.+Carruptauthor=M.+Cuendet&title=HDAC6+as+a+target+for+neurodegenerative+diseases%3A+what+makes+it+different+from+the+other+HDACs%3F&doi=10.1186%2F1750-1326-8-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?</span></div><div class="casAuthors">Simoes-Pires, Claudia; Zwick, Vincent; Nurisso, Alessandra; Schenker, Esther; Carrupt, Pierre-Alain; Cuendet, Muriel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) inhibitors have been demonstrated to be beneficial in animal models of neurodegenerative diseases.  Such results were mainly assocd. with the epigenetic modulation caused by HDACs, esp. those from class I, via chromatin deacetylation.  However, other mechanisms may contribute to the neuroprotective effect of HDAC inhibitors, since each HDAC may present distinct specific functions within the neurodegenerative cascades.  Such an example is HDAC6 for which the role in neurodegeneration has been partially elucidated so far.  The strategy to be adopted in promising therapeutics targeting HDAC6 is still controversial.  Specific inhibitors exert neuroprotection by increasing the acetylation levels of α-tubulin with subsequent improvement of the axonal transport, which is usually impaired in neurodegenerative disorders.  On the other hand, an induction of HDAC6 would theor. contribute to the degrdn. of protein aggregates which characterize various neurodegenerative disorders, including Alzheimer's, Parkinson's and Hutington's diseases.  This review describes the specific role of HDAC6 compared to the other HDACs in the context of neurodegeneration, by collecting in silico, in vitro and in vivo results regarding the inhibition and/or knockdown of HDAC6 and other HDACs.  Moreover, structure, function, subcellular localization, as well as the level of HDAC6 expression within brain regions are reviewed and compared to the other HDAC isoforms.  In various neurodegenerative diseases, the mechanisms underlying HDAC6 interaction with other proteins seem to be a promising approach in understanding the modulation of HDAC6 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorL59x4ppImrVg90H21EOLACvtfcHk0ljxkklMjImwhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVCjtbg%253D&md5=9a07e67b73798e75b3f8eb9d554cad92</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-8-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-8-7%26sid%3Dliteratum%253Aachs%26aulast%3DSimoes-Pires%26aufirst%3DC.%26aulast%3DZwick%26aufirst%3DV.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSchenker%26aufirst%3DE.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCuendet%26aufirst%3DM.%26atitle%3DHDAC6%2520as%2520a%2520target%2520for%2520neurodegenerative%2520diseases%253A%2520what%2520makes%2520it%2520different%2520from%2520the%2520other%2520HDACs%253F%26jtitle%3DMol.%2520Neurodegener.%26date%3D2013%26volume%3D8%26spage%3D7%26doi%3D10.1186%2F1750-1326-8-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianciardi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catania, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frullanti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallerini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzetti, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imperatore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amabile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzorusso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated alpha-tubulin defect which improves after iHDAC6 treatment in Rett syndrome</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2018.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.yexcr.2018.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29730163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlyrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2018&pages=225-235&author=E.+Landucciauthor=M.+Brindisiauthor=L.+Bianciardiauthor=L.+M.+Cataniaauthor=S.+Dagaauthor=S.+Crociauthor=E.+Frullantiauthor=C.+Falleriniauthor=S.+Butiniauthor=S.+Brogiauthor=S.+Furiniauthor=R.+Melaniauthor=A.+Molinaroauthor=F.+C.+Lorenzettiauthor=V.+Imperatoreauthor=S.+Amabileauthor=J.+Marianiauthor=F.+Mariauthor=F.+Arianiauthor=T.+Pizzorussoauthor=A.+M.+Pintoauthor=F.+M.+Vaccarinoauthor=A.+Renieriauthor=G.+Campianiauthor=I.+Meloni&title=iPSC-derived+neurons+profiling+reveals+GABAergic+circuit+disruption+and+acetylated+alpha-tubulin+defect+which+improves+after+iHDAC6+treatment+in+Rett+syndrome&doi=10.1016%2Fj.yexcr.2018.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome</span></div><div class="casAuthors">Landucci, Elisa; Brindisi, Margherita; Bianciardi, Laura; Catania, Lorenza M.; Daga, Sergio; Croci, Susanna; Frullanti, Elisa; Fallerini, Chiara; Butini, Stefania; Brogi, Simone; Furini, Simone; Melani, Riccardo; Molinaro, Angelo; Lorenzetti, Flaminia Clelia; Imperatore, Valentina; Amabile, Sonia; Mariani, Jessica; Mari, Francesca; Ariani, Francesca; Pizzorusso, Tommaso; Pinto, Anna Maria; Vaccarino, Flora M.; Renieri, Alessandra; Campiani, Giuseppe; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mutations in MECP2 gene have been identified in more than 95% of patients with classic Rett syndrome, one of the most common neurodevelopmental disorders in females.  Taking advantage of the breakthrough technol. of genetic reprogramming, we investigated transcriptome changes in neurons differentiated from induced Pluripotent Stem Cells (iPSCs) derived from patients with different mutations.  Profiling by RNA-seq in terminally differentiated neurons revealed a prominent GABAergic circuit disruption along with a perturbation of cytoskeleton dynamics.  In particular, in mutated neurons we identified a significant decrease of acetylated α-tubulin which can be reverted by treatment with selective inhibitors of HDAC6, the main α-tubulin deacetylase.  These findings contribute to shed light on Rett pathogenic mechanisms and provide hints for the treatment of Rett-assocd. epileptic behavior as well as for the definition of new therapeutic strategies for Rett syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJNxVTWah1EbVg90H21EOLACvtfcHk0ljxkklMjImwhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlyrt7k%253D&md5=f62d6a257bde8931a05dcb2079c5b691</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2018.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DBianciardi%26aufirst%3DL.%26aulast%3DCatania%26aufirst%3DL.%2BM.%26aulast%3DDaga%26aufirst%3DS.%26aulast%3DCroci%26aufirst%3DS.%26aulast%3DFrullanti%26aufirst%3DE.%26aulast%3DFallerini%26aufirst%3DC.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DFurini%26aufirst%3DS.%26aulast%3DMelani%26aufirst%3DR.%26aulast%3DMolinaro%26aufirst%3DA.%26aulast%3DLorenzetti%26aufirst%3DF.%2BC.%26aulast%3DImperatore%26aufirst%3DV.%26aulast%3DAmabile%26aufirst%3DS.%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DPizzorusso%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DA.%2BM.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DiPSC-derived%2520neurons%2520profiling%2520reveals%2520GABAergic%2520circuit%2520disruption%2520and%2520acetylated%2520alpha-tubulin%2520defect%2520which%2520improves%2520after%2520iHDAC6%2520treatment%2520in%2520Rett%2520syndrome%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2018%26volume%3D368%26spage%3D225%26epage%3D235%26doi%3D10.1016%2Fj.yexcr.2018.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiheb, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irobi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1038/nm.2396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnm.2396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21785432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=968-974&author=C.+d%E2%80%99Ydewalleauthor=J.+Krishnanauthor=D.+M.+Chihebauthor=P.+Van+Dammeauthor=J.+Irobiauthor=A.+P.+Kozikowskiauthor=P.+Vanden+Bergheauthor=V.+Timmermanauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=HDAC6+inhibitors+reverse+axonal+loss+in+a+mouse+model+of+mutant+HSPB1-induced+Charcot-Marie-Tooth+disease&doi=10.1038%2Fnm.2396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease</span></div><div class="casAuthors">d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Irobi, Joy; Kozikowski, Alan P.; Vanden Berghe, Pieter; Timmerman, Vincent; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system.  Mutations in the 27-kDa small heat-shock protein gene (HSPB1) cause axonal CMT or distal hereditary motor neuropathy (distal HMN).  We developed and characterized transgenic mice expressing two different HSPB1 mutations (S135F and P182L) in neurons only.  These mice showed all features of CMT or distal HMN dependent on the mutation.  Expression of mutant HSPB1 decreased acetylated α-tubulin abundance and induced severe axonal transport deficits.  An increase of α-tubulin acetylation induced by pharmacol. inhibition of histone deacetylase 6 (HDAC6) cor. the axonal transport defects caused by HSPB1 mutations and rescued the CMT phenotype of symptomatic mutant HSPB1 mice.  Our findings demonstrate the pathogenic role of α-tubulin deacetylation in mutant HSPB1-induced neuropathies and offer perspectives for using HDAC6 inhibitors as a therapeutic strategy for hereditary axonopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcNnO5Y6PAjLVg90H21EOLACvtfcHk0ljIDcMsqpXASw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlamu7o%253D&md5=3571d817e9a3d61d8df5f1dd6fc8358c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnm.2396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2396%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DKrishnan%26aufirst%3DJ.%26aulast%3DChiheb%26aufirst%3DD.%2BM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DIrobi%26aufirst%3DJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520inhibitors%2520reverse%2520axonal%2520loss%2520in%2520a%2520mouse%2520model%2520of%2520mutant%2520HSPB1-induced%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D968%26epage%3D974%26doi%3D10.1038%2Fnm.2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e42983</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0042983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0042983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22937007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42983&author=C.+Kimauthor=H.+Choiauthor=E.+S.+Jungauthor=W.+Leeauthor=S.+Ohauthor=N.+L.+Jeonauthor=I.+Mook-Jung&title=HDAC6+inhibitor+blocks+amyloid+beta-induced+impairment+of+mitochondrial+transport+in+hippocampal+neurons&doi=10.1371%2Fjournal.pone.0042983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons</span></div><div class="casAuthors">Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Oh, Soojung; Jeon, Noo Li; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42983</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Even though the disruption of axonal transport is an important pathophysiol. factor in neurodegenerative diseases including Alzheimer's disease (AD), the relationship between disruption of axonal transport and pathogenesis of AD is poorly understood.  Considering that α-tubulin acetylation is an important factor in axonal transport and that Aβ impairs mitochondrial axonal transport, we manipulated the level of α-tubulin acetylation in hippocampal neurons with Aβ cultured in a microfluidic system and examd. its effect on mitochondrial axonal transport.  We found that inhibiting histone deacetylase 6 (HDAC6), which deacetylates α-tubulin, significantly restored the velocity and motility of the mitochondria in both anterograde and retrograde axonal transports, which would be otherwise compromised by Aβ.  The inhibition of HDAC6 also recovered the length of the mitochondria that had been shortened by Aβ to a normal level.  These results suggest that the inhibition of HDAC6 significantly rescues hippocampal neurons from Aβ-induced impairment of mitochondrial axonal transport as well as mitochondrial length.  The results presented in this paper identify HDAC6 as an important regulator of mitochondrial transport as well as elongation and, thus, a potential target whose pharmacol. inhibition contributes to improving mitochondrial dynamics in Aβ treated neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu1Z5ERylDarVg90H21EOLACvtfcHk0ljIDcMsqpXASw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GqsbzI&md5=695715a67114dfb9e88518b9ee3968de</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042983%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DJeon%26aufirst%3DN.%2BL.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DHDAC6%2520inhibitor%2520blocks%2520amyloid%2520beta-induced%2520impairment%2520of%2520mitochondrial%2520transport%2520in%2520hippocampal%2520neurons%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De42983%26doi%3D10.1371%2Fjournal.pone.0042983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chahrour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">The story of Rett syndrome: from clinic to neurobiology</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2007.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17988628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=422-437&author=M.+Chahrourauthor=H.+Y.+Zoghbi&title=The+story+of+Rett+syndrome%3A+from+clinic+to+neurobiology&doi=10.1016%2Fj.neuron.2007.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The story of Rett syndrome: from clinic to neurobiology</span></div><div class="casAuthors">Chahrour, Maria; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">422-437</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor involved in chromatin remodeling and the modulation of RNA splicing.  MECP2 aberrations result in a constellation of neuropsychiatric abnormalities, whereby both loss of function and gain in MECP2 dosage lead to similar neurol. phenotypes.  Recent studies demonstrate disease reversibility in RTT mouse models, suggesting that the neurol. defects in MECP2 disorders are not permanent.  To investigate the potential for restoring neuronal function in RTT patients, it is essential to identify MeCP2 targets or modifiers of the phenotype that can be therapeutically modulated.  Moreover, deciphering the mol. underpinnings of RTT is likely to contribute to the understanding of the pathogenesis of a broader class of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopG5K6_7b0rrVg90H21EOLACvtfcHk0ljIDcMsqpXASw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP&md5=95dd875581895cb15bd31e65d6eb4002</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DThe%2520story%2520of%2520Rett%2520syndrome%253A%2520from%2520clinic%2520to%2520neurobiology%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D422%26epage%3D437%26doi%3D10.1016%2Fj.neuron.2007.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coenraads, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, D. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpot, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarquinio, D. C.</span></span> <span> </span><span class="NLM_article-title">Rett Syndrome: Crossing the threshold to clinical translation</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2015.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.tins.2015.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26830113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=100-113&author=D.+M.+Katzauthor=A.+Birdauthor=M.+Coenraadsauthor=S.+J.+Grayauthor=D.+U.+Menonauthor=B.+D.+Philpotauthor=D.+C.+Tarquinio&title=Rett+Syndrome%3A+Crossing+the+threshold+to+clinical+translation&doi=10.1016%2Fj.tins.2015.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome- crossing the threshold to clinical translation</span></div><div class="casAuthors">Katz, David M.; Bird, Adrian; Coenraads, Monica; Gray, Steven J.; Menon, Debashish U.; Philpot, Benjamin D.; Tarquinio, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-113</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lying at the intersection between neurobiol. and epigenetics, Rett syndrome (RTT) has garnered intense interest in recent years, not only from a broad range of academic scientists, but also from the pharmaceutical and biotechnol. industries.  In addn. to the crit. need for treatments for this devastating disorder, optimism for developing RTT treatments derives from a unique convergence of factors, including a known monogenic cause, reversibility of symptoms in preclin. models, a strong clin. research infrastructure highlighted by an NIH-funded natural history study and well-established clinics with significant patient populations.  Here, we review recent advances in understanding the biol. of RTT, particularly promising preclin. findings, lessons from past clin. trials, and crit. elements of trial design for rare disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocisGeKOAgv7Vg90H21EOLACvtfcHk0liGVvXPcXwAXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKiug%253D%253D&md5=aa540ce98ff3ae270678082659413a3a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2015.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2015.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DD.%2BM.%26aulast%3DBird%26aufirst%3DA.%26aulast%3DCoenraads%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DS.%2BJ.%26aulast%3DMenon%26aufirst%3DD.%2BU.%26aulast%3DPhilpot%26aufirst%3DB.%2BD.%26aulast%3DTarquinio%26aufirst%3DD.%2BC.%26atitle%3DRett%2520Syndrome%253A%2520Crossing%2520the%2520threshold%2520to%2520clinical%2520translation%26jtitle%3DTrends%2520Neurosci.%26date%3D2016%26volume%3D39%26spage%3D100%26epage%3D113%26doi%3D10.1016%2Fj.tins.2015.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt-Engerstrom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opitz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. F.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence</span>. <i>Am. J. Med. Genet. Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1002/ajmg.1320250506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fajmg.1320250506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=47-59&author=B.+Hagbergauthor=I.+Witt-Engerstromauthor=J.+M.+Opitzauthor=J.+F.+Reynolds&title=Rett+syndrome%3A+a+suggested+staging+system+for+describing+impairment+profile+with+increasing+age+towards+adolescence&doi=10.1002%2Fajmg.1320250506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fajmg.1320250506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.1320250506%26sid%3Dliteratum%253Aachs%26aulast%3DHagberg%26aufirst%3DB.%26aulast%3DWitt-Engerstrom%26aufirst%3DI.%26aulast%3DOpitz%26aufirst%3DJ.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BF.%26atitle%3DRett%2520syndrome%253A%2520a%2520suggested%2520staging%2520system%2520for%2520describing%2520impairment%2520profile%2520with%2520increasing%2520age%2520towards%2520adolescence%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%2520Suppl.%26date%3D1986%26volume%3D25%26spage%3D47%26epage%3D59%26doi%3D10.1002%2Fajmg.1320250506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Zeev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewiecka-Jaworska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veneselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djuric, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisgaard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejaski Bosnjak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogliati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintaudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melegh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djukic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span> <span> </span><span class="NLM_article-title">Rett networked database: an integrated clinical and genetic network of Rett syndrome databases</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1002/humu.22072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fhumu.22072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22415763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=1031-1036&author=E.+Grilloauthor=L.+Villardauthor=A.+Clarkeauthor=B.+Ben+Zeevauthor=M.+Pinedaauthor=N.+Bahi-Buissonauthor=A.+Hryniewiecka-Jaworskaauthor=T.+Bienvenuauthor=J.+Armstrongauthor=A.+Roche-Martinezauthor=F.+Mariauthor=E.+Veneselliauthor=S.+Russoauthor=A.+Vignoliauthor=G.+Piniauthor=M.+Djuricauthor=A.+M.+Bisgaardauthor=V.+Mejaski+Bosnjakauthor=N.+Polgarauthor=F.+Cogliatiauthor=K.+Ravnauthor=M.+Pintaudiauthor=B.+Meleghauthor=D.+Craiuauthor=A.+Djukicauthor=A.+Renieri&title=Rett+networked+database%3A+an+integrated+clinical+and+genetic+network+of+Rett+syndrome+databases&doi=10.1002%2Fhumu.22072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Rett networked database: An integrated clinical and genetic network of Rett syndrome databases</span></div><div class="casAuthors">Grillo, Elisa; Villard, Laurent; Clarke, Angus; Ben Zeev, Bruria; Pineda, Mercedes; Bahi-Buisson, Nadia; Hryniewiecka-Jaworska, Anna; Bienvenu, Thierry; Armstrong, Judith; Martinez, Ana Roche; Mari, Francesca; Veneselli, Edvige; Russo, Silvia; Vignoli, Aglaia; Pini, Giorgio; Djuric, Milena; Bisgaard, Anne-Marie; Mejaski Bosnjak, Vlatka; Polgar, Noemi; Cogliati, Francesca; Ravn, Kirstine; Pintaudi, Maria; Melegh, Bela; Craiu, Dana; Djukic, Aleksandra; Renieri, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Rett syndrome (RTT) is a neurodevelopmental disorder with one principal phenotype and several distinct, atypical variants (Zappella, early seizure onset and congenital variants).  Mutations in MECP2 are found in most cases of classic RTT but at least two addnl. genes, CDKL5 and FOXG1, can underlie some (usually variant) cases.  There is only limited correlation between genotype and phenotype.  The Rett Networked Database () has been established to share clin. and genetic information.  Through an "adaptor" process of data harmonization, a set of 293 clin. items and 16 genetic items was generated; 62 clin. and 7 genetic items constitute the core dataset; 23 clin. items contain longitudinal information.  The database contains information on 1838 patients from 11 countries (Dec. 2011), with or without mutations in known genes.  These nos. can expand indefinitely.  Data are entered by a clinician in each center who supervises accuracy.  This network was constructed to make available pooled international data for the study of RTT natural history and genotype-phenotype correlation and to indicate the proportion of patients with specific clin. features and mutations.  We expect that the network will serve for the recruitment of patients into clin. trials and for developing quality measures to drive up stds. of medical management.  Hum Mutat 33:1031-1036, 2012. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApy2ISiZXI7Vg90H21EOLACvtfcHk0liGVvXPcXwAXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVantrc%253D&md5=403d2b340a73065b4425c481648f1a49</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22072%26sid%3Dliteratum%253Aachs%26aulast%3DGrillo%26aufirst%3DE.%26aulast%3DVillard%26aufirst%3DL.%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DBen%2BZeev%26aufirst%3DB.%26aulast%3DPineda%26aufirst%3DM.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DHryniewiecka-Jaworska%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DT.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DRoche-Martinez%26aufirst%3DA.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DVeneselli%26aufirst%3DE.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DVignoli%26aufirst%3DA.%26aulast%3DPini%26aufirst%3DG.%26aulast%3DDjuric%26aufirst%3DM.%26aulast%3DBisgaard%26aufirst%3DA.%2BM.%26aulast%3DMejaski%2BBosnjak%26aufirst%3DV.%26aulast%3DPolgar%26aufirst%3DN.%26aulast%3DCogliati%26aufirst%3DF.%26aulast%3DRavn%26aufirst%3DK.%26aulast%3DPintaudi%26aufirst%3DM.%26aulast%3DMelegh%26aufirst%3DB.%26aulast%3DCraiu%26aufirst%3DD.%26aulast%3DDjukic%26aufirst%3DA.%26aulast%3DRenieri%26aufirst%3DA.%26atitle%3DRett%2520networked%2520database%253A%2520an%2520integrated%2520clinical%2520and%2520genetic%2520network%2520of%2520Rett%2520syndrome%2520databases%26jtitle%3DHum.%2520Mutat.%26date%3D2012%26volume%3D33%26spage%3D1031%26epage%3D1036%26doi%3D10.1002%2Fhumu.22072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: a complex disorder with simple roots</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1038/nrg3897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrg3897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25732612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1KhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=261-275&author=M.+J.+Lystauthor=A.+Bird&title=Rett+syndrome%3A+a+complex+disorder+with+simple+roots&doi=10.1038%2Fnrg3897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome: a complex disorder with simple roots</span></div><div class="casAuthors">Lyst, Matthew J.; Bird, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurol. disorder caused by mutations in the X-linked gene MECP2 (methyl-CpG-binding protein 2).  Two decades of research have fostered the view that MeCP2 is a multifunctional chromatin protein that integrates diverse aspects of neuronal biol.  More recently, studies have focused on specific RTT-assocd. mutations within the protein.  This work has yielded mol. insights into the crit. functions of MeCP2 that promise to simplify our understanding of RTT pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMfNncpoOgE7Vg90H21EOLACvtfcHk0ljThDK8UsC1Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1KhtLY%253D&md5=40ce34ac999a1fbd831f475fb0e3b448</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnrg3897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3897%26sid%3Dliteratum%253Aachs%26aulast%3DLyst%26aufirst%3DM.%2BJ.%26aulast%3DBird%26aufirst%3DA.%26atitle%3DRett%2520syndrome%253A%2520a%2520complex%2520disorder%2520with%2520simple%2520roots%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2015%26volume%3D16%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrg3897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laherty, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span> <span> </span><span class="NLM_article-title">Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1038/30764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F30764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=9620804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=386-389&author=X.+Nanauthor=H.+H.+Ngauthor=C.+A.+Johnsonauthor=C.+D.+Lahertyauthor=B.+M.+Turnerauthor=R.+N.+Eisenmanauthor=A.+Bird&title=Transcriptional+repression+by+the+methyl-CpG-binding+protein+MeCP2+involves+a+histone+deacetylase+complex&doi=10.1038%2F30764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</span></div><div class="casAuthors">Nan, Xinsheng; Ng, Huck-Hui; Johnson, Colin A.; Laherty, Carol D.; Turner, Bryan M.; Eisenman, Robert N.; Bird, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6683</span>),
    <span class="NLM_cas:pages">386-389</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Cytosine residues in the sequence 5'CpG (cytosine-guanine) are often postsynthetically methylated in animal genomes.  CpG methylation is involved in long-term silencing of certain genes during mammalian development and in repression of viral genomes.  The methyl-CpG-binding proteins MeCP1 and MeCP2 interact specifically with methylated DNA and mediate transcriptional repression.  Here we study the mechanism of repression by MeCP2, and abundant nuclear protein that is essential for mouse embryogenesis.  MeCP2 binds tightly to chromosomes in a methylation-dependent manner.  It contains a transcriptional-repression domain (TRD) that can function at a distance in vivo and in vivo.  We show that a region of MeCP2 that localizes with the TRD assocs. with a corepressor complex contg. the transcriptional repressor mSin3A and histone deacetylases.  Transcriptional repression in vivo is relieved by the deacetylase inhibitor trichostatin A20, indicating that deacetylation of histones (and/or of other proteins) is an essential component of this repression mechanism.  The data suggest that two global mechanisms of gene regulation, DNA methylation and histone deacetylation, can be linked by MeCP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCn89hNfZyH7Vg90H21EOLACvtfcHk0ljThDK8UsC1Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKgurc%253D&md5=ee6cd28de0d05b82233654cc9e52e384</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2F30764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F30764%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DX.%26aulast%3DNg%26aufirst%3DH.%2BH.%26aulast%3DJohnson%26aufirst%3DC.%2BA.%26aulast%3DLaherty%26aufirst%3DC.%2BD.%26aulast%3DTurner%26aufirst%3DB.%2BM.%26aulast%3DEisenman%26aufirst%3DR.%2BN.%26aulast%3DBird%26aufirst%3DA.%26atitle%3DTranscriptional%2520repression%2520by%2520the%2520methyl-CpG-binding%2520protein%2520MeCP2%2520involves%2520a%2520histone%2520deacetylase%2520complex%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D386%26epage%3D389%26doi%3D10.1038%2F30764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, G. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermaak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landsberger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strouboulis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffe, A. P.</span></span> <span> </span><span class="NLM_article-title">Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=9620779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Cqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=187-191&author=P.+L.+Jonesauthor=G.+C.+J.+Veenstraauthor=P.+A.+Wadeauthor=D.+Vermaakauthor=S.+U.+Kassauthor=N.+Landsbergerauthor=J.+Strouboulisauthor=A.+P.+Wolffe&title=Methylated+DNA+and+MeCP2+recruit+histone+deacetylase+to+repress+transcription&doi=10.1038%2F561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</span></div><div class="casAuthors">Jones, Peter L.; Veenstra, Gert Jan C.; Wade, Paul A.; Vermaak, Danielle; Kass, Stefan U.; Landsberger, Nicoletta; Strouboulis, John; Wolffe, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-191</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">CpG methylation in vertebrates correlates with alterations in chromatin structure and gene silencing.  Differences in DNA-methylation status are assocd. with imprinting phenomena and carcinogenesis.  In Xenopus laevis oocytes, DNA methylation dominantly silences transcription through the assembly of a repressive nucleosomal array.  Methylated DNA assembled into chromatin binds the transcriptional repressor MeCP2 which cofractionates with Sin3 and histone deacetylase.  Silencing conferred by MeCP2 and methylated DNA can be relieved by inhibition of histone deacetylase, facilitating the remodelling of chromatin and transcriptional activation.  These results establish a direct causal relationship between DNA methylation-dependent transcriptional silencing and the modification of chromatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXfSPMCeRFrVg90H21EOLACvtfcHk0ljThDK8UsC1Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Cqsbg%253D&md5=7afb73d9c06e2ed71134b97c59be5bb2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2F561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F561%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BL.%26aulast%3DVeenstra%26aufirst%3DG.%2BC.%2BJ.%26aulast%3DWade%26aufirst%3DP.%2BA.%26aulast%3DVermaak%26aufirst%3DD.%26aulast%3DKass%26aufirst%3DS.%2BU.%26aulast%3DLandsberger%26aufirst%3DN.%26aulast%3DStrouboulis%26aufirst%3DJ.%26aulast%3DWolffe%26aufirst%3DA.%2BP.%26atitle%3DMethylated%2520DNA%2520and%2520MeCP2%2520recruit%2520histone%2520deacetylase%2520to%2520repress%2520transcription%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D19%26spage%3D187%26epage%3D191%26doi%3D10.1038%2F561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambi, F.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: the complex nature of a monogenic disease</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1007/s00109-003-0444-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00109-003-0444-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12750821" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=346-354&author=A.+Renieriauthor=I.+Meloniauthor=I.+Longoauthor=F.+Arianiauthor=F.+Mariauthor=C.+Pescucciauthor=F.+Cambi&title=Rett+syndrome%3A+the+complex+nature+of+a+monogenic+disease&doi=10.1007%2Fs00109-003-0444-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1007%2Fs00109-003-0444-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-003-0444-9%26sid%3Dliteratum%253Aachs%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DMeloni%26aufirst%3DI.%26aulast%3DLongo%26aufirst%3DI.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DPescucci%26aufirst%3DC.%26aulast%3DCambi%26aufirst%3DF.%26atitle%3DRett%2520syndrome%253A%2520the%2520complex%2520nature%2520of%2520a%2520monogenic%2520disease%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2003%26volume%3D81%26spage%3D346%26epage%3D354%26doi%3D10.1007%2Fs00109-003-0444-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gold, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacina, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrill, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulou, J.</span></span> <span> </span><span class="NLM_article-title">MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/s00109-014-1202-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00109-014-1202-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25209898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=63-72&author=W.+A.+Goldauthor=T.+A.+Lacinaauthor=L.+C.+Cantrillauthor=J.+Christodoulou&title=MeCP2+deficiency+is+associated+with+reduced+levels+of+tubulin+acetylation+and+can+be+restored+using+HDAC6+inhibitors&doi=10.1007%2Fs00109-014-1202-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors</span></div><div class="casAuthors">Gold, W. A.; Lacina, T. A.; Cantrill, L. C.; Christodoulou, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Rett syndrome (RTT) is a severe neurodevelopmental disorder, predominantly caused by loss of function mutations in the X-linked methyl-CpG-binding protein 2 (MECP2) gene.  Despite the genetic cause being known in the majority of cases, the pathophysiol. of the neurol. phenotype of RTT is largely unknown.  Tubulin and the microtubule network play an essential role in neuronal function whereby the acetylation state of microtubules dictates the efficiency of neuronal migration and differentiation, synaptic targeting and mol. motor trafficking of mRNA, high-energy mitochondria and brain-derived neurotrophic factor (BDNF)-contg. vesicles.  Recent reports have shown perturbations in tubulin and microtubule dynamics in MeCP2-deficient cells, suggesting a link between the aberrations of these cellular entities and the neurobiol. of RTT.  We have interrogated the functional state of the microtubule network in fibroblasts derived from two patients with RTT as well as cortical neurons from a RTT mouse model and obsd. a redn. in acetylated α-tubulin and an increase in the tubulin-specific deacetylase, histone deacetylase 6 (HDAC6).  Furthermore, we show that inhibition of HDAC6 by Tubastatin A can restore tubulin acetylation levels.  We also demonstrate microtubule instability in the RTT patient fibroblasts in response to nocodazole, which is progressively ameliorated in a mutation-dependent manner by Tubastatin A.  We conclude that Tubastatin A is capable of counteracting the microtubule defects obsd. in MeCP2-deficient cells, which could in turn lead to the restoration of mol. trafficking along the microtubules and thus could be a potentially new therapeutic option for RTT.  Key message: Cells from MeCP2-deficient cells show reduced levels of acetylated α-tubulin.  Cells from two patients and a RTT mouse model have increased levels of HDAC6 but not sirtuin 2 (SIRT2).  Inhibition of HDAC6 by Tubastatin A increases the in vitro acetylation of α-tubulin.  Inhibition of HDAC6 by Tubastatin A does not increase MECP2 expression.  Cells from two patients show microtubule instability, which is ameliorated by Tubastatin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo7Mx65AjB6rVg90H21EOLACvtfcHk0li0co3CJpaWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsbrK&md5=8b26f2d58d8c0e76a8952778935f6857</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1007%2Fs00109-014-1202-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-014-1202-x%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DW.%2BA.%26aulast%3DLacina%26aufirst%3DT.%2BA.%26aulast%3DCantrill%26aufirst%3DL.%2BC.%26aulast%3DChristodoulou%26aufirst%3DJ.%26atitle%3DMeCP2%2520deficiency%2520is%2520associated%2520with%2520reduced%2520levels%2520of%2520tubulin%2520acetylation%2520and%2520can%2520be%2520restored%2520using%2520HDAC6%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2015%26volume%3D93%26spage%3D63%26epage%3D72%26doi%3D10.1007%2Fs00109-014-1202-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaenisch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span> <span> </span><span class="NLM_article-title">Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1126/science.1086446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1086446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14593183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=885-889&author=W.+G.+Chenauthor=Q.+Changauthor=Y.+Linauthor=A.+Meissnerauthor=A.+E.+Westauthor=E.+C.+Griffithauthor=R.+Jaenischauthor=M.+E.+Greenberg&title=Derepression+of+BDNF+transcription+involves+calcium-dependent+phosphorylation+of+MeCP2&doi=10.1126%2Fscience.1086446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2</span></div><div class="casAuthors">Chen, Wen G.; Chang, Qiang; Lin, Yingxi; Meissner, Alexander; West, Anne E.; Griffith, Eric C.; Jaenisch, Rudolf; Greenberg, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">885-890</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mutations in MeCP2, which encodes a protein that has been proposed to function as a global transcriptional repressor, are the cause of Rett syndrome (RTT), an X-linked progressive neurol. disorder.  Although the selective inactivation of MeCP2 in neurons is sufficient to confer a Rett-like phenotype in mice, the specific functions of MeCP2 in postmitotic neurons are not known.  We find that MeCP2 binds selectively to BDNF promoter III and functions to repress expression of the BDNF gene.  Membrane depolarization triggers the calcium-dependent phosphorylation and release of MeCP2 from BDNF promoter III, thereby facilitating transcription.  These studies indicate that MeCP2 plays a key role in the control of neuronal activity-dependent gene regulation and suggest that the deregulation of this process may underlie the pathol. of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqadiNFQZ3QvbVg90H21EOLACvtfcHk0li0co3CJpaWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrc%253D&md5=3e5db4c68bb97dd46a105be5369f3856</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1126%2Fscience.1086446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1086446%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BG.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMeissner%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DA.%2BE.%26aulast%3DGriffith%26aufirst%3DE.%2BC.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DDerepression%2520of%2520BDNF%2520transcription%2520involves%2520calcium-dependent%2520phosphorylation%2520of%2520MeCP2%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D885%26epage%3D889%26doi%3D10.1126%2Fscience.1086446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinowich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. E.</span></span> <span> </span><span class="NLM_article-title">DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1126/science.1090842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1090842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14593184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=890-893&author=K.+Martinowichauthor=D.+Hattoriauthor=H.+Wuauthor=S.+Fouseauthor=F.+Heauthor=Y.+Huauthor=G.+Fanauthor=Y.+E.+Sun&title=DNA+methylation-related+chromatin+remodeling+in+activity-dependent+BDNF+gene+regulation&doi=10.1126%2Fscience.1090842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Methylation-Related Chromatin Remodeling in Activity- Dependent Bdnf Gene Regulation</span></div><div class="casAuthors">Martinowich, Keri; Hattori, Daisuke; Wu, Hao; Fouse, Shaun; He, Fei; Hu, Yan; Fan, Guoping; Sun, Yi E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">890-893</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In conjunction with histone modifications, DNA methylation plays crit. roles in gene silencing through chromatin remodeling.  Changes in DNA methylation perturb neuronal function, and mutations in a methyl-CpG-binding protein, MeCP2, are assocd. with Rett syndrome.  We report that increased synthesis of brain-derived neurotrophic factor (BDNF) in neurons after depolarization correlates with a decrease in CpG methylation within the regulatory region of the Bdnf gene.  Moreover, increased Bdnf transcription involves dissocn. of the MeCP2-histone deacetylase-mSin3A repression complex from its promoter.  Our findings suggest that DNA methylation-related chromatin remodeling is important for activity-dependent gene regulation that may be crit. for neural plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxCJ2-ML-CTrVg90H21EOLACvtfcHk0li0co3CJpaWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt74%253D&md5=7045c55e0c2b4e3cecbd2f526924cbd5</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090842%26sid%3Dliteratum%253Aachs%26aulast%3DMartinowich%26aufirst%3DK.%26aulast%3DHattori%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DFouse%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DY.%2BE.%26atitle%3DDNA%2520methylation-related%2520chromatin%2520remodeling%2520in%2520activity-dependent%2520BDNF%2520gene%2520regulation%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D890%26epage%3D893%26doi%3D10.1126%2Fscience.1090842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span> <span> </span><span class="NLM_article-title">Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.09.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2006.09.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17046689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=255-269&author=Z.+Zhouauthor=E.+J.+Hongauthor=S.+Cohenauthor=W.+N.+Zhaoauthor=H.+Y.+Hoauthor=L.+Schmidtauthor=W.+G.+Chenauthor=Y.+Linauthor=E.+Savnerauthor=E.+C.+Griffithauthor=L.+Huauthor=J.+A.+Steenauthor=C.+J.+Weitzauthor=M.+E.+Greenberg&title=Brain-specific+phosphorylation+of+MeCP2+regulates+activity-dependent+Bdnf+transcription%2C+dendritic+growth%2C+and+spine+maturation&doi=10.1016%2Fj.neuron.2006.09.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</span></div><div class="casAuthors">Zhou, Zhaolan; Hong, Elizabeth J.; Cohen, Sonia; Zhao, Wen-ning; Ho, Hsin-yi Henry; Schmidt, Lauren; Chen, Wen G.; Lin, Yingxi; Savner, Erin; Griffith, Eric C.; Hu, Linda; Steen, Judith A. J.; Weitz, Charles J.; Greenberg, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-269</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations or duplications in MECP2 cause Rett and Rett-like syndromes, neurodevelopmental disorders characterized by mental retardation, motor dysfunction, and autistic behaviors.  MeCP2 is expressed in many mammalian tissues and functions as a global repressor of transcription; however, the mol. mechanisms by which MeCP2 dysfunction leads to the neural-specific phenotypes of RTT remain poorly understood.  Here, we show that neuronal activity and subsequent calcium influx trigger the de novo phosphorylation of MeCP2 at serine 421 (S421) by a CaMKII-dependent mechanism.  MeCP2 S421 phosphorylation is induced selectively in the brain in response to physiol. stimuli.  Significantly, we find that S421 phosphorylation controls the ability of MeCP2 to regulate dendritic patterning, spine morphogenesis, and the activity-dependent induction of Bdnf transcription.  These findings suggest that, by triggering MeCP2 phosphorylation, neuronal activity regulates a program of gene expression that mediates nervous system maturation and that disruption of this process in individuals with mutations in MeCP2 may underlie the neural-specific pathol. of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxLdcw-A5OYLVg90H21EOLACvtfcHk0lj4JuI3dBInUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbjM&md5=cff541952b1b71843ed94a707201d13e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHong%26aufirst%3DE.%2BJ.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DHo%26aufirst%3DH.%2BY.%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%2BG.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DSavner%26aufirst%3DE.%26aulast%3DGriffith%26aufirst%3DE.%2BC.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSteen%26aufirst%3DJ.%2BA.%26aulast%3DWeitz%26aufirst%3DC.%2BJ.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DBrain-specific%2520phosphorylation%2520of%2520MeCP2%2520regulates%2520activity-dependent%2520Bdnf%2520transcription%252C%2520dendritic%2520growth%252C%2520and%2520spine%2520maturation%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D255%26epage%3D269%26doi%3D10.1016%2Fj.neuron.2006.09.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaenisch, R.</span></span> <span> </span><span class="NLM_article-title">The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2005.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2005.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16446138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1eiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=341-348&author=Q.+Changauthor=G.+Khareauthor=V.+Daniauthor=S.+Nelsonauthor=R.+Jaenisch&title=The+disease+progression+of+Mecp2+mutant+mice+is+affected+by+the+level+of+BDNF+expression&doi=10.1016%2Fj.neuron.2005.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression</span></div><div class="casAuthors">Chang, Qiang; Khare, Gargi; Dani, Vardhan; Nelson, Sacha; Jaenisch, Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-348</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations in the MECP2 gene cause Rett syndrome (RTT).  Bdnf is a MeCP2 target gene; however, its role in RTT pathogenesis is unknown.  We examd. Bdnf conditional mutant mice for RTT-relevant pathologies and obsd. that loss of BDNF caused smaller brain size, smaller CA2 neurons, smaller glomerulus size, and a characteristic hindlimb-clasping phenotype.  BDNF protein level was reduced in Mecp2 mutant mice, and deletion of Bdnf in Mecp2 mutants caused an earlier onset of RTT-like symptoms.  To assess whether this interaction was functional and potentially therapeutically relevant, we increased BDNF expression in the Mecp2 mutant brain with a conditional Bdnf transgene.  BDNF overexpression extended the lifespan, rescued a locomotor defect, and reversed an electrophysiol. deficit obsd. in Mecp2 mutants.  Our results provide in vivo evidence for a functional interaction between Mecp2 and Bdnf and demonstrate the physiol. significance of altered BDNF expression/signaling in RTT disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kHXzBB8YvrVg90H21EOLACvtfcHk0lj4JuI3dBInUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1eiurw%253D&md5=8d0e8abc255205b6580345142620bc97</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2005.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2005.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DKhare%26aufirst%3DG.%26aulast%3DDani%26aufirst%3DV.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DJaenisch%26aufirst%3DR.%26atitle%3DThe%2520disease%2520progression%2520of%2520Mecp2%2520mutant%2520mice%2520is%2520affected%2520by%2520the%2520level%2520of%2520BDNF%2520expression%26jtitle%3DNeuron%26date%3D2006%26volume%3D49%26spage%3D341%26epage%3D348%26doi%3D10.1016%2Fj.neuron.2005.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span> <span> </span><span class="NLM_article-title">Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">10911</span>– <span class="NLM_lpage">10915</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1810-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1810-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17050729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFynsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10911-10915&author=H.+Wangauthor=S.+A.+Chanauthor=M.+Ogierauthor=D.+Hellardauthor=Q.+Wangauthor=C.+Smithauthor=D.+M.+Katz&title=Dysregulation+of+brain-derived+neurotrophic+factor+expression+and+neurosecretory+function+in+Mecp2+null+mice&doi=10.1523%2FJNEUROSCI.1810-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice</span></div><div class="casAuthors">Wang, Hong; Chan, Shyue-an; Ogier, Michael; Hellard, David; Wang, Qifang; Smith, Corey; Katz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">10911-10915</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Disruptions in brain-derived neurotrophic factor (BDNF) expression are proposed to contribute to the mol. pathogenesis of Rett syndrome (RTT), a severe neurol. disorder caused by loss-of-function mutations in methyl-CpG-binding protein-2 (MeCP2).  Although MeCP2 is a transcriptional regulator of BDNF, it is unknown how MeCP2 mutations affect transsynaptic BDNF signaling.  Our findings demonstrate an early, abnormal neurosecretory phenotype in MeCP2-deficient neurons characterized by significant increases in the percentage of cellular BDNF content available for release.  However, loss of MeCP2 also results in deficits in total cell BDNF content that are developmentally regulated in a cell-type-specific manner.  Thus, the net effect of MeCP2 loss on abs. BDNF secretion changes with age and is detd. by both the amt. of BDNF available for release and progressive declines in total cellular BDNF.  We propose, therefore, that loss of MeCP2 function disrupts transsynaptic BDNF signaling by perturbing the normal balance between BDNF protein levels and secretion.  However, mutant neurons are capable of secreting wild-type levels of BDNF in response to high-frequency elec. stimulation.  In addn., we found elevated exocytic function in Mecp2-/y adrenal chromaffin cells, indicating that the Mecp2 null mutation is assocd. with alternations of neurosecretion that are not restricted to BDNF.  These findings are the first examples of abnormal neuropeptide and catecholamine secretion in a mouse model of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVYNTyHHxfcbVg90H21EOLACvtfcHk0lj4JuI3dBInUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFynsr7O&md5=5d6791c001c81acf0699996f01ff3ba1</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1810-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1810-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DS.%2BA.%26aulast%3DOgier%26aufirst%3DM.%26aulast%3DHellard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DKatz%26aufirst%3DD.%2BM.%26atitle%3DDysregulation%2520of%2520brain-derived%2520neurotrophic%2520factor%2520expression%2520and%2520neurosecretory%2520function%2520in%2520Mecp2%2520null%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10911%26epage%3D10915%26doi%3D10.1523%2FJNEUROSCI.1810-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span> <span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">10912</span>– <span class="NLM_lpage">10917</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1869-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1869-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17913925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=10912-10917&author=M.+Ogierauthor=H.+Wangauthor=E.+Hongauthor=Q.+Wangauthor=M.+E.+Greenbergauthor=D.+M.+Katz&title=Brain-derived+neurotrophic+factor+expression+and+respiratory+function+improve+after+ampakine+treatment+in+a+mouse+model+of+Rett+syndrome&doi=10.1523%2FJNEUROSCI.1869-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome</span></div><div class="casAuthors">Ogier, Michael; Wang, Hong; Hong, Elizabeth; Wang, Qifang; Greenberg, Michael E.; Katz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10912-10917</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is caused by loss-of-function mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2).  Although MeCP2 is thought to act as a transcriptional repressor of brain-derived neurotrophic factor (BDNF), Mecp2 null mice, which develop an RTT-like phenotype, exhibit progressive deficits in BDNF expression.  These deficits are particularly significant in the brainstem and nodose cranial sensory ganglia (NGs), structures crit. for cardiorespiratory homeostasis, and may be linked to the severe respiratory abnormalities characteristic of RTT.  Therefore, the present study used Mecp2 null mice to further define the role of MeCP2 in regulation of BDNF expression and neural function, focusing on NG neurons and respiratory control.  We find that mutant neurons express significantly lower levels of BDNF than wild-type cells in vitro, as in vivo, under both depolarizing and nondepolarizing conditions.  However, BDNF levels in mutant NG cells can be increased by chronic depolarization in vitro or by treatment of Mecp2 null mice with CX546, an ampakine drug that facilitates activation of glutamatergic AMPA receptors.  Ampakine-treated Mecp2 null mice also exhibit marked functional improvement, characterized by restoration of normal breathing frequency and minute vol.  These data demonstrate that BDNF expression remains plastic in Mecp2 null mice and raise the possibility that ampakine compds. could be of therapeutic value in the treatment of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiktLEp6zGPrVg90H21EOLACvtfcHk0lirQCrbpc4QAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyit77F&md5=9dae9aa4defedefcc7ac08ca0f62f10b</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1869-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1869-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DOgier%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26aulast%3DKatz%26aufirst%3DD.%2BM.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520expression%2520and%2520respiratory%2520function%2520improve%2520after%2520ampakine%2520treatment%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520syndrome%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D10912%26epage%3D10917%26doi%3D10.1523%2FJNEUROSCI.1869-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calfa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larimore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17087</span>– <span class="NLM_lpage">17092</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205271109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1205271109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23027959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17087-17092&author=W.+Liauthor=G.+Calfaauthor=J.+Larimoreauthor=L.+Pozzo-Miller&title=Activity-dependent+BDNF+release+and+TRPC+signaling+is+impaired+in+hippocampal+neurons+of+Mecp2+mutant+mice&doi=10.1073%2Fpnas.1205271109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice</span></div><div class="casAuthors">Li, Wei; Calfa, Gaston; Larimore, Jennifer; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17087-17092, S17087/1-S17087/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Dysfunction of the neurotrophin brain-derived neurotrophic factor (BDNF) is implicated in Rett syndrome (RTT), but the state of its releasable pool and downstream signaling in mice lacking methyl-CpG-binding protein-2 (Mecp2) is unknown.  Here, we show that membrane currents and dendritic Ca2+ signals evoked by recombinant BDNF or an activator of diacylglycerol (DAG)-sensitive transient receptor potential canonical (TRPC) channels are impaired in CA3 pyramidal neurons of symptomatic Mecp2 mutant mice.  TRPC3 and TRPC6 mRNA and protein levels are lower in Mecp2 mutant hippocampus, and chromatin immunopptn.  (ChIP) identified Trpc3 as a target of MeCP2 transcriptional regulation.  BDNF mRNA and protein levels are also lower in Mecp2 mutant hippocampus and dentate gyrus granule cells, which is reflected in impaired activity-dependent release of endogenous BDNF estd. from TRPC currents and dendritic Ca2+ signals in CA3 pyramidal neurons.  These results identify the gene encoding TRPC3 channels as a MeCP2 target and suggest a potential therapeutic strategy to boost impaired BDNF signaling in RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOPVEdM2eqSbVg90H21EOLACvtfcHk0lirQCrbpc4QAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsLbO&md5=dff6806a40e218cbb0bcf452670994b1</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205271109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205271109%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DCalfa%26aufirst%3DG.%26aulast%3DLarimore%26aufirst%3DJ.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DActivity-dependent%2520BDNF%2520release%2520and%2520TRPC%2520signaling%2520is%2520impaired%2520in%2520hippocampal%2520neurons%2520of%2520Mecp2%2520mutant%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17087%26epage%3D17092%26doi%3D10.1073%2Fpnas.1205271109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneussel, M.</span></span> <span> </span><span class="NLM_article-title">Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2010.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.tins.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20541813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=362-372&author=C.+Jankeauthor=M.+Kneussel&title=Tubulin+post-translational+modifications%3A+encoding+functions+on+the+neuronal+microtubule+cytoskeleton&doi=10.1016%2Fj.tins.2010.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton</span></div><div class="casAuthors">Janke, Carsten; Kneussel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">362-372</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past decades, a range of post-translational modifications has been discovered on tubulins, the major constituents of microtubules.  Pioneering studies have described the occurrence and dynamics of these modifications and provided first insights into their potential functions in regulating the microtubule cytoskeleton.  By contrast, several tubulin-modifying enzymes were only discovered in the last few years, and studies on mol. mechanisms and cellular functions of tubulin modifications are just beginning to emerge.  This review highlights the roles of tubulin modifications in neurons.  Recent studies are also discussed in relation to how the combinatorial use of tubulin modifications could generate a dynamic microtubule code, and how such a code might regulate basic as well as higher-order neuronal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQpu8-slRP7Vg90H21EOLACvtfcHk0lirQCrbpc4QAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFOgtLo%253D&md5=02ed3a8248b2403d0fcbb47863180b50</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DKneussel%26aufirst%3DM.%26atitle%3DTubulin%2520post-translational%2520modifications%253A%2520encoding%2520functions%2520on%2520the%2520neuronal%2520microtubule%2520cytoskeleton%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D362%26epage%3D372%26doi%3D10.1016%2Fj.tins.2010.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarenkova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelman, D. B.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates mitochondrial transport in hippocampal neurons</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e10848</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0010848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0010848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20520769" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e10848&author=S.+Chenauthor=G.+C.+Owensauthor=H.+Makarenkovaauthor=D.+B.+Edelman&title=HDAC6+regulates+mitochondrial+transport+in+hippocampal+neurons&doi=10.1371%2Fjournal.pone.0010848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0010848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0010848%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DOwens%26aufirst%3DG.%2BC.%26aulast%3DMakarenkova%26aufirst%3DH.%26aulast%3DEdelman%26aufirst%3DD.%2BB.%26atitle%3DHDAC6%2520regulates%2520mitochondrial%2520transport%2520in%2520hippocampal%2520neurons%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De10848%26doi%3D10.1371%2Fjournal.pone.0010848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delepine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nectoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span> <span> </span><span class="NLM_article-title">MeCP2 deficiency is associated with impaired microtubule stability</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>587</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2012.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.febslet.2012.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23238081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ku7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=245-253&author=C.+Delepineauthor=J.+Nectouxauthor=N.+Bahi-Buissonauthor=J.+Chellyauthor=T.+Bienvenu&title=MeCP2+deficiency+is+associated+with+impaired+microtubule+stability&doi=10.1016%2Fj.febslet.2012.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">MeCP2 deficiency is associated with impaired microtubule stability</span></div><div class="casAuthors">Delepine, Chloe; Nectoux, Juliette; Bahi-Buisson, Nadia; Chelly, Jamel; Bienvenu, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations.  Previous studies performed on Mecp2-deficient brain showed striking changes in neuronal maturation.  We recently showed that MeCP2 deficiency affects microtubule (MT) dynamics in RTT astrocytes.  Here, we analyze MT stability in primary fibroblast cultures from patients with RTT syndrome and identify a significant decrease in stability compared to controls.  Furthermore, we found that MT stability was reduced both in cells expressing the mutant or the wild-type allele in RTT fibroblasts, suggesting that mutated cells could damage wild-type ones through a non-cell-autonomous pathway.  These results suggest that MeCP2 has a stabilizing role on MT dynamics and that its deficiency could lead to impaired MT stability that may explain in part the dendritic abnormalities obsd. in RTT brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfVISwfhNEbVg90H21EOLACvtfcHk0liczn24-1E6cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ku7nM&md5=942ef1c49fc4ae54b75faa30608f79fb</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DDelepine%26aufirst%3DC.%26aulast%3DNectoux%26aufirst%3DJ.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBienvenu%26aufirst%3DT.%26atitle%3DMeCP2%2520deficiency%2520is%2520associated%2520with%2520impaired%2520microtubule%2520stability%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D245%26epage%3D253%26doi%3D10.1016%2Fj.febslet.2012.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nectoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delepine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khelfaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span> <span> </span><span class="NLM_article-title">Altered microtubule dynamics in Mecp2-deficient astrocytes</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1002/jnr.23001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fjnr.23001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22252744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=990-998&author=J.+Nectouxauthor=C.+Florianauthor=C.+Delepineauthor=N.+Bahi-Buissonauthor=M.+Khelfaouiauthor=S.+Reibelauthor=J.+Chellyauthor=T.+Bienvenu&title=Altered+microtubule+dynamics+in+Mecp2-deficient+astrocytes&doi=10.1002%2Fjnr.23001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Altered microtubule dynamics in Mecp2-deficient astrocytes</span></div><div class="casAuthors">Nectoux, Juliette; Florian, Cedrick; Delepine, Chloe; Bahi-Buisson, Nadia; Khelfaoui, Malik; Reibel, Sophie; Chelly, Jamel; Bienvenu, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">990-998</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the gene MECP2 encoding the methyl-CpG binding protein 2.  This genetic disease affects predominantly girls and is characterized by a period of normal development that lasts for 8-18 mo, followed by neurol. regression affecting both motor and mental abilities.  Previous studies performed on brains from RTT subjects and Mecp2-deficient mice showed striking changes in neuronal maturation and dendritic arborization.  Recently, we showed that expression of stathmin-like 2 (STMN2) was significantly reduced in fibroblasts from RTT patients, and similar results were obtained in the cerebellum of Mecp2-deficient mice.  Because assembly and dynamics of microtubules are known to be modulated by STMN2, we studied microtubule dynamics in brain cells from Mecp2-deficient mice.  We obsd. that Mecp2 deficiency affects microtubule dynamics in astrocytes from Mecp2-deficient mice.  Our data reinforce the fact that the loss of Mecp2 in astrocytes may influence the onset and progression of RTT.  These results imply that Mecp2 has a stabilizing role in microtubule dynamics and that Mecp2 deficiency, which is assocd. with STMN2 down-regulation, could lead to impaired microtubule stability, hence explaining the dendritic abnormalities obsd. in RTT brains. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-NJY-_lR-rVg90H21EOLACvtfcHk0liczn24-1E6cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2ksw%253D%253D&md5=0f46dd22d8ce691001788bdf82758c61</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23001%26sid%3Dliteratum%253Aachs%26aulast%3DNectoux%26aufirst%3DJ.%26aulast%3DFlorian%26aufirst%3DC.%26aulast%3DDelepine%26aufirst%3DC.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DKhelfaoui%26aufirst%3DM.%26aulast%3DReibel%26aufirst%3DS.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBienvenu%26aufirst%3DT.%26atitle%3DAltered%2520microtubule%2520dynamics%2520in%2520Mecp2-deficient%2520astrocytes%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2012%26volume%3D90%26spage%3D990%26epage%3D998%26doi%3D10.1002%2Fjnr.23001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panayotis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges-Correia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, L.</span></span> <span> </span><span class="NLM_article-title">Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2011.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2011.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22127389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=786-795&author=J.+C.+Rouxauthor=D.+Zalaauthor=N.+Panayotisauthor=A.+Borges-Correiaauthor=F.+Saudouauthor=L.+Villard&title=Modification+of+Mecp2+dosage+alters+axonal+transport+through+the+Huntingtin%2FHap1+pathway&doi=10.1016%2Fj.nbd.2011.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway</span></div><div class="casAuthors">Roux, Jean-Christophe; Zala, Diana; Panayotis, Nicolas; Borges-Correia, Ana; Saudou, Frederic; Villard, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mecp2 deficiency or overexpression causes a wide spectrum of neurol. diseases in humans among which Rett Syndrome is the prototype.  Pathogenic mechanisms are thought to involve transcriptional deregulation of target genes such as Bdnf together with defects in the general transcriptional program of affected cells.  Here we found that two master genes, Huntingtin (Htt) and huntingtin-assocd. protein (Hap1), involved in the control of Bdnf axonal transport, are altered in the brain of Mecp2-deficient mice.  We also revealed an in vivo defect of Bdnf transport throughout the cortico striatal pathway of Mecp2-deficient animals.  We found that the velocity of Bdnf-contg. vesicles is reduced in vitro in the Mecp2-deficient axons and this deficit can be rescued by the re-expression of Mecp2.  The defect in axonal transport is not restricted to Bdnf since transport of the amyloid precursor protein (App) that is Htt and Hap1-dependent is also altered.  Finally, treating Mecp2-deficient mice with cysteamine, a mol. increasing the secretion of Bdnf vesicles, improved the lifespan and reduced motor defects, suggesting a new therapeutic strategy for Rett syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7dy9l4DfUQbVg90H21EOLACvtfcHk0liczn24-1E6cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKjsQ%253D%253D&md5=4f208a5a7a9cfd13474e5db913bde567</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DJ.%2BC.%26aulast%3DZala%26aufirst%3DD.%26aulast%3DPanayotis%26aufirst%3DN.%26aulast%3DBorges-Correia%26aufirst%3DA.%26aulast%3DSaudou%26aufirst%3DF.%26aulast%3DVillard%26aufirst%3DL.%26atitle%3DModification%2520of%2520Mecp2%2520dosage%2520alters%2520axonal%2520transport%2520through%2520the%2520Huntingtin%252FHap1%2520pathway%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D45%26spage%3D786%26epage%3D795%26doi%3D10.1016%2Fj.nbd.2011.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">10842</span>– <span class="NLM_lpage">10846</span>, <span class="refDoi"> DOI: 10.1021/ja102758v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A&doi=10.1021%2Fja102758v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0lhnhkoom4Usxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846%26doi%3D10.1021%2Fja102758v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asthana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">22516</span>– <span class="NLM_lpage">22526</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.489328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M113.489328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23798680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Whsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22516-22526&author=J.+Asthanaauthor=S.+Kapoorauthor=R.+Mohanauthor=D.+Panda&title=Inhibition+of+HDAC6+deacetylase+activity+increases+its+binding+with+microtubules+and+suppresses+microtubule+dynamic+instability+in+MCF-7+cells&doi=10.1074%2Fjbc.M113.489328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells</span></div><div class="casAuthors">Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">22516-22526</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The post-translational modification of tubulin appears to be a highly controlled mechanism that regulates microtubule functioning.  Acetylation of the .vepsiln.-amino group of Lys-40 of α-tubulin marks stable microtubules, although the causal relationship between tubulin acetylation and microtubule stability has remained poorly understood.  HDAC6, the tubulin deacetylase, plays a key role in maintaining typical distribution of acetylated microtubules in cells.  Here, by using tubastatin A, an HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC6, we have explored whether tubulin acetylation has a role in regulating microtubule stability.  We found that whereas both pharmacol. inhibition of HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacol. inhibition of HDAC6 activity leads to an increase in microtubule stability against cold and nocodazole-induced depolymg. conditions.  Tubastatin A treatment suppressed the dynamics of individual microtubules in MCF-7 cells and delayed the reassembly of depolymd. microtubules.  Interestingly, both the localization of HDAC6 on microtubules and the amt. of HDAC6 assocd. with polymeric fraction of tubulin were found to increase in the tubastatin A-treated cells compared with the control cells, suggesting that the pharmacol. inhibition of HDAC6 enhances the binding of HDAC6 to microtubules.  The evidence presented in this study indicated that the increased binding of HDAC6, rather than the acetylation per se, causes microtubule stability.  The results are in support of a hypothesis that in addn. to its deacetylase function, HDAC6 might function as a MAP that regulates microtubule dynamics under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg9tZTljw347Vg90H21EOLACvtfcHk0lhnhkoom4Usxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Whsr%252FJ&md5=455f7258d82d50403329a6c5e78c98d8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.489328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.489328%26sid%3Dliteratum%253Aachs%26aulast%3DAsthana%26aufirst%3DJ.%26aulast%3DKapoor%26aufirst%3DS.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DPanda%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520HDAC6%2520deacetylase%2520activity%2520increases%2520its%2520binding%2520with%2520microtubules%2520and%2520suppresses%2520microtubule%2520dynamic%2520instability%2520in%2520MCF-7%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D22516%26epage%3D22526%26doi%3D10.1074%2Fjbc.M113.489328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Outeiro, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathearn, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amore, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochet, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feany, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazantsev, A. G.</span></span> <span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lhnhkoom4Usxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadakata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saruta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itohara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, T.</span></span> <span> </span><span class="NLM_article-title">Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">21104</span>– <span class="NLM_lpage">21109</span>, <span class="refDoi"> DOI: 10.1073/pnas.1210055109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1210055109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23213205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1eltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21104-21109&author=T.+Sadakataauthor=Y.+Shinodaauthor=M.+Okaauthor=Y.+Sekineauthor=Y.+Satoauthor=C.+Sarutaauthor=H.+Miwaauthor=M.+Tanakaauthor=S.+Itoharaauthor=T.+Furuichi&title=Reduced+axonal+localization+of+a+Caps2+splice+variant+impairs+axonal+release+of+BDNF+and+causes+autistic-like+behavior+in+mice&doi=10.1073%2Fpnas.1210055109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice</span></div><div class="casAuthors">Sadakata, Tetsushi; Shinoda, Yo; Oka, Megumi; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Miwa, Hideki; Tanaka, Mika; Itohara, Shigeyoshi; Furuichi, Teiichi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21104-21109, S21104/1-S21104/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ca2+-dependent activator protein for secretion 2 (CAPS2 or CADPS2) potently promotes the release of brain-derived neurotrophic factor (BDNF).  A rare splicing form of CAPS2 with deletion of exon3 (dex3) was identified to be overrepresented in some patients with autism.  Here, we generated Caps2-dex3 mice and verified a severe impairment in axonal Caps2-dex3 localization, contributing to a redn. in BDNF release from axons.  In addn., circuit connectivity, measured by spine and interneuron d., was diminished globally.  The collective effect of reduced axonal BDNF release during development was a striking and selective repertoire of deficits in social- and anxiety-related behaviors.  Together, these findings represent a unique mouse model of a mol. mechanism linking BDNF-mediated coordination of brain development to autism-related behaviors and patient genotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc96UoJSRDnbVg90H21EOLACvtfcHk0lhGKbTABUuL1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1eltA%253D%253D&md5=ecb7d91553b49157c3ca8eda4ee58f35</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210055109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210055109%26sid%3Dliteratum%253Aachs%26aulast%3DSadakata%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DY.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DSaruta%26aufirst%3DC.%26aulast%3DMiwa%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DItohara%26aufirst%3DS.%26aulast%3DFuruichi%26aufirst%3DT.%26atitle%3DReduced%2520axonal%2520localization%2520of%2520a%2520Caps2%2520splice%2520variant%2520impairs%2520axonal%2520release%2520of%2520BDNF%2520and%2520causes%2520autistic-like%2520behavior%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21104%26epage%3D21109%26doi%3D10.1073%2Fpnas.1210055109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span>. <i>Front. Cell Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3389%2Ffncel.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24639629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=68&author=X.+Xuauthor=A.+P.+Kozikowskiauthor=L.+Pozzo-Miller&title=A+selective+histone+deacetylase-6+inhibitor+improves+BDNF+trafficking+in+hippocampal+neurons+from+Mecp2+knockout+mice%3A+implications+for+Rett+syndrome&doi=10.3389%2Ffncel.2014.00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span></div><div class="casAuthors">Xu, Xin; Kozikowski, Alan P.; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/9</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by loss-of-function mutations in the transcriptional modulator methyl-CpG-binding protein 2 (MECP2).  One of the most prominent gene targets of MeCP2 is brain-derived neurotrophic factor (Bdnf), a potent modulator of activity-dependent synaptic development, function and plasticity.  Dysfunctional BDNF signaling has been demonstrated in several pathophysiol. mechanisms of RTT disease progression.  To evaluate whether the dynamics of BDNF trafficking is affected by Mecp2 deletion, we analyzed movements of BDNF tagged with yellow fluorescent protein (YFP) in cultured hippocampal neurons by time-lapse fluorescence imaging.  We found that both anterograde and retrograde vesicular trafficking of BDNF-YFP are significantly impaired in Mecp2 knockout hippocampal neurons.  Selective inhibitors of histone deacetylase 6 (HDAC6) show neuroprotective effects in neurodegenerative diseases and stimulate microtubule-dependent vesicular trafficking of BDNF-contg. dense core vesicles.  Here, we show that the selective HDAC6 inhibitor Tubastatin-A increased the velocity of BDNF-YFP vesicles in Mecp2 knockout neurons in both directions by increasing α-tubulin acetylation.  Tubastatin-A also restored activity-dependent BDNF release from Mecp2 knockout neurons to levels comparable to those shown by wildtype neurons.  These findings demonstrate that a selective HDAC6 inhibitor is a potential pharmacol. strategy to reverse cellular and synaptic impairments in RTT resulting from impaired BDNF signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTWjdzmjqurVg90H21EOLACvtfcHk0lhGKbTABUuL1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM&md5=ead557e0e05455dd86fa959e7edeb5bc</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DA%2520selective%2520histone%2520deacetylase-6%2520inhibitor%2520improves%2520BDNF%2520trafficking%2520in%2520hippocampal%2520neurons%2520from%2520Mecp2%2520knockout%2520mice%253A%2520implications%2520for%2520Rett%2520syndrome%26jtitle%3DFront.%2520Cell%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D68%26doi%3D10.3389%2Ffncel.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">The benefits and limitations of animal models for translational research in neurodegenerative diseases</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1038/nm.2224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnm.2224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21052075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2jtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1210-1214&author=M.+Jucker&title=The+benefits+and+limitations+of+animal+models+for+translational+research+in+neurodegenerative+diseases&doi=10.1038%2Fnm.2224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits and limitations of animal models for translational research in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1210-1214</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Age-related neurodegenerative diseases are largely limited to humans and rarely occur spontaneously in animals.  Genetically engineered mouse models recapitulate aspects of the corresponding human diseases and are instrumental in studying disease mechanisms and testing therapeutic strategies.  If considered within the range of their validity, mouse models have been predictive of clin. outcome.  Translational failure is less the result of the incomplete nature of the models than of inadequate preclin. studies and misinterpretation of the models.  This commentary summarizes current models and highlights key questions we should be asking about animal models, as well as questions that cannot be answered with the current models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ7ygIlgmbPbVg90H21EOLACvtfcHk0lhGKbTABUuL1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2jtrvF&md5=7e0f31fc015a073dbad54784f1cb0fbf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnm.2224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2224%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DThe%2520benefits%2520and%2520limitations%2520of%2520animal%2520models%2520for%2520translational%2520research%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D1210%26epage%3D1214%26doi%3D10.1038%2Fnm.2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0li0kAjEINBP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonini, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palejev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span> <span> </span><span class="NLM_article-title">Modeling human cortical development in vitro using induced pluripotent stem cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">12770</span>– <span class="NLM_lpage">12775</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202944109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1202944109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22761314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlelsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=12770-12775&author=J.+Marianiauthor=M.+V.+Simoniniauthor=D.+Palejevauthor=L.+Tomasiniauthor=G.+Coppolaauthor=A.+M.+Szekelyauthor=T.+L.+Horvathauthor=F.+M.+Vaccarino&title=Modeling+human+cortical+development+in+vitro+using+induced+pluripotent+stem+cells&doi=10.1073%2Fpnas.1202944109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling human cortical development in vitro using induced pluripotent stem cells</span></div><div class="casAuthors">Mariani, Jessica; Simonini, Maria Vittoria; Palejev, Dean; Tomasini, Livia; Coppola, Gianfilippo; Szekely, Anna M.; Horvath, Tamas L.; Vaccarino, Flora M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12770-12775, S12770/1-S12770/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human induced pluripotent stem cells (hiPSCs) are emerging as a tool for understanding human brain development at cellular, mol., and genomic levels.  Here we show that hiPSCs grown in suspension in the presence of rostral neuralizing factors can generate 3D structures contg. polarized radial glia, intermediate progenitors, and a spectrum of layer-specific cortical neurons reminiscent of their organization in vivo.  The hiPSC-derived multilayered structures express a gene expression profile typical of the embryonic telencephalon but not that of other CNS regions.  Their transcriptome is highly enriched in transcription factors controlling the specification, growth, and patterning of the dorsal telencephalon and displays highest correlation with that of the early human cerebral cortical wall at 8-10 wk after conception.  Thus, hiPSC are capable of enacting a transcriptional program specifying human telencephalic (pallial) development.  This model will allow the study of human brain development as well as disorders of the human cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Bd7VT--LF7Vg90H21EOLACvtfcHk0li0kAjEINBP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlelsbfE&md5=243ef8562af7cd0e0113b13f51fcbc82</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202944109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202944109%26sid%3Dliteratum%253Aachs%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DSimonini%26aufirst%3DM.%2BV.%26aulast%3DPalejev%26aufirst%3DD.%26aulast%3DTomasini%26aufirst%3DL.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DSzekely%26aufirst%3DA.%2BM.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26atitle%3DModeling%2520human%2520cortical%2520development%2520in%2520vitro%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D12770%26epage%3D12775%26doi%3D10.1073%2Fpnas.1202944109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abyzov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amenduni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palejev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigorenko, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelphrey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span> <span> </span><span class="NLM_article-title">FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2015.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26186191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KgtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=375-390&author=J.+Marianiauthor=G.+Coppolaauthor=P.+Zhangauthor=A.+Abyzovauthor=L.+Proviniauthor=L.+Tomasiniauthor=M.+Amenduniauthor=A.+Szekelyauthor=D.+Palejevauthor=M.+Wilsonauthor=M.+Gersteinauthor=E.+L.+Grigorenkoauthor=K.+Chawarskaauthor=K.+A.+Pelphreyauthor=J.+R.+Howeauthor=F.+M.+Vaccarino&title=FOXG1-dependent+dysregulation+of+GABA%2Fglutamate+neuron+differentiation+in+autism+spectrum+disorders&doi=10.1016%2Fj.cell.2015.06.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">FOXG1-Dependent Dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</span></div><div class="casAuthors">Mariani, Jessica; Coppola, Gianfilippo; Zhang, Ping; Abyzov, Alexej; Provini, Lauren; Tomasini, Livia; Amenduni, Mariangela; Szekely, Anna; Palejev, Dean; Wilson, Michael; Gerstein, Mark; Grigorenko, Elena L.; Chawarska, Katarzyna; Pelphrey, Kevin A.; Howe, James R.; Vaccarino, Flora M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-390</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a disorder of brain development.  Most cases lack a clear etiol. or genetic basis, and the difficulty of re-enacting human brain development has precluded understanding of ASD pathophysiol.  Here we use three-dimensional neural cultures (organoids) derived from induced pluripotent stem cells (iPSCs) to investigate neurodevelopmental alterations in individuals with severe idiopathic ASD.  While no known underlying genomic mutation could be identified, transcriptome and gene network analyses revealed upregulation of genes involved in cell proliferation, neuronal differentiation, and synaptic assembly.  ASD-derived organoids exhibit an accelerated cell cycle and overprodn. of GABAergic inhibitory neurons.  Using RNA interference, we show that overexpression of the transcription factor FOXG1 is responsible for the overprodn. of GABAergic neurons.  Altered expression of gene network modules and FOXG1 are pos. correlated with symptom severity.  Our data suggest that a shift toward GABAergic neuron fate caused by FOXG1 is a developmental precursor of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SqefHRDom7Vg90H21EOLACvtfcHk0li0kAjEINBP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KgtLrN&md5=946bcc3d3d1818cac587d3ab8e3b49b3</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DAbyzov%26aufirst%3DA.%26aulast%3DProvini%26aufirst%3DL.%26aulast%3DTomasini%26aufirst%3DL.%26aulast%3DAmenduni%26aufirst%3DM.%26aulast%3DSzekely%26aufirst%3DA.%26aulast%3DPalejev%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DGerstein%26aufirst%3DM.%26aulast%3DGrigorenko%26aufirst%3DE.%2BL.%26aulast%3DChawarska%26aufirst%3DK.%26aulast%3DPelphrey%26aufirst%3DK.%2BA.%26aulast%3DHowe%26aufirst%3DJ.%2BR.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26atitle%3DFOXG1-dependent%2520dysregulation%2520of%2520GABA%252Fglutamate%2520neuron%2520differentiation%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DCell%26date%3D2015%26volume%3D162%26spage%3D375%26epage%3D390%26doi%3D10.1016%2Fj.cell.2015.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makinson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huguenard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barres, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, S. P.</span></span> <span> </span><span class="NLM_article-title">Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnmeth.3415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26005811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=671-678&author=A.+M.+Pascaauthor=S.+A.+Sloanauthor=L.+E.+Clarkeauthor=Y.+Tianauthor=C.+D.+Makinsonauthor=N.+Huberauthor=C.+H.+Kimauthor=J.+Y.+Parkauthor=N.+A.+O%E2%80%99Rourkeauthor=K.+D.+Nguyenauthor=S.+J.+Smithauthor=J.+R.+Huguenardauthor=D.+H.+Geschwindauthor=B.+A.+Barresauthor=S.+P.+Pasca&title=Functional+cortical+neurons+and+astrocytes+from+human+pluripotent+stem+cells+in+3D+culture&doi=10.1038%2Fnmeth.3415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture</span></div><div class="casAuthors">Pasca, Anca M.; Sloan, Steven A.; Clarke, Laura E.; Tian, Yuan; Makinson, Christopher D.; Huber, Nina; Kim, Chul Hoon; Park, Jin-Young; O'Rourke, Nancy A.; Nguyen, Khoa D.; Smith, Stephen J.; Huguenard, John R.; Geschwind, Daniel H.; Barres, Ben A.; Pasca, Sergiu P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human cerebral cortex develops through an elaborate succession of cellular events that, when disrupted, can lead to neuropsychiatric disease.  The ability to reprogram somatic cells into pluripotent cells that can be differentiated in vitro provides a unique opportunity to study normal and abnormal corticogenesis.  Here, we present a simple and reproducible 3D culture approach for generating a laminated cerebral cortex-like structure, named human cortical spheroids (hCSs), from pluripotent stem cells. hCSs contain neurons from both deep and superficial cortical layers and map transcriptionally to in vivo fetal development.  These neurons are electrophysiol. mature, display spontaneous activity, are surrounded by nonreactive astrocytes and form functional synapses.  Expts. in acute hCS slices demonstrate that cortical neurons participate in network activity and produce complex synaptic events.  These 3D cultures should allow a detailed interrogation of human cortical development, function and disease, and may prove a versatile platform for generating other neuronal and glial subtypes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNa7ccGUSi7Vg90H21EOLACvtfcHk0lhNynmj4hrGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbfI&md5=ffb4210fe76f1524c5a80811a9320195</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3415%26sid%3Dliteratum%253Aachs%26aulast%3DPasca%26aufirst%3DA.%2BM.%26aulast%3DSloan%26aufirst%3DS.%2BA.%26aulast%3DClarke%26aufirst%3DL.%2BE.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMakinson%26aufirst%3DC.%2BD.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DN.%2BA.%26aulast%3DNguyen%26aufirst%3DK.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DHuguenard%26aufirst%3DJ.%2BR.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DBarres%26aufirst%3DB.%2BA.%26aulast%3DPasca%26aufirst%3DS.%2BP.%26atitle%3DFunctional%2520cortical%2520neurons%2520and%2520astrocytes%2520from%2520human%2520pluripotent%2520stem%2520cells%2520in%25203D%2520culture%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D671%26epage%3D678%26doi%3D10.1038%2Fnmeth.3415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vowles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustacchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argoud, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponting, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span> <span> </span><span class="NLM_article-title">Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fhmg%2Fddv637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26740550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aitrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=989-1000&author=A.+E.+Handelauthor=S.+Chintawarauthor=T.+Lalicauthor=E.+Whiteleyauthor=J.+Vowlesauthor=A.+Giustacchiniauthor=K.+Argoudauthor=P.+Soppauthor=M.+Nakanishiauthor=R.+Bowdenauthor=S.+Cowleyauthor=S.+Neweyauthor=C.+Akermanauthor=C.+P.+Pontingauthor=M.+Z.+Cader&title=Assessing+similarity+to+primary+tissue+and+cortical+layer+identity+in+induced+pluripotent+stem+cell-derived+cortical+neurons+through+single-cell+transcriptomics&doi=10.1093%2Fhmg%2Fddv637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics</span></div><div class="casAuthors">Handel, Adam E.; Chintawar, Satyan; Lalic, Tatjana; Whiteley, Emma; Vowles, Jane; Giustacchini, Alice; Argoud, Karene; Sopp, Paul; Nakanishi, Mahito; Bowden, Rory; Cowley, Sally; Newey, Sarah; Akerman, Colin; Ponting, Chris P.; Cader, M. Zameel</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Induced pluripotent stem cell (iPSC)-derived cortical neurons potentially present a powerful new model to understand corticogenesis and neurol. disease.  Previous work has established that differentiation protocols can produce cortical neurons, but little has been done to characterize these at cellular resoln.  In particular, it is unclear to what extent in vitro two-dimensional, relatively disordered culture conditions recapitulate the development of in vivo cortical layer identity.  Single- cell multiplex reverse transcriptase-quant. polymerase chain reaction (RT-qPCR) was used to interrogate the expression of genes previously implicated in cortical layer or phenotypic identity in individual cells.  Totally, 93.6% of single cells derived from iPSCs expressed genes indicative of neuronal identity.  High proportions of single neurons derived from iPSCs expressed glutamatergic receptors and synaptic genes.  And, 68.4% of iPSC-derived neurons expressing at least one layer marker could be assigned to a laminar identity using canonical cortical layer marker genes.  We compared single-cell RNA-seq of our iPSC- derived neurons to available single-cell RNA-seq data from human fetal and adult brain and found that iPSC-derived cortical neurons closely resembled primary fetal brain cells.  Unexpectedly, a subpopulation of iPSC-derived neurons co-expressed canonical fetal deep and upper cortical layer markers.  However, this appeared to be concordant with data from primary cells.  Our results therefore provide reassurance that iPSC-derived cortical neurons are highly similar to primary cortical neurons at the level of single cells but suggest that current layer markers, although effective, may not be able to disambiguate cortical layer identity in all cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK9bxZFfeN4rVg90H21EOLACvtfcHk0lhNynmj4hrGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aitrrM&md5=25fb8692b273437a2acb05ad8ef8820a</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv637%26sid%3Dliteratum%253Aachs%26aulast%3DHandel%26aufirst%3DA.%2BE.%26aulast%3DChintawar%26aufirst%3DS.%26aulast%3DLalic%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DE.%26aulast%3DVowles%26aufirst%3DJ.%26aulast%3DGiustacchini%26aufirst%3DA.%26aulast%3DArgoud%26aufirst%3DK.%26aulast%3DSopp%26aufirst%3DP.%26aulast%3DNakanishi%26aufirst%3DM.%26aulast%3DBowden%26aufirst%3DR.%26aulast%3DCowley%26aufirst%3DS.%26aulast%3DNewey%26aufirst%3DS.%26aulast%3DAkerman%26aufirst%3DC.%26aulast%3DPonting%26aufirst%3DC.%2BP.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26atitle%3DAssessing%2520similarity%2520to%2520primary%2520tissue%2520and%2520cortical%2520layer%2520identity%2520in%2520induced%2520pluripotent%2520stem%2520cell-derived%2520cortical%2520neurons%2520through%2520single-cell%2520transcriptomics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D989%26epage%3D1000%26doi%3D10.1093%2Fhmg%2Fddv637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amenduni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Filippis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disciglio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epistolato, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mencarelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayek, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">iPS cells to model CDKL5-related disorders</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1255</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2011.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fejhg.2011.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21750574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1246-1255&author=M.+Amenduniauthor=R.+De+Filippisauthor=A.+Y.+Cheungauthor=V.+Disciglioauthor=M.+C.+Epistolatoauthor=F.+Arianiauthor=F.+Mariauthor=M.+A.+Mencarelliauthor=Y.+Hayekauthor=A.+Renieriauthor=J.+Ellisauthor=I.+Meloni&title=iPS+cells+to+model+CDKL5-related+disorders&doi=10.1038%2Fejhg.2011.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">iPS cells to model CDKL5-related disorders</span></div><div class="casAuthors">Amenduni, Mariangela; De Filippis, Roberta; Cheung, Aaron Y. L.; Disciglio, Vittoria; Epistolato, Maria Carmela; Ariani, Francesca; Mari, Francesca; Mencarelli, Maria Antonietta; Hayek, Youssef; Renieri, Alessandra; Ellis, James; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1246-1255</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a progressive neurol. disorder representing one of the most common causes of mental retardation in females.  To date mutations in three genes have been assocd. with this condition.  Classic RTT is caused by mutations in the MECP2 gene, whereas variants can be due to mutations in either MECP2 or FOXG1 or CDKL5.  Mutations in CDKL5 have been identified both in females with the early onset seizure variant of RTT and in males with X-linked epileptic encephalopathy.  To address this issue we established a human cellular model for CDKL5-related disease using the recently developed technol. of induced pluripotent stem cells (iPSCs).  IPSCs can be expanded indefinitely and differentiated in vitro into many different cell types, including neurons.  CDKL5 is a kinase protein highly expressed in neurons, but its exact function inside the cell is unknown.  These features make them the ideal tool to study disease mechanisms directly on the primarily affected neuronal cells.  We derived iPSCs from fibroblasts of one female with p.Q347X and one male with p.T288I mutation, affected by early onset seizure variant and X-linked epileptic encephalopathy, resp.  We demonstrated that female CDKL5-mutated iPSCs maintain X-chromosome inactivation and clones express either the mutant CDKL5 allele or the wild-type allele that serve as an ideal exptl. control.  Array CGH indicates normal isogenic mol. karyotypes without detection of de novo CNVs in the CDKL5-mutated iPSCs.  Furthermore, the iPS cells can be differentiated into neurons and are thus suitable to model disease pathogenesis in vitro.  European Journal of Human Genetics (2011) 19, 1246-1255; doi:10.1038/ejhg.2011.131; published online 13 July 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNiV80sqXJbVg90H21EOLACvtfcHk0lhl6QFMMxulsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsL3E&md5=bc44dbd82a75d1f9a96de3c36f14f60a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2011.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2011.131%26sid%3Dliteratum%253Aachs%26aulast%3DAmenduni%26aufirst%3DM.%26aulast%3DDe%2BFilippis%26aufirst%3DR.%26aulast%3DCheung%26aufirst%3DA.%2BY.%26aulast%3DDisciglio%26aufirst%3DV.%26aulast%3DEpistolato%26aufirst%3DM.%2BC.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DMencarelli%26aufirst%3DM.%2BA.%26aulast%3DHayek%26aufirst%3DY.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DiPS%2520cells%2520to%2520model%2520CDKL5-related%2520disorders%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2011%26volume%3D19%26spage%3D1246%26epage%3D1255%26doi%3D10.1038%2Fejhg.2011.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patriarchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amabile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frullanti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Rizzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olimpico, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, MF. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1(±) patients and in foxg1(±) mice</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2015.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fejhg.2015.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26443267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1KrsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=871-880&author=T.+Patriarchiauthor=S.+Amabileauthor=E.+Frullantiauthor=E.+Landucciauthor=C.+Lo+Rizzoauthor=F.+Arianiauthor=M.+Costaauthor=F.+Olimpicoauthor=J.+W.+Hellauthor=MF.+M.+Vaccarinoauthor=A.+Renieriauthor=I.+Meloni&title=Imbalance+of+excitatory%2Finhibitory+synaptic+protein+expression+in+iPSC-derived+neurons+from+FOXG1%28%C2%B1%29+patients+and+in+foxg1%28%C2%B1%29+mice&doi=10.1038%2Fejhg.2015.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+/- patients and in foxg1+/- mice</span></div><div class="casAuthors">Patriarchi, Tommaso; Amabile, Sonia; Frullanti, Elisa; Landucci, Elisa; Lo Rizzo, Caterina; Ariani, Francesca; Costa, Mario; Olimpico, Francesco; Hell, Johannes W.; Vaccarino, Flora M.; Renieri, Alessandra; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-880</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurodevelopmental disorder assocd. with mutations in either MECP2, CDKL5 or FOXG1.  The precise mol. mechanisms that lead to the pathogenesis of RTT have yet to be elucidated.  We recently reported that expression of GluD1 (orphan glutamate receptor δ-1 subunit) is increased in iPSC-derived neurons obtained from patients with mutations in either MECP2 or CDKL5.  GluD1 controls synaptic differentiation and shifts the balance between excitatory and inhibitory synapses toward the latter.  Thus, an increase in GluD1 might be a crit. factor in the etiol. of RTT by affecting the excitatory/inhibitory balance in the developing brain.  To test this hypothesis, we generated iPSC-derived neurons from FOXG1+/- patients.  We analyzed mRNA and protein levels of GluD1 together with key markers of excitatory and inhibitory synapses in these iPSC-derived neurons and in Foxg1+/- mouse fetal (E11.5) and adult (P70) brains.  We found strong correlation between iPSC-derived neurons and fetal mouse brains, where GluD1 and inhibitory synaptic markers (GAD67 and GABA AR-α1) were increased, whereas the levels of a no. of excitatory synaptic markers (VGLUT1, GluA1, GluN1 and PSD-95) were decreased.  In adult mice, GluD1 was decreased along with all GABAergic and glutamatergic markers.  Our findings further the understanding of the etiol. of RTT by introducing a new pathol. event occurring in the brain of FOXG1+/- patients during embryonic development and its time-dependent shift toward a general decrease in brain synapses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokd0vSjL9P8bVg90H21EOLACvtfcHk0lhl6QFMMxulsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1KrsbbP&md5=7c3e00875afc0fb189934039e808b65f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2015.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2015.216%26sid%3Dliteratum%253Aachs%26aulast%3DPatriarchi%26aufirst%3DT.%26aulast%3DAmabile%26aufirst%3DS.%26aulast%3DFrullanti%26aufirst%3DE.%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DLo%2BRizzo%26aufirst%3DC.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DOlimpico%26aufirst%3DF.%26aulast%3DHell%26aufirst%3DJ.%2BW.%26aulast%3DVaccarino%26aufirst%3DMF.%2BM.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DImbalance%2520of%2520excitatory%252Finhibitory%2520synaptic%2520protein%2520expression%2520in%2520iPSC-derived%2520neurons%2520from%2520FOXG1%2528%25C2%25B1%2529%2520patients%2520and%2520in%2520foxg1%2528%25C2%25B1%2529%2520mice%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D24%26spage%3D871%26epage%3D880%26doi%3D10.1038%2Fejhg.2015.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetto, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carromeu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muotri, A. R.</span></span> <span> </span><span class="NLM_article-title">A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21074045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=527-539&author=M.+C.+Marchettoauthor=C.+Carromeuauthor=A.+Acabauthor=D.+Yuauthor=G.+W.+Yeoauthor=Y.+Muauthor=G.+Chenauthor=F.+H.+Gageauthor=A.+R.+Muotri&title=A+model+for+neural+development+and+treatment+of+Rett+syndrome+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.cell.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-539</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype.  Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts.  RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons.  Neurons derived from RTT-iPSCs had fewer synapses, reduced spine d., smaller soma size, altered calcium signaling and electrophysiol. defects when compared to controls.  Our data uncovered early alterations in developing human RTT neurons.  Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects.  Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed.  Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVs6bKz90wyLVg90H21EOLACvtfcHk0lhl6QFMMxulsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE&md5=e65138528f9ad3678f5c8e0e0cf2d162</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DCarromeu%26aufirst%3DC.%26aulast%3DAcab%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DA%2520model%2520for%2520neural%2520development%2520and%2520treatment%2520of%2520Rett%2520syndrome%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%26date%3D2010%26volume%3D143%26spage%3D527%26epage%3D539%26doi%3D10.1016%2Fj.cell.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerinck, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span> <span> </span><span class="NLM_article-title">Investigating synapse formation and function using human pluripotent stem cell-derived neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3010</span>, <span class="refDoi"> DOI: 10.1073/pnas.1007753108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1007753108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21278334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=3005-3010&author=J.+E.+Kimauthor=M.+L.+O%E2%80%99Sullivanauthor=C.+A.+Sanchezauthor=M.+Hwangauthor=M.+A.+Israelauthor=K.+Brennandauthor=T.+J.+Deerinckauthor=L.+S.+Goldsteinauthor=F.+H.+Gageauthor=M.+H.+Ellismanauthor=A.+Ghosh&title=Investigating+synapse+formation+and+function+using+human+pluripotent+stem+cell-derived+neurons&doi=10.1073%2Fpnas.1007753108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating synapse formation and function using human pluripotent stem cell-derived neurons</span></div><div class="casAuthors">Kim, Ji-Eun; O'Sullivan, Matthew L.; Sanchez, Christopher A.; Hwang, Minju; Israel, Mason A.; Brennand, Kristen; Deerinck, Thomas J.; Goldstein, Lawrence S. B.; Gage, Fred H.; Ellisman, Mark H.; Ghosh, Anirvan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3005-3010, S3005/1-S3005/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A major goal of stem-cell research is to identify conditions that reliably regulate their differentiation into specific cell types.  This goal is particularly important for human stem cells if they are to be used for in vivo transplantation or as a platform for drug development.  Here, we describe the establishment of procedures to direct the differentiation of human embryonic stem cells and human induced pluripotent stem cells into forebrain neurons that are capable of forming synaptic connections.  In addn., HEK293T cells expressing Neuroligin (NLGN) 3 and NLGN4, but not those contg. autism-assocd. mutations, are able to induce presynaptic differentiation in human induced pluripotent stem cell-derived neurons.  We show that a mutant NLGN4 contg. an in-frame deletion is unable to localize correctly to the cell surface when overexpressed and fails to enhance synapse formation in human induced pluripotent stem cell-derived neurons.  These findings establish human pluripotent stem cell-derived neurons as a viable model for the study of synaptic differentiation and function under normal and disorder-assocd. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqgsEAm1cNH7Vg90H21EOLACvtfcHk0lhlv7fpusCZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVSjsLg%253D&md5=d8a08911e3382550c0f6b854f4b3398e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007753108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007753108%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DM.%2BL.%26aulast%3DSanchez%26aufirst%3DC.%2BA.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DBrennand%26aufirst%3DK.%26aulast%3DDeerinck%26aufirst%3DT.%2BJ.%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DEllisman%26aufirst%3DM.%2BH.%26aulast%3DGhosh%26aufirst%3DA.%26atitle%3DInvestigating%2520synapse%2520formation%2520and%2520function%2520using%2520human%2520pluripotent%2520stem%2520cell-derived%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D3005%26epage%3D3010%26doi%3D10.1073%2Fpnas.1007753108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeja, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrer, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N. S.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(16)30375-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS1470-2045%2816%2930375-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27646843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2isb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1569-1578&author=A.+J.+Yeeauthor=W.+I.+Bensingerauthor=J.+G.+Supkoauthor=P.+M.+Voorheesauthor=J.+G.+Berdejaauthor=P.+G.+Richardsonauthor=E.+N.+Libbyauthor=E.+E.+Wallaceauthor=N.+E.+Birrerauthor=J.+N.+Burkeauthor=D.+L.+Tamangauthor=M.+Yangauthor=S.+S.+Jonesauthor=C.+A.+Wheelerauthor=R.+J.+Markelewiczauthor=N.+S.+Raje&title=Ricolinostat+plus+lenalidomide%2C+and+dexamethasone+in+relapsed+or+refractory+multiple+myeloma%3A+a+multicentre+phase+1b+trial&doi=10.1016%2FS1470-2045%2816%2930375-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial</span></div><div class="casAuthors">Yee, Andrew J.; Bensinger, William I.; Supko, Jeffrey G.; Voorhees, Peter M.; Berdeja, Jesus G.; Richardson, Paul G.; Libby, Edward N.; Wallace, Ellen E.; Birrer, Nicole E.; Burke, Jill N.; Tamang, David L.; Yang, Min; Jones, Simon S.; Wheeler, Catherine A.; Markelewicz, Robert J.; Raje, Noopur S.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors are an important new class of therapeutics for treating multiple myeloma.  Ricolinostat (ACY-1215) is the first oral selective HDAC6 inhibitor with reduced class I HDAC activity to be studied clin.  Motivated by findings from preclin. studies showing potent synergistic activity with ricolinostat and lenalidomide, our goal was to assess the safety and preliminary activity of the combination of ricolinostat with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma.  In this multicenter phase 1b trial, we recruited patients aged 18 years or older with previously treated relapsed or refractory multiple myeloma from five cancer centers in the USA.  Inclusion criteria included a Karnofsky Performance Status score of at least 70, measureable disease, adequate bone marrow reserve, adequate hepatic function, and a creatinine clearance of at least 50 mL per min.  Exclusion criteria included previous exposure to HDAC inhibitors; previous allogeneic stem-cell transplantation; previous autologous stem-cell transplantation within 12 wk of baseline; active systemic infection; malignancy within the last 5 years; known or suspected HIV, hepatitis B, or hepatitis C infection; a QTc Fridericia of more than 480 ms; and substantial cardiovascular, gastrointestinal, psychiatric, or other medical disorders.  We gave escalating doses (from 40-240 mg once daily to 160 mg twice daily) of oral ricolinostat according to a std. 3 + 3 design according to three different regimens on days 1-21 with a conventional 28 day schedule of oral lenalidomide (from 15 mg [in one cohort] to 25 mg [in all other cohorts] once daily) and oral dexamethasone (40 mg weekly).  Primary outcomes were dose-limiting toxicities, the max. tolerated dose of ricolinostat in this combination, and the dose and schedule of ricolinostat recommended for further phase 2 investigation.  Secondary outcomes were the pharmacokinetics and pharmacodynamics of ricolinostat in this combination and the preliminary anti-tumor activity of this treatment.  The trial is closed to accrual and is registered at ClinicalTrials.gov, no. NCT01583283.  Between July 12, 2012, and Aug 20, 2015, we enrolled 38 patients.  We obsd. two dose-limiting toxicities with ricolinostat 160 mg twice daily: one (2%) grade 3 syncope and one (2%) grade 3 myalgia event in different cohorts.  A max. tolerated dose was not reached.  We chose ricolinostat 160 mg once daily on days 1-21 of a 28 day cycle as the recommended dose for future phase 2 studies in combination with lenalidomide 25 mg and dexamethasone 40 mg.  The most common adverse events were fatigue (grade 1-2 in 14 [37%] patients; grade 3 in seven [18%]) and diarrhea (grade 1-2 in 15 [39%] patients; grade 3 in two [5%]).  Our pharmacodynamic studies showed that at clin. relevant doses, ricolinostat selectively inhibits HDAC6 while retaining a low and tolerable level of class I HDAC inhibition.  The pharmacokinetics of ricolinostat and lenalidomide were not affected by co-administration.  In a preliminary assessment of antitumor activity, 21 (55% [95% CI 38-71]) of 38 patients had an overall response.  The findings from this study provide preliminary evidence that ricolinostat is a safe and well tolerated selective HDAC6 inhibitor, which might partner well with lenalidomide and dexamethasone to enhance their efficacy in relapsed or refractory multiple myeloma.Acetylon Pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWXWsO-vNKY7Vg90H21EOLACvtfcHk0lhlv7fpusCZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2isb7J&md5=59fea63c11b7bce7be6bd74f195af04b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2930375-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252930375-8%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DA.%2BJ.%26aulast%3DBensinger%26aufirst%3DW.%2BI.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DBerdeja%26aufirst%3DJ.%2BG.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DLibby%26aufirst%3DE.%2BN.%26aulast%3DWallace%26aufirst%3DE.%2BE.%26aulast%3DBirrer%26aufirst%3DN.%2BE.%26aulast%3DBurke%26aufirst%3DJ.%2BN.%26aulast%3DTamang%26aufirst%3DD.%2BL.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%2BA.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DRaje%26aufirst%3DN.%2BS.%26atitle%3DRicolinostat%2520plus%2520lenalidomide%252C%2520and%2520dexamethasone%2520in%2520relapsed%2520or%2520refractory%2520multiple%2520myeloma%253A%2520a%2520multicentre%2520phase%25201b%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2016%26volume%3D17%26spage%3D1569%26epage%3D1578%26doi%3D10.1016%2FS1470-2045%2816%2930375-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogl, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3307</span>– <span class="NLM_lpage">3315</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1158%2F1078-0432.CCR-16-2526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28053023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3307-3315&author=D.+T.+Voglauthor=N.+Rajeauthor=S.+Jagannathauthor=P.+Richardsonauthor=P.+Hariauthor=R.+Orlowskiauthor=J.+G.+Supkoauthor=D.+Tamangauthor=M.+Yangauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=R.+J.+Markelewiczauthor=S.+Lonial&title=Ricolinostat%2C+the+first+selective+histone+deacetylase+6+inhibitor%2C+in+combination+with+bortezomib+and+dexamethasone+for+relapsed+or+refractory+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-16-2526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma</span></div><div class="casAuthors">Vogl, Dan T.; Raje, Noopur; Jagannath, Sundar; Richardson, Paul; Hari, Parameswaran; Orlowski, Robert; Supko, Jeffrey G.; Tamang, David; Yang, Min; Jones, Simon S.; Wheeler, Catherine; Markelewicz, Robert J.; Lonial, Sagar</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3307-3315</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Histone deacetylase (HDAC) inhibition improves the efficacy of proteasome inhibition for multiple myeloma but adds substantial toxicity.  Preclin. models suggest that the obsd. synergy is due to the role of HDAC6 in mediating resistance to proteasome inhibition via the aggresome/autophagy pathway of protein degrdn.  Exptl. Design: We conducted a phase I/II trial of the HDAC6-selective inhibitor ricolinostat to define the safety, preliminary efficacy, and recommended phase II dose in combination with std. proteasome inhibitor therapy.  Patients with relapsed or refractory multiple myeloma received oral ricolinostat on days 1-5 and 8-12 of each 21-day cycle.  Results: Single-agent ricolinostat therapy resulted in neither significant toxicity nor clin. responses.  Combination therapy with bortezomib and dexamethasone was well-tolerated during dose escalation but led to dose-limiting diarrhea in an expansion cohort at a ricolinostat dose of 160 mg twice daily.  Combination therapy at a ricolinostat dose of 160 mg daily in a second expansion cohort was well tolerated, with less severe hematol., gastrointestinal, and constitutional toxicities compared with published data on nonselective HDAC inhibitors.  The overall response rate in combination with daily ricolinostat at ≥160 mg was 37%.  The response rate to combination therapy among bortezomib-refractory patients was 14%.  Samples taken during therapy showed dose-dependent increases of acetylated tubulin in peripheral blood lymphocytes.  Conclusions: At the recommended phase II dose of ricolinostat of 160 mg daily, the combination with bortezomib and dexamethasone is safe, well-tolerated, and active, suggesting that selective inhibition of HDAC6 is a promising approach to multiple myeloma therapy.  Clin Cancer Res; 23(13); 3307-15. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQogphgLWbLVg90H21EOLACvtfcHk0lhlv7fpusCZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurbL&md5=2dd174501d2f331aeb0eff42072001d1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2526%26sid%3Dliteratum%253Aachs%26aulast%3DVogl%26aufirst%3DD.%2BT.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHari%26aufirst%3DP.%26aulast%3DOrlowski%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26atitle%3DRicolinostat%252C%2520the%2520first%2520selective%2520histone%2520deacetylase%25206%2520inhibitor%252C%2520in%2520combination%2520with%2520bortezomib%2520and%2520dexamethasone%2520for%2520relapsed%2520or%2520refractory%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3307%26epage%3D3315%26doi%3D10.1158%2F1078-0432.CCR-16-2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barisic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeys, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirotkovic-Skerlev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span> <span> </span><span class="NLM_article-title">Charcot-Marie-Tooth disease: a clinico-genetic confrontation</span>. <i>Ann. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1111/j.1469-1809.2007.00412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1469-1809.2007.00412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18215208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlSnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2008&pages=416-441&author=N.+Barisicauthor=K.+G.+Claeysauthor=M.+Sirotkovic-Skerlevauthor=A.+Lofgrenauthor=E.+Nelisauthor=P.+De+Jongheauthor=V.+Timmerman&title=Charcot-Marie-Tooth+disease%3A+a+clinico-genetic+confrontation&doi=10.1111%2Fj.1469-1809.2007.00412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Charcot-Marie-Tooth disease: a clinico-genetic confrontation</span></div><div class="casAuthors">Barisic, N.; Claeys, K. G.; Sirotkovic-Skerlev, M.; Lofgren, A.; Nelis, E.; De Jonghe, P.; Timmerman, V.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Human Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">416-441</span>CODEN:
                <span class="NLM_cas:coden">ANHGAA</span>;
        ISSN:<span class="NLM_cas:issn">0003-4800</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder.  It represents a group of clin. and genetically heterogeneous inherited neuropathies.  Here, we review the results of mol. genetic investigations and the clin. and neurophysiol. features of the different CMT subtypes.  The products of genes assocd. with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity.  Identifying the mol. basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiol. mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system.  The results of mol. genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7PsU6ZFnr7Vg90H21EOLACvtfcHk0liT_SVqnpu6vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlSnsLw%253D&md5=0a64c893f9dbc59d7918f6640285b6b3</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-1809.2007.00412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-1809.2007.00412.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarisic%26aufirst%3DN.%26aulast%3DClaeys%26aufirst%3DK.%2BG.%26aulast%3DSirotkovic-Skerlev%26aufirst%3DM.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DNelis%26aufirst%3DE.%26aulast%3DDe%2BJonghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26atitle%3DCharcot-Marie-Tooth%2520disease%253A%2520a%2520clinico-genetic%2520confrontation%26jtitle%3DAnn.%2520Hum.%2520Genet.%26date%3D2008%26volume%3D72%26spage%3D416%26epage%3D441%26doi%3D10.1111%2Fj.1469-1809.2007.00412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies</span>. <i>Nat. Clin. Pract. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/ncpneuro0071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fncpneuro0071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16932520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=45-53&author=S.+Zuchnerauthor=J.+M.+Vance&title=Mechanisms+of+disease%3A+a+molecular+genetic+update+on+hereditary+axonal+neuropathies&doi=10.1038%2Fncpneuro0071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies</span></div><div class="casAuthors">Zuchner, Stephan; Vance, Jeffery M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Hereditary axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clin. subsumed under the name of Charcot-Marie-Tooth (CMT) disease type 2 (CMT2).  Historically, two classes of CMT have been differentiated: demyelinating forms of CMT (CMT1), in which nerve conduction velocities are decreased, and the axonal CMT2 forms, in which nerve conduction velocities are preserved.  Recently, a no. of genes that are defective in patients with the main forms of CMT2 have been identified.  The mol. dissection of cellular functions of the related gene products has only just begun, and detailed pathophysiol. models are still lacking.  The known CMT2-related genes represent key players in these pathways, however, and are likely to provide powerful tools for identifying targets for future therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMs7ufBCnTrVg90H21EOLACvtfcHk0liT_SVqnpu6vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sit7c%253D&md5=bdf63030e099a66309bea5e09dda4b2a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0071%26sid%3Dliteratum%253Aachs%26aulast%3DZuchner%26aufirst%3DS.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520disease%253A%2520a%2520molecular%2520genetic%2520update%2520on%2520hereditary%2520axonal%2520neuropathies%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2006%26volume%3D2%26spage%3D45%26epage%3D53%26doi%3D10.1038%2Fncpneuro0071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baets, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span> <span> </span><span class="NLM_article-title">Recent advances in Charcot-Marie-Tooth disease</span>. <i>Curr. Opin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1097/WCO.0000000000000131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1097%2FWCO.0000000000000131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25110935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=532-540&author=J.+Baetsauthor=P.+De+Jongheauthor=V.+Timmerman&title=Recent+advances+in+Charcot-Marie-Tooth+disease&doi=10.1097%2FWCO.0000000000000131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in Charcot-Marie-Tooth disease</span></div><div class="casAuthors">Baets, Jonathan; De Jonghe, Peter; Timmerman, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-540</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This article focuses on recent advances in Charcot-Marie-Tooth disease, in particular addns. to the genetic spectrum, novel paradigms in mol. techniques and an update on therapeutic strategies.  Recent findings: Several new Charcot-Marie-Tooth disease-causing genes have been recently identified, further enlarging the genetic diversity and phenotypic variability, including: SBF1, DHTKD1, TFG, MARS, HARS, HINT1, TRIM1, AIFM1, PDK3 and GNB4.  The increasing availability and affordability of next-generation sequencing technologies has ramped up gene discovery and drastically changed genetic screening strategies.  All large-scale trials studying the effect of ascorbic acid in Charcot-Marie-Tooth 1A have now been completed and were neg.  Efforts have been made to design more robust outcome-measures for clin. trials.  Promising results with lonaprisan, curcumin and histone deacetylase 6 inhibitors have been obtained in animal models.  Summary: Charcot-Marie-Tooth is the most common form of inherited peripheral neuropathy and represents the most prevalent hereditary neuromuscular disorder.  The genetic spectrum spans more than 70 genes.  Gene discovery has been revolutionized recently by new high-throughput mol. technologies.  In addn., the phenotypic diversity has grown tremendously.  This is a major challenge for geneticists and neurologists.  No effective therapy is available for Charcot-Marie-Tooth.  Several large trials with ascorbic acid were neg. but research into novel compds. continues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0GRcFvnx47Vg90H21EOLACvtfcHk0lj4a-FTGY3qUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7zI&md5=3b9c2df656ec2f209699c918b3d5b649</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1097%2FWCO.0000000000000131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0000000000000131%26sid%3Dliteratum%253Aachs%26aulast%3DBaets%26aufirst%3DJ.%26aulast%3DDe%2BJonghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26atitle%3DRecent%2520advances%2520in%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2014%26volume%3D27%26spage%3D532%26epage%3D540%26doi%3D10.1097%2FWCO.0000000000000131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Charcot-Marie-Tooth disease: emerging mechanisms and therapies</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.biocel.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22575637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVanu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1299-1304&author=C.+d%E2%80%99Ydewalleauthor=V.+Benoyauthor=L.+Van+Den+Bosch&title=Charcot-Marie-Tooth+disease%3A+emerging+mechanisms+and+therapies&doi=10.1016%2Fj.biocel.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Charcot-Marie-Tooth disease: Emerging mechanisms and therapies</span></div><div class="casAuthors">d'Ydewalle, Constantin; Benoy, Veronick; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1299-1304</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Charcot-Marie-Tooth disease is the most common inherited disorder of the peripheral nervous system.  The disease is characterized by a progressive muscle weakness and atrophy, sensory loss, foot (and hand) deformities and steppage gait.  While many of the genes assocd. with axonal CMT have been identified, to date it is unknown which mechanism(s) causes the disease.  However, genetic findings indicate that the underlying mechanisms mainly converge to the axonal cytoskeleton.  In this review, we will summarize the evidence for this pathogenic convergence.  Furthermore, recent work with new transgenic mouse models has led to the identification of histone deacetylase 6 as a potential therapeutic target for inherited peripheral neuropathies.  This enzyme deacetylates microtubules and plays a crucial role in the regulation of axonal transport.  These findings offer new perspectives for a potential therapy to treat axonal Charcot-Marie-Tooth disease and other neurodegenerative disorders characterized by axonal transport defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyxs8gcEvFMLVg90H21EOLACvtfcHk0lj4a-FTGY3qUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVanu74%253D&md5=8e0bbf15bc33aea5eac88bbc0c129b19</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DCharcot-Marie-Tooth%2520disease%253A%2520emerging%2520mechanisms%2520and%2520therapies%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D1299%26epage%3D1304%26doi%3D10.1016%2Fj.biocel.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. C.</span></span> <span> </span><span class="NLM_article-title">Role of axonal transport in neurodegenerative diseases</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1146/annurev.neuro.31.061307.090711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1146%2Fannurev.neuro.31.061307.090711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18558852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12nsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=151-173&author=K.+J.+De+Vosauthor=A.+J.+Griersonauthor=S.+Ackerleyauthor=C.+C.+Miller&title=Role+of+axonal+transport+in+neurodegenerative+diseases&doi=10.1146%2Fannurev.neuro.31.061307.090711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Role of axonal transport in neurodegenerative diseases</span></div><div class="casAuthors">De Vos, Kurt J.; Grierson, Andrew J.; Ackerley, Steven; Miller, Christopher C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-173</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Many major human neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), display axonal pathologies including abnormal accumulations of proteins and organelles.  Such pathologies highlight damage to the axon as part of the pathogenic process and, in particular, damage to transport of cargoes through axons.  Indeed, we now know that disruption of axonal transport is an early and perhaps causative event in many of these diseases.  Here, we review the role of axonal transport in neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnDowciI21rrVg90H21EOLACvtfcHk0lj4a-FTGY3qUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12nsro%253D&md5=479969475f424e76896be30ede954b4c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.31.061307.090711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.31.061307.090711%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVos%26aufirst%3DK.%2BJ.%26aulast%3DGrierson%26aufirst%3DA.%2BJ.%26aulast%3DAckerley%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DC.%2BC.%26atitle%3DRole%2520of%2520axonal%2520transport%2520in%2520neurodegenerative%2520diseases%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D31%26spage%3D151%26epage%3D173%26doi%3D10.1146%2Fannurev.neuro.31.061307.090711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanbe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, A.</span></span> <span> </span><span class="NLM_article-title">The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">3189</span>– <span class="NLM_lpage">3197</span>, <span class="refDoi"> DOI: 10.1002/jnr.22460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fjnr.22460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20645406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOqsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=3189-3197&author=J.+Yamauchiauthor=T.+Toriiauthor=S.+Kusakawaauthor=A.+Sanbeauthor=K.+Nakamuraauthor=S.+Takashimaauthor=H.+Hamasakiauthor=S.+Kawaguchiauthor=Y.+Miyamotoauthor=A.+Tanoue&title=The+mood+stabilizer+valproic+acid+improves+defective+neurite+formation+caused+by+Charcot-Marie-Tooth+disease-associated+mutant+Rab7+through+the+JNK+signaling+pathway&doi=10.1002%2Fjnr.22460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The mood stabilizer valproic acid improves defective neurite formation caused by charcot-marie-tooth disease-associated mutant Rab7 through the JNK signaling pathway</span></div><div class="casAuthors">Yamauchi, Junji; Torii, Tomohiro; Kusakawa, Shinji; Sanbe, Atsushi; Nakamura, Kazuaki; Takashima, Shou; Hamasaki, Hajime; Kawaguchi, Shogo; Miyamoto, Yuki; Tanoue, Akito</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3189-3197</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth (CMT) disease is the most frequent peripheral neuropathy affecting the Schwann cells and neurons.  CMT disease type 2 (CMT2) neuropathies are characterized by peripheral nerve aberrance.  Four missense mutations of Rab7, a small GTPase of the Rab family involved in intracellular vesicular trafficking, are assocd. with the CMT2B phenotype.  Despite a growing body of evidence concerning the gene structures responsible for genetically heterogenous CMT2B and other CMT2 neuropathies, little is known about the in vitro neuropathy model and how CMT2B-assocd. mutation-caused aberrant neuritogenesis is properly reversed.  Here, we show that valproic acid (VPA), a classical mood-stabilizing drug, improves defective neurite formation in N1E-115 neuroblastoma cells regardless of which CMT2B-assocd. Rab7 mutant protein is expressed.  The effect is mediated by c-Jun N-terminal kinase (JNK) signaling, but not by deacetylase inhibition activity of VPA itself.  Furthermore, VPA has similar effects in dorsal root ganglion (DRG) neurons expressing any of the four mutant Rab7 proteins.  Thus, VPA has a previously unknown potential to improve defective neuritogenesis assocd. with CMT2B in vitro, indicating that JNK should be a potential therapeutic target for treatments aimed at improving neuritogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4MXIarJIUrVg90H21EOLACvtfcHk0ljDSNqlNdzEvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOqsr%252FE&md5=30e6d7e7f25a0cdff96c01bc47e75a63</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22460%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DJ.%26aulast%3DTorii%26aufirst%3DT.%26aulast%3DKusakawa%26aufirst%3DS.%26aulast%3DSanbe%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DHamasaki%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DTanoue%26aufirst%3DA.%26atitle%3DThe%2520mood%2520stabilizer%2520valproic%2520acid%2520improves%2520defective%2520neurite%2520formation%2520caused%2520by%2520Charcot-Marie-Tooth%2520disease-associated%2520mutant%2520Rab7%2520through%2520the%2520JNK%2520signaling%2520pathway%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D3189%26epage%3D3197%26doi%3D10.1002%2Fjnr.22460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingl, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 as a potential therapeutic target for peripheral nerve disorders</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1080/14728222.2018.1541235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1080%2F14728222.2018.1541235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30360671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yjs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=993-1007&author=R.+Priorauthor=L.+Van+Helleputteauthor=Y.+E.+Klinglauthor=L.+Van+Den%0ABosch&title=HDAC6+as+a+potential+therapeutic+target+for+peripheral+nerve+disorders&doi=10.1080%2F14728222.2018.1541235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 as a potential therapeutic target for peripheral nerve disorders</span></div><div class="casAuthors">Prior, Robert; Van Helleputte, Lawrence; Klingl, Yvonne Eileen; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">993-1007</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Peripheral neuropathies are a heterogeneous group of diseases that are characterized by a progressive, ascending loss of nerve function arising from the peripheral regions of the limbs.  The phenotypic overlap between different types of hereditary and acquired peripheral neuropathies indicates that similar pathophysiol. processes are at play.  Many downstream pathways in peripheral neurons, such as axonal transport, protein degrdn., and interactions with Schwann cells, organelle damage, channelopathies, and neuroinflammatory signaling, have been proposed and each affects peripheral nerves in a neg. way.  Histone deacetylase 6 (HDAC6) plays an important role at the intersection of these converging pathogenic pathways.  The enzymic deacetylase activity of HDAC6 is upregulated in neurodegenerative disorders and typically results in downstream neuronal stress.: The role of HDAC6 in the common pathogenic mechanisms of peripheral neuropathies.  In addn., we discuss the current preclin. and clin. HDAC6 inhibitors (HDAC6i), their chem. structure, development, and limitations.: The development and testing of non-hydroxamic acid-based, should be the focus of the future research.  Moreover, HDAC6i should be further investigated as a preventative measure and therapeutic strategy for inherited and acquired peripheral neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2jB4EbteqLVg90H21EOLACvtfcHk0ljDSNqlNdzEvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yjs7zM&md5=7527a80523a1a6d8e6ac738159a2fdc0</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1080%2F14728222.2018.1541235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2018.1541235%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DR.%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DKlingl%26aufirst%3DY.%2BE.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520peripheral%2520nerve%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2018%26volume%3D22%26spage%3D993%26epage%3D1007%26doi%3D10.1080%2F14728222.2018.1541235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frojuello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot-Marie-Tooth disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyktLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=240-258&author=S.+Shenauthor=V.+Benoyauthor=J.+A.+Bergmanauthor=J.+H.+Kalinauthor=M.+Frojuelloauthor=G.+Vistoliauthor=W.+Haeckauthor=L.+Van+Den%0ABoschauthor=A.+P.+Kozikowski&title=Bicyclic-capped+histone+deacetylase+6+inhibitors+with+improved+activity+in+a+model+of+axonal+Charcot-Marie-Tooth+disease&doi=10.1021%2Facschemneuro.5b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Shen, Sida; Benoy, Veronick; Bergman, Joel A.; Kalin, Jay H.; Frojuello, Mariana; Vistoli, Giulio; Haeck, Wanda; Van Den Bosch, Ludo; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-258</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth (CMT) disease is a disorder of the peripheral nervous system where progressive degeneration of motor and sensory nerves leads to motor problems and sensory loss and for which no pharmacol. treatment is available.  Recently, it has been shown in a model for the axonal form of CMT that histone deacetylase 6 (HDAC6) can serve as a target for the development of a pharmacol. therapy.  Therefore, the authors aimed at developing new selective and activity-specific HDAC6 inhibitors with improved biochem. properties.  By utilizing a bicyclic cap as the structural scaffold from which to build upon, the authors developed several analogs that showed improved potency compared to tubastatin A while maintaining excellent selectivity compared to HDAC1.  Further screening in N2a cells examg. both the acetylation of α-tubulin and histones narrowed down the library of compds. to three potent and selective HDAC6 inhibitors.  In mutant HSPB1-expressing DRG neurons, serving as an in vitro model for CMT2, these inhibitors were able to restore the mitochondrial axonal transport deficits.  Combining structure-based development of HDAC6 inhibitors, screening in N2a cells and in a neuronal model for CMT2F, and preliminary ADMET and pharmacokinetic profiles, resulted in the selection of compd. I that possesses improved biochem., functional, and druglike properties compared to tubastatin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEQ8GZug94Z7Vg90H21EOLACvtfcHk0ljDSNqlNdzEvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyktLvF&md5=79b7f824103b5a0f799f1d69fafed7de</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00286%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DFrojuello%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DBicyclic-capped%2520histone%2520deacetylase%25206%2520inhibitors%2520with%2520improved%2520activity%2520in%2520a%2520model%2520of%2520axonal%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D240%26epage%3D258%26doi%3D10.1021%2Facschemneuro.5b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot-Marie-Tooth disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs13311-016-0501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27957719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=417-428&author=V.+Benoyauthor=P.+Vanden+Bergheauthor=M.+Jarpeauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=Development+of+improved+HDAC6+inhibitors+as+pharmacological+therapy+for+axonal+Charcot-Marie-Tooth+disease&doi=10.1007%2Fs13311-016-0501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Benoy, Veronick; Vanden Berghe, Pieter; Jarpe, Matthew; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recently, we identified histone deacetylase 6, which deacetylates α-tubulin, as a potential therapeutic target in axonal CMT.  Pharmacol. inhibition of the deacetylating function of HDAC6 reversed the motor and sensory deficits in a mouse model for mutant "small heat shock protein B1"-induced CMT2 at the behavioral and electrophysiol. level.  In order to translate this potential therapeutic strategy into a clin. application, small drug-like mols. that are potent and selective HDAC6 inhibitors are essential.  To screen for these, we developed a method that consisted of 3 distinct phases and that was based on the pathol. findings in the mutant HSPB1-induced CMT2 mouse model.  Three different inhibitors (ACY-738, ACY-775, and ACY-1215) were tested and demonstrated to be both potent and selective HDAC6 inhibitors.  Moreover, these inhibitors increased the innervation of the neuromuscular junctions in the gastrocnemius muscle and improved the motor and sensory nerve conduction, confirming that HDAC6 inhibition is a potential therapeutic strategy in CMT2.  Furthermore, ACY-1215 is an interesting lead mol. as it is currently tested in clin. trials for cancer.  Taken together, these results may speed up the translation of pharmacol. inhibition of HDAC6 into a therapy against CMT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJr47ap41l7Vg90H21EOLACvtfcHk0liXQEd9dWgXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO&md5=cb382132da19455955c1b432cf59aa5e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0501-z%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520improved%2520HDAC6%2520inhibitors%2520as%2520pharmacological%2520therapy%2520for%2520axonal%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D417%26epage%3D428%26doi%3D10.1007%2Fs13311-016-0501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eykens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossaert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaspers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gysemans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2017.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2017.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29197621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWlsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2018&pages=59-69&author=L.+Van+Helleputteauthor=M.+Katerauthor=D.+P.+Cookauthor=C.+Eykensauthor=E.+Rossaertauthor=W.+Haeckauthor=T.+Jaspersauthor=N.+Geensauthor=P.+Vanden+Bergheauthor=C.+Gysemansauthor=C.+Mathieuauthor=W.+Robberechtauthor=P.+Van+Dammeauthor=G.+Cavalettiauthor=M.+Jarpeauthor=L.+Van+Den%0ABosch&title=Inhibition+of+histone+deacetylase+6+%28HDAC6%29+protects+against+vincristine-induced+peripheral+neuropathies+and+inhibits+tumor+growth&doi=10.1016%2Fj.nbd.2017.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth</span></div><div class="casAuthors">Van Helleputte, Lawrence; Kater, Mandy; Cook, Dana P.; Eykens, Caroline; Rossaert, Elisabeth; Haeck, Wanda; Jaspers, Tom; Geens, Natasja; Vanden Berghe, Pieter; Gysemans, Conny; Mathieu, Chantal; Robberecht, Wim; Van Damme, Philip; Cavaletti, Guido; Jarpe, Matthew; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As cancer is becoming more and more a chronic disease, a large proportion of patients is confronted with devastating side effects of certain anti-cancer drugs.  The most common neurol. complications are painful peripheral neuropathies.  Chemotherapeutics that interfere with microtubules, including plant-derived vinca-alkaloids such as vincristine, can cause these chemotherapy-induced peripheral neuropathies (CIPN).  Available treatments focus on symptom alleviation and pain redn. rather than prevention of the neuropathy.  The aim of this study was to investigate the potential of specific histone deacetylase 6 (HDAC6) inhibitors as a preventive therapy for CIPN using multiple rodent models for vincristine-induced peripheral neuropathies (VIPN).  HDAC6 inhibition increased the levels of acetylated α-tubulin in tissues of rodents undergoing vincristine-based chemotherapy, which correlates to a reduced severity of the neurol. symptoms, both at the electrophysiol. and the behavioral level.  Mechanistically, disturbances in axonal transport of mitochondria is considered as an important contributing factor in the pathophysiol. of VIPN.  As vincristine interferes with the polymn. of microtubules, we investigated whether disturbances in axonal transport could contribute to VIPN.  We obsd. that increasing α-tubulin acetylation through HDAC6 inhibition restores vincristine-induced defects of axonal transport in cultured dorsal root ganglion neurons.  Finally, we assured that HDAC6-inhibition offers neuroprotection without interfering with the anti-cancer efficacy of vincristine using a mouse model for acute lymphoblastic leukemia.  Taken together, our results emphasize the therapeutic potential of HDAC6 inhibitors with beneficial effects both on vincristine-induced neurotoxicity, as well as on tumor proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQhf8w1l_xLVg90H21EOLACvtfcHk0liXQEd9dWgXsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWlsbzO&md5=5d423c59af112360f1a389b3fc055e12</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2017.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2017.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DKater%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DD.%2BP.%26aulast%3DEykens%26aufirst%3DC.%26aulast%3DRossaert%26aufirst%3DE.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DJaspers%26aufirst%3DT.%26aulast%3DGeens%26aufirst%3DN.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DGysemans%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DC.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DCavaletti%26aufirst%3DG.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520protects%2520against%2520vincristine-induced%2520peripheral%2520neuropathies%2520and%2520inhibits%2520tumor%2520growth%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2018%26volume%3D111%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.nbd.2017.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caskey, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. L.</span></span> <span> </span><span class="NLM_article-title">Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1007</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03461-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41467-018-03461-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29520015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrpt1Wmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1007&author=Z.+Moauthor=X.+Zhaoauthor=H.+Liuauthor=Q.+Huauthor=X.+Q.+Chenauthor=J.+Phamauthor=N.+Weiauthor=Z.+Liuauthor=J.+Zhouauthor=R.+W.+Burgessauthor=S.+L.+Pfaffauthor=C.+T.+Caskeyauthor=C.+Wuauthor=G.+Baiauthor=X.+L.+Yang&title=Aberrant+GlyRS-HDAC6+interaction+linked+to+axonal+transport+deficits+in+Charcot-Marie-Tooth+neuropathy&doi=10.1038%2Fs41467-018-03461-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy</span></div><div class="casAuthors">Mo Zhongying; Liu Huaqing; Hu Qinghua; Pham Jessica; Wei Na; Liu Ze; Zhou Jiadong; Bai Ge; Yang Xiang-Lei; Zhao Xiaobei; Chen Xu-Qiao; Wu Chengbiao; Burgess Robert W; Pfaff Samuel L; Bai Ge; Caskey C Thomas; Wu Chengbiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1007</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dominant mutations in glycyl-tRNA synthetase (GlyRS) cause a subtype of Charcot-Marie-Tooth neuropathy (CMT2D).  Although previous studies have shown that GlyRS mutants aberrantly interact with Nrp1, giving insight into the disease's specific effects on motor neurons, these cannot explain length-dependent axonal degeneration.  Here, we report that GlyRS mutants interact aberrantly with HDAC6 and stimulate its deacetylase activity on α-tubulin.  A decrease in α-tubulin acetylation and deficits in axonal transport are observed in mice peripheral nerves prior to disease onset.  An HDAC6 inhibitor used to restore α-tubulin acetylation rescues axonal transport deficits and improves motor functions of CMT2D mice.  These results link the aberrant GlyRS-HDAC6 interaction to CMT2D pathology and suggest HDAC6 as an effective therapeutic target.  Moreover, the HDAC6 interaction differs from Nrp1 interaction among GlyRS mutants and correlates with divergent clinical presentations, indicating the existence of multiple and different mechanisms in CMT2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDPByhVBrFcnthwrmtH4OBfW6udTcc2ebXxl9Y5Wqwrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrpt1Wmuw%253D%253D&md5=d6f04db92a21e7732f87cc064cd99905</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03461-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03461-z%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%2BQ.%26aulast%3DPham%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBurgess%26aufirst%3DR.%2BW.%26aulast%3DPfaff%26aufirst%3DS.%2BL.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%2BL.%26atitle%3DAberrant%2520GlyRS-HDAC6%2520interaction%2520linked%2520to%2520axonal%2520transport%2520deficits%2520in%2520Charcot-Marie-Tooth%2520neuropathy%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1007%26doi%3D10.1038%2Fs41467-018-03461-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheveneels, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schevenels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1093/brain/awx375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fbrain%2Fawx375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29415205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MvovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2018&pages=673-687&author=V.+Benoyauthor=L.+Van+Helleputteauthor=R.+Priorauthor=C.+d%E2%80%99Ydewalleauthor=W.+Haeckauthor=N.+Geensauthor=W.+Scheveneelsauthor=B.+Schevenelsauthor=M.+Z.+Caderauthor=K.+Talbotauthor=A.+P.+Kozikowskiauthor=P.+Vanden+Bergheauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=HDAC6+is+a+therapeutic+target+in+mutant+GARS-induced+Charcot-Marie-Tooth+disease&doi=10.1093%2Fbrain%2Fawx375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease</span></div><div class="casAuthors">Benoy Veronick; Van Helleputte Lawrence; Prior Robert; d'Ydewalle Constantin; Haeck Wanda; Geens Natasja; Scheveneels Wendy; Schevenels Begga; Van Damme Philip; Robberecht Wim; Van Den Bosch Ludo; Benoy Veronick; Van Helleputte Lawrence; Prior Robert; d'Ydewalle Constantin; Haeck Wanda; Geens Natasja; Scheveneels Wendy; Schevenels Begga; Van Damme Philip; Robberecht Wim; Van Den Bosch Ludo; Cader M Zameel; Talbot Kevin; Cader M Zameel; Kozikowski Alan P; Vanden Berghe Pieter; Van Damme Philip; Robberecht Wim</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-687</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peripheral nerve axons require a well-organized axonal microtubule network for efficient transport to ensure the constant crosstalk between soma and synapse.  Mutations in more than 80 different genes cause Charcot-Marie-Tooth disease, which is the most common inherited disorder affecting peripheral nerves.  This genetic heterogeneity has hampered the development of therapeutics for Charcot-Marie-Tooth disease.  The aim of this study was to explore whether histone deacetylase 6 (HDAC6) can serve as a therapeutic target focusing on the mutant glycyl-tRNA synthetase (GlyRS/GARS)-induced peripheral neuropathy.  Peripheral nerves and dorsal root ganglia from the C201R mutant Gars mouse model showed reduced acetylated α-tubulin levels.  In primary dorsal root ganglion neurons, mutant GlyRS affected neurite length and disrupted normal mitochondrial transport.  We demonstrated that GlyRS co-immunoprecipitated with HDAC6 and that this interaction was blocked by tubastatin A, a selective inhibitor of the deacetylating function of HDAC6.  Moreover, HDAC6 inhibition restored mitochondrial axonal transport in mutant GlyRS-expressing neurons.  Systemic delivery of a specific HDAC6 inhibitor increased α-tubulin acetylation in peripheral nerves and partially restored nerve conduction and motor behaviour in mutant Gars mice.  Our study demonstrates that α-tubulin deacetylation and disrupted axonal transport may represent a common pathogenic mechanism underlying Charcot-Marie-Tooth disease and it broadens the therapeutic potential of selective HDAC6 inhibition to other genetic forms of axonal Charcot-Marie-Tooth disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWZDeBfZexjBWfpMXQLRstfW6udTcc2ebXxl9Y5Wqwrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvovVSmsA%253D%253D&md5=6f39292d1113deb16ab6d57039ac4977</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawx375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawx375%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DPrior%26aufirst%3DR.%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DGeens%26aufirst%3DN.%26aulast%3DScheveneels%26aufirst%3DW.%26aulast%3DSchevenels%26aufirst%3DB.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26aulast%3DTalbot%26aufirst%3DK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520is%2520a%2520therapeutic%2520target%2520in%2520mutant%2520GARS-induced%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DBrain%26date%3D2018%26volume%3D141%26spage%3D673%26epage%3D687%26doi%3D10.1093%2Fbrain%2Fawx375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B.-O.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitors rescued the defective axonal mitochondrial movement in motor neurons derived from the induced pluripotent stem cells of peripheral neuropathy patients with HSPB1 mutation</span>. <i>Stem. Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">9475981</span>, <span class="refDoi"> DOI: 10.1155/2016/9475981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2016%2F9475981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28105056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=9475981&author=J.-Y.+Kimauthor=S.-Y.+Wooauthor=Y.+B.+Hongauthor=H.+Choiauthor=J.+Kimauthor=H.+Choiauthor=I.+Mook-Jungauthor=N.+Haauthor=J.+Kyungauthor=S.+K.+Kooauthor=S.-C.+Jungauthor=B.-O.+Choi&title=HDAC6+inhibitors+rescued+the+defective+axonal+mitochondrial+movement+in+motor+neurons+derived+from+the+induced+pluripotent+stem+cells+of+peripheral+neuropathy+patients+with+HSPB1+mutation&doi=10.1155%2F2016%2F9475981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with HSPB1 Mutation</span></div><div class="casAuthors">Kim Ji-Yon; Woo So-Youn; Hong Young Bin; Choi Heesun; Kim Jisoo; Choi Hyunjung; Mook-Jung Inhee; Ha Nina; Kyung Jangbeen; Koo Soo Kyung; Jung Sung-Chul; Choi Byung-Ok</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9475981</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">The Charcot-Marie-Tooth disease 2F (CMT2F) and distal hereditary motor neuropathy 2B (dHMN2B) are caused by autosomal dominantly inherited mutations of the heat shock 27 kDa protein 1 (HSPB1) gene and there are no specific therapies available yet.  Here, we assessed the potential therapeutic effect of HDAC6 inhibitors on peripheral neuropathy with HSPB1 mutation using in vitro model of motor neurons derived from induced pluripotent stem cells (iPSCs) of CMT2F and dHMN2B patients.  The absolute velocity of mitochondrial movements and the percentage of moving mitochondria in axons were lower both in CMT2F-motor neurons and in dHMN2B-motor neurons than those in controls, and the severity of the defective mitochondrial movement was different between the two disease models.  CMT2F-motor neurons and dHMN2B-motor neurons also showed reduced α-tubulin acetylation compared with controls.  The newly developed HDAC6 inhibitors, CHEMICAL X4 and CHEMICAL X9, increased acetylation of α-tubulin and reversed axonal movement defects of mitochondria in CMT2F-motor neurons and dHMN2B-motor neurons.  Our results suggest that the neurons derived from patient-specific iPSCs can be used in drug screening including HDAC6 inhibitors targeting peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIJGiIlA3U8a91pGlMMoT5fW6udTcc2ebXxl9Y5Wqwrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nsFSgtQ%253D%253D&md5=f4a8b6cd96e4b227830b08e5df8bbfe8</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9475981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9475981%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DWoo%26aufirst%3DS.-Y.%26aulast%3DHong%26aufirst%3DY.%2BB.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DHa%26aufirst%3DN.%26aulast%3DKyung%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%2BK.%26aulast%3DJung%26aufirst%3DS.-C.%26aulast%3DChoi%26aufirst%3DB.-O.%26atitle%3DHDAC6%2520inhibitors%2520rescued%2520the%2520defective%2520axonal%2520mitochondrial%2520movement%2520in%2520motor%2520neurons%2520derived%2520from%2520the%2520induced%2520pluripotent%2520stem%2520cells%2520of%2520peripheral%2520neuropathy%2520patients%2520with%2520HSPB1%2520mutation%26jtitle%3DStem.%2520Cells%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D9475981%26doi%3D10.1155%2F2016%2F9475981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relitti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span> <span> </span><span class="NLM_article-title">A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.4155%2Ffmc-2018-0315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30907134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=463-487&author=G.+Chemiauthor=M.+Brindisiauthor=S.+Brogiauthor=N.+Relittiauthor=S.+Butiniauthor=S.+Gemmaauthor=G.+Campiani&title=A+light+in+the+dark%3A+state+of+the+art+and+perspectives+in+optogenetics+and+optopharmacology+for+restoring+vision&doi=10.4155%2Ffmc-2018-0315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision</span></div><div class="casAuthors">Chemi, Giulia; Brindisi, Margherita; Brogi, Simone; Relitti, Nicola; Butini, Stefania; Gemma, Sandra; Campiani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-487</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In the last decade, innovative therapeutic strategies against inherited retinal degenerations (IRDs) have emerged.  In particular, chem.- and opto-genetics approaches or a combination of them have been identified for modulating neuronal/optical activity in order to restore vision in blinding diseases.  The 'chem.-genetics approach' (optopharmacol.) uses small mols. (exogenous photoswitches) for restoring light sensitivity by activating ion channels.  The 'opto-genetics approach' employs light-activated photosensitive proteins (exogenous opsins), introduced by viral vectors in injured tissues, to restore light response.  These approaches offer control of neuronal activities with spatial precision and limited invasiveness, although with some drawbacks.  Currently, a combined therapeutic strategy (optogenetic pharmacol.) is emerging.  This review describes the state of the art and provides an overview of the future perspectives in vision restoration.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJXPEzCj_JfbVg90H21EOLACvtfcHk0liC4TZh8ljpSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslGmsr4%253D&md5=8b7195d4c8fe41291228d2cfb1d0d8f9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0315%26sid%3Dliteratum%253Aachs%26aulast%3DChemi%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DRelitti%26aufirst%3DN.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3DA%2520light%2520in%2520the%2520dark%253A%2520state%2520of%2520the%2520art%2520and%2520perspectives%2520in%2520optogenetics%2520and%2520optopharmacology%2520for%2520restoring%2520vision%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D463%26epage%3D487%26doi%3D10.4155%2Ffmc-2018-0315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falsini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A. G.</span></span> <span> </span><span class="NLM_article-title">Inherited retinal degeneration: genetics, disease characterization, and outcome measures</span>. <i>J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">2109014</span>, <span class="refDoi"> DOI: 10.1155/2017/2109014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2017%2F2109014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29098082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1M7nt1GrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=2109014&author=N.+W.+Khanauthor=B.+Falsiniauthor=M.+Kondoauthor=A.+G.+Robson&title=Inherited+retinal+degeneration%3A+genetics%2C+disease+characterization%2C+and+outcome+measures&doi=10.1155%2F2017%2F2109014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited Retinal Degeneration: Genetics, Disease Characterization, and Outcome Measures</span></div><div class="casAuthors">Khan Naheed W; Falsini Benedetto; Kondo Mineo; Robson Anthony G; Robson Anthony G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of ophthalmology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2109014</span>
        ISSN:<span class="NLM_cas:issn">2090-004X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7oFyKDDqccXELvajU9pjPfW6udTcc2eZHfpJYfk2Zd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7nt1GrtA%253D%253D&md5=0d4f0b697eabb2297d62c5ec76b571ff</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2109014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2109014%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%2BW.%26aulast%3DFalsini%26aufirst%3DB.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DRobson%26aufirst%3DA.%2BG.%26atitle%3DInherited%2520retinal%2520degeneration%253A%2520genetics%252C%2520disease%2520characterization%252C%2520and%2520outcome%2520measures%26jtitle%3DJ.%2520Ophthalmol.%26date%3D2017%26volume%3D2017%26spage%3D2109014%26doi%3D10.1155%2F2017%2F2109014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zrenner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e112142</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0112142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0112142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25392995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e112142&author=B.+Arango-Gonzalezauthor=D.+Trifunovicauthor=A.+Sahabogluauthor=K.+Kranzauthor=S.+Michalakisauthor=P.+Farinelliauthor=S.+Kochauthor=F.+Kochauthor=S.+Cottetauthor=U.+Janssen-Bienholdauthor=K.+Dedekauthor=M.+Bielauthor=E.+Zrennerauthor=T.+Eulerauthor=P.+Ekstromauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Identification+of+a+common+non-apoptotic+cell+death+mechanism+in+hereditary+retinal+degeneration&doi=10.1371%2Fjournal.pone.0112142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span></div><div class="casAuthors">Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstroem, Per; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e112142/1-e112142/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration.  We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death.  We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance.  Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose.  Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEcYvkyewtrVg90H21EOLACvtfcHk0liC4TZh8ljpSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL&md5=53c0c17980aa77b6c8addc7cff796a1a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0112142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0112142%26sid%3Dliteratum%253Aachs%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKranz%26aufirst%3DK.%26aulast%3DMichalakis%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DCottet%26aufirst%3DS.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DDedek%26aufirst%3DK.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DZrenner%26aufirst%3DE.%26aulast%3DEuler%26aufirst%3DT.%26aulast%3DEkstrom%26aufirst%3DP.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520a%2520common%2520non-apoptotic%2520cell%2520death%2520mechanism%2520in%2520hereditary%2520retinal%2520degeneration%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De112142%26doi%3D10.1371%2Fjournal.pone.0112142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Athanasiou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellingham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheetham, M. E.</span></span> <span> </span><span class="NLM_article-title">The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy</span>. <i>Prog. Retinal Eye Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.preteyeres.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.preteyeres.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29042326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSgu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=1-23&author=D.+Athanasiouauthor=M.+Aguilaauthor=J.+Bellinghamauthor=W.+Liauthor=C.+McCulleyauthor=P.+J.+Reevesauthor=M.+E.+Cheetham&title=The+molecular+and+cellular+basis+of+rhodopsin+retinitis+pigmentosa+reveals+potential+strategies+for+therapy&doi=10.1016%2Fj.preteyeres.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy</span></div><div class="casAuthors">Athanasiou, Dimitra; Aguila, Monica; Bellingham, James; Li, Wenwen; McCulley, Caroline; Reeves, Philip J.; Cheetham, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Retinal and Eye Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-23</span>CODEN:
                <span class="NLM_cas:coden">PRTRES</span>;
        ISSN:<span class="NLM_cas:issn">1350-9462</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding condition, retinitis pigmentosa (RP).  Over 150 different mutations in rhodopsin have been identified and, collectively, they are the most common cause of autosomal dominant RP (adRP).  Mutations in rhodopsin are also assocd. with dominant congenital stationary night blindness (adCSNB) and, less frequently, recessive RP (arRP).  Recessive RP is usually assocd. with loss of rhodopsin function, whereas the dominant conditions are a consequence of gain of function and/or dominant neg. activity.  The in-depth characterization of many rhodopsin mutations has revealed that there are distinct consequences on the protein structure and function assocd. with different mutations.  Here we categorise rhodopsin mutations into seven discrete classes; with defects ranging from misfolding and disruption of proteostasis, through mislocalisation and disrupted intracellular traffic to instability and altered function.  Rhodopsin adRP offers a unique paradigm to understand how disturbances in photoreceptor homeostasis can lead to neuronal cell death.  Furthermore, a wide range of therapies have been tested in rhodopsin RP, from gene therapy and gene editing to pharmacol. interventions.  The understanding of the disease mechanisms assocd. with rhodopsin RP and the development of targeted therapies offer the potential of treatment for this currently untreatable neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3e2zCdSM5WrVg90H21EOLACvtfcHk0lj79xZlcfdRxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSgu73E&md5=93487ef4f9df69000f0899d5d1343a8d</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.preteyeres.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.preteyeres.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DAthanasiou%26aufirst%3DD.%26aulast%3DAguila%26aufirst%3DM.%26aulast%3DBellingham%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMcCulley%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DP.%2BJ.%26aulast%3DCheetham%26aufirst%3DM.%2BE.%26atitle%3DThe%2520molecular%2520and%2520cellular%2520basis%2520of%2520rhodopsin%2520retinitis%2520pigmentosa%2520reveals%2520potential%2520strategies%2520for%2520therapy%26jtitle%3DProg.%2520Retinal%2520Eye%2520Res.%26date%3D2018%26volume%3D62%26spage%3D1%26epage%3D23%26doi%3D10.1016%2Fj.preteyeres.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho-Pelluz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alavi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kustermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span> <span> </span><span class="NLM_article-title">Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e24</span>, <span class="refDoi"> DOI: 10.1038/cddis.2010.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2010.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21364632" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=e24&author=J.+Sancho-Pelluzauthor=M.+V.+Alaviauthor=A.+Sahabogluauthor=S.+Kustermannauthor=P.+Farinelliauthor=S.+Azadiauthor=T.+van+Veenauthor=F.+J.+Romeroauthor=F.+Paquet-Durandauthor=P.+Ekstrom&title=Excessive+HDAC+activation+is+critical+for+neurodegeneration+in+the+rd1+mouse&doi=10.1038%2Fcddis.2010.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2010.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2010.4%26sid%3Dliteratum%253Aachs%26aulast%3DSancho-Pelluz%26aufirst%3DJ.%26aulast%3DAlavi%26aufirst%3DM.%2BV.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKustermann%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DAzadi%26aufirst%3DS.%26aulast%3Dvan%2BVeen%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BJ.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26aulast%3DEkstrom%26aufirst%3DP.%26atitle%3DExcessive%2520HDAC%2520activation%2520is%2520critical%2520for%2520neurodegeneration%2520in%2520the%2520rd1%2520mouse%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2010%26volume%3D1%26spage%3De24%26doi%3D10.1038%2Fcddis.2010.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase: Therapeutic targets in retinal degeneration</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>854</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-17121-0_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2F978-3-319-17121-0_61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26427446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSqs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=854&publication_year=2016&pages=455-461&author=C.+Dalyauthor=J.+Yinauthor=B.+N.+Kennedy&title=Histone+Deacetylase%3A+Therapeutic+targets+in+retinal+degeneration&doi=10.1007%2F978-3-319-17121-0_61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase: Therapeutic Targets in Retinal Degeneration</span></div><div class="casAuthors">Daly, Conor; Yin, Jun; Kennedy, Breandan N.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">854</span>
        (<span class="NLM_cas:issue">Retinal Degenerative Diseases</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Previous studies report that retinitis pigmentosa (RP) patients treated with the histone deacetylase inhibitor (HDACi) valproic acid (VPA) present with improved visual fields and delayed vision loss.  However, other studies report poor efficacy and safety of HDACi in other cohorts of retinal degeneration patients.  Furthermore, the mol. mechanisms by which HDACi can improve visual function is unknown, albeit HDACi can attenuate pro-apoptotic stimuli and induce expression of neuroprotective factors.  Thus, further anal. of HDACi is warranted in pre-clin. models of retinal degeneration including zebrafish.  Anal. of HDAC expression in developing zebrafish reveals diverse temporal expression patterns during development and maturation of visual function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppoyCN3Bq6jrVg90H21EOLACvtfcHk0lj79xZlcfdRxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSqs7zP&md5=6001a12674f08b63519f7b421247a51a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-17121-0_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-17121-0_61%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26atitle%3DHistone%2520Deacetylase%253A%2520Therapeutic%2520targets%2520in%2520retinal%2520degeneration%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2016%26volume%3D854%26spage%3D455%26epage%3D461%26doi%3D10.1007%2F978-3-319-17121-0_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhard-Kurz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitzmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e488</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2013.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23392176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVykt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e488&author=A.+Sahabogluauthor=O.+Paquet-Durandauthor=J.+Dietterauthor=K.+Denglerauthor=S.+Bernhard-Kurzauthor=P.+A.+Ekstromauthor=B.+Hitzmannauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Retinitis+pigmentosa%3A+rapid+neurodegeneration+is+governed+by+slow+cell+death+mechanisms&doi=10.1038%2Fcddis.2013.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms</span></div><div class="casAuthors">Sahaboglu, A.; Paquet-Durand, O.; Dietter, J.; Dengler, K.; Bernhard-Kurz, S.; Ekstroem, P. A. R.; Hitzmann, B.; Ueffing, M.; Paquet-Durand, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">e488</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For most neurodegenerative diseases the precise duration of an individual cell's death is unknown, which is an obstacle when counteractive measures are being considered.  To address this, we used the rd1 mouse model for retinal neurodegeneration, characterized by phosphodiesterase-6 (PDE6) dysfunction and photoreceptor death triggered by high cyclic guanosine-mono-phosphate (cGMP) levels.  Using cellular data on cGMP accumulation, cell death, and survival, we created math. models to simulate the temporal development of the degeneration.  We validated model predictions using organotypic retinal explant cultures derived from wild-type animals and exposed to the selective PDE6 inhibitor zaprinast.  Together, photoreceptor data and modeling for the first time delineated three major cell death phases in a complex neuronal tissue: (1) initiation, taking up to 36 h, (2) execution, lasting another 40 h, and finally (3) clearance, lasting about 7 h.  Surprisingly, photoreceptor neurodegeneration was noticeably slower than necrosis or apoptosis, suggesting a different mechanism of death for these neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiOMSMKJt17Vg90H21EOLACvtfcHk0ligmTv1H-myfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVykt77N&md5=7c8b73cc63fa41a561fae11f987ef4f0</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.12%26sid%3Dliteratum%253Aachs%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DPaquet-Durand%26aufirst%3DO.%26aulast%3DDietter%26aufirst%3DJ.%26aulast%3DDengler%26aufirst%3DK.%26aulast%3DBernhard-Kurz%26aufirst%3DS.%26aulast%3DEkstrom%26aufirst%3DP.%2BA.%26aulast%3DHitzmann%26aufirst%3DB.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DRetinitis%2520pigmentosa%253A%2520rapid%2520neurodegeneration%2520is%2520governed%2520by%2520slow%2520cell%2520death%2520mechanisms%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De488%26doi%3D10.1038%2Fcddis.2013.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danciger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applebury, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farber, D. B.</span></span> <span> </span><span class="NLM_article-title">Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/347677a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F347677a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1977087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=677-680&author=C.+Bowesauthor=T.+Liauthor=M.+Dancigerauthor=L.+C.+Baxterauthor=M.+L.+Appleburyauthor=D.+B.+Farber&title=Retinal+degeneration+in+the+rd+mouse+is+caused+by+a+defect+in+the+beta+subunit+of+rod+cGMP-phosphodiesterase&doi=10.1038%2F347677a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase</span></div><div class="casAuthors">Bowes, Cathy; Li, Tiansen; Danciger, Michael; Baxter, Leslie C.; Applebury, Meredithe L.; Farber, Debora B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6294</span>),
    <span class="NLM_cas:pages">677-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Mice homozygous for the rd mutation display hereditary retinal degeneration, and the classic rd lines serve as a model for human retinitis pigmentosa.  In affected animals, the retinal rod photoreceptor cells begin degenerating at about postnatal day 8, and by 4 wk no photoreceptors are left.  Degeneration is preceded by accumulation of cyclic GMP in the retina and is correlated with deficient activity of the rod photoreceptor cGMP-phosphodiesterase.  A candidate cDNA for the rd gene was isolated from a mouse retinal library and characterization of cDNAs encoding all subunits of bovine photoreceptor phosphodiesterase was completed.  The candidate cDNA shows strong homol. with a cDNA encoding the bovine phosphodiesterase β subunit.  Here, evidence is presented that the candidate cDNA is the murine homolog of bovine phosphodiesterase β cDNA.  It is concluded that the mouse rd locus encodes the rod photoreceptor cGMP-phosphodiesterase β subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZy8akRsDITLVg90H21EOLACvtfcHk0ligmTv1H-myfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFKj&md5=10365cd2cc2e06e3c45a5511eb6bdfc5</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2F347677a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347677a0%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DDanciger%26aufirst%3DM.%26aulast%3DBaxter%26aufirst%3DL.%2BC.%26aulast%3DApplebury%26aufirst%3DM.%2BL.%26aulast%3DFarber%26aufirst%3DD.%2BB.%26atitle%3DRetinal%2520degeneration%2520in%2520the%2520rd%2520mouse%2520is%2520caused%2520by%2520a%2520defect%2520in%2520the%2520beta%2520subunit%2520of%2520rod%2520cGMP-phosphodiesterase%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D677%26epage%3D680%26doi%3D10.1038%2F347677a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackam, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otteson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowers, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leveillard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campochiaro, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zack, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2929</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.1167/iovs.03-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1167%2Fiovs.03-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15326104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BD2cvhvFarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=2929-2942&author=A.+S.+Hackamauthor=R.+Stromauthor=D.+Liuauthor=J.+Qianauthor=C.+Wangauthor=D.+Ottesonauthor=T.+Gunatilakaauthor=R.+H.+Farkasauthor=I.+Chowersauthor=M.+Kageyamaauthor=T.+Leveillardauthor=J.+A.+Sahelauthor=P.+A.+Campochiaroauthor=G.+Parmigianiauthor=D.+J.+Zack&title=Identification+of+gene+expression+changes+associated+with+the+progression+of+retinal+degeneration+in+the+rd1+mouse&doi=10.1167%2Fiovs.03-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse</span></div><div class="casAuthors">Hackam Abigail S; Strom Richelle; Liu Dongmei; Qian Jiang; Wang Chenwei; Otteson Deborah; Gunatilaka Tushara; Farkas Ronald H; Chowers Itay; Kageyama Masaaki; Leveillard Thierry; Sahel Jose-Alain; Campochiaro Peter A; Parmigiani Giovanni; Zack Donald J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2929-42</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  One approach to gaining insight into the biological pathways contributing to rod and cone photoreceptor death is to identify patterns of gene expression changes.  In the present study, a custom retinal microarray was developed to analyze the rd1 mouse, a well-characterized animal model of human retinal degeneration.  METHODS:  A microarray was constructed containing cDNA fragments corresponding to genes known or postulated to be involved in normal retinal function, development, and disease.  Gene expression in rd1 retina was compared with age-matched control retinas at three time points: the peak of rod degeneration (postnatal day [P]14), early in cone degeneration (P35), and during cone degeneration (P50).  Selected microarray results were confirmed with real-time PCR.  The cellular distribution of one of the differentially expressed genes, dickkopf 3 (Dkk3), was assessed by in situ hybridization.  RESULTS:  At each stage of degeneration, there was only limited overlap of the genes that showed increased expression, suggesting the involvement of temporally distinct molecular pathways.  Genes active in transport mechanisms and in signaling pathways were differentially expressed during rod degeneration, whereas genes with functions in protein modification and cellular metabolism were differentially expressed during cone degeneration.  Increased expression of genes involved in cell proliferation pathways and oxidative stress was observed at each time point.  CONCLUSIONS:  These microarray results provide clues to understanding the molecular pathways underlying photoreceptor degeneration and indicate directions for future studies.  In addition, comparisons of normal and degenerated retina identified numerous genes and ESTs that are potentially enriched in rod photoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCUI8DZVGxHuWhZTslLrfffW6udTcc2eYrIeXs3Guf_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvhvFarug%253D%253D&md5=c86bc5311ec1db9a00037de90146750a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1167%2Fiovs.03-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.03-1184%26sid%3Dliteratum%253Aachs%26aulast%3DHackam%26aufirst%3DA.%2BS.%26aulast%3DStrom%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DOtteson%26aufirst%3DD.%26aulast%3DGunatilaka%26aufirst%3DT.%26aulast%3DFarkas%26aufirst%3DR.%2BH.%26aulast%3DChowers%26aufirst%3DI.%26aulast%3DKageyama%26aufirst%3DM.%26aulast%3DLeveillard%26aufirst%3DT.%26aulast%3DSahel%26aufirst%3DJ.%2BA.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520changes%2520associated%2520with%2520the%2520progression%2520of%2520retinal%2520degeneration%2520in%2520the%2520rd1%2520mouse%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2004%26volume%3D45%26spage%3D2929%26epage%3D2942%26doi%3D10.1167%2Fiovs.03-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petridou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comitato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marigo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Primary rod and cone degeneration is prevented by HDAC inhibition</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1074</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-75402-4_45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2F978-3-319-75402-4_45" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29721965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2018&pages=367-373&author=D.+Trifunovicauthor=E.+Petridouauthor=A.+Comitatoauthor=V.+Marigoauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Primary+rod+and+cone+degeneration+is+prevented+by+HDAC+inhibition&doi=10.1007%2F978-3-319-75402-4_45"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Primary rod and cone degeneration is prevented by HDAC inhibition</span></div><div class="casAuthors">Trifunovic, Dragana; Petridou, Eleni; Comitato, Antonella; Marigo, Valeria; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1074</span>
        (<span class="NLM_cas:issue">Retinal Degenerative Diseases</span>),
    <span class="NLM_cas:pages">367-373</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Photoreceptor cell death in inherited retinal degeneration is accompanied by over-activation of histone deacetylases (HDAC).  Excessive HDAC activity is found both in primary rod degeneration (such as in the rd10 mouse) and in primary cone death, including the cone photoreceptor function loss 1 (cpfl1) mouse.  We evaluated the potential of pharmacol. HDAC inhibition to prevent photoreceptor degeneration in primary rod and cone degeneration.  We show that a single in vivo treatment of cpfl1 mice with the HDAC inhibitor trichostatin A (TSA) resulted in a significant protection of cpfl1 mutant cones.  Similarly, HDAC inhibition with the clin. approved HDAC inhibitor vorinostat (SAHA) resulted in a significant improvement of rod survival in rd10 retinal explant cultures.  Altogether, these results highlight the feasibility of targeted neuroprotection in vivo and create hope to maintain vision in patients suffering from both rod and cone dystrophies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Ee2pargmHrVg90H21EOLACvtfcHk0lg-MuVyikLmdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVertbg%253D&md5=48f645cd4daa35cb12a375478abab62b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-75402-4_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-75402-4_45%26sid%3Dliteratum%253Aachs%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DPetridou%26aufirst%3DE.%26aulast%3DComitato%26aufirst%3DA.%26aulast%3DMarigo%26aufirst%3DV.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DPrimary%2520rod%2520and%2520cone%2520degeneration%2520is%2520prevented%2520by%2520HDAC%2520inhibition%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2018%26volume%3D1074%26spage%3D367%26epage%3D373%26doi%3D10.1007%2F978-3-319-75402-4_45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comitato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Amo, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urtti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenijevic, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marigo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4472</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddw275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fhmg%2Fddw275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28172811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFaktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=4462-4472&author=D.+Trifunovicauthor=B.+Arango-Gonzalezauthor=A.+Comitatoauthor=M.+Barthauthor=E.+M.+Del+Amoauthor=M.+Kulkarniauthor=A.+Sahabogluauthor=S.+M.+Hauckauthor=A.+Urttiauthor=Y.+Arsenijevicauthor=M.+Ueffingauthor=V.+Marigoauthor=F.+Paquet-Durand&title=HDAC+inhibition+in+the+cpfl1+mouse+protects+degenerating+cone+photoreceptors+in+vivo&doi=10.1093%2Fhmg%2Fddw275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo</span></div><div class="casAuthors">Trifunovic, Dragana; Arango-Gonzalez, Blanca; Comitato, Antonella; Barth, Melanie; del Amo, Eva M.; Kulkarni, Manoj; Sahaboglu, Ayse; Hauck, Stefanie M.; Urtti, Arto; Arsenijevic, Yvan; Ueffing, Marius; Marigo, Valeria; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4462-4472</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cone photoreceptor cell death as it occurs in certain hereditary retinal diseases is devastating, with the affected patients suffering from a loss of accurate and color vision.  Regrettably, these hereditary cone diseases are still untreatable to date.  Thus, the identification of substances able to block or restrain cone cell death is of primary importance.  We studied the neuroprotective effects of a histone deacetylase inhibitor, Trichostatin A (TSA), in a mouse model of inherited, primary cone degeneration (cpfi,1).  We show that HDAC inhibition protects cpfi,1 cones in vitro, in retinal explant cultures.  More importantly, in vivo, a single intravitreal TSA injection significantly increased cone survival for up to 16 days post-injection.  In addn., the abnormal, incomplete cone migration pattern in the cpfi,1 retina was significantly improved by HDAC inhibition.  These findings suggest a crucial role for HDAC activity in primary cone degeneration and highlight a new avenue for future therapy developments for cone dystrophies and retinal diseases assocd. with impaired cone migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKe6ueDLsrbVg90H21EOLACvtfcHk0lg-MuVyikLmdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFaktr8%253D&md5=f70d924be45ce875d9a562c5b8216317</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddw275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddw275%26sid%3Dliteratum%253Aachs%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DComitato%26aufirst%3DA.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DDel%2BAmo%26aufirst%3DE.%2BM.%26aulast%3DKulkarni%26aufirst%3DM.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DHauck%26aufirst%3DS.%2BM.%26aulast%3DUrtti%26aufirst%3DA.%26aulast%3DArsenijevic%26aufirst%3DY.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DMarigo%26aufirst%3DV.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DHDAC%2520inhibition%2520in%2520the%2520cpfl1%2520mouse%2520protects%2520degenerating%2520cone%2520photoreceptors%2520in%2520vivo%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D4462%26epage%3D4472%26doi%3D10.1093%2Fhmg%2Fddw275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzekov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checchi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigelow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of valproic acid for retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1136/bjo.2009.175356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2009.175356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20647559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivVGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=89-93&author=C.+M.+Clemsonauthor=R.+Tzekovauthor=M.+Krebsauthor=J.+M.+Checchiauthor=C.+Bigelowauthor=S.+Kaushal&title=Therapeutic+potential+of+valproic+acid+for+retinitis+pigmentosa&doi=10.1136%2Fbjo.2009.175356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of valproic acid for retinitis pigmentosa</span></div><div class="casAuthors">Clemson C M; Tzekov R; Krebs M; Checchi J M; Bigelow C; Kaushal S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND/AIM:  To examine the efficacy and safety of valproic acid (VPA) in patients with retinitis pigmentosa (RP).  METHODS:  Thirteen eyes were examined before and after brief treatment (average 4 months) with VPA.  Visual fields (VF) for each eye were defined using digitised Goldmann Kinetic Perimetry tracings.  VF areas were log-transformed and VF loss/gain relative to baseline was calculated.  Visual acuity was measured using a Snellen chart at a distance of 20&emsp14;feet (6.1 m).  Values were converted to the logarithm of the minimum angle of resolution (logMAR) score.  RESULTS:  Nine eyes had improved VF with treatment, two eyes had decreased VF and two eyes experienced no change, with an overall average increase of 11%.  Assuming typical loss in VF area without treatment, this increase in VF was statistically significant (p<0.02).  An average decrease (0.172) in the logMAR scores was seen in these 13 eyes, which translates to a positive change in Snellen score of approximately 20/47 to 20/32, which was significant (p<0.02) assuming no loss in acuity without treatment.  Side effects were mild and well tolerated.  CONCLUSION:  Treatment with VPA is suggestive of a therapeutic benefit to patients with RP.  A placebo-controlled clinical trial will be necessary to assess the efficacy and safety of VPA for RP rigorously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUlsoY-cDkdlWTCLT8lX9SfW6udTcc2eYdaPQz0r_FUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivVGnuw%253D%253D&md5=7f73f128600812d49280a54aeaf30005</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2009.175356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2009.175356%26sid%3Dliteratum%253Aachs%26aulast%3DClemson%26aufirst%3DC.%2BM.%26aulast%3DTzekov%26aufirst%3DR.%26aulast%3DKrebs%26aufirst%3DM.%26aulast%3DChecchi%26aufirst%3DJ.%2BM.%26aulast%3DBigelow%26aufirst%3DC.%26aulast%3DKaushal%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520of%2520valproic%2520acid%2520for%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D89%26epage%3D93%26doi%3D10.1136%2Fbjo.2009.175356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phiel, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, P. S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">36734</span>– <span class="NLM_lpage">36741</span>, <span class="refDoi"> DOI: 10.1074/jbc.M101287200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M101287200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11473107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36734-36741&author=C.+J.+Phielauthor=F.+Zhangauthor=E.+Y.+Huangauthor=M.+G.+Guentherauthor=M.+A.+Lazarauthor=P.+S.+Klein&title=Histone+deacetylase+is+a+direct+target+of+valproic+acid%2C+a+potent+anticonvulsant%2C+mood+stabilizer%2C+and+teratogen&doi=10.1074%2Fjbc.M101287200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span></div><div class="casAuthors">Phiel, Christopher J.; Zhang, Fang; Huang, Eric Y.; Guenther, Matthew G.; Lazar, Mitchell A.; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36734-36741</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Valproic acid is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its mechanisms of action in any of these settings are unknown.  We report that valproic acid activates Wnt-dependent gene expression, similar to lithium, the mainstay of therapy for bipolar disorder.  Valproic acid, however, acts through a distinct pathway that involves direct inhibition of histone deacetylase (IC50 for HDAC1=0.4 mM).  At therapeutic levels, valproic acid mimics the histone deacetylase inhibitor trichostatin A, causing hyperacetylation of histones in cultured cells.  Valproic acid, like trichostatin A, also activates transcription from diverse exogenous and endogenous promoters.  Furthermore, valproic acid and trichostatin A have remarkably similar teratogenic effects in vertebrate embryos, while non-teratogenic analogs of valproic acid do not inhibit histone deacetylase and do not activate transcription.  Based on these observations, we propose that inhibition of histone deacetylase provides a mechanism for valproic acid-induced birth defects and could also explain the efficacy of valproic acid in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZDcS-2BIhrVg90H21EOLACvtfcHk0lhvioU7Cy5lJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D&md5=6c1daa317cfb4c0cd8c8c2a21d4ed07c</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101287200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101287200%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BY.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DHistone%2520deacetylase%2520is%2520a%2520direct%2520target%2520of%2520valproic%2520acid%252C%2520a%2520potent%2520anticonvulsant%252C%2520mood%2520stabilizer%252C%2520and%2520teratogen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36734%26epage%3D36741%26doi%3D10.1074%2Fjbc.M101287200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel-DiFranco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berson, E. L.</span></span> <span> </span><span class="NLM_article-title">Lack of scientific rationale for use of valproic acid for retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">744</span>, <span class="refDoi"> DOI: 10.1136/bjo.2010.198176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2010.198176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21131379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3MvkvF2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=744&author=M.+A.+Sandbergauthor=B.+Rosnerauthor=C.+Weigel-DiFrancoauthor=E.+L.+Berson&title=Lack+of+scientific+rationale+for+use+of+valproic+acid+for+retinitis+pigmentosa&doi=10.1136%2Fbjo.2010.198176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of scientific rationale for use of valproic acid for retinitis pigmentosa</span></div><div class="casAuthors">Sandberg Michael A; Rosner Bernard; Weigel-DiFranco Carol; Berson Eliot L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">744</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6k3RMgtNpPUodMGTatQ7LfW6udTcc2eYdaPQz0r_FUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvkvF2lug%253D%253D&md5=aa694046bb303965966d53d6cb7af86f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2010.198176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2010.198176%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DM.%2BA.%26aulast%3DRosner%26aufirst%3DB.%26aulast%3DWeigel-DiFranco%26aufirst%3DC.%26aulast%3DBerson%26aufirst%3DE.%2BL.%26atitle%3DLack%2520of%2520scientific%2520rationale%2520for%2520use%2520of%2520valproic%2520acid%2520for%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D744%26doi%3D10.1136%2Fbjo.2010.198176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Schooneveld, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Genderen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollemeijer, J. G.</span></span> <span> </span><span class="NLM_article-title">The conclusions of Clemson et al concerning valproic acid are premature</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">153</span>, author reply 153–154. <span class="refDoi"> DOI: 10.1136/bjo.2010.194373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2010.194373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20971790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fjt1ansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=153&author=M.+J.+van+Schooneveldauthor=L.+I.+van+den+Bornauthor=M.+van+Genderenauthor=J.+G.+Bollemeijer&title=The+conclusions+of+Clemson+et+al+concerning+valproic+acid+are+premature&doi=10.1136%2Fbjo.2010.194373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The conclusions of Clemson et al concerning valproic acid are premature</span></div><div class="casAuthors">van Schooneveld Mary J; van den Born L Ingeborgh; van Genderen Mies; Bollemeijer Jan-Geert</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153; author reply 153-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx7PqrnsgMqDAEfvC7EH1LfW6udTcc2eYdaPQz0r_FUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fjt1ansA%253D%253D&md5=6cb9d9c3e6aff623a64adbc1e55dd817</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2010.194373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2010.194373%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BSchooneveld%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DL.%2BI.%26aulast%3Dvan%2BGenderen%26aufirst%3DM.%26aulast%3DBollemeijer%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520conclusions%2520of%2520Clemson%2520et%2520al%2520concerning%2520valproic%2520acid%2520are%2520premature%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D153%26doi%3D10.1136%2Fbjo.2010.194373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisk, R. A.</span></span> <span> </span><span class="NLM_article-title">Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2012-301950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjophthalmol-2012-301950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22581401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC38nislCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2012&pages=1154-1155&author=R.+A.+Sisk&title=Valproic+acid+treatment+may+be+harmful+in+non-dominant+forms+of+retinitis+pigmentosa&doi=10.1136%2Fbjophthalmol-2012-301950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa</span></div><div class="casAuthors">Sisk Robert A</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1154-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS95IHV4KOJDb5XHngOXiV_fW6udTcc2eaEJhBrd1eaqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nislCguw%253D%253D&md5=9b40779f2a69af746041100fb5e42282</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2012-301950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2012-301950%26sid%3Dliteratum%253Aachs%26aulast%3DSisk%26aufirst%3DR.%2BA.%26atitle%3DValproic%2520acid%2520treatment%2520may%2520be%2520harmful%2520in%2520non-dominant%2520forms%2520of%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2012%26volume%3D96%26spage%3D1154%26epage%3D1155%26doi%3D10.1136%2Fbjophthalmol-2012-301950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhullar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, C. N.</span></span> <span> </span><span class="NLM_article-title">Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2013-303084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjophthalmol-2013-303084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23603755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3srmvVKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=895-899&author=S.+Bhallaauthor=D.+Joshiauthor=S.+Bhullarauthor=D.+Kasugaauthor=Y.+Parkauthor=C.+N.+Kay&title=Long-term+follow-up+for+efficacy+and+safety+of+treatment+of+retinitis+pigmentosa+with+valproic+acid&doi=10.1136%2Fbjophthalmol-2013-303084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid</span></div><div class="casAuthors">Bhalla Sheena; Joshi Deval; Bhullar Shaminder; Kasuga Daniel; Park Yeonhee; Kay Christine N</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  The purpose of this study was to determine the long-term efficacy and safety of valproic acid (VPA) treatment in patients with pigmentary retinal dystrophies.  METHODS:  A retrospective chart review was conducted on 31 patients with a diagnosis of pigmentary retinal dystrophy prescribed VPA at a single centre.  Visual field (VF), visual acuity (VA), length of treatment, liver enzymes and side effects were analysed.  VF areas were defined using Goldmann VF (GVF) tracings recorded before, during and after VPA treatment using the V4e isopter for each eye.  Using custom software, planimetric areas of VF were calculated.  RESULTS:  Five of the patients (10 eyes) had two Goldmann VF tracings, allowing comparison between baseline and follow-up VF.  After 9.8 months of VPA, VF decreased by 0.145 cm(2) (26.478%) (p=0.432).  For 22 of the patients (41 eyes), VA data was available, and logarithm of the minimum angle of resolution (logMAR) score changed by 0.056 log units (representing a decline in VA) after 14.9 months on VPA (p=0.002).  Twelve patients (38.7%) reported negative side effects related to VPA use.  CONCLUSIONS:  VPA plays a complex role in patients with pigmentary retinal dystrophies and may be associated with VA and field decline as well as adverse side effects.  Physicians should use caution with using VPA for pigmentary retinal dystrophies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5kCK1XfDcXoYPsCkJIw00fW6udTcc2eaEJhBrd1eaqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srmvVKqug%253D%253D&md5=424604b6570c4360c0406714603834de</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2013-303084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2013-303084%26sid%3Dliteratum%253Aachs%26aulast%3DBhalla%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DD.%26aulast%3DBhullar%26aufirst%3DS.%26aulast%3DKasuga%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKay%26aufirst%3DC.%2BN.%26atitle%3DLong-term%2520follow-up%2520for%2520efficacy%2520and%2520safety%2520of%2520treatment%2520of%2520retinitis%2520pigmentosa%2520with%2520valproic%2520acid%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2013%26volume%3D97%26spage%3D895%26epage%3D899%26doi%3D10.1136%2Fbjophthalmol-2013-303084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vent-Schmidt, R. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, O. L.</span></span> <span> </span><span class="NLM_article-title">Opposing effects of valproic acid treatment mediated by histone deacetylase inhibitor activity in four transgenic X. laevis models of retinitis pigmentosa</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1647-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1647-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28490005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVOqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1039-1054&author=R.+Y.+J.+Vent-Schmidtauthor=R.+H.+Wenauthor=Z.+Zongauthor=C.+N.+Chiuauthor=B.+M.+Tamauthor=C.+G.+Mayauthor=O.+L.+Moritz&title=Opposing+effects+of+valproic+acid+treatment+mediated+by+histone+deacetylase+inhibitor+activity+in+four+transgenic+X.+laevis+models+of+retinitis+pigmentosa&doi=10.1523%2FJNEUROSCI.1647-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of valproic acid treatment mediated by histone deacetylase inhibitor activity in four transgenic X. laevis models of retinitis pigmentosa</span></div><div class="casAuthors">Vent-Schmidt, Ruanne Y. J.; Wen, Runxia H.; Zong, Zusheng; Chiu, Colette N.; Tam, Beatrice M.; May, Christopher G.; Moritz, Orson L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1039-1054</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Retinitis pigmentosa (RP) is an inherited retinal degeneration (RD) that leads to blindness for which no treatment is available.  RP is frequently caused by mutations in Rhodopsin; in some animal models, RD is exacerbated by light.  Valproic acid (VPA) is a proposed treatment for RP and other neurodegenerative disorders, with a phase II trial for RP under way.  However, the therapeutic mechanism is unclear, with minimal research supporting its use in RP.  We investigated the effects of VPA on Xenopus laevis models of RP expressing human P23H, T17M, T4K, and Q344ter rhodopsins, which are assocd. with RP in humans.  VPA ameliorated RD assocd. with P23H rhodopsin and promoted clearing of mutant rhodopsin from photoreceptors.  The effect was equal to that of dark rearing, with no additive effect obsd.  Rescue of visual function was confirmed by electroretinog.  In contrast, VPA exacerbated RD caused by T17M rhodopsin in light, but had no effect in darkness.  Effects in T4K and Q344ter rhodopsin models were also neg.  These effects of VPA were paralleled by treatment with three addnl. histone deacetylase (HDAC) inhibitors, but not other antipsychotics, chem. chaperones, or VPA structural analogs.  In WT retinas, VPA treatment increased histone H3 acetylation.  In addn., electron microscopy showed increased autophagosomes in rod inner segments with HDAC inhibitor (HDACi) treatment, potentially linking the therapeutic effects in P23H rhodopsin animals and neg. effects in other models with autophagy.  Our results suggest that the success or failure of VPA treatment is dependent on genotype and that HDACi treatment is contraindicated for some RP cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnJviRhCP7LVg90H21EOLACvtfcHk0lip-4IlLpcCpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVOqs7c%253D&md5=5572bc66f80a2bc051c6d851edab96c4</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1647-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1647-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DVent-Schmidt%26aufirst%3DR.%2BY.%2BJ.%26aulast%3DWen%26aufirst%3DR.%2BH.%26aulast%3DZong%26aufirst%3DZ.%26aulast%3DChiu%26aufirst%3DC.%2BN.%26aulast%3DTam%26aufirst%3DB.%2BM.%26aulast%3DMay%26aufirst%3DC.%2BG.%26aulast%3DMoritz%26aufirst%3DO.%2BL.%26atitle%3DOpposing%2520effects%2520of%2520valproic%2520acid%2520treatment%2520mediated%2520by%2520histone%2520deacetylase%2520inhibitor%2520activity%2520in%2520four%2520transgenic%2520X.%2520laevis%2520models%2520of%2520retinitis%2520pigmentosa%26jtitle%3DJ.%2520Neurosci.%26date%3D2017%26volume%3D37%26spage%3D1039%26epage%3D1054%26doi%3D10.1523%2FJNEUROSCI.1647-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter-Landsberg, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3028</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2017.415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29048427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e3028&author=J.+Leykauthor=C.+Dalyauthor=U.+Janssen-Bienholdauthor=B.+N.+Kennedyauthor=C.+Richter-Landsberg&title=HDAC6+inhibition+by+tubastatin+A+is+protective+against+oxidative+stress+in+a+photoreceptor+cell+line+and+restores+visual+function+in+a+zebrafish+model+of+inherited+blindness&doi=10.1038%2Fcddis.2017.415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span></div><div class="casAuthors">Leyk, Janina; Daly, Conor; Janssen-Bienhold, Ulrike; Kennedy, Breandan N.; Richter-Landsberg, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e3028</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinal diseases, such as hereditary retinitis pigmentosa and age-related macular degeneration, are characterized by the progressive loss of photoreceptors.  Histone deacetylase 6 (HDAC6) is considered as a stress surveillance factor and a potential target for neuroprotection and regeneration.  Overexpression of HDAC6 has been connected to neurodegenerative disorders, and its suppression may provide protection.  Here we show that HDAC6 is constitutively present in the mouse retina, and in the cone-like mouse cell line 661W.  In 661W cells HDAC6 inhibition by the specific inhibitor tubastatin A (TST) led to the acetylation of α-tubulin, which is a major substrate for HDAC6.  After oxidative stress, exerted by hydrogen peroxide, TST promoted cell survival and the upregulation of heat-shock proteins HSP70 and HSP25 by activation of heat-shock transcription factor 1.  Furthermore, in response to oxidative stress the redox regulatory protein peroxiredoxin 1 (Prx1) was modulated in 661W cells by HDAC6 inhibition.  The peroxide reducing activity of Prx1 is dependent on its acetylation, which is mediated by HDAC6.  Pre-incubation with TST prevented the inactivation of Prx1 and its preserved activity may exert protective effects in photoreceptor cells.  To det. whether TST treatment has a therapeutic effect on visual function, the dyeucd6 zebrafish model of inherited sight loss was utilized.  Zebrafish have developed as a suitable model system for pharmacol. testing.  In vivo application of TST caused the hyperacetylation of α-tubulin, indicating that HDAC6 is active in this model.  Furthermore, TST was sufficient to rescue visual function and retinal morphol.  Hence, HDAC6 inhibition and the regulation of peroxiredoxin activity may play a significant role in protecting retinal cells and in particular photoreceptors, which are exposed to high levels of reactive oxygen species derived from oxidative stress-induced injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltlSmCwk0BrVg90H21EOLACvtfcHk0lhJMRozj5CgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL&md5=d6a6315da7b623e42cc3784dd76cd444</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.415%26sid%3Dliteratum%253Aachs%26aulast%3DLeyk%26aufirst%3DJ.%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26atitle%3DHDAC6%2520inhibition%2520by%2520tubastatin%2520A%2520is%2520protective%2520against%2520oxidative%2520stress%2520in%2520a%2520photoreceptor%2520cell%2520line%2520and%2520restores%2520visual%2520function%2520in%2520a%2520zebrafish%2520model%2520of%2520inherited%2520blindness%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De3028%26doi%3D10.1038%2Fcddis.2017.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sontake, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasam, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naren, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madala, S. K.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulation of fibroblast activation in pulmonary fibrosis</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e91454</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.91454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1172%2Fjci.insight.91454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28239659" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=e91454&author=V.+Sontakeauthor=Y.+Wangauthor=R.+K.+Kasamauthor=D.+Sinnerauthor=G.+B.+Reddyauthor=A.+P.+Narenauthor=F.+X.+McCormackauthor=E.+S.+Whiteauthor=A.+G.+Jeggaauthor=S.+K.+Madala&title=Hsp90+regulation+of+fibroblast+activation+in+pulmonary+fibrosis&doi=10.1172%2Fjci.insight.91454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.91454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.91454%26sid%3Dliteratum%253Aachs%26aulast%3DSontake%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKasam%26aufirst%3DR.%2BK.%26aulast%3DSinner%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DNaren%26aufirst%3DA.%2BP.%26aulast%3DMcCormack%26aufirst%3DF.%2BX.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DJegga%26aufirst%3DA.%2BG.%26aulast%3DMadala%26aufirst%3DS.%2BK.%26atitle%3DHsp90%2520regulation%2520of%2520fibroblast%2520activation%2520in%2520pulmonary%2520fibrosis%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3De91454%26doi%3D10.1172%2Fjci.insight.91454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. G.</span></span> <span> </span><span class="NLM_article-title">Idiopathic pulmonary fibrosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">1941</span>– <span class="NLM_lpage">1952</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)30866-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0140-6736%2817%2930866-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28365056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjtl2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=1941-1952&author=L.+Richeldiauthor=H.+R.+Collardauthor=M.+G.+Jones&title=Idiopathic+pulmonary+fibrosis&doi=10.1016%2FS0140-6736%2817%2930866-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Richeldi Luca; Collard Harold R; Jones Mark G</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10082</span>),
    <span class="NLM_cas:pages">1941-1952</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease.  Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is destroyed, which leads to decreased lung compliance, disrupted gas exchange, and ultimately respiratory failure and death.  In less than a decade, understanding of the pathogenesis and management of this disease has been transformed, and two disease-modifying therapies have been approved, worldwide.  In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis.  This disease has improved understanding of the mechanisms of lung fibrosis, and offers hope that similar approaches will transform the management of patients with other progressive fibrotic lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKegwoJx_MJWhHGZei4OW9fW6udTcc2eZMK0eYwZatMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjtl2htA%253D%253D&md5=0b2ef2ea9cd8ff31f45be28b34a93a88</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2930866-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252930866-8%26sid%3Dliteratum%253Aachs%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3DCollard%26aufirst%3DH.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BG.%26atitle%3DIdiopathic%2520pulmonary%2520fibrosis%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D1941%26epage%3D1952%26doi%3D10.1016%2FS0140-6736%2817%2930866-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Bois, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costabel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Maulf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stowasser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenker-Herceg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, H. R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">2071</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1402584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1056%2FNEJMoa1402584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24836310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=2071-2082&author=L.+Richeldiauthor=R.+M.+du+Boisauthor=G.+Raghuauthor=A.+Azumaauthor=K.+K.+Brownauthor=U.+Costabelauthor=V.+Cottinauthor=K.+R.+Flahertyauthor=D.+M.+Hansellauthor=Y.+Inoueauthor=D.+S.+Kimauthor=M.+Kolbauthor=A.+G.+Nicholsonauthor=P.+W.+Nobleauthor=M.+Selmanauthor=H.+Taniguchiauthor=M.+Brunauthor=F.+Le+Maulfauthor=M.+Girardauthor=S.+Stowasserauthor=R.+Schlenker-Hercegauthor=B.+Disseauthor=H.+R.+Collard&title=Efficacy+and+safety+of+nintedanib+in+idiopathic+pulmonary+fibrosis&doi=10.1056%2FNEJMoa1402584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K.; Costabel, Ulrich; Cottin, Vincent; Flaherty, Kevin R.; Hansell, David M.; Inoue, Yoshikazu; Kim, Dong Soon; Kolb, Martin; Nicholson, Andrew G.; Noble, Paul W.; Selman, Moises; Taniguchi, Hiroyuki; Brun, Michele; Le Maulf, Florence; Girard, Mannaig; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Disse, Bernd; Collard, Harold R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2071-2082, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases.  A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis.  Methods: We conducted two replicate 52-wk, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis.  The primary end point was the annual rate of decline in forced vital capacity (FVC).  Key secondary end points were the time to the first acute exacerbation and the change from baseline in the total score on the St.  George's Respiratory Questionnaire, both assessed over a 52-wk period.  Results: A total of 1066 patients were randomly assigned in a 3:2 ratio to receive nintedanib or placebo.  The adjusted annual rate of change in FVC was -114.7 mL with nintedanib vs. -239.9 mL with placebo (difference, 125.3 mL; 95% confidence interval [CI], 77.7 to 172.8; P < 0.001) in INPULSIS-1 and -113.6 mL with nintedanib vs. -207.3 mL with placebo (difference, 93.7 mL; 95% CI, 44.8 to 142.7; P < 0.001) in INPULSIS-2.  In INPULSIS-1, there was no significant difference between the nintedanib and placebo groups in the time to the first acute exacerbation (hazard ratio with nintedanib, 1.15; 95% CI, 0.54 to 2.42; P = 0.67); in INPULSIS-2, there was a significant benefit with nintedanib vs. placebo (hazard ratio, 0.38; 95% CI, 0.19 to 0.77; P = 0.005).  The most frequent adverse event in the nintedanib groups was diarrhea, with rates of 61.5% and 18.6% in the nintedanib and placebo groups, resp., in INPULSIS-1 and 63.2% and 18.3% in the two groups, resp., in INPULSIS-2.  Conclusions: In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of disease progression; nintedanib was frequently assocd. with diarrhea, which led to discontinuation of the study medication in less than 5% of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGuOhVKeZaSrVg90H21EOLACvtfcHk0lisT9vzu9WqTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbfK&md5=be977cd3b402c7c401f4a3dfaa0f484f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1402584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1402584%26sid%3Dliteratum%253Aachs%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DRaghu%26aufirst%3DG.%26aulast%3DAzuma%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DCostabel%26aufirst%3DU.%26aulast%3DCottin%26aufirst%3DV.%26aulast%3DFlaherty%26aufirst%3DK.%2BR.%26aulast%3DHansell%26aufirst%3DD.%2BM.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DD.%2BS.%26aulast%3DKolb%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DA.%2BG.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DBrun%26aufirst%3DM.%26aulast%3DLe%2BMaulf%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DM.%26aulast%3DStowasser%26aufirst%3DS.%26aulast%3DSchlenker-Herceg%26aufirst%3DR.%26aulast%3DDisse%26aufirst%3DB.%26aulast%3DCollard%26aufirst%3DH.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520nintedanib%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D2071%26epage%3D2082%26doi%3D10.1056%2FNEJMoa1402584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, T. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Bernardini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaspole, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassberg, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardatzke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swigris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span> <span> </span><span class="NLM_article-title">A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">2083</span>– <span class="NLM_lpage">2092</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1402582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1056%2FNEJMoa1402582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24836312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGktrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=2083-2092&author=T.+E.+Kingauthor=W.+Z.+Bradfordauthor=S.+Castro-Bernardiniauthor=E.+A.+Faganauthor=I.+Glaspoleauthor=M.+K.+Glassbergauthor=E.+Gorinaauthor=P.+M.+Hopkinsauthor=D.+Kardatzkeauthor=L.+Lancasterauthor=D.+J.+Ledererauthor=S.+D.+Nathanauthor=C.+A.+Pereiraauthor=S.+A.+Sahnauthor=R.+Sussmanauthor=J.+J.+Swigrisauthor=P.+W.+Noble&title=A+phase+3+trial+of+pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis&doi=10.1056%2FNEJMoa1402582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis</span></div><div class="casAuthors">King, Talmadge E.; Bradford, Williamson Z.; Castro-Bernardini, Socorro; Fagan, Elizabeth A.; Glaspole, Ian; Glassberg, Marilyn K.; Gorina, Eduard; Hopkins, Peter M.; Kardatzke, David; Lancaster, Lisa; Lederer, David J.; Nathan, Steven D.; Pereira, Carlos A.; Sahn, Steven A.; Sussman, Robert; Swigris, Jeffrey J.; Noble, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2083-2092, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced vital capacity (FVC) or vital capacity, in patients with idiopathic pulmonary fibrosis; in the third trial, this end point was not achieved.  We sought to confirm the beneficial effect of pirfenidone on disease progression in such patients.  Methods: In this phase 3 study, we randomly assigned 555 patients with idiopathic pulmonary fibrosis to receive either oral pirfenidone (2403 mg per day) or placebo for 52 wk.  The primary end point was the change in FVC or death at week 52.  Secondary end points were the 6-min walk distance, progression-free survival, dyspnea, and death from any cause or from idiopathic pulmonary fibrosis.  Results: In the pirfenidone group, as compared with the placebo group, there was a relative redn. of 47.9% in the proportion of patients who had an abs. decline of 10 percentage points or more in the percentage of the predicted FVC or who died; there was also a relative increase of 132.5% in the proportion of patients with no decline in FVC (P < 0.001).  Pirfenidone reduced the decline in the 6-min walk distance (P = 0.04) and improved progression-free survival (P < 0.001).  There was no significant between-group difference in dyspnea scores (P = 0.16) or in rates of death from any cause (P = 0.10) or from idiopathic pulmonary fibrosis (P = 0.23).  However, in a prespecified pooled anal. incorporating results from two previous phase 3 trials, the between-group difference favoring pirfenidone was significant for death from any cause (P = 0.01) and from idiopathic pulmonary fibrosis (P = 0.006).  Gastrointestinal and skin-related adverse events were more common in the pirfenidone group than in the placebo group but rarely led to treatment discontinuation.  Conclusions: Pirfenidone, as compared with placebo, reduced disease progression, as reflected by lung function, exercise tolerance, and progression-free survival, in patients with idiopathic pulmonary fibrosis.  Treatment was assocd. with an acceptable sideeffect profile and fewer deaths.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBkQ8hqTWxxLVg90H21EOLACvtfcHk0lisT9vzu9WqTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGktrrJ&md5=17bfe4782c11521d3b7890ae387bbaf6</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1402582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1402582%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DT.%2BE.%26aulast%3DBradford%26aufirst%3DW.%2BZ.%26aulast%3DCastro-Bernardini%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DE.%2BA.%26aulast%3DGlaspole%26aufirst%3DI.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DGorina%26aufirst%3DE.%26aulast%3DHopkins%26aufirst%3DP.%2BM.%26aulast%3DKardatzke%26aufirst%3DD.%26aulast%3DLancaster%26aufirst%3DL.%26aulast%3DLederer%26aufirst%3DD.%2BJ.%26aulast%3DNathan%26aufirst%3DS.%2BD.%26aulast%3DPereira%26aufirst%3DC.%2BA.%26aulast%3DSahn%26aufirst%3DS.%2BA.%26aulast%3DSussman%26aufirst%3DR.%26aulast%3DSwigris%26aufirst%3DJ.%2BJ.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520pirfenidone%2520in%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D2083%26epage%3D2092%26doi%3D10.1056%2FNEJMoa1402582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase: a potential therapeutic target for fibrotic disorders</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.168385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1124%2Fjpet.110.168385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20719940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWgtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=266-272&author=M.+Pangauthor=S.+Zhuang&title=Histone+deacetylase%3A+a+potential+therapeutic+target+for+fibrotic+disorders&doi=10.1124%2Fjpet.110.168385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase: a potential therapeutic target for fibrotic disorders</span></div><div class="casAuthors">Pang, Maoyin; Zhuang, Shougang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-272</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes that balance the acetylation activities of histone acetyltransferases on chromatin remodeling and play essential roles in regulating gene transcription.  In the past several years, the role of HDACs in cancer initiation and progression, as well as the therapeutic effects of HDAC inhibitors in various types of cancer, has been well studied.  Recent studies indicated that HDAC activity is also assocd. with the development and progression of some chronic diseases characterized by fibrosis, including chronic kidney disease, cardiac hypertrophy, and idiopathic pulmonary fibrosis.  Here, we review what is known about HDACs in the progression of tissue fibrosis and the potential applications of HDAC inhibitors in the treatment of disorders assocd. with fibroblast activation and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LH-qEviQW7Vg90H21EOLACvtfcHk0lisT9vzu9WqTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWgtLfL&md5=3d9517a6e247c4b75b99e511c0a5be56</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.168385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.168385%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DM.%26aulast%3DZhuang%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%253A%2520a%2520potential%2520therapeutic%2520target%2520for%2520fibrotic%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D266%26epage%3D272%26doi%3D10.1124%2Fjpet.110.168385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">21065</span>– <span class="NLM_lpage">21073</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802786200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M802786200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18499657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21065-21073&author=B.+Shanauthor=T.+P.+Yaoauthor=H.+T.+Nguyenauthor=Y.+Zhuoauthor=D.+R.+Levyauthor=R.+C.+Klingsbergauthor=H.+Taoauthor=M.+L.+Palmerauthor=K.+N.+Holderauthor=J.+A.+Lasky&title=Requirement+of+HDAC6+for+transforming+growth+factor-beta1-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M802786200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span></div><div class="casAuthors">Shan, Bin; Yao, Tso-pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21065-21073</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aberrant expression of transforming growth factor (TGF)-β1 in the tumor microenvironment and fibrotic lesions plays a crit. role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT).  EMT promotes tumor cell motility and invasiveness.  How EMT affects motility and invasion is not well understood.  Here we report that HDAC6 is a novel modulator of TGF-β1-induced EMT.  HDAC6 is a microtubule-assocd. deacetylase that predominantly deacetylates nonhistone proteins, including α-tubulin, and regulates cell motility.  We showed that TGF-β1-induced EMT is accompanied by HDAC6-dependent deacetylation of α-tubulin.  Importantly, inhibition of HDAC6 by small interfering RNA or the small mol. inhibitor tubacin attenuated the TGF-β1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers.  Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-β1.  Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of α-tubulin as well as the expression of EMT markers.  These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-β-SMAD3 signaling cascade.  Our results identify HDAC6 as a crit. regulator of EMT and a potential therapeutic target against pathol. EMT, a key event for tumor progression and fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcx6lyo8vYbVg90H21EOLACvtfcHk0lhsaR0N5mK9Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D&md5=41e37f298b484fc259266bdc4aa2eff5</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802786200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802786200%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLevy%26aufirst%3DD.%2BR.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPalmer%26aufirst%3DM.%2BL.%26aulast%3DHolder%26aufirst%3DK.%2BN.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DRequirement%2520of%2520HDAC6%2520for%2520transforming%2520growth%2520factor-beta1-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21065%26epage%3D21073%26doi%3D10.1074%2Fjbc.M802786200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwajah, M. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lareu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunath, M.</span></span> <span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1183/09031936.00084808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1183%2F09031936.00084808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19224893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=145-155&author=Z.+Wangauthor=C.+Chenauthor=S.+N.+Fingerauthor=M.+M.+M.+Kwajahauthor=M.+Jungauthor=H.+Schwarzauthor=N.+Swansonauthor=F.+F.+Lareuauthor=M.+Raghunath&title=Suberoylanilide+hydroxamic+acid%3A+a+potential+epigenetic+therapeutic+agent+for+lung+fibrosis%3F&doi=10.1183%2F09031936.00084808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?</span></div><div class="casAuthors">Wang, Z.; Chen, C.; Finger, S. N.; Kwajah, S.; Jung, M.; Schwarz, H.; Swanson, N.; Lareu, R. R.; Raghunath, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-155</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Pulmonary fibrosis represents a fatal stage of interstitial lung diseases of known and idiopathic etiol.  No effective therapy is currently available.  Based on an indication-discovery approach we present novel in vitro evidence that the histone deacetylases inhibitor suberoylanilide hydroxamic acid (SAHA), an FDA approved anti-cancer drug, has antifibrotic and anti-inflammatory potential.  Human lung fibroblasts (fetal, adult and idiopathic adult pulmonary fibrosis) were treated with transforming growth factor (TGF)-β1 with or without SAHA.  Collagen deposition, α-smooth muscle actin (α-SMA) expression, matrix metalloproteinase (MMP)1 activity, tissue inhibitor of MMP (TIMP)1 prodn., apoptosis and cell proliferation were assessed.  Pro-inflammatory cytokines relevant to pulmonary fibrosis were assayed in SAHA-treated human peripheral blood mononuclear cells (PBMC) and its subpopulations.  SAHA abrogated TGF-β1 effects on all the fibroblast lines by preventing their transdifferentiation into α-SMA pos. myofibroblasts and increased collagen deposition without inducing apoptosis.  However, MMP1 activity and TIMP1 prodn. was modulated without a clear fibrolytic effect.  SAHA also inhibited serum-induced proliferation of the fibroblast lines and caused hyperacetylation of α-tubulin and histone.  Cytokine secretion was inhibited from PBMC and lymphocytes at nonapoptotic concns.  Taken together, these data demonstrate combined antifibrotic and anti-inflammatory properties of SAHA, suggesting its therapeutic potential for pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobJkxg4nldAbVg90H21EOLACvtfcHk0lhsaR0N5mK9Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFegsLc%253D&md5=e482cd2845bb8d2e9c9372422ac0c046</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1183%2F09031936.00084808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00084808%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFinger%26aufirst%3DS.%2BN.%26aulast%3DKwajah%26aufirst%3DM.%2BM.%2BM.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DN.%26aulast%3DLareu%26aufirst%3DF.%2BF.%26aulast%3DRaghunath%26aufirst%3DM.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%253A%2520a%2520potential%2520epigenetic%2520therapeutic%2520agent%2520for%2520lung%2520fibrosis%253F%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2009%26volume%3D34%26spage%3D145%26epage%3D155%26doi%3D10.1183%2F09031936.00084808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition</span>. <i>Am. J. Physiol. Lung. Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">L864</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00128.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1152%2Fajplung.00128.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19700647" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=L864-870&author=W.+Guoauthor=B.+Shanauthor=R.+C.+Klingsbergauthor=X.+Qinauthor=J.+A.+Lasky&title=Abrogation+of+TGF-beta1-induced+fibroblast-myofibroblast+differentiation+by+histone+deacetylase+inhibition&doi=10.1152%2Fajplung.00128.2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00128.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00128.2009%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DAbrogation%2520of%2520TGF-beta1-induced%2520fibroblast-myofibroblast%2520differentiation%2520by%2520histone%2520deacetylase%2520inhibition%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung.%2520Cell.%2520Mol.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DL864%26epage%3D870%26doi%3D10.1152%2Fajplung.00128.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coward, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">4325</span>– <span class="NLM_lpage">4339</span>, <span class="refDoi"> DOI: 10.1128/MCB.01776-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.01776-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19487460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=4325-4339&author=W.+R.+Cowardauthor=K.+Wattsauthor=C.+A.+Feghali-Bostwickauthor=A.+Knoxauthor=L.+Pang&title=Defective+histone+acetylation+is+responsible+for+the+diminished+expression+of+cyclooxygenase+2+in+idiopathic+pulmonary+fibrosis&doi=10.1128%2FMCB.01776-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Coward, William R.; Watts, Keiria; Feghali-Bostwick, Carol A.; Knox, Alan; Pang, Linhua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4325-4339</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Diminished cyclooxygenase 2 (COX-2) expression in fibroblasts, with a resultant defect in the prodn. of the antifibrotic mediator prostaglandin E2, plays a key role in the pathogenesis of idiopathic pulmonary fibrosis (IPF).  Here, we have characterized the mol. mechanism.  We found that COX-2 mRNA levels in fibroblasts from patients with IPF (F-IPF) were significantly lower than those in fibroblasts from nonfibrotic lungs (F-NL) after transforming growth factor β1 and interleukin-1β treatment but that COX-2 mRNA degrdn. rates were similar, suggesting defective transcription.  A reporter gene assay showed that there were no clear differences between F-IPF and F-NL in transcription factor involvement and activation in COX-2 gene transcription.  However, a chromatin immunopptn. assay revealed that transcription factor binding to the COX-2 promoter in F-IPF was reduced compared to that in F-NL, an effect that was dynamically linked to reduced histone H3 and H4 acetylation due to decreased recruitment of histone acetyltransferases (HATs) and increased recruitment of transcriptional corepressor complexes to the COX-2 promoter.  The treatment of F-IPF with histone deacetylase (HDAC) inhibitors together with cytokines increased histone H3 and H4 acetylation.  Both HDAC inhibitors and the overexpression of HATs restored cytokine-induced COX-2 mRNA and protein expression in F-IPF.  The results demonstrate that epigenetic abnormality in the form of histone hypoacetylation is responsible for diminished COX-2 expression in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSSnifK3wMbVg90H21EOLACvtfcHk0lhsaR0N5mK9Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFeht70%253D&md5=ba1bd68c4cc1998eba19818585ad7198</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1128%2FMCB.01776-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01776-08%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DW.%2BR.%26aulast%3DWatts%26aufirst%3DK.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%2BA.%26aulast%3DKnox%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DDefective%2520histone%2520acetylation%2520is%2520responsible%2520for%2520the%2520diminished%2520expression%2520of%2520cyclooxygenase%25202%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D4325%26epage%3D4339%26doi%3D10.1128%2FMCB.01776-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coward, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2874</span>– <span class="NLM_lpage">2886</span>, <span class="refDoi"> DOI: 10.1128/MCB.01527-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.01527-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20404089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotFGqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=2874-2886&author=W.+R.+Cowardauthor=K.+Wattsauthor=C.+A.+Feghali-Bostwickauthor=G.+Jenkinsauthor=L.+Pang&title=Repression+of+IP-10+by+interactions+between+histone+deacetylation+and+hypermethylation+in+idiopathic+pulmonary+fibrosis&doi=10.1128%2FMCB.01527-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Coward, William R.; Watts, Keira; Feghali-Bostwick, Carol A.; Jenkins, Gisli; Pang, Linhua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2874-2886</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Targeted repression of a subset of key genes involved in tissue remodeling is a cardinal feature of idiopathic pulmonary fibrosis (IPF).  The mechanism is unclear but is potentially important in disease pathogenesis and therapeutic targeting.  We have previously reported that defective histone acetylation is responsible for the repression of the antifibrotic cyclooxygenase-2 gene.  Here we extended our study to the repression of another antifibrotic gene, the potent angiostatic chemokine gamma interferon (IFN-γ)-inducible protein of 10 kDa (IP-10), in lung fibroblasts from patients with IPF.  We revealed tht this involved not only histone deacetylation, as with cyclooxygenase-2 repression, but also histone H3 hypermethylation, as a result of decreased recruitment of histone acetyltransferases and increased presence of histone deacetylase (HDAC)-contg. repressor complexes, histone methyltransferases G9a and SUV39H1, and heterochromatin protein 1 at the IP-10 promoter, leading to reduced transcription factor binding.  More importantly, treatment of diseased cells with HDAC or G9a inhibitors similarly reversed the repressive histone deacetylation and hypermethylation and restored IP-10 expression.  These findings strongly suggest that epigenetic dysregulation involving interactions between histone deacetylation and hypermethylation is responsible for targeted repression of IP-10 and potentially other antifibrotic genes in fibrotic lung disease and that this is amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriNpAI5yLEcrVg90H21EOLACvtfcHk0lggrc3mAvVn2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotFGqsrk%253D&md5=a809c233f0819967db4dfaadb0493207</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FMCB.01527-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01527-09%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DW.%2BR.%26aulast%3DWatts%26aufirst%3DK.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%2BA.%26aulast%3DJenkins%26aufirst%3DG.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DRepression%2520of%2520IP-10%2520by%2520interactions%2520between%2520histone%2520deacetylation%2520and%2520hypermethylation%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D2874%26epage%3D2886%26doi%3D10.1128%2FMCB.01527-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagood, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambalavanan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1183/09031936.00095113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1183%2F09031936.00095113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24603818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKnu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=1448-1458&author=Y.+Y.+Sandersauthor=J.+S.+Hagoodauthor=H.+Liuauthor=W.+Zhangauthor=N.+Ambalavananauthor=V.+J.+Thannickal&title=Histone+deacetylase+inhibition+promotes+fibroblast+apoptosis+and+ameliorates+pulmonary+fibrosis+in+mice&doi=10.1183%2F09031936.00095113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice</span></div><div class="casAuthors">Sanders, Yan Y.; Hagood, James S.; Liu, Hui; Zhang, Wei; Ambalavanan, Namasivayam; Thannickal, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1448-1458</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a fatal disease, and therapeutic agents have shown only modest efficacy.  Epigenetic alterations contribute to the pathogenesis of IPF.  The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has been approved for clin. use in cancer; however, its potential efficacy in modulating fibroblast survival and lung fibrosis has not been extensively investigated.  We investigated the effects of SAHA on apoptosis of primary IPF myofibroblasts and on injury-induced lung fibrosis in a murine model.  SAHA-induced apoptosis of IPF myofibroblasts, an effect that was mediated, at least in part, by upregulation of the pro-apoptotic gene Bak and downregulation of the anti-apoptotic gene Bcl-xL.  Alterations in the expression of these apoptosis-related genes were assocd. with histone modifications and changes in DNA methylation.  In addn. to the expected higher levels of histone acetylation in treated cells, we also detected changes in other histone modifications, such as histone methylation.  In a murine model of bleomycin-induced pulmonary fibrosis, SAHA-treated mice displayed decreased lung fibrosis and improved lung function compared to the bleomycin only group.  These results suggest that histone deacetylase inhibitors may offer a new therapeutic strategy in IPF by modulating myofibroblast susceptibility to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruyks7TCWdMbVg90H21EOLACvtfcHk0lggrc3mAvVn2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKnu73J&md5=86f2617a181392acfc8040c9449d8102</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1183%2F09031936.00095113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00095113%26sid%3Dliteratum%253Aachs%26aulast%3DSanders%26aufirst%3DY.%2BY.%26aulast%3DHagood%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DAmbalavanan%26aufirst%3DN.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520promotes%2520fibroblast%2520apoptosis%2520and%2520ameliorates%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2014%26volume%3D43%26spage%3D1448%26epage%3D1458%26doi%3D10.1183%2F09031936.00095113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scruggs, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaghy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslona, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters-Golden, M.</span></span> <span> </span><span class="NLM_article-title">Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e621</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2013.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23640463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e621&author=S.+K.+Huangauthor=A.+M.+Scruggsauthor=J.+Donaghyauthor=J.+C.+Horowitzauthor=Z.+Zaslonaauthor=S.+Przybranowskiauthor=E.+S.+Whiteauthor=M.+Peters-Golden&title=Histone+modifications+are+responsible+for+decreased+Fas+expression+and+apoptosis+resistance+in+fibrotic+lung+fibroblasts&doi=10.1038%2Fcddis.2013.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts</span></div><div class="casAuthors">Huang, S. K.; Scruggs, A. M.; Donaghy, J.; Horowitz, J. C.; Zaslona, Z.; Przybranowski, S.; White, E. S.; Peters-Golden, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">e621</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the recruitment of fibroblasts to areas of injury is crit. for wound healing, their subsequent apoptosis is necessary in order to prevent excessive scarring.  Fibroproliferative diseases, such as pulmonary fibrosis, are often characterized by fibroblast resistance to apoptosis, but the mechanism(s) for this resistance remains elusive.  Here, we employed a murine model of pulmonary fibrosis and cells from patients with idiopathic pulmonary fibrosis (IPF) to explore epigenetic mechanisms that may be responsible for the decreased expression of Fas, a cell surface death receptor whose expression has been obsd. to be decreased in pulmonary fibrosis.  Murine pulmonary fibrosis was elicited by intratracheal injection of bleomycin.  Fibroblasts cultured from bleomycin-treated mice exhibited decreased Fas expression and resistance to Fas-mediated apoptosis compared with cells from saline-treated control mice.  Although there were no differences in DNA methylation, the Fas promoter in fibroblasts from bleomycin-treated mice exhibited decreased histone acetylation and increased histone 3 lysine 9 trimethylation (H3K9Me3).  This was assocd. with increased histone deacetylase (HDAC)-2 and HDAC4 expression.  Treatment with HDAC inhibitors increased Fas expression and restored susceptibility to Fas-mediated apoptosis.  Fibroblasts from patients with IPF likewise exhibited decreased histone acetylation and increased H3K9Me3 at the Fas promoter and increased their expression of Fas in the presence of an HDAC inhibitor.  These findings demonstrate the crit. role of histone modifications in the development of fibroblast resistance to apoptosis in both a murine model and in patients with pulmonary fibrosis and suggest novel approaches to therapy for progressive fibroproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolF98lz1dAMLVg90H21EOLACvtfcHk0lggrc3mAvVn2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrsL%252FF&md5=4a37654e2f02707d65643f2d2829c781</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.146%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BK.%26aulast%3DScruggs%26aufirst%3DA.%2BM.%26aulast%3DDonaghy%26aufirst%3DJ.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26aulast%3DZaslona%26aufirst%3DZ.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DPeters-Golden%26aufirst%3DM.%26atitle%3DHistone%2520modifications%2520are%2520responsible%2520for%2520decreased%2520Fas%2520expression%2520and%2520apoptosis%2520resistance%2520in%2520fibrotic%2520lung%2520fibroblasts%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De621%26doi%3D10.1038%2Fcddis.2013.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henneke, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Beck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellusci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2014-206411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fthoraxjnl-2014-206411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26359372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1022-1032&author=M.+Korfeiauthor=S.+Skwarnaauthor=I.+Hennekeauthor=B.+MacKenzieauthor=O.+Klymenkoauthor=S.+Saitoauthor=C.+Ruppertauthor=D.+von+der%0ABeckauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=S.+Bellusciauthor=B.+Crestaniauthor=S.+S.+Pullamsettiauthor=L.+Finkauthor=W.+Seegerauthor=O.+H.+Kramerauthor=A.+Guenther&title=Aberrant+expression+and+activity+of+histone+deacetylases+in+sporadic+idiopathic+pulmonary+fibrosis&doi=10.1136%2Fthoraxjnl-2014-206411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei Martina; Skwarna Sylwia; Henneke Ingrid; MacKenzie BreAnne; Klymenko Oleksiy; von der Beck Daniel; Mahavadi Poornima; Saito Shigeki; Ruppert Clemens; Bellusci Saverio; Seeger Werner; Klepetko Walter; Crestani Bruno; Pullamsetti Soni Savai; Fink Ludger; Kramer Oliver Holger; Guenther Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thorax</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1022-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activation and differentiation of fibroblasts into contractile protein-expressing myofibroblasts and their acquired apoptosis-resistant phenotype are critical factors towards the development of idiopathic pulmonary fibrosis (IPF), a fatal disease characterised by distorted pulmonary structure and excessive extracellular matrix (ECM) deposition.  The molecular mechanisms underlying these processes in IPF remain incompletely understood.  We investigated the possible implication of aberrant overexpression and activity of histone deacetylases (HDACs) in IPF.  METHODS:  We analysed lung tissues from patients with sporadic IPF (n=26) and non-diseased control lungs (n=16) for expression of class I and II HDACs.  Primary IPF fibroblasts were treated with HDAC inhibitors (HDACi) LBH589 or valproic acid (VPA).  RESULTS:  Compared to control lungs, protein levels of class I (HDAC1, HDAC2, HDAC3, HDAC8) and class II HDACs (HDAC4, HDAC 5, HDAC 7, HDAC 9) were significantly elevated in IPF lungs.  Using immunohistochemistry, strong induction of nearly all HDAC enzymes was observed in myofibroblasts of fibroblast foci and in abnormal bronchiolar basal cells at sites of aberrant re-epithelialisation in IPF lungs, but not in controls.  Treatment of primary IPF fibroblasts with the pan-HDACi LBH589 resulted in significantly reduced expression of genes associated with ECM synthesis, proliferation and cell survival, as well as in suppression of HDAC7, and was paralleled by induction of endoplasmic reticulum stress and apoptosis.  The profibrotic and apoptosis-resistant phenotype of IPF fibroblasts was also partly attenuated by the class I HDACi VPA.  CONCLUSIONS:  Aberrant overexpression of HDACs in basal cells of IPF lungs may contribute to the bronchiolisation process in this disease.  Similarly, generation and apoptosis resistance of IPF fibroblasts are mediated by enhanced activity of HDAC enzymes.  Therefore, pan-HDAC inhibition by LBH589 may present a novel therapeutic option for patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJNhSDZx9hyjKfW6udTcc2eaHTbWDusbpG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D&md5=621f4bd5c66ff41ed4c4cbf894644a4a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2014-206411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2014-206411%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DHenneke%26aufirst%3DI.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DKlymenko%26aufirst%3DO.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3Dvon%2Bder%2BBeck%26aufirst%3DD.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DBellusci%26aufirst%3DS.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DAberrant%2520expression%2520and%2520activity%2520of%2520histone%2520deacetylases%2520in%2520sporadic%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DThorax%26date%3D2015%26volume%3D70%26spage%3D1022%26epage%3D1032%26doi%3D10.1136%2Fthoraxjnl-2014-206411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelmaszek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillappagari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0207915</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0207915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0207915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30481203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFSis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0207915&author=M.+Korfeiauthor=D.+Stelmaszekauthor=B.+MacKenzieauthor=S.+Skwarnaauthor=S.+Chillappagariauthor=A.+C.+Bachauthor=C.+Ruppertauthor=S.+Saitoauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=L.+Finkauthor=W.+Seegerauthor=J.+A.+Laskyauthor=S.+S.+Pullamsettiauthor=O.+H.+Kramerauthor=A.+Guenther&title=Comparison+of+the+antifibrotic+effects+of+the+pan-histone+deacetylase-inhibitor+panobinostat+versus+the+IPF-drug+pirfenidone+in+fibroblasts+from+patients+with+idiopathic+pulmonary+fibrosis&doi=10.1371%2Fjournal.pone.0207915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei, Martina; Stelmaszek, Daniel; MacKenzie, BreAnne; Skwarna, Sylwia; Chillappagari, Shashipavan; Bach, Anna C.; Ruppert, Clemens; Saito, Shigeki; Mahavadi, Poornima; Klepetko, Walter; Fink, Ludger; Seeger, Werner; Lasky, Joseph A.; Pullamsetti, Soni S.; Kraemer, Oliver H.; Guenther, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0207915/1-e0207915/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a poor prognosis.  Pirfenidone is the first antifibrotic agent to be approved for IPF-treatment as it is able to slow down disease progression.  However, there is no curative treatment other than lung transplantation.  Because epigenetic alterations are assocd. with IPF, histone deacetylase (HDAC)-inhibitors have recently been proven to attenuate fibrotic remodeling in vitro and in vivo.  This study compared the effects of pirfenidone with the pan-HDAC-inhibitor panobinostat/LBH589, a FDA-approved drug for the treatment of multiple myeloma, head-to-head on survival, fibrotic activity and proliferation of primary IPF-fibroblasts in vitro.  Methods Primary fibroblasts from six IPF-patients were incubated for 24h with vehicle (0.25% DMSO), panobinostat (LBH589, 85 nM) or pirfenidone (2.7 mM), followed by assessment of proliferation and expression analyses for profibrotic and anti-apoptosis genes, as well as for ER stress and apoptosis-markers.  In addn., the expression status of all HDAC enzymes was examd.  Results Treatment of IPF-fibroblasts with panobinostat or pirfenidone resulted in a downregulated expression of various extracellular matrix (ECM)-assocd. genes, as compared to vehicle-treated cells.  In agreement, both drugs decreased protein level of phosphorylated (p)-STAT3, a transcription factor mediating profibrotic responses, in treated IPF-fibroblasts.  Further, an increase in histone acetylation was obsd. in response to both treatments, but was much more pronounced and excessive in panobinostat-treated IPF-fibroblasts.  Panobinostat, but not pirfenidone, led to a significant suppression of proliferation in IPF-fibroblasts, as indicated by WST1- and BrdU assay and markedly diminished levels of cyclin-D1 and p-histone H3.  Furthermore, panobinostat-treatment enhanced α-tubulin-acetylation, decreased the expression of survival-related genes Bcl-XL and BIRC5/survivin, and was assocd. with induction of ER stress and apoptosis in IPF-fibroblasts.  In contrast, pirfenidone-treatment maintained Bcl-XL expression, and was neither assocd. with ER stress-induction nor any apoptotic signaling.  Pirfenidone also led to increased expression of HDAC6 and sirtuin-2, and enhanced α-tubulin-deacetylation.  But in line with its ability to increase histone acetylation, pirfenidone reduced the expression of HDAC enzymes HDAC1, -2 and -9.  Conclusions We conclude that, beside other antifibrotic mechanisms, pirfenidone reduces profibrotic signaling also through STAT3 inactivation and weak epigenetic alterations in IPF-fibroblasts, and permits survival of (altered) fibroblasts.  The pan-HDAC-inhibitor panobinostat reduces profibrotic phenotypes while inducing cell cycle arrest and apoptosis in IPF-fibroblasts, thus indicating more efficiency than pirfenidone in inactivating IPF-fibroblasts.  We therefore believe that HDAC-inhibitors such as panobinostat can present a novel therapeutic strategy for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotQcZ-wK8eKbVg90H21EOLACvtfcHk0ljSe0pMiINKqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFSis7Y%253D&md5=1c7323ccf2557580915815b69bd62fc9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0207915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0207915%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DStelmaszek%26aufirst%3DD.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DChillappagari%26aufirst%3DS.%26aulast%3DBach%26aufirst%3DA.%2BC.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DComparison%2520of%2520the%2520antifibrotic%2520effects%2520of%2520the%2520pan-histone%2520deacetylase-inhibitor%2520panobinostat%2520versus%2520the%2520IPF-drug%2520pirfenidone%2520in%2520fibroblasts%2520from%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0207915%26doi%3D10.1371%2Fjournal.pone.0207915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haitchi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottmann, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2011-0040OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1165%2Frcmb.2011-0040OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22246864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=687-694&author=E.+R.+Daviesauthor=H.+M.+Haitchiauthor=T.+H.+Thatcherauthor=P.+J.+Simeauthor=R.+M.+Kottmannauthor=A.+Ganesanauthor=G.+Packhamauthor=K.+M.+O%E2%80%99Reillyauthor=D.+E.+Davies&title=Spiruchostatin+A+inhibits+proliferation+and+differentiation+of+fibroblasts+from+patients+with+pulmonary+fibrosis&doi=10.1165%2Frcmb.2011-0040OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis</span></div><div class="casAuthors">Davies, Elizabeth R.; Haitchi, Hans Michael; Thatcher, Thomas H.; Sime, Patricia J.; Kottmann, R. Matthew; Ganesan, Arasu; Packham, Graham; O'Reilly, Katherine M. A.; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">687-694</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disorder characterized by the proliferation of interstitial fibroblasts and the deposition of extracellular matrix causing impaired gas exchange.  Spiruchostatin A (SpA) is a histone deacetylase inhibitor (HDI) with selectivity toward Class I enzymes, which distinguishes it from other nonspecific HDIs that are reported to inhibit (myo)fibroblast proliferation and differentiation.  Because the selectivity of HDIs may be important clin., we postulated that SpA inhibits the proliferation and differentiation of IPF fibroblasts.  Primary fibroblasts were grown from lung biopsy explants obtained from patients with IPF or from normal control subjects, using two-dimensional or three-dimensional culture models.  The effect of SpA on fibroproliferation in serum-contg. medium ± transforming growth factor (TGF)-β1 was quantified by methylene blue binding.  The acetylation of histone H3, the expression of the cell-cycle inhibitor p21waf1, and the myofibroblast markers α-smooth muscle actin (α-SMA) and collagens I and III were detd. by Western blotting, quant. RT-PCR, immunofluorescent staining, or colorimetry.  SpA inhibited the proliferation of IPF or normal fibroblasts in a time-dependent and concn.-dependent manner (concn. required to achieve 50% inhibition = 3.8 ± 0.4 nM vs. 7.8 ± 0.2 nM, resp.; P < 0.05), with little cytotoxicity.  Western blot analyses revealed that SpA caused a concn.-dependent increase in histone H3 acetylation, paralleling its antiproliferative effect.  SpA also increased p21waf1 expression, suggesting that direct cell-cycle regulation was the mechanism of inhibiting proliferation.  Although treatment with TGF-β1 induced myofibroblast differentiation assocd. with increased expression of α-SMA, collagen I and collagen III and sol. collagen release, these responses were potently inhibited by SpA.  These data support the concept that bicyclic tetrapeptide HDIs merit further investigation as potential treatments for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopyBhe4I9WE7Vg90H21EOLACvtfcHk0lguLAJVudV2-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyjtLg%253D&md5=a2591a60860a08499af17ce2eef116fa</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0040OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0040OC%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DE.%2BR.%26aulast%3DHaitchi%26aufirst%3DH.%2BM.%26aulast%3DThatcher%26aufirst%3DT.%2BH.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DKottmann%26aufirst%3DR.%2BM.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BM.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DSpiruchostatin%2520A%2520inhibits%2520proliferation%2520and%2520differentiation%2520of%2520fibroblasts%2520from%2520patients%2520with%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D687%26epage%3D694%26doi%3D10.1165%2Frcmb.2011-0040OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conforti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzetani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molyneaux, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorley, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetley, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skipp, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, K. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">48737</span>– <span class="NLM_lpage">48754</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.18632%2Foncotarget.17114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28467787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1crjs1CjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=48737-48754&author=F.+Confortiauthor=E.+R.+Daviesauthor=C.+J.+Calderwoodauthor=T.+H.+Thatcherauthor=M.+G.+Jonesauthor=D.+E.+Smartauthor=S.+Mahajanauthor=A.+Alzetaniauthor=T.+Havelockauthor=T.+M.+Maherauthor=P.+L.+Molyneauxauthor=A.+J.+Thorleyauthor=T.+D.+Tetleyauthor=J.+A.+Warnerauthor=G.+Packhamauthor=A.+Ganesanauthor=P.+J.+Skippauthor=B.+J.+Marshallauthor=L.+Richeldiauthor=P.+J.+Simeauthor=K.+M.+A.+O%E2%80%99Reillyauthor=D.+E.+Davies&title=The+histone+deacetylase+inhibitor%2C+romidepsin%2C+as+a+potential+treatment+for+pulmonary+fibrosis&doi=10.18632%2Foncotarget.17114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis</span></div><div class="casAuthors">Conforti Franco; Davies Elizabeth R; Calderwood Claire J; Jones Mark G; Smart David E; Warner Jane A; Richeldi Luca; Davies Donna E; Conforti Franco; Davies Elizabeth R; Jones Mark G; Smart David E; Havelock Tom; Warner Jane A; Richeldi Luca; O'Reilly Katherine M A; Davies Donna E; Thatcher Thomas H; Sime Patricia J; Mahajan Sumeet; Warner Jane A; Skipp Paul J; Davies Donna E; Alzetani Aiman; Havelock Tom; Marshall Benjamin J; Richeldi Luca; Maher Toby M; Molyneaux Philip L; Maher Toby M; Molyneaux Philip L; Thorley Andrew J; Tetley Teresa D; Packham Graham; Ganesan A; O'Reilly Katherine M A; O'Reilly Katherine M A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">48737-48754</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive disease that usually affects elderly people.  It has a poor prognosis and there are limited therapies.  Since epigenetic alterations are associated with IPF, histone deacetylase (HDAC) inhibitors offer a novel therapeutic strategy to address the unmet medical need.  This study investigated the potential of romidepsin, an FDA-approved HDAC inhibitor, as an anti-fibrotic treatment and evaluated biomarkers of target engagement that may have utility in future clinical trials.  The anti-fibrotic effects of romidepsin were evaluated both in vitro and in vivo together with any harmful effect on alveolar type II cells (ATII).  Bronchoalveolar lavage fluid (BALF) from IPF or control donors was analyzed for the presence of lysyl oxidase (LOX).  In parallel with an increase in histone acetylation, romidepsin potently inhibited fibroblast proliferation, myofibroblast differentiation and LOX expression.  ATII cell numbers and their lamellar bodies were unaffected.  In vivo, romidepsin inhibited bleomycin-induced pulmonary fibrosis in association with suppression of LOX expression.  LOX was significantly elevated in BALF of IPF patients compared to controls.  These data show the anti-fibrotic effects of romidepsin, supporting its potential use as novel treatment for IPF with LOX as a companion biomarker for evaluation of early on-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVn-pfX7PHl-RS7coPn-RtfW6udTcc2eYuYikzsQK1x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjs1CjtA%253D%253D&md5=f30248c911d1fda219d521496d346b2b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17114%26sid%3Dliteratum%253Aachs%26aulast%3DConforti%26aufirst%3DF.%26aulast%3DDavies%26aufirst%3DE.%2BR.%26aulast%3DCalderwood%26aufirst%3DC.%2BJ.%26aulast%3DThatcher%26aufirst%3DT.%2BH.%26aulast%3DJones%26aufirst%3DM.%2BG.%26aulast%3DSmart%26aufirst%3DD.%2BE.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DAlzetani%26aufirst%3DA.%26aulast%3DHavelock%26aufirst%3DT.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DMolyneaux%26aufirst%3DP.%2BL.%26aulast%3DThorley%26aufirst%3DA.%2BJ.%26aulast%3DTetley%26aufirst%3DT.%2BD.%26aulast%3DWarner%26aufirst%3DJ.%2BA.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DSkipp%26aufirst%3DP.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BJ.%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BM.%2BA.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%252C%2520romidepsin%252C%2520as%2520a%2520potential%2520treatment%2520for%2520pulmonary%2520fibrosis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D48737%26epage%3D48754%26doi%3D10.18632%2Foncotarget.17114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henneke, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Beck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellusci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2014-206411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fthoraxjnl-2014-206411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26359372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1022-1032&author=M.+Korfeiauthor=S.+Skwarnaauthor=I.+Hennekeauthor=B.+MacKenzieauthor=O.+Klymenkoauthor=S.+Saitoauthor=C.+Ruppertauthor=D.+von+der%0ABeckauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=S.+Bellusciauthor=B.+Crestaniauthor=S.+S.+Pullamsettiauthor=L.+Finkauthor=W.+Seegerauthor=O.+H.+Kramerauthor=A.+Guenther&title=Aberrant+expression+and+activity+of+histone+deacetylases+in+sporadic+idiopathic+pulmonary+fibrosis&doi=10.1136%2Fthoraxjnl-2014-206411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei Martina; Skwarna Sylwia; Henneke Ingrid; MacKenzie BreAnne; Klymenko Oleksiy; von der Beck Daniel; Mahavadi Poornima; Saito Shigeki; Ruppert Clemens; Bellusci Saverio; Seeger Werner; Klepetko Walter; Crestani Bruno; Pullamsetti Soni Savai; Fink Ludger; Kramer Oliver Holger; Guenther Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thorax</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1022-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activation and differentiation of fibroblasts into contractile protein-expressing myofibroblasts and their acquired apoptosis-resistant phenotype are critical factors towards the development of idiopathic pulmonary fibrosis (IPF), a fatal disease characterised by distorted pulmonary structure and excessive extracellular matrix (ECM) deposition.  The molecular mechanisms underlying these processes in IPF remain incompletely understood.  We investigated the possible implication of aberrant overexpression and activity of histone deacetylases (HDACs) in IPF.  METHODS:  We analysed lung tissues from patients with sporadic IPF (n=26) and non-diseased control lungs (n=16) for expression of class I and II HDACs.  Primary IPF fibroblasts were treated with HDAC inhibitors (HDACi) LBH589 or valproic acid (VPA).  RESULTS:  Compared to control lungs, protein levels of class I (HDAC1, HDAC2, HDAC3, HDAC8) and class II HDACs (HDAC4, HDAC 5, HDAC 7, HDAC 9) were significantly elevated in IPF lungs.  Using immunohistochemistry, strong induction of nearly all HDAC enzymes was observed in myofibroblasts of fibroblast foci and in abnormal bronchiolar basal cells at sites of aberrant re-epithelialisation in IPF lungs, but not in controls.  Treatment of primary IPF fibroblasts with the pan-HDACi LBH589 resulted in significantly reduced expression of genes associated with ECM synthesis, proliferation and cell survival, as well as in suppression of HDAC7, and was paralleled by induction of endoplasmic reticulum stress and apoptosis.  The profibrotic and apoptosis-resistant phenotype of IPF fibroblasts was also partly attenuated by the class I HDACi VPA.  CONCLUSIONS:  Aberrant overexpression of HDACs in basal cells of IPF lungs may contribute to the bronchiolisation process in this disease.  Similarly, generation and apoptosis resistance of IPF fibroblasts are mediated by enhanced activity of HDAC enzymes.  Therefore, pan-HDAC inhibition by LBH589 may present a novel therapeutic option for patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJNhSDZx9hyjKfW6udTcc2eYroI0iyUs4HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D&md5=621f4bd5c66ff41ed4c4cbf894644a4a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2014-206411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2014-206411%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DHenneke%26aufirst%3DI.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DKlymenko%26aufirst%3DO.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3Dvon%2Bder%2BBeck%26aufirst%3DD.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DBellusci%26aufirst%3DS.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DAberrant%2520expression%2520and%2520activity%2520of%2520histone%2520deacetylases%2520in%2520sporadic%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DThorax%26date%3D2015%26volume%3D70%26spage%3D1022%26epage%3D1032%26doi%3D10.1136%2Fthoraxjnl-2014-206411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inomata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishijima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokuho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, A.</span></span> <span> </span><span class="NLM_article-title">XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.pupt.2017.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28315487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=61-69&author=K.+Kamioauthor=A.+Azumaauthor=J.+Usukiauthor=K.+Matsudaauthor=M.+Inomataauthor=N.+Nishijimaauthor=S.+Itakuraauthor=H.+Hayashiauthor=T.+Kashiwadaauthor=N.+Kokuhoauthor=K.+Atsumiauthor=T.+Yamaguchiauthor=K.+Fujitaauthor=Y.+Saitoauthor=S.+Abeauthor=K.+Kubotaauthor=A.+Gemma&title=XPLN+is+modulated+by+HDAC+inhibitors+and+negatively+regulates+SPARC+expression+by+targeting+mTORC2+in+human+lung+fibroblasts&doi=10.1016%2Fj.pupt.2017.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts</span></div><div class="casAuthors">Kamio, Koichiro; Azuma, Arata; Usuki, Jiro; Matsuda, Kuniko; Inomata, Minoru; Nishijima, Nobuhiko; Itakura, Shioto; Hayashi, Hiroki; Kashiwada, Takeru; Kokuho, Nariaki; Atsumi, Kenichiro; Yamaguchi, Tomoyoshi; Fujita, Kazue; Saito, Yoshinobu; Abe, Shinji; Kubota, Kaoru; Gemma, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unclear.  Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that participates in the assembly and turnover of the extracellular matrix, whose expression is regulated by transforming growth factor (TGF)-β1 through activation of mammalian target of rapamycin complex 2 (mTORC2).  Exchange factor found in platelets, leukemic, and neuronal tissues (XPLN) is an endogenous inhibitor of mTORC2.  However, whether XPLN modulates SPARC expression remains unknown.  Herein, we investigated the regulatory mechanisms of XPLN in human lung fibroblasts.  Effect of XPLN on mTORC2 activity was evaluated by silencing XPLN in human fetal lung fibroblasts (HFL-1 cells), using small interfering RNA.  SPARC expression was quantified by quant. real-time RT-PCR and western blotting.  Fibroblasts were treated with TGF-β1, histone deacetylase (HDAC) inhibitors, entinostat, or vorinostat, to assess their effects on XPLN expression.  Moreover, the effect of mTORC1 inhibition on SPARC and XPLN was examd.  XPLN depletion stimulated SPARC expression and Akt phosphorylation on Ser473.  TGF-β1 treatment down-regulated XPLN via Smad 2/3.  XPLN mRNA expression was up-regulated upon treatment with HDAC inhibitors in a concn.-dependent manner, and TGF-β1-induced SPARC expression was reversed by entinostat treatment. mTORC1 inhibition by rapamycin and Raptor depletion stimulated SPARC expression.  In conclusion, this is the first study describing the involvement of XPLN in the regulation of SPARC.  These findings may help uncover the regulatory mechanisms of the mTORC2-SPARC axis.  The up-regulation of XPLN by HDAC inhibitors may be a novel therapeutic approach in patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3owvooqDmErVg90H21EOLACvtfcHk0ljDWXmc3XX1Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWnt7s%253D&md5=d68c0ba0b3dcb8d493898a7e03f689be</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKamio%26aufirst%3DK.%26aulast%3DAzuma%26aufirst%3DA.%26aulast%3DUsuki%26aufirst%3DJ.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DInomata%26aufirst%3DM.%26aulast%3DNishijima%26aufirst%3DN.%26aulast%3DItakura%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKashiwada%26aufirst%3DT.%26aulast%3DKokuho%26aufirst%3DN.%26aulast%3DAtsumi%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DGemma%26aufirst%3DA.%26atitle%3DXPLN%2520is%2520modulated%2520by%2520HDAC%2520inhibitors%2520and%2520negatively%2520regulates%2520SPARC%2520expression%2520by%2520targeting%2520mTORC2%2520in%2520human%2520lung%2520fibroblasts%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D44%26spage%3D61%26epage%3D69%26doi%3D10.1016%2Fj.pupt.2017.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Tubastatin ameliorates pulmonary fibrosis by targeting the TGF-beta-PI3K-Akt pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186615</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0186615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0186615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29045477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186615&author=S.+Saitoauthor=Y.+Zhuangauthor=B.+Shanauthor=S.+Danchukauthor=F.+Luoauthor=M.+Korfeiauthor=A.+Guentherauthor=J.+A.+Lasky&title=Tubastatin+ameliorates+pulmonary+fibrosis+by+targeting+the+TGF-beta-PI3K-Akt+pathway&doi=10.1371%2Fjournal.pone.0186615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span></div><div class="casAuthors">Saito, Shigeki; Zhuang, Yan; Shan, Bin; Danchuk, Svitlana; Luo, Fayong; Korfei, Martina; Guenther, Andreas; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186615/1-e0186615/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease.  Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition).  However, the role of HDAC6 in pulmonary fibrosis is unknown.  Methods HDAC6 expression in IPF and control lungs was assessed by quant. real-time PCR (qRT-PCR) and immunoblots.  Lung fibroblasts were treated with TGF-β1 ± HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots.  Mice were treated with bleomycin (oropharyngeal aspiration; single dose) ± Tubastatin (i.p. injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining.  In a sep. expt., HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner.  Results HDAC6 expression was deregulated in IPF lungs.  Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-β1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) assocn.  Tubastatin repressed TGF-β1-induced S6K phosphorylation, HIF-1α expression, and VEGF expression.  Tubastatin also repressed TGF-β1-induced inhibition of LC3B-II (a marker of autophagosome formation).  In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression.  However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice.  Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-β1-induced collagen expression in lung fibroblasts.  Conclusions HDAC6 expression is altered during lung fibrogenesis.  Tubastatin represses TGF-β1-induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1α-VEGF axis and autophagy.  Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not.  Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGFβ-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorEUu1wcAKXLVg90H21EOLACvtfcHk0ljDWXmc3XX1Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO&md5=67dfcd8dfe9baac9d5273163c2cf3543</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186615%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DDanchuk%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DTubastatin%2520ameliorates%2520pulmonary%2520fibrosis%2520by%2520targeting%2520the%2520TGF-beta-PI3K-Akt%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186615%26doi%3D10.1371%2Fjournal.pone.0186615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. H.</span></span> <span> </span><span class="NLM_article-title">Loss of alpha-tubulin acetylation is associated with TGF-beta-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5405</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.713123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M115.713123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26763233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1GjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=5396-5405&author=S.+Guauthor=Y.+Liuauthor=B.+Zhuauthor=K.+Dingauthor=T.+P.+Yaoauthor=F.+Chenauthor=L.+Zhanauthor=P.+Xuauthor=M.+Ehrlichauthor=T.+Liangauthor=X.+Linauthor=X.+H.+Feng&title=Loss+of+alpha-tubulin+acetylation+is+associated+with+TGF-beta-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M115.713123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition</span></div><div class="casAuthors">Gu, Shuchen; Liu, Yanjing; Zhu, Bowen; Ding, Ke; Yao, Tso-Pang; Chen, Fenfang; Zhan, Lixing; Xu, Pinglong; Ehrlich, Marcelo; Liang, Tingbo; Lin, Xia; Feng, Xin-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5396-5405</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The epithelial-to-mesenchymal transition (EMT) is a process by which differentiated epithelial cells reprogram gene expression, lose their junctions and polarity, reorganize their cytoskeleton, increase cell motility and assume a mesenchymal morphol.  Despite the crit. functions of the microtubule (MT) in cytoskeletal organization, how it participates in EMT induction and maintenance remains poorly understood.  Here we report that acetylated α-tubulin, which plays an important role in microtubule (MT) stabilization and cell morphol., can serve as a novel regulator and marker of EMT.  A high level of acetylated α-tubulin was correlated with epithelial morphol. and it profoundly decreased during TGF-β-induced EMT.  We found that TGF-β increased the activity of HDAC6, a major deacetylase of α-tubulin, without affecting its expression levels.  Treatment with HDAC6 inhibitor tubacin or TGF-β type I receptor inhibitor SB431542 restored the level of acetylated α-tubulin and consequently blocked EMT.  Our results demonstrate that acetylated α-tubulin can serve as a marker of EMT and that HDAC6 represents an important regulator during EMT process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqboOMmwm08rVg90H21EOLACvtfcHk0ljgP0LicGPrqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1GjtLw%253D&md5=4462779365b48d0b9a65440fef03ba11</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.713123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.713123%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DZhan%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DEhrlich%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%2BH.%26atitle%3DLoss%2520of%2520alpha-tubulin%2520acetylation%2520is%2520associated%2520with%2520TGF-beta-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D5396%26epage%3D5405%26doi%3D10.1074%2Fjbc.M115.713123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roach, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutcliffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradding, P.</span></span> <span> </span><span class="NLM_article-title">A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">342</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-18555-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41598-017-18555-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29321510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MzpsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=342&author=K.+M.+Roachauthor=A.+Sutcliffeauthor=L.+Matthewsauthor=G.+Elliottauthor=C.+Newbyauthor=Y.+Amraniauthor=P.+Bradding&title=A+model+of+human+lung+fibrogenesis+for+the+assessment+of+anti-fibrotic+strategies+in+idiopathic+pulmonary+fibrosis&doi=10.1038%2Fs41598-017-18555-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Roach Katy M; Sutcliffe Amanda; Matthews Laura; Elliott Gill; Newby Chris; Amrani Yassine; Bradding Peter</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with limited therapeutic options.  KCa3.1 ion channels play a critical role in TGFβ1-dependent pro-fibrotic responses in human lung myofibroblasts.  We aimed to develop a human lung parenchymal model of fibrogenesis and test the efficacy of the selective KCa3.1 blocker senicapoc. 2 mm(3) pieces of human lung parenchyma were cultured for 7 days in DMEM ± TGFβ1 (10 ng/ml) and pro-fibrotic pathways examined by RT-PCR, immunohistochemistry and collagen secretion.  Following 7 days of culture with TGFβ1, 41 IPF- and fibrosis-associated genes were significantly upregulated.  Immunohistochemical staining demonstrated increased expression of ECM proteins and fibroblast-specific protein after TGFβ1-stimulation.  Collagen secretion was significantly increased following TGFβ1-stimulation.  These pro-fibrotic responses were attenuated by senicapoc, but not by dexamethasone.  This 7 day ex vivo model of human lung fibrogenesis recapitulates pro-fibrotic events evident in IPF and is sensitive to KCa3.1 channel inhibition.  By maintaining the complex cell-cell and cell-matrix interactions of human tissue, and removing cross-species heterogeneity, this model may better predict drug efficacy in clinical trials and accelerate drug development in IPF.  KCa3.1 channels are a promising target for the treatment of IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHd2NrbcVPpmBAiYWy6n3SfW6udTcc2eabOYzk5qj10rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzpsVylsg%253D%253D&md5=5c6c2186e0bbd6d2d9614b757e8f01f2</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-18555-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-18555-9%26sid%3Dliteratum%253Aachs%26aulast%3DRoach%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DG.%26aulast%3DNewby%26aufirst%3DC.%26aulast%3DAmrani%26aufirst%3DY.%26aulast%3DBradding%26aufirst%3DP.%26atitle%3DA%2520model%2520of%2520human%2520lung%2520fibrogenesis%2520for%2520the%2520assessment%2520of%2520anti-fibrotic%2520strategies%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D342%26doi%3D10.1038%2Fs41598-017-18555-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVWqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1817-1828&author=W.+Luauthor=X.+Yaoauthor=P.+Ouyangauthor=N.+Dongauthor=D.+Wuauthor=X.+Jiangauthor=Z.+Wuauthor=C.+Zhangauthor=Z.+Xuauthor=Y.+Tangauthor=S.+Zouauthor=M.+Liuauthor=J.+Liauthor=M.+Zengauthor=P.+Linauthor=F.+Chengauthor=J.+Huang&title=Drug+repurposing+of+histone+deacetylase+inhibitors+that+alleviate+neutrophilic+inflammation+in+acute+lung+injury+and+idiopathic+pulmonary+fibrosis+via+inhibiting+leukotriene+A4+hydrolase+and+blocking+LTB4+biosynthesis&doi=10.1021%2Facs.jmedchem.6b01507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis</span></div><div class="casAuthors">Lu, Weiqiang; Yao, Xue; Ouyang, Ping; Dong, Ningning; Wu, Dang; Jiang, Xingwu; Wu, Zengrui; Zhang, Chen; Xu, Zhongyu; Tang, Yun; Zou, Shien; Liu, Mingyao; Li, Jian; Zeng, Minghua; Lin, Ping; Cheng, Feixiong; Huang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-1828</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) and idiopathic pulmonary fibrosis (IPF) are both serious public health problems with high incidence and mortality rate in adults, and with few drugs available for the efficient treatment in clinic.  In this study, the authors identified that two known histone deacetylase (HDAC) inhibitors, suberanilohydroxamic acid (SAHA, 1) and its analog 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide (2), are effective inhibitors of Leukotriene A4 hydrolase (LTA4H), a key enzyme in the biosynthesis of leukotriene B4 (LTB4), across a panel of 18 HDAC inhibitors, using enzymic assay, thermofluor assay, and x-ray Crystallog. investigation.  Importantly, both 1 and 2 markedly diminish early neutrophilic inflammation in mouse models of ALI and IPF under a clin. safety dose.  Detailed mechanisms of down-regulation of proinflammatory cytokines by 1 or 2 were detd. in vivo.  Collectively, 1 and 2 would provide promising agents with well-known clin. safety for potential treatment in patients with ALI and IPF via pharmacol. inhibiting LAT4H and blocking LTB4 biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZIoiPhzUZBrVg90H21EOLACvtfcHk0lgiLtbgimc08A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVWqurk%253D&md5=a94045bbbe5514eb48b1468b54cac0b5</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01507%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DOuyang%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DDrug%2520repurposing%2520of%2520histone%2520deacetylase%2520inhibitors%2520that%2520alleviate%2520neutrophilic%2520inflammation%2520in%2520acute%2520lung%2520injury%2520and%2520idiopathic%2520pulmonary%2520fibrosis%2520via%2520inhibiting%2520leukotriene%2520A4%2520hydrolase%2520and%2520blocking%2520LTB4%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1817%26epage%3D1828%26doi%3D10.1021%2Facs.jmedchem.6b01507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Giuseppe Campiani, Caterina Cavella, Jeremy D. Osko, Margherita Brindisi, Nicola Relitti, Simone Brogi, A. Prasanth Saraswati, Stefano Federico, Giulia Chemi, Samuele Maramai, Gabriele Carullo, Benedikt Jaeger, Alfonso Carleo, Rosaria Benedetti, Federica Sarno, Stefania Lamponi, Paola Rottoli, Elena Bargagli, Carlo Bertucci, Daniele Tedesco, Daniel Herp, Johanna Senger, Giovina Ruberti, Fulvio Saccoccia, Simona Saponara, Beatrice Gorelli, Massimo Valoti, Breándan Kennedy, Husvinee Sundaramurthi, Stefania Butini, Manfred Jung, Katy M. Roach, Lucia Altucci, Peter Bradding, David W. Christianson, Sandra Gemma, <span class="NLM_string-name hlFld-ContribAuthor">Antje Prasse</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9960-9988. <a href="https://doi.org/10.1021/acs.jmedchem.1c00184" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00184%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHarnessing%252Bthe%252BRole%252Bof%252BHDAC6%252Bin%252BIdiopathic%252BPulmonary%252BFibrosis%25253A%252BDesign%25252C%252BSynthesis%25252C%252BStructural%252BAnalysis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPotent%252BInhibitors%26aulast%3DCampiani%26aufirst%3DGiuseppe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D12072021%26volume%3D64%26issue%3D14%26spage%3D9960%26epage%3D9988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Norberto Sánchez-Cruz, <span class="NLM_string-name hlFld-ContribAuthor">José L. Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic Target Fishing with Accurate Machine Learning Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8208-8220. <a href="https://doi.org/10.1021/acs.jmedchem.1c00020" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEpigenetic%252BTarget%252BFishing%252Bwith%252BAccurate%252BMachine%252BLearning%252BModels%26aulast%3DS%25C3%25A1nchez-Cruz%26aufirst%3DNorberto%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06012021%26date%3D26032021%26volume%3D64%26issue%3D12%26spage%3D8208%26epage%3D8220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng He, C. James Chou, Matthias Scheiner, Eleonora Poeta, Natalia Yuan Chen, Sandra Gunesch, Matthias Hoffmann, Christoph Sotriffer, Barbara Monti, Tangui Maurice, <span class="NLM_string-name hlFld-ContribAuthor">Michael Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3794-3812. <a href="https://doi.org/10.1021/acs.jmedchem.0c01940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMelatonin-%252Band%252BFerulic%252BAcid-Based%252BHDAC6%252BSelective%252BInhibitors%252BExhibit%252BPronounced%252BImmunomodulatory%252BEffects%252BIn%252BVitro%252Band%252BNeuroprotective%252BEffects%252Bin%252Ba%252BPharmacological%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BMouse%252BModel%26aulast%3DHe%26aufirst%3DFeng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09112020%26date%3D26032021%26volume%3D64%26issue%3D7%26spage%3D3794%26epage%3D3812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xin-Hui Zhang, Qin-Ma, Hui-Pan Wu, Mussa Yussuf Khamis, Yi-Han Li, Li-Ying Ma, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Min Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1362-1391. <a href="https://doi.org/10.1021/acs.jmedchem.0c01782" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01782%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BReview%252Bof%252BProgress%252Bin%252BHistone%252BDeacetylase%252B6%252BInhibitors%252BResearch%25253A%252BStructural%252BSpecificity%252Band%252BFunctional%252BDiversity%26aulast%3DZhang%26aufirst%3DXin-Hui%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D01022021%26volume%3D64%26issue%3D3%26spage%3D1362%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Terence C. S. Ho, Alex H. Y. Chan, <span class="NLM_string-name hlFld-ContribAuthor">A. Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12460-12484. <a href="https://doi.org/10.1021/acs.jmedchem.0c00830" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00830%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThirty%252BYears%252Bof%252BHDAC%252BInhibitors%25253A%252B2020%252BInsight%252Band%252BHindsight%26aulast%3DHo%26aufirst%3DTerence%2BC.%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D16072020%26date%3D01072020%26volume%3D63%26issue%3D21%26spage%3D12460%26epage%3D12484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">A. Prasanth Saraswati, Nicola Relitti, Margherita Brindisi, Jeremy D. Osko, Giulia Chemi, Stefano Federico, Alessandro Grillo, Simone Brogi, Niamh H. McCabe, Richard C. Turkington, Ola Ibrahim, Jeffrey O’Sullivan, Stefania Lamponi, Magda Ghanim, Vincent P. Kelly, Daniela Zisterer, Rebecca Amet, Patricia Hannon Barroeta, Francesca Vanni, Cristina Ulivieri, Daniel Herp, Federica Sarno, Antonella Di Costanzo, Fulvio Saccoccia, Giovina Ruberti, Manfred Jung, Lucia Altucci, Sandra Gemma, Stefania Butini, David W. Christianson, <span class="NLM_string-name hlFld-ContribAuthor">Giuseppe Campiani</span>. </span><span class="cited-content_cbyCitation_article-title">Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2268-2276. <a href="https://doi.org/10.1021/acsmedchemlett.0c00395" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00395%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiroindoline-Capped%252BSelective%252BHDAC6%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252BStructural%252BAnalysis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DSaraswati%26aufirst%3DA.%2BPrasanth%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D29092020%26date%3D05102020%26date%3D29092020%26volume%3D11%26issue%3D11%26spage%3D2268%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nina Reßing, Melf Sönnichsen, Jeremy D. Osko, Andrea Schöler, Julian Schliehe-Diecks, Alexander Skerhut, Arndt Borkhardt, Julia Hauer, Matthias U. Kassack, David. W. Christianson, Sanil Bhatia, <span class="NLM_string-name hlFld-ContribAuthor">Finn K. Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Synthesis, Binding Mode, and Structure–Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10339-10351. <a href="https://doi.org/10.1021/acs.jmedchem.9b01888" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01888%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulticomponent%252BSynthesis%25252C%252BBinding%252BMode%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BSelective%252BHistone%252BDeacetylase%252B6%252B%252528HDAC6%252529%252BInhibitors%252Bwith%252BBifurcated%252BCapping%252BGroups%26aulast%3DRe%25C3%259Fing%26aufirst%3DNina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16052020%26date%3D01092020%26date%3D17082020%26volume%3D63%26issue%3D18%26spage%3D10339%26epage%3D10351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gabriele Carullo, Stefano Federico, Nicola Relitti, Sandra Gemma, Stefania Butini, <span class="NLM_string-name hlFld-ContribAuthor">Giuseppe Campiani</span>. </span><span class="cited-content_cbyCitation_article-title">Retinitis Pigmentosa and Retinal Degenerations: Deciphering Pathways and Targets for Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (15)
                                     , 2173-2191. <a href="https://doi.org/10.1021/acschemneuro.0c00358" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00358%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRetinitis%252BPigmentosa%252Band%252BRetinal%252BDegenerations%25253A%252BDeciphering%252BPathways%252Band%252BTargets%252Bfor%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCarullo%26aufirst%3DGabriele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09062020%26date%3D26062020%26date%3D09072020%26date%3D26062020%26volume%3D11%26issue%3D15%26spage%3D2173%26epage%3D2191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorenzo  Flori</span>, <span class="hlFld-ContribAuthor ">Giovanni  Petrarolo</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Concettina  La Motta</span>, <span class="hlFld-ContribAuthor ">Lara  Testai</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Calderone</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel SIRT1 activators endowed with cardioprotective profile. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>165 </em>, 105930. <a href="https://doi.org/10.1016/j.ejps.2021.105930" title="DOI URL">https://doi.org/10.1016/j.ejps.2021.105930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2021.105930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2021.105930%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DIdentification%252Bof%252Bnovel%252BSIRT1%252Bactivators%252Bendowed%252Bwith%252Bcardioprotective%252Bprofile%26aulast%3DFlori%26aufirst%3DLorenzo%26date%3D2021%26volume%3D165%26spage%3D105930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>, <span class="hlFld-ContribAuthor ">Prabal  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Vinylogous Aza‐Michael Addition of Urea Derivatives with
              p
              ‐Quinone Methides Followed by Oxidative Dearomative Cyclization: Approach to Spiroimidazolidinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (11)
                                     , 2813-2824. <a href="https://doi.org/10.1002/adsc.202100077" title="DOI URL">https://doi.org/10.1002/adsc.202100077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100077%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DVinylogous%252BAza%2525E2%252580%252590Michael%252BAddition%252Bof%252BUrea%252BDerivatives%252Bwith%252Bp%252B%2525E2%252580%252590Quinone%252BMethides%252BFollowed%252Bby%252BOxidative%252BDearomative%252BCyclization%25253A%252BApproach%252Bto%252BSpiroimidazolidinone%252BDerivatives%26aulast%3DKaur%26aufirst%3DNavpreet%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D11%26spage%3D2813%26epage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marisa G.  Santibáñez‐Morán</span>, <span class="hlFld-ContribAuthor ">José L.  Medina‐Franco</span>. </span><span class="cited-content_cbyCitation_article-title">The Acid/Base Characterization of Molecules with Epigenetic Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (11)
                                     , 1745-1754. <a href="https://doi.org/10.1002/cmdc.202001009" title="DOI URL">https://doi.org/10.1002/cmdc.202001009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202001009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202001009%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BAcid%25252FBase%252BCharacterization%252Bof%252BMolecules%252Bwith%252BEpigenetic%252BActivity%26aulast%3DSantib%25C3%25A1%25C3%25B1ez%25E2%2580%2590Mor%25C3%25A1n%26aufirst%3DMarisa%2BG.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D11%26spage%3D1745%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qihao  Xu</span>, <span class="hlFld-ContribAuthor ">Yanhua  Mou</span>, <span class="hlFld-ContribAuthor ">Siyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Gao</span>, <span class="hlFld-ContribAuthor ">Yulong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangwei  Xu</span>, <span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Wenlong  Jia</span>, <span class="hlFld-ContribAuthor ">Meihui  Zhang</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of selective histone deacetylase 6 (HDAC6) inhibitors bearing benzoindazole or pyrazoloindazole scaffold as surface recognition motif. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>111 </em>, 104910. <a href="https://doi.org/10.1016/j.bioorg.2021.104910" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104910%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bselective%252Bhistone%252Bdeacetylase%252B6%252B%252528HDAC6%252529%252Binhibitors%252Bbearing%252Bbenzoindazole%252Bor%252Bpyrazoloindazole%252Bscaffold%252Bas%252Bsurface%252Brecognition%252Bmotif%26aulast%3DXu%26aufirst%3DQihao%26date%3D2021%26volume%3D111%26spage%3D104910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Guo</span>, <span class="hlFld-ContribAuthor ">Zixue  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyi  Huang</span>, <span class="hlFld-ContribAuthor ">Qinwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianqi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113383. <a href="https://doi.org/10.1016/j.ejmech.2021.113383" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113383%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbrain%252Bpenetrant%252Bbenzazepine-based%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%252Bfor%252Balleviating%252Bstroke-induced%252Bbrain%252Binfarction%26aulast%3DGuo%26aufirst%3DZheng%26date%3D2021%26volume%3D218%26spage%3D113383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Pedro S. M.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol‐3‐kinase (PI3K): Current and Future Prospects. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 448-457. <a href="https://doi.org/10.1002/cmdc.202000643" title="DOI URL">https://doi.org/10.1002/cmdc.202000643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000643%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMultitarget%252BInhibition%252Bof%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252Band%252BPhosphatidylinositol%2525E2%252580%2525903%2525E2%252580%252590kinase%252B%252528PI3K%252529%25253A%252BCurrent%252Band%252BFuture%252BProspects%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D448%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tam T.  Quach</span>, <span class="hlFld-ContribAuthor ">Harrison J.  Stratton</span>, <span class="hlFld-ContribAuthor ">Rajesh  Khanna</span>, <span class="hlFld-ContribAuthor ">Pappachan E.  Kolattukudy</span>, <span class="hlFld-ContribAuthor ">Jérome  Honnorat</span>, <span class="hlFld-ContribAuthor ">Kathrin  Meyer</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Duchemin</span>. </span><span class="cited-content_cbyCitation_article-title">Intellectual disability: dendritic anomalies and emerging genetic perspectives. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica</span><span> <strong>2021,</strong> <em>141 </em>
                                    (2)
                                     , 139-158. <a href="https://doi.org/10.1007/s00401-020-02244-5" title="DOI URL">https://doi.org/10.1007/s00401-020-02244-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00401-020-02244-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00401-020-02244-5%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%26atitle%3DIntellectual%252Bdisability%25253A%252Bdendritic%252Banomalies%252Band%252Bemerging%252Bgenetic%252Bperspectives%26aulast%3DQuach%26aufirst%3DTam%2BT.%26date%3D2021%26date%3D2020%26volume%3D141%26issue%3D2%26spage%3D139%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Relitti</span>, <span class="hlFld-ContribAuthor ">A. Prasanth  Saraswati</span>, <span class="hlFld-ContribAuthor ">Giulia  Chemi</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Daniel  Herp</span>, <span class="hlFld-ContribAuthor ">Karin  Schmidtkunz</span>, <span class="hlFld-ContribAuthor ">Fulvio  Saccoccia</span>, <span class="hlFld-ContribAuthor ">Giovina  Ruberti</span>, <span class="hlFld-ContribAuthor ">Cristina  Ulivieri</span>, <span class="hlFld-ContribAuthor ">Francesca  Vanni</span>, <span class="hlFld-ContribAuthor ">Federica  Sarno</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>, <span class="hlFld-ContribAuthor ">Stefania  Lamponi</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 112998. <a href="https://doi.org/10.1016/j.ejmech.2020.112998" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112998%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bquinolone-based%252Bpotent%252Band%252Bselective%252BHDAC6%252Binhibitors%25253A%252BSynthesis%25252C%252Bmolecular%252Bmodeling%252Bstudies%252Band%252Bbiological%252Binvestigation%26aulast%3DRelitti%26aufirst%3DNicola%26date%3D2021%26volume%3D212%26spage%3D112998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Jenke</span>, <span class="hlFld-ContribAuthor ">Nina  Reßing</span>, <span class="hlFld-ContribAuthor ">Finn K.  Hansen</span>, <span class="hlFld-ContribAuthor ">Achim  Aigner</span>, <span class="hlFld-ContribAuthor ">Thomas  Büch</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 634. <a href="https://doi.org/10.3390/cancers13040634" title="DOI URL">https://doi.org/10.3390/cancers13040634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040634%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DAnticancer%252BTherapy%252Bwith%252BHDAC%252BInhibitors%25253A%252BMechanism-Based%252BCombination%252BStrategies%252Band%252BFuture%252BPerspectives%26aulast%3DJenke%26aufirst%3DRobert%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Sida  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112887. <a href="https://doi.org/10.1016/j.ejmech.2020.112887" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112887%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMercaptoacetamide%25253A%252BA%252Bpromising%252Bzinc-binding%252Bgroup%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%26aulast%3DTavares%26aufirst%3DMaur%25C3%25ADcio%2BT.%26date%3D2021%26volume%3D209%26spage%3D112887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Pulya</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Swati  Biswas</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC6 as privileged target in drug discovery: A perspective. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>163 </em>, 105274. <a href="https://doi.org/10.1016/j.phrs.2020.105274" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105274%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHDAC6%252Bas%252Bprivileged%252Btarget%252Bin%252Bdrug%252Bdiscovery%25253A%252BA%252Bperspective%26aulast%3DPulya%26aufirst%3DSravani%26date%3D2021%26volume%3D163%26spage%3D105274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoe  Sessions</span>, <span class="hlFld-ContribAuthor ">Norberto  Sánchez-Cruz</span>, <span class="hlFld-ContribAuthor ">Fernando D.  Prieto-Martínez</span>, <span class="hlFld-ContribAuthor ">Vinicius M.  Alves</span>, <span class="hlFld-ContribAuthor ">Hudson P.  Santos</span>, <span class="hlFld-ContribAuthor ">Eugene  Muratov</span>, <span class="hlFld-ContribAuthor ">Alexander  Tropsha</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on cheminformatics approaches to epigenetic drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2268-2276. <a href="https://doi.org/10.1016/j.drudis.2020.09.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.09.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.09.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRecent%252Bprogress%252Bon%252Bcheminformatics%252Bapproaches%252Bto%252Bepigenetic%252Bdrug%252Bdiscovery%26aulast%3DSessions%26aufirst%3DZoe%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2268%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingying  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Yu</span>, <span class="hlFld-ContribAuthor ">Xiying  Hou</span>, <span class="hlFld-ContribAuthor ">Jialu  Li</span>, <span class="hlFld-ContribAuthor ">Tingting  Li</span>, <span class="hlFld-ContribAuthor ">Andong  Qiu</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Shougang  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Renal Physiology</span><span> <strong>2020,</strong> <em>319 </em>
                                    (6)
                                     , F1003-F1014. <a href="https://doi.org/10.1152/ajprenal.00261.2020" title="DOI URL">https://doi.org/10.1152/ajprenal.00261.2020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajprenal.00261.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajprenal.00261.2020%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Renal%2520Physiology%26atitle%3DHistone%252Bdeacetylase%252B6%252Binhibition%252Bmitigates%252Brenal%252Bfibrosis%252Bby%252Bsuppressing%252BTGF-%2525CE%2525B2%252Band%252BEGFR%252Bsignaling%252Bpathways%252Bin%252Bobstructive%252Bnephropathy%26aulast%3DChen%26aufirst%3DXingying%26date%3D2020%26volume%3D319%26issue%3D6%26spage%3DF1003%26epage%3DF1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Luparello</span>, <span class="hlFld-ContribAuthor ">Manuela  Mauro</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Arizza</span>, <span class="hlFld-ContribAuthor ">Mirella  Vazzana</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Deacetylase Inhibitors from Marine Invertebrates. </span><span class="cited-content_cbyCitation_journal-name">Biology</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 429. <a href="https://doi.org/10.3390/biology9120429" title="DOI URL">https://doi.org/10.3390/biology9120429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biology9120429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiology9120429%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%26atitle%3DHistone%252BDeacetylase%252BInhibitors%252Bfrom%252BMarine%252BInvertebrates%26aulast%3DLuparello%26aufirst%3DClaudio%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Pedro de S. M.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Sagrillo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2177-2211. <a href="https://doi.org/10.1002/med.21701" title="DOI URL">https://doi.org/10.1002/med.21701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21701%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistone%252Bdeacetylases%252Bas%252Btargets%252Bfor%252Bthe%252Btreatment%252Bof%252Bneurodegenerative%252Bdisorders%25253A%252BChallenges%252Band%252Bfuture%252Bopportunities%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2177%26epage%3D2211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mona  Dawood</span>, <span class="hlFld-ContribAuthor ">Mohamed  Elbadawi</span>, <span class="hlFld-ContribAuthor ">Madeleine  Böckers</span>, <span class="hlFld-ContribAuthor ">Gerhard  Bringmann</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>129 </em>, 110454. <a href="https://doi.org/10.1016/j.biopha.2020.110454" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110454%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DMolecular%252Bdocking-based%252Bvirtual%252Bdrug%252Bscreening%252Brevealing%252Ban%252Boxofluorenyl%252Bbenzamide%252Band%252Ba%252Bbromonaphthalene%252Bsulfonamido%252Bhydroxybenzoic%252Bacid%252Bas%252BHDAC6%252Binhibitors%252Bwith%252Bcytotoxicity%252Bagainst%252Bleukemia%252Bcells%26aulast%3DDawood%26aufirst%3DMona%26date%3D2020%26volume%3D129%26spage%3D110454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irshad Maajid  Taily</span>, <span class="hlFld-ContribAuthor ">Debarshi  Saha</span>, <span class="hlFld-ContribAuthor ">Prabal  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed regio- and stereoselective access to allyl ureas/carbamates: facile synthesis of imidazolidinones and oxazepinones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (33)
                                     , 6564-6570. <a href="https://doi.org/10.1039/D0OB01514H" title="DOI URL">https://doi.org/10.1039/D0OB01514H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01514H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01514H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalyzed%252Bregio-%252Band%252Bstereoselective%252Baccess%252Bto%252Ballyl%252Bureas%25252Fcarbamates%25253A%252Bfacile%252Bsynthesis%252Bof%252Bimidazolidinones%252Band%252Boxazepinones%26aulast%3DTaily%26aufirst%3DIrshad%2BMaajid%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D33%26spage%3D6564%26epage%3D6570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehab  Ghazy</span>, <span class="hlFld-ContribAuthor ">Patrik  Zeyen</span>, <span class="hlFld-ContribAuthor ">Daniel  Herp</span>, <span class="hlFld-ContribAuthor ">Martin  Hügle</span>, <span class="hlFld-ContribAuthor ">Karin  Schmidtkunz</span>, <span class="hlFld-ContribAuthor ">Frank  Erdmann</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Matthias  Schmidt</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Morales</span>, <span class="hlFld-ContribAuthor ">Christophe  Romier</span>, <span class="hlFld-ContribAuthor ">Stefan  Günther</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112338. <a href="https://doi.org/10.1016/j.ejmech.2020.112338" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112338%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bdual%252Btargeting%252Binhibitors%252Bof%252Bhistone%252Bdeacetylase%252B6%25252F8%252Band%252Bbromodomain%252BBRPF1%26aulast%3DGhazy%26aufirst%3DEhab%26date%3D2020%26volume%3D200%26spage%3D112338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vittoria  Cicaloni</span>, <span class="hlFld-ContribAuthor ">Alessandra  Pecorelli</span>, <span class="hlFld-ContribAuthor ">Laura  Tinti</span>, <span class="hlFld-ContribAuthor ">Marco  Rossi</span>, <span class="hlFld-ContribAuthor ">Mascia  Benedusi</span>, <span class="hlFld-ContribAuthor ">Carlo  Cervellati</span>, <span class="hlFld-ContribAuthor ">Ottavia  Spiga</span>, <span class="hlFld-ContribAuthor ">Annalisa  Santucci</span>, <span class="hlFld-ContribAuthor ">Joussef  Hayek</span>, <span class="hlFld-ContribAuthor ">Laura  Salvini</span>, <span class="hlFld-ContribAuthor ">Cristina  Tinti</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Valacchi</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomic profiling reveals mitochondrial alterations in Rett syndrome. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2020,</strong> <em>155 </em>, 37-48. <a href="https://doi.org/10.1016/j.freeradbiomed.2020.05.014" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2020.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2020.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2020.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DProteomic%252Bprofiling%252Breveals%252Bmitochondrial%252Balterations%252Bin%252BRett%252Bsyndrome%26aulast%3DCicaloni%26aufirst%3DVittoria%26date%3D2020%26volume%3D155%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrui  He</span>, <span class="hlFld-ContribAuthor ">Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Tao  Zhuo</span>, <span class="hlFld-ContribAuthor ">Zi  Hui</span>, <span class="hlFld-ContribAuthor ">Tian  Xie</span>, <span class="hlFld-ContribAuthor ">Xiang-Yang  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019). </span><span class="cited-content_cbyCitation_journal-name">Recent Patents on Anti-Cancer Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 32-48. <a href="https://doi.org/10.2174/1574892815666200217125419" title="DOI URL">https://doi.org/10.2174/1574892815666200217125419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574892815666200217125419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574892815666200217125419%26sid%3Dliteratum%253Aachs%26jtitle%3DRecent%2520Patents%2520on%2520Anti-Cancer%2520Drug%2520Discovery%26atitle%3DNovel%252BSelective%252BHistone%252BDeacetylase%252B6%252B%252528HDAC6%252529%252BInhibitors%25253A%252BA%252BPatent%252BReview%252B%2525282016-2019%252529%26aulast%3DHe%26aufirst%3DXingrui%26date%3D2020%26volume%3D15%26issue%3D1%26spage%3D32%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hajar  Sirous</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Calderone</span>, <span class="hlFld-ContribAuthor ">Giulia  Chemi</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (8)
                                     , 1952. <a href="https://doi.org/10.3390/molecules25081952" title="DOI URL">https://doi.org/10.3390/molecules25081952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25081952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25081952%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComputer-Driven%252BDevelopment%252Bof%252Ban%252Bin%252BSilico%252BTool%252Bfor%252BFinding%252BSelective%252BHistone%252BDeacetylase%252B1%252BInhibitors%26aulast%3DSirous%26aufirst%3DHajar%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D8%26spage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sida  Shen</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 121-136. <a href="https://doi.org/10.1080/13543776.2019.1708901" title="DOI URL">https://doi.org/10.1080/13543776.2019.1708901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1708901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1708901%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%252Bin%252Bneurodegenerative%252Bdiseases%252B%2525282014-2019%252529%26aulast%3DShen%26aufirst%3DSida%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D2%26spage%3D121%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hélène  Losson</span>, <span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 318. <a href="https://doi.org/10.3390/cancers12020318" title="DOI URL">https://doi.org/10.3390/cancers12020318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12020318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12020318%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DHDAC6%2525E2%252580%252594An%252BEmerging%252BTarget%252BAgainst%252BChronic%252BMyeloid%252BLeukemia%25253F%26aulast%3DLosson%26aufirst%3DH%25C3%25A9l%25C3%25A8ne%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0008.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. FDA approved HDAC inhibitors <b>1</b>–<b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HDAC6 structure: domain organization and functions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Interaction of HDAC6 with α-tubulin and HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Interaction of HDAC6 with ubiquitin and tau protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. HDAC6-dependent and independent activation of EMT by TGF-β1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of HDAC inhibitors <b>5</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/medium/jm9b00924_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of HDAC inhibitors <b>11</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b00924/20200106/images/large/jm9b00924_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00924&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 175 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crick, F. H.</span></span> <span> </span><span class="NLM_article-title">Molecular structure of nucleic acids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/171737a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F171737a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=13054692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaG2cXivVGktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=737-738&author=J.+D.+Watsonauthor=F.+H.+Crick&title=Molecular+structure+of+nucleic+acids&doi=10.1038%2F171737a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure of nucleic acids. A structure for deoxyribose nucleic acid</span></div><div class="casAuthors">Watson, J. D.; Crick, F. H. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">737-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">W. and C. propose a new structure for the Na salt of deoxyribose nucleic acid.  This structure, which loosely resembles Furberg's model No. 1 (C.A. 47, 9924g), has 2 helical polynucleotide chains each coiled around the same axis but whose sequence of atoms runs in opposite directions.  The chains are held together by H-bonding between purine and pyrimidine bases, a purine of 1 chain bonded to a pyrimidine of the other.  Full details will be published elsewhere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphu-DopoWzBrVg90H21EOLACvtfcHk0lh-8MrakLUmQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXivVGktA%253D%253D&md5=66b78cf4b12c8c5ced56ff75a9468f35</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F171737a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F171737a0%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DCrick%26aufirst%3DF.%2BH.%26atitle%3DMolecular%2520structure%2520of%2520nucleic%2520acids%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D737%26epage%3D738%26doi%3D10.1038%2F171737a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crick, F.</span></span> <span> </span><span class="NLM_article-title">Central dogma of molecular biology</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">561</span>, <span class="refDoi"> DOI: 10.1038/227561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F227561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=4913914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaE3cXltVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1970&pages=561&author=F.+Crick&title=Central+dogma+of+molecular+biology&doi=10.1038%2F227561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Central dogma of molecular biology</span></div><div class="casAuthors">Crick, Francis H. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">5258</span>),
    <span class="NLM_cas:pages">561-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The history of the central dogma of mol. biol., which states that residue-by-residue transfer of sequential information cannot occur from protein to protein or to nucleic acid, is presented; and the 9 possible transfers are tentatively regrouped into 3 classes:  general, special, and unknown transfers (those postulated by the central dogma).  The general transfers, DNA → DNA (the arrow represents directional flow of detailed sequence information), DNA → RNA, and RNA → protein, are those that can occur in all cells.  Special transfers, RNA → RNA, RNA → DNA, and DNA → protein, may occur in special circumstances.  Unknown transfers, protein → protein, protein → DNA, protein → RNA, the central dogma postulates, never occur.  The current validity of the central dogma is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyCHO3CXZWbVg90H21EOLACvtfcHk0ljhg247ELY9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXltVGgtLw%253D&md5=ed1c1371c5593a29eaab6937a9338f96</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F227561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F227561a0%26sid%3Dliteratum%253Aachs%26aulast%3DCrick%26aufirst%3DF.%26atitle%3DCentral%2520dogma%2520of%2520molecular%2520biology%26jtitle%3DNature%26date%3D1970%26volume%3D227%26spage%3D561%26doi%3D10.1038%2F227561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waddington, C. H.</span></span> <span> </span><span class="NLM_article-title">The epigenotype</span>. <i>Endeavour</i> <span class="NLM_year" style="font-weight: bold;">1942</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1942&pages=18-20&author=C.+H.+Waddington&title=The+epigenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaddington%26aufirst%3DC.%2BH.%26atitle%3DThe%2520epigenotype%26jtitle%3DEndeavour%26date%3D1942%26volume%3D1%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenuwein, T.</span></span> <span> </span><span class="NLM_article-title">The molecular hallmarks of epigenetic control</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">487</span>, <span class="refDoi"> DOI: 10.1038/nrg.2016.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrg.2016.59" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27346641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGiur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=487&author=C.+D.+Allisauthor=T.+Jenuwein&title=The+molecular+hallmarks+of+epigenetic+control&doi=10.1038%2Fnrg.2016.59"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular hallmarks of epigenetic control</span></div><div class="casAuthors">Allis, C. David; Jenuwein, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">487-500</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Over the past 20 years, breakthrough discoveries of chromatin-modifying enzymes and assocd. mechanisms that alter chromatin in response to physiol. or pathol. signals have transformed our knowledge of epigenetics from a collection of curious biol. phenomena to a functionally dissected research field.  Here, we provide a personal perspective on the development of epigenetics, from its historical origins to what we define as 'the modern era of epigenetic research'.  We primarily highlight key mol. mechanisms of and conceptual advances in epigenetic control that have changed our understanding of normal and perturbed development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Q3sD-IHiK7Vg90H21EOLACvtfcHk0ljhg247ELY9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGiur%252FJ&md5=dbbff4b5de8a0316f16664f73f3ad16d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrg.2016.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg.2016.59%26sid%3Dliteratum%253Aachs%26aulast%3DAllis%26aufirst%3DC.%2BD.%26aulast%3DJenuwein%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520hallmarks%2520of%2520epigenetic%2520control%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2016%26volume%3D17%26spage%3D487%26doi%3D10.1038%2Fnrg.2016.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span> <span> </span><span class="NLM_article-title">Mapping human epigenomes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24074860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFenu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2013&pages=39-55&author=C.+M.+Riveraauthor=B.+Ren&title=Mapping+human+epigenomes&doi=10.1016%2Fj.cell.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping human epigenomes</span></div><div class="casAuthors">Rivera, Chloe M.; Ren, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  As the second dimension to the genome, the epigenome contains key information specific to every type of cells.  Thousands of human epigenome maps have been produced in recent years thanks to rapid development of high throughput epigenome mapping technologies.  In this review, we discuss the current epigenome mapping toolkit and utilities of epigenome maps.  We focus particularly on mapping of DNA methylation, chromatin modification state, and chromatin structures, and emphasize the use of epigenome maps to delineate human gene regulatory sequences and developmental programs.  We also provide a perspective on the progress of the epigenomics field and challenges ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriI0hyLI1-SLVg90H21EOLACvtfcHk0ljhg247ELY9Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFenu7zM&md5=3bc3da71a7f0e29af650bed05c55151c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DC.%2BM.%26aulast%3DRen%26aufirst%3DB.%26atitle%3DMapping%2520human%2520epigenomes%26jtitle%3DCell%26date%3D2013%26volume%3D155%26spage%3D39%26epage%3D55%26doi%3D10.1016%2Fj.cell.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mill, J.</span></span> <span> </span><span class="NLM_article-title">Toward an integrated genetic and epigenetic approach to Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1188</span>– <span class="NLM_lpage">1191</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2010.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neurobiolaging.2010.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21497948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlGjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1188-1191&author=J.+Mill&title=Toward+an+integrated+genetic+and+epigenetic+approach+to+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2010.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toward an integrated genetic and epigenetic approach to Alzheimer's disease</span></div><div class="casAuthors">Mill, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1188-1191</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Epigenetics is the study of mitotically heritable, but reversible, changes in gene expression brought about principally through alterations in DNA methylation and chromatin structure.  The comprehensive review by Mastroeni et al. (Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P., Rogers, J., 2010.  Epigenetic mechanisms in Alzheimer's disease.  Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.08.017) in this issue describes mounting evidence for an involvement of epigenetic alterations in the etiol. of Alzheimer's disease (AD), highlighting the potential of epigenomic approaches for uncovering novel mol. pathways involved in pathol.  Here, we briefly describe some methodol. issues related to epigenomic studies using postmortem brain tissue in Alzheimer's disease, and argue for an integrated genetic-epigenetic approach to disease etiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeRo28Vn9PtbVg90H21EOLACvtfcHk0lhVgvPz1H6SAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlGjt78%253D&md5=bc695601b1b18a9b90e0dce57ef6a309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMill%26aufirst%3DJ.%26atitle%3DToward%2520an%2520integrated%2520genetic%2520and%2520epigenetic%2520approach%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D1188%26epage%3D1191%26doi%3D10.1016%2Fj.neurobiolaging.2010.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestler-Parr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesoro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molsen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. A.</span></span> <span> </span><span class="NLM_article-title">Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group</span>. <i>Value Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1016/j.jval.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.jval.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26409619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283msVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=906-914&author=T.+Richterauthor=S.+Nestler-Parrauthor=R.+Babelaauthor=Z.+M.+Khanauthor=T.+Tesoroauthor=E.+Molsenauthor=D.+A.+Hughes&title=Rare+disease+terminology+and+definitions%E2%80%94a+systematic+global+review%3A+report+of+the+ISPOR+rare+disease+special+interest+group&doi=10.1016%2Fj.jval.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group</span></div><div class="casAuthors">Richter Trevor; Nestler-Parr Sandra; Babela Robert; Khan Zeba M; Tesoro Theresa; Molsen Elizabeth; Hughes Dyfrig A</div><div class="citationInfo"><span class="NLM_cas:title">Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">906-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  At present, there is no universal definition of rare disease.  OBJECTIVE:  To provide an overview of rare disease definitions currently used globally.  METHODS:  We systematically searched for definitions related to rare disease from organizations in 32 international jurisdictions.  Descriptive statistics of definitions were generated and prevalence thresholds were calculated.  RESULTS:  We identified 296 definitions from 1109 organizations.  The terms "rare disease(s)" and "orphan drug(s)" were used most frequently (38% and 27% of the definitions, respectively).  Qualitative descriptors such as "life-threatening" were used infrequently.  A prevalence threshold was specified in at least one definition in 88% of the jurisdictions.  The average prevalence threshold across organizations within individual jurisdictions ranged from 5 to 76 cases/100,000 people.  Most jurisdictions (66%) had an average prevalence threshold between 40 and 50 cases/100,000 people, with a global average of 40 cases/100,000 people.  Prevalence thresholds used by different organizations within individual jurisdictions varied substantially.  Across jurisdictions, umbrella patient organizations had the highest (most liberal) average prevalence threshold (47 cases/100,000 people), whereas private payers had the lowest threshold (18 cases/100,000 people).  CONCLUSIONS:  Despite variation in the terminology and prevalence thresholds used to define rare diseases among different jurisdictions and organizations, the terms "rare disease" and "orphan drug" are used most widely and the average prevalence threshold is between 40 and 50 cases/100,000 people.  These findings highlight the existing diversity among definitions of rare diseases, but suggest that any attempts to harmonize rare disease definitions should focus on standardizing objective criteria such as prevalence thresholds and avoid qualitative descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGgRGZSIdH-bGbPKh4T9eAfW6udTcc2ebA7g7pcn7F4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283msVWltg%253D%253D&md5=cf6307a9e73556b7f8399c81e18fb6bf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jval.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jval.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DT.%26aulast%3DNestler-Parr%26aufirst%3DS.%26aulast%3DBabela%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DZ.%2BM.%26aulast%3DTesoro%26aufirst%3DT.%26aulast%3DMolsen%26aufirst%3DE.%26aulast%3DHughes%26aufirst%3DD.%2BA.%26atitle%3DRare%2520disease%2520terminology%2520and%2520definitions%25E2%2580%2594a%2520systematic%2520global%2520review%253A%2520report%2520of%2520the%2520ISPOR%2520rare%2520disease%2520special%2520interest%2520group%26jtitle%3DValue%2520Health%26date%3D2015%26volume%3D18%26spage%3D906%26epage%3D914%26doi%3D10.1016%2Fj.jval.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Institute of Medicine</span>.  <i>Rare
Diseases and Orphan Products: Accelerating Research and Development</i>; <span class="NLM_publisher-name">The National Academies Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2010</span>; p  <span class="NLM_fpage">442</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=442&author=Institute+of+Medicine&title=Rare%0ADiseases+and+Orphan+Products%3A+Accelerating+Research+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DRare%250ADiseases%2520and%2520Orphan%2520Products%253A%2520Accelerating%2520Research%2520and%2520Development%26pub%3DThe%2520National%2520Academies%2520Press%26date%3D2010%26spage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3389%2Ffncel.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24639629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=68&author=X.+Xuauthor=A.+Kozikowskiauthor=L.+Pozzo-Miller&title=A+selective+histone+deacetylase-6+inhibitor+improves+BDNF+trafficking+in+hippocampal+neurons+from+Mecp2+knockout+mice%3A+implications+for+Rett+syndrome&doi=10.3389%2Ffncel.2014.00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span></div><div class="casAuthors">Xu, Xin; Kozikowski, Alan P.; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/9</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by loss-of-function mutations in the transcriptional modulator methyl-CpG-binding protein 2 (MECP2).  One of the most prominent gene targets of MeCP2 is brain-derived neurotrophic factor (Bdnf), a potent modulator of activity-dependent synaptic development, function and plasticity.  Dysfunctional BDNF signaling has been demonstrated in several pathophysiol. mechanisms of RTT disease progression.  To evaluate whether the dynamics of BDNF trafficking is affected by Mecp2 deletion, we analyzed movements of BDNF tagged with yellow fluorescent protein (YFP) in cultured hippocampal neurons by time-lapse fluorescence imaging.  We found that both anterograde and retrograde vesicular trafficking of BDNF-YFP are significantly impaired in Mecp2 knockout hippocampal neurons.  Selective inhibitors of histone deacetylase 6 (HDAC6) show neuroprotective effects in neurodegenerative diseases and stimulate microtubule-dependent vesicular trafficking of BDNF-contg. dense core vesicles.  Here, we show that the selective HDAC6 inhibitor Tubastatin-A increased the velocity of BDNF-YFP vesicles in Mecp2 knockout neurons in both directions by increasing α-tubulin acetylation.  Tubastatin-A also restored activity-dependent BDNF release from Mecp2 knockout neurons to levels comparable to those shown by wildtype neurons.  These findings demonstrate that a selective HDAC6 inhibitor is a potential pharmacol. strategy to reverse cellular and synaptic impairments in RTT resulting from impaired BDNF signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTWjdzmjqurVg90H21EOLACvtfcHk0li3sOALPj4pAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM&md5=ead557e0e05455dd86fa959e7edeb5bc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DA%2520selective%2520histone%2520deacetylase-6%2520inhibitor%2520improves%2520BDNF%2520trafficking%2520in%2520hippocampal%2520neurons%2520from%2520Mecp2%2520knockout%2520mice%253A%2520implications%2520for%2520Rett%2520syndrome%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D68%26doi%3D10.3389%2Ffncel.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amir, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Veyver, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1038/13810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F13810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10508514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=185-188&author=R.+E.+Amirauthor=I.+B.+Van+den+Veyverauthor=M.+Wanauthor=C.+Q.+Tranauthor=U.+Franckeauthor=H.+Y.+Zoghbi&title=Rett+syndrome+is+caused+by+mutations+in+X-linked+MECP2%2C+encoding+methyl-CpG-binding+protein+2&doi=10.1038%2F13810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span></div><div class="casAuthors">Amir, Ruthie E.; Van den Veyver, Ignatia B.; Wan, Mimi; Tran, Charles Q.; Francke, Uta; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-188</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Rett syndrome (RTT, MIM 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females, with an incidence of 1 in 10,000-15,000.  Patients with classic RTT appear to develop normally until 6-18 mo of age, then gradually lose speech and purposeful hand use, and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements.  After initial regression, the condition stabilizes and patients usually survive into adulthood.  As RTT occurs almost exclusively in females, it has been proposed that RTT is caused by an X-linked dominant mutation with lethality in hemizygous males.  Previous exclusion mapping studies using RTT families mapped the locus to Xq28.  Using a systematic gene screening approach, the authors have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT.  MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A.  In 5 of 21 sporadic patients, the authors found 3 de novo missense mutations in the region encoding the highly conserved methyl-binding domain (MBD) as well as a de novo frameshift and a de novo nonsense mutation, both of which disrupt the transcription repression domain (TRD).  In two affected half-sisters of a RTT family, the authors found segregation of an addnl. missense mutation not detected in their obligate carrier mother.  This suggests that the mother is a germline mosaic for this mutation.  The authors' study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yw7uglP4ErVg90H21EOLACvtfcHk0li3sOALPj4pAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D&md5=ca0a168eb91cd1514c38058a1955c289</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F13810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13810%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DR.%2BE.%26aulast%3DVan%2Bden%2BVeyver%26aufirst%3DI.%2BB.%26aulast%3DWan%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DC.%2BQ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DRett%2520syndrome%2520is%2520caused%2520by%2520mutations%2520in%2520X-linked%2520MECP2%252C%2520encoding%2520methyl-CpG-binding%2520protein%25202%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D185%26epage%3D188%26doi%3D10.1038%2F13810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdasco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteller, M.</span></span> <span> </span><span class="NLM_article-title">Genetic syndromes caused by mutations in epigenetic genes</span>. <i>Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1007/s00439-013-1271-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00439-013-1271-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23370504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12ksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=359-383&author=M.+Berdascoauthor=M.+Esteller&title=Genetic+syndromes+caused+by+mutations+in+epigenetic+genes&doi=10.1007%2Fs00439-013-1271-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic syndromes caused by mutations in epigenetic genes</span></div><div class="casAuthors">Berdasco, Maria; Esteller, Manel</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-383</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The orchestrated organization of epigenetic factors that control chromatin dynamism, including DNA methylation, histone marks, non-coding RNAs (ncRNAs) and chromatin-remodeling proteins, is essential for the proper function of tissue homeostasis, cell identity and development.  Indeed, deregulation of epigenetic profiles has been described in several human pathologies, including complex diseases (such as cancer, cardiovascular and neurol. diseases), metabolic pathologies (type 2 diabetes and obesity) and imprinting disorders.  Over the last decade it has become increasingly clear that mutations of genes involved in epigenetic mechanism, such as DNA methyltransferases, methyl-binding domain proteins, histone deacetylases, histone methylases and members of the SWI/SNF family of chromatin remodelers are linked to human disorders, including Immunodeficiency Centromeric instability Facial syndrome 1, Rett syndrome, Rubinstein-Taybi syndrome, Sotos syndrome or alpha-thalassemia/mental retardation X-linked syndrome, among others.  As new members of the epigenetic machinery are described, the no. of human syndromes assocd. with epigenetic alterations increases.  As recent examples, mutations of histone demethylases and members of the non-coding RNA machinery have recently been assocd. with Kabuki syndrome, Claes-Jensen X-linked mental retardation syndrome and Goiter syndrome.  In this review, we describe the variety of germline mutations of epigenetic modifiers that are known to be assocd. with human disorders, and discuss the therapeutic potential of epigenetic drugs as palliative care strategies in the treatment of such disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobmk0XWyUOd7Vg90H21EOLACvtfcHk0li3sOALPj4pAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12ksbk%253D&md5=2c80c7b4c0a2a5c18f18dc5426c9cbbd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00439-013-1271-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-013-1271-x%26sid%3Dliteratum%253Aachs%26aulast%3DBerdasco%26aufirst%3DM.%26aulast%3DEsteller%26aufirst%3DM.%26atitle%3DGenetic%2520syndromes%2520caused%2520by%2520mutations%2520in%2520epigenetic%2520genes%26jtitle%3DHum.%2520Genet.%26date%3D2013%26volume%3D132%26spage%3D359%26epage%3D383%26doi%3D10.1007%2Fs00439-013-1271-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186615</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0186615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0186615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29045477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186615&author=S.+Saitoauthor=Y.+Zhuangauthor=B.+Shanauthor=S.+Danchukauthor=F.+Luoauthor=M.+Korfeiauthor=A.+Guentherauthor=J.+A.+Lasky&title=Tubastatin+ameliorates+pulmonary+fibrosis+by+targeting+the+TGF%CE%B2-PI3K-Akt+pathway&doi=10.1371%2Fjournal.pone.0186615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span></div><div class="casAuthors">Saito, Shigeki; Zhuang, Yan; Shan, Bin; Danchuk, Svitlana; Luo, Fayong; Korfei, Martina; Guenther, Andreas; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186615/1-e0186615/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease.  Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition).  However, the role of HDAC6 in pulmonary fibrosis is unknown.  Methods HDAC6 expression in IPF and control lungs was assessed by quant. real-time PCR (qRT-PCR) and immunoblots.  Lung fibroblasts were treated with TGF-β1 ± HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots.  Mice were treated with bleomycin (oropharyngeal aspiration; single dose) ± Tubastatin (i.p. injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining.  In a sep. expt., HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner.  Results HDAC6 expression was deregulated in IPF lungs.  Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-β1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) assocn.  Tubastatin repressed TGF-β1-induced S6K phosphorylation, HIF-1α expression, and VEGF expression.  Tubastatin also repressed TGF-β1-induced inhibition of LC3B-II (a marker of autophagosome formation).  In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression.  However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice.  Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-β1-induced collagen expression in lung fibroblasts.  Conclusions HDAC6 expression is altered during lung fibrogenesis.  Tubastatin represses TGF-β1-induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1α-VEGF axis and autophagy.  Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not.  Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGFβ-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorEUu1wcAKXLVg90H21EOLACvtfcHk0lgcBaApIhEvuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO&md5=67dfcd8dfe9baac9d5273163c2cf3543</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186615%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DDanchuk%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DTubastatin%2520ameliorates%2520pulmonary%2520fibrosis%2520by%2520targeting%2520the%2520TGF%25CE%25B2-PI3K-Akt%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186615%26doi%3D10.1371%2Fjournal.pone.0186615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. A.</span></span> <span> </span><span class="NLM_article-title">Epigenetics of idiopathic pulmonary fibrosis</span>. <i>Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.trsl.2014.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.trsl.2014.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24746870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1eht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2015&pages=48-60&author=I.+V.+Yangauthor=D.+A.+Schwartz&title=Epigenetics+of+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.trsl.2014.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetics of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Yang, Ivana V.; Schwartz, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">TRRECL</span>;
        ISSN:<span class="NLM_cas:issn">1878-1810</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a complex lung disease of unknown etiol.  Development of IPF is influenced by both genetic and environmental factors.  Recent work by our and other groups has identified strong genetic predisposition factors for the development of pulmonary fibrosis, and cigarette smoke remains the most strongly assocd. environmental exposure risk factor.  Gene expression profiling studies of IPF lung have taught us quite a bit about the biol. of this fatal disease, and those of peripheral blood have provided important biomarkers.  However, epigenetic marks may be the missing link that connects the environmental exposure in genetically predisposed individuals to transcriptional changes assocd. with disease development.  Moreover, epigenetic marks represent a promising therapeutic target for IPF.  In this review, the disease is introduced, genetic and gene expression studies in IPF are summarized, exposures relevant to IPF and known epigenetic changes assocd. with cigarette smoke exposure are discussed, and epigenetic studies conducted so far in IPF are summarized.  Limitations, challenges, and future opportunities in this field are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrucclb9qMiKbVg90H21EOLACvtfcHk0lgcBaApIhEvuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1eht74%253D&md5=f239cc89ca03fb73326c6a285711750d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2014.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2014.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DI.%2BV.%26aulast%3DSchwartz%26aufirst%3DD.%2BA.%26atitle%3DEpigenetics%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DTransl.%2520Res.%26date%3D2015%26volume%3D165%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.trsl.2014.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter-Landsberg, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3028</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2017.415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29048427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e3028&author=J.+Leykauthor=C.+Dalyauthor=U.+Janssen-Bienholdauthor=B.+N.+Kennedyauthor=C.+Richter-Landsberg&title=HDAC6+inhibition+by+tubastatin+A+is+protective+against+oxidative+stress+in+a+photoreceptor+cell+line+and+restores+visual+function+in+a+zebrafish+model+of+inherited+blindness&doi=10.1038%2Fcddis.2017.415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span></div><div class="casAuthors">Leyk, Janina; Daly, Conor; Janssen-Bienhold, Ulrike; Kennedy, Breandan N.; Richter-Landsberg, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e3028</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinal diseases, such as hereditary retinitis pigmentosa and age-related macular degeneration, are characterized by the progressive loss of photoreceptors.  Histone deacetylase 6 (HDAC6) is considered as a stress surveillance factor and a potential target for neuroprotection and regeneration.  Overexpression of HDAC6 has been connected to neurodegenerative disorders, and its suppression may provide protection.  Here we show that HDAC6 is constitutively present in the mouse retina, and in the cone-like mouse cell line 661W.  In 661W cells HDAC6 inhibition by the specific inhibitor tubastatin A (TST) led to the acetylation of α-tubulin, which is a major substrate for HDAC6.  After oxidative stress, exerted by hydrogen peroxide, TST promoted cell survival and the upregulation of heat-shock proteins HSP70 and HSP25 by activation of heat-shock transcription factor 1.  Furthermore, in response to oxidative stress the redox regulatory protein peroxiredoxin 1 (Prx1) was modulated in 661W cells by HDAC6 inhibition.  The peroxide reducing activity of Prx1 is dependent on its acetylation, which is mediated by HDAC6.  Pre-incubation with TST prevented the inactivation of Prx1 and its preserved activity may exert protective effects in photoreceptor cells.  To det. whether TST treatment has a therapeutic effect on visual function, the dyeucd6 zebrafish model of inherited sight loss was utilized.  Zebrafish have developed as a suitable model system for pharmacol. testing.  In vivo application of TST caused the hyperacetylation of α-tubulin, indicating that HDAC6 is active in this model.  Furthermore, TST was sufficient to rescue visual function and retinal morphol.  Hence, HDAC6 inhibition and the regulation of peroxiredoxin activity may play a significant role in protecting retinal cells and in particular photoreceptors, which are exposed to high levels of reactive oxygen species derived from oxidative stress-induced injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltlSmCwk0BrVg90H21EOLACvtfcHk0ljG09gYalK-8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL&md5=d6a6315da7b623e42cc3784dd76cd444</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.415%26sid%3Dliteratum%253Aachs%26aulast%3DLeyk%26aufirst%3DJ.%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26atitle%3DHDAC6%2520inhibition%2520by%2520tubastatin%2520A%2520is%2520protective%2520against%2520oxidative%2520stress%2520in%2520a%2520photoreceptor%2520cell%2520line%2520and%2520restores%2520visual%2520function%2520in%2520a%2520zebrafish%2520model%2520of%2520inherited%2520blindness%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De3028%26doi%3D10.1038%2Fcddis.2017.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot–Marie–Tooth disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs13311-016-0501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27957719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=417-428&author=V.+Benoyauthor=P.+Vanden+Bergheauthor=M.+Jarpeauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=Development+of+improved+HDAC6+inhibitors+as+pharmacological+therapy+for+axonal+Charcot%E2%80%93Marie%E2%80%93Tooth+disease&doi=10.1007%2Fs13311-016-0501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Benoy, Veronick; Vanden Berghe, Pieter; Jarpe, Matthew; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recently, we identified histone deacetylase 6, which deacetylates α-tubulin, as a potential therapeutic target in axonal CMT.  Pharmacol. inhibition of the deacetylating function of HDAC6 reversed the motor and sensory deficits in a mouse model for mutant "small heat shock protein B1"-induced CMT2 at the behavioral and electrophysiol. level.  In order to translate this potential therapeutic strategy into a clin. application, small drug-like mols. that are potent and selective HDAC6 inhibitors are essential.  To screen for these, we developed a method that consisted of 3 distinct phases and that was based on the pathol. findings in the mutant HSPB1-induced CMT2 mouse model.  Three different inhibitors (ACY-738, ACY-775, and ACY-1215) were tested and demonstrated to be both potent and selective HDAC6 inhibitors.  Moreover, these inhibitors increased the innervation of the neuromuscular junctions in the gastrocnemius muscle and improved the motor and sensory nerve conduction, confirming that HDAC6 inhibition is a potential therapeutic strategy in CMT2.  Furthermore, ACY-1215 is an interesting lead mol. as it is currently tested in clin. trials for cancer.  Taken together, these results may speed up the translation of pharmacol. inhibition of HDAC6 into a therapy against CMT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJr47ap41l7Vg90H21EOLACvtfcHk0ljG09gYalK-8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO&md5=cb382132da19455955c1b432cf59aa5e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0501-z%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520improved%2520HDAC6%2520inhibitors%2520as%2520pharmacological%2520therapy%2520for%2520axonal%2520Charcot%25E2%2580%2593Marie%25E2%2580%2593Tooth%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D417%26epage%3D428%26doi%3D10.1007%2Fs13311-016-0501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verreault, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almouzni, G.</span></span> <span> </span><span class="NLM_article-title">Chromatin challenges during DNA replication and repair</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2007.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17320509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=721-733&author=A.+Grothauthor=W.+Rochaauthor=A.+Verreaultauthor=G.+Almouzni&title=Chromatin+challenges+during+DNA+replication+and+repair&doi=10.1016%2Fj.cell.2007.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin challenges during DNA replication and repair</span></div><div class="casAuthors">Groth, Anja; Rocha, Walter; Verreault, Alain; Almouzni, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-733</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Inheritance and maintenance of the DNA sequence and its organization into chromatin are central for eukaryotic life.  To orchestrate DNA-replication and -repair processes in the context of chromatin is a challenge, both in terms of accessibility and maintenance of chromatin organization.  To meet the challenge of maintenance, cells have evolved efficient nucleosome-assembly pathways and chromatin-maturation mechanisms that reproduce chromatin organization in the wake of DNA replication and repair.  The aim of this Review is to describe how these pathways operate and to highlight how the epigenetic landscape may be stably maintained even in the face of dramatic changes in chromatin structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLdiwkoydTZ7Vg90H21EOLACvtfcHk0liLJeDmbvNZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12isr4%253D&md5=d10072a37109161edccac5ba24ef88f5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DGroth%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DW.%26aulast%3DVerreault%26aufirst%3DA.%26aulast%3DAlmouzni%26aufirst%3DG.%26atitle%3DChromatin%2520challenges%2520during%2520DNA%2520replication%2520and%2520repair%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D721%26epage%3D733%26doi%3D10.1016%2Fj.cell.2007.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shahbazian, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunstein, M.</span></span> <span> </span><span class="NLM_article-title">Functions of site-specific histone acetylation and deacetylation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.052705.162114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1146%2Fannurev.biochem.76.052705.162114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17362198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=75-100&author=M.+D.+Shahbazianauthor=M.+Grunstein&title=Functions+of+site-specific+histone+acetylation+and+deacetylation&doi=10.1146%2Fannurev.biochem.76.052705.162114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functions of site-specific histone acetylation and deacetylation</span></div><div class="casAuthors">Shahbazian, Mona D.; Grunstein, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-100</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Histone acetylation regulates many cellular processes, and specific acetylation marks, either singly or in combination, produce distinct outcomes.  For example, the acetylation pattern on newly synthesized histones is important for their assembly into nucleosomes by histone chaperones.  Addnl., the degree of chromatin compaction and folding may be regulated by acetylation of histone H4 at Lys-16.  Histone acetylation also regulates the formation of heterochromatin; deacetylation of H4 Lys-16 is important for the spreading of heterochromatin components, whereas acetylation of this site serves as a barrier to this spreading.  Finally, histone acetylation is crit. for gene transcription, but recent results suggest that deacetylation of certain sites also plays an important role.  There are many histone acetyltransferases (HATs) and deacetylases, with differing preferences for the various histone proteins and for specific sites on individual histones.  Detg. how these enzymes create distinct acetylation patterns and regulate the functional outcome is an important challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2iL3QDzZh-7Vg90H21EOLACvtfcHk0liLJeDmbvNZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7O&md5=51fb46ba44a7f0c614c812baddb4e65e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.052705.162114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.052705.162114%26sid%3Dliteratum%253Aachs%26aulast%3DShahbazian%26aufirst%3DM.%2BD.%26aulast%3DGrunstein%26aufirst%3DM.%26atitle%3DFunctions%2520of%2520site-specific%2520histone%2520acetylation%2520and%2520deacetylation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D75%26epage%3D100%26doi%3D10.1146%2Fannurev.biochem.76.052705.162114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ausió, J.</span></span> <span> </span><span class="NLM_article-title">Effects of histone acetylation on the solubility and folding of the chromatin fiber</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">12764</span>– <span class="NLM_lpage">12768</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100501200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M100501200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11279082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=12764-12768&author=X.+Wangauthor=C.+Heauthor=S.+C.+Mooreauthor=J.+Ausi%C3%B3&title=Effects+of+histone+acetylation+on+the+solubility+and+folding+of+the+chromatin+fiber&doi=10.1074%2Fjbc.M100501200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of histone acetylation on the solubility and folding of the chromatin fiber</span></div><div class="casAuthors">Wang, Xiaoying; He, Cheng; Moore, Susan C.; Ausio, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12764-12768</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The folding ability of chromatin fractions contg. approx. identical nucleosome nos. and the same linker histone compn., but with different extents of core histone acetylation, were analyzed by anal. ultracentrifugation.  It was found that the acetylated fractions consistently exhibited a relatively small but significantly lower extent of compaction than that of their native nonacetylated counterparts.  This was regardless of the extent of the size distribution heterogeneity of the fractions analyzed.  Furthermore the acetylated chromatin fibers exhibited an enhanced soly. in both NaCl and MgCl2, which is neither the result of a differential binding affinity of the linker histones to chromatin nor of an alteration in the relative amts. of the histone H1 variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkairv1oZy6LVg90H21EOLACvtfcHk0liLJeDmbvNZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyntbg%253D&md5=e720255bfeebeb905aa097940fa10e0a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100501200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100501200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DS.%2BC.%26aulast%3DAusi%25C3%25B3%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520histone%2520acetylation%2520on%2520the%2520solubility%2520and%2520folding%2520of%2520the%2520chromatin%2520fiber%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D12764%26epage%3D12768%26doi%3D10.1074%2Fjbc.M100501200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shogren-Knaak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, C. L.</span></span> <span> </span><span class="NLM_article-title">Histone H4-K16 acetylation controls chromatin structure and protein interactions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1126/science.1124000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1124000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16469925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2006&pages=844-847&author=M.+Shogren-Knaakauthor=H.+Ishiiauthor=J.-M.+Sunauthor=M.+J.+Pazinauthor=J.+R.+Davieauthor=C.+L.+Peterson&title=Histone+H4-K16+acetylation+controls+chromatin+structure+and+protein+interactions&doi=10.1126%2Fscience.1124000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions</span></div><div class="casAuthors">Shogren-Knaak, Michael; Ishii, Haruhiko; Sun, Jian-Min; Pazin, Michael J.; Davie, James R.; Peterson, Craig L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">5762</span>),
    <span class="NLM_cas:pages">844-847</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Acetylation of histone H4 on lysine 16 (H4-K16Ac) is a prevalent and reversible posttranslational chromatin modification in eukaryotes.  To characterize the structural and functional role of this mark, we used a native chem. ligation strategy to generate histone H4 that was homogeneously acetylated at K16.  The incorporation of this modified histone into nucleosomal arrays inhibits the formation of compact 30-nm-like fibers and impedes the ability of chromatin to form cross-fiber interactions.  H4-K16Ac also inhibits the ability of the ATP-utilizing chromatin assembly and remodeling enzyme ACF to mobilize a mononucleosome, indicating that this single histone modification modulates both higher order chromatin structure and functional interactions between a nonhistone protein and the chromatin fiber.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqawsTg7m9LQLVg90H21EOLACvtfcHk0lgpxfea5GYuSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFylsLY%253D&md5=c82b2fe14098f9e30a0aba389d11fb67</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1124000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1124000%26sid%3Dliteratum%253Aachs%26aulast%3DShogren-Knaak%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DJ.-M.%26aulast%3DPazin%26aufirst%3DM.%2BJ.%26aulast%3DDavie%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DC.%2BL.%26atitle%3DHistone%2520H4-K16%2520acetylation%2520controls%2520chromatin%2520structure%2520and%2520protein%2520interactions%26jtitle%3DScience%26date%3D2006%26volume%3D311%26spage%3D844%26epage%3D847%26doi%3D10.1126%2Fscience.1124000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldog, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khramtsov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghs, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichenstein, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehested, M.</span></span> <span> </span><span class="NLM_article-title">Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1042/BJ20070779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1042%2FBJ20070779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17868033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2008&pages=581-589&author=N.+Khanauthor=M.+Jeffersauthor=S.+Kumarauthor=C.+Hackettauthor=F.+Boldogauthor=N.+Khramtsovauthor=X.+Qianauthor=E.+Millsauthor=S.+C.+Berghsauthor=N.+Careyauthor=P.+W.+Finnauthor=L.+S.+Collinsauthor=A.+Tumberauthor=J.+W.+Ritchieauthor=P.+B.+Jensenauthor=H.+S.+Lichensteinauthor=M.+Sehested&title=Determination+of+the+class+and+isoform+selectivity+of+small-molecule+histone+deacetylase+inhibitors&doi=10.1042%2FBJ20070779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors</span></div><div class="casAuthors">Khan, Nagma; Jeffers, Michael; Kumar, Sampath; Hackett, Craig; Boldog, Ferenc; Khramtsov, Nicholai; Qian, Xiaozhong; Mills, Evan; Berghs, Stanny C.; Carey, Nessa; Finn, Paul W.; Collins, Laura S.; Tumber, Anthony; Ritchie, James W.; Jensen, Peter Buhl; Lichenstein, Henri S.; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The human HDAC (histone deacetylase) family, a well-validated anticancer target, plays a key role in the control of gene expression through regulation of transcription.  While HDACs can be subdivided into three main classes, the class I, class II and class III HDACs (sirtuins), it is presently unclear whether inhibiting multiple HDACs using pan-HDAC inhibitors, or targeting specific isoforms that show aberrant levels in tumors, will prove more effective as an anticancer strategy in the clinic.  To address the above issues, we have tested a no. of clin. relevant HDACis (HDAC inhibitors) against a panel of rhHDAC (recombinant human HDAC) isoforms.  Eight rhHDACs were expressed using a baculoviral system, and a Fluor de Lys (Biomol International) HDAC assay was optimized for each purified isoform.  The potency and selectivity of ten HDACs on class I isoforms (rhHDAC1, rhHDAC2, rhHDAC3 and rhHDAC8) and class II HDAC isoforms (rhHDAC4, rhHDAC6, rhHDAC7 and rhHDAC9) was detd.  MS-275 was HDAC1-selective, MGCD0103 was HDAC1- and HDAC2-selective, apicidin was HDAC2- and HDAC3-selective and valproic acid was a specific inhibitor of class I HDACs.  The hydroxamic acid-derived compds. (trichostatin A, NVP-LAQ824, panobinostat, ITF2357, vorinostat and belinostat) were potent pan-HDAC inhibitors.  The growth-inhibitory effect of the HDACis on HeLa cells showed that both pan-HDAC and class-I-specific inhibitors inhibited cell growth.  The results also showed that both pan-HDAC and class-I-specific inhibitor treatment resulted in increased acetylation of histones, but only pan-HDAC inhibitor treatment resulted in increased tubulin acetylation, which is in agreement with their activity towards the HDAC6 isoform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHb1RAVCAf77Vg90H21EOLACvtfcHk0lgpxfea5GYuSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSru7o%253D&md5=6d268ef4776d3165c6b0a61179642969</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1042%2FBJ20070779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070779%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJeffers%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHackett%26aufirst%3DC.%26aulast%3DBoldog%26aufirst%3DF.%26aulast%3DKhramtsov%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DBerghs%26aufirst%3DS.%2BC.%26aulast%3DCarey%26aufirst%3DN.%26aulast%3DFinn%26aufirst%3DP.%2BW.%26aulast%3DCollins%26aufirst%3DL.%2BS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DJ.%2BW.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DLichenstein%26aufirst%3DH.%2BS.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520the%2520class%2520and%2520isoform%2520selectivity%2520of%2520small-molecule%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D409%26spage%3D581%26epage%3D589%26doi%3D10.1042%2FBJ20070779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Presegué, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaquero, A.</span></span> <span> </span><span class="NLM_article-title">The dual role of sirtuins in cancer</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1177/1947601911417862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1177%2F1947601911417862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21941620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCgu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=648-662&author=L.+Bosch-Presegu%C3%A9author=A.+Vaquero&title=The+dual+role+of+sirtuins+in+cancer&doi=10.1177%2F1947601911417862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The dual role of sirtuins in cancer</span></div><div class="casAuthors">Bosch-Presegue, Laia; Vaquero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">648-662</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Among the greatest challenges facing organisms is that of detecting and effectively responding to life-threatening environmental changes that are intimately assocd. with metabolic fluctuations and certain forms of stress.  These conditions have been linked to the onset of many human pathologies, including cancer.  Over the past decade, members of the Sir2 family, or sirtuins, have been described as major players in sensing and coordinating stress response.  Evidence has imputed mammalian sirtuins in carcinogenesis, although the mechanisms involved seem to be more diverse and complex than previously anticipated.  Some sirtuins, such as SirT2 and SirT6, seem to work as tumor suppressors, but others, such as SirT1, are apparently bifunctional: operating as both tumor suppressors and oncogenic factors depending on the context and the study conditions.  The mechanisms underlying these apparently contradictory activities are not well understood, although recent findings suggest that they might actually be two sides of the same coin.  In this review, the authors summarize current knowledge on the functional implications of sirtuins in cancer and discuss possible explanations for their functional duality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuaHytg5hPbVg90H21EOLACvtfcHk0lhq3zjI8wQUFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCgu7jP&md5=1ec812b225a9204016a2d10e2b30a949</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1947601911417862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911417862%26sid%3Dliteratum%253Aachs%26aulast%3DBosch-Presegu%25C3%25A9%26aufirst%3DL.%26aulast%3DVaquero%26aufirst%3DA.%26atitle%3DThe%2520dual%2520role%2520of%2520sirtuins%2520in%2520cancer%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D648%26epage%3D662%26doi%3D10.1177%2F1947601911417862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span> <span> </span><span class="NLM_article-title">Sirtuins: critical regulators at the crossroads between cancer and aging</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5489</span>– <span class="NLM_lpage">5504</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.onc.1210616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17694089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFersro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5489-5504&author=L.+Saundersauthor=E.+Verdin&title=Sirtuins%3A+critical+regulators+at+the+crossroads+between+cancer+and+aging&doi=10.1038%2Fsj.onc.1210616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins: critical regulators at the crossroads between cancer and aging</span></div><div class="casAuthors">Saunders, L. R.; Verdin, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5489-5504</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sirtuins (SIRTs 1-7), or class III histone deacetylases (HDACs), are protein deacetylases/ADP ribosyltransferases that target a wide range of cellular proteins in the nucleus, cytoplasm, and mitochondria for post-translational modification by acetylation (SIRT1, -2, -3 and -5) or ADP ribosylation (SIRT4 and -6).  The orthologs of sirtuins in lower organisms play a crit. role in regulating lifespan.  As cancer is a disease of aging, we discuss the growing implications of the sirtuins in protecting against cancer development.  Sirtuins regulate the cellular responses to stress and ensure that damaged DNA is not propagated and that mutations do not accumulate.  SIRT1 also promotes replicative senescence under conditions of chronic stress.  By participating in the stress response to genomic insults, sirtuins are thought to protect against cancer, but they are also emerging as direct participants in the growth of some cancers.  Here, we review the growing implications of sirtuins both in cancer prevention and as specific and novel cancer therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTDJ1i__5BHrVg90H21EOLACvtfcHk0lhq3zjI8wQUFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFersro%253D&md5=d9d7e96428e124991c6fe9bcb9fe55d2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210616%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DSirtuins%253A%2520critical%2520regulators%2520at%2520the%2520crossroads%2520between%2520cancer%2520and%2520aging%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5489%26epage%3D5504%26doi%3D10.1038%2Fsj.onc.1210616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delcuve, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, J. R.</span></span> <span> </span><span class="NLM_article-title">Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/1868-7083-4-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1186%2F1868-7083-4-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22414492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlyqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=5&author=G.+P.+Delcuveauthor=D.+H.+Khanauthor=J.+R.+Davie&title=Roles+of+histone+deacetylases+in+epigenetic+regulation%3A+emerging+paradigms+from+studies+with+inhibitors&doi=10.1186%2F1868-7083-4-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors</span></div><div class="casAuthors">Delcuve, Genevieve P.; Khan, Dilshad H.; Davie, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The zinc-dependent mammalian histone deacetylase (HDAC) family comprises 11 enzymes, which have specific and crit. functions in development and tissue homeostasis.  Mounting evidence points to a link between misregulated HDAC activity and many oncol. and nononcol. diseases.  Thus the development of HDAC inhibitors for therapeutic treatment garners a lot of interest from academic researchers and biotechnol. entrepreneurs.  Numerous studies of HDAC inhibitor specificities and mol. mechanisms of action are ongoing.  In one of these studies, mass spectrometry was used to characterize the affinities and selectivities of HDAC inhibitors toward native HDAC multiprotein complexes in cell exts.  Such a novel approach reproduces in vivo mol. interactions more accurately than std. studies using purified proteins or protein domains as targets and could be very useful in the isolation of inhibitors with superior clin. efficacy and decreased toxicity compared to the ones presently tested or approved.  HDAC inhibitor induced-transcriptional reprogramming, believed to contribute largely to their therapeutic benefits, is achieved through various and complex mechanisms not fully understood, including histone deacetylation, transcription factor or regulator (including HDAC1) deacetylation followed by chromatin remodeling and pos. or neg. outcome regarding transcription initiation.  Although only a very low percentage of protein-coding genes are affected by the action of HDAC inhibitors, about 40% of noncoding microRNAs are upregulated or downregulated.  Moreover, a whole new world of long noncoding RNAs is emerging, revealing a new class of potential targets for HDAC inhibition.  HDAC inhibitors might also regulate transcription elongation and have been shown to impinge on alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobz_EWcDenLbVg90H21EOLACvtfcHk0lgdNQE6gFHVww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlyqtbY%253D&md5=6a9242d0f759866a231a22803dcf46b8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1868-7083-4-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1868-7083-4-5%26sid%3Dliteratum%253Aachs%26aulast%3DDelcuve%26aufirst%3DG.%2BP.%26aulast%3DKhan%26aufirst%3DD.%2BH.%26aulast%3DDavie%26aufirst%3DJ.%2BR.%26atitle%3DRoles%2520of%2520histone%2520deacetylases%2520in%2520epigenetic%2520regulation%253A%2520emerging%2520paradigms%2520from%2520studies%2520with%2520inhibitors%26jtitle%3DClin.%2520Epigenet.%26date%3D2012%26volume%3D4%26spage%3D5%26doi%3D10.1186%2F1868-7083-4-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, I.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibitors as anti-inflammatory agents</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.bjp.0707166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17325655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=829-831&author=I.+Adcock&title=HDAC+inhibitors+as+anti-inflammatory+agents&doi=10.1038%2Fsj.bjp.0707166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitors as anti-inflammatory agents</span></div><div class="casAuthors">Adcock, I. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Diverse cellular functions including the regulation of inflammatory gene expression, DNA repair and cell proliferation are regulated by changes in the acetylation status of histones and non-histone proteins.  Many human diseases, particularly cancer, have been assocd. with altered patterns of histone acetylation.  Furthermore, abnormal expression and activation of histone acetyltransferases, which act as transcriptional co-activators, has been reported in inflammatory diseases.  Histone deacetylase (HDAC) inhibitors have been developed clin. for malignancies due to their effects on apoptosis.  More recently, in vitro and in vivo data indicates that HDAC inhibitors may be anti-inflammatory due to their effects on cell death acting through acetylation of non-histone proteins.  Although there are concerns over the long-term safety of these agents, they may prove useful particularly in situations where current anti-inflammatory therapies are suboptimal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgMCgv5sxZbVg90H21EOLACvtfcHk0lgdNQE6gFHVww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ntL8%253D&md5=9efe612e1b0e8fd5a4d166248e4da8f2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707166%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DI.%26atitle%3DHDAC%2520inhibitors%2520as%2520anti-inflammatory%2520agents%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D829%26epage%3D831%26doi%3D10.1038%2Fsj.bjp.0707166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, P.</span></span> <span> </span><span class="NLM_article-title">Inside HDACs with more selective HDAC inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2016.05.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27318122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWns7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=451-483&author=J.+Rocheauthor=P.+Bertrand&title=Inside+HDACs+with+more+selective+HDAC+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inside HDACs with more selective HDAC inhibitors</span></div><div class="casAuthors">Roche, Joelle; Bertrand, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-483</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Inhibitors of histone deacetylases (HDACs) are nowadays part of the therapeutic arsenal mainly against cancers, with four compds. approved by the Food and Drug Administration.  During the last five years, several groups have made continuous efforts to improve this class of compds., designing more selective compds. or compds. with multiple capacities.  After a survey of the HDAC biol. and structures, this review summarizes the results of the chemists working in this field, and highlights when possible the behavior of the mols. inside their targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHO5YBuaN7c7Vg90H21EOLACvtfcHk0lgdNQE6gFHVww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWns7%252FI&md5=3bbd062c1fb8a402c039e20bacd4af14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DJ.%26aulast%3DBertrand%26aufirst%3DP.%26atitle%3DInside%2520HDACs%2520with%2520more%2520selective%2520HDAC%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483%26doi%3D10.1016%2Fj.ejmech.2016.05.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1111/febs.12079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Ffebs.12079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23181831" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2012&pages=775-793&author=Y.+Liauthor=D.+Shinauthor=S.+H.+Kwon&title=Histone+deacetylase+6+plays+a+role+as+a+distinct+regulator+of+diverse+cellular+processes&doi=10.1111%2Ffebs.12079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12079%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26atitle%3DHistone%2520deacetylase%25206%2520plays%2520a%2520role%2520as%2520a%2520distinct%2520regulator%2520of%2520diverse%2520cellular%2520processes%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D280%26spage%3D775%26epage%3D793%26doi%3D10.1111%2Ffebs.12079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, C. A. M.</span></span> <span> </span><span class="NLM_article-title">Beyond the selective inhibition of histone deacetylase 6</span>. <i>Mini. Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160428115959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.2174%2F1389557516666160428115959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27121714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1175-1184&author=D.+A.+Rodriguesauthor=S.+Thotaauthor=C.+A.+M.+Fraga&title=Beyond+the+selective+inhibition+of+histone+deacetylase+6&doi=10.2174%2F1389557516666160428115959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Selective Inhibition of Histone Deacetylase 6</span></div><div class="casAuthors">Rodrigues, Daniel A.; Thota, Sreekanth; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) catalyzes the removal of acetyl groups from the lysine residues of a series of non-histone proteins, e.g., -tubulin, Hsp90 and cortactin.  HDAC6 is a unique deacetylase enzyme that is related to various processes that may be important in oncol., immunol. and neurol. fields, which makes the study of selective inhibitors extremely important to understand the function of this enzyme and to validate HDAC6 as a drug target through the development of clin. candidates.  Therefore, this review describes the structure-activity and structureselectivity relationships of HDAC6 inhibitors, which were divided into two main classes, bulky and lipophilic cap groups and inhibitors with Ph linkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbHYjlHhuAC7Vg90H21EOLACvtfcHk0lirz24oqjXAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnM&md5=fe940915b5ff69c061d09fd7ad129d87</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160428115959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160428115959%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DBeyond%2520the%2520selective%2520inhibition%2520of%2520histone%2520deacetylase%25206%26jtitle%3DMini.%2520Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1175%26epage%3D1184%26doi%3D10.2174%2F1389557516666160428115959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span> <span> </span><span class="NLM_article-title">Two catalytic domains are required for protein deacetylation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">2401</span>– <span class="NLM_lpage">2404</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500241200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C500241200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16272578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=2401-2404&author=Y.+Zhangauthor=B.+Gilquinauthor=S.+Khochbinauthor=P.+Matthias&title=Two+catalytic+domains+are+required+for+protein+deacetylation&doi=10.1074%2Fjbc.C500241200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two Catalytic Domains Are Required for Protein Deacetylation</span></div><div class="casAuthors">Zhang, Yu; Gilquin, Benoit; Khochbin, Saadi; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2401-2404</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC)-6 was recently identified as a dual substrate, possibly multisubstrate, deacetylase that can act both on acetylated histone tails and on α-tubulin acetylated on Lys40.  HDAC-6 is unique among deacetylases in having two hdac domains, and we have used this enzyme as a useful model to dissect the structural requirements for the deacetylation reaction.  In this report, we show that both hdac domains are required for the intact deacetylase activity of HDAC-6 in vitro and in vivo.  The spatial arrangement of these two domains in HDAC-6 is essential and alteration of the linker region between the two domains severely affects the catalytic activity.  Artificial chimeric HDACs, made by replacing the hdac domains in HDAC-6 with corresponding domains from other class II HDACs, show de novo deacetylase activity.  Taken together, our results demonstrate for the first time that the spatial arrangement of hdac domains is crit. for in vivo deacetylation reaction and may provide a useful model for the development of novel HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwsRUedc-X1LVg90H21EOLACvtfcHk0lirz24oqjXAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVaruw%253D%253D&md5=7d7a32194709c18c0870e93022585624</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500241200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500241200%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DKhochbin%26aufirst%3DS.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DTwo%2520catalytic%2520domains%2520are%2520required%2520for%2520protein%2520deacetylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D2401%26epage%3D2404%26doi%3D10.1074%2Fjbc.C500241200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozinger, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassig, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Three proteins define a class of human histone deacetylases related to yeast Hda1p</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">4868</span>– <span class="NLM_lpage">4873</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.9.4868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.96.9.4868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10220385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4868-4873&author=C.+M.+Grozingerauthor=C.+A.+Hassigauthor=S.+L.+Schreiber&title=Three+proteins+define+a+class+of+human+histone+deacetylases+related+to+yeast+Hda1p&doi=10.1073%2Fpnas.96.9.4868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Three proteins define a class of human histone deacetylases related to yeast Hda1p</span></div><div class="casAuthors">Grozinger, Christina M.; Hassig, Christian A.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4868-4873</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene expression is in part controlled by chromatin remodeling factors and the acetylation state of nucleosomal histones.  The latter process is regulated by histone acetyltransferases and histone deacetylases (HDACs).  Previously, three human and five yeast HDAC enzymes had been identified.  These can be categorized into two classes: the first class represented by yeast Rpd3-like proteins and the second by yeast Hda1-like proteins.  Human HDAC1, HDAC2, and HDAC3 proteins are members of the first class, whereas no class II human HDAC proteins had been identified.  The amino acid sequence of Hda1p was used to search the GenBank/expressed sequence tag databases to identify partial sequences from three putative class II human HDAC proteins.  The corresponding full-length cDNAs were cloned and defined as HDAC4, HDAC5, and HDAC6.  These proteins possess certain features present in the conserved catalytic domains of class I human HDACs, but also contain addnl. sequence domains.  Interestingly, HDAC6 contains an internal duplication of two catalytic domains, which appear to function independently of each other.  These class II HDAC proteins have differential mRNA expression in human tissues and possess in vitro HDAC activity that is inhibited by trichostatin A.  Coimmunopptn. expts. indicate that these HDAC proteins are not components of the previously identified HDAC1 and HDAC2 NRD and mSin3A complexes.  However, HDAC4 and HDAC5 assoc. with HDAC3 in vivo.  This finding suggests that the human class II HDAC enzymes may function in cellular processes distinct from those of HDAC1 and HDAC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcejIcOOdQtrVg90H21EOLACvtfcHk0lgbDvbKqHnMyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVKms7s%253D&md5=923a1617e1ed850f39fb5247e6baf14f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.9.4868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.9.4868%26sid%3Dliteratum%253Aachs%26aulast%3DGrozinger%26aufirst%3DC.%2BM.%26aulast%3DHassig%26aufirst%3DC.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DThree%2520proteins%2520define%2520a%2520class%2520of%2520human%2520histone%2520deacetylases%2520related%2520to%2520yeast%2520Hda1p%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D4868%26epage%3D4873%26doi%3D10.1073%2Fpnas.96.9.4868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.-C.</span></span> <span> </span><span class="NLM_article-title">Characterization of the two catalytic domains in histone deacetylase 6</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.12.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.bbrc.2005.12.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16412385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2006&pages=45-50&author=H.+Zouauthor=Y.+Wuauthor=M.+Navreauthor=B.-C.+Sang&title=Characterization+of+the+two+catalytic+domains+in+histone+deacetylase+6&doi=10.1016%2Fj.bbrc.2005.12.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the two catalytic domains in histone deacetylase 6</span></div><div class="casAuthors">Zou, Hua; Wu, Yiqin; Navre, Marc; Sang, Bi-Ching</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-50</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is the only known HDAC with two potentially functional catalytic domains, yet the role towards substrate played by these two domains remains ambiguous.  Most studies report HDAC6 activities measured using either immune complexes or in vitro translated products.  Here, we characterize the activity of highly purified recombinant HDAC6, mutants with active site histidine mutations in each domain (H216A and H611A), and individual catalytic domains.  The deacetylase activities of these proteins, as well as their kinetic parameters, were measured using histone, α-tubulin, and fluorogenic acetylated lysine as substrates.  Mutant H216A only slightly lowers the catalytic rate.  However, mutant H611A decreases the catalytic rate more than 5000-fold.  The first domain expressed alone is not catalytically active.  In contrast, the second domain shows only a modest decrease in substrate binding and product formation rate.  Our results indicate that the in vitro deacetylase activity of HDAC6 resides in the C-terminal second catalytic domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ljQmtqSmN7Vg90H21EOLACvtfcHk0lgbDvbKqHnMyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslygtg%253D%253D&md5=160f566a8fdd2756e398869647e54fe7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.12.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.12.144%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DSang%26aufirst%3DB.-C.%26atitle%3DCharacterization%2520of%2520the%2520two%2520catalytic%2520domains%2520in%2520histone%2520deacetylase%25206%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D341%26spage%3D45%26epage%3D50%26doi%3D10.1016%2Fj.bbrc.2005.12.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seigneurin-Berny, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">8035</span>– <span class="NLM_lpage">8044</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.23.8035-8044.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.21.23.8035-8044.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11689694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotl2gtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=8035-8044&author=D.+Seigneurin-Bernyauthor=A.+Verdelauthor=S.+Curtetauthor=C.+Lemercierauthor=J.+Garinauthor=S.+Rousseauxauthor=S.+Khochbin&title=Identification+of+components+of+the+murine+histone+deacetylase+6+complex%3A+link+between+acetylation+and+ubiquitination+signaling+pathways&doi=10.1128%2FMCB.21.23.8035-8044.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways</span></div><div class="casAuthors">Seigneurin-Berny, Daphne; Verdel, Andre; Curtet, Sandrine; Lemercier, Claudie; Garin, Jerome; Rousseaux, Sophie; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8035-8044</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The immunopurifn. of the endogenous cytoplasmic murine histone deacetylase 6 (mHDAC6), a member of the class II HDACs, from mouse testis cytosolic exts. allowed the identification of two assocd. proteins.  Both were mammalian homologues of yeast proteins known to interact with each other and involved in the ubiquitin signaling pathway: p97/VCP/Cdc48p, a homolog of yeast Cdc48p, and phospholipase A2-activating protein, a homolog of yeast UFD3 (ubiquitin fusion degrdn. protein 3).  Moreover, in the C-terminal region of mHDAC6, a conserved zinc finger-contg. domain named ZnF-UBP, also present in several ubiquitin-specific proteases, was discovered and was shown to mediate the specific binding of ubiquitin by mHDAC6.  By using a ubiquitin pull-down approach, nine major ubiquitin-binding proteins were identified in mouse testis cytosolic exts., and mHDAC6 was found to be one of them.  All of these findings strongly suggest that mHDAC6 could be involved in the control of protein ubiquitination.  The investigation of biochem. properties of the mHDAC6 complex in vitro further supported this hypothesis and clearly established a link between protein acetylation and protein ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr46PPvjekckbVg90H21EOLACvtfcHk0lgbDvbKqHnMyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotl2gtLs%253D&md5=82eccf722f2702e987e74d2fb5138c2b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.23.8035-8044.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.23.8035-8044.2001%26sid%3Dliteratum%253Aachs%26aulast%3DSeigneurin-Berny%26aufirst%3DD.%26aulast%3DVerdel%26aufirst%3DA.%26aulast%3DCurtet%26aufirst%3DS.%26aulast%3DLemercier%26aufirst%3DC.%26aulast%3DGarin%26aufirst%3DJ.%26aulast%3DRousseaux%26aufirst%3DS.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520components%2520of%2520the%2520murine%2520histone%2520deacetylase%25206%2520complex%253A%2520link%2520between%2520acetylation%2520and%2520ubiquitination%2520signaling%2520pathways%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D8035%26epage%3D8044%26doi%3D10.1128%2FMCB.21.23.8035-8044.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hook, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, R. N.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">13425</span>– <span class="NLM_lpage">13430</span>, <span class="refDoi"> DOI: 10.1073/pnas.172511699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.172511699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12354939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13425-13430&author=S.+S.+Hookauthor=A.+Orianauthor=S.+M.+Cowleyauthor=R.+N.+Eisenman&title=Histone+deacetylase+6+binds+polyubiquitin+through+its+zinc+finger+%28PAZ+domain%29+and+copurifies+with+deubiquitinating+enzymes&doi=10.1073%2Fpnas.172511699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes</span></div><div class="casAuthors">Hook, Sara S.; Orian, Amir; Cowley, Shaun M.; Eisenman, Robert N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13425-13430</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are thought to function as crit. mediators of transcriptional repression.  However, the physiol. targets and posttranslational modifications of the class II HDACs are largely unknown.  Here we show that the C terminus of HDAC 6 is both necessary and sufficient for specific assocn. with polyubiquitin.  This region contains a putative zinc finger but lacks significant similarity to other known ubiquitin binding domains.  Thus, we have designated this region as a PAZ domain, for Polyubiquitin Assocd. Zinc finger.  Although the PAZ domain possesses homol. with the zinc finger of deubiquitinating enzymes, it is dispensable for the deubiquitinating activity we find assocd. with HDAC6 following immunopurifn.  We also show that both HDAC 5 and HDAC 6 are ubiquitinated in vitro and in vivo.  However, both of these proteins are stable in vivo and do not appear to be targeted for rapid degrdn. by the proteasome.  Thus, HDAC6 is linked to the ubiquitin system via ubiquitin conjugation, polyubiquitin binding, and copurifn. with deubiquitinating enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo98Vuze3Eua7Vg90H21EOLACvtfcHk0lh7eeYQE0GwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKmsrw%253D&md5=1000bc2fc966f1d66c7198364691bc80</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172511699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172511699%26sid%3Dliteratum%253Aachs%26aulast%3DHook%26aufirst%3DS.%2BS.%26aulast%3DOrian%26aufirst%3DA.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DEisenman%26aufirst%3DR.%2BN.%26atitle%3DHistone%2520deacetylase%25206%2520binds%2520polyubiquitin%2520through%2520its%2520zinc%2520finger%2520%2528PAZ%2520domain%2529%2520and%2520copurifies%2520with%2520deubiquitinating%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13425%26epage%3D13430%26doi%3D10.1073%2Fpnas.172511699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. M.</span></span> <span> </span><span class="NLM_article-title">Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">146493</span>, <span class="refDoi"> DOI: 10.1155/2011/146493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2011%2F146493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21234400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M7hsFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=146493&author=Y.+L.+Yaoauthor=W.+M.+Yang&title=Beyond+histone+and+deacetylase%3A+an+overview+of+cytoplasmic+histone+deacetylases+and+their+nonhistone+substrates&doi=10.1155%2F2011%2F146493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates</span></div><div class="casAuthors">Yao Ya-Li; Yang Wen-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146493</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylation of lysines is a prominent form of modification in mammalian proteins.  Deacetylation of proteins is catalyzed by histone deacetylases, traditionally named after their role in histone deacetylation, transcriptional modulation, and epigenetic regulation.  Despite the link between histone deacetylases and chromatin structure, some of the histone deacetylases reside in various compartments in the cytoplasm.  Here, we review how these cytoplasmic histone deacetylases are regulated, the identification of nonhistone substrates, and the functional implications of their nondeacetylase enzymatic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR4UMp7VaIC6qx48Rj5GnGofW6udTcc2ebpVB8aUPvNl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7hsFajtQ%253D%253D&md5=bedcf26e85122904932428ec42166e3d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1155%2F2011%2F146493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F146493%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DW.%2BM.%26atitle%3DBeyond%2520histone%2520and%2520deacetylase%253A%2520an%2520overview%2520of%2520cytoplasmic%2520histone%2520deacetylases%2520and%2520their%2520nonhistone%2520substrates%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2011%26volume%3D2011%26spage%3D146493%26doi%3D10.1155%2F2011%2F146493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin</span>. <i>Protein Pept. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.2174/092986610791112620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.2174%2F092986610791112620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19961433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVahtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=555-558&author=Z.+Zhaoauthor=H.+Xuauthor=W.+Gong&title=Histone+deacetylase+6+%28HDAC6%29+is+an+independent+deacetylase+for+alpha-tubulin&doi=10.2174%2F092986610791112620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 (HDAC6) is an independent deacetylase for α-tubulin</span></div><div class="casAuthors">Zhao, Zhiqiang; Xu, Hang; Gong, Weimin</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-558</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a cytosolic enzyme that catalyzes the deacetylation of several proteins.  Acetylated tubulin was recently identified as a physiol. substrate of HDAC6.  However in previous reports, all in vitro binding and enzymic assays were accomplished with only partially purified protein samples.  Therefore, it still remained unclear whether HDAC6 alone could interact with tubulin and catalyze deacetylation.  Here, both binding and enzymic assays were conducted using recombinant-derived HDAC6 and purified α/β tubulin to eliminate possible contamination.  The results clearly demonstrated that the interaction between HDAC6 and tubulin was independent of other proteins.  In addn., HDAC6 could independently catalyze the deacetylation of both the tubulin dimer and microtubule polymer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYmCtVND6snrVg90H21EOLACvtfcHk0lhmjckXveL6Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVahtLc%253D&md5=833f3282749b11d7080c45da2941ba95</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F092986610791112620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986610791112620%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26atitle%3DHistone%2520deacetylase%25206%2520%2528HDAC6%2529%2520is%2520an%2520independent%2520deacetylase%2520for%2520alpha-tubulin%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2010%26volume%3D17%26spage%3D555%26epage%3D558%26doi%3D10.2174%2F092986610791112620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas-Burgos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olashaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dent, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17643370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=197-213&author=X.+Zhangauthor=Z.+Yuanauthor=Y.+Zhangauthor=S.+Yongauthor=A.+Salas-Burgosauthor=J.+Koomenauthor=N.+Olashawauthor=J.+T.+Parsonsauthor=X.+J.+Yangauthor=S.+R.+Dentauthor=T.+P.+Yaoauthor=W.+S.+Laneauthor=E.+Seto&title=HDAC6+modulates+cell+motility+by+altering+the+acetylation+level+of+cortactin&doi=10.1016%2Fj.molcel.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 modulates cell motility by altering the acetylation level of cortactin</span></div><div class="casAuthors">Zhang, Xiaohong; Yuan, Zhigang; Zhang, Yingtao; Yong, Sarah; Salas-Burgos, Alexis; Koomen, John; Olashaw, Nancy; Parsons, J. Thomas; Yang, Xiang-Jiao; Dent, Sharon R.; Yao, Tso-Pang; Lane, William S.; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-213</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a tubulin-specific deacetylase that regulates microtubule-dependent cell movement.  In this study, we identify the F-actin-binding protein cortactin as a HDAC6 substrate.  We demonstrate that HDAC6 binds cortactin and that overexpression of HDAC6 leads to hypoacetylation of cortactin, whereas inhibition of HDAC6 activity leads to cortactin hyperacetylation.  HDAC6 alters the ability of cortactin to bind F-actin by modulating a "charge patch" in its repeat region.  Introduction of charge-preserving or charge-neutralizing mutations in this cortactin repeat region correlates with the gain or loss of F-actin binding ability, resp.  Cells expressing a charge-neutralizing cortactin mutant were less motile than control cells or cells expressing a charge-preserving mutant.  These findings suggest that, in addn. to its role in microtubule-dependent cell motility, HDAC6 influences actin-dependent cell motility by altering the acetylation status of cortactin, which, in turn, changes the F-actin binding activity of cortactin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSM-mAzzZOrVg90H21EOLACvtfcHk0lhmjckXveL6Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFamtLg%253D&md5=752a0203b7cde321c9c5de07fba79ca7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYong%26aufirst%3DS.%26aulast%3DSalas-Burgos%26aufirst%3DA.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DOlashaw%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DDent%26aufirst%3DS.%2BR.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHDAC6%2520modulates%2520cell%2520motility%2520by%2520altering%2520the%2520acetylation%2520level%2520of%2520cortactin%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D197%26epage%3D213%26doi%3D10.1016%2Fj.molcel.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">An acetylation site in the middle domain of Hsp90 regulates chaperone function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2006.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17218278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=151-159&author=B.+T.+Scrogginsauthor=K.+Robzykauthor=D.+Wangauthor=M.+G.+Marcuauthor=S.+Tsutsumiauthor=K.+Beebeauthor=R.+J.+Cotterauthor=S.+Feltsauthor=D.+Toftauthor=L.+Karnitzauthor=N.+Rosenauthor=L.+Neckers&title=An+acetylation+site+in+the+middle+domain+of+Hsp90+regulates+chaperone+function&doi=10.1016%2Fj.molcel.2006.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An acetylation site in the middle domain of Hsp90 regulates chaperone function</span></div><div class="casAuthors">Scroggins, Bradley T.; Robzyk, Kenneth; Wang, Dongxia; Marcu, Monica G.; Tsutsumi, Shinji; Beebe, Kristin; Cotter, Robert J.; Felts, Sara; Toft, David; Karnitz, Larry; Rosen, Neal; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-159</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) chaperones represent a key subset of signaling proteins necessary for malignant transformation.  Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation.  Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity.  However, direct detn. of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites.  We now demonstrate that Hsp90 K294 is acetylated.  Mutational anal. of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding.  In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation.  These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposaZEwc5nC7Vg90H21EOLACvtfcHk0lhmjckXveL6Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurk%253D&md5=abcc378115fc49ffcf3bf4a96289b18a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26aulast%3DRobzyk%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DKarnitz%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DAn%2520acetylation%2520site%2520in%2520the%2520middle%2520domain%2520of%2520Hsp90%2520regulates%2520chaperone%2520function%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D25%26spage%3D151%26epage%3D159%26doi%3D10.1016%2Fj.molcel.2006.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakiewicz, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comb, M. J.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">12686</span>– <span class="NLM_lpage">12690</span>, <span class="refDoi"> DOI: 10.1074/jbc.C700185200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C700185200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18356165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlGkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=12686-12690&author=Y.+Liauthor=X.+Zhangauthor=R.+D.+Polakiewiczauthor=T.+P.+Yaoauthor=M.+J.+Comb&title=HDAC6+is+required+for+epidermal+growth+factor-induced+beta-catenin+nuclear+localization&doi=10.1074%2Fjbc.C700185200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization</span></div><div class="casAuthors">Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Yao, Tso-Pang; Comb, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12686-12690</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nuclear translocation of β-catenin is a hallmark of Wnt signaling and is assocd. with various cancers.  In addn. to the canonical Wnt pathway activated by Wnt ligands, growth factors such as epidermal growth factor (EGF) also induce β-catenin dissocn. from the adherens junction complex, translocation into the nucleus, and activation of target genes such as c-myc.  Here we report that EGF-induced β-catenin nuclear localization and activation of c-myc are dependent on the deacetylase HDAC6.  We show that EGF induces HDAC6 translocation to the caveolae membrane and assocn. with β-catenin.  HDAC6 deacetylates β-catenin at lysine 49, a site frequently mutated in anaplastic thyroid cancer, and inhibits β-catenin phosphorylation at serine 45.  HDAC6 inactivation blocks EGF-induced β-catenin nuclear localization and decreases c-Myc expression, leading to inhibition of tumor cell proliferation.  These results suggest that EGF-induced nuclear localization of β-catenin is regulated by HDAC6-dependent deacetylation and provide a new mechanism by which HDAC inhibitors prevent tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgCOcF77MEkLVg90H21EOLACvtfcHk0lhlrdc-KioWpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlGkur8%253D&md5=96cf7599f54ca2c3713bb1dc71708db5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C700185200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C700185200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DHDAC6%2520is%2520required%2520for%2520epidermal%2520growth%2520factor-induced%2520beta-catenin%2520nuclear%2520localization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D12686%26epage%3D12690%26doi%3D10.1074%2Fjbc.C700185200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+B.+Parmigianiauthor=W.+S.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+A.+Marks&title=HDAC6+is+a+specific+deacetylase+of+peroxiredoxins+and+is+involved+in+redox+regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0lhlrdc-KioWpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%2BB.%26aulast%3DXu%26aufirst%3DW.%2BS.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHDAC6%2520is%2520a%2520specific%2520deacetylase%2520of%2520peroxiredoxins%2520and%2520is%2520involved%2520in%2520redox%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riolo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakirevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altura, R. A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">10885</span>– <span class="NLM_lpage">10893</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.308791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M111.308791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22334690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10885-10893&author=M.+T.+Rioloauthor=Z.+A.+Cooperauthor=M.+P.+Hollowayauthor=Y.+Chengauthor=C.+Bianchiauthor=E.+Yakirevichauthor=L.+Maauthor=Y.+E.+Chinauthor=R.+A.+Altura&title=Histone+deacetylase+6+%28HDAC6%29+deacetylates+survivin+for+its+nuclear+export+in+breast+cancer&doi=10.1074%2Fjbc.M111.308791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer</span></div><div class="casAuthors">Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Bianchi, Cesario; Yakirevich, Evgeny; Ma, Li; Chin, Y. Eugene; Altura, Rachel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10885-10893</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Survivin is an oncogenic protein that is highly expressed in breast cancer and has a dual function that is dependent on its subcellular localization.  In the cytosol, survivin blocks programmed cell death by inactivating caspase proteins; however, in the nucleus it facilitates cell division by regulating chromosomal movement and cytokinesis.  In prior work, we showed that survivin is acetylated by CREB-binding protein (CBP), which restricts its localization to the nuclear compartment and thereby inhibits its anti-apoptotic function.  Here, we identify histone deacetylase 6 (HDAC6) as responsible for abrogating CBP-mediated survivin acetylation in the estrogen receptor (ER)-pos. breast cancer cell line, MCF-7.  HDAC6 directly binds survivin, an interaction that is enhanced by CBP.  In quiescent breast cancer cells in culture and in malignant tissue sections from ER+ breast tumors, HDAC6 localizes to a perinuclear region of the cell, undergoing transport to the nucleus following CBP activation where it then deacetylates survivin.  Genetically modified mouse embryonic fibroblasts that lack mhdac6 localize survivin predominantly to the nuclear compartment, whereas wild-type mouse embryonic fibroblasts localize survivin to distinct cytoplasmic structures.  Together, these data imply that HDAC6 deacetylates survivin to regulate its nuclear export, a feature that may provide a novel target for patients with ER+ breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Ddc8wIGMMbVg90H21EOLACvtfcHk0lhCwbpBl_zpFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVWmu7Y%253D&md5=89d158f33f2717499a93c1dfb21d9813</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.308791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.308791%26sid%3Dliteratum%253Aachs%26aulast%3DRiolo%26aufirst%3DM.%2BT.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BP.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DYakirevich%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChin%26aufirst%3DY.%2BE.%26aulast%3DAltura%26aufirst%3DR.%2BA.%26atitle%3DHistone%2520deacetylase%25206%2520%2528HDAC6%2529%2520deacetylates%2520survivin%2520for%2520its%2520nuclear%2520export%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10885%26epage%3D10893%26doi%3D10.1074%2Fjbc.M111.308791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. V.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05564.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1471-4159.2008.05564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18636984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=2119-2130&author=H.+Dingauthor=P.+J.+Dolanauthor=G.+V.+Johnson&title=Histone+deacetylase+6+interacts+with+the+microtubule-associated+protein+tau&doi=10.1111%2Fj.1471-4159.2008.05564.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span></div><div class="casAuthors">Ding, Huiping; Dolan, Philip J.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2130</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6), a unique cytoplasmic deacetylase, likely plays a role in neurodegeneration by coordinating cell responses to abnormal protein aggregation.  Here, we provide in vitro and in vivo evidence that HDAC6 interacts with tau, a microtubule-assocd. protein that forms neurofibrillary tangles in Alzheimer's disease.  This interaction is mediated by the microtubule-binding domain on tau and the Ser/Glu tetradecapeptide domain on HDAC6.  Treatment with tubacin, a selective inhibitor of tubulin deacetylation activity of HDAC6, did not disrupt HDAC6-tau interaction.  Nonetheless tubacin treatment attenuated site-specific tau phosphorylation, as did shRNA-mediated knockdown of HDAC6.  Proteasome inhibition potentiated HDAC6-tau interactions and facilitated the concn. and co-localization of HDAC6 and tau in a perinuclear aggresome-like compartment, independent of HDAC6 tubulin deacetylase activity.  Furthermore, we obsd. that in Alzheimer's disease brains the protein level of HDAC6 was significantly increased.  These findings establish HDAC6 as a tau-interacting protein and as a potential modulator of tau phosphorylation and accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OtxbhpBU9LVg90H21EOLACvtfcHk0lhCwbpBl_zpFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM&md5=cf63da19f8f887459227b620d9a0898b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05564.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DDolan%26aufirst%3DP.%2BJ.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DHistone%2520deacetylase%25206%2520interacts%2520with%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D2119%26epage%3D2130%26doi%3D10.1111%2Fj.1471-4159.2008.05564.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">IIp45 inhibits cell migration through inhibition of HDAC6</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3560</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.063354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M109.063354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20008322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=3554-3560&author=Y.+Wuauthor=S.+W.+Songauthor=J.+Sunauthor=J.+M.+Brunerauthor=G.+N.+Fullerauthor=W.+Zhang&title=IIp45+inhibits+cell+migration+through+inhibition+of+HDAC6&doi=10.1074%2Fjbc.M109.063354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">IIp45 inhibits cell migration through inhibition of HDAC6</span></div><div class="casAuthors">Wu, Ying; Song, Sonya W.; Sun, Ji-Yuan; Bruner, Janet M.; Fuller, Gregory N.; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3554-3560</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">IIp45 (aka MIIP) is a newly discovered gene whose protein product inhibits cell migration.  HDAC6 is a class IIb deacetylase that specifically deacetylates α-tubulin, modulates microtubule dynamics, and promotes cell migration.  A yeast two-hybrid assay using IIp45 as bait identified HDAC6 protein as a binding partner of IIp45.  This phys. interaction of the two functionally antagonistic proteins was confirmed by glutathione S-transferase pulldown assay and co-immunopptn. assay in human cells.  Serial deletion constructs of HDAC6 were used to characterize the interaction of HDAC6 and IIp45, and this anal. found that the two catalytic domains of HDAC6 protein are required for IIp45 binding.  We examd. the protein expression patterns of IIp45 and HDAC6 in glioma tissues.  Elevated protein levels of HDAC6 were found in high grade glioma samples, in contrast to the decreased protein expression of IIp45.  The potential neg. regulation of HDAC6 expression by IIp45 was confirmed in cell lines with altered IIp45 expression by constitutive overexpression or small interfering RNA knockdown.  Protein turnover study revealed that overexpression of IIp45 significantly reduces the intracellular protein stability of endogenous HDAC6, indicating a possible mechanism for the neg. regulation of HDAC6 by IIp45.  Results from the HDAC activity assay demonstrated that overexpressed IIp45 effectively decreases HDAC6 activity, increases acetylated α-tubulin, and reduces cell migration.  The increased cell migration resulting from siIIp45 knockdown was significantly reversed by co-transfection of siHDAC6.  Thus, we report here for the first time a novel mechanism by which IIp45 inhibits cell motility through inhibition of HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_QSPx5PoB7Vg90H21EOLACvtfcHk0ljwKPQKdfWq3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmsb8%253D&md5=1869f13661eaf0871d99c51ccf3fceb2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.063354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.063354%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DBruner%26aufirst%3DJ.%2BM.%26aulast%3DFuller%26aufirst%3DG.%2BN.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DIIp45%2520inhibits%2520cell%2520migration%2520through%2520inhibition%2520of%2520HDAC6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D3554%26epage%3D3560%26doi%3D10.1074%2Fjbc.M109.063354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lissanu
Deribe, Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashaker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaidzidis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milutinovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratchmarova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buerkle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetchko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittanakom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurisica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagoev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerial, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagljar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikic, I.</span></span> <span> </span><span class="NLM_article-title">Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6</span>. <i>Sci. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">ra84</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2000576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscisignal.2000576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20029029" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=ra84&author=Y+Lissanu%0ADeribeauthor=P.+Wildauthor=A.+Chandrashakerauthor=J.+Curakauthor=M.+H.+H.+Schmidtauthor=Y.+Kalaidzidisauthor=N.+Milutinovicauthor=I.+Kratchmarovaauthor=L.+Buerkleauthor=M.+J.+Fetchkoauthor=P.+Schmidtauthor=S.+Kittanakomauthor=K.+R.+Brownauthor=I.+Jurisicaauthor=B.+Blagoevauthor=M.+Zerialauthor=I.+Stagljarauthor=I.+Dikic&title=Regulation+of+epidermal+growth+factor+receptor+trafficking+by+lysine+deacetylase+HDAC6&doi=10.1126%2Fscisignal.2000576"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000576%26sid%3Dliteratum%253Aachs%26aulast%3DLissanu%2BDeribe%26aufirst%3DY%26aulast%3DWild%26aufirst%3DP.%26aulast%3DChandrashaker%26aufirst%3DA.%26aulast%3DCurak%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%2BH.%2BH.%26aulast%3DKalaidzidis%26aufirst%3DY.%26aulast%3DMilutinovic%26aufirst%3DN.%26aulast%3DKratchmarova%26aufirst%3DI.%26aulast%3DBuerkle%26aufirst%3DL.%26aulast%3DFetchko%26aufirst%3DM.%2BJ.%26aulast%3DSchmidt%26aufirst%3DP.%26aulast%3DKittanakom%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DK.%2BR.%26aulast%3DJurisica%26aufirst%3DI.%26aulast%3DBlagoev%26aufirst%3DB.%26aulast%3DZerial%26aufirst%3DM.%26aulast%3DStagljar%26aufirst%3DI.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DRegulation%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520trafficking%2520by%2520lysine%2520deacetylase%2520HDAC6%26jtitle%3DSci.%2520Signal.%26date%3D2009%26volume%3D2%26spage%3Dra84%26doi%3D10.1126%2Fscisignal.2000576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardiola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">455</span>, <span class="refDoi"> DOI: 10.1038/417455a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F417455a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12024216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.-F.+Wangauthor=T.-P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase&doi=10.1038%2F417455a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a microtubule-associated deacetylase</span></div><div class="casAuthors">Hubbert, Charlotte; Guardiola, Amaris; Shao, Rong; Kawaguchi, Yoshiharu; Ito, Akihiro; Nixon, Andrew; Yoshida, Minoru; Wang, Xiao-Fan; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6887</span>),
    <span class="NLM_cas:pages">455-458</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reversible acetylation of α-tubulin has been implicated in regulating microtubule stability and function.  The distribution of acetylated α-tubulin is tightly controlled and stereotypic.  Acetylated α-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts.  However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known.  Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase.  HDAC6 is localized exclusively in the cytoplasm, where it assocs. with microtubules and localizes with the microtubule motor complex contg. p150glued.  In vivo, the overexpression of HDAC6 leads to a global deacetylation of α-tubulin, whereas a decrease in HDAC6 increases α-tubulin acetylation.  In vitro, purified HDAC6 potently deacetylates α-tubulin in assembled microtubules.  Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility.  Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biol. processes beyond histone metab. and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76Er3MrWtO7Vg90H21EOLACvtfcHk0ljwKPQKdfWq3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D&md5=f18cbb0af388925c606e822358ba3da6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2F417455a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417455a%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26doi%3D10.1038%2F417455a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrador, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbrunn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranjo-Suárez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Cófreces, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente-Manzanares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ávila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Madrid, F.</span></span> <span> </span><span class="NLM_article-title">Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3445</span>, <span class="refDoi"> DOI: 10.1091/mbc.e06-01-0008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1091%2Fmbc.e06-01-0008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16738306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1ynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=3435-3445&author=J.+R.+Cabreroauthor=J.+M.+Serradorauthor=O.+Barreiroauthor=M.+Mittelbrunnauthor=S.+Naranjo-Su%C3%A1rezauthor=N.+Mart%C3%ADn-C%C3%B3frecesauthor=M.+Vicente-Manzanaresauthor=R.+Mazitschekauthor=J.+E.+Bradnerauthor=J.+%C3%81vilaauthor=A.+Valenzuela-Fern%C3%A1ndezauthor=F.+S%C3%A1nchez-Madrid&title=Lymphocyte+chemotaxis+is+regulated+by+histone+deacetylase+6%2C+independently+of+its+deacetylase+activity&doi=10.1091%2Fmbc.e06-01-0008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity</span></div><div class="casAuthors">Cabrero, J. Roman; Serrador, Juan M.; Barreiro, Olga; Mittelbrunn, Maria; Naranjo-Suarez, Salvador; Martin-Cofreces, Noa; Vicente-Manzanares, Miguel; Mazitschek, Ralph; Bradner, James E.; Avila, Jesus; Valenzuela-Fernandez, Agustin; Sanchez-Madrid, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3435-3445</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">In this work, the role of HDAC6, a type II histone deacetylase with tubulin deacetylase activity, in lymphocyte polarity, motility, and transmigration was explored.  HDAC6 was localized at dynamic subcellular structures as leading lamellipodia and the uropod in migrating T-cells.  However, HDAC6 activity did not appear to be involved in the polarity of migrating lymphocytes.  Overexpression of HDAC6 in freshly isolated lymphocytes and T-cell lines increased the lymphocyte migration mediated by chemokines and their transendothelial migration under shear flow.  Accordingly, the knockdown of HDAC6 expression in T-cells diminished their chemotactic capability.  Addnl. expts. with HDAC6 inhibitors (trichostatin, tubacin), other structural related mols. (niltubacin, MAZ-1391), and HDAC6 dead mutants showed that the deacetylase activity of HDAC6 was not involved in the modulatory effect of this mol. on cell migration.  Our results indicate that HDAC6 has an important role in the chemotaxis of T-lymphocytes, which is independent of its tubulin deacetylase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBwf0ZB--02rVg90H21EOLACvtfcHk0liTj3hlW-4sXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1ynt70%253D&md5=1b1889ad68cbcd1d6fa1e24f8ab40704</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e06-01-0008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e06-01-0008%26sid%3Dliteratum%253Aachs%26aulast%3DCabrero%26aufirst%3DJ.%2BR.%26aulast%3DSerrador%26aufirst%3DJ.%2BM.%26aulast%3DBarreiro%26aufirst%3DO.%26aulast%3DMittelbrunn%26aufirst%3DM.%26aulast%3DNaranjo-Su%25C3%25A1rez%26aufirst%3DS.%26aulast%3DMart%25C3%25ADn-C%25C3%25B3freces%26aufirst%3DN.%26aulast%3DVicente-Manzanares%26aufirst%3DM.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3D%25C3%2581vila%26aufirst%3DJ.%26aulast%3DValenzuela-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez-Madrid%26aufirst%3DF.%26atitle%3DLymphocyte%2520chemotaxis%2520is%2520regulated%2520by%2520histone%2520deacetylase%25206%252C%2520independently%2520of%2520its%2520deacetylase%2520activity%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2006%26volume%3D17%26spage%3D3435%26epage%3D3445%26doi%3D10.1091%2Fmbc.e06-01-0008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2005.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15916966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.-T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.-P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span></div><div class="casAuthors">Kovacs, Jeffrey J.; Murphy, Patrick J. M.; Gaillard, Stephanie; Zhao, Xuan; Wu, June-Tai; Nicchitta, Christopher V.; Yoshida, Minoru; Toft, David O.; Pratt, William B.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) and its accessory cochaperones function by facilitating the structural maturation and complex assembly of client proteins, including steroid hormone receptors and selected kinases.  By promoting the activity and stability of these signaling proteins, Hsp90 has emerged as a crit. modulator in cell signaling.  Here, we present evidence that Hsp90 chaperone activity is regulated by reversible acetylation and controlled by the deacetylase HDAC6.  We show that HDAC6 functions as an Hsp90 deacetylase.  Inactivation of HDAC6 leads to Hsp90 hyperacetylation, its dissocn. from an essential cochaperone, p23, and a loss of chaperone activity.  In HDAC6-deficient cells, Hsp90-dependent maturation of the glucocorticoid receptor (GR) is compromised, resulting in GR defective in ligand binding, nuclear translocation, and transcriptional activation.  Our results identify Hsp90 as a target of HDAC6 and suggest reversible acetylation as a unique mechanism that regulates Hsp90 chaperone complex activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rzQe2Zsw_7Vg90H21EOLACvtfcHk0liTj3hlW-4sXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D&md5=338a8456c56a74d82ad3d28cbccae33f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.-T.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.molcel.2005.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vourc’h, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1101/gad.436407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1101%2Fgad.436407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17785525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVaks73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2172-2181&author=C.+Boyaultauthor=Y.+Zhangauthor=S.+Fritahauthor=C.+Caronauthor=B.+Gilquinauthor=S.+H.+Kwonauthor=C.+Garridoauthor=T.-P.+Yaoauthor=C.+Vourc%E2%80%99hauthor=P.+Matthiasauthor=S.+Khochbin&title=HDAC6+controls+major+cell+response+pathways+to+cytotoxic+accumulation+of+protein+aggregates&doi=10.1101%2Fgad.436407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates</span></div><div class="casAuthors">Boyault, Cyril; Zhang, Yu; Fritah, Sabrina; Caron, Cecile; Gilquin, Benoit; Kwon, So Hee; Garrido, Carmen; Yao, Tso-Pang; Vourc'h, Claire; Matthias, Patrick; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A cellular defense mechanism counteracts the deleterious effects of misfolded protein accumulation by eliciting a stress response.  The cytoplasmic deacetylase HDAC6 (histone deacetylase 6) was previously shown to be a key element in this response by coordinating the clearance of protein aggregates through aggresome formation and their autophagic degrdn.  Here, for the first time, we demonstrate that HDAC6 is involved in another crucial cell response to the accumulation of ubiquitinated protein aggregates, and unravel its mol. basis.  Indeed, our data show that HDAC6 senses ubiquitinated cellular aggregates and consequently induces the expression of major cellular chaperones by triggering the dissocn. of a repressive HDAC6/HSP1 (heat-shock factor 1)/HSP90 (heat-shock protein 90) complex and a subsequent HSF1 activation.  HDAC6 therefore appears as a master regulator of the cell protective response to cytotoxic protein aggregate formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1-1tZncylbbVg90H21EOLACvtfcHk0lgLNQcsS94Mnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVaks73M&md5=b136e00ef15ffbb770f40f9d708e63be</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1101%2Fgad.436407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.436407%26sid%3Dliteratum%253Aachs%26aulast%3DBoyault%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFritah%26aufirst%3DS.%26aulast%3DCaron%26aufirst%3DC.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DKwon%26aufirst%3DS.%2BH.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DT.-P.%26aulast%3DVourc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DMatthias%26aufirst%3DP.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DHDAC6%2520controls%2520major%2520cell%2520response%2520pathways%2520to%2520cytotoxic%2520accumulation%2520of%2520protein%2520aggregates%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D2172%26epage%3D2181%26doi%3D10.1101%2Fgad.436407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaurin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-P.</span></span> <span> </span><span class="NLM_article-title">The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00939-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0092-8674%2803%2900939-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14675537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWgurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2003&pages=727-738&author=Y.+Kawaguchiauthor=J.+J.+Kovacsauthor=A.+McLaurinauthor=J.+M.+Vanceauthor=A.+Itoauthor=T.-P.+Yao&title=The+deacetylase+HDAC6+regulates+aggresome+formation+and+cell+viability+in+response+to+misfolded+protein+stress&doi=10.1016%2FS0092-8674%2803%2900939-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</span></div><div class="casAuthors">Kawaguchi, Yoshiharu; Kovacs, Jeffrey J.; McLaurin, Adam; Vance, Jeffery M.; Ito, Akihiro; Yao, Tso-pang</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The efficient clearance of cytotoxic misfolded protein aggregates is crit. for cell survival.  Misfolded protein aggregates are transported and removed from the cytoplasm by dynein motors via the microtubule network to a novel organelle termed the aggresome where they are processed.  However, the means by which dynein motors recognize misfolded protein cargo, and the cellular factors that regulate aggresome formation, remain unknown.  We have discovered that HDAC6, a microtubule-assocd. deacetylase, is a component of the aggresome.  We demonstrate that HDAC6 has the capacity to bind both polyubiquitinated misfolded proteins and dynein motors, thereby acting to recruit misfolded protein cargo to dynein motors for transport to aggresomes.  Indeed, cells deficient in HDAC6 fail to clear misfolded protein aggregates from the cytoplasm, cannot form aggresomes properly, and are hypersensitive to the accumulation of misfolded proteins.  These findings identify HDAC6 as a crucial player in the cellular management of misfolded protein-induced stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnh-j9NJeDLrVg90H21EOLACvtfcHk0lgLNQcsS94Mnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWgurfL&md5=4bb225e89efa841c73b6ca12284cbb06</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900939-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900939-5%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMcLaurin%26aufirst%3DA.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DT.-P.%26atitle%3DThe%2520deacetylase%2520HDAC6%2520regulates%2520aggresome%2520formation%2520and%2520cell%2520viability%2520in%2520response%2520to%2520misfolded%2520protein%2520stress%26jtitle%3DCell%26date%3D2003%26volume%3D115%26spage%3D727%26epage%3D738%26doi%3D10.1016%2FS0092-8674%2803%2900939-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopito, R. R.</span></span> <span> </span><span class="NLM_article-title">Aggresomes, inclusion bodies and protein aggregation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/S0962-8924(00)01852-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0962-8924%2800%2901852-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11121744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot12ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=524-530&author=R.+R.+Kopito&title=Aggresomes%2C+inclusion+bodies+and+protein+aggregation&doi=10.1016%2FS0962-8924%2800%2901852-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Aggresomes, inclusion bodies and protein aggregation</span></div><div class="casAuthors">Kopito, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">524-530</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 49 refs.  Intracellular and extracellular accumulation of aggregated protein are linked to many diseases, including ageing-related neurodegeneration and systemic amyloidosis.  Cells avoid accumulating potentially toxic aggregates by mechanisms including the suppression of aggregate formation by mol. chaperones and the degrdn. of misfolded proteins by proteasomes.  Once formed, aggregates tend to be refractory to proteolysis and to accumulate in inclusion bodies.  This accumulation has been assumed to be a diffusion-limited process, but recent studies suggest that, in animal cells, aggregated proteins are specifically delivered to inclusion bodies by dynein-dependent retrograde transport on microtubules.  This microtubule-dependent inclusion body is called an aggresome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAaQXcIeg9hLVg90H21EOLACvtfcHk0ljZXfcadO2d7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot12ltL0%253D&md5=333f16b97bbb712f16cb887462323546</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2800%2901852-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252800%252901852-3%26sid%3Dliteratum%253Aachs%26aulast%3DKopito%26aufirst%3DR.%2BR.%26atitle%3DAggresomes%252C%2520inclusion%2520bodies%2520and%2520protein%2520aggregation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2000%26volume%3D10%26spage%3D524%26epage%3D530%26doi%3D10.1016%2FS0962-8924%2800%2901852-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilquin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Klaucke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khochbin, S.</span></span> <span> </span><span class="NLM_article-title">HDAC6–p97/VCP controlled polyubiquitin chain turnover</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3357</span>– <span class="NLM_lpage">3366</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.emboj.7601210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16810319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1yqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3357-3366&author=C.+Boyaultauthor=B.+Gilquinauthor=Y.+Zhangauthor=V.+Rybinauthor=E.+Garmanauthor=W.+Meyer-Klauckeauthor=P.+Matthiasauthor=C.+W.+M%C3%BCllerauthor=S.+Khochbin&title=HDAC6%E2%80%93p97%2FVCP+controlled+polyubiquitin+chain+turnover&doi=10.1038%2Fsj.emboj.7601210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6-p97/VCP controlled polyubiquitin chain turnover</span></div><div class="casAuthors">Boyault, Cyril; Gilquin, Benoit; Zhang, Yu; Rybin, Vladimir; Garman, Elspeth; Meyer-Klaucke, Wolfram; Matthias, Patrick; Mueller, Christoph W.; Khochbin, Saadi</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3357-3366</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HDAC6 is a unique cytoplasmic deacetylase capable of interacting with ubiquitin.  Using a combination of biophys., biochem. and biol. approaches, we have characterized the ubiquitin-binding domain of HDAC6, named ZnF-UBP, and investigated its biol. functions.  These studies show that the three Zn ion-contg. HDAC6 ZnF-UBP domain presents the highest known affinity for ubiquitin monomers and mediates the ability of HDAC6 to neg. control the cellular polyubiquitin chain turnover.  We further show that HDAC6-interacting chaperone, p97/VCP, dissocs. the HDAC6-ubiquitin complexes and counteracts the ability of HDAC6 to promote the accumulation of polyubiquitinated proteins.  We propose that a finely tuned balance of HDAC6 and p97/VCP concns. dets. the fate of ubiquitinated misfolded proteins: p97/VCP would promote protein degrdn. and ubiquitin turnover, whereas HDAC6 would favor the accumulation of ubiquitinated protein aggregates and inclusion body formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCcS1_T95D37Vg90H21EOLACvtfcHk0ljZXfcadO2d7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1yqtbc%253D&md5=a44c580c374cef04665f889f991bc7c1</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601210%26sid%3Dliteratum%253Aachs%26aulast%3DBoyault%26aufirst%3DC.%26aulast%3DGilquin%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DRybin%26aufirst%3DV.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DMeyer-Klaucke%26aufirst%3DW.%26aulast%3DMatthias%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BW.%26aulast%3DKhochbin%26aufirst%3DS.%26atitle%3DHDAC6%25E2%2580%2593p97%252FVCP%2520controlled%2520polyubiquitin%2520chain%2520turnover%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3357%26epage%3D3366%26doi%3D10.1038%2Fsj.emboj.7601210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vij, N.</span></span> <span> </span><span class="NLM_article-title">AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00462.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1582-4934.2008.00462.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18798739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Whu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=2511-2518&author=N.+Vij&title=AAA+ATPase+p97%2FVCP%3A+cellular+functions%2C+disease+and+therapeutic+potential&doi=10.1111%2Fj.1582-4934.2008.00462.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential</span></div><div class="casAuthors">Vij, Neeraj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6A</span>),
    <span class="NLM_cas:pages">2511-2518</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  P97/VCP, a member of the AAA-ATPase super family, has been assocd. with a wide variety of essential cellular protein pathways com prising: (i) nuclear envelope reconstruction, (ii) cell cycle, (iii) Golgi reassembly, (iv) suppression of apoptosis and (v) DNA-damage response [1-6].  In addn., vasolin-contg. protein (VCP) dislodges the ubiquitinated proteins from the endoplasmic reticulum (ER) and chaperones them to the cytosol for proteasomal degrdn. by endoplasmic reticulum-assocd. degrdn. (ERAD) [7].  The interactions of VCP in the endoplasmic reticulum-assocd. degrdn. (ERAD) pathway det. the substrate selection for proteasomal degrdn.  Moreover, the interaction with VCP is also required for the ubiquitination of substrate.  VCP is phosphorylated by the master cellular kinase, Akt as a mechanism to regulate ERAD [8].  These multiple interactions in protein degrdn. pathways points to central role of VCP in misfolded protein degrdn.  VCP has a poly-glutamine and ubiquitin-binding capacity and is involved in proteasomal degrdn., cytosolic aggregation and processing of polyQ and polyUb aggregates in neurodegenerative and other misfolded protein diseases [9, 10].  Mutations in VCP gene are also linked to a protein deposition disorder, IBMFD [11].  We propose VCP as a therapeutic target for diseases caused by cytosolic protein aggregation or degrdn. of misfolded protein.  We predict that selective interference of VCP interaction(s) with aberrant protein or its ERAD function will be an effective therapeutic site to rescue functional misfolded protein in diseases like cystic fibrosis and alpha-1-trypsin deficiency.  The control of VCP expression is also proposed to be a potential therapeutic target in ex-polyQ-induced neurodegenerative diseases [12].  The further functional characterization of VCP and assocd. proteins in these diseases will help in designing of selective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB8IsWhgUyobVg90H21EOLACvtfcHk0lh6aeccAyewAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Whu74%253D&md5=aa87bb41523de02cf3165f0ddee33bd7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00462.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00462.x%26sid%3Dliteratum%253Aachs%26aulast%3DVij%26aufirst%3DN.%26atitle%3DAAA%2520ATPase%2520p97%252FVCP%253A%2520cellular%2520functions%252C%2520disease%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D2511%26epage%3D2518%26doi%3D10.1111%2Fj.1582-4934.2008.00462.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span> <span> </span><span class="NLM_article-title">The novel histone deacetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">655</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0688-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41419-018-0688-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29844403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=655&author=S.-J.+Fanauthor=F.-I.+Huangauthor=J.-P.+Liouauthor=C.-R.+Yang&title=The+novel+histone+deacetylase+6+inhibitor%2C+MPT0G211%2C+ameliorates+tau+phosphorylation+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41419-018-0688-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Fan Sheng-Jun; Huang Fang-I; Yang Chia-Ron; Liou Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">655</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a dreadful neurodegenerative disease that leads to severe impairment of cognitive function, leading to a drastic decline in the quality of life.  The primary pathological features of AD include senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs), comprising aggregated amyloid β (Aβ) and hyperphosphorylated tau protein, respectively, in the hippocampus of AD patients.  Histone deacetylase 6 (HDAC6) is a key enzyme in this neurodegenerative disease, in particular, as it relates to tau hyperphosphorylation.  This study aimed to investigate the protective effects and mechanism of the novel HDAC6 inhibitor, MPT0G211, using an AD model.  Our results indicated that MPT0G211 significantly reduced tau phosphorylation and aggregation, the processes highly correlated with the formation of NFTs.  This HDAC6 inhibitory activity resulted in an increase in acetylated Hsp90, which decreased Hsp90 and HDAC6 binding, causing ubiquitination of phosphorylated tau proteins.  In addition, a significant increase of phospho-glycogen synthase kinase-3β (phospho-GSK3β) on Ser9 (the inactive form) through Akt phosphorylation was associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment.  In AD in vivo models, MPT0G211 appeared to ameliorate learning and memory impairment in animals.  Furthermore, MPT0G211 treatment reduced the amount of phosphorylated tau in the hippocampal CA1 region.  In summary, MPT0G211 treatment appears to be a promising strategy for improving the AD phenotypes, including tau hyperphosphorylation and aggregation, neurodegeneration, and learning and memory impairment, making it a valuable agent for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThODJPxWFHy0EgZCMqtRBifW6udTcc2ebJHuyPv5IjQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D&md5=5b9b227e4df99bd8150004e7342c214c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0688-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0688-5%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.-J.%26aulast%3DHuang%26aufirst%3DF.-I.%26aulast%3DLiou%26aufirst%3DJ.-P.%26aulast%3DYang%26aufirst%3DC.-R.%26atitle%3DThe%2520novel%2520histone%2520deacetylase%25206%2520inhibitor%252C%2520MPT0G211%252C%2520ameliorates%2520tau%2520phosphorylation%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D655%26doi%3D10.1038%2Fs41419-018-0688-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiery, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeman, J. P.</span></span> <span> </span><span class="NLM_article-title">Complex networks orchestrate epithelial–mesenchymal transitions</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1038/nrm1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrm1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16493418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=131-142&author=J.+P.+Thieryauthor=J.+P.+Sleeman&title=Complex+networks+orchestrate+epithelial%E2%80%93mesenchymal+transitions&doi=10.1038%2Fnrm1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Complex networks orchestrate epithelial-mesenchymal transitions</span></div><div class="casAuthors">Thiery, Jean Paul; Sleeman, Jonathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epithelial-mesenchymal transition is an indispensable mechanism during morphogenesis, as without mesenchymal cells, tissues and organs will never be formed.  However, epithelial-cell plasticity, coupled to the transient or permanent formation of mesenchyme, goes far beyond the problem of cell-lineage segregation.  Understanding how mesenchymal cells arise from an epithelial default status will also have a strong impact in unraveling the mechanisms that control fibrosis and cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi1bapHui8_rVg90H21EOLACvtfcHk0lh6aeccAyewAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWltLg%253D&md5=e336d638cb16ff351ef77b2c3ac09d06</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrm1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1835%26sid%3Dliteratum%253Aachs%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26atitle%3DComplex%2520networks%2520orchestrate%2520epithelial%25E2%2580%2593mesenchymal%2520transitions%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D131%26epage%3D142%26doi%3D10.1038%2Fnrm1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavadil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttinger, E. P.</span></span> <span> </span><span class="NLM_article-title">TGF-β and epithelial-to-mesenchymal transitions</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5764</span>– <span class="NLM_lpage">5774</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1208927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fsj.onc.1208927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16123809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=5764-5774&author=J.+Zavadilauthor=E.+P.+B%C3%B6ttinger&title=TGF-%CE%B2+and+epithelial-to-mesenchymal+transitions&doi=10.1038%2Fsj.onc.1208927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">TGF-β and epithelial-to-mesenchymal transitions</span></div><div class="casAuthors">Zavadil, Jiri; Boettinger, Erwin P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5764-5774</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Remarkable phenotype plasticity of epithelial cells underlies morphogenesis, epithelial repair and tumor invasiveness.  Detailed understanding of the contextual cues and mol. mediators that control epithelial plasticity will be required in order to develop viable therapeutic approaches targeting epithelial-to-mesenchymal transition (EMT), an advanced manifestation of epithelial plasticity.  Members of the transforming growth factor (TGF-β) family of growth factors can initiate and maintain EMT in a variety of biol. systems and pathophysiol. context by activating major signaling pathways and transcriptional regulators integrated in extensive signaling networks.  Here we will review the distinct physiol. contexts of EMT and the underlying mol. signaling networks controlled by TGF-β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPUSiLxo47c7Vg90H21EOLACvtfcHk0lgysUI0Vxo2hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVertbw%253D&md5=7c08c348502658fd0e79543670c6c30d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208927%26sid%3Dliteratum%253Aachs%26aulast%3DZavadil%26aufirst%3DJ.%26aulast%3DB%25C3%25B6ttinger%26aufirst%3DE.%2BP.%26atitle%3DTGF-%25CE%25B2%2520and%2520epithelial-to-mesenchymal%2520transitions%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D5764%26epage%3D5774%26doi%3D10.1038%2Fsj.onc.1208927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldschmidt-Clermont, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">Transforming growth factor-β–induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000118599.25944.D5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1161%2F01.RES.0000118599.25944.D5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14739161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVGlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=617-625&author=S.+Zhuauthor=P.+J.+Goldschmidt-Clermontauthor=C.+Dong&title=Transforming+growth+factor-%CE%B2%E2%80%93induced+inhibition+of+myogenesis+is+mediated+through+Smad+pathway+and+is+modulated+by+microtubule+dynamic+stability&doi=10.1161%2F01.RES.0000118599.25944.D5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming Growth Factor-β-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability</span></div><div class="casAuthors">Zhu, Shoukang; Goldschmidt-Clermont, Pascal J.; Dong, Chunming</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-625</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The expression of muscle-specific genes assocd. with myogenesis is controlled by several myogenic transcription factors, including myogenin and MEF2D.  Transforming growth factor-β (TGF-β) has been shown to inhibit myogenesis, yet the mol. mechanisms underlying such inhibition are not known.  In the present study, TGF-β was shown to inhibit myogenin and MEF2D expression and myotube formation in C2C12 myoblasts cultured in differentiation medium in a cell d.-dependent manner.  Transfection of C2C12 cells with Smad7, an antagonist for TGF-β/Smad signaling, restored the capacity of these cells to differentiate in the presence of TGF-β or when cultured in growth medium at low confluence, conditions that hinder muscle differentiation.  Moreover, nocodazole, a microtubule-destabilizing agent, enhanced the inhibition of myogenesis exerted by TGF-β, an effect that could be restored by tubulin-polymg. agent taxol, both of which have been shown to affect Smad-microtubule interaction and regulate TGF-β/Smad signaling.  The authors' results indicate that TGF-β inhibits myogenesis, at least in part, via Smad pathway, and provide evidence that low-dose pharmacol. agents taxol and nocodazole can be used as a means to modulate myogenesis without affecting cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4lzd3-EYPbVg90H21EOLACvtfcHk0lgysUI0Vxo2hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVGlu7Y%253D&md5=cc2a87fd5c31ccc8c7fa4d1fbd780872</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000118599.25944.D5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000118599.25944.D5%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DGoldschmidt-Clermont%26aufirst%3DP.%2BJ.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%25E2%2580%2593induced%2520inhibition%2520of%2520myogenesis%2520is%2520mediated%2520through%2520Smad%2520pathway%2520and%2520is%2520modulated%2520by%2520microtubule%2520dynamic%2520stability%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D94%26spage%3D617%26epage%3D625%26doi%3D10.1161%2F01.RES.0000118599.25944.D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T.-p.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">21065</span>– <span class="NLM_lpage">21073</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802786200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M802786200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18499657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21065-21073&author=B.+Shanauthor=T.-p.+Yaoauthor=H.+T.+Nguyenauthor=Y.+Zhuoauthor=D.+R.+Levyauthor=R.+C.+Klingsbergauthor=H.+Taoauthor=M.+L.+Palmerauthor=K.+N.+Holderauthor=J.+A.+Lasky&title=Requirement+of+HDAC6+for+transforming+growth+factor-%CE%B21-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M802786200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span></div><div class="casAuthors">Shan, Bin; Yao, Tso-pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21065-21073</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aberrant expression of transforming growth factor (TGF)-β1 in the tumor microenvironment and fibrotic lesions plays a crit. role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT).  EMT promotes tumor cell motility and invasiveness.  How EMT affects motility and invasion is not well understood.  Here we report that HDAC6 is a novel modulator of TGF-β1-induced EMT.  HDAC6 is a microtubule-assocd. deacetylase that predominantly deacetylates nonhistone proteins, including α-tubulin, and regulates cell motility.  We showed that TGF-β1-induced EMT is accompanied by HDAC6-dependent deacetylation of α-tubulin.  Importantly, inhibition of HDAC6 by small interfering RNA or the small mol. inhibitor tubacin attenuated the TGF-β1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers.  Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-β1.  Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of α-tubulin as well as the expression of EMT markers.  These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-β-SMAD3 signaling cascade.  Our results identify HDAC6 as a crit. regulator of EMT and a potential therapeutic target against pathol. EMT, a key event for tumor progression and fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcx6lyo8vYbVg90H21EOLACvtfcHk0liWz-w3G_LYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D&md5=41e37f298b484fc259266bdc4aa2eff5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802786200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802786200%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DT.-p.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLevy%26aufirst%3DD.%2BR.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPalmer%26aufirst%3DM.%2BL.%26aulast%3DHolder%26aufirst%3DK.%2BN.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DRequirement%2520of%2520HDAC6%2520for%2520transforming%2520growth%2520factor-%25CE%25B21-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21065%26epage%3D21073%26doi%3D10.1074%2Fjbc.M802786200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venta-Perez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdjument-Bromage, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaneva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">9633</span>– <span class="NLM_lpage">9638</span>, <span class="refDoi"> DOI: 10.1073/pnas.0803749105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0803749105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18606987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9633-9638&author=R.+Parmigianiauthor=W.+Xuauthor=G.+Venta-Perezauthor=H.+Erdjument-Bromageauthor=M.+Yanevaauthor=P.+Tempstauthor=P.+Marks&title=HDAC6+is+a+specific+deacetylase+of+peroxiredoxins+and+is+involved+in+redox+regulation&doi=10.1073%2Fpnas.0803749105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation</span></div><div class="casAuthors">Parmigiani, R. B.; Xu, W. S.; Venta-Perez, G.; Erdjumen-Bromage, H.; Yaneva, M.; Tempst, P.; Marks, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9633-9638</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Eighteen histone deacetylases (HDACs) are present in humans, categorized into 2 groups: (1) Zn-dependent enzymes (HDAC1-11) and (2) NAD-dependent enzymes (sirtuins 1-7).  Among Zn-dependent HDACs, HDAC6 is unique.  It has a cytoplasmic localization, 2 catalytic sites, a ubiquitin-binding site, and it selectively deacetylates α-tubulin and Hsp90.  Here, the authors report the discovery that the redox regulatory proteins, peroxiredoxins (Prxs) I and II are specific targets of HDAC6 in human prostate cancer cells.  Prxs are antioxidant enzymes whose main function is H2O2 redn.  Prxs are elevated in many cancers and neurodegenerative diseases.  The acetylated form of Prx accumulates in the absence of an active HDAC6.  Acetylation of Prx increases its reducing activity, its resistance to superoxidn., and its resistance to transition to high-mol.-wt. complexes.  Thus, HDAC6 and Prxs are targets for modulating intracellular redox status in therapeutic strategies for disorders as disparate as cancers and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPhHinn-zsRbVg90H21EOLACvtfcHk0liWz-w3G_LYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovVOjt7g%253D&md5=205d33a2f6c154d83b1d1cee59d29108</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0803749105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0803749105%26sid%3Dliteratum%253Aachs%26aulast%3DParmigiani%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DVenta-Perez%26aufirst%3DG.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DYaneva%26aufirst%3DM.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DP.%26atitle%3DHDAC6%2520is%2520a%2520specific%2520deacetylase%2520of%2520peroxiredoxins%2520and%2520is%2520involved%2520in%2520redox%2520regulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9633%26epage%3D9638%26doi%3D10.1073%2Fpnas.0803749105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hah, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">28775</span>– <span class="NLM_lpage">28784</span>, <span class="refDoi"> DOI: 10.1074/jbc.M505362200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M505362200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15941719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFSnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=28775-28784&author=J.+C.+Moonauthor=Y.-S.+Hahauthor=W.+Y.+Kimauthor=B.+G.+Jungauthor=H.+H.+Jangauthor=J.+R.+Leeauthor=S.+Y.+Kimauthor=Y.+M.+Leeauthor=M.+G.+Jeonauthor=C.+W.+Kimauthor=M.+J.+Choauthor=S.+Y.+Lee&title=Oxidative+stress-dependent+structural+and+functional+switching+of+a+human+2-Cys+peroxiredoxin+isotype+II+that+enhances+HeLa+cell+resistance+to+H2O2-induced+cell+death&doi=10.1074%2Fjbc.M505362200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress-dependent Structural and Functional Switching of a Human 2-Cys Peroxiredoxin Isotype II That Enhances HeLa Cell Resistance to H2O2-induced Cell Death</span></div><div class="casAuthors">Moon, Jeong Chan; Hah, Young-Sool; Kim, Woe Yeon; Jung, Bae Gyo; Jang, Ho Hee; Lee, Jung Ro; Kim, Sun Young; Lee, Young Mee; Jeon, Min Gyu; Kim, Choong Won; Cho, Moo Je; Lee, Sang Yeol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">28775-28784</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although biochem. properties of 2-Cys peroxiredoxins (Prxs) have been extensively studied, their real physiol. functions in higher eukaryotic cells remain obscure and certainly warrant further study.  Here we demonstrated that human (h) PrxII, a cytosolic isotype of human 2-Cys Prx, has dual functions as a peroxidase and a mol. chaperone, and that these different functions are closely assocd. with its adoption of distinct protein structures.  Upon exposure to oxidative stress, hPrxII assumes a high mol. wt. complex structure that has a highly efficient chaperone function.  However, the subsequent removal of stressors induces the dissocn. of this protein structure into low mol. wt. proteins and triggers a chaperone-to-peroxidase functional switch.  The formation of a high mol. wt. hPrxII complex depends on the hyperoxidn. of its N-terminal peroxidatizable Cys residue as well as on its C-terminal domain, which contains a "YF motif" that is exclusively found in eukaryotic 2-Cys Prxs.  A C-terminally truncated hPrxII exists as low and oligomeric protein species and does not respond to oxidative stress.  Moreover, this C-terminal deletion of hPrxII converted it from an oxidn.-sensitive to a hyperoxidn.-resistant form of peroxidase.  When functioning as a chaperone, hPrxII protects HeLa cells from H2O2-induced cell death, as measured by a terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling assay and fluorescence-activated cell sorting anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqugN3_X8eFy7Vg90H21EOLACvtfcHk0li3VCqNnAQxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFSnt70%253D&md5=980903047d1ca308ece4cfb62f0fed64</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505362200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505362200%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.%2BC.%26aulast%3DHah%26aufirst%3DY.-S.%26aulast%3DKim%26aufirst%3DW.%2BY.%26aulast%3DJung%26aufirst%3DB.%2BG.%26aulast%3DJang%26aufirst%3DH.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DJeon%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DC.%2BW.%26aulast%3DCho%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26atitle%3DOxidative%2520stress-dependent%2520structural%2520and%2520functional%2520switching%2520of%2520a%2520human%25202-Cys%2520peroxiredoxin%2520isotype%2520II%2520that%2520enhances%2520HeLa%2520cell%2520resistance%2520to%2520H2O2-induced%2520cell%2520death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D28775%26epage%3D28784%26doi%3D10.1074%2Fjbc.M505362200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, L. B.</span></span> <span> </span><span class="NLM_article-title">Structure, mechanism and regulation of peroxiredoxins</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/S0968-0004(02)00003-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0968-0004%2802%2900003-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12517450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=32-40&author=Z.+A.+Woodauthor=E.+Schr%C3%B6derauthor=J.+R.+Harrisauthor=L.+B.+Poole&title=Structure%2C+mechanism+and+regulation+of+peroxiredoxins&doi=10.1016%2FS0968-0004%2802%2900003-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, mechanism and regulation of peroxiredoxins</span></div><div class="casAuthors">Wood, Zachary A.; Schroder, Ewald; Robin Harris, J.; Poole, Leslie B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-40</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Peroxiredoxins (Prxs) are a ubiquitous family of antioxidant enzymes that also control cytokine-induced peroxide levels which mediate signal transduction in mammalian cells.  Prxs can be regulated by changes to phosphorylation, redox and possibly oligomerization states.  Prxs are divided into 3 classes: (1) typical 2-Cys Prxs; (2) atypical 2-Cys Prxs; and (3) 1-Cys Prxs.  All Prxs share the same basic catalytic mechanism, in which an active site Cys (the peroxidatic Cys) residue is oxidized to a sulfenic acid by the peroxide substrate.  The recycling of the sulfenic acid back to a thiol is what distinguishes the 3 enzyme classes.  Using crystal structures, a detailed catalytic cycle has been derived for typical 2-Cys Prxs, including a model for the redox-regulated oligomeric state proposed to control enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5HZUm7rTYLVg90H21EOLACvtfcHk0li3VCqNnAQxtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFGh&md5=3d4017f1989545b079330ec73929352f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2802%2900003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252802%252900003-8%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DZ.%2BA.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DJ.%2BR.%26aulast%3DPoole%26aufirst%3DL.%2BB.%26atitle%3DStructure%252C%2520mechanism%2520and%2520regulation%2520of%2520peroxiredoxins%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D32%26epage%3D40%26doi%3D10.1016%2FS0968-0004%2802%2900003-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hockly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathasivam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazi-Noori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowden, P. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, G. P.</span></span> <span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington’s disease</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">2041</span>– <span class="NLM_lpage">2046</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437870100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.0437870100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12576549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=2041-2046&author=E.+Hocklyauthor=V.+M.+Richonauthor=B.+Woodmanauthor=D.+L.+Smithauthor=X.+Zhouauthor=E.+Rosaauthor=K.+Sathasivamauthor=S.+Ghazi-Nooriauthor=A.+Mahalauthor=P.+A.+S.+Lowdenauthor=J.+S.+Steffanauthor=J.+L.+Marshauthor=L.+M.+Thompsonauthor=C.+M.+Lewisauthor=P.+A.+Marksauthor=G.+P.+Bates&title=Suberoylanilide+hydroxamic+acid%2C+a+histone+deacetylase+inhibitor%2C+ameliorates+motor+deficits+in+a+mouse+model+of+Huntington%E2%80%99s+disease&doi=10.1073%2Fpnas.0437870100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease</span></div><div class="casAuthors">Hockly, Emma; Richon, Victoria M.; Woodman, Benjamin; Smith, Donna L.; Zhou, Xianbo; Rosa, Eddie; Sathasivam, Kirupa; Ghazi-Noori, Shabnam; Mahal, Amarbirpal; Lowden, Philip A. S.; Steffan, Joan S.; Marsh, J. Lawrence; Thompson, Leslie M.; Lewis, Cathryn M.; Marks, Paul A.; Bates, Gillian P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2041-2046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is an inherited, progressive neurol. disorder that is caused by a CAG/polyglutamine repeat expansion and for which there is no effective therapy.  Recent evidence indicates that transcriptional dysregulation may contribute to the mol. pathogenesis of this disease.  Supporting this view, administration of histone deacetylase (HDAC) inhibitors has been shown to rescue lethality and photoreceptor neurodegeneration in a Drosophila model of polyglutamine disease.  To further explore the therapeutic potential of HDAC inhibitors, we have conducted preclin. trials with suberoylanilide hydroxamic acid (SAHA), a potent HDAC inhibitor, in the R6/2 HD mouse model.  We show that SAHA crosses the blood-brain barrier and increases histone acetylation in the brain.  We found that SAHA could be administered orally in drinking water when complexed with cyclodextrins.  SAHA dramatically improved the motor impairment in R6/2 mice, clearly validating the pursuit of this class of compds. as HD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpy-3Y7VV7UbVg90H21EOLACvtfcHk0ljqivn-hS78EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGrsbs%253D&md5=4096dcbfeeeafd00c51ccb01e4ee29a5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437870100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437870100%26sid%3Dliteratum%253Aachs%26aulast%3DHockly%26aufirst%3DE.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DRosa%26aufirst%3DE.%26aulast%3DSathasivam%26aufirst%3DK.%26aulast%3DGhazi-Noori%26aufirst%3DS.%26aulast%3DMahal%26aufirst%3DA.%26aulast%3DLowden%26aufirst%3DP.%2BA.%2BS.%26aulast%3DSteffan%26aufirst%3DJ.%2BS.%26aulast%3DMarsh%26aufirst%3DJ.%2BL.%26aulast%3DThompson%26aufirst%3DL.%2BM.%26aulast%3DLewis%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%252C%2520a%2520histone%2520deacetylase%2520inhibitor%252C%2520ameliorates%2520motor%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D2041%26epage%3D2046%26doi%3D10.1073%2Fpnas.0437870100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipiani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calingasan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2005.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2005.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16289867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=40-49&author=S.+Petriauthor=M.+Kiaeiauthor=K.+Kipianiauthor=J.+Chenauthor=N.+Y.+Calingasanauthor=J.+P.+Crowauthor=M.+F.+Beal&title=Additive+neuroprotective+effects+of+a+histone+deacetylase+inhibitor+and+a+catalytic+antioxidant+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis&doi=10.1016%2Fj.nbd.2005.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Petri, Susanne; Kiaei, Mahmoud; Kipiani, Khatuna; Chen, Junyu; Calingasan, Noel Y.; Crow, John P.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-49</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">ALS is a devastating neurodegenerative disorder for which no effective treatment exists.  Multiple mol. mechanisms are involved in the pathogenesis.  We tested the catalytic antioxidant AEOL 10150, the histone deacetylase inhibitor phenylbutyrate (PBA), and the combination of PBA and AEOL 10150 in the G93A transgenic mouse model, administered from disease onset.  AEOL 10150 alone improved motor function and extended survival by 11%, PBA alone significantly improved motor function and extended survival by 13%.  PBA and AEOL 10150 together increased survival by 19%.  Increased histone acetylation was confirmed by Western blot.  Quant. real-time RT-PCR anal. revealed upregulation of compds. capable of protecting cells against oxidative stress and apoptosis.  Markers of oxidative damage were reduced in the lumbar spinal cord as compared to vehicle administration.  These results suggest that agents inhibiting apoptosis and blocking oxidative stress show efficacy in treating mutant-SOD1-assocd. ALS and that a combination of agents targeting different disease mechanisms may exert additive therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcg3A_6aRI8rVg90H21EOLACvtfcHk0ljqivn-hS78EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOjtb4%253D&md5=a29246feff52c648ede9a267a595dc14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2005.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2005.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DPetri%26aufirst%3DS.%26aulast%3DKiaei%26aufirst%3DM.%26aulast%3DKipiani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCalingasan%26aufirst%3DN.%2BY.%26aulast%3DCrow%26aufirst%3DJ.%2BP.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAdditive%2520neuroprotective%2520effects%2520of%2520a%2520histone%2520deacetylase%2520inhibitor%2520and%2520a%2520catalytic%2520antioxidant%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D22%26spage%3D40%26epage%3D49%26doi%3D10.1016%2Fj.nbd.2005.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of potent and selective HDAC6 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2017.10.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29133060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2ntbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1406-1418&author=X.-X.+Wangauthor=R.-Z.+Wanauthor=Z.-P.+Liu&title=Recent+advances+in+the+discovery+of+potent+and+selective+HDAC6+inhibitors&doi=10.1016%2Fj.ejmech.2017.10.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of potent and selective HDAC6 inhibitors</span></div><div class="casAuthors">Wang, Xiu-Xiu; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1406-1418</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase HDAC6, a member of the class IIb HDAC family, is unique among HDAC enzymes in having two active catalytic domains, and has unique physiol. function.  In addn. to the modification of histone, HDAC6 targets specific substrates including α-tubulin and HSP90, and are involved in protein trafficking and degrdn., cell shape and migration.  Selective HDAC6 inhibitors are an emerging class of pharmaceuticals due to the involvement of HDAC6 in different pathways related to neurodegenerative diseases, cancer, and immunol.  Therefore, extensive investigations have been made in the discovery of selective HDAC6 inhibitors.  Based on their different zinc binding groups (ZBGs), in this review, HDAC6 inhibitors are grouped as hydroxamic acids, a sulfur contg. ZBG based derivs. and other ZBG-derived compds., and their enzymic inhibitory activity, selectivity and other biol. activities are introduced and summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdsNBEWGhpCrVg90H21EOLACvtfcHk0lj_iuO9PBwRJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2ntbrM&md5=f24fea971dbed247e1bb2568f85d1703</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.040%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-X.%26aulast%3DWan%26aufirst%3DR.-Z.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520potent%2520and%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1406%26epage%3D1418%26doi%3D10.1016%2Fj.ejmech.2017.10.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, S.</span></span> <span> </span><span class="NLM_article-title">The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2337</span>, <span class="refDoi"> DOI: 10.3390/ijms19082337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3390%2Fijms19082337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2337&author=M.+Cosenzaauthor=S.+Pozzi&title=The+therapeutic+strategy+of+HDAC6+inhibitors+in+lymphoproliferative+disease&doi=10.3390%2Fijms19082337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease</span></div><div class="casAuthors">Cosenza, Maria; Pozzi, Samantha</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2337/1-2337/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are master regulators of chromatin remodeling, acting as epigenetic regulators of gene expression.  In the last decade, inhibition of HDACs has become a target for specific epigenetic modifications related to cancer development.  Overexpression of HDAC has been obsd. in several hematol. malignancies.  Therefore, the observation that HDACs might play a role in various hematol. malignancies has brought to the development of HDAC inhibitors as potential antitumor agents.  Recently, the class IIb, HDAC6, has emerged as one potential selective HDACi.  This isoenzyme represents an important pharmacol. target for selective inhibition.  Its selectivity may reduce the toxicity related to the off-target effects of pan-HDAC inhibitors.  HDAC6 has also been studied in cancer esp. for its ability to coordinate a variety of cellular processes that are important for cancer pathogenesis.  HDAC6 has been reported to be overexpressed in lymphoid cells and its inhibition has demonstrated activity in preclin. and clin. study of lymphoproliferative disease.  Various studies of HDAC6 inhibitors alone and in combination with other agents provide strong scientific rationale for the evaluation of these new agents in the clin. setting of hematol. malignancies.  In this review, we describe the HDACs, their inhibitors, and the recent advances of HDAC6 inhibitors, their mechanisms of action and role in lymphoproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40AmGWIhm0rVg90H21EOLACvtfcHk0lj_iuO9PBwRJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVGhtrY%253D&md5=e2f63affb8a194d516a2465e772f46c1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3390%2Fijms19082337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19082337%26sid%3Dliteratum%253Aachs%26aulast%3DCosenza%26aufirst%3DM.%26aulast%3DPozzi%26aufirst%3DS.%26atitle%3DThe%2520therapeutic%2520strategy%2520of%2520HDAC6%2520inhibitors%2520in%2520lymphoproliferative%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D2337%26doi%3D10.3390%2Fijms19082337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucinella, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iside, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span> <span> </span><span class="NLM_article-title">Novel spiroindoline HDAC inhibitors: synthesis, molecular modelling and biological studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.ejmech.2018.07.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30092367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOntbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=127-138&author=M.+Brindisiauthor=J.+Sengerauthor=C.+Cavellaauthor=A.+Grilloauthor=G.+Chemiauthor=S.+Gemmaauthor=D.+M.+Cucinellaauthor=S.+Lamponiauthor=F.+Sarnoauthor=C.+Isideauthor=A.+Nebbiosoauthor=E.+Novellinoauthor=T.+B.+Shaikauthor=C.+Romierauthor=D.+Herpauthor=M.+Jungauthor=S.+Butiniauthor=G.+Campianiauthor=L.+Altucciauthor=S.+Brogi&title=Novel+spiroindoline+HDAC+inhibitors%3A+synthesis%2C+molecular+modelling+and+biological+studies&doi=10.1016%2Fj.ejmech.2018.07.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies</span></div><div class="casAuthors">Brindisi, Margherita; Senger, Johanna; Cavella, Caterina; Grillo, Alessandro; Chemi, Giulia; Gemma, Sandra; Cucinella, Dora Mariagrazia; Lamponi, Stefania; Sarno, Federica; Iside, Concetta; Nebbioso, Angela; Novellino, Ettore; Shaik, Tajith Baba; Romier, Christophe; Herp, Daniel; Jung, Manfred; Butini, Stefania; Campiani, Giuseppe; Altucci, Lucia; Brogi, Simone</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Spiroindolinylmethyl arylhydroxamates such as I (R = t-BuOCO, Me, MeCO, t-BuCO) were prepd. as selective inhibitors of histone deacetylase 6 (HDAC6) for potential use as antitumor agents.  The spiroindolinylmethyl arylhydroxamates were prepd. using a one-pot Fischer indole synthesis of cyclohexane- or piperidinecarboxaldehydes and phenylhydrazine followed by indolenine redn. and reductive amination with formylarylcarboxylates as the key step.  The inhibition of HDAC1 and HDAC6 by the spiroindolinylmethyl arylhydroxamates was detd. and mol. docking calcns. of their binding to HDAC1 and HDAC6 performed; in addn., their calcd. lipophilicities, biol. permeabilities, polar mol. surface areas, and hERG inhibition were detd.  The inhibition of HDAC8 by I (R = t-BuOCO), its effect on metastasis and its toxicity to mouse fibroblasts, and the effect of I (R = t-BuOCO, t-BuCO) on HDAC acetylation in cells were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBNiJdoIAsrVg90H21EOLACvtfcHk0limdscdot6S6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOntbnJ&md5=e12eadf2c73e321b1a733c1cbfdfc822</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DCavella%26aufirst%3DC.%26aulast%3DGrillo%26aufirst%3DA.%26aulast%3DChemi%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCucinella%26aufirst%3DD.%2BM.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DSarno%26aufirst%3DF.%26aulast%3DIside%26aufirst%3DC.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DHerp%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DBrogi%26aufirst%3DS.%26atitle%3DNovel%2520spiroindoline%2520HDAC%2520inhibitors%253A%2520synthesis%252C%2520molecular%2520modelling%2520and%2520biological%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.ejmech.2018.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iside, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span> <span> </span><span class="NLM_article-title">Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1573</span>– <span class="NLM_lpage">1587</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.4155%2Ffmc-2016-0068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27556815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1573-1587&author=M.+Brindisiauthor=C.+Cavellaauthor=S.+Brogiauthor=A.+Nebbiosoauthor=J.+Sengerauthor=S.+Maramaiauthor=A.+Ciottaauthor=C.+Isideauthor=S.+Butiniauthor=S.+Lamponiauthor=E.+Novellinoauthor=L.+Altucciauthor=M.+Jungauthor=G.+Campianiauthor=S.+Gemma&title=Phenylpyrrole-based+HDAC+inhibitors%3A+synthesis%2C+molecular+modeling+and+biological+studies&doi=10.4155%2Ffmc-2016-0068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies</span></div><div class="casAuthors">Brindisi, Margherita; Cavella, Caterina; Brogi, Simone; Nebbioso, Angela; Senger, Johanna; Maramai, Samuele; Ciotta, Alfonso; Iside, Concetta; Butini, Stefania; Lamponi, Stefania; Novellino, Ettore; Altucci, Lucia; Jung, Manfred; Campiani, Giuseppe; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1573-1587</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Histone deacetylases (HDACs) regulate the expression and activity of numerous proteins involved in the initiation and progression of cancer.  Currently, three hydroxamate-contg. HDAC pan-inhibitors have been approved as antitumor agents.  Results: We herein present the development of a series of novel phenylpyrrole-based derivs. stemmed from combined computational and medicinal chem. efforts to rationally modulate HDAC1/6 isoform selectivity.  In vitro activity on HDAC1 and HDAC6 isoforms and the effects of selected analogs on histone H3 and α-tubulin acetylation levels were detd.  Cell-based data evidenced, for selected compds., a promising antitumor potential and low toxicity on normal cells.  Conclusion: The newly developed compds. represent a valuable starting point for the development of novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFqELfTrUoFLVg90H21EOLACvtfcHk0limdscdot6S6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3E&md5=c96f8bfe2d30f2c2a90766531d9853ad</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0068%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DCavella%26aufirst%3DC.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DCiotta%26aufirst%3DA.%26aulast%3DIside%26aufirst%3DC.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DPhenylpyrrole-based%2520HDAC%2520inhibitors%253A%2520synthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520studies%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1573%26epage%3D1587%26doi%3D10.4155%2Ffmc-2016-0068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnchembio.2134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27454933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=741-747&author=Y.+Haiauthor=D.+W.+Christianson&title=Histone+deacetylase+6+structure+and+molecular+basis+of+catalysis+and+inhibition&doi=10.1038%2Fnchembio.2134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span></div><div class="casAuthors">Hai, Yang; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">741-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a crit. target for drug design because of its role in oncogenic transformation and cancer metastasis, and is unique among all histone deacetylases in that it contains tandem catalytic domains designated CD1 and CD2.  We now report the crystal structures of CD2 from Homo sapiens HDAC6 and of CD1 and CD2 from Danio rerio HDAC6.  We correlated these structures with activity measurements using 13 different substrates.  The catalytic activity of CD2 from both species exhibited broad substrate specificity, whereas that of CD1 was highly specific for substrates bearing C-terminal acetyllysine residues.  Crystal structures of substrate complexes yielded unprecedented snapshots of the catalytic mechanism.  Addnl., crystal structures of complexes with eight different inhibitors, including belinostat and panobinostat (currently used in cancer chemotherapy), the macrocyclic tetrapeptide HC toxin, and the HDAC6-specific inhibitor N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide, revealed surprising new insight regarding changes in Zn2+ coordination and isoenzyme-specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCfziGBHBRLVg90H21EOLACvtfcHk0ljlmDtHIYaT-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ&md5=e167bc6f66e00923da4f2bced2b306b9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2134%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DY.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520structure%2520and%2520molecular%2520basis%2520of%2520catalysis%2520and%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D741%26epage%3D747%26doi%3D10.1038%2Fnchembio.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogl, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span> <span> </span><span class="NLM_article-title">Rocilinostat (ACY-1215), a selective HDAC6 inhibitor, alone and in combination with bortezomib in multiple myeloma: preliminary results from the first-in-humans phase I/II study</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">4061</span>– <span class="NLM_lpage">4061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1182%2Fblood.V120.21.4061.4061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=4061-4061&author=N.+Rajeauthor=P.+N.+Hariauthor=D.+T.+Voglauthor=S.+Jagannathauthor=R.+Z.+Orlowskiauthor=J.+G.+Supkoauthor=P.+Stephensonauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=S.+Lonial&title=Rocilinostat+%28ACY-1215%29%2C+a+selective+HDAC6+inhibitor%2C+alone+and+in+combination+with+bortezomib+in+multiple+myeloma%3A+preliminary+results+from+the+first-in-humans+phase+I%2FII+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1182%2Fblood.V120.21.4061.4061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V120.21.4061.4061%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DHari%26aufirst%3DP.%2BN.%26aulast%3DVogl%26aufirst%3DD.%2BT.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DStephenson%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DLonial%26aufirst%3DS.%26atitle%3DRocilinostat%2520%2528ACY-1215%2529%252C%2520a%2520selective%2520HDAC6%2520inhibitor%252C%2520alone%2520and%2520in%2520combination%2520with%2520bortezomib%2520in%2520multiple%2520myeloma%253A%2520preliminary%2520results%2520from%2520the%2520first-in-humans%2520phase%2520I%252FII%2520study%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D4061%26epage%3D4061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce-Lara, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosko, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahlis, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reece, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat (ACY-1215), the first selective HDAC6 inhibitor, combines safely with pomalidomide and dexamethasone and shows promising early results in relapsed-and-refractory myeloma (ACE-MM-102 study)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4228</span>– <span class="NLM_lpage">4228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1182%2Fblood.V126.23.4228.4228" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=4228-4228&author=N.+S.+Rajeauthor=W.+Bensingerauthor=C.+E.+Coleauthor=S.+Lonialauthor=S.+Jagannathauthor=C.+E.+Arce-Laraauthor=J.+Valentauthor=A.+E.+Roskoauthor=W.+A.+Harbauthor=I.+Sandhuauthor=N.+J.+Bahlisauthor=D.+Reeceauthor=E.+Terposauthor=J.+Supkoauthor=D.+Tamangauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=R.+J.+Markelewiczauthor=P.+G.+Richardson&title=Ricolinostat+%28ACY-1215%29%2C+the+first+selective+HDAC6+inhibitor%2C+combines+safely+with+pomalidomide+and+dexamethasone+and+shows+promising+early+results+in+relapsed-and-refractory+myeloma+%28ACE-MM-102+study%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1182%2Fblood.V126.23.4228.4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V126.23.4228.4228%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%2BS.%26aulast%3DBensinger%26aufirst%3DW.%26aulast%3DCole%26aufirst%3DC.%2BE.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DArce-Lara%26aufirst%3DC.%2BE.%26aulast%3DValent%26aufirst%3DJ.%26aulast%3DRosko%26aufirst%3DA.%2BE.%26aulast%3DHarb%26aufirst%3DW.%2BA.%26aulast%3DSandhu%26aufirst%3DI.%26aulast%3DBahlis%26aufirst%3DN.%2BJ.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26atitle%3DRicolinostat%2520%2528ACY-1215%2529%252C%2520the%2520first%2520selective%2520HDAC6%2520inhibitor%252C%2520combines%2520safely%2520with%2520pomalidomide%2520and%2520dexamethasone%2520and%2520shows%2520promising%2520early%2520results%2520in%2520relapsed-and-refractory%2520myeloma%2520%2528ACE-MM-102%2520study%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D4228%26epage%3D4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardiola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1038/417455a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F417455a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12024216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455-458&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.+F.+Wangauthor=T.+P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase&doi=10.1038%2F417455a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a microtubule-associated deacetylase</span></div><div class="casAuthors">Hubbert, Charlotte; Guardiola, Amaris; Shao, Rong; Kawaguchi, Yoshiharu; Ito, Akihiro; Nixon, Andrew; Yoshida, Minoru; Wang, Xiao-Fan; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6887</span>),
    <span class="NLM_cas:pages">455-458</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reversible acetylation of α-tubulin has been implicated in regulating microtubule stability and function.  The distribution of acetylated α-tubulin is tightly controlled and stereotypic.  Acetylated α-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts.  However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known.  Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase.  HDAC6 is localized exclusively in the cytoplasm, where it assocs. with microtubules and localizes with the microtubule motor complex contg. p150glued.  In vivo, the overexpression of HDAC6 leads to a global deacetylation of α-tubulin, whereas a decrease in HDAC6 increases α-tubulin acetylation.  In vitro, purified HDAC6 potently deacetylates α-tubulin in assembled microtubules.  Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility.  Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biol. processes beyond histone metab. and gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp76Er3MrWtO7Vg90H21EOLACvtfcHk0lhTscV_JwUKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVersr4%253D&md5=f18cbb0af388925c606e822358ba3da6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2F417455a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417455a%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26epage%3D458%26doi%3D10.1038%2F417455a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2005.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.molcel.2005.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15916966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.+T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.+P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span></div><div class="casAuthors">Kovacs, Jeffrey J.; Murphy, Patrick J. M.; Gaillard, Stephanie; Zhao, Xuan; Wu, June-Tai; Nicchitta, Christopher V.; Yoshida, Minoru; Toft, David O.; Pratt, William B.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) and its accessory cochaperones function by facilitating the structural maturation and complex assembly of client proteins, including steroid hormone receptors and selected kinases.  By promoting the activity and stability of these signaling proteins, Hsp90 has emerged as a crit. modulator in cell signaling.  Here, we present evidence that Hsp90 chaperone activity is regulated by reversible acetylation and controlled by the deacetylase HDAC6.  We show that HDAC6 functions as an Hsp90 deacetylase.  Inactivation of HDAC6 leads to Hsp90 hyperacetylation, its dissocn. from an essential cochaperone, p23, and a loss of chaperone activity.  In HDAC6-deficient cells, Hsp90-dependent maturation of the glucocorticoid receptor (GR) is compromised, resulting in GR defective in ligand binding, nuclear translocation, and transcriptional activation.  Our results identify Hsp90 as a target of HDAC6 and suggest reversible acetylation as a unique mechanism that regulates Hsp90 chaperone complex activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rzQe2Zsw_7Vg90H21EOLACvtfcHk0lhTscV_JwUKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFOksb4%253D&md5=338a8456c56a74d82ad3d28cbccae33f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.molcel.2005.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bali, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pranpat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaraswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyapalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">26729</span>– <span class="NLM_lpage">26734</span>, <span class="refDoi"> DOI: 10.1074/jbc.C500186200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.C500186200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15937340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Ggs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26729-26734&author=P.+Baliauthor=M.+Pranpatauthor=J.+Bradnerauthor=M.+Balasisauthor=W.+Fiskusauthor=F.+Guoauthor=K.+Rochaauthor=S.+Kumaraswamyauthor=S.+Boyapalleauthor=P.+Atadjaauthor=E.+Setoauthor=K.+Bhalla&title=Inhibition+of+histone+deacetylase+6+acetylates+and+disrupts+the+chaperone+function+of+heat+shock+protein+90%3A+a+novel+basis+for+antileukemia+activity+of+histone+deacetylase+inhibitors&doi=10.1074%2Fjbc.C500186200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors</span></div><div class="casAuthors">Bali, Purva; Pranpat, Michael; Bradner, James; Balasis, Maria; Fiskus, Warren; Guo, Fei; Rocha, Kathy; Kumaraswamy, Sandhya; Boyapalle, Sandhya; Atadja, Peter; Seto, Edward; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">26729-26734</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hydroxamic acid (HAA) analog pan-histone deacetylase (HDAC) inhibitors (HDIs) LAQ824 and LBH589 have been shown to induce acetylation and inhibit the ATP binding and chaperone function of heat shock protein (HSP) 90.  This promotes the polyubiquitylation and degrdn. of the pro-growth and pro-survival client proteins Bcr-Abl, mutant FLT-3, c-Raf, and AKT in human leukemia cells.  HDAC6 is a member of the class IIB HDACs.  It is predominantly cytosolic, microtubule-assocd. α-tubulin deacetylase that is also known to promote aggresome inclusion of the misfolded polyubiquitylated proteins.  Here the authors demonstrate that in the Bcr-abl oncogene expressing human leukemia K562 cells, HDAC6 can be coimmunopptd. with HSP90, and the knock-down of HDAC6 by its siRNA induced the acetylation of HSP90 and α-tubulin.  Depletion of HDAC6 levels also inhibited the binding of HSP90 to ATP, reduced the chaperone assocn. of HSP90 with its client proteins, e.g.  Bcr-Abl, and induced polyubiquitylation and partial depletion of Bcr-Abl.  Conversely, the ectopic overexpression of HDAC6 inhibited LAQ824-induced acetylation of HSP90 and α-tubulin and reduced LAQ824-mediated depletion of Bcr-Abl, AKT, and c-Raf.  Collectively, these findings indicate that HDAC6 is also an HSP90 deacetylase.  Targeted inhibition of HDAC6 leads to acetylation of HSP90 and disruption of its chaperone function, resulting in polyubiquitylation and depletion of pro-growth and pro-survival HSP90 client proteins including Bcr-Abl.  Depletion of HDAC6 sensitized human leukemia cells to HAA-HDIs and proteasome inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzNG3KM62J7Vg90H21EOLACvtfcHk0lh2vo2v3yYZ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Ggs7w%253D&md5=0d634a576233827dc91d6b3044e56546</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500186200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500186200%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DP.%26aulast%3DPranpat%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DBalasis%26aufirst%3DM.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DK.%26aulast%3DKumaraswamy%26aufirst%3DS.%26aulast%3DBoyapalle%26aufirst%3DS.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520acetylates%2520and%2520disrupts%2520the%2520chaperone%2520function%2520of%2520heat%2520shock%2520protein%252090%253A%2520a%2520novel%2520basis%2520for%2520antileukemia%2520activity%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26729%26epage%3D26734%26doi%3D10.1074%2Fjbc.C500186200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">8637</span>– <span class="NLM_lpage">8647</span>, <span class="refDoi"> DOI: 10.1128/MCB.00393-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.00393-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17938201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=8637-8647&author=Y.+S.+Gaoauthor=C.+C.+Hubbertauthor=J.+Luauthor=Y.+S.+Leeauthor=J.+Y.+Leeauthor=T.+P.+Yao&title=Histone+deacetylase+6+regulates+growth+factor-induced+actin+remodeling+and+endocytosis&doi=10.1128%2FMCB.00393-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis</span></div><div class="casAuthors">Gao, Ya-sheng; Hubbert, Charlotte C.; Lu, Jianrong; Lee, Yi-Shan; Lee, Joo-Yong; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8637-8647</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a cytoplasmic deacetylase that uniquely catalyzes α-tubulin deacetylation and promotes cell motility.  However, the mechanism underlying HDAC6-dependent cell migration and the role for microtubule acetylation in motility are not known.  Here we show that HDAC6-induced global microtubule deacetylation was not sufficient to stimulate cell migration.  Unexpectedly, in response to growth factor stimulation, HDAC6 underwent rapid translocation to actin-enriched membrane ruffles and subsequently became assocd. with macropinosomes, the vesicles for fluid-phase endocytosis.  Supporting the importance of these assocns., membrane ruffle formation, macropinocytosis, and cell migration were all impaired in HDAC6-deficient cells.  Conversely, elevated HDAC6 levels promoted membrane ruffle formation with a concomitant increase in macropinocytosis and motility.  In search for an HDAC6 target, we found that heat shock protein 90 (Hsp90), another prominent substrate of HDAC6, was also recruited to membrane ruffles and macropinosomes.  Significantly, inhibition of Hsp90 activity suppressed membrane ruffling and cell migration, while expression of an acetylation-resistant Hsp90 mutant promoted ruffle formation.  Our results uncover a surprising role for HDAC6 in actin remodeling-dependent processes and identify the actin cytoskeleton as an important target of HDAC6-regulated protein deacetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxVaghZhsYZ7Vg90H21EOLACvtfcHk0lh2vo2v3yYZ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Cjug%253D%253D&md5=549e4ce46d614fea654bd69603c650c5</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1128%2FMCB.00393-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00393-07%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BS.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHistone%2520deacetylase%25206%2520regulates%2520growth%2520factor-induced%2520actin%2520remodeling%2520and%2520endocytosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D8637%26epage%3D8647%26doi%3D10.1128%2FMCB.00393-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dompierre, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrin, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordelieres, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3571</span>– <span class="NLM_lpage">3583</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0037-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.0037-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17392473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3571-3583&author=J.+P.+Dompierreauthor=J.+D.+Godinauthor=B.+C.+Charrinauthor=F.+P.+Cordelieresauthor=S.+J.+Kingauthor=S.+Humbertauthor=F.+Saudou&title=Histone+deacetylase+6+inhibition+compensates+for+the+transport+deficit+in+Huntington%E2%80%99s+disease+by+increasing+tubulin+acetylation&doi=10.1523%2FJNEUROSCI.0037-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation</span></div><div class="casAuthors">Dompierre, Jim P.; Godin, Juliette D.; Charrin, Benedicte C.; Cordelieres, Fabrice P.; King, Stephen J.; Humbert, Sandrine; Saudou, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3571-3583</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A defect in microtubule (MT)-based transport contributes to the neuronal toxicity obsd. in Huntington's disease (HD).  Histone deacetylase (HDAC) inhibitors show neuroprotective effects in this devastating neurodegenerative disorder.  We report here that HDAC inhibitors, including trichostatin A (TSA), increase vesicular transport of brain-derived neurotrophic factor (BDNF) by inhibiting HDAC6, thereby increasing acetylation at lysine 40 of α-tubulin.  MT acetylation in vitro and in cells causes the recruitment of the mol. motors dynein and kinesin-1 to MTs.  In neurons, acetylation at lysine 40 of α-tubulin increases the flux of vesicles and the subsequent release of BDNF.  We show that tubulin acetylation is reduced in HD brains and that TSA compensates for the transport- and release-defect phenotypes that are obsd. in disease.  Our findings reveal that HDAC6 inhibition and acetylation at lysine 40 of α-tubulin may be therapeutic targets of interest in disorders such as HD in which intracellular transport is altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHOlSuVjT9a7Vg90H21EOLACvtfcHk0lgtGT4WJa5m6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOjsLg%253D&md5=eda05dd830c0e02e621466563092900e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0037-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0037-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DDompierre%26aufirst%3DJ.%2BP.%26aulast%3DGodin%26aufirst%3DJ.%2BD.%26aulast%3DCharrin%26aufirst%3DB.%2BC.%26aulast%3DCordelieres%26aufirst%3DF.%2BP.%26aulast%3DKing%26aufirst%3DS.%2BJ.%26aulast%3DHumbert%26aufirst%3DS.%26aulast%3DSaudou%26aufirst%3DF.%26atitle%3DHistone%2520deacetylase%25206%2520inhibition%2520compensates%2520for%2520the%2520transport%2520deficit%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520increasing%2520tubulin%2520acetylation%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D3571%26epage%3D3583%26doi%3D10.1523%2FJNEUROSCI.0037-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reed, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jih, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyhofer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaertig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhey, K. J.</span></span> <span> </span><span class="NLM_article-title">Microtubule acetylation promotes kinesin-1 binding and transport</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2166</span>– <span class="NLM_lpage">2172</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2006.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cub.2006.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17084703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjtLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2166-2172&author=N.+A.+Reedauthor=D.+Caiauthor=T.+L.+Blasiusauthor=G.+T.+Jihauthor=E.+Meyhoferauthor=J.+Gaertigauthor=K.+J.+Verhey&title=Microtubule+acetylation+promotes+kinesin-1+binding+and+transport&doi=10.1016%2Fj.cub.2006.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Acetylation Promotes Kinesin-1 Binding and Transport</span></div><div class="casAuthors">Reed, Nathan A.; Cai, Dawen; Blasius, T. Lynne; Jih, Gloria T.; Meyhofer, Edgar; Gaertig, Jacek; Verhey, Kristen J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2166-2172</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Long-distance intracellular delivery is driven by kinesin and dynein motor proteins that ferry cargoes along microtubule tracks.  Current models postulate that directional trafficking is governed by known biophys. properties of these motors-kinesins generally move to the plus ends of microtubules in the cell periphery, whereas cytoplasmic dynein moves to the minus ends in the cell center.  However, these models are insufficient to explain how polarized protein trafficking to subcellular domains is accomplished.  We show that the kinesin-1 cargo protein JNK-interacting protein 1 (JIP1) is localized to only a subset of neurites in cultured neuronal cells.  The mechanism of polarized trafficking appears to involve the preferential recognition of microtubules contg. specific posttranslational modifications (PTMs) by the kinesin-1 motor domain.  Using a genetic approach to eliminate specific PTMs, we show that the loss of a single modification, α-tubulin acetylation at Lys-40, influences the binding and motility of kinesin-1 in vitro.  In addn., pharmacol. treatments that increase microtubule acetylation cause a redirection of kinesin-1 transport of JIP1 to nearly all neurite tips in vivo.  These results suggest that microtubule PTMs are important markers of distinct microtubule populations and that they act to control motor protein trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LH6Ksw7IYLVg90H21EOLACvtfcHk0lgtGT4WJa5m6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjtLzN&md5=912493542c364849cc77b29aafbc3a01</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DN.%2BA.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DBlasius%26aufirst%3DT.%2BL.%26aulast%3DJih%26aufirst%3DG.%2BT.%26aulast%3DMeyhofer%26aufirst%3DE.%26aulast%3DGaertig%26aufirst%3DJ.%26aulast%3DVerhey%26aufirst%3DK.%2BJ.%26atitle%3DMicrotubule%2520acetylation%2520promotes%2520kinesin-1%2520binding%2520and%2520transport%26jtitle%3DCurr.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D2166%26epage%3D2172%26doi%3D10.1016%2Fj.cub.2006.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbert, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span> <span> </span><span class="NLM_article-title">The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">11219</span>– <span class="NLM_lpage">11226</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.042754</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M109.042754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20133936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11219-11226&author=Y.+S.+Gaoauthor=C.+C.+Hubbertauthor=T.+P.+Yao&title=The+microtubule-associated+histone+deacetylase+6+%28HDAC6%29+regulates+epidermal+growth+factor+receptor+%28EGFR%29+endocytic+trafficking+and+degradation&doi=10.1074%2Fjbc.M109.042754"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation</span></div><div class="casAuthors">Gao, Ya-sheng; Hubbert, Charlotte C.; Yao, Tso-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">11219-11226</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a microtubule-assocd. deacetylase with tubulin deacetylase activity, and it binds dynein motors.  Recent studies revealed that microtubule acetylation affects the affinity and processivity of microtubule motors.  These unique properties implicate a role for HDAC6 in intracellular organelle transport.  Here, we show that HDAC6 assocs. with the endosomal compartments and controls epidermal growth factor receptor (EGFR) trafficking and degrdn.  We found that loss of HDAC6 promoted EGFR degrdn.  Mechanistically, HDAC6 deficiency did not cause aberrant EGFR internalization and recycling.  Rather, it resulted in accelerated segregation of EGFR from early endosomes and premature delivery of EGFR to the late endosomal and lysosomal compartments.  The deregulated EGFR endocytic trafficking was accompanied by an increase in microtubule-dependent movement of EGFR-bearing vesicles, revealing a novel regulation of EGFR vesicular trafficking and degrdn. by the microtubule deacetylase HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1BxF_ZY-3ULVg90H21EOLACvtfcHk0lgtGT4WJa5m6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFGlsLs%253D&md5=57eb3c30f45b2fa74ca64c741eb478c8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.042754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.042754%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BS.%26aulast%3DHubbert%26aufirst%3DC.%2BC.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DThe%2520microtubule-associated%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520regulates%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520endocytic%2520trafficking%2520and%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11219%26epage%3D11226%26doi%3D10.1074%2Fjbc.M109.042754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 alpha-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.jns.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21377170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFKmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2011&pages=1-8&author=G.+Liauthor=H.+Jiangauthor=M.+Changauthor=H.+Xieauthor=L.+Hu&title=HDAC6+alpha-tubulin+deacetylase%3A+a+potential+therapeutic+target+in+neurodegenerative+diseases&doi=10.1016%2Fj.jns.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases</span></div><div class="casAuthors">Li, Guoyi; Jiang, Huiyi; Chang, Ming; Xie, Hongrong; Hu, Linsen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs), or lysine deacetylases (KDAC), are epigenetic regulators that catalyze the removal of acetyl moieties from the tails of lysine residues of histones and other proteins.  To date, eighteen HDAC family members (HDAC1-11 and SIRT1-7) have been identified and grouped into four classes according to their homol. to yeast histone deacetylases.  HDACs play an important role in regulating gene transcription as well as a variety of cellular functions.  Recent studies have found that HDAC6 (α-tubulin deacetylase) has the novel ability to capture α-tubulin as a substrate and regulate the physiol. level of its acetylated form.  In addn., a growing body of evidence suggests that α-tubulin deacetylase plays a crit. role in the cellular response to the accumulation of misfolded and aggregated proteins, which are a prominent pathol. feature common to many age-related neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases.  Therefore, the role of α-tubulin deacetylase and its potential as a therapeutic target for neurodegenerative diseases are areas of rapidly expanding investigation.  Here we review the research of the role played by HDAC6 in the regulation of tubulin modification and aggresome formation.  We also summarize the specific inhibitors of HDAC6 and address reports that implicate HDAC6 in various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVloOrNKWBLVg90H21EOLACvtfcHk0liP9rbOPc7QVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFKmt7k%253D&md5=983e14b8e7fe8ef1cbb1005cfb677e06</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DHDAC6%2520alpha-tubulin%2520deacetylase%253A%2520a%2520potential%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2011%26volume%3D304%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.jns.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieland, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fass, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samiei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. H.</span></span> <span> </span><span class="NLM_article-title">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1038/nature10849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnature10849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22388814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=222-226&author=J.+Graffauthor=D.+Reiauthor=J.+S.+Guanauthor=W.+Y.+Wangauthor=J.+Seoauthor=K.+M.+Hennigauthor=T.+J.+Nielandauthor=D.+M.+Fassauthor=P.+F.+Kaoauthor=M.+Kahnauthor=S.+C.+Suauthor=A.+Samieiauthor=N.+Josephauthor=S.+J.+Haggartyauthor=I.+Delalleauthor=L.+H.+Tsai&title=An+epigenetic+blockade+of+cognitive+functions+in+the+neurodegenerating+brain&doi=10.1038%2Fnature10849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">An epigenetic blockade of cognitive functions in the neurodegenerating brain</span></div><div class="casAuthors">Graff Johannes; Rei Damien; Guan Ji-Song; Wang Wen-Yuan; Seo Jinsoo; Hennig Krista M; Nieland Thomas J F; Fass Daniel M; Kao Patricia F; Kahn Martin; Su Susan C; Samiei Alireza; Joseph Nadine; Haggarty Stephen J; Delalle Ivana; Tsai Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7388</span>),
    <span class="NLM_cas:pages">222-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease.  The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge.  Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible.  This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease.  Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression.  Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments.  These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_TBTrhihJh3WEEzDrymxmfW6udTcc2eZM70Bc88JICrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383ptlCjtw%253D%253D&md5=6e567f82c587972acbdf75fbb06d2954</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnature10849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10849%26sid%3Dliteratum%253Aachs%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRei%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DW.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DNieland%26aufirst%3DT.%2BJ.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DKao%26aufirst%3DP.%2BF.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BC.%26aulast%3DSamiei%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DDelalle%26aufirst%3DI.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DAn%2520epigenetic%2520blockade%2520of%2520cognitive%2520functions%2520in%2520the%2520neurodegenerating%2520brain%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D222%26epage%3D226%26doi%3D10.1038%2Fnature10849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrin, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrell-Pages, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dompierre, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangone, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordelieres, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span> <span> </span><span class="NLM_article-title">Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2004.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15242649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFejtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=127-138&author=L.+R.+Gauthierauthor=B.+C.+Charrinauthor=M.+Borrell-Pagesauthor=J.+P.+Dompierreauthor=H.+Rangoneauthor=F.+P.+Cordelieresauthor=J.+De+Meyauthor=M.+E.+MacDonaldauthor=V.+Lessmannauthor=S.+Humbertauthor=F.+Saudou&title=Huntingtin+controls+neurotrophic+support+and+survival+of+neurons+by+enhancing+BDNF+vesicular+transport+along+microtubules&doi=10.1016%2Fj.cell.2004.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules</span></div><div class="casAuthors">Gauthier, Laurent R.; Charrin, Benedicte C.; Borrell-Pages, Maria; Dompierre, Jim P.; Rangone, Helene; Cordelieres, Fabrice P.; De Mey, Jan; MacDonald, Marcy E.; Lessmann, Volkmar; Humbert, Sandrine; Saudou, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Polyglutamine expansion (polyQ) in the protein huntingtin is pathogenic and responsible for the neuronal toxicity assocd. with Huntington's disease (HD).  Although wild-type huntingtin possesses antiapoptotic properties, the relationship between the neuroprotective functions of huntingtin and pathogenesis of HD remains unclear.  Here, we show that huntingtin specifically enhances vesicular transport of brain-derived neurotrophic factor (BDNF) along microtubules.  Huntingtin-mediated transport involves huntingtin-assocd. protein-1 (HAP1) and the p150Glued subunit of dynactin, an essential component of mol. motors.  BDNF transport is attenuated both in the disease context and by reducing the levels of wild-type huntingtin.  The alteration of the huntingtin/HAP1/p150Glued complex correlates with reduced assocn. of motor proteins with microtubules.  Finally, we find that the polyQ-huntingtin-induced transport deficit results in the loss of neurotrophic support and neuronal toxicity.  Our findings indicate that a key role of huntingtin is to promote BDNF transport and suggest that loss of this function might contribute to pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpItkddoAVvnrVg90H21EOLACvtfcHk0lgpRJI49okRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFejtbc%253D&md5=99f2a8c0a66ae1a2168c2454c60bf682</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DL.%2BR.%26aulast%3DCharrin%26aufirst%3DB.%2BC.%26aulast%3DBorrell-Pages%26aufirst%3DM.%26aulast%3DDompierre%26aufirst%3DJ.%2BP.%26aulast%3DRangone%26aufirst%3DH.%26aulast%3DCordelieres%26aufirst%3DF.%2BP.%26aulast%3DDe%2BMey%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DLessmann%26aufirst%3DV.%26aulast%3DHumbert%26aufirst%3DS.%26aulast%3DSaudou%26aufirst%3DF.%26atitle%3DHuntingtin%2520controls%2520neurotrophic%2520support%2520and%2520survival%2520of%2520neurons%2520by%2520enhancing%2520BDNF%2520vesicular%2520transport%2520along%2520microtubules%26jtitle%3DCell%26date%3D2004%26volume%3D118%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.cell.2004.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ragot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietropaolo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinquant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinekugel, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. H.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington’s disease</span>. <i>Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00361</span>, <span class="refDoi"> DOI: 10.1002/brb3.361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fbrb3.361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26445700" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e00361&author=A.+Ragotauthor=S.+Pietropaoloauthor=J.+Vincentauthor=P.+Delageauthor=H.+Zhangauthor=B.+Allinquantauthor=X.+Leinekugelauthor=A.+Fischerauthor=Y.+H.+Cho&title=Genetic+deletion+of+the+Histone+Deacetylase+6+exacerbates+selected+behavioral+deficits+in+the+R6%2F1+mouse+model+for+Huntington%E2%80%99s+disease&doi=10.1002%2Fbrb3.361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fbrb3.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbrb3.361%26sid%3Dliteratum%253Aachs%26aulast%3DRagot%26aufirst%3DA.%26aulast%3DPietropaolo%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DJ.%26aulast%3DDelage%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAllinquant%26aufirst%3DB.%26aulast%3DLeinekugel%26aufirst%3DX.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DCho%26aufirst%3DY.%2BH.%26atitle%3DGenetic%2520deletion%2520of%2520the%2520Histone%2520Deacetylase%25206%2520exacerbates%2520selected%2520behavioral%2520deficits%2520in%2520the%2520R6%252F1%2520mouse%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Behav.%26date%3D2015%26volume%3D5%26spage%3De00361%26doi%3D10.1002%2Fbrb3.361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govindarajan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sananbenesi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluter, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span> <span> </span><span class="NLM_article-title">Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Femmm.201201923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23184605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFeh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=52-63&author=N.+Govindarajanauthor=P.+Raoauthor=S.+Burkhardtauthor=F.+Sananbenesiauthor=O.+M.+Schluterauthor=F.+Bradkeauthor=J.+Luauthor=A.+Fischer&title=Reducing+HDAC6+ameliorates+cognitive+deficits+in+a+mouse+model+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Femmm.201201923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease</span></div><div class="casAuthors">Govindarajan, Nambirajan; Rao, Pooja; Burkhardt, Susanne; Sananbenesi, Farahnaz; Schlueter, Oliver M.; Bradke, Frank; Lu, Jianrong; Fischer, Andre</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are currently being discussed as promising therapeutic targets to treat neurodegenerative diseases.  However, the role of specific HDACs in cognition and neurodegeneration remains poorly understood.  Here, we investigate the function of HDAC6, a class II member of the HDAC superfamily, in the adult mouse brain.  We report that mice lacking HDAC6 are cognitively normal but reducing endogenous HDAC6 levels restores learning and memory and α-tubulin acetylation in a mouse model for Alzheimer's disease (AD).  Our data suggest that this therapeutic effect is, at least in part, linked to the observation that loss of HDAC6 renders neurons resistant to amyloid-β-mediated impairment of mitochondrial trafficking.  Thus, our study suggests that targeting HDAC6 could be a suitable strategy to ameliorate cognitive decline obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogV6jnfwqJarVg90H21EOLACvtfcHk0liPR5Q5DPIL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFeh&md5=07ebf0d298c0927f3d736ab881118da5</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201923%26sid%3Dliteratum%253Aachs%26aulast%3DGovindarajan%26aufirst%3DN.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DBurkhardt%26aufirst%3DS.%26aulast%3DSananbenesi%26aufirst%3DF.%26aulast%3DSchluter%26aufirst%3DO.%2BM.%26aulast%3DBradke%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DReducing%2520HDAC6%2520ameliorates%2520cognitive%2520deficits%2520in%2520a%2520mouse%2520model%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D52%26epage%3D63%26doi%3D10.1002%2Femmm.201201923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simoes-Pires, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwick, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurisso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span> <span> </span><span class="NLM_article-title">HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-8-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1186%2F1750-1326-8-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23356410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVCjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=7&author=C.+Simoes-Piresauthor=V.+Zwickauthor=A.+Nurissoauthor=E.+Schenkerauthor=P.+A.+Carruptauthor=M.+Cuendet&title=HDAC6+as+a+target+for+neurodegenerative+diseases%3A+what+makes+it+different+from+the+other+HDACs%3F&doi=10.1186%2F1750-1326-8-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?</span></div><div class="casAuthors">Simoes-Pires, Claudia; Zwick, Vincent; Nurisso, Alessandra; Schenker, Esther; Carrupt, Pierre-Alain; Cuendet, Muriel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) inhibitors have been demonstrated to be beneficial in animal models of neurodegenerative diseases.  Such results were mainly assocd. with the epigenetic modulation caused by HDACs, esp. those from class I, via chromatin deacetylation.  However, other mechanisms may contribute to the neuroprotective effect of HDAC inhibitors, since each HDAC may present distinct specific functions within the neurodegenerative cascades.  Such an example is HDAC6 for which the role in neurodegeneration has been partially elucidated so far.  The strategy to be adopted in promising therapeutics targeting HDAC6 is still controversial.  Specific inhibitors exert neuroprotection by increasing the acetylation levels of α-tubulin with subsequent improvement of the axonal transport, which is usually impaired in neurodegenerative disorders.  On the other hand, an induction of HDAC6 would theor. contribute to the degrdn. of protein aggregates which characterize various neurodegenerative disorders, including Alzheimer's, Parkinson's and Hutington's diseases.  This review describes the specific role of HDAC6 compared to the other HDACs in the context of neurodegeneration, by collecting in silico, in vitro and in vivo results regarding the inhibition and/or knockdown of HDAC6 and other HDACs.  Moreover, structure, function, subcellular localization, as well as the level of HDAC6 expression within brain regions are reviewed and compared to the other HDAC isoforms.  In various neurodegenerative diseases, the mechanisms underlying HDAC6 interaction with other proteins seem to be a promising approach in understanding the modulation of HDAC6 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorL59x4ppImrVg90H21EOLACvtfcHk0liPR5Q5DPIL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVCjtbg%253D&md5=9a07e67b73798e75b3f8eb9d554cad92</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-8-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-8-7%26sid%3Dliteratum%253Aachs%26aulast%3DSimoes-Pires%26aufirst%3DC.%26aulast%3DZwick%26aufirst%3DV.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSchenker%26aufirst%3DE.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCuendet%26aufirst%3DM.%26atitle%3DHDAC6%2520as%2520a%2520target%2520for%2520neurodegenerative%2520diseases%253A%2520what%2520makes%2520it%2520different%2520from%2520the%2520other%2520HDACs%253F%26jtitle%3DMol.%2520Neurodegener.%26date%3D2013%26volume%3D8%26spage%3D7%26doi%3D10.1186%2F1750-1326-8-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianciardi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catania, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frullanti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallerini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzetti, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imperatore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amabile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzorusso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated alpha-tubulin defect which improves after iHDAC6 treatment in Rett syndrome</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2018.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.yexcr.2018.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29730163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlyrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2018&pages=225-235&author=E.+Landucciauthor=M.+Brindisiauthor=L.+Bianciardiauthor=L.+M.+Cataniaauthor=S.+Dagaauthor=S.+Crociauthor=E.+Frullantiauthor=C.+Falleriniauthor=S.+Butiniauthor=S.+Brogiauthor=S.+Furiniauthor=R.+Melaniauthor=A.+Molinaroauthor=F.+C.+Lorenzettiauthor=V.+Imperatoreauthor=S.+Amabileauthor=J.+Marianiauthor=F.+Mariauthor=F.+Arianiauthor=T.+Pizzorussoauthor=A.+M.+Pintoauthor=F.+M.+Vaccarinoauthor=A.+Renieriauthor=G.+Campianiauthor=I.+Meloni&title=iPSC-derived+neurons+profiling+reveals+GABAergic+circuit+disruption+and+acetylated+alpha-tubulin+defect+which+improves+after+iHDAC6+treatment+in+Rett+syndrome&doi=10.1016%2Fj.yexcr.2018.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome</span></div><div class="casAuthors">Landucci, Elisa; Brindisi, Margherita; Bianciardi, Laura; Catania, Lorenza M.; Daga, Sergio; Croci, Susanna; Frullanti, Elisa; Fallerini, Chiara; Butini, Stefania; Brogi, Simone; Furini, Simone; Melani, Riccardo; Molinaro, Angelo; Lorenzetti, Flaminia Clelia; Imperatore, Valentina; Amabile, Sonia; Mariani, Jessica; Mari, Francesca; Ariani, Francesca; Pizzorusso, Tommaso; Pinto, Anna Maria; Vaccarino, Flora M.; Renieri, Alessandra; Campiani, Giuseppe; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mutations in MECP2 gene have been identified in more than 95% of patients with classic Rett syndrome, one of the most common neurodevelopmental disorders in females.  Taking advantage of the breakthrough technol. of genetic reprogramming, we investigated transcriptome changes in neurons differentiated from induced Pluripotent Stem Cells (iPSCs) derived from patients with different mutations.  Profiling by RNA-seq in terminally differentiated neurons revealed a prominent GABAergic circuit disruption along with a perturbation of cytoskeleton dynamics.  In particular, in mutated neurons we identified a significant decrease of acetylated α-tubulin which can be reverted by treatment with selective inhibitors of HDAC6, the main α-tubulin deacetylase.  These findings contribute to shed light on Rett pathogenic mechanisms and provide hints for the treatment of Rett-assocd. epileptic behavior as well as for the definition of new therapeutic strategies for Rett syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJNxVTWah1EbVg90H21EOLACvtfcHk0lgX168QtgWALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlyrt7k%253D&md5=f62d6a257bde8931a05dcb2079c5b691</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2018.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DBianciardi%26aufirst%3DL.%26aulast%3DCatania%26aufirst%3DL.%2BM.%26aulast%3DDaga%26aufirst%3DS.%26aulast%3DCroci%26aufirst%3DS.%26aulast%3DFrullanti%26aufirst%3DE.%26aulast%3DFallerini%26aufirst%3DC.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DFurini%26aufirst%3DS.%26aulast%3DMelani%26aufirst%3DR.%26aulast%3DMolinaro%26aufirst%3DA.%26aulast%3DLorenzetti%26aufirst%3DF.%2BC.%26aulast%3DImperatore%26aufirst%3DV.%26aulast%3DAmabile%26aufirst%3DS.%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DPizzorusso%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DA.%2BM.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DiPSC-derived%2520neurons%2520profiling%2520reveals%2520GABAergic%2520circuit%2520disruption%2520and%2520acetylated%2520alpha-tubulin%2520defect%2520which%2520improves%2520after%2520iHDAC6%2520treatment%2520in%2520Rett%2520syndrome%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2018%26volume%3D368%26spage%3D225%26epage%3D235%26doi%3D10.1016%2Fj.yexcr.2018.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiheb, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irobi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1038/nm.2396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnm.2396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21785432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=968-974&author=C.+d%E2%80%99Ydewalleauthor=J.+Krishnanauthor=D.+M.+Chihebauthor=P.+Van+Dammeauthor=J.+Irobiauthor=A.+P.+Kozikowskiauthor=P.+Vanden+Bergheauthor=V.+Timmermanauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=HDAC6+inhibitors+reverse+axonal+loss+in+a+mouse+model+of+mutant+HSPB1-induced+Charcot-Marie-Tooth+disease&doi=10.1038%2Fnm.2396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease</span></div><div class="casAuthors">d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Irobi, Joy; Kozikowski, Alan P.; Vanden Berghe, Pieter; Timmerman, Vincent; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system.  Mutations in the 27-kDa small heat-shock protein gene (HSPB1) cause axonal CMT or distal hereditary motor neuropathy (distal HMN).  We developed and characterized transgenic mice expressing two different HSPB1 mutations (S135F and P182L) in neurons only.  These mice showed all features of CMT or distal HMN dependent on the mutation.  Expression of mutant HSPB1 decreased acetylated α-tubulin abundance and induced severe axonal transport deficits.  An increase of α-tubulin acetylation induced by pharmacol. inhibition of histone deacetylase 6 (HDAC6) cor. the axonal transport defects caused by HSPB1 mutations and rescued the CMT phenotype of symptomatic mutant HSPB1 mice.  Our findings demonstrate the pathogenic role of α-tubulin deacetylation in mutant HSPB1-induced neuropathies and offer perspectives for using HDAC6 inhibitors as a therapeutic strategy for hereditary axonopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcNnO5Y6PAjLVg90H21EOLACvtfcHk0lgX168QtgWALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlamu7o%253D&md5=3571d817e9a3d61d8df5f1dd6fc8358c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnm.2396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2396%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DKrishnan%26aufirst%3DJ.%26aulast%3DChiheb%26aufirst%3DD.%2BM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DIrobi%26aufirst%3DJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520inhibitors%2520reverse%2520axonal%2520loss%2520in%2520a%2520mouse%2520model%2520of%2520mutant%2520HSPB1-induced%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D968%26epage%3D974%26doi%3D10.1038%2Fnm.2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e42983</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0042983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0042983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22937007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42983&author=C.+Kimauthor=H.+Choiauthor=E.+S.+Jungauthor=W.+Leeauthor=S.+Ohauthor=N.+L.+Jeonauthor=I.+Mook-Jung&title=HDAC6+inhibitor+blocks+amyloid+beta-induced+impairment+of+mitochondrial+transport+in+hippocampal+neurons&doi=10.1371%2Fjournal.pone.0042983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons</span></div><div class="casAuthors">Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Oh, Soojung; Jeon, Noo Li; Mook-Jung, Inhee</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42983</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Even though the disruption of axonal transport is an important pathophysiol. factor in neurodegenerative diseases including Alzheimer's disease (AD), the relationship between disruption of axonal transport and pathogenesis of AD is poorly understood.  Considering that α-tubulin acetylation is an important factor in axonal transport and that Aβ impairs mitochondrial axonal transport, we manipulated the level of α-tubulin acetylation in hippocampal neurons with Aβ cultured in a microfluidic system and examd. its effect on mitochondrial axonal transport.  We found that inhibiting histone deacetylase 6 (HDAC6), which deacetylates α-tubulin, significantly restored the velocity and motility of the mitochondria in both anterograde and retrograde axonal transports, which would be otherwise compromised by Aβ.  The inhibition of HDAC6 also recovered the length of the mitochondria that had been shortened by Aβ to a normal level.  These results suggest that the inhibition of HDAC6 significantly rescues hippocampal neurons from Aβ-induced impairment of mitochondrial axonal transport as well as mitochondrial length.  The results presented in this paper identify HDAC6 as an important regulator of mitochondrial transport as well as elongation and, thus, a potential target whose pharmacol. inhibition contributes to improving mitochondrial dynamics in Aβ treated neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu1Z5ERylDarVg90H21EOLACvtfcHk0ljdCXRYzB7LPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GqsbzI&md5=695715a67114dfb9e88518b9ee3968de</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042983%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DJeon%26aufirst%3DN.%2BL.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DHDAC6%2520inhibitor%2520blocks%2520amyloid%2520beta-induced%2520impairment%2520of%2520mitochondrial%2520transport%2520in%2520hippocampal%2520neurons%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De42983%26doi%3D10.1371%2Fjournal.pone.0042983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chahrour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">The story of Rett syndrome: from clinic to neurobiology</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2007.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17988628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=422-437&author=M.+Chahrourauthor=H.+Y.+Zoghbi&title=The+story+of+Rett+syndrome%3A+from+clinic+to+neurobiology&doi=10.1016%2Fj.neuron.2007.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The story of Rett syndrome: from clinic to neurobiology</span></div><div class="casAuthors">Chahrour, Maria; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">422-437</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor involved in chromatin remodeling and the modulation of RNA splicing.  MECP2 aberrations result in a constellation of neuropsychiatric abnormalities, whereby both loss of function and gain in MECP2 dosage lead to similar neurol. phenotypes.  Recent studies demonstrate disease reversibility in RTT mouse models, suggesting that the neurol. defects in MECP2 disorders are not permanent.  To investigate the potential for restoring neuronal function in RTT patients, it is essential to identify MeCP2 targets or modifiers of the phenotype that can be therapeutically modulated.  Moreover, deciphering the mol. underpinnings of RTT is likely to contribute to the understanding of the pathogenesis of a broader class of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopG5K6_7b0rrVg90H21EOLACvtfcHk0ljdCXRYzB7LPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP&md5=95dd875581895cb15bd31e65d6eb4002</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DThe%2520story%2520of%2520Rett%2520syndrome%253A%2520from%2520clinic%2520to%2520neurobiology%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D422%26epage%3D437%26doi%3D10.1016%2Fj.neuron.2007.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coenraads, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, D. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpot, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarquinio, D. C.</span></span> <span> </span><span class="NLM_article-title">Rett Syndrome: Crossing the threshold to clinical translation</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2015.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.tins.2015.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26830113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=100-113&author=D.+M.+Katzauthor=A.+Birdauthor=M.+Coenraadsauthor=S.+J.+Grayauthor=D.+U.+Menonauthor=B.+D.+Philpotauthor=D.+C.+Tarquinio&title=Rett+Syndrome%3A+Crossing+the+threshold+to+clinical+translation&doi=10.1016%2Fj.tins.2015.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome- crossing the threshold to clinical translation</span></div><div class="casAuthors">Katz, David M.; Bird, Adrian; Coenraads, Monica; Gray, Steven J.; Menon, Debashish U.; Philpot, Benjamin D.; Tarquinio, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-113</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lying at the intersection between neurobiol. and epigenetics, Rett syndrome (RTT) has garnered intense interest in recent years, not only from a broad range of academic scientists, but also from the pharmaceutical and biotechnol. industries.  In addn. to the crit. need for treatments for this devastating disorder, optimism for developing RTT treatments derives from a unique convergence of factors, including a known monogenic cause, reversibility of symptoms in preclin. models, a strong clin. research infrastructure highlighted by an NIH-funded natural history study and well-established clinics with significant patient populations.  Here, we review recent advances in understanding the biol. of RTT, particularly promising preclin. findings, lessons from past clin. trials, and crit. elements of trial design for rare disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocisGeKOAgv7Vg90H21EOLACvtfcHk0ljdCXRYzB7LPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKiug%253D%253D&md5=aa540ce98ff3ae270678082659413a3a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2015.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2015.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DD.%2BM.%26aulast%3DBird%26aufirst%3DA.%26aulast%3DCoenraads%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DS.%2BJ.%26aulast%3DMenon%26aufirst%3DD.%2BU.%26aulast%3DPhilpot%26aufirst%3DB.%2BD.%26aulast%3DTarquinio%26aufirst%3DD.%2BC.%26atitle%3DRett%2520Syndrome%253A%2520Crossing%2520the%2520threshold%2520to%2520clinical%2520translation%26jtitle%3DTrends%2520Neurosci.%26date%3D2016%26volume%3D39%26spage%3D100%26epage%3D113%26doi%3D10.1016%2Fj.tins.2015.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt-Engerstrom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opitz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. F.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence</span>. <i>Am. J. Med. Genet. Suppl.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1002/ajmg.1320250506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fajmg.1320250506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=47-59&author=B.+Hagbergauthor=I.+Witt-Engerstromauthor=J.+M.+Opitzauthor=J.+F.+Reynolds&title=Rett+syndrome%3A+a+suggested+staging+system+for+describing+impairment+profile+with+increasing+age+towards+adolescence&doi=10.1002%2Fajmg.1320250506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fajmg.1320250506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.1320250506%26sid%3Dliteratum%253Aachs%26aulast%3DHagberg%26aufirst%3DB.%26aulast%3DWitt-Engerstrom%26aufirst%3DI.%26aulast%3DOpitz%26aufirst%3DJ.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BF.%26atitle%3DRett%2520syndrome%253A%2520a%2520suggested%2520staging%2520system%2520for%2520describing%2520impairment%2520profile%2520with%2520increasing%2520age%2520towards%2520adolescence%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%2520Suppl.%26date%3D1986%26volume%3D25%26spage%3D47%26epage%3D59%26doi%3D10.1002%2Fajmg.1320250506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Zeev, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewiecka-Jaworska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veneselli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djuric, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisgaard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejaski Bosnjak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogliati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintaudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melegh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djukic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span> <span> </span><span class="NLM_article-title">Rett networked database: an integrated clinical and genetic network of Rett syndrome databases</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1002/humu.22072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fhumu.22072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22415763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=1031-1036&author=E.+Grilloauthor=L.+Villardauthor=A.+Clarkeauthor=B.+Ben+Zeevauthor=M.+Pinedaauthor=N.+Bahi-Buissonauthor=A.+Hryniewiecka-Jaworskaauthor=T.+Bienvenuauthor=J.+Armstrongauthor=A.+Roche-Martinezauthor=F.+Mariauthor=E.+Veneselliauthor=S.+Russoauthor=A.+Vignoliauthor=G.+Piniauthor=M.+Djuricauthor=A.+M.+Bisgaardauthor=V.+Mejaski+Bosnjakauthor=N.+Polgarauthor=F.+Cogliatiauthor=K.+Ravnauthor=M.+Pintaudiauthor=B.+Meleghauthor=D.+Craiuauthor=A.+Djukicauthor=A.+Renieri&title=Rett+networked+database%3A+an+integrated+clinical+and+genetic+network+of+Rett+syndrome+databases&doi=10.1002%2Fhumu.22072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Rett networked database: An integrated clinical and genetic network of Rett syndrome databases</span></div><div class="casAuthors">Grillo, Elisa; Villard, Laurent; Clarke, Angus; Ben Zeev, Bruria; Pineda, Mercedes; Bahi-Buisson, Nadia; Hryniewiecka-Jaworska, Anna; Bienvenu, Thierry; Armstrong, Judith; Martinez, Ana Roche; Mari, Francesca; Veneselli, Edvige; Russo, Silvia; Vignoli, Aglaia; Pini, Giorgio; Djuric, Milena; Bisgaard, Anne-Marie; Mejaski Bosnjak, Vlatka; Polgar, Noemi; Cogliati, Francesca; Ravn, Kirstine; Pintaudi, Maria; Melegh, Bela; Craiu, Dana; Djukic, Aleksandra; Renieri, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1031-1036</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Rett syndrome (RTT) is a neurodevelopmental disorder with one principal phenotype and several distinct, atypical variants (Zappella, early seizure onset and congenital variants).  Mutations in MECP2 are found in most cases of classic RTT but at least two addnl. genes, CDKL5 and FOXG1, can underlie some (usually variant) cases.  There is only limited correlation between genotype and phenotype.  The Rett Networked Database () has been established to share clin. and genetic information.  Through an "adaptor" process of data harmonization, a set of 293 clin. items and 16 genetic items was generated; 62 clin. and 7 genetic items constitute the core dataset; 23 clin. items contain longitudinal information.  The database contains information on 1838 patients from 11 countries (Dec. 2011), with or without mutations in known genes.  These nos. can expand indefinitely.  Data are entered by a clinician in each center who supervises accuracy.  This network was constructed to make available pooled international data for the study of RTT natural history and genotype-phenotype correlation and to indicate the proportion of patients with specific clin. features and mutations.  We expect that the network will serve for the recruitment of patients into clin. trials and for developing quality measures to drive up stds. of medical management.  Hum Mutat 33:1031-1036, 2012. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApy2ISiZXI7Vg90H21EOLACvtfcHk0liwuuxUM06Tiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVantrc%253D&md5=403d2b340a73065b4425c481648f1a49</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22072%26sid%3Dliteratum%253Aachs%26aulast%3DGrillo%26aufirst%3DE.%26aulast%3DVillard%26aufirst%3DL.%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DBen%2BZeev%26aufirst%3DB.%26aulast%3DPineda%26aufirst%3DM.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DHryniewiecka-Jaworska%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DT.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DRoche-Martinez%26aufirst%3DA.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DVeneselli%26aufirst%3DE.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DVignoli%26aufirst%3DA.%26aulast%3DPini%26aufirst%3DG.%26aulast%3DDjuric%26aufirst%3DM.%26aulast%3DBisgaard%26aufirst%3DA.%2BM.%26aulast%3DMejaski%2BBosnjak%26aufirst%3DV.%26aulast%3DPolgar%26aufirst%3DN.%26aulast%3DCogliati%26aufirst%3DF.%26aulast%3DRavn%26aufirst%3DK.%26aulast%3DPintaudi%26aufirst%3DM.%26aulast%3DMelegh%26aufirst%3DB.%26aulast%3DCraiu%26aufirst%3DD.%26aulast%3DDjukic%26aufirst%3DA.%26aulast%3DRenieri%26aufirst%3DA.%26atitle%3DRett%2520networked%2520database%253A%2520an%2520integrated%2520clinical%2520and%2520genetic%2520network%2520of%2520Rett%2520syndrome%2520databases%26jtitle%3DHum.%2520Mutat.%26date%3D2012%26volume%3D33%26spage%3D1031%26epage%3D1036%26doi%3D10.1002%2Fhumu.22072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: a complex disorder with simple roots</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1038/nrg3897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnrg3897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25732612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1KhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=261-275&author=M.+J.+Lystauthor=A.+Bird&title=Rett+syndrome%3A+a+complex+disorder+with+simple+roots&doi=10.1038%2Fnrg3897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome: a complex disorder with simple roots</span></div><div class="casAuthors">Lyst, Matthew J.; Bird, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurol. disorder caused by mutations in the X-linked gene MECP2 (methyl-CpG-binding protein 2).  Two decades of research have fostered the view that MeCP2 is a multifunctional chromatin protein that integrates diverse aspects of neuronal biol.  More recently, studies have focused on specific RTT-assocd. mutations within the protein.  This work has yielded mol. insights into the crit. functions of MeCP2 that promise to simplify our understanding of RTT pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMfNncpoOgE7Vg90H21EOLACvtfcHk0li63hSi4Mzjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1KhtLY%253D&md5=40ce34ac999a1fbd831f475fb0e3b448</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnrg3897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3897%26sid%3Dliteratum%253Aachs%26aulast%3DLyst%26aufirst%3DM.%2BJ.%26aulast%3DBird%26aufirst%3DA.%26atitle%3DRett%2520syndrome%253A%2520a%2520complex%2520disorder%2520with%2520simple%2520roots%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2015%26volume%3D16%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrg3897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laherty, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, A.</span></span> <span> </span><span class="NLM_article-title">Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1038/30764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F30764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=9620804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=386-389&author=X.+Nanauthor=H.+H.+Ngauthor=C.+A.+Johnsonauthor=C.+D.+Lahertyauthor=B.+M.+Turnerauthor=R.+N.+Eisenmanauthor=A.+Bird&title=Transcriptional+repression+by+the+methyl-CpG-binding+protein+MeCP2+involves+a+histone+deacetylase+complex&doi=10.1038%2F30764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</span></div><div class="casAuthors">Nan, Xinsheng; Ng, Huck-Hui; Johnson, Colin A.; Laherty, Carol D.; Turner, Bryan M.; Eisenman, Robert N.; Bird, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6683</span>),
    <span class="NLM_cas:pages">386-389</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Cytosine residues in the sequence 5'CpG (cytosine-guanine) are often postsynthetically methylated in animal genomes.  CpG methylation is involved in long-term silencing of certain genes during mammalian development and in repression of viral genomes.  The methyl-CpG-binding proteins MeCP1 and MeCP2 interact specifically with methylated DNA and mediate transcriptional repression.  Here we study the mechanism of repression by MeCP2, and abundant nuclear protein that is essential for mouse embryogenesis.  MeCP2 binds tightly to chromosomes in a methylation-dependent manner.  It contains a transcriptional-repression domain (TRD) that can function at a distance in vivo and in vivo.  We show that a region of MeCP2 that localizes with the TRD assocs. with a corepressor complex contg. the transcriptional repressor mSin3A and histone deacetylases.  Transcriptional repression in vivo is relieved by the deacetylase inhibitor trichostatin A20, indicating that deacetylation of histones (and/or of other proteins) is an essential component of this repression mechanism.  The data suggest that two global mechanisms of gene regulation, DNA methylation and histone deacetylation, can be linked by MeCP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCn89hNfZyH7Vg90H21EOLACvtfcHk0li63hSi4Mzjfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKgurc%253D&md5=ee6cd28de0d05b82233654cc9e52e384</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2F30764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F30764%26sid%3Dliteratum%253Aachs%26aulast%3DNan%26aufirst%3DX.%26aulast%3DNg%26aufirst%3DH.%2BH.%26aulast%3DJohnson%26aufirst%3DC.%2BA.%26aulast%3DLaherty%26aufirst%3DC.%2BD.%26aulast%3DTurner%26aufirst%3DB.%2BM.%26aulast%3DEisenman%26aufirst%3DR.%2BN.%26aulast%3DBird%26aufirst%3DA.%26atitle%3DTranscriptional%2520repression%2520by%2520the%2520methyl-CpG-binding%2520protein%2520MeCP2%2520involves%2520a%2520histone%2520deacetylase%2520complex%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D386%26epage%3D389%26doi%3D10.1038%2F30764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, G. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermaak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landsberger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strouboulis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolffe, A. P.</span></span> <span> </span><span class="NLM_article-title">Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=9620779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK1cXls1Cqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=187-191&author=P.+L.+Jonesauthor=G.+C.+J.+Veenstraauthor=P.+A.+Wadeauthor=D.+Vermaakauthor=S.+U.+Kassauthor=N.+Landsbergerauthor=J.+Strouboulisauthor=A.+P.+Wolffe&title=Methylated+DNA+and+MeCP2+recruit+histone+deacetylase+to+repress+transcription&doi=10.1038%2F561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</span></div><div class="casAuthors">Jones, Peter L.; Veenstra, Gert Jan C.; Wade, Paul A.; Vermaak, Danielle; Kass, Stefan U.; Landsberger, Nicoletta; Strouboulis, John; Wolffe, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-191</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">CpG methylation in vertebrates correlates with alterations in chromatin structure and gene silencing.  Differences in DNA-methylation status are assocd. with imprinting phenomena and carcinogenesis.  In Xenopus laevis oocytes, DNA methylation dominantly silences transcription through the assembly of a repressive nucleosomal array.  Methylated DNA assembled into chromatin binds the transcriptional repressor MeCP2 which cofractionates with Sin3 and histone deacetylase.  Silencing conferred by MeCP2 and methylated DNA can be relieved by inhibition of histone deacetylase, facilitating the remodelling of chromatin and transcriptional activation.  These results establish a direct causal relationship between DNA methylation-dependent transcriptional silencing and the modification of chromatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXfSPMCeRFrVg90H21EOLACvtfcHk0liQ84d9TvWdtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls1Cqsbg%253D&md5=7afb73d9c06e2ed71134b97c59be5bb2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2F561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F561%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BL.%26aulast%3DVeenstra%26aufirst%3DG.%2BC.%2BJ.%26aulast%3DWade%26aufirst%3DP.%2BA.%26aulast%3DVermaak%26aufirst%3DD.%26aulast%3DKass%26aufirst%3DS.%2BU.%26aulast%3DLandsberger%26aufirst%3DN.%26aulast%3DStrouboulis%26aufirst%3DJ.%26aulast%3DWolffe%26aufirst%3DA.%2BP.%26atitle%3DMethylated%2520DNA%2520and%2520MeCP2%2520recruit%2520histone%2520deacetylase%2520to%2520repress%2520transcription%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D19%26spage%3D187%26epage%3D191%26doi%3D10.1038%2F561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambi, F.</span></span> <span> </span><span class="NLM_article-title">Rett syndrome: the complex nature of a monogenic disease</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1007/s00109-003-0444-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00109-003-0444-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=12750821" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2003&pages=346-354&author=A.+Renieriauthor=I.+Meloniauthor=I.+Longoauthor=F.+Arianiauthor=F.+Mariauthor=C.+Pescucciauthor=F.+Cambi&title=Rett+syndrome%3A+the+complex+nature+of+a+monogenic+disease&doi=10.1007%2Fs00109-003-0444-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1007%2Fs00109-003-0444-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-003-0444-9%26sid%3Dliteratum%253Aachs%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DMeloni%26aufirst%3DI.%26aulast%3DLongo%26aufirst%3DI.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DPescucci%26aufirst%3DC.%26aulast%3DCambi%26aufirst%3DF.%26atitle%3DRett%2520syndrome%253A%2520the%2520complex%2520nature%2520of%2520a%2520monogenic%2520disease%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2003%26volume%3D81%26spage%3D346%26epage%3D354%26doi%3D10.1007%2Fs00109-003-0444-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gold, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacina, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrill, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulou, J.</span></span> <span> </span><span class="NLM_article-title">MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors</span>. <i>J. Mol. Med. (Heidelberg, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/s00109-014-1202-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs00109-014-1202-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25209898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=63-72&author=W.+A.+Goldauthor=T.+A.+Lacinaauthor=L.+C.+Cantrillauthor=J.+Christodoulou&title=MeCP2+deficiency+is+associated+with+reduced+levels+of+tubulin+acetylation+and+can+be+restored+using+HDAC6+inhibitors&doi=10.1007%2Fs00109-014-1202-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors</span></div><div class="casAuthors">Gold, W. A.; Lacina, T. A.; Cantrill, L. C.; Christodoulou, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Rett syndrome (RTT) is a severe neurodevelopmental disorder, predominantly caused by loss of function mutations in the X-linked methyl-CpG-binding protein 2 (MECP2) gene.  Despite the genetic cause being known in the majority of cases, the pathophysiol. of the neurol. phenotype of RTT is largely unknown.  Tubulin and the microtubule network play an essential role in neuronal function whereby the acetylation state of microtubules dictates the efficiency of neuronal migration and differentiation, synaptic targeting and mol. motor trafficking of mRNA, high-energy mitochondria and brain-derived neurotrophic factor (BDNF)-contg. vesicles.  Recent reports have shown perturbations in tubulin and microtubule dynamics in MeCP2-deficient cells, suggesting a link between the aberrations of these cellular entities and the neurobiol. of RTT.  We have interrogated the functional state of the microtubule network in fibroblasts derived from two patients with RTT as well as cortical neurons from a RTT mouse model and obsd. a redn. in acetylated α-tubulin and an increase in the tubulin-specific deacetylase, histone deacetylase 6 (HDAC6).  Furthermore, we show that inhibition of HDAC6 by Tubastatin A can restore tubulin acetylation levels.  We also demonstrate microtubule instability in the RTT patient fibroblasts in response to nocodazole, which is progressively ameliorated in a mutation-dependent manner by Tubastatin A.  We conclude that Tubastatin A is capable of counteracting the microtubule defects obsd. in MeCP2-deficient cells, which could in turn lead to the restoration of mol. trafficking along the microtubules and thus could be a potentially new therapeutic option for RTT.  Key message: Cells from MeCP2-deficient cells show reduced levels of acetylated α-tubulin.  Cells from two patients and a RTT mouse model have increased levels of HDAC6 but not sirtuin 2 (SIRT2).  Inhibition of HDAC6 by Tubastatin A increases the in vitro acetylation of α-tubulin.  Inhibition of HDAC6 by Tubastatin A does not increase MECP2 expression.  Cells from two patients show microtubule instability, which is ameliorated by Tubastatin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo7Mx65AjB6rVg90H21EOLACvtfcHk0liQ84d9TvWdtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsbrK&md5=8b26f2d58d8c0e76a8952778935f6857</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1007%2Fs00109-014-1202-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-014-1202-x%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DW.%2BA.%26aulast%3DLacina%26aufirst%3DT.%2BA.%26aulast%3DCantrill%26aufirst%3DL.%2BC.%26aulast%3DChristodoulou%26aufirst%3DJ.%26atitle%3DMeCP2%2520deficiency%2520is%2520associated%2520with%2520reduced%2520levels%2520of%2520tubulin%2520acetylation%2520and%2520can%2520be%2520restored%2520using%2520HDAC6%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2015%26volume%3D93%26spage%3D63%26epage%3D72%26doi%3D10.1007%2Fs00109-014-1202-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaenisch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span> <span> </span><span class="NLM_article-title">Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1126/science.1086446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1086446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14593183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=885-889&author=W.+G.+Chenauthor=Q.+Changauthor=Y.+Linauthor=A.+Meissnerauthor=A.+E.+Westauthor=E.+C.+Griffithauthor=R.+Jaenischauthor=M.+E.+Greenberg&title=Derepression+of+BDNF+transcription+involves+calcium-dependent+phosphorylation+of+MeCP2&doi=10.1126%2Fscience.1086446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2</span></div><div class="casAuthors">Chen, Wen G.; Chang, Qiang; Lin, Yingxi; Meissner, Alexander; West, Anne E.; Griffith, Eric C.; Jaenisch, Rudolf; Greenberg, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">885-890</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mutations in MeCP2, which encodes a protein that has been proposed to function as a global transcriptional repressor, are the cause of Rett syndrome (RTT), an X-linked progressive neurol. disorder.  Although the selective inactivation of MeCP2 in neurons is sufficient to confer a Rett-like phenotype in mice, the specific functions of MeCP2 in postmitotic neurons are not known.  We find that MeCP2 binds selectively to BDNF promoter III and functions to repress expression of the BDNF gene.  Membrane depolarization triggers the calcium-dependent phosphorylation and release of MeCP2 from BDNF promoter III, thereby facilitating transcription.  These studies indicate that MeCP2 plays a key role in the control of neuronal activity-dependent gene regulation and suggest that the deregulation of this process may underlie the pathol. of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqadiNFQZ3QvbVg90H21EOLACvtfcHk0ljd7xeGUuzbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrc%253D&md5=3e5db4c68bb97dd46a105be5369f3856</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1126%2Fscience.1086446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1086446%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BG.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMeissner%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DA.%2BE.%26aulast%3DGriffith%26aufirst%3DE.%2BC.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DDerepression%2520of%2520BDNF%2520transcription%2520involves%2520calcium-dependent%2520phosphorylation%2520of%2520MeCP2%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D885%26epage%3D889%26doi%3D10.1126%2Fscience.1086446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinowich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. E.</span></span> <span> </span><span class="NLM_article-title">DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1126/science.1090842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1090842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=14593184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=890-893&author=K.+Martinowichauthor=D.+Hattoriauthor=H.+Wuauthor=S.+Fouseauthor=F.+Heauthor=Y.+Huauthor=G.+Fanauthor=Y.+E.+Sun&title=DNA+methylation-related+chromatin+remodeling+in+activity-dependent+BDNF+gene+regulation&doi=10.1126%2Fscience.1090842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Methylation-Related Chromatin Remodeling in Activity- Dependent Bdnf Gene Regulation</span></div><div class="casAuthors">Martinowich, Keri; Hattori, Daisuke; Wu, Hao; Fouse, Shaun; He, Fei; Hu, Yan; Fan, Guoping; Sun, Yi E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">890-893</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In conjunction with histone modifications, DNA methylation plays crit. roles in gene silencing through chromatin remodeling.  Changes in DNA methylation perturb neuronal function, and mutations in a methyl-CpG-binding protein, MeCP2, are assocd. with Rett syndrome.  We report that increased synthesis of brain-derived neurotrophic factor (BDNF) in neurons after depolarization correlates with a decrease in CpG methylation within the regulatory region of the Bdnf gene.  Moreover, increased Bdnf transcription involves dissocn. of the MeCP2-histone deacetylase-mSin3A repression complex from its promoter.  Our findings suggest that DNA methylation-related chromatin remodeling is important for activity-dependent gene regulation that may be crit. for neural plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxCJ2-ML-CTrVg90H21EOLACvtfcHk0ljd7xeGUuzbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt74%253D&md5=7045c55e0c2b4e3cecbd2f526924cbd5</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090842%26sid%3Dliteratum%253Aachs%26aulast%3DMartinowich%26aufirst%3DK.%26aulast%3DHattori%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DFouse%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DY.%2BE.%26atitle%3DDNA%2520methylation-related%2520chromatin%2520remodeling%2520in%2520activity-dependent%2520BDNF%2520gene%2520regulation%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D890%26epage%3D893%26doi%3D10.1126%2Fscience.1090842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span> <span> </span><span class="NLM_article-title">Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.09.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2006.09.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17046689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=255-269&author=Z.+Zhouauthor=E.+J.+Hongauthor=S.+Cohenauthor=W.+N.+Zhaoauthor=H.+Y.+Hoauthor=L.+Schmidtauthor=W.+G.+Chenauthor=Y.+Linauthor=E.+Savnerauthor=E.+C.+Griffithauthor=L.+Huauthor=J.+A.+Steenauthor=C.+J.+Weitzauthor=M.+E.+Greenberg&title=Brain-specific+phosphorylation+of+MeCP2+regulates+activity-dependent+Bdnf+transcription%2C+dendritic+growth%2C+and+spine+maturation&doi=10.1016%2Fj.neuron.2006.09.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</span></div><div class="casAuthors">Zhou, Zhaolan; Hong, Elizabeth J.; Cohen, Sonia; Zhao, Wen-ning; Ho, Hsin-yi Henry; Schmidt, Lauren; Chen, Wen G.; Lin, Yingxi; Savner, Erin; Griffith, Eric C.; Hu, Linda; Steen, Judith A. J.; Weitz, Charles J.; Greenberg, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-269</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations or duplications in MECP2 cause Rett and Rett-like syndromes, neurodevelopmental disorders characterized by mental retardation, motor dysfunction, and autistic behaviors.  MeCP2 is expressed in many mammalian tissues and functions as a global repressor of transcription; however, the mol. mechanisms by which MeCP2 dysfunction leads to the neural-specific phenotypes of RTT remain poorly understood.  Here, we show that neuronal activity and subsequent calcium influx trigger the de novo phosphorylation of MeCP2 at serine 421 (S421) by a CaMKII-dependent mechanism.  MeCP2 S421 phosphorylation is induced selectively in the brain in response to physiol. stimuli.  Significantly, we find that S421 phosphorylation controls the ability of MeCP2 to regulate dendritic patterning, spine morphogenesis, and the activity-dependent induction of Bdnf transcription.  These findings suggest that, by triggering MeCP2 phosphorylation, neuronal activity regulates a program of gene expression that mediates nervous system maturation and that disruption of this process in individuals with mutations in MeCP2 may underlie the neural-specific pathol. of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxLdcw-A5OYLVg90H21EOLACvtfcHk0ljjaXjSF8hHVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbjM&md5=cff541952b1b71843ed94a707201d13e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DHong%26aufirst%3DE.%2BJ.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DHo%26aufirst%3DH.%2BY.%26aulast%3DSchmidt%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%2BG.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DSavner%26aufirst%3DE.%26aulast%3DGriffith%26aufirst%3DE.%2BC.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSteen%26aufirst%3DJ.%2BA.%26aulast%3DWeitz%26aufirst%3DC.%2BJ.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26atitle%3DBrain-specific%2520phosphorylation%2520of%2520MeCP2%2520regulates%2520activity-dependent%2520Bdnf%2520transcription%252C%2520dendritic%2520growth%252C%2520and%2520spine%2520maturation%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D255%26epage%3D269%26doi%3D10.1016%2Fj.neuron.2006.09.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaenisch, R.</span></span> <span> </span><span class="NLM_article-title">The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2005.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.neuron.2005.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16446138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1eiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=341-348&author=Q.+Changauthor=G.+Khareauthor=V.+Daniauthor=S.+Nelsonauthor=R.+Jaenisch&title=The+disease+progression+of+Mecp2+mutant+mice+is+affected+by+the+level+of+BDNF+expression&doi=10.1016%2Fj.neuron.2005.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression</span></div><div class="casAuthors">Chang, Qiang; Khare, Gargi; Dani, Vardhan; Nelson, Sacha; Jaenisch, Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-348</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations in the MECP2 gene cause Rett syndrome (RTT).  Bdnf is a MeCP2 target gene; however, its role in RTT pathogenesis is unknown.  We examd. Bdnf conditional mutant mice for RTT-relevant pathologies and obsd. that loss of BDNF caused smaller brain size, smaller CA2 neurons, smaller glomerulus size, and a characteristic hindlimb-clasping phenotype.  BDNF protein level was reduced in Mecp2 mutant mice, and deletion of Bdnf in Mecp2 mutants caused an earlier onset of RTT-like symptoms.  To assess whether this interaction was functional and potentially therapeutically relevant, we increased BDNF expression in the Mecp2 mutant brain with a conditional Bdnf transgene.  BDNF overexpression extended the lifespan, rescued a locomotor defect, and reversed an electrophysiol. deficit obsd. in Mecp2 mutants.  Our results provide in vivo evidence for a functional interaction between Mecp2 and Bdnf and demonstrate the physiol. significance of altered BDNF expression/signaling in RTT disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7kHXzBB8YvrVg90H21EOLACvtfcHk0ljjaXjSF8hHVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1eiurw%253D&md5=8d0e8abc255205b6580345142620bc97</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2005.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2005.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DKhare%26aufirst%3DG.%26aulast%3DDani%26aufirst%3DV.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DJaenisch%26aufirst%3DR.%26atitle%3DThe%2520disease%2520progression%2520of%2520Mecp2%2520mutant%2520mice%2520is%2520affected%2520by%2520the%2520level%2520of%2520BDNF%2520expression%26jtitle%3DNeuron%26date%3D2006%26volume%3D49%26spage%3D341%26epage%3D348%26doi%3D10.1016%2Fj.neuron.2005.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span> <span> </span><span class="NLM_article-title">Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">10911</span>– <span class="NLM_lpage">10915</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1810-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1810-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17050729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFynsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10911-10915&author=H.+Wangauthor=S.+A.+Chanauthor=M.+Ogierauthor=D.+Hellardauthor=Q.+Wangauthor=C.+Smithauthor=D.+M.+Katz&title=Dysregulation+of+brain-derived+neurotrophic+factor+expression+and+neurosecretory+function+in+Mecp2+null+mice&doi=10.1523%2FJNEUROSCI.1810-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice</span></div><div class="casAuthors">Wang, Hong; Chan, Shyue-an; Ogier, Michael; Hellard, David; Wang, Qifang; Smith, Corey; Katz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">10911-10915</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Disruptions in brain-derived neurotrophic factor (BDNF) expression are proposed to contribute to the mol. pathogenesis of Rett syndrome (RTT), a severe neurol. disorder caused by loss-of-function mutations in methyl-CpG-binding protein-2 (MeCP2).  Although MeCP2 is a transcriptional regulator of BDNF, it is unknown how MeCP2 mutations affect transsynaptic BDNF signaling.  Our findings demonstrate an early, abnormal neurosecretory phenotype in MeCP2-deficient neurons characterized by significant increases in the percentage of cellular BDNF content available for release.  However, loss of MeCP2 also results in deficits in total cell BDNF content that are developmentally regulated in a cell-type-specific manner.  Thus, the net effect of MeCP2 loss on abs. BDNF secretion changes with age and is detd. by both the amt. of BDNF available for release and progressive declines in total cellular BDNF.  We propose, therefore, that loss of MeCP2 function disrupts transsynaptic BDNF signaling by perturbing the normal balance between BDNF protein levels and secretion.  However, mutant neurons are capable of secreting wild-type levels of BDNF in response to high-frequency elec. stimulation.  In addn., we found elevated exocytic function in Mecp2-/y adrenal chromaffin cells, indicating that the Mecp2 null mutation is assocd. with alternations of neurosecretion that are not restricted to BDNF.  These findings are the first examples of abnormal neuropeptide and catecholamine secretion in a mouse model of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVYNTyHHxfcbVg90H21EOLACvtfcHk0lgWj7CLEdYfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFynsr7O&md5=5d6791c001c81acf0699996f01ff3ba1</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1810-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1810-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DS.%2BA.%26aulast%3DOgier%26aufirst%3DM.%26aulast%3DHellard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DKatz%26aufirst%3DD.%2BM.%26atitle%3DDysregulation%2520of%2520brain-derived%2520neurotrophic%2520factor%2520expression%2520and%2520neurosecretory%2520function%2520in%2520Mecp2%2520null%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10911%26epage%3D10915%26doi%3D10.1523%2FJNEUROSCI.1810-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, D. M.</span></span> <span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">10912</span>– <span class="NLM_lpage">10917</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1869-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1869-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17913925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyit77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=10912-10917&author=M.+Ogierauthor=H.+Wangauthor=E.+Hongauthor=Q.+Wangauthor=M.+E.+Greenbergauthor=D.+M.+Katz&title=Brain-derived+neurotrophic+factor+expression+and+respiratory+function+improve+after+ampakine+treatment+in+a+mouse+model+of+Rett+syndrome&doi=10.1523%2FJNEUROSCI.1869-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome</span></div><div class="casAuthors">Ogier, Michael; Wang, Hong; Hong, Elizabeth; Wang, Qifang; Greenberg, Michael E.; Katz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10912-10917</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is caused by loss-of-function mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2).  Although MeCP2 is thought to act as a transcriptional repressor of brain-derived neurotrophic factor (BDNF), Mecp2 null mice, which develop an RTT-like phenotype, exhibit progressive deficits in BDNF expression.  These deficits are particularly significant in the brainstem and nodose cranial sensory ganglia (NGs), structures crit. for cardiorespiratory homeostasis, and may be linked to the severe respiratory abnormalities characteristic of RTT.  Therefore, the present study used Mecp2 null mice to further define the role of MeCP2 in regulation of BDNF expression and neural function, focusing on NG neurons and respiratory control.  We find that mutant neurons express significantly lower levels of BDNF than wild-type cells in vitro, as in vivo, under both depolarizing and nondepolarizing conditions.  However, BDNF levels in mutant NG cells can be increased by chronic depolarization in vitro or by treatment of Mecp2 null mice with CX546, an ampakine drug that facilitates activation of glutamatergic AMPA receptors.  Ampakine-treated Mecp2 null mice also exhibit marked functional improvement, characterized by restoration of normal breathing frequency and minute vol.  These data demonstrate that BDNF expression remains plastic in Mecp2 null mice and raise the possibility that ampakine compds. could be of therapeutic value in the treatment of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiktLEp6zGPrVg90H21EOLACvtfcHk0lgWj7CLEdYfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyit77F&md5=9dae9aa4defedefcc7ac08ca0f62f10b</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1869-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1869-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DOgier%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DGreenberg%26aufirst%3DM.%2BE.%26aulast%3DKatz%26aufirst%3DD.%2BM.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520expression%2520and%2520respiratory%2520function%2520improve%2520after%2520ampakine%2520treatment%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520syndrome%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D10912%26epage%3D10917%26doi%3D10.1523%2FJNEUROSCI.1869-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calfa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larimore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17087</span>– <span class="NLM_lpage">17092</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205271109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1205271109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23027959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17087-17092&author=W.+Liauthor=G.+Calfaauthor=J.+Larimoreauthor=L.+Pozzo-Miller&title=Activity-dependent+BDNF+release+and+TRPC+signaling+is+impaired+in+hippocampal+neurons+of+Mecp2+mutant+mice&doi=10.1073%2Fpnas.1205271109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice</span></div><div class="casAuthors">Li, Wei; Calfa, Gaston; Larimore, Jennifer; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17087-17092, S17087/1-S17087/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Dysfunction of the neurotrophin brain-derived neurotrophic factor (BDNF) is implicated in Rett syndrome (RTT), but the state of its releasable pool and downstream signaling in mice lacking methyl-CpG-binding protein-2 (Mecp2) is unknown.  Here, we show that membrane currents and dendritic Ca2+ signals evoked by recombinant BDNF or an activator of diacylglycerol (DAG)-sensitive transient receptor potential canonical (TRPC) channels are impaired in CA3 pyramidal neurons of symptomatic Mecp2 mutant mice.  TRPC3 and TRPC6 mRNA and protein levels are lower in Mecp2 mutant hippocampus, and chromatin immunopptn.  (ChIP) identified Trpc3 as a target of MeCP2 transcriptional regulation.  BDNF mRNA and protein levels are also lower in Mecp2 mutant hippocampus and dentate gyrus granule cells, which is reflected in impaired activity-dependent release of endogenous BDNF estd. from TRPC currents and dendritic Ca2+ signals in CA3 pyramidal neurons.  These results identify the gene encoding TRPC3 channels as a MeCP2 target and suggest a potential therapeutic strategy to boost impaired BDNF signaling in RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOPVEdM2eqSbVg90H21EOLACvtfcHk0lgWj7CLEdYfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsLbO&md5=dff6806a40e218cbb0bcf452670994b1</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205271109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205271109%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DCalfa%26aufirst%3DG.%26aulast%3DLarimore%26aufirst%3DJ.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DActivity-dependent%2520BDNF%2520release%2520and%2520TRPC%2520signaling%2520is%2520impaired%2520in%2520hippocampal%2520neurons%2520of%2520Mecp2%2520mutant%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17087%26epage%3D17092%26doi%3D10.1073%2Fpnas.1205271109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneussel, M.</span></span> <span> </span><span class="NLM_article-title">Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2010.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.tins.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20541813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=362-372&author=C.+Jankeauthor=M.+Kneussel&title=Tubulin+post-translational+modifications%3A+encoding+functions+on+the+neuronal+microtubule+cytoskeleton&doi=10.1016%2Fj.tins.2010.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton</span></div><div class="casAuthors">Janke, Carsten; Kneussel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">362-372</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past decades, a range of post-translational modifications has been discovered on tubulins, the major constituents of microtubules.  Pioneering studies have described the occurrence and dynamics of these modifications and provided first insights into their potential functions in regulating the microtubule cytoskeleton.  By contrast, several tubulin-modifying enzymes were only discovered in the last few years, and studies on mol. mechanisms and cellular functions of tubulin modifications are just beginning to emerge.  This review highlights the roles of tubulin modifications in neurons.  Recent studies are also discussed in relation to how the combinatorial use of tubulin modifications could generate a dynamic microtubule code, and how such a code might regulate basic as well as higher-order neuronal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQpu8-slRP7Vg90H21EOLACvtfcHk0libYQN6uOYrMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFOgtLo%253D&md5=02ed3a8248b2403d0fcbb47863180b50</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DKneussel%26aufirst%3DM.%26atitle%3DTubulin%2520post-translational%2520modifications%253A%2520encoding%2520functions%2520on%2520the%2520neuronal%2520microtubule%2520cytoskeleton%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D362%26epage%3D372%26doi%3D10.1016%2Fj.tins.2010.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarenkova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelman, D. B.</span></span> <span> </span><span class="NLM_article-title">HDAC6 regulates mitochondrial transport in hippocampal neurons</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e10848</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0010848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0010848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20520769" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e10848&author=S.+Chenauthor=G.+C.+Owensauthor=H.+Makarenkovaauthor=D.+B.+Edelman&title=HDAC6+regulates+mitochondrial+transport+in+hippocampal+neurons&doi=10.1371%2Fjournal.pone.0010848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0010848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0010848%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DOwens%26aufirst%3DG.%2BC.%26aulast%3DMakarenkova%26aufirst%3DH.%26aulast%3DEdelman%26aufirst%3DD.%2BB.%26atitle%3DHDAC6%2520regulates%2520mitochondrial%2520transport%2520in%2520hippocampal%2520neurons%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De10848%26doi%3D10.1371%2Fjournal.pone.0010848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delepine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nectoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span> <span> </span><span class="NLM_article-title">MeCP2 deficiency is associated with impaired microtubule stability</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>587</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2012.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.febslet.2012.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23238081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ku7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=245-253&author=C.+Delepineauthor=J.+Nectouxauthor=N.+Bahi-Buissonauthor=J.+Chellyauthor=T.+Bienvenu&title=MeCP2+deficiency+is+associated+with+impaired+microtubule+stability&doi=10.1016%2Fj.febslet.2012.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">MeCP2 deficiency is associated with impaired microtubule stability</span></div><div class="casAuthors">Delepine, Chloe; Nectoux, Juliette; Bahi-Buisson, Nadia; Chelly, Jamel; Bienvenu, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations.  Previous studies performed on Mecp2-deficient brain showed striking changes in neuronal maturation.  We recently showed that MeCP2 deficiency affects microtubule (MT) dynamics in RTT astrocytes.  Here, we analyze MT stability in primary fibroblast cultures from patients with RTT syndrome and identify a significant decrease in stability compared to controls.  Furthermore, we found that MT stability was reduced both in cells expressing the mutant or the wild-type allele in RTT fibroblasts, suggesting that mutated cells could damage wild-type ones through a non-cell-autonomous pathway.  These results suggest that MeCP2 has a stabilizing role on MT dynamics and that its deficiency could lead to impaired MT stability that may explain in part the dendritic abnormalities obsd. in RTT brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfVISwfhNEbVg90H21EOLACvtfcHk0lg5ERg1AAAtaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ku7nM&md5=942ef1c49fc4ae54b75faa30608f79fb</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DDelepine%26aufirst%3DC.%26aulast%3DNectoux%26aufirst%3DJ.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBienvenu%26aufirst%3DT.%26atitle%3DMeCP2%2520deficiency%2520is%2520associated%2520with%2520impaired%2520microtubule%2520stability%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D245%26epage%3D253%26doi%3D10.1016%2Fj.febslet.2012.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nectoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delepine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahi-Buisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khelfaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, T.</span></span> <span> </span><span class="NLM_article-title">Altered microtubule dynamics in Mecp2-deficient astrocytes</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1002/jnr.23001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fjnr.23001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22252744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=990-998&author=J.+Nectouxauthor=C.+Florianauthor=C.+Delepineauthor=N.+Bahi-Buissonauthor=M.+Khelfaouiauthor=S.+Reibelauthor=J.+Chellyauthor=T.+Bienvenu&title=Altered+microtubule+dynamics+in+Mecp2-deficient+astrocytes&doi=10.1002%2Fjnr.23001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Altered microtubule dynamics in Mecp2-deficient astrocytes</span></div><div class="casAuthors">Nectoux, Juliette; Florian, Cedrick; Delepine, Chloe; Bahi-Buisson, Nadia; Khelfaoui, Malik; Reibel, Sophie; Chelly, Jamel; Bienvenu, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">990-998</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the gene MECP2 encoding the methyl-CpG binding protein 2.  This genetic disease affects predominantly girls and is characterized by a period of normal development that lasts for 8-18 mo, followed by neurol. regression affecting both motor and mental abilities.  Previous studies performed on brains from RTT subjects and Mecp2-deficient mice showed striking changes in neuronal maturation and dendritic arborization.  Recently, we showed that expression of stathmin-like 2 (STMN2) was significantly reduced in fibroblasts from RTT patients, and similar results were obtained in the cerebellum of Mecp2-deficient mice.  Because assembly and dynamics of microtubules are known to be modulated by STMN2, we studied microtubule dynamics in brain cells from Mecp2-deficient mice.  We obsd. that Mecp2 deficiency affects microtubule dynamics in astrocytes from Mecp2-deficient mice.  Our data reinforce the fact that the loss of Mecp2 in astrocytes may influence the onset and progression of RTT.  These results imply that Mecp2 has a stabilizing role in microtubule dynamics and that Mecp2 deficiency, which is assocd. with STMN2 down-regulation, could lead to impaired microtubule stability, hence explaining the dendritic abnormalities obsd. in RTT brains. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-NJY-_lR-rVg90H21EOLACvtfcHk0lg5ERg1AAAtaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2ksw%253D%253D&md5=0f46dd22d8ce691001788bdf82758c61</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23001%26sid%3Dliteratum%253Aachs%26aulast%3DNectoux%26aufirst%3DJ.%26aulast%3DFlorian%26aufirst%3DC.%26aulast%3DDelepine%26aufirst%3DC.%26aulast%3DBahi-Buisson%26aufirst%3DN.%26aulast%3DKhelfaoui%26aufirst%3DM.%26aulast%3DReibel%26aufirst%3DS.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBienvenu%26aufirst%3DT.%26atitle%3DAltered%2520microtubule%2520dynamics%2520in%2520Mecp2-deficient%2520astrocytes%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2012%26volume%3D90%26spage%3D990%26epage%3D998%26doi%3D10.1002%2Fjnr.23001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roux, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panayotis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges-Correia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saudou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, L.</span></span> <span> </span><span class="NLM_article-title">Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2011.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2011.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22127389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=786-795&author=J.+C.+Rouxauthor=D.+Zalaauthor=N.+Panayotisauthor=A.+Borges-Correiaauthor=F.+Saudouauthor=L.+Villard&title=Modification+of+Mecp2+dosage+alters+axonal+transport+through+the+Huntingtin%2FHap1+pathway&doi=10.1016%2Fj.nbd.2011.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway</span></div><div class="casAuthors">Roux, Jean-Christophe; Zala, Diana; Panayotis, Nicolas; Borges-Correia, Ana; Saudou, Frederic; Villard, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mecp2 deficiency or overexpression causes a wide spectrum of neurol. diseases in humans among which Rett Syndrome is the prototype.  Pathogenic mechanisms are thought to involve transcriptional deregulation of target genes such as Bdnf together with defects in the general transcriptional program of affected cells.  Here we found that two master genes, Huntingtin (Htt) and huntingtin-assocd. protein (Hap1), involved in the control of Bdnf axonal transport, are altered in the brain of Mecp2-deficient mice.  We also revealed an in vivo defect of Bdnf transport throughout the cortico striatal pathway of Mecp2-deficient animals.  We found that the velocity of Bdnf-contg. vesicles is reduced in vitro in the Mecp2-deficient axons and this deficit can be rescued by the re-expression of Mecp2.  The defect in axonal transport is not restricted to Bdnf since transport of the amyloid precursor protein (App) that is Htt and Hap1-dependent is also altered.  Finally, treating Mecp2-deficient mice with cysteamine, a mol. increasing the secretion of Bdnf vesicles, improved the lifespan and reduced motor defects, suggesting a new therapeutic strategy for Rett syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7dy9l4DfUQbVg90H21EOLACvtfcHk0lg5ERg1AAAtaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKjsQ%253D%253D&md5=4f208a5a7a9cfd13474e5db913bde567</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DRoux%26aufirst%3DJ.%2BC.%26aulast%3DZala%26aufirst%3DD.%26aulast%3DPanayotis%26aufirst%3DN.%26aulast%3DBorges-Correia%26aufirst%3DA.%26aulast%3DSaudou%26aufirst%3DF.%26aulast%3DVillard%26aufirst%3DL.%26atitle%3DModification%2520of%2520Mecp2%2520dosage%2520alters%2520axonal%2520transport%2520through%2520the%2520Huntingtin%252FHap1%2520pathway%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D45%26spage%3D786%26epage%3D795%26doi%3D10.1016%2Fj.nbd.2011.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">10842</span>– <span class="NLM_lpage">10846</span>, <span class="refDoi"> DOI: 10.1021/ja102758v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A&doi=10.1021%2Fja102758v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0lgnJN5hNnOQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846%26doi%3D10.1021%2Fja102758v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asthana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">22516</span>– <span class="NLM_lpage">22526</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.489328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M113.489328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23798680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Whsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22516-22526&author=J.+Asthanaauthor=S.+Kapoorauthor=R.+Mohanauthor=D.+Panda&title=Inhibition+of+HDAC6+deacetylase+activity+increases+its+binding+with+microtubules+and+suppresses+microtubule+dynamic+instability+in+MCF-7+cells&doi=10.1074%2Fjbc.M113.489328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells</span></div><div class="casAuthors">Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">22516-22526</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The post-translational modification of tubulin appears to be a highly controlled mechanism that regulates microtubule functioning.  Acetylation of the .vepsiln.-amino group of Lys-40 of α-tubulin marks stable microtubules, although the causal relationship between tubulin acetylation and microtubule stability has remained poorly understood.  HDAC6, the tubulin deacetylase, plays a key role in maintaining typical distribution of acetylated microtubules in cells.  Here, by using tubastatin A, an HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC6, we have explored whether tubulin acetylation has a role in regulating microtubule stability.  We found that whereas both pharmacol. inhibition of HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacol. inhibition of HDAC6 activity leads to an increase in microtubule stability against cold and nocodazole-induced depolymg. conditions.  Tubastatin A treatment suppressed the dynamics of individual microtubules in MCF-7 cells and delayed the reassembly of depolymd. microtubules.  Interestingly, both the localization of HDAC6 on microtubules and the amt. of HDAC6 assocd. with polymeric fraction of tubulin were found to increase in the tubastatin A-treated cells compared with the control cells, suggesting that the pharmacol. inhibition of HDAC6 enhances the binding of HDAC6 to microtubules.  The evidence presented in this study indicated that the increased binding of HDAC6, rather than the acetylation per se, causes microtubule stability.  The results are in support of a hypothesis that in addn. to its deacetylase function, HDAC6 might function as a MAP that regulates microtubule dynamics under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg9tZTljw347Vg90H21EOLACvtfcHk0lgnJN5hNnOQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Whsr%252FJ&md5=455f7258d82d50403329a6c5e78c98d8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.489328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.489328%26sid%3Dliteratum%253Aachs%26aulast%3DAsthana%26aufirst%3DJ.%26aulast%3DKapoor%26aufirst%3DS.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DPanda%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520HDAC6%2520deacetylase%2520activity%2520increases%2520its%2520binding%2520with%2520microtubules%2520and%2520suppresses%2520microtubule%2520dynamic%2520instability%2520in%2520MCF-7%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D22516%26epage%3D22526%26doi%3D10.1074%2Fjbc.M113.489328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Outeiro, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathearn, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amore, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochet, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feany, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazantsev, A. G.</span></span> <span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lhvUwpmOhJkkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadakata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saruta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itohara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, T.</span></span> <span> </span><span class="NLM_article-title">Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">21104</span>– <span class="NLM_lpage">21109</span>, <span class="refDoi"> DOI: 10.1073/pnas.1210055109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1210055109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23213205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1eltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21104-21109&author=T.+Sadakataauthor=Y.+Shinodaauthor=M.+Okaauthor=Y.+Sekineauthor=Y.+Satoauthor=C.+Sarutaauthor=H.+Miwaauthor=M.+Tanakaauthor=S.+Itoharaauthor=T.+Furuichi&title=Reduced+axonal+localization+of+a+Caps2+splice+variant+impairs+axonal+release+of+BDNF+and+causes+autistic-like+behavior+in+mice&doi=10.1073%2Fpnas.1210055109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice</span></div><div class="casAuthors">Sadakata, Tetsushi; Shinoda, Yo; Oka, Megumi; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Miwa, Hideki; Tanaka, Mika; Itohara, Shigeyoshi; Furuichi, Teiichi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">21104-21109, S21104/1-S21104/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ca2+-dependent activator protein for secretion 2 (CAPS2 or CADPS2) potently promotes the release of brain-derived neurotrophic factor (BDNF).  A rare splicing form of CAPS2 with deletion of exon3 (dex3) was identified to be overrepresented in some patients with autism.  Here, we generated Caps2-dex3 mice and verified a severe impairment in axonal Caps2-dex3 localization, contributing to a redn. in BDNF release from axons.  In addn., circuit connectivity, measured by spine and interneuron d., was diminished globally.  The collective effect of reduced axonal BDNF release during development was a striking and selective repertoire of deficits in social- and anxiety-related behaviors.  Together, these findings represent a unique mouse model of a mol. mechanism linking BDNF-mediated coordination of brain development to autism-related behaviors and patient genotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc96UoJSRDnbVg90H21EOLACvtfcHk0lhvUwpmOhJkkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1eltA%253D%253D&md5=ecb7d91553b49157c3ca8eda4ee58f35</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210055109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210055109%26sid%3Dliteratum%253Aachs%26aulast%3DSadakata%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DY.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DSekine%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DSaruta%26aufirst%3DC.%26aulast%3DMiwa%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DItohara%26aufirst%3DS.%26aulast%3DFuruichi%26aufirst%3DT.%26atitle%3DReduced%2520axonal%2520localization%2520of%2520a%2520Caps2%2520splice%2520variant%2520impairs%2520axonal%2520release%2520of%2520BDNF%2520and%2520causes%2520autistic-like%2520behavior%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21104%26epage%3D21109%26doi%3D10.1073%2Fpnas.1210055109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzo-Miller, L.</span></span> <span> </span><span class="NLM_article-title">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span>. <i>Front. Cell Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.3389%2Ffncel.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24639629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=68&author=X.+Xuauthor=A.+P.+Kozikowskiauthor=L.+Pozzo-Miller&title=A+selective+histone+deacetylase-6+inhibitor+improves+BDNF+trafficking+in+hippocampal+neurons+from+Mecp2+knockout+mice%3A+implications+for+Rett+syndrome&doi=10.3389%2Ffncel.2014.00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome</span></div><div class="casAuthors">Xu, Xin; Kozikowski, Alan P.; Pozzo-Miller, Lucas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68/1-68/9</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a neurodevelopmental disorder caused by loss-of-function mutations in the transcriptional modulator methyl-CpG-binding protein 2 (MECP2).  One of the most prominent gene targets of MeCP2 is brain-derived neurotrophic factor (Bdnf), a potent modulator of activity-dependent synaptic development, function and plasticity.  Dysfunctional BDNF signaling has been demonstrated in several pathophysiol. mechanisms of RTT disease progression.  To evaluate whether the dynamics of BDNF trafficking is affected by Mecp2 deletion, we analyzed movements of BDNF tagged with yellow fluorescent protein (YFP) in cultured hippocampal neurons by time-lapse fluorescence imaging.  We found that both anterograde and retrograde vesicular trafficking of BDNF-YFP are significantly impaired in Mecp2 knockout hippocampal neurons.  Selective inhibitors of histone deacetylase 6 (HDAC6) show neuroprotective effects in neurodegenerative diseases and stimulate microtubule-dependent vesicular trafficking of BDNF-contg. dense core vesicles.  Here, we show that the selective HDAC6 inhibitor Tubastatin-A increased the velocity of BDNF-YFP vesicles in Mecp2 knockout neurons in both directions by increasing α-tubulin acetylation.  Tubastatin-A also restored activity-dependent BDNF release from Mecp2 knockout neurons to levels comparable to those shown by wildtype neurons.  These findings demonstrate that a selective HDAC6 inhibitor is a potential pharmacol. strategy to reverse cellular and synaptic impairments in RTT resulting from impaired BDNF signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTWjdzmjqurVg90H21EOLACvtfcHk0ljAWFqwHYOUSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVynu7nM&md5=ead557e0e05455dd86fa959e7edeb5bc</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DA%2520selective%2520histone%2520deacetylase-6%2520inhibitor%2520improves%2520BDNF%2520trafficking%2520in%2520hippocampal%2520neurons%2520from%2520Mecp2%2520knockout%2520mice%253A%2520implications%2520for%2520Rett%2520syndrome%26jtitle%3DFront.%2520Cell%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D68%26doi%3D10.3389%2Ffncel.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">The benefits and limitations of animal models for translational research in neurodegenerative diseases</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1038/nm.2224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnm.2224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21052075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2jtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1210-1214&author=M.+Jucker&title=The+benefits+and+limitations+of+animal+models+for+translational+research+in+neurodegenerative+diseases&doi=10.1038%2Fnm.2224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits and limitations of animal models for translational research in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1210-1214</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Age-related neurodegenerative diseases are largely limited to humans and rarely occur spontaneously in animals.  Genetically engineered mouse models recapitulate aspects of the corresponding human diseases and are instrumental in studying disease mechanisms and testing therapeutic strategies.  If considered within the range of their validity, mouse models have been predictive of clin. outcome.  Translational failure is less the result of the incomplete nature of the models than of inadequate preclin. studies and misinterpretation of the models.  This commentary summarizes current models and highlights key questions we should be asking about animal models, as well as questions that cannot be answered with the current models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ7ygIlgmbPbVg90H21EOLACvtfcHk0ljAWFqwHYOUSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2jtrvF&md5=7e0f31fc015a073dbad54784f1cb0fbf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnm.2224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2224%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DThe%2520benefits%2520and%2520limitations%2520of%2520animal%2520models%2520for%2520translational%2520research%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D1210%26epage%3D1214%26doi%3D10.1038%2Fnm.2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0lgoeR-h_19tBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonini, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palejev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span> <span> </span><span class="NLM_article-title">Modeling human cortical development in vitro using induced pluripotent stem cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">12770</span>– <span class="NLM_lpage">12775</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202944109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1202944109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22761314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlelsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=12770-12775&author=J.+Marianiauthor=M.+V.+Simoniniauthor=D.+Palejevauthor=L.+Tomasiniauthor=G.+Coppolaauthor=A.+M.+Szekelyauthor=T.+L.+Horvathauthor=F.+M.+Vaccarino&title=Modeling+human+cortical+development+in+vitro+using+induced+pluripotent+stem+cells&doi=10.1073%2Fpnas.1202944109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling human cortical development in vitro using induced pluripotent stem cells</span></div><div class="casAuthors">Mariani, Jessica; Simonini, Maria Vittoria; Palejev, Dean; Tomasini, Livia; Coppola, Gianfilippo; Szekely, Anna M.; Horvath, Tamas L.; Vaccarino, Flora M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12770-12775, S12770/1-S12770/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human induced pluripotent stem cells (hiPSCs) are emerging as a tool for understanding human brain development at cellular, mol., and genomic levels.  Here we show that hiPSCs grown in suspension in the presence of rostral neuralizing factors can generate 3D structures contg. polarized radial glia, intermediate progenitors, and a spectrum of layer-specific cortical neurons reminiscent of their organization in vivo.  The hiPSC-derived multilayered structures express a gene expression profile typical of the embryonic telencephalon but not that of other CNS regions.  Their transcriptome is highly enriched in transcription factors controlling the specification, growth, and patterning of the dorsal telencephalon and displays highest correlation with that of the early human cerebral cortical wall at 8-10 wk after conception.  Thus, hiPSC are capable of enacting a transcriptional program specifying human telencephalic (pallial) development.  This model will allow the study of human brain development as well as disorders of the human cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Bd7VT--LF7Vg90H21EOLACvtfcHk0lhYWYjn8G1qXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlelsbfE&md5=243ef8562af7cd0e0113b13f51fcbc82</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202944109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202944109%26sid%3Dliteratum%253Aachs%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DSimonini%26aufirst%3DM.%2BV.%26aulast%3DPalejev%26aufirst%3DD.%26aulast%3DTomasini%26aufirst%3DL.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DSzekely%26aufirst%3DA.%2BM.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26atitle%3DModeling%2520human%2520cortical%2520development%2520in%2520vitro%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D12770%26epage%3D12775%26doi%3D10.1073%2Fpnas.1202944109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abyzov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amenduni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekely, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palejev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigorenko, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelphrey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, F. M.</span></span> <span> </span><span class="NLM_article-title">FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.06.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2015.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26186191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KgtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2015&pages=375-390&author=J.+Marianiauthor=G.+Coppolaauthor=P.+Zhangauthor=A.+Abyzovauthor=L.+Proviniauthor=L.+Tomasiniauthor=M.+Amenduniauthor=A.+Szekelyauthor=D.+Palejevauthor=M.+Wilsonauthor=M.+Gersteinauthor=E.+L.+Grigorenkoauthor=K.+Chawarskaauthor=K.+A.+Pelphreyauthor=J.+R.+Howeauthor=F.+M.+Vaccarino&title=FOXG1-dependent+dysregulation+of+GABA%2Fglutamate+neuron+differentiation+in+autism+spectrum+disorders&doi=10.1016%2Fj.cell.2015.06.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">FOXG1-Dependent Dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</span></div><div class="casAuthors">Mariani, Jessica; Coppola, Gianfilippo; Zhang, Ping; Abyzov, Alexej; Provini, Lauren; Tomasini, Livia; Amenduni, Mariangela; Szekely, Anna; Palejev, Dean; Wilson, Michael; Gerstein, Mark; Grigorenko, Elena L.; Chawarska, Katarzyna; Pelphrey, Kevin A.; Howe, James R.; Vaccarino, Flora M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-390</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a disorder of brain development.  Most cases lack a clear etiol. or genetic basis, and the difficulty of re-enacting human brain development has precluded understanding of ASD pathophysiol.  Here we use three-dimensional neural cultures (organoids) derived from induced pluripotent stem cells (iPSCs) to investigate neurodevelopmental alterations in individuals with severe idiopathic ASD.  While no known underlying genomic mutation could be identified, transcriptome and gene network analyses revealed upregulation of genes involved in cell proliferation, neuronal differentiation, and synaptic assembly.  ASD-derived organoids exhibit an accelerated cell cycle and overprodn. of GABAergic inhibitory neurons.  Using RNA interference, we show that overexpression of the transcription factor FOXG1 is responsible for the overprodn. of GABAergic neurons.  Altered expression of gene network modules and FOXG1 are pos. correlated with symptom severity.  Our data suggest that a shift toward GABAergic neuron fate caused by FOXG1 is a developmental precursor of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SqefHRDom7Vg90H21EOLACvtfcHk0lhYWYjn8G1qXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KgtLrN&md5=946bcc3d3d1818cac587d3ab8e3b49b3</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DCoppola%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DAbyzov%26aufirst%3DA.%26aulast%3DProvini%26aufirst%3DL.%26aulast%3DTomasini%26aufirst%3DL.%26aulast%3DAmenduni%26aufirst%3DM.%26aulast%3DSzekely%26aufirst%3DA.%26aulast%3DPalejev%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DGerstein%26aufirst%3DM.%26aulast%3DGrigorenko%26aufirst%3DE.%2BL.%26aulast%3DChawarska%26aufirst%3DK.%26aulast%3DPelphrey%26aufirst%3DK.%2BA.%26aulast%3DHowe%26aufirst%3DJ.%2BR.%26aulast%3DVaccarino%26aufirst%3DF.%2BM.%26atitle%3DFOXG1-dependent%2520dysregulation%2520of%2520GABA%252Fglutamate%2520neuron%2520differentiation%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DCell%26date%3D2015%26volume%3D162%26spage%3D375%26epage%3D390%26doi%3D10.1016%2Fj.cell.2015.06.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makinson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huguenard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barres, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, S. P.</span></span> <span> </span><span class="NLM_article-title">Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fnmeth.3415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26005811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=671-678&author=A.+M.+Pascaauthor=S.+A.+Sloanauthor=L.+E.+Clarkeauthor=Y.+Tianauthor=C.+D.+Makinsonauthor=N.+Huberauthor=C.+H.+Kimauthor=J.+Y.+Parkauthor=N.+A.+O%E2%80%99Rourkeauthor=K.+D.+Nguyenauthor=S.+J.+Smithauthor=J.+R.+Huguenardauthor=D.+H.+Geschwindauthor=B.+A.+Barresauthor=S.+P.+Pasca&title=Functional+cortical+neurons+and+astrocytes+from+human+pluripotent+stem+cells+in+3D+culture&doi=10.1038%2Fnmeth.3415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture</span></div><div class="casAuthors">Pasca, Anca M.; Sloan, Steven A.; Clarke, Laura E.; Tian, Yuan; Makinson, Christopher D.; Huber, Nina; Kim, Chul Hoon; Park, Jin-Young; O'Rourke, Nancy A.; Nguyen, Khoa D.; Smith, Stephen J.; Huguenard, John R.; Geschwind, Daniel H.; Barres, Ben A.; Pasca, Sergiu P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human cerebral cortex develops through an elaborate succession of cellular events that, when disrupted, can lead to neuropsychiatric disease.  The ability to reprogram somatic cells into pluripotent cells that can be differentiated in vitro provides a unique opportunity to study normal and abnormal corticogenesis.  Here, we present a simple and reproducible 3D culture approach for generating a laminated cerebral cortex-like structure, named human cortical spheroids (hCSs), from pluripotent stem cells. hCSs contain neurons from both deep and superficial cortical layers and map transcriptionally to in vivo fetal development.  These neurons are electrophysiol. mature, display spontaneous activity, are surrounded by nonreactive astrocytes and form functional synapses.  Expts. in acute hCS slices demonstrate that cortical neurons participate in network activity and produce complex synaptic events.  These 3D cultures should allow a detailed interrogation of human cortical development, function and disease, and may prove a versatile platform for generating other neuronal and glial subtypes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNa7ccGUSi7Vg90H21EOLACvtfcHk0lhYWYjn8G1qXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbfI&md5=ffb4210fe76f1524c5a80811a9320195</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3415%26sid%3Dliteratum%253Aachs%26aulast%3DPasca%26aufirst%3DA.%2BM.%26aulast%3DSloan%26aufirst%3DS.%2BA.%26aulast%3DClarke%26aufirst%3DL.%2BE.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMakinson%26aufirst%3DC.%2BD.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DN.%2BA.%26aulast%3DNguyen%26aufirst%3DK.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DHuguenard%26aufirst%3DJ.%2BR.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DBarres%26aufirst%3DB.%2BA.%26aulast%3DPasca%26aufirst%3DS.%2BP.%26atitle%3DFunctional%2520cortical%2520neurons%2520and%2520astrocytes%2520from%2520human%2520pluripotent%2520stem%2520cells%2520in%25203D%2520culture%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D671%26epage%3D678%26doi%3D10.1038%2Fnmeth.3415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chintawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vowles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustacchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argoud, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponting, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span> <span> </span><span class="NLM_article-title">Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">989</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fhmg%2Fddv637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26740550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aitrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=989-1000&author=A.+E.+Handelauthor=S.+Chintawarauthor=T.+Lalicauthor=E.+Whiteleyauthor=J.+Vowlesauthor=A.+Giustacchiniauthor=K.+Argoudauthor=P.+Soppauthor=M.+Nakanishiauthor=R.+Bowdenauthor=S.+Cowleyauthor=S.+Neweyauthor=C.+Akermanauthor=C.+P.+Pontingauthor=M.+Z.+Cader&title=Assessing+similarity+to+primary+tissue+and+cortical+layer+identity+in+induced+pluripotent+stem+cell-derived+cortical+neurons+through+single-cell+transcriptomics&doi=10.1093%2Fhmg%2Fddv637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics</span></div><div class="casAuthors">Handel, Adam E.; Chintawar, Satyan; Lalic, Tatjana; Whiteley, Emma; Vowles, Jane; Giustacchini, Alice; Argoud, Karene; Sopp, Paul; Nakanishi, Mahito; Bowden, Rory; Cowley, Sally; Newey, Sarah; Akerman, Colin; Ponting, Chris P.; Cader, M. Zameel</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">989-1000</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Induced pluripotent stem cell (iPSC)-derived cortical neurons potentially present a powerful new model to understand corticogenesis and neurol. disease.  Previous work has established that differentiation protocols can produce cortical neurons, but little has been done to characterize these at cellular resoln.  In particular, it is unclear to what extent in vitro two-dimensional, relatively disordered culture conditions recapitulate the development of in vivo cortical layer identity.  Single- cell multiplex reverse transcriptase-quant. polymerase chain reaction (RT-qPCR) was used to interrogate the expression of genes previously implicated in cortical layer or phenotypic identity in individual cells.  Totally, 93.6% of single cells derived from iPSCs expressed genes indicative of neuronal identity.  High proportions of single neurons derived from iPSCs expressed glutamatergic receptors and synaptic genes.  And, 68.4% of iPSC-derived neurons expressing at least one layer marker could be assigned to a laminar identity using canonical cortical layer marker genes.  We compared single-cell RNA-seq of our iPSC- derived neurons to available single-cell RNA-seq data from human fetal and adult brain and found that iPSC-derived cortical neurons closely resembled primary fetal brain cells.  Unexpectedly, a subpopulation of iPSC-derived neurons co-expressed canonical fetal deep and upper cortical layer markers.  However, this appeared to be concordant with data from primary cells.  Our results therefore provide reassurance that iPSC-derived cortical neurons are highly similar to primary cortical neurons at the level of single cells but suggest that current layer markers, although effective, may not be able to disambiguate cortical layer identity in all cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK9bxZFfeN4rVg90H21EOLACvtfcHk0ljnov00BEhRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aitrrM&md5=25fb8692b273437a2acb05ad8ef8820a</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv637%26sid%3Dliteratum%253Aachs%26aulast%3DHandel%26aufirst%3DA.%2BE.%26aulast%3DChintawar%26aufirst%3DS.%26aulast%3DLalic%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DE.%26aulast%3DVowles%26aufirst%3DJ.%26aulast%3DGiustacchini%26aufirst%3DA.%26aulast%3DArgoud%26aufirst%3DK.%26aulast%3DSopp%26aufirst%3DP.%26aulast%3DNakanishi%26aufirst%3DM.%26aulast%3DBowden%26aufirst%3DR.%26aulast%3DCowley%26aufirst%3DS.%26aulast%3DNewey%26aufirst%3DS.%26aulast%3DAkerman%26aufirst%3DC.%26aulast%3DPonting%26aufirst%3DC.%2BP.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26atitle%3DAssessing%2520similarity%2520to%2520primary%2520tissue%2520and%2520cortical%2520layer%2520identity%2520in%2520induced%2520pluripotent%2520stem%2520cell-derived%2520cortical%2520neurons%2520through%2520single-cell%2520transcriptomics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D989%26epage%3D1000%26doi%3D10.1093%2Fhmg%2Fddv637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amenduni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Filippis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disciglio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epistolato, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mencarelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayek, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">iPS cells to model CDKL5-related disorders</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1255</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2011.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fejhg.2011.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21750574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1246-1255&author=M.+Amenduniauthor=R.+De+Filippisauthor=A.+Y.+Cheungauthor=V.+Disciglioauthor=M.+C.+Epistolatoauthor=F.+Arianiauthor=F.+Mariauthor=M.+A.+Mencarelliauthor=Y.+Hayekauthor=A.+Renieriauthor=J.+Ellisauthor=I.+Meloni&title=iPS+cells+to+model+CDKL5-related+disorders&doi=10.1038%2Fejhg.2011.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">iPS cells to model CDKL5-related disorders</span></div><div class="casAuthors">Amenduni, Mariangela; De Filippis, Roberta; Cheung, Aaron Y. L.; Disciglio, Vittoria; Epistolato, Maria Carmela; Ariani, Francesca; Mari, Francesca; Mencarelli, Maria Antonietta; Hayek, Youssef; Renieri, Alessandra; Ellis, James; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1246-1255</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a progressive neurol. disorder representing one of the most common causes of mental retardation in females.  To date mutations in three genes have been assocd. with this condition.  Classic RTT is caused by mutations in the MECP2 gene, whereas variants can be due to mutations in either MECP2 or FOXG1 or CDKL5.  Mutations in CDKL5 have been identified both in females with the early onset seizure variant of RTT and in males with X-linked epileptic encephalopathy.  To address this issue we established a human cellular model for CDKL5-related disease using the recently developed technol. of induced pluripotent stem cells (iPSCs).  IPSCs can be expanded indefinitely and differentiated in vitro into many different cell types, including neurons.  CDKL5 is a kinase protein highly expressed in neurons, but its exact function inside the cell is unknown.  These features make them the ideal tool to study disease mechanisms directly on the primarily affected neuronal cells.  We derived iPSCs from fibroblasts of one female with p.Q347X and one male with p.T288I mutation, affected by early onset seizure variant and X-linked epileptic encephalopathy, resp.  We demonstrated that female CDKL5-mutated iPSCs maintain X-chromosome inactivation and clones express either the mutant CDKL5 allele or the wild-type allele that serve as an ideal exptl. control.  Array CGH indicates normal isogenic mol. karyotypes without detection of de novo CNVs in the CDKL5-mutated iPSCs.  Furthermore, the iPS cells can be differentiated into neurons and are thus suitable to model disease pathogenesis in vitro.  European Journal of Human Genetics (2011) 19, 1246-1255; doi:10.1038/ejhg.2011.131; published online 13 July 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNiV80sqXJbVg90H21EOLACvtfcHk0ljnov00BEhRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsL3E&md5=bc44dbd82a75d1f9a96de3c36f14f60a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2011.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2011.131%26sid%3Dliteratum%253Aachs%26aulast%3DAmenduni%26aufirst%3DM.%26aulast%3DDe%2BFilippis%26aufirst%3DR.%26aulast%3DCheung%26aufirst%3DA.%2BY.%26aulast%3DDisciglio%26aufirst%3DV.%26aulast%3DEpistolato%26aufirst%3DM.%2BC.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DMari%26aufirst%3DF.%26aulast%3DMencarelli%26aufirst%3DM.%2BA.%26aulast%3DHayek%26aufirst%3DY.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DiPS%2520cells%2520to%2520model%2520CDKL5-related%2520disorders%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2011%26volume%3D19%26spage%3D1246%26epage%3D1255%26doi%3D10.1038%2Fejhg.2011.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patriarchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amabile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frullanti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Rizzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olimpico, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccarino, MF. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, I.</span></span> <span> </span><span class="NLM_article-title">Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1(±) patients and in foxg1(±) mice</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2015.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fejhg.2015.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26443267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1KrsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=871-880&author=T.+Patriarchiauthor=S.+Amabileauthor=E.+Frullantiauthor=E.+Landucciauthor=C.+Lo+Rizzoauthor=F.+Arianiauthor=M.+Costaauthor=F.+Olimpicoauthor=J.+W.+Hellauthor=MF.+M.+Vaccarinoauthor=A.+Renieriauthor=I.+Meloni&title=Imbalance+of+excitatory%2Finhibitory+synaptic+protein+expression+in+iPSC-derived+neurons+from+FOXG1%28%C2%B1%29+patients+and+in+foxg1%28%C2%B1%29+mice&doi=10.1038%2Fejhg.2015.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+/- patients and in foxg1+/- mice</span></div><div class="casAuthors">Patriarchi, Tommaso; Amabile, Sonia; Frullanti, Elisa; Landucci, Elisa; Lo Rizzo, Caterina; Ariani, Francesca; Costa, Mario; Olimpico, Francesco; Hell, Johannes W.; Vaccarino, Flora M.; Renieri, Alessandra; Meloni, Ilaria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-880</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a severe neurodevelopmental disorder assocd. with mutations in either MECP2, CDKL5 or FOXG1.  The precise mol. mechanisms that lead to the pathogenesis of RTT have yet to be elucidated.  We recently reported that expression of GluD1 (orphan glutamate receptor δ-1 subunit) is increased in iPSC-derived neurons obtained from patients with mutations in either MECP2 or CDKL5.  GluD1 controls synaptic differentiation and shifts the balance between excitatory and inhibitory synapses toward the latter.  Thus, an increase in GluD1 might be a crit. factor in the etiol. of RTT by affecting the excitatory/inhibitory balance in the developing brain.  To test this hypothesis, we generated iPSC-derived neurons from FOXG1+/- patients.  We analyzed mRNA and protein levels of GluD1 together with key markers of excitatory and inhibitory synapses in these iPSC-derived neurons and in Foxg1+/- mouse fetal (E11.5) and adult (P70) brains.  We found strong correlation between iPSC-derived neurons and fetal mouse brains, where GluD1 and inhibitory synaptic markers (GAD67 and GABA AR-α1) were increased, whereas the levels of a no. of excitatory synaptic markers (VGLUT1, GluA1, GluN1 and PSD-95) were decreased.  In adult mice, GluD1 was decreased along with all GABAergic and glutamatergic markers.  Our findings further the understanding of the etiol. of RTT by introducing a new pathol. event occurring in the brain of FOXG1+/- patients during embryonic development and its time-dependent shift toward a general decrease in brain synapses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokd0vSjL9P8bVg90H21EOLACvtfcHk0ljrpsWQFZHsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1KrsbbP&md5=7c3e00875afc0fb189934039e808b65f</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2015.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2015.216%26sid%3Dliteratum%253Aachs%26aulast%3DPatriarchi%26aufirst%3DT.%26aulast%3DAmabile%26aufirst%3DS.%26aulast%3DFrullanti%26aufirst%3DE.%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DLo%2BRizzo%26aufirst%3DC.%26aulast%3DAriani%26aufirst%3DF.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DOlimpico%26aufirst%3DF.%26aulast%3DHell%26aufirst%3DJ.%2BW.%26aulast%3DVaccarino%26aufirst%3DMF.%2BM.%26aulast%3DRenieri%26aufirst%3DA.%26aulast%3DMeloni%26aufirst%3DI.%26atitle%3DImbalance%2520of%2520excitatory%252Finhibitory%2520synaptic%2520protein%2520expression%2520in%2520iPSC-derived%2520neurons%2520from%2520FOXG1%2528%25C2%25B1%2529%2520patients%2520and%2520in%2520foxg1%2528%25C2%25B1%2529%2520mice%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D24%26spage%3D871%26epage%3D880%26doi%3D10.1038%2Fejhg.2015.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetto, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carromeu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muotri, A. R.</span></span> <span> </span><span class="NLM_article-title">A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.cell.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21074045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=527-539&author=M.+C.+Marchettoauthor=C.+Carromeuauthor=A.+Acabauthor=D.+Yuauthor=G.+W.+Yeoauthor=Y.+Muauthor=G.+Chenauthor=F.+H.+Gageauthor=A.+R.+Muotri&title=A+model+for+neural+development+and+treatment+of+Rett+syndrome+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.cell.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-539</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype.  Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts.  RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons.  Neurons derived from RTT-iPSCs had fewer synapses, reduced spine d., smaller soma size, altered calcium signaling and electrophysiol. defects when compared to controls.  Our data uncovered early alterations in developing human RTT neurons.  Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects.  Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed.  Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVs6bKz90wyLVg90H21EOLACvtfcHk0ljrpsWQFZHsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE&md5=e65138528f9ad3678f5c8e0e0cf2d162</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DCarromeu%26aufirst%3DC.%26aulast%3DAcab%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DA%2520model%2520for%2520neural%2520development%2520and%2520treatment%2520of%2520Rett%2520syndrome%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%26date%3D2010%26volume%3D143%26spage%3D527%26epage%3D539%26doi%3D10.1016%2Fj.cell.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerinck, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gage, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span> <span> </span><span class="NLM_article-title">Investigating synapse formation and function using human pluripotent stem cell-derived neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3010</span>, <span class="refDoi"> DOI: 10.1073/pnas.1007753108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1073%2Fpnas.1007753108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21278334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=3005-3010&author=J.+E.+Kimauthor=M.+L.+O%E2%80%99Sullivanauthor=C.+A.+Sanchezauthor=M.+Hwangauthor=M.+A.+Israelauthor=K.+Brennandauthor=T.+J.+Deerinckauthor=L.+S.+Goldsteinauthor=F.+H.+Gageauthor=M.+H.+Ellismanauthor=A.+Ghosh&title=Investigating+synapse+formation+and+function+using+human+pluripotent+stem+cell-derived+neurons&doi=10.1073%2Fpnas.1007753108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating synapse formation and function using human pluripotent stem cell-derived neurons</span></div><div class="casAuthors">Kim, Ji-Eun; O'Sullivan, Matthew L.; Sanchez, Christopher A.; Hwang, Minju; Israel, Mason A.; Brennand, Kristen; Deerinck, Thomas J.; Goldstein, Lawrence S. B.; Gage, Fred H.; Ellisman, Mark H.; Ghosh, Anirvan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3005-3010, S3005/1-S3005/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A major goal of stem-cell research is to identify conditions that reliably regulate their differentiation into specific cell types.  This goal is particularly important for human stem cells if they are to be used for in vivo transplantation or as a platform for drug development.  Here, we describe the establishment of procedures to direct the differentiation of human embryonic stem cells and human induced pluripotent stem cells into forebrain neurons that are capable of forming synaptic connections.  In addn., HEK293T cells expressing Neuroligin (NLGN) 3 and NLGN4, but not those contg. autism-assocd. mutations, are able to induce presynaptic differentiation in human induced pluripotent stem cell-derived neurons.  We show that a mutant NLGN4 contg. an in-frame deletion is unable to localize correctly to the cell surface when overexpressed and fails to enhance synapse formation in human induced pluripotent stem cell-derived neurons.  These findings establish human pluripotent stem cell-derived neurons as a viable model for the study of synaptic differentiation and function under normal and disorder-assocd. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqgsEAm1cNH7Vg90H21EOLACvtfcHk0ljrpsWQFZHsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVSjsLg%253D&md5=d8a08911e3382550c0f6b854f4b3398e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007753108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007753108%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DM.%2BL.%26aulast%3DSanchez%26aufirst%3DC.%2BA.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DBrennand%26aufirst%3DK.%26aulast%3DDeerinck%26aufirst%3DT.%2BJ.%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DEllisman%26aufirst%3DM.%2BH.%26aulast%3DGhosh%26aufirst%3DA.%26atitle%3DInvestigating%2520synapse%2520formation%2520and%2520function%2520using%2520human%2520pluripotent%2520stem%2520cell-derived%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D3005%26epage%3D3010%26doi%3D10.1073%2Fpnas.1007753108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhees, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeja, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libby, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrer, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N. S.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(16)30375-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS1470-2045%2816%2930375-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27646843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2isb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1569-1578&author=A.+J.+Yeeauthor=W.+I.+Bensingerauthor=J.+G.+Supkoauthor=P.+M.+Voorheesauthor=J.+G.+Berdejaauthor=P.+G.+Richardsonauthor=E.+N.+Libbyauthor=E.+E.+Wallaceauthor=N.+E.+Birrerauthor=J.+N.+Burkeauthor=D.+L.+Tamangauthor=M.+Yangauthor=S.+S.+Jonesauthor=C.+A.+Wheelerauthor=R.+J.+Markelewiczauthor=N.+S.+Raje&title=Ricolinostat+plus+lenalidomide%2C+and+dexamethasone+in+relapsed+or+refractory+multiple+myeloma%3A+a+multicentre+phase+1b+trial&doi=10.1016%2FS1470-2045%2816%2930375-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial</span></div><div class="casAuthors">Yee, Andrew J.; Bensinger, William I.; Supko, Jeffrey G.; Voorhees, Peter M.; Berdeja, Jesus G.; Richardson, Paul G.; Libby, Edward N.; Wallace, Ellen E.; Birrer, Nicole E.; Burke, Jill N.; Tamang, David L.; Yang, Min; Jones, Simon S.; Wheeler, Catherine A.; Markelewicz, Robert J.; Raje, Noopur S.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors are an important new class of therapeutics for treating multiple myeloma.  Ricolinostat (ACY-1215) is the first oral selective HDAC6 inhibitor with reduced class I HDAC activity to be studied clin.  Motivated by findings from preclin. studies showing potent synergistic activity with ricolinostat and lenalidomide, our goal was to assess the safety and preliminary activity of the combination of ricolinostat with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma.  In this multicenter phase 1b trial, we recruited patients aged 18 years or older with previously treated relapsed or refractory multiple myeloma from five cancer centers in the USA.  Inclusion criteria included a Karnofsky Performance Status score of at least 70, measureable disease, adequate bone marrow reserve, adequate hepatic function, and a creatinine clearance of at least 50 mL per min.  Exclusion criteria included previous exposure to HDAC inhibitors; previous allogeneic stem-cell transplantation; previous autologous stem-cell transplantation within 12 wk of baseline; active systemic infection; malignancy within the last 5 years; known or suspected HIV, hepatitis B, or hepatitis C infection; a QTc Fridericia of more than 480 ms; and substantial cardiovascular, gastrointestinal, psychiatric, or other medical disorders.  We gave escalating doses (from 40-240 mg once daily to 160 mg twice daily) of oral ricolinostat according to a std. 3 + 3 design according to three different regimens on days 1-21 with a conventional 28 day schedule of oral lenalidomide (from 15 mg [in one cohort] to 25 mg [in all other cohorts] once daily) and oral dexamethasone (40 mg weekly).  Primary outcomes were dose-limiting toxicities, the max. tolerated dose of ricolinostat in this combination, and the dose and schedule of ricolinostat recommended for further phase 2 investigation.  Secondary outcomes were the pharmacokinetics and pharmacodynamics of ricolinostat in this combination and the preliminary anti-tumor activity of this treatment.  The trial is closed to accrual and is registered at ClinicalTrials.gov, no. NCT01583283.  Between July 12, 2012, and Aug 20, 2015, we enrolled 38 patients.  We obsd. two dose-limiting toxicities with ricolinostat 160 mg twice daily: one (2%) grade 3 syncope and one (2%) grade 3 myalgia event in different cohorts.  A max. tolerated dose was not reached.  We chose ricolinostat 160 mg once daily on days 1-21 of a 28 day cycle as the recommended dose for future phase 2 studies in combination with lenalidomide 25 mg and dexamethasone 40 mg.  The most common adverse events were fatigue (grade 1-2 in 14 [37%] patients; grade 3 in seven [18%]) and diarrhea (grade 1-2 in 15 [39%] patients; grade 3 in two [5%]).  Our pharmacodynamic studies showed that at clin. relevant doses, ricolinostat selectively inhibits HDAC6 while retaining a low and tolerable level of class I HDAC inhibition.  The pharmacokinetics of ricolinostat and lenalidomide were not affected by co-administration.  In a preliminary assessment of antitumor activity, 21 (55% [95% CI 38-71]) of 38 patients had an overall response.  The findings from this study provide preliminary evidence that ricolinostat is a safe and well tolerated selective HDAC6 inhibitor, which might partner well with lenalidomide and dexamethasone to enhance their efficacy in relapsed or refractory multiple myeloma.Acetylon Pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWXWsO-vNKY7Vg90H21EOLACvtfcHk0lh9d77Fk2C0ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2isb7J&md5=59fea63c11b7bce7be6bd74f195af04b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2930375-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252930375-8%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DA.%2BJ.%26aulast%3DBensinger%26aufirst%3DW.%2BI.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DVoorhees%26aufirst%3DP.%2BM.%26aulast%3DBerdeja%26aufirst%3DJ.%2BG.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DLibby%26aufirst%3DE.%2BN.%26aulast%3DWallace%26aufirst%3DE.%2BE.%26aulast%3DBirrer%26aufirst%3DN.%2BE.%26aulast%3DBurke%26aufirst%3DJ.%2BN.%26aulast%3DTamang%26aufirst%3DD.%2BL.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%2BA.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DRaje%26aufirst%3DN.%2BS.%26atitle%3DRicolinostat%2520plus%2520lenalidomide%252C%2520and%2520dexamethasone%2520in%2520relapsed%2520or%2520refractory%2520multiple%2520myeloma%253A%2520a%2520multicentre%2520phase%25201b%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2016%26volume%3D17%26spage%3D1569%26epage%3D1578%26doi%3D10.1016%2FS1470-2045%2816%2930375-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogl, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markelewicz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonial, S.</span></span> <span> </span><span class="NLM_article-title">Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3307</span>– <span class="NLM_lpage">3315</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-2526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1158%2F1078-0432.CCR-16-2526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28053023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3307-3315&author=D.+T.+Voglauthor=N.+Rajeauthor=S.+Jagannathauthor=P.+Richardsonauthor=P.+Hariauthor=R.+Orlowskiauthor=J.+G.+Supkoauthor=D.+Tamangauthor=M.+Yangauthor=S.+S.+Jonesauthor=C.+Wheelerauthor=R.+J.+Markelewiczauthor=S.+Lonial&title=Ricolinostat%2C+the+first+selective+histone+deacetylase+6+inhibitor%2C+in+combination+with+bortezomib+and+dexamethasone+for+relapsed+or+refractory+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-16-2526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma</span></div><div class="casAuthors">Vogl, Dan T.; Raje, Noopur; Jagannath, Sundar; Richardson, Paul; Hari, Parameswaran; Orlowski, Robert; Supko, Jeffrey G.; Tamang, David; Yang, Min; Jones, Simon S.; Wheeler, Catherine; Markelewicz, Robert J.; Lonial, Sagar</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3307-3315</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Histone deacetylase (HDAC) inhibition improves the efficacy of proteasome inhibition for multiple myeloma but adds substantial toxicity.  Preclin. models suggest that the obsd. synergy is due to the role of HDAC6 in mediating resistance to proteasome inhibition via the aggresome/autophagy pathway of protein degrdn.  Exptl. Design: We conducted a phase I/II trial of the HDAC6-selective inhibitor ricolinostat to define the safety, preliminary efficacy, and recommended phase II dose in combination with std. proteasome inhibitor therapy.  Patients with relapsed or refractory multiple myeloma received oral ricolinostat on days 1-5 and 8-12 of each 21-day cycle.  Results: Single-agent ricolinostat therapy resulted in neither significant toxicity nor clin. responses.  Combination therapy with bortezomib and dexamethasone was well-tolerated during dose escalation but led to dose-limiting diarrhea in an expansion cohort at a ricolinostat dose of 160 mg twice daily.  Combination therapy at a ricolinostat dose of 160 mg daily in a second expansion cohort was well tolerated, with less severe hematol., gastrointestinal, and constitutional toxicities compared with published data on nonselective HDAC inhibitors.  The overall response rate in combination with daily ricolinostat at ≥160 mg was 37%.  The response rate to combination therapy among bortezomib-refractory patients was 14%.  Samples taken during therapy showed dose-dependent increases of acetylated tubulin in peripheral blood lymphocytes.  Conclusions: At the recommended phase II dose of ricolinostat of 160 mg daily, the combination with bortezomib and dexamethasone is safe, well-tolerated, and active, suggesting that selective inhibition of HDAC6 is a promising approach to multiple myeloma therapy.  Clin Cancer Res; 23(13); 3307-15. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQogphgLWbLVg90H21EOLACvtfcHk0lh9d77Fk2C0ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSnurbL&md5=2dd174501d2f331aeb0eff42072001d1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-2526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-2526%26sid%3Dliteratum%253Aachs%26aulast%3DVogl%26aufirst%3DD.%2BT.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHari%26aufirst%3DP.%26aulast%3DOrlowski%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DWheeler%26aufirst%3DC.%26aulast%3DMarkelewicz%26aufirst%3DR.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26atitle%3DRicolinostat%252C%2520the%2520first%2520selective%2520histone%2520deacetylase%25206%2520inhibitor%252C%2520in%2520combination%2520with%2520bortezomib%2520and%2520dexamethasone%2520for%2520relapsed%2520or%2520refractory%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D3307%26epage%3D3315%26doi%3D10.1158%2F1078-0432.CCR-16-2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barisic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeys, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirotkovic-Skerlev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span> <span> </span><span class="NLM_article-title">Charcot-Marie-Tooth disease: a clinico-genetic confrontation</span>. <i>Ann. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1111/j.1469-1809.2007.00412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1111%2Fj.1469-1809.2007.00412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18215208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlSnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2008&pages=416-441&author=N.+Barisicauthor=K.+G.+Claeysauthor=M.+Sirotkovic-Skerlevauthor=A.+Lofgrenauthor=E.+Nelisauthor=P.+De+Jongheauthor=V.+Timmerman&title=Charcot-Marie-Tooth+disease%3A+a+clinico-genetic+confrontation&doi=10.1111%2Fj.1469-1809.2007.00412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Charcot-Marie-Tooth disease: a clinico-genetic confrontation</span></div><div class="casAuthors">Barisic, N.; Claeys, K. G.; Sirotkovic-Skerlev, M.; Lofgren, A.; Nelis, E.; De Jonghe, P.; Timmerman, V.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Human Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">416-441</span>CODEN:
                <span class="NLM_cas:coden">ANHGAA</span>;
        ISSN:<span class="NLM_cas:issn">0003-4800</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder.  It represents a group of clin. and genetically heterogeneous inherited neuropathies.  Here, we review the results of mol. genetic investigations and the clin. and neurophysiol. features of the different CMT subtypes.  The products of genes assocd. with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity.  Identifying the mol. basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiol. mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system.  The results of mol. genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7PsU6ZFnr7Vg90H21EOLACvtfcHk0lh9d77Fk2C0ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlSnsLw%253D&md5=0a64c893f9dbc59d7918f6640285b6b3</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-1809.2007.00412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-1809.2007.00412.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarisic%26aufirst%3DN.%26aulast%3DClaeys%26aufirst%3DK.%2BG.%26aulast%3DSirotkovic-Skerlev%26aufirst%3DM.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DNelis%26aufirst%3DE.%26aulast%3DDe%2BJonghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26atitle%3DCharcot-Marie-Tooth%2520disease%253A%2520a%2520clinico-genetic%2520confrontation%26jtitle%3DAnn.%2520Hum.%2520Genet.%26date%3D2008%26volume%3D72%26spage%3D416%26epage%3D441%26doi%3D10.1111%2Fj.1469-1809.2007.00412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies</span>. <i>Nat. Clin. Pract. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/ncpneuro0071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fncpneuro0071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=16932520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=45-53&author=S.+Zuchnerauthor=J.+M.+Vance&title=Mechanisms+of+disease%3A+a+molecular+genetic+update+on+hereditary+axonal+neuropathies&doi=10.1038%2Fncpneuro0071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies</span></div><div class="casAuthors">Zuchner, Stephan; Vance, Jeffery M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Hereditary axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clin. subsumed under the name of Charcot-Marie-Tooth (CMT) disease type 2 (CMT2).  Historically, two classes of CMT have been differentiated: demyelinating forms of CMT (CMT1), in which nerve conduction velocities are decreased, and the axonal CMT2 forms, in which nerve conduction velocities are preserved.  Recently, a no. of genes that are defective in patients with the main forms of CMT2 have been identified.  The mol. dissection of cellular functions of the related gene products has only just begun, and detailed pathophysiol. models are still lacking.  The known CMT2-related genes represent key players in these pathways, however, and are likely to provide powerful tools for identifying targets for future therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMs7ufBCnTrVg90H21EOLACvtfcHk0lhiAW1C5zrpfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sit7c%253D&md5=bdf63030e099a66309bea5e09dda4b2a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0071%26sid%3Dliteratum%253Aachs%26aulast%3DZuchner%26aufirst%3DS.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520disease%253A%2520a%2520molecular%2520genetic%2520update%2520on%2520hereditary%2520axonal%2520neuropathies%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2006%26volume%3D2%26spage%3D45%26epage%3D53%26doi%3D10.1038%2Fncpneuro0071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baets, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span> <span> </span><span class="NLM_article-title">Recent advances in Charcot-Marie-Tooth disease</span>. <i>Curr. Opin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1097/WCO.0000000000000131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1097%2FWCO.0000000000000131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25110935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=532-540&author=J.+Baetsauthor=P.+De+Jongheauthor=V.+Timmerman&title=Recent+advances+in+Charcot-Marie-Tooth+disease&doi=10.1097%2FWCO.0000000000000131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in Charcot-Marie-Tooth disease</span></div><div class="casAuthors">Baets, Jonathan; De Jonghe, Peter; Timmerman, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-540</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This article focuses on recent advances in Charcot-Marie-Tooth disease, in particular addns. to the genetic spectrum, novel paradigms in mol. techniques and an update on therapeutic strategies.  Recent findings: Several new Charcot-Marie-Tooth disease-causing genes have been recently identified, further enlarging the genetic diversity and phenotypic variability, including: SBF1, DHTKD1, TFG, MARS, HARS, HINT1, TRIM1, AIFM1, PDK3 and GNB4.  The increasing availability and affordability of next-generation sequencing technologies has ramped up gene discovery and drastically changed genetic screening strategies.  All large-scale trials studying the effect of ascorbic acid in Charcot-Marie-Tooth 1A have now been completed and were neg.  Efforts have been made to design more robust outcome-measures for clin. trials.  Promising results with lonaprisan, curcumin and histone deacetylase 6 inhibitors have been obtained in animal models.  Summary: Charcot-Marie-Tooth is the most common form of inherited peripheral neuropathy and represents the most prevalent hereditary neuromuscular disorder.  The genetic spectrum spans more than 70 genes.  Gene discovery has been revolutionized recently by new high-throughput mol. technologies.  In addn., the phenotypic diversity has grown tremendously.  This is a major challenge for geneticists and neurologists.  No effective therapy is available for Charcot-Marie-Tooth.  Several large trials with ascorbic acid were neg. but research into novel compds. continues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0GRcFvnx47Vg90H21EOLACvtfcHk0lhiAW1C5zrpfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7zI&md5=3b9c2df656ec2f209699c918b3d5b649</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1097%2FWCO.0000000000000131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0000000000000131%26sid%3Dliteratum%253Aachs%26aulast%3DBaets%26aufirst%3DJ.%26aulast%3DDe%2BJonghe%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DV.%26atitle%3DRecent%2520advances%2520in%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2014%26volume%3D27%26spage%3D532%26epage%3D540%26doi%3D10.1097%2FWCO.0000000000000131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Charcot-Marie-Tooth disease: emerging mechanisms and therapies</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.biocel.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22575637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVanu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=1299-1304&author=C.+d%E2%80%99Ydewalleauthor=V.+Benoyauthor=L.+Van+Den+Bosch&title=Charcot-Marie-Tooth+disease%3A+emerging+mechanisms+and+therapies&doi=10.1016%2Fj.biocel.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Charcot-Marie-Tooth disease: Emerging mechanisms and therapies</span></div><div class="casAuthors">d'Ydewalle, Constantin; Benoy, Veronick; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1299-1304</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Charcot-Marie-Tooth disease is the most common inherited disorder of the peripheral nervous system.  The disease is characterized by a progressive muscle weakness and atrophy, sensory loss, foot (and hand) deformities and steppage gait.  While many of the genes assocd. with axonal CMT have been identified, to date it is unknown which mechanism(s) causes the disease.  However, genetic findings indicate that the underlying mechanisms mainly converge to the axonal cytoskeleton.  In this review, we will summarize the evidence for this pathogenic convergence.  Furthermore, recent work with new transgenic mouse models has led to the identification of histone deacetylase 6 as a potential therapeutic target for inherited peripheral neuropathies.  This enzyme deacetylates microtubules and plays a crucial role in the regulation of axonal transport.  These findings offer new perspectives for a potential therapy to treat axonal Charcot-Marie-Tooth disease and other neurodegenerative disorders characterized by axonal transport defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyxs8gcEvFMLVg90H21EOLACvtfcHk0lhiAW1C5zrpfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVanu74%253D&md5=8e0bbf15bc33aea5eac88bbc0c129b19</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DCharcot-Marie-Tooth%2520disease%253A%2520emerging%2520mechanisms%2520and%2520therapies%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D1299%26epage%3D1304%26doi%3D10.1016%2Fj.biocel.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grierson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. C.</span></span> <span> </span><span class="NLM_article-title">Role of axonal transport in neurodegenerative diseases</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1146/annurev.neuro.31.061307.090711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1146%2Fannurev.neuro.31.061307.090711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18558852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12nsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=151-173&author=K.+J.+De+Vosauthor=A.+J.+Griersonauthor=S.+Ackerleyauthor=C.+C.+Miller&title=Role+of+axonal+transport+in+neurodegenerative+diseases&doi=10.1146%2Fannurev.neuro.31.061307.090711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Role of axonal transport in neurodegenerative diseases</span></div><div class="casAuthors">De Vos, Kurt J.; Grierson, Andrew J.; Ackerley, Steven; Miller, Christopher C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-173</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Many major human neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), display axonal pathologies including abnormal accumulations of proteins and organelles.  Such pathologies highlight damage to the axon as part of the pathogenic process and, in particular, damage to transport of cargoes through axons.  Indeed, we now know that disruption of axonal transport is an early and perhaps causative event in many of these diseases.  Here, we review the role of axonal transport in neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnDowciI21rrVg90H21EOLACvtfcHk0lhmuEXhcBvIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12nsro%253D&md5=479969475f424e76896be30ede954b4c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.31.061307.090711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.31.061307.090711%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVos%26aufirst%3DK.%2BJ.%26aulast%3DGrierson%26aufirst%3DA.%2BJ.%26aulast%3DAckerley%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DC.%2BC.%26atitle%3DRole%2520of%2520axonal%2520transport%2520in%2520neurodegenerative%2520diseases%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D31%26spage%3D151%26epage%3D173%26doi%3D10.1146%2Fannurev.neuro.31.061307.090711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanbe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoue, A.</span></span> <span> </span><span class="NLM_article-title">The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">3189</span>– <span class="NLM_lpage">3197</span>, <span class="refDoi"> DOI: 10.1002/jnr.22460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1002%2Fjnr.22460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20645406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOqsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=3189-3197&author=J.+Yamauchiauthor=T.+Toriiauthor=S.+Kusakawaauthor=A.+Sanbeauthor=K.+Nakamuraauthor=S.+Takashimaauthor=H.+Hamasakiauthor=S.+Kawaguchiauthor=Y.+Miyamotoauthor=A.+Tanoue&title=The+mood+stabilizer+valproic+acid+improves+defective+neurite+formation+caused+by+Charcot-Marie-Tooth+disease-associated+mutant+Rab7+through+the+JNK+signaling+pathway&doi=10.1002%2Fjnr.22460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">The mood stabilizer valproic acid improves defective neurite formation caused by charcot-marie-tooth disease-associated mutant Rab7 through the JNK signaling pathway</span></div><div class="casAuthors">Yamauchi, Junji; Torii, Tomohiro; Kusakawa, Shinji; Sanbe, Atsushi; Nakamura, Kazuaki; Takashima, Shou; Hamasaki, Hajime; Kawaguchi, Shogo; Miyamoto, Yuki; Tanoue, Akito</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3189-3197</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth (CMT) disease is the most frequent peripheral neuropathy affecting the Schwann cells and neurons.  CMT disease type 2 (CMT2) neuropathies are characterized by peripheral nerve aberrance.  Four missense mutations of Rab7, a small GTPase of the Rab family involved in intracellular vesicular trafficking, are assocd. with the CMT2B phenotype.  Despite a growing body of evidence concerning the gene structures responsible for genetically heterogenous CMT2B and other CMT2 neuropathies, little is known about the in vitro neuropathy model and how CMT2B-assocd. mutation-caused aberrant neuritogenesis is properly reversed.  Here, we show that valproic acid (VPA), a classical mood-stabilizing drug, improves defective neurite formation in N1E-115 neuroblastoma cells regardless of which CMT2B-assocd. Rab7 mutant protein is expressed.  The effect is mediated by c-Jun N-terminal kinase (JNK) signaling, but not by deacetylase inhibition activity of VPA itself.  Furthermore, VPA has similar effects in dorsal root ganglion (DRG) neurons expressing any of the four mutant Rab7 proteins.  Thus, VPA has a previously unknown potential to improve defective neuritogenesis assocd. with CMT2B in vitro, indicating that JNK should be a potential therapeutic target for treatments aimed at improving neuritogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4MXIarJIUrVg90H21EOLACvtfcHk0lhmuEXhcBvIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOqsr%252FE&md5=30e6d7e7f25a0cdff96c01bc47e75a63</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22460%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DJ.%26aulast%3DTorii%26aufirst%3DT.%26aulast%3DKusakawa%26aufirst%3DS.%26aulast%3DSanbe%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DHamasaki%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DS.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DTanoue%26aufirst%3DA.%26atitle%3DThe%2520mood%2520stabilizer%2520valproic%2520acid%2520improves%2520defective%2520neurite%2520formation%2520caused%2520by%2520Charcot-Marie-Tooth%2520disease-associated%2520mutant%2520Rab7%2520through%2520the%2520JNK%2520signaling%2520pathway%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D3189%26epage%3D3197%26doi%3D10.1002%2Fjnr.22460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingl, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 as a potential therapeutic target for peripheral nerve disorders</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.1080/14728222.2018.1541235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1080%2F14728222.2018.1541235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30360671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yjs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=993-1007&author=R.+Priorauthor=L.+Van+Helleputteauthor=Y.+E.+Klinglauthor=L.+Van+Den%0ABosch&title=HDAC6+as+a+potential+therapeutic+target+for+peripheral+nerve+disorders&doi=10.1080%2F14728222.2018.1541235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 as a potential therapeutic target for peripheral nerve disorders</span></div><div class="casAuthors">Prior, Robert; Van Helleputte, Lawrence; Klingl, Yvonne Eileen; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">993-1007</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Peripheral neuropathies are a heterogeneous group of diseases that are characterized by a progressive, ascending loss of nerve function arising from the peripheral regions of the limbs.  The phenotypic overlap between different types of hereditary and acquired peripheral neuropathies indicates that similar pathophysiol. processes are at play.  Many downstream pathways in peripheral neurons, such as axonal transport, protein degrdn., and interactions with Schwann cells, organelle damage, channelopathies, and neuroinflammatory signaling, have been proposed and each affects peripheral nerves in a neg. way.  Histone deacetylase 6 (HDAC6) plays an important role at the intersection of these converging pathogenic pathways.  The enzymic deacetylase activity of HDAC6 is upregulated in neurodegenerative disorders and typically results in downstream neuronal stress.: The role of HDAC6 in the common pathogenic mechanisms of peripheral neuropathies.  In addn., we discuss the current preclin. and clin. HDAC6 inhibitors (HDAC6i), their chem. structure, development, and limitations.: The development and testing of non-hydroxamic acid-based, should be the focus of the future research.  Moreover, HDAC6i should be further investigated as a preventative measure and therapeutic strategy for inherited and acquired peripheral neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2jB4EbteqLVg90H21EOLACvtfcHk0lhmuEXhcBvIZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yjs7zM&md5=7527a80523a1a6d8e6ac738159a2fdc0</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1080%2F14728222.2018.1541235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2018.1541235%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DR.%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DKlingl%26aufirst%3DY.%2BE.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520peripheral%2520nerve%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2018%26volume%3D22%26spage%3D993%26epage%3D1007%26doi%3D10.1080%2F14728222.2018.1541235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frojuello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot-Marie-Tooth disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyktLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=240-258&author=S.+Shenauthor=V.+Benoyauthor=J.+A.+Bergmanauthor=J.+H.+Kalinauthor=M.+Frojuelloauthor=G.+Vistoliauthor=W.+Haeckauthor=L.+Van+Den%0ABoschauthor=A.+P.+Kozikowski&title=Bicyclic-capped+histone+deacetylase+6+inhibitors+with+improved+activity+in+a+model+of+axonal+Charcot-Marie-Tooth+disease&doi=10.1021%2Facschemneuro.5b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Shen, Sida; Benoy, Veronick; Bergman, Joel A.; Kalin, Jay H.; Frojuello, Mariana; Vistoli, Giulio; Haeck, Wanda; Van Den Bosch, Ludo; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-258</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth (CMT) disease is a disorder of the peripheral nervous system where progressive degeneration of motor and sensory nerves leads to motor problems and sensory loss and for which no pharmacol. treatment is available.  Recently, it has been shown in a model for the axonal form of CMT that histone deacetylase 6 (HDAC6) can serve as a target for the development of a pharmacol. therapy.  Therefore, the authors aimed at developing new selective and activity-specific HDAC6 inhibitors with improved biochem. properties.  By utilizing a bicyclic cap as the structural scaffold from which to build upon, the authors developed several analogs that showed improved potency compared to tubastatin A while maintaining excellent selectivity compared to HDAC1.  Further screening in N2a cells examg. both the acetylation of α-tubulin and histones narrowed down the library of compds. to three potent and selective HDAC6 inhibitors.  In mutant HSPB1-expressing DRG neurons, serving as an in vitro model for CMT2, these inhibitors were able to restore the mitochondrial axonal transport deficits.  Combining structure-based development of HDAC6 inhibitors, screening in N2a cells and in a neuronal model for CMT2F, and preliminary ADMET and pharmacokinetic profiles, resulted in the selection of compd. I that possesses improved biochem., functional, and druglike properties compared to tubastatin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEQ8GZug94Z7Vg90H21EOLACvtfcHk0ljuhjP-C_vR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyktLvF&md5=79b7f824103b5a0f799f1d69fafed7de</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00286%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DFrojuello%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DBicyclic-capped%2520histone%2520deacetylase%25206%2520inhibitors%2520with%2520improved%2520activity%2520in%2520a%2520model%2520of%2520axonal%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D240%26epage%3D258%26doi%3D10.1021%2Facschemneuro.5b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot-Marie-Tooth disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">428</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2Fs13311-016-0501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=27957719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=417-428&author=V.+Benoyauthor=P.+Vanden+Bergheauthor=M.+Jarpeauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=Development+of+improved+HDAC6+inhibitors+as+pharmacological+therapy+for+axonal+Charcot-Marie-Tooth+disease&doi=10.1007%2Fs13311-016-0501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease</span></div><div class="casAuthors">Benoy, Veronick; Vanden Berghe, Pieter; Jarpe, Matthew; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recently, we identified histone deacetylase 6, which deacetylates α-tubulin, as a potential therapeutic target in axonal CMT.  Pharmacol. inhibition of the deacetylating function of HDAC6 reversed the motor and sensory deficits in a mouse model for mutant "small heat shock protein B1"-induced CMT2 at the behavioral and electrophysiol. level.  In order to translate this potential therapeutic strategy into a clin. application, small drug-like mols. that are potent and selective HDAC6 inhibitors are essential.  To screen for these, we developed a method that consisted of 3 distinct phases and that was based on the pathol. findings in the mutant HSPB1-induced CMT2 mouse model.  Three different inhibitors (ACY-738, ACY-775, and ACY-1215) were tested and demonstrated to be both potent and selective HDAC6 inhibitors.  Moreover, these inhibitors increased the innervation of the neuromuscular junctions in the gastrocnemius muscle and improved the motor and sensory nerve conduction, confirming that HDAC6 inhibition is a potential therapeutic strategy in CMT2.  Furthermore, ACY-1215 is an interesting lead mol. as it is currently tested in clin. trials for cancer.  Taken together, these results may speed up the translation of pharmacol. inhibition of HDAC6 into a therapy against CMT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJr47ap41l7Vg90H21EOLACvtfcHk0ljuhjP-C_vR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2ku7vO&md5=cb382132da19455955c1b432cf59aa5e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0501-z%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520improved%2520HDAC6%2520inhibitors%2520as%2520pharmacological%2520therapy%2520for%2520axonal%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D417%26epage%3D428%26doi%3D10.1007%2Fs13311-016-0501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eykens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossaert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaspers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gysemans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den
Bosch, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2017.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.nbd.2017.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29197621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWlsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2018&pages=59-69&author=L.+Van+Helleputteauthor=M.+Katerauthor=D.+P.+Cookauthor=C.+Eykensauthor=E.+Rossaertauthor=W.+Haeckauthor=T.+Jaspersauthor=N.+Geensauthor=P.+Vanden+Bergheauthor=C.+Gysemansauthor=C.+Mathieuauthor=W.+Robberechtauthor=P.+Van+Dammeauthor=G.+Cavalettiauthor=M.+Jarpeauthor=L.+Van+Den%0ABosch&title=Inhibition+of+histone+deacetylase+6+%28HDAC6%29+protects+against+vincristine-induced+peripheral+neuropathies+and+inhibits+tumor+growth&doi=10.1016%2Fj.nbd.2017.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth</span></div><div class="casAuthors">Van Helleputte, Lawrence; Kater, Mandy; Cook, Dana P.; Eykens, Caroline; Rossaert, Elisabeth; Haeck, Wanda; Jaspers, Tom; Geens, Natasja; Vanden Berghe, Pieter; Gysemans, Conny; Mathieu, Chantal; Robberecht, Wim; Van Damme, Philip; Cavaletti, Guido; Jarpe, Matthew; Van Den Bosch, Ludo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As cancer is becoming more and more a chronic disease, a large proportion of patients is confronted with devastating side effects of certain anti-cancer drugs.  The most common neurol. complications are painful peripheral neuropathies.  Chemotherapeutics that interfere with microtubules, including plant-derived vinca-alkaloids such as vincristine, can cause these chemotherapy-induced peripheral neuropathies (CIPN).  Available treatments focus on symptom alleviation and pain redn. rather than prevention of the neuropathy.  The aim of this study was to investigate the potential of specific histone deacetylase 6 (HDAC6) inhibitors as a preventive therapy for CIPN using multiple rodent models for vincristine-induced peripheral neuropathies (VIPN).  HDAC6 inhibition increased the levels of acetylated α-tubulin in tissues of rodents undergoing vincristine-based chemotherapy, which correlates to a reduced severity of the neurol. symptoms, both at the electrophysiol. and the behavioral level.  Mechanistically, disturbances in axonal transport of mitochondria is considered as an important contributing factor in the pathophysiol. of VIPN.  As vincristine interferes with the polymn. of microtubules, we investigated whether disturbances in axonal transport could contribute to VIPN.  We obsd. that increasing α-tubulin acetylation through HDAC6 inhibition restores vincristine-induced defects of axonal transport in cultured dorsal root ganglion neurons.  Finally, we assured that HDAC6-inhibition offers neuroprotection without interfering with the anti-cancer efficacy of vincristine using a mouse model for acute lymphoblastic leukemia.  Taken together, our results emphasize the therapeutic potential of HDAC6 inhibitors with beneficial effects both on vincristine-induced neurotoxicity, as well as on tumor proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQhf8w1l_xLVg90H21EOLACvtfcHk0ljuhjP-C_vR6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWlsbzO&md5=5d423c59af112360f1a389b3fc055e12</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2017.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2017.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DKater%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DD.%2BP.%26aulast%3DEykens%26aufirst%3DC.%26aulast%3DRossaert%26aufirst%3DE.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DJaspers%26aufirst%3DT.%26aulast%3DGeens%26aufirst%3DN.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DGysemans%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DC.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DCavaletti%26aufirst%3DG.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520protects%2520against%2520vincristine-induced%2520peripheral%2520neuropathies%2520and%2520inhibits%2520tumor%2520growth%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2018%26volume%3D111%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.nbd.2017.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caskey, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. L.</span></span> <span> </span><span class="NLM_article-title">Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1007</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03461-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41467-018-03461-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29520015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrpt1Wmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1007&author=Z.+Moauthor=X.+Zhaoauthor=H.+Liuauthor=Q.+Huauthor=X.+Q.+Chenauthor=J.+Phamauthor=N.+Weiauthor=Z.+Liuauthor=J.+Zhouauthor=R.+W.+Burgessauthor=S.+L.+Pfaffauthor=C.+T.+Caskeyauthor=C.+Wuauthor=G.+Baiauthor=X.+L.+Yang&title=Aberrant+GlyRS-HDAC6+interaction+linked+to+axonal+transport+deficits+in+Charcot-Marie-Tooth+neuropathy&doi=10.1038%2Fs41467-018-03461-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy</span></div><div class="casAuthors">Mo Zhongying; Liu Huaqing; Hu Qinghua; Pham Jessica; Wei Na; Liu Ze; Zhou Jiadong; Bai Ge; Yang Xiang-Lei; Zhao Xiaobei; Chen Xu-Qiao; Wu Chengbiao; Burgess Robert W; Pfaff Samuel L; Bai Ge; Caskey C Thomas; Wu Chengbiao</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1007</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dominant mutations in glycyl-tRNA synthetase (GlyRS) cause a subtype of Charcot-Marie-Tooth neuropathy (CMT2D).  Although previous studies have shown that GlyRS mutants aberrantly interact with Nrp1, giving insight into the disease's specific effects on motor neurons, these cannot explain length-dependent axonal degeneration.  Here, we report that GlyRS mutants interact aberrantly with HDAC6 and stimulate its deacetylase activity on α-tubulin.  A decrease in α-tubulin acetylation and deficits in axonal transport are observed in mice peripheral nerves prior to disease onset.  An HDAC6 inhibitor used to restore α-tubulin acetylation rescues axonal transport deficits and improves motor functions of CMT2D mice.  These results link the aberrant GlyRS-HDAC6 interaction to CMT2D pathology and suggest HDAC6 as an effective therapeutic target.  Moreover, the HDAC6 interaction differs from Nrp1 interaction among GlyRS mutants and correlates with divergent clinical presentations, indicating the existence of multiple and different mechanisms in CMT2D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDPByhVBrFcnthwrmtH4OBfW6udTcc2eZbD4_OQnSyIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrpt1Wmuw%253D%253D&md5=d6f04db92a21e7732f87cc064cd99905</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03461-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03461-z%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%2BQ.%26aulast%3DPham%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBurgess%26aufirst%3DR.%2BW.%26aulast%3DPfaff%26aufirst%3DS.%2BL.%26aulast%3DCaskey%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%2BL.%26atitle%3DAberrant%2520GlyRS-HDAC6%2520interaction%2520linked%2520to%2520axonal%2520transport%2520deficits%2520in%2520Charcot-Marie-Tooth%2520neuropathy%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1007%26doi%3D10.1038%2Fs41467-018-03461-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Helleputte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Ydewalle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheveneels, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schevenels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cader, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robberecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bosch, L.</span></span> <span> </span><span class="NLM_article-title">HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1093/brain/awx375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fbrain%2Fawx375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29415205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MvovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2018&pages=673-687&author=V.+Benoyauthor=L.+Van+Helleputteauthor=R.+Priorauthor=C.+d%E2%80%99Ydewalleauthor=W.+Haeckauthor=N.+Geensauthor=W.+Scheveneelsauthor=B.+Schevenelsauthor=M.+Z.+Caderauthor=K.+Talbotauthor=A.+P.+Kozikowskiauthor=P.+Vanden+Bergheauthor=P.+Van+Dammeauthor=W.+Robberechtauthor=L.+Van+Den+Bosch&title=HDAC6+is+a+therapeutic+target+in+mutant+GARS-induced+Charcot-Marie-Tooth+disease&doi=10.1093%2Fbrain%2Fawx375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease</span></div><div class="casAuthors">Benoy Veronick; Van Helleputte Lawrence; Prior Robert; d'Ydewalle Constantin; Haeck Wanda; Geens Natasja; Scheveneels Wendy; Schevenels Begga; Van Damme Philip; Robberecht Wim; Van Den Bosch Ludo; Benoy Veronick; Van Helleputte Lawrence; Prior Robert; d'Ydewalle Constantin; Haeck Wanda; Geens Natasja; Scheveneels Wendy; Schevenels Begga; Van Damme Philip; Robberecht Wim; Van Den Bosch Ludo; Cader M Zameel; Talbot Kevin; Cader M Zameel; Kozikowski Alan P; Vanden Berghe Pieter; Van Damme Philip; Robberecht Wim</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-687</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peripheral nerve axons require a well-organized axonal microtubule network for efficient transport to ensure the constant crosstalk between soma and synapse.  Mutations in more than 80 different genes cause Charcot-Marie-Tooth disease, which is the most common inherited disorder affecting peripheral nerves.  This genetic heterogeneity has hampered the development of therapeutics for Charcot-Marie-Tooth disease.  The aim of this study was to explore whether histone deacetylase 6 (HDAC6) can serve as a therapeutic target focusing on the mutant glycyl-tRNA synthetase (GlyRS/GARS)-induced peripheral neuropathy.  Peripheral nerves and dorsal root ganglia from the C201R mutant Gars mouse model showed reduced acetylated α-tubulin levels.  In primary dorsal root ganglion neurons, mutant GlyRS affected neurite length and disrupted normal mitochondrial transport.  We demonstrated that GlyRS co-immunoprecipitated with HDAC6 and that this interaction was blocked by tubastatin A, a selective inhibitor of the deacetylating function of HDAC6.  Moreover, HDAC6 inhibition restored mitochondrial axonal transport in mutant GlyRS-expressing neurons.  Systemic delivery of a specific HDAC6 inhibitor increased α-tubulin acetylation in peripheral nerves and partially restored nerve conduction and motor behaviour in mutant Gars mice.  Our study demonstrates that α-tubulin deacetylation and disrupted axonal transport may represent a common pathogenic mechanism underlying Charcot-Marie-Tooth disease and it broadens the therapeutic potential of selective HDAC6 inhibition to other genetic forms of axonal Charcot-Marie-Tooth disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWZDeBfZexjBWfpMXQLRstfW6udTcc2eZbD4_OQnSyIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvovVSmsA%253D%253D&md5=6f39292d1113deb16ab6d57039ac4977</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawx375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawx375%26sid%3Dliteratum%253Aachs%26aulast%3DBenoy%26aufirst%3DV.%26aulast%3DVan%2BHelleputte%26aufirst%3DL.%26aulast%3DPrior%26aufirst%3DR.%26aulast%3Dd%25E2%2580%2599Ydewalle%26aufirst%3DC.%26aulast%3DHaeck%26aufirst%3DW.%26aulast%3DGeens%26aufirst%3DN.%26aulast%3DScheveneels%26aufirst%3DW.%26aulast%3DSchevenels%26aufirst%3DB.%26aulast%3DCader%26aufirst%3DM.%2BZ.%26aulast%3DTalbot%26aufirst%3DK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DVanden%2BBerghe%26aufirst%3DP.%26aulast%3DVan%2BDamme%26aufirst%3DP.%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DVan%2BDen%2BBosch%26aufirst%3DL.%26atitle%3DHDAC6%2520is%2520a%2520therapeutic%2520target%2520in%2520mutant%2520GARS-induced%2520Charcot-Marie-Tooth%2520disease%26jtitle%3DBrain%26date%3D2018%26volume%3D141%26spage%3D673%26epage%3D687%26doi%3D10.1093%2Fbrain%2Fawx375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B.-O.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibitors rescued the defective axonal mitochondrial movement in motor neurons derived from the induced pluripotent stem cells of peripheral neuropathy patients with HSPB1 mutation</span>. <i>Stem. Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">9475981</span>, <span class="refDoi"> DOI: 10.1155/2016/9475981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2016%2F9475981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28105056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1c7nsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=9475981&author=J.-Y.+Kimauthor=S.-Y.+Wooauthor=Y.+B.+Hongauthor=H.+Choiauthor=J.+Kimauthor=H.+Choiauthor=I.+Mook-Jungauthor=N.+Haauthor=J.+Kyungauthor=S.+K.+Kooauthor=S.-C.+Jungauthor=B.-O.+Choi&title=HDAC6+inhibitors+rescued+the+defective+axonal+mitochondrial+movement+in+motor+neurons+derived+from+the+induced+pluripotent+stem+cells+of+peripheral+neuropathy+patients+with+HSPB1+mutation&doi=10.1155%2F2016%2F9475981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with HSPB1 Mutation</span></div><div class="casAuthors">Kim Ji-Yon; Woo So-Youn; Hong Young Bin; Choi Heesun; Kim Jisoo; Choi Hyunjung; Mook-Jung Inhee; Ha Nina; Kyung Jangbeen; Koo Soo Kyung; Jung Sung-Chul; Choi Byung-Ok</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9475981</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">The Charcot-Marie-Tooth disease 2F (CMT2F) and distal hereditary motor neuropathy 2B (dHMN2B) are caused by autosomal dominantly inherited mutations of the heat shock 27 kDa protein 1 (HSPB1) gene and there are no specific therapies available yet.  Here, we assessed the potential therapeutic effect of HDAC6 inhibitors on peripheral neuropathy with HSPB1 mutation using in vitro model of motor neurons derived from induced pluripotent stem cells (iPSCs) of CMT2F and dHMN2B patients.  The absolute velocity of mitochondrial movements and the percentage of moving mitochondria in axons were lower both in CMT2F-motor neurons and in dHMN2B-motor neurons than those in controls, and the severity of the defective mitochondrial movement was different between the two disease models.  CMT2F-motor neurons and dHMN2B-motor neurons also showed reduced α-tubulin acetylation compared with controls.  The newly developed HDAC6 inhibitors, CHEMICAL X4 and CHEMICAL X9, increased acetylation of α-tubulin and reversed axonal movement defects of mitochondria in CMT2F-motor neurons and dHMN2B-motor neurons.  Our results suggest that the neurons derived from patient-specific iPSCs can be used in drug screening including HDAC6 inhibitors targeting peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIJGiIlA3U8a91pGlMMoT5fW6udTcc2eYzxkrKqdiqN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7nsFSgtQ%253D%253D&md5=f4a8b6cd96e4b227830b08e5df8bbfe8</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9475981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9475981%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DWoo%26aufirst%3DS.-Y.%26aulast%3DHong%26aufirst%3DY.%2BB.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DHa%26aufirst%3DN.%26aulast%3DKyung%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DS.%2BK.%26aulast%3DJung%26aufirst%3DS.-C.%26aulast%3DChoi%26aufirst%3DB.-O.%26atitle%3DHDAC6%2520inhibitors%2520rescued%2520the%2520defective%2520axonal%2520mitochondrial%2520movement%2520in%2520motor%2520neurons%2520derived%2520from%2520the%2520induced%2520pluripotent%2520stem%2520cells%2520of%2520peripheral%2520neuropathy%2520patients%2520with%2520HSPB1%2520mutation%26jtitle%3DStem.%2520Cells%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D9475981%26doi%3D10.1155%2F2016%2F9475981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relitti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span> <span> </span><span class="NLM_article-title">A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.4155%2Ffmc-2018-0315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30907134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=463-487&author=G.+Chemiauthor=M.+Brindisiauthor=S.+Brogiauthor=N.+Relittiauthor=S.+Butiniauthor=S.+Gemmaauthor=G.+Campiani&title=A+light+in+the+dark%3A+state+of+the+art+and+perspectives+in+optogenetics+and+optopharmacology+for+restoring+vision&doi=10.4155%2Ffmc-2018-0315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision</span></div><div class="casAuthors">Chemi, Giulia; Brindisi, Margherita; Brogi, Simone; Relitti, Nicola; Butini, Stefania; Gemma, Sandra; Campiani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-487</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In the last decade, innovative therapeutic strategies against inherited retinal degenerations (IRDs) have emerged.  In particular, chem.- and opto-genetics approaches or a combination of them have been identified for modulating neuronal/optical activity in order to restore vision in blinding diseases.  The 'chem.-genetics approach' (optopharmacol.) uses small mols. (exogenous photoswitches) for restoring light sensitivity by activating ion channels.  The 'opto-genetics approach' employs light-activated photosensitive proteins (exogenous opsins), introduced by viral vectors in injured tissues, to restore light response.  These approaches offer control of neuronal activities with spatial precision and limited invasiveness, although with some drawbacks.  Currently, a combined therapeutic strategy (optogenetic pharmacol.) is emerging.  This review describes the state of the art and provides an overview of the future perspectives in vision restoration.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJXPEzCj_JfbVg90H21EOLACvtfcHk0lgsnlJEj8PMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslGmsr4%253D&md5=8b7195d4c8fe41291228d2cfb1d0d8f9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0315%26sid%3Dliteratum%253Aachs%26aulast%3DChemi%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DRelitti%26aufirst%3DN.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3DA%2520light%2520in%2520the%2520dark%253A%2520state%2520of%2520the%2520art%2520and%2520perspectives%2520in%2520optogenetics%2520and%2520optopharmacology%2520for%2520restoring%2520vision%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D463%26epage%3D487%26doi%3D10.4155%2Ffmc-2018-0315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falsini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A. G.</span></span> <span> </span><span class="NLM_article-title">Inherited retinal degeneration: genetics, disease characterization, and outcome measures</span>. <i>J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">2109014</span>, <span class="refDoi"> DOI: 10.1155/2017/2109014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1155%2F2017%2F2109014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29098082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1M7nt1GrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=2109014&author=N.+W.+Khanauthor=B.+Falsiniauthor=M.+Kondoauthor=A.+G.+Robson&title=Inherited+retinal+degeneration%3A+genetics%2C+disease+characterization%2C+and+outcome+measures&doi=10.1155%2F2017%2F2109014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited Retinal Degeneration: Genetics, Disease Characterization, and Outcome Measures</span></div><div class="casAuthors">Khan Naheed W; Falsini Benedetto; Kondo Mineo; Robson Anthony G; Robson Anthony G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of ophthalmology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2109014</span>
        ISSN:<span class="NLM_cas:issn">2090-004X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7oFyKDDqccXELvajU9pjPfW6udTcc2eYzxkrKqdiqN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7nt1GrtA%253D%253D&md5=0d4f0b697eabb2297d62c5ec76b571ff</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1155%2F2017%2F2109014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F2109014%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%2BW.%26aulast%3DFalsini%26aufirst%3DB.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DRobson%26aufirst%3DA.%2BG.%26atitle%3DInherited%2520retinal%2520degeneration%253A%2520genetics%252C%2520disease%2520characterization%252C%2520and%2520outcome%2520measures%26jtitle%3DJ.%2520Ophthalmol.%26date%3D2017%26volume%3D2017%26spage%3D2109014%26doi%3D10.1155%2F2017%2F2109014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zrenner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e112142</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0112142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0112142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=25392995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e112142&author=B.+Arango-Gonzalezauthor=D.+Trifunovicauthor=A.+Sahabogluauthor=K.+Kranzauthor=S.+Michalakisauthor=P.+Farinelliauthor=S.+Kochauthor=F.+Kochauthor=S.+Cottetauthor=U.+Janssen-Bienholdauthor=K.+Dedekauthor=M.+Bielauthor=E.+Zrennerauthor=T.+Eulerauthor=P.+Ekstromauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Identification+of+a+common+non-apoptotic+cell+death+mechanism+in+hereditary+retinal+degeneration&doi=10.1371%2Fjournal.pone.0112142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span></div><div class="casAuthors">Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstroem, Per; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e112142/1-e112142/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration.  We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death.  We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance.  Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose.  Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEcYvkyewtrVg90H21EOLACvtfcHk0linuz-xZbgGjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL&md5=53c0c17980aa77b6c8addc7cff796a1a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0112142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0112142%26sid%3Dliteratum%253Aachs%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKranz%26aufirst%3DK.%26aulast%3DMichalakis%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DCottet%26aufirst%3DS.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DDedek%26aufirst%3DK.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DZrenner%26aufirst%3DE.%26aulast%3DEuler%26aufirst%3DT.%26aulast%3DEkstrom%26aufirst%3DP.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520a%2520common%2520non-apoptotic%2520cell%2520death%2520mechanism%2520in%2520hereditary%2520retinal%2520degeneration%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De112142%26doi%3D10.1371%2Fjournal.pone.0112142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Athanasiou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellingham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheetham, M. E.</span></span> <span> </span><span class="NLM_article-title">The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy</span>. <i>Prog. Retinal Eye Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.preteyeres.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.preteyeres.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29042326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSgu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=1-23&author=D.+Athanasiouauthor=M.+Aguilaauthor=J.+Bellinghamauthor=W.+Liauthor=C.+McCulleyauthor=P.+J.+Reevesauthor=M.+E.+Cheetham&title=The+molecular+and+cellular+basis+of+rhodopsin+retinitis+pigmentosa+reveals+potential+strategies+for+therapy&doi=10.1016%2Fj.preteyeres.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy</span></div><div class="casAuthors">Athanasiou, Dimitra; Aguila, Monica; Bellingham, James; Li, Wenwen; McCulley, Caroline; Reeves, Philip J.; Cheetham, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Retinal and Eye Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-23</span>CODEN:
                <span class="NLM_cas:coden">PRTRES</span>;
        ISSN:<span class="NLM_cas:issn">1350-9462</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inherited mutations in the rod visual pigment, rhodopsin, cause the degenerative blinding condition, retinitis pigmentosa (RP).  Over 150 different mutations in rhodopsin have been identified and, collectively, they are the most common cause of autosomal dominant RP (adRP).  Mutations in rhodopsin are also assocd. with dominant congenital stationary night blindness (adCSNB) and, less frequently, recessive RP (arRP).  Recessive RP is usually assocd. with loss of rhodopsin function, whereas the dominant conditions are a consequence of gain of function and/or dominant neg. activity.  The in-depth characterization of many rhodopsin mutations has revealed that there are distinct consequences on the protein structure and function assocd. with different mutations.  Here we categorise rhodopsin mutations into seven discrete classes; with defects ranging from misfolding and disruption of proteostasis, through mislocalisation and disrupted intracellular traffic to instability and altered function.  Rhodopsin adRP offers a unique paradigm to understand how disturbances in photoreceptor homeostasis can lead to neuronal cell death.  Furthermore, a wide range of therapies have been tested in rhodopsin RP, from gene therapy and gene editing to pharmacol. interventions.  The understanding of the disease mechanisms assocd. with rhodopsin RP and the development of targeted therapies offer the potential of treatment for this currently untreatable neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3e2zCdSM5WrVg90H21EOLACvtfcHk0linuz-xZbgGjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSgu73E&md5=93487ef4f9df69000f0899d5d1343a8d</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.preteyeres.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.preteyeres.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DAthanasiou%26aufirst%3DD.%26aulast%3DAguila%26aufirst%3DM.%26aulast%3DBellingham%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMcCulley%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DP.%2BJ.%26aulast%3DCheetham%26aufirst%3DM.%2BE.%26atitle%3DThe%2520molecular%2520and%2520cellular%2520basis%2520of%2520rhodopsin%2520retinitis%2520pigmentosa%2520reveals%2520potential%2520strategies%2520for%2520therapy%26jtitle%3DProg.%2520Retinal%2520Eye%2520Res.%26date%3D2018%26volume%3D62%26spage%3D1%26epage%3D23%26doi%3D10.1016%2Fj.preteyeres.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho-Pelluz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alavi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kustermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span> <span> </span><span class="NLM_article-title">Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e24</span>, <span class="refDoi"> DOI: 10.1038/cddis.2010.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2010.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21364632" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=e24&author=J.+Sancho-Pelluzauthor=M.+V.+Alaviauthor=A.+Sahabogluauthor=S.+Kustermannauthor=P.+Farinelliauthor=S.+Azadiauthor=T.+van+Veenauthor=F.+J.+Romeroauthor=F.+Paquet-Durandauthor=P.+Ekstrom&title=Excessive+HDAC+activation+is+critical+for+neurodegeneration+in+the+rd1+mouse&doi=10.1038%2Fcddis.2010.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2010.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2010.4%26sid%3Dliteratum%253Aachs%26aulast%3DSancho-Pelluz%26aufirst%3DJ.%26aulast%3DAlavi%26aufirst%3DM.%2BV.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKustermann%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DAzadi%26aufirst%3DS.%26aulast%3Dvan%2BVeen%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BJ.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26aulast%3DEkstrom%26aufirst%3DP.%26atitle%3DExcessive%2520HDAC%2520activation%2520is%2520critical%2520for%2520neurodegeneration%2520in%2520the%2520rd1%2520mouse%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2010%26volume%3D1%26spage%3De24%26doi%3D10.1038%2Fcddis.2010.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span> <span> </span><span class="NLM_article-title">Histone Deacetylase: Therapeutic targets in retinal degeneration</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>854</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-17121-0_61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2F978-3-319-17121-0_61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26427446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSqs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=854&publication_year=2016&pages=455-461&author=C.+Dalyauthor=J.+Yinauthor=B.+N.+Kennedy&title=Histone+Deacetylase%3A+Therapeutic+targets+in+retinal+degeneration&doi=10.1007%2F978-3-319-17121-0_61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase: Therapeutic Targets in Retinal Degeneration</span></div><div class="casAuthors">Daly, Conor; Yin, Jun; Kennedy, Breandan N.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">854</span>
        (<span class="NLM_cas:issue">Retinal Degenerative Diseases</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Previous studies report that retinitis pigmentosa (RP) patients treated with the histone deacetylase inhibitor (HDACi) valproic acid (VPA) present with improved visual fields and delayed vision loss.  However, other studies report poor efficacy and safety of HDACi in other cohorts of retinal degeneration patients.  Furthermore, the mol. mechanisms by which HDACi can improve visual function is unknown, albeit HDACi can attenuate pro-apoptotic stimuli and induce expression of neuroprotective factors.  Thus, further anal. of HDACi is warranted in pre-clin. models of retinal degeneration including zebrafish.  Anal. of HDAC expression in developing zebrafish reveals diverse temporal expression patterns during development and maturation of visual function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppoyCN3Bq6jrVg90H21EOLACvtfcHk0linuz-xZbgGjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSqs7zP&md5=6001a12674f08b63519f7b421247a51a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-17121-0_61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-17121-0_61%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26atitle%3DHistone%2520Deacetylase%253A%2520Therapeutic%2520targets%2520in%2520retinal%2520degeneration%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2016%26volume%3D854%26spage%3D455%26epage%3D461%26doi%3D10.1007%2F978-3-319-17121-0_61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dengler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhard-Kurz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitzmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e488</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2013.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23392176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVykt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e488&author=A.+Sahabogluauthor=O.+Paquet-Durandauthor=J.+Dietterauthor=K.+Denglerauthor=S.+Bernhard-Kurzauthor=P.+A.+Ekstromauthor=B.+Hitzmannauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Retinitis+pigmentosa%3A+rapid+neurodegeneration+is+governed+by+slow+cell+death+mechanisms&doi=10.1038%2Fcddis.2013.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms</span></div><div class="casAuthors">Sahaboglu, A.; Paquet-Durand, O.; Dietter, J.; Dengler, K.; Bernhard-Kurz, S.; Ekstroem, P. A. R.; Hitzmann, B.; Ueffing, M.; Paquet-Durand, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">e488</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For most neurodegenerative diseases the precise duration of an individual cell's death is unknown, which is an obstacle when counteractive measures are being considered.  To address this, we used the rd1 mouse model for retinal neurodegeneration, characterized by phosphodiesterase-6 (PDE6) dysfunction and photoreceptor death triggered by high cyclic guanosine-mono-phosphate (cGMP) levels.  Using cellular data on cGMP accumulation, cell death, and survival, we created math. models to simulate the temporal development of the degeneration.  We validated model predictions using organotypic retinal explant cultures derived from wild-type animals and exposed to the selective PDE6 inhibitor zaprinast.  Together, photoreceptor data and modeling for the first time delineated three major cell death phases in a complex neuronal tissue: (1) initiation, taking up to 36 h, (2) execution, lasting another 40 h, and finally (3) clearance, lasting about 7 h.  Surprisingly, photoreceptor neurodegeneration was noticeably slower than necrosis or apoptosis, suggesting a different mechanism of death for these neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiOMSMKJt17Vg90H21EOLACvtfcHk0lg2Ugsdu5Y5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVykt77N&md5=7c8b73cc63fa41a561fae11f987ef4f0</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.12%26sid%3Dliteratum%253Aachs%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DPaquet-Durand%26aufirst%3DO.%26aulast%3DDietter%26aufirst%3DJ.%26aulast%3DDengler%26aufirst%3DK.%26aulast%3DBernhard-Kurz%26aufirst%3DS.%26aulast%3DEkstrom%26aufirst%3DP.%2BA.%26aulast%3DHitzmann%26aufirst%3DB.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DRetinitis%2520pigmentosa%253A%2520rapid%2520neurodegeneration%2520is%2520governed%2520by%2520slow%2520cell%2520death%2520mechanisms%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De488%26doi%3D10.1038%2Fcddis.2013.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danciger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applebury, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farber, D. B.</span></span> <span> </span><span class="NLM_article-title">Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/347677a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2F347677a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1977087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=677-680&author=C.+Bowesauthor=T.+Liauthor=M.+Dancigerauthor=L.+C.+Baxterauthor=M.+L.+Appleburyauthor=D.+B.+Farber&title=Retinal+degeneration+in+the+rd+mouse+is+caused+by+a+defect+in+the+beta+subunit+of+rod+cGMP-phosphodiesterase&doi=10.1038%2F347677a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase</span></div><div class="casAuthors">Bowes, Cathy; Li, Tiansen; Danciger, Michael; Baxter, Leslie C.; Applebury, Meredithe L.; Farber, Debora B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6294</span>),
    <span class="NLM_cas:pages">677-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Mice homozygous for the rd mutation display hereditary retinal degeneration, and the classic rd lines serve as a model for human retinitis pigmentosa.  In affected animals, the retinal rod photoreceptor cells begin degenerating at about postnatal day 8, and by 4 wk no photoreceptors are left.  Degeneration is preceded by accumulation of cyclic GMP in the retina and is correlated with deficient activity of the rod photoreceptor cGMP-phosphodiesterase.  A candidate cDNA for the rd gene was isolated from a mouse retinal library and characterization of cDNAs encoding all subunits of bovine photoreceptor phosphodiesterase was completed.  The candidate cDNA shows strong homol. with a cDNA encoding the bovine phosphodiesterase β subunit.  Here, evidence is presented that the candidate cDNA is the murine homolog of bovine phosphodiesterase β cDNA.  It is concluded that the mouse rd locus encodes the rod photoreceptor cGMP-phosphodiesterase β subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZy8akRsDITLVg90H21EOLACvtfcHk0lg2Ugsdu5Y5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFKj&md5=10365cd2cc2e06e3c45a5511eb6bdfc5</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2F347677a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347677a0%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DDanciger%26aufirst%3DM.%26aulast%3DBaxter%26aufirst%3DL.%2BC.%26aulast%3DApplebury%26aufirst%3DM.%2BL.%26aulast%3DFarber%26aufirst%3DD.%2BB.%26atitle%3DRetinal%2520degeneration%2520in%2520the%2520rd%2520mouse%2520is%2520caused%2520by%2520a%2520defect%2520in%2520the%2520beta%2520subunit%2520of%2520rod%2520cGMP-phosphodiesterase%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D677%26epage%3D680%26doi%3D10.1038%2F347677a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackam, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otteson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowers, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leveillard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campochiaro, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zack, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2929</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.1167/iovs.03-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1167%2Fiovs.03-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=15326104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BD2cvhvFarug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=2929-2942&author=A.+S.+Hackamauthor=R.+Stromauthor=D.+Liuauthor=J.+Qianauthor=C.+Wangauthor=D.+Ottesonauthor=T.+Gunatilakaauthor=R.+H.+Farkasauthor=I.+Chowersauthor=M.+Kageyamaauthor=T.+Leveillardauthor=J.+A.+Sahelauthor=P.+A.+Campochiaroauthor=G.+Parmigianiauthor=D.+J.+Zack&title=Identification+of+gene+expression+changes+associated+with+the+progression+of+retinal+degeneration+in+the+rd1+mouse&doi=10.1167%2Fiovs.03-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse</span></div><div class="casAuthors">Hackam Abigail S; Strom Richelle; Liu Dongmei; Qian Jiang; Wang Chenwei; Otteson Deborah; Gunatilaka Tushara; Farkas Ronald H; Chowers Itay; Kageyama Masaaki; Leveillard Thierry; Sahel Jose-Alain; Campochiaro Peter A; Parmigiani Giovanni; Zack Donald J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2929-42</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  One approach to gaining insight into the biological pathways contributing to rod and cone photoreceptor death is to identify patterns of gene expression changes.  In the present study, a custom retinal microarray was developed to analyze the rd1 mouse, a well-characterized animal model of human retinal degeneration.  METHODS:  A microarray was constructed containing cDNA fragments corresponding to genes known or postulated to be involved in normal retinal function, development, and disease.  Gene expression in rd1 retina was compared with age-matched control retinas at three time points: the peak of rod degeneration (postnatal day [P]14), early in cone degeneration (P35), and during cone degeneration (P50).  Selected microarray results were confirmed with real-time PCR.  The cellular distribution of one of the differentially expressed genes, dickkopf 3 (Dkk3), was assessed by in situ hybridization.  RESULTS:  At each stage of degeneration, there was only limited overlap of the genes that showed increased expression, suggesting the involvement of temporally distinct molecular pathways.  Genes active in transport mechanisms and in signaling pathways were differentially expressed during rod degeneration, whereas genes with functions in protein modification and cellular metabolism were differentially expressed during cone degeneration.  Increased expression of genes involved in cell proliferation pathways and oxidative stress was observed at each time point.  CONCLUSIONS:  These microarray results provide clues to understanding the molecular pathways underlying photoreceptor degeneration and indicate directions for future studies.  In addition, comparisons of normal and degenerated retina identified numerous genes and ESTs that are potentially enriched in rod photoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCUI8DZVGxHuWhZTslLrfffW6udTcc2eaVC_74Ew0uNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvhvFarug%253D%253D&md5=c86bc5311ec1db9a00037de90146750a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1167%2Fiovs.03-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.03-1184%26sid%3Dliteratum%253Aachs%26aulast%3DHackam%26aufirst%3DA.%2BS.%26aulast%3DStrom%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DOtteson%26aufirst%3DD.%26aulast%3DGunatilaka%26aufirst%3DT.%26aulast%3DFarkas%26aufirst%3DR.%2BH.%26aulast%3DChowers%26aufirst%3DI.%26aulast%3DKageyama%26aufirst%3DM.%26aulast%3DLeveillard%26aufirst%3DT.%26aulast%3DSahel%26aufirst%3DJ.%2BA.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DZack%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520changes%2520associated%2520with%2520the%2520progression%2520of%2520retinal%2520degeneration%2520in%2520the%2520rd1%2520mouse%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2004%26volume%3D45%26spage%3D2929%26epage%3D2942%26doi%3D10.1167%2Fiovs.03-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petridou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comitato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marigo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Primary rod and cone degeneration is prevented by HDAC inhibition</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1074</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-75402-4_45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1007%2F978-3-319-75402-4_45" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29721965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2018&pages=367-373&author=D.+Trifunovicauthor=E.+Petridouauthor=A.+Comitatoauthor=V.+Marigoauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Primary+rod+and+cone+degeneration+is+prevented+by+HDAC+inhibition&doi=10.1007%2F978-3-319-75402-4_45"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Primary rod and cone degeneration is prevented by HDAC inhibition</span></div><div class="casAuthors">Trifunovic, Dragana; Petridou, Eleni; Comitato, Antonella; Marigo, Valeria; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1074</span>
        (<span class="NLM_cas:issue">Retinal Degenerative Diseases</span>),
    <span class="NLM_cas:pages">367-373</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Photoreceptor cell death in inherited retinal degeneration is accompanied by over-activation of histone deacetylases (HDAC).  Excessive HDAC activity is found both in primary rod degeneration (such as in the rd10 mouse) and in primary cone death, including the cone photoreceptor function loss 1 (cpfl1) mouse.  We evaluated the potential of pharmacol. HDAC inhibition to prevent photoreceptor degeneration in primary rod and cone degeneration.  We show that a single in vivo treatment of cpfl1 mice with the HDAC inhibitor trichostatin A (TSA) resulted in a significant protection of cpfl1 mutant cones.  Similarly, HDAC inhibition with the clin. approved HDAC inhibitor vorinostat (SAHA) resulted in a significant improvement of rod survival in rd10 retinal explant cultures.  Altogether, these results highlight the feasibility of targeted neuroprotection in vivo and create hope to maintain vision in patients suffering from both rod and cone dystrophies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Ee2pargmHrVg90H21EOLACvtfcHk0li7H4rz6Nz5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVertbg%253D&md5=48f645cd4daa35cb12a375478abab62b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-75402-4_45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-75402-4_45%26sid%3Dliteratum%253Aachs%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DPetridou%26aufirst%3DE.%26aulast%3DComitato%26aufirst%3DA.%26aulast%3DMarigo%26aufirst%3DV.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DPrimary%2520rod%2520and%2520cone%2520degeneration%2520is%2520prevented%2520by%2520HDAC%2520inhibition%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2018%26volume%3D1074%26spage%3D367%26epage%3D373%26doi%3D10.1007%2F978-3-319-75402-4_45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comitato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Amo, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urtti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenijevic, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marigo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4472</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddw275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1093%2Fhmg%2Fddw275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28172811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFaktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=4462-4472&author=D.+Trifunovicauthor=B.+Arango-Gonzalezauthor=A.+Comitatoauthor=M.+Barthauthor=E.+M.+Del+Amoauthor=M.+Kulkarniauthor=A.+Sahabogluauthor=S.+M.+Hauckauthor=A.+Urttiauthor=Y.+Arsenijevicauthor=M.+Ueffingauthor=V.+Marigoauthor=F.+Paquet-Durand&title=HDAC+inhibition+in+the+cpfl1+mouse+protects+degenerating+cone+photoreceptors+in+vivo&doi=10.1093%2Fhmg%2Fddw275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo</span></div><div class="casAuthors">Trifunovic, Dragana; Arango-Gonzalez, Blanca; Comitato, Antonella; Barth, Melanie; del Amo, Eva M.; Kulkarni, Manoj; Sahaboglu, Ayse; Hauck, Stefanie M.; Urtti, Arto; Arsenijevic, Yvan; Ueffing, Marius; Marigo, Valeria; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4462-4472</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cone photoreceptor cell death as it occurs in certain hereditary retinal diseases is devastating, with the affected patients suffering from a loss of accurate and color vision.  Regrettably, these hereditary cone diseases are still untreatable to date.  Thus, the identification of substances able to block or restrain cone cell death is of primary importance.  We studied the neuroprotective effects of a histone deacetylase inhibitor, Trichostatin A (TSA), in a mouse model of inherited, primary cone degeneration (cpfi,1).  We show that HDAC inhibition protects cpfi,1 cones in vitro, in retinal explant cultures.  More importantly, in vivo, a single intravitreal TSA injection significantly increased cone survival for up to 16 days post-injection.  In addn., the abnormal, incomplete cone migration pattern in the cpfi,1 retina was significantly improved by HDAC inhibition.  These findings suggest a crucial role for HDAC activity in primary cone degeneration and highlight a new avenue for future therapy developments for cone dystrophies and retinal diseases assocd. with impaired cone migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKe6ueDLsrbVg90H21EOLACvtfcHk0li7H4rz6Nz5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFaktr8%253D&md5=f70d924be45ce875d9a562c5b8216317</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddw275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddw275%26sid%3Dliteratum%253Aachs%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DComitato%26aufirst%3DA.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DDel%2BAmo%26aufirst%3DE.%2BM.%26aulast%3DKulkarni%26aufirst%3DM.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DHauck%26aufirst%3DS.%2BM.%26aulast%3DUrtti%26aufirst%3DA.%26aulast%3DArsenijevic%26aufirst%3DY.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DMarigo%26aufirst%3DV.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DHDAC%2520inhibition%2520in%2520the%2520cpfl1%2520mouse%2520protects%2520degenerating%2520cone%2520photoreceptors%2520in%2520vivo%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D4462%26epage%3D4472%26doi%3D10.1093%2Fhmg%2Fddw275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzekov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checchi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigelow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushal, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of valproic acid for retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1136/bjo.2009.175356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2009.175356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20647559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivVGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=89-93&author=C.+M.+Clemsonauthor=R.+Tzekovauthor=M.+Krebsauthor=J.+M.+Checchiauthor=C.+Bigelowauthor=S.+Kaushal&title=Therapeutic+potential+of+valproic+acid+for+retinitis+pigmentosa&doi=10.1136%2Fbjo.2009.175356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of valproic acid for retinitis pigmentosa</span></div><div class="casAuthors">Clemson C M; Tzekov R; Krebs M; Checchi J M; Bigelow C; Kaushal S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND/AIM:  To examine the efficacy and safety of valproic acid (VPA) in patients with retinitis pigmentosa (RP).  METHODS:  Thirteen eyes were examined before and after brief treatment (average 4 months) with VPA.  Visual fields (VF) for each eye were defined using digitised Goldmann Kinetic Perimetry tracings.  VF areas were log-transformed and VF loss/gain relative to baseline was calculated.  Visual acuity was measured using a Snellen chart at a distance of 20&emsp14;feet (6.1 m).  Values were converted to the logarithm of the minimum angle of resolution (logMAR) score.  RESULTS:  Nine eyes had improved VF with treatment, two eyes had decreased VF and two eyes experienced no change, with an overall average increase of 11%.  Assuming typical loss in VF area without treatment, this increase in VF was statistically significant (p<0.02).  An average decrease (0.172) in the logMAR scores was seen in these 13 eyes, which translates to a positive change in Snellen score of approximately 20/47 to 20/32, which was significant (p<0.02) assuming no loss in acuity without treatment.  Side effects were mild and well tolerated.  CONCLUSION:  Treatment with VPA is suggestive of a therapeutic benefit to patients with RP.  A placebo-controlled clinical trial will be necessary to assess the efficacy and safety of VPA for RP rigorously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUlsoY-cDkdlWTCLT8lX9SfW6udTcc2eaxLwsrY_jIdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivVGnuw%253D%253D&md5=7f73f128600812d49280a54aeaf30005</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2009.175356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2009.175356%26sid%3Dliteratum%253Aachs%26aulast%3DClemson%26aufirst%3DC.%2BM.%26aulast%3DTzekov%26aufirst%3DR.%26aulast%3DKrebs%26aufirst%3DM.%26aulast%3DChecchi%26aufirst%3DJ.%2BM.%26aulast%3DBigelow%26aufirst%3DC.%26aulast%3DKaushal%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520of%2520valproic%2520acid%2520for%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D89%26epage%3D93%26doi%3D10.1136%2Fbjo.2009.175356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phiel, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, P. S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">36734</span>– <span class="NLM_lpage">36741</span>, <span class="refDoi"> DOI: 10.1074/jbc.M101287200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M101287200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=11473107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36734-36741&author=C.+J.+Phielauthor=F.+Zhangauthor=E.+Y.+Huangauthor=M.+G.+Guentherauthor=M.+A.+Lazarauthor=P.+S.+Klein&title=Histone+deacetylase+is+a+direct+target+of+valproic+acid%2C+a+potent+anticonvulsant%2C+mood+stabilizer%2C+and+teratogen&doi=10.1074%2Fjbc.M101287200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</span></div><div class="casAuthors">Phiel, Christopher J.; Zhang, Fang; Huang, Eric Y.; Guenther, Matthew G.; Lazar, Mitchell A.; Klein, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36734-36741</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Valproic acid is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its mechanisms of action in any of these settings are unknown.  We report that valproic acid activates Wnt-dependent gene expression, similar to lithium, the mainstay of therapy for bipolar disorder.  Valproic acid, however, acts through a distinct pathway that involves direct inhibition of histone deacetylase (IC50 for HDAC1=0.4 mM).  At therapeutic levels, valproic acid mimics the histone deacetylase inhibitor trichostatin A, causing hyperacetylation of histones in cultured cells.  Valproic acid, like trichostatin A, also activates transcription from diverse exogenous and endogenous promoters.  Furthermore, valproic acid and trichostatin A have remarkably similar teratogenic effects in vertebrate embryos, while non-teratogenic analogs of valproic acid do not inhibit histone deacetylase and do not activate transcription.  Based on these observations, we propose that inhibition of histone deacetylase provides a mechanism for valproic acid-induced birth defects and could also explain the efficacy of valproic acid in the treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBZDcS-2BIhrVg90H21EOLACvtfcHk0lj4KQKKQ27iVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yrurw%253D&md5=6c1daa317cfb4c0cd8c8c2a21d4ed07c</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M101287200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M101287200%26sid%3Dliteratum%253Aachs%26aulast%3DPhiel%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DE.%2BY.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26atitle%3DHistone%2520deacetylase%2520is%2520a%2520direct%2520target%2520of%2520valproic%2520acid%252C%2520a%2520potent%2520anticonvulsant%252C%2520mood%2520stabilizer%252C%2520and%2520teratogen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36734%26epage%3D36741%26doi%3D10.1074%2Fjbc.M101287200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel-DiFranco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berson, E. L.</span></span> <span> </span><span class="NLM_article-title">Lack of scientific rationale for use of valproic acid for retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">744</span>, <span class="refDoi"> DOI: 10.1136/bjo.2010.198176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2010.198176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=21131379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3MvkvF2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=744&author=M.+A.+Sandbergauthor=B.+Rosnerauthor=C.+Weigel-DiFrancoauthor=E.+L.+Berson&title=Lack+of+scientific+rationale+for+use+of+valproic+acid+for+retinitis+pigmentosa&doi=10.1136%2Fbjo.2010.198176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of scientific rationale for use of valproic acid for retinitis pigmentosa</span></div><div class="casAuthors">Sandberg Michael A; Rosner Bernard; Weigel-DiFranco Carol; Berson Eliot L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">744</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6k3RMgtNpPUodMGTatQ7LfW6udTcc2eYSSCgQgbekYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvkvF2lug%253D%253D&md5=aa694046bb303965966d53d6cb7af86f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2010.198176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2010.198176%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DM.%2BA.%26aulast%3DRosner%26aufirst%3DB.%26aulast%3DWeigel-DiFranco%26aufirst%3DC.%26aulast%3DBerson%26aufirst%3DE.%2BL.%26atitle%3DLack%2520of%2520scientific%2520rationale%2520for%2520use%2520of%2520valproic%2520acid%2520for%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D744%26doi%3D10.1136%2Fbjo.2010.198176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Schooneveld, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Genderen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollemeijer, J. G.</span></span> <span> </span><span class="NLM_article-title">The conclusions of Clemson et al concerning valproic acid are premature</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">153</span>, author reply 153–154. <span class="refDoi"> DOI: 10.1136/bjo.2010.194373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjo.2010.194373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20971790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fjt1ansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=153&author=M.+J.+van+Schooneveldauthor=L.+I.+van+den+Bornauthor=M.+van+Genderenauthor=J.+G.+Bollemeijer&title=The+conclusions+of+Clemson+et+al+concerning+valproic+acid+are+premature&doi=10.1136%2Fbjo.2010.194373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The conclusions of Clemson et al concerning valproic acid are premature</span></div><div class="casAuthors">van Schooneveld Mary J; van den Born L Ingeborgh; van Genderen Mies; Bollemeijer Jan-Geert</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153; author reply 153-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx7PqrnsgMqDAEfvC7EH1LfW6udTcc2eYSSCgQgbekYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fjt1ansA%253D%253D&md5=6cb9d9c3e6aff623a64adbc1e55dd817</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2010.194373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2010.194373%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BSchooneveld%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DL.%2BI.%26aulast%3Dvan%2BGenderen%26aufirst%3DM.%26aulast%3DBollemeijer%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520conclusions%2520of%2520Clemson%2520et%2520al%2520concerning%2520valproic%2520acid%2520are%2520premature%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2011%26volume%3D95%26spage%3D153%26doi%3D10.1136%2Fbjo.2010.194373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sisk, R. A.</span></span> <span> </span><span class="NLM_article-title">Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2012-301950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjophthalmol-2012-301950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22581401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC38nislCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2012&pages=1154-1155&author=R.+A.+Sisk&title=Valproic+acid+treatment+may+be+harmful+in+non-dominant+forms+of+retinitis+pigmentosa&doi=10.1136%2Fbjophthalmol-2012-301950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa</span></div><div class="casAuthors">Sisk Robert A</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1154-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS95IHV4KOJDb5XHngOXiV_fW6udTcc2eakTNK_FnGjRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nislCguw%253D%253D&md5=9b40779f2a69af746041100fb5e42282</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2012-301950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2012-301950%26sid%3Dliteratum%253Aachs%26aulast%3DSisk%26aufirst%3DR.%2BA.%26atitle%3DValproic%2520acid%2520treatment%2520may%2520be%2520harmful%2520in%2520non-dominant%2520forms%2520of%2520retinitis%2520pigmentosa%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2012%26volume%3D96%26spage%3D1154%26epage%3D1155%26doi%3D10.1136%2Fbjophthalmol-2012-301950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhullar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, C. N.</span></span> <span> </span><span class="NLM_article-title">Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2013-303084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fbjophthalmol-2013-303084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23603755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC3srmvVKqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=895-899&author=S.+Bhallaauthor=D.+Joshiauthor=S.+Bhullarauthor=D.+Kasugaauthor=Y.+Parkauthor=C.+N.+Kay&title=Long-term+follow-up+for+efficacy+and+safety+of+treatment+of+retinitis+pigmentosa+with+valproic+acid&doi=10.1136%2Fbjophthalmol-2013-303084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid</span></div><div class="casAuthors">Bhalla Sheena; Joshi Deval; Bhullar Shaminder; Kasuga Daniel; Park Yeonhee; Kay Christine N</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">895-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  The purpose of this study was to determine the long-term efficacy and safety of valproic acid (VPA) treatment in patients with pigmentary retinal dystrophies.  METHODS:  A retrospective chart review was conducted on 31 patients with a diagnosis of pigmentary retinal dystrophy prescribed VPA at a single centre.  Visual field (VF), visual acuity (VA), length of treatment, liver enzymes and side effects were analysed.  VF areas were defined using Goldmann VF (GVF) tracings recorded before, during and after VPA treatment using the V4e isopter for each eye.  Using custom software, planimetric areas of VF were calculated.  RESULTS:  Five of the patients (10 eyes) had two Goldmann VF tracings, allowing comparison between baseline and follow-up VF.  After 9.8 months of VPA, VF decreased by 0.145 cm(2) (26.478%) (p=0.432).  For 22 of the patients (41 eyes), VA data was available, and logarithm of the minimum angle of resolution (logMAR) score changed by 0.056 log units (representing a decline in VA) after 14.9 months on VPA (p=0.002).  Twelve patients (38.7%) reported negative side effects related to VPA use.  CONCLUSIONS:  VPA plays a complex role in patients with pigmentary retinal dystrophies and may be associated with VA and field decline as well as adverse side effects.  Physicians should use caution with using VPA for pigmentary retinal dystrophies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5kCK1XfDcXoYPsCkJIw00fW6udTcc2eakTNK_FnGjRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srmvVKqug%253D%253D&md5=424604b6570c4360c0406714603834de</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2013-303084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2013-303084%26sid%3Dliteratum%253Aachs%26aulast%3DBhalla%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DD.%26aulast%3DBhullar%26aufirst%3DS.%26aulast%3DKasuga%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKay%26aufirst%3DC.%2BN.%26atitle%3DLong-term%2520follow-up%2520for%2520efficacy%2520and%2520safety%2520of%2520treatment%2520of%2520retinitis%2520pigmentosa%2520with%2520valproic%2520acid%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2013%26volume%3D97%26spage%3D895%26epage%3D899%26doi%3D10.1136%2Fbjophthalmol-2013-303084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vent-Schmidt, R. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, O. L.</span></span> <span> </span><span class="NLM_article-title">Opposing effects of valproic acid treatment mediated by histone deacetylase inhibitor activity in four transgenic X. laevis models of retinitis pigmentosa</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1647-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1523%2FJNEUROSCI.1647-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28490005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVOqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1039-1054&author=R.+Y.+J.+Vent-Schmidtauthor=R.+H.+Wenauthor=Z.+Zongauthor=C.+N.+Chiuauthor=B.+M.+Tamauthor=C.+G.+Mayauthor=O.+L.+Moritz&title=Opposing+effects+of+valproic+acid+treatment+mediated+by+histone+deacetylase+inhibitor+activity+in+four+transgenic+X.+laevis+models+of+retinitis+pigmentosa&doi=10.1523%2FJNEUROSCI.1647-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Opposing effects of valproic acid treatment mediated by histone deacetylase inhibitor activity in four transgenic X. laevis models of retinitis pigmentosa</span></div><div class="casAuthors">Vent-Schmidt, Ruanne Y. J.; Wen, Runxia H.; Zong, Zusheng; Chiu, Colette N.; Tam, Beatrice M.; May, Christopher G.; Moritz, Orson L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1039-1054</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Retinitis pigmentosa (RP) is an inherited retinal degeneration (RD) that leads to blindness for which no treatment is available.  RP is frequently caused by mutations in Rhodopsin; in some animal models, RD is exacerbated by light.  Valproic acid (VPA) is a proposed treatment for RP and other neurodegenerative disorders, with a phase II trial for RP under way.  However, the therapeutic mechanism is unclear, with minimal research supporting its use in RP.  We investigated the effects of VPA on Xenopus laevis models of RP expressing human P23H, T17M, T4K, and Q344ter rhodopsins, which are assocd. with RP in humans.  VPA ameliorated RD assocd. with P23H rhodopsin and promoted clearing of mutant rhodopsin from photoreceptors.  The effect was equal to that of dark rearing, with no additive effect obsd.  Rescue of visual function was confirmed by electroretinog.  In contrast, VPA exacerbated RD caused by T17M rhodopsin in light, but had no effect in darkness.  Effects in T4K and Q344ter rhodopsin models were also neg.  These effects of VPA were paralleled by treatment with three addnl. histone deacetylase (HDAC) inhibitors, but not other antipsychotics, chem. chaperones, or VPA structural analogs.  In WT retinas, VPA treatment increased histone H3 acetylation.  In addn., electron microscopy showed increased autophagosomes in rod inner segments with HDAC inhibitor (HDACi) treatment, potentially linking the therapeutic effects in P23H rhodopsin animals and neg. effects in other models with autophagy.  Our results suggest that the success or failure of VPA treatment is dependent on genotype and that HDACi treatment is contraindicated for some RP cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnJviRhCP7LVg90H21EOLACvtfcHk0ljm4TLd3rvRyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVOqs7c%253D&md5=5572bc66f80a2bc051c6d851edab96c4</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1647-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1647-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DVent-Schmidt%26aufirst%3DR.%2BY.%2BJ.%26aulast%3DWen%26aufirst%3DR.%2BH.%26aulast%3DZong%26aufirst%3DZ.%26aulast%3DChiu%26aufirst%3DC.%2BN.%26aulast%3DTam%26aufirst%3DB.%2BM.%26aulast%3DMay%26aufirst%3DC.%2BG.%26aulast%3DMoritz%26aufirst%3DO.%2BL.%26atitle%3DOpposing%2520effects%2520of%2520valproic%2520acid%2520treatment%2520mediated%2520by%2520histone%2520deacetylase%2520inhibitor%2520activity%2520in%2520four%2520transgenic%2520X.%2520laevis%2520models%2520of%2520retinitis%2520pigmentosa%26jtitle%3DJ.%2520Neurosci.%26date%3D2017%26volume%3D37%26spage%3D1039%26epage%3D1054%26doi%3D10.1523%2FJNEUROSCI.1647-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter-Landsberg, C.</span></span> <span> </span><span class="NLM_article-title">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3028</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2017.415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29048427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e3028&author=J.+Leykauthor=C.+Dalyauthor=U.+Janssen-Bienholdauthor=B.+N.+Kennedyauthor=C.+Richter-Landsberg&title=HDAC6+inhibition+by+tubastatin+A+is+protective+against+oxidative+stress+in+a+photoreceptor+cell+line+and+restores+visual+function+in+a+zebrafish+model+of+inherited+blindness&doi=10.1038%2Fcddis.2017.415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness</span></div><div class="casAuthors">Leyk, Janina; Daly, Conor; Janssen-Bienhold, Ulrike; Kennedy, Breandan N.; Richter-Landsberg, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e3028</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinal diseases, such as hereditary retinitis pigmentosa and age-related macular degeneration, are characterized by the progressive loss of photoreceptors.  Histone deacetylase 6 (HDAC6) is considered as a stress surveillance factor and a potential target for neuroprotection and regeneration.  Overexpression of HDAC6 has been connected to neurodegenerative disorders, and its suppression may provide protection.  Here we show that HDAC6 is constitutively present in the mouse retina, and in the cone-like mouse cell line 661W.  In 661W cells HDAC6 inhibition by the specific inhibitor tubastatin A (TST) led to the acetylation of α-tubulin, which is a major substrate for HDAC6.  After oxidative stress, exerted by hydrogen peroxide, TST promoted cell survival and the upregulation of heat-shock proteins HSP70 and HSP25 by activation of heat-shock transcription factor 1.  Furthermore, in response to oxidative stress the redox regulatory protein peroxiredoxin 1 (Prx1) was modulated in 661W cells by HDAC6 inhibition.  The peroxide reducing activity of Prx1 is dependent on its acetylation, which is mediated by HDAC6.  Pre-incubation with TST prevented the inactivation of Prx1 and its preserved activity may exert protective effects in photoreceptor cells.  To det. whether TST treatment has a therapeutic effect on visual function, the dyeucd6 zebrafish model of inherited sight loss was utilized.  Zebrafish have developed as a suitable model system for pharmacol. testing.  In vivo application of TST caused the hyperacetylation of α-tubulin, indicating that HDAC6 is active in this model.  Furthermore, TST was sufficient to rescue visual function and retinal morphol.  Hence, HDAC6 inhibition and the regulation of peroxiredoxin activity may play a significant role in protecting retinal cells and in particular photoreceptors, which are exposed to high levels of reactive oxygen species derived from oxidative stress-induced injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrltlSmCwk0BrVg90H21EOLACvtfcHk0lj-IiVUrHNdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKmurbL&md5=d6a6315da7b623e42cc3784dd76cd444</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.415%26sid%3Dliteratum%253Aachs%26aulast%3DLeyk%26aufirst%3DJ.%26aulast%3DDaly%26aufirst%3DC.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DB.%2BN.%26aulast%3DRichter-Landsberg%26aufirst%3DC.%26atitle%3DHDAC6%2520inhibition%2520by%2520tubastatin%2520A%2520is%2520protective%2520against%2520oxidative%2520stress%2520in%2520a%2520photoreceptor%2520cell%2520line%2520and%2520restores%2520visual%2520function%2520in%2520a%2520zebrafish%2520model%2520of%2520inherited%2520blindness%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De3028%26doi%3D10.1038%2Fcddis.2017.415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sontake, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasam, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naren, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madala, S. K.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulation of fibroblast activation in pulmonary fibrosis</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e91454</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.91454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1172%2Fjci.insight.91454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28239659" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=e91454&author=V.+Sontakeauthor=Y.+Wangauthor=R.+K.+Kasamauthor=D.+Sinnerauthor=G.+B.+Reddyauthor=A.+P.+Narenauthor=F.+X.+McCormackauthor=E.+S.+Whiteauthor=A.+G.+Jeggaauthor=S.+K.+Madala&title=Hsp90+regulation+of+fibroblast+activation+in+pulmonary+fibrosis&doi=10.1172%2Fjci.insight.91454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.91454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.91454%26sid%3Dliteratum%253Aachs%26aulast%3DSontake%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKasam%26aufirst%3DR.%2BK.%26aulast%3DSinner%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DNaren%26aufirst%3DA.%2BP.%26aulast%3DMcCormack%26aufirst%3DF.%2BX.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DJegga%26aufirst%3DA.%2BG.%26aulast%3DMadala%26aufirst%3DS.%2BK.%26atitle%3DHsp90%2520regulation%2520of%2520fibroblast%2520activation%2520in%2520pulmonary%2520fibrosis%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3De91454%26doi%3D10.1172%2Fjci.insight.91454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. G.</span></span> <span> </span><span class="NLM_article-title">Idiopathic pulmonary fibrosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">1941</span>– <span class="NLM_lpage">1952</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)30866-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2FS0140-6736%2817%2930866-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28365056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1cvjtl2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=1941-1952&author=L.+Richeldiauthor=H.+R.+Collardauthor=M.+G.+Jones&title=Idiopathic+pulmonary+fibrosis&doi=10.1016%2FS0140-6736%2817%2930866-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Richeldi Luca; Collard Harold R; Jones Mark G</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10082</span>),
    <span class="NLM_cas:pages">1941-1952</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease.  Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is destroyed, which leads to decreased lung compliance, disrupted gas exchange, and ultimately respiratory failure and death.  In less than a decade, understanding of the pathogenesis and management of this disease has been transformed, and two disease-modifying therapies have been approved, worldwide.  In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis.  This disease has improved understanding of the mechanisms of lung fibrosis, and offers hope that similar approaches will transform the management of patients with other progressive fibrotic lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKegwoJx_MJWhHGZei4OW9fW6udTcc2eblmyC0LusQOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvjtl2htA%253D%253D&md5=0b2ef2ea9cd8ff31f45be28b34a93a88</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2930866-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252930866-8%26sid%3Dliteratum%253Aachs%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3DCollard%26aufirst%3DH.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BG.%26atitle%3DIdiopathic%2520pulmonary%2520fibrosis%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D1941%26epage%3D1952%26doi%3D10.1016%2FS0140-6736%2817%2930866-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Bois, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costabel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Maulf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stowasser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenker-Herceg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collard, H. R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">2071</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1402584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1056%2FNEJMoa1402584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24836310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=2071-2082&author=L.+Richeldiauthor=R.+M.+du+Boisauthor=G.+Raghuauthor=A.+Azumaauthor=K.+K.+Brownauthor=U.+Costabelauthor=V.+Cottinauthor=K.+R.+Flahertyauthor=D.+M.+Hansellauthor=Y.+Inoueauthor=D.+S.+Kimauthor=M.+Kolbauthor=A.+G.+Nicholsonauthor=P.+W.+Nobleauthor=M.+Selmanauthor=H.+Taniguchiauthor=M.+Brunauthor=F.+Le+Maulfauthor=M.+Girardauthor=S.+Stowasserauthor=R.+Schlenker-Hercegauthor=B.+Disseauthor=H.+R.+Collard&title=Efficacy+and+safety+of+nintedanib+in+idiopathic+pulmonary+fibrosis&doi=10.1056%2FNEJMoa1402584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K.; Costabel, Ulrich; Cottin, Vincent; Flaherty, Kevin R.; Hansell, David M.; Inoue, Yoshikazu; Kim, Dong Soon; Kolb, Martin; Nicholson, Andrew G.; Noble, Paul W.; Selman, Moises; Taniguchi, Hiroyuki; Brun, Michele; Le Maulf, Florence; Girard, Mannaig; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Disse, Bernd; Collard, Harold R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2071-2082, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases.  A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis.  Methods: We conducted two replicate 52-wk, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis.  The primary end point was the annual rate of decline in forced vital capacity (FVC).  Key secondary end points were the time to the first acute exacerbation and the change from baseline in the total score on the St.  George's Respiratory Questionnaire, both assessed over a 52-wk period.  Results: A total of 1066 patients were randomly assigned in a 3:2 ratio to receive nintedanib or placebo.  The adjusted annual rate of change in FVC was -114.7 mL with nintedanib vs. -239.9 mL with placebo (difference, 125.3 mL; 95% confidence interval [CI], 77.7 to 172.8; P < 0.001) in INPULSIS-1 and -113.6 mL with nintedanib vs. -207.3 mL with placebo (difference, 93.7 mL; 95% CI, 44.8 to 142.7; P < 0.001) in INPULSIS-2.  In INPULSIS-1, there was no significant difference between the nintedanib and placebo groups in the time to the first acute exacerbation (hazard ratio with nintedanib, 1.15; 95% CI, 0.54 to 2.42; P = 0.67); in INPULSIS-2, there was a significant benefit with nintedanib vs. placebo (hazard ratio, 0.38; 95% CI, 0.19 to 0.77; P = 0.005).  The most frequent adverse event in the nintedanib groups was diarrhea, with rates of 61.5% and 18.6% in the nintedanib and placebo groups, resp., in INPULSIS-1 and 63.2% and 18.3% in the two groups, resp., in INPULSIS-2.  Conclusions: In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of disease progression; nintedanib was frequently assocd. with diarrhea, which led to discontinuation of the study medication in less than 5% of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGuOhVKeZaSrVg90H21EOLACvtfcHk0lj-IiVUrHNdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbfK&md5=be977cd3b402c7c401f4a3dfaa0f484f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1402584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1402584%26sid%3Dliteratum%253Aachs%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DRaghu%26aufirst%3DG.%26aulast%3DAzuma%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DCostabel%26aufirst%3DU.%26aulast%3DCottin%26aufirst%3DV.%26aulast%3DFlaherty%26aufirst%3DK.%2BR.%26aulast%3DHansell%26aufirst%3DD.%2BM.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DD.%2BS.%26aulast%3DKolb%26aufirst%3DM.%26aulast%3DNicholson%26aufirst%3DA.%2BG.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DBrun%26aufirst%3DM.%26aulast%3DLe%2BMaulf%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DM.%26aulast%3DStowasser%26aufirst%3DS.%26aulast%3DSchlenker-Herceg%26aufirst%3DR.%26aulast%3DDisse%26aufirst%3DB.%26aulast%3DCollard%26aufirst%3DH.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520nintedanib%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D2071%26epage%3D2082%26doi%3D10.1056%2FNEJMoa1402584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, T. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Bernardini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaspole, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassberg, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kardatzke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swigris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, P. W.</span></span> <span> </span><span class="NLM_article-title">A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">2083</span>– <span class="NLM_lpage">2092</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1402582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1056%2FNEJMoa1402582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24836312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGktrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=2083-2092&author=T.+E.+Kingauthor=W.+Z.+Bradfordauthor=S.+Castro-Bernardiniauthor=E.+A.+Faganauthor=I.+Glaspoleauthor=M.+K.+Glassbergauthor=E.+Gorinaauthor=P.+M.+Hopkinsauthor=D.+Kardatzkeauthor=L.+Lancasterauthor=D.+J.+Ledererauthor=S.+D.+Nathanauthor=C.+A.+Pereiraauthor=S.+A.+Sahnauthor=R.+Sussmanauthor=J.+J.+Swigrisauthor=P.+W.+Noble&title=A+phase+3+trial+of+pirfenidone+in+patients+with+idiopathic+pulmonary+fibrosis&doi=10.1056%2FNEJMoa1402582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis</span></div><div class="casAuthors">King, Talmadge E.; Bradford, Williamson Z.; Castro-Bernardini, Socorro; Fagan, Elizabeth A.; Glaspole, Ian; Glassberg, Marilyn K.; Gorina, Eduard; Hopkins, Peter M.; Kardatzke, David; Lancaster, Lisa; Lederer, David J.; Nathan, Steven D.; Pereira, Carlos A.; Sahn, Steven A.; Sussman, Robert; Swigris, Jeffrey J.; Noble, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2083-2092, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced vital capacity (FVC) or vital capacity, in patients with idiopathic pulmonary fibrosis; in the third trial, this end point was not achieved.  We sought to confirm the beneficial effect of pirfenidone on disease progression in such patients.  Methods: In this phase 3 study, we randomly assigned 555 patients with idiopathic pulmonary fibrosis to receive either oral pirfenidone (2403 mg per day) or placebo for 52 wk.  The primary end point was the change in FVC or death at week 52.  Secondary end points were the 6-min walk distance, progression-free survival, dyspnea, and death from any cause or from idiopathic pulmonary fibrosis.  Results: In the pirfenidone group, as compared with the placebo group, there was a relative redn. of 47.9% in the proportion of patients who had an abs. decline of 10 percentage points or more in the percentage of the predicted FVC or who died; there was also a relative increase of 132.5% in the proportion of patients with no decline in FVC (P < 0.001).  Pirfenidone reduced the decline in the 6-min walk distance (P = 0.04) and improved progression-free survival (P < 0.001).  There was no significant between-group difference in dyspnea scores (P = 0.16) or in rates of death from any cause (P = 0.10) or from idiopathic pulmonary fibrosis (P = 0.23).  However, in a prespecified pooled anal. incorporating results from two previous phase 3 trials, the between-group difference favoring pirfenidone was significant for death from any cause (P = 0.01) and from idiopathic pulmonary fibrosis (P = 0.006).  Gastrointestinal and skin-related adverse events were more common in the pirfenidone group than in the placebo group but rarely led to treatment discontinuation.  Conclusions: Pirfenidone, as compared with placebo, reduced disease progression, as reflected by lung function, exercise tolerance, and progression-free survival, in patients with idiopathic pulmonary fibrosis.  Treatment was assocd. with an acceptable sideeffect profile and fewer deaths.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBkQ8hqTWxxLVg90H21EOLACvtfcHk0lgVQyUVf1blBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGktrrJ&md5=17bfe4782c11521d3b7890ae387bbaf6</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1402582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1402582%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DT.%2BE.%26aulast%3DBradford%26aufirst%3DW.%2BZ.%26aulast%3DCastro-Bernardini%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DE.%2BA.%26aulast%3DGlaspole%26aufirst%3DI.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DGorina%26aufirst%3DE.%26aulast%3DHopkins%26aufirst%3DP.%2BM.%26aulast%3DKardatzke%26aufirst%3DD.%26aulast%3DLancaster%26aufirst%3DL.%26aulast%3DLederer%26aufirst%3DD.%2BJ.%26aulast%3DNathan%26aufirst%3DS.%2BD.%26aulast%3DPereira%26aufirst%3DC.%2BA.%26aulast%3DSahn%26aufirst%3DS.%2BA.%26aulast%3DSussman%26aufirst%3DR.%26aulast%3DSwigris%26aufirst%3DJ.%2BJ.%26aulast%3DNoble%26aufirst%3DP.%2BW.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520pirfenidone%2520in%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D2083%26epage%3D2092%26doi%3D10.1056%2FNEJMoa1402582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase: a potential therapeutic target for fibrotic disorders</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.168385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1124%2Fjpet.110.168385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20719940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWgtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=266-272&author=M.+Pangauthor=S.+Zhuang&title=Histone+deacetylase%3A+a+potential+therapeutic+target+for+fibrotic+disorders&doi=10.1124%2Fjpet.110.168385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase: a potential therapeutic target for fibrotic disorders</span></div><div class="casAuthors">Pang, Maoyin; Zhuang, Shougang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-272</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes that balance the acetylation activities of histone acetyltransferases on chromatin remodeling and play essential roles in regulating gene transcription.  In the past several years, the role of HDACs in cancer initiation and progression, as well as the therapeutic effects of HDAC inhibitors in various types of cancer, has been well studied.  Recent studies indicated that HDAC activity is also assocd. with the development and progression of some chronic diseases characterized by fibrosis, including chronic kidney disease, cardiac hypertrophy, and idiopathic pulmonary fibrosis.  Here, we review what is known about HDACs in the progression of tissue fibrosis and the potential applications of HDAC inhibitors in the treatment of disorders assocd. with fibroblast activation and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LH-qEviQW7Vg90H21EOLACvtfcHk0lgVQyUVf1blBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWgtLfL&md5=3d9517a6e247c4b75b99e511c0a5be56</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.168385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.168385%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DM.%26aulast%3DZhuang%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%253A%2520a%2520potential%2520therapeutic%2520target%2520for%2520fibrotic%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D266%26epage%3D272%26doi%3D10.1124%2Fjpet.110.168385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">21065</span>– <span class="NLM_lpage">21073</span>, <span class="refDoi"> DOI: 10.1074/jbc.M802786200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M802786200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=18499657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21065-21073&author=B.+Shanauthor=T.+P.+Yaoauthor=H.+T.+Nguyenauthor=Y.+Zhuoauthor=D.+R.+Levyauthor=R.+C.+Klingsbergauthor=H.+Taoauthor=M.+L.+Palmerauthor=K.+N.+Holderauthor=J.+A.+Lasky&title=Requirement+of+HDAC6+for+transforming+growth+factor-beta1-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M802786200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of HDAC6 for transforming growth factor-β1-induced epithelial-mesenchymal transition</span></div><div class="casAuthors">Shan, Bin; Yao, Tso-pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21065-21073</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aberrant expression of transforming growth factor (TGF)-β1 in the tumor microenvironment and fibrotic lesions plays a crit. role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT).  EMT promotes tumor cell motility and invasiveness.  How EMT affects motility and invasion is not well understood.  Here we report that HDAC6 is a novel modulator of TGF-β1-induced EMT.  HDAC6 is a microtubule-assocd. deacetylase that predominantly deacetylates nonhistone proteins, including α-tubulin, and regulates cell motility.  We showed that TGF-β1-induced EMT is accompanied by HDAC6-dependent deacetylation of α-tubulin.  Importantly, inhibition of HDAC6 by small interfering RNA or the small mol. inhibitor tubacin attenuated the TGF-β1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers.  Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-β1.  Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of α-tubulin as well as the expression of EMT markers.  These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-β-SMAD3 signaling cascade.  Our results identify HDAC6 as a crit. regulator of EMT and a potential therapeutic target against pathol. EMT, a key event for tumor progression and fibrogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcx6lyo8vYbVg90H21EOLACvtfcHk0lgpzR-oPYMCZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrt7Y%253D&md5=41e37f298b484fc259266bdc4aa2eff5</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802786200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802786200%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLevy%26aufirst%3DD.%2BR.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DPalmer%26aufirst%3DM.%2BL.%26aulast%3DHolder%26aufirst%3DK.%2BN.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DRequirement%2520of%2520HDAC6%2520for%2520transforming%2520growth%2520factor-beta1-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D21065%26epage%3D21073%26doi%3D10.1074%2Fjbc.M802786200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwajah, M. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lareu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunath, M.</span></span> <span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1183/09031936.00084808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1183%2F09031936.00084808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19224893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFegsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=145-155&author=Z.+Wangauthor=C.+Chenauthor=S.+N.+Fingerauthor=M.+M.+M.+Kwajahauthor=M.+Jungauthor=H.+Schwarzauthor=N.+Swansonauthor=F.+F.+Lareuauthor=M.+Raghunath&title=Suberoylanilide+hydroxamic+acid%3A+a+potential+epigenetic+therapeutic+agent+for+lung+fibrosis%3F&doi=10.1183%2F09031936.00084808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?</span></div><div class="casAuthors">Wang, Z.; Chen, C.; Finger, S. N.; Kwajah, S.; Jung, M.; Schwarz, H.; Swanson, N.; Lareu, R. R.; Raghunath, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-155</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Pulmonary fibrosis represents a fatal stage of interstitial lung diseases of known and idiopathic etiol.  No effective therapy is currently available.  Based on an indication-discovery approach we present novel in vitro evidence that the histone deacetylases inhibitor suberoylanilide hydroxamic acid (SAHA), an FDA approved anti-cancer drug, has antifibrotic and anti-inflammatory potential.  Human lung fibroblasts (fetal, adult and idiopathic adult pulmonary fibrosis) were treated with transforming growth factor (TGF)-β1 with or without SAHA.  Collagen deposition, α-smooth muscle actin (α-SMA) expression, matrix metalloproteinase (MMP)1 activity, tissue inhibitor of MMP (TIMP)1 prodn., apoptosis and cell proliferation were assessed.  Pro-inflammatory cytokines relevant to pulmonary fibrosis were assayed in SAHA-treated human peripheral blood mononuclear cells (PBMC) and its subpopulations.  SAHA abrogated TGF-β1 effects on all the fibroblast lines by preventing their transdifferentiation into α-SMA pos. myofibroblasts and increased collagen deposition without inducing apoptosis.  However, MMP1 activity and TIMP1 prodn. was modulated without a clear fibrolytic effect.  SAHA also inhibited serum-induced proliferation of the fibroblast lines and caused hyperacetylation of α-tubulin and histone.  Cytokine secretion was inhibited from PBMC and lymphocytes at nonapoptotic concns.  Taken together, these data demonstrate combined antifibrotic and anti-inflammatory properties of SAHA, suggesting its therapeutic potential for pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobJkxg4nldAbVg90H21EOLACvtfcHk0lgpzR-oPYMCZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFegsLc%253D&md5=e482cd2845bb8d2e9c9372422ac0c046</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1183%2F09031936.00084808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00084808%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFinger%26aufirst%3DS.%2BN.%26aulast%3DKwajah%26aufirst%3DM.%2BM.%2BM.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DN.%26aulast%3DLareu%26aufirst%3DF.%2BF.%26aulast%3DRaghunath%26aufirst%3DM.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%253A%2520a%2520potential%2520epigenetic%2520therapeutic%2520agent%2520for%2520lung%2520fibrosis%253F%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2009%26volume%3D34%26spage%3D145%26epage%3D155%26doi%3D10.1183%2F09031936.00084808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingsberg, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition</span>. <i>Am. J. Physiol. Lung. Cell. Mol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">L864</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00128.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1152%2Fajplung.00128.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19700647" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=L864-870&author=W.+Guoauthor=B.+Shanauthor=R.+C.+Klingsbergauthor=X.+Qinauthor=J.+A.+Lasky&title=Abrogation+of+TGF-beta1-induced+fibroblast-myofibroblast+differentiation+by+histone+deacetylase+inhibition&doi=10.1152%2Fajplung.00128.2009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00128.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00128.2009%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DKlingsberg%26aufirst%3DR.%2BC.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DAbrogation%2520of%2520TGF-beta1-induced%2520fibroblast-myofibroblast%2520differentiation%2520by%2520histone%2520deacetylase%2520inhibition%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung.%2520Cell.%2520Mol.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DL864%26epage%3D870%26doi%3D10.1152%2Fajplung.00128.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coward, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">4325</span>– <span class="NLM_lpage">4339</span>, <span class="refDoi"> DOI: 10.1128/MCB.01776-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.01776-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=19487460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=4325-4339&author=W.+R.+Cowardauthor=K.+Wattsauthor=C.+A.+Feghali-Bostwickauthor=A.+Knoxauthor=L.+Pang&title=Defective+histone+acetylation+is+responsible+for+the+diminished+expression+of+cyclooxygenase+2+in+idiopathic+pulmonary+fibrosis&doi=10.1128%2FMCB.01776-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Coward, William R.; Watts, Keiria; Feghali-Bostwick, Carol A.; Knox, Alan; Pang, Linhua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4325-4339</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Diminished cyclooxygenase 2 (COX-2) expression in fibroblasts, with a resultant defect in the prodn. of the antifibrotic mediator prostaglandin E2, plays a key role in the pathogenesis of idiopathic pulmonary fibrosis (IPF).  Here, we have characterized the mol. mechanism.  We found that COX-2 mRNA levels in fibroblasts from patients with IPF (F-IPF) were significantly lower than those in fibroblasts from nonfibrotic lungs (F-NL) after transforming growth factor β1 and interleukin-1β treatment but that COX-2 mRNA degrdn. rates were similar, suggesting defective transcription.  A reporter gene assay showed that there were no clear differences between F-IPF and F-NL in transcription factor involvement and activation in COX-2 gene transcription.  However, a chromatin immunopptn. assay revealed that transcription factor binding to the COX-2 promoter in F-IPF was reduced compared to that in F-NL, an effect that was dynamically linked to reduced histone H3 and H4 acetylation due to decreased recruitment of histone acetyltransferases (HATs) and increased recruitment of transcriptional corepressor complexes to the COX-2 promoter.  The treatment of F-IPF with histone deacetylase (HDAC) inhibitors together with cytokines increased histone H3 and H4 acetylation.  Both HDAC inhibitors and the overexpression of HATs restored cytokine-induced COX-2 mRNA and protein expression in F-IPF.  The results demonstrate that epigenetic abnormality in the form of histone hypoacetylation is responsible for diminished COX-2 expression in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSSnifK3wMbVg90H21EOLACvtfcHk0lgpzR-oPYMCZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFeht70%253D&md5=ba1bd68c4cc1998eba19818585ad7198</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1128%2FMCB.01776-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01776-08%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DW.%2BR.%26aulast%3DWatts%26aufirst%3DK.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%2BA.%26aulast%3DKnox%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DDefective%2520histone%2520acetylation%2520is%2520responsible%2520for%2520the%2520diminished%2520expression%2520of%2520cyclooxygenase%25202%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D4325%26epage%3D4339%26doi%3D10.1128%2FMCB.01776-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coward, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span> <span> </span><span class="NLM_article-title">Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2874</span>– <span class="NLM_lpage">2886</span>, <span class="refDoi"> DOI: 10.1128/MCB.01527-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1128%2FMCB.01527-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=20404089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotFGqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=2874-2886&author=W.+R.+Cowardauthor=K.+Wattsauthor=C.+A.+Feghali-Bostwickauthor=G.+Jenkinsauthor=L.+Pang&title=Repression+of+IP-10+by+interactions+between+histone+deacetylation+and+hypermethylation+in+idiopathic+pulmonary+fibrosis&doi=10.1128%2FMCB.01527-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Coward, William R.; Watts, Keira; Feghali-Bostwick, Carol A.; Jenkins, Gisli; Pang, Linhua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2874-2886</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Targeted repression of a subset of key genes involved in tissue remodeling is a cardinal feature of idiopathic pulmonary fibrosis (IPF).  The mechanism is unclear but is potentially important in disease pathogenesis and therapeutic targeting.  We have previously reported that defective histone acetylation is responsible for the repression of the antifibrotic cyclooxygenase-2 gene.  Here we extended our study to the repression of another antifibrotic gene, the potent angiostatic chemokine gamma interferon (IFN-γ)-inducible protein of 10 kDa (IP-10), in lung fibroblasts from patients with IPF.  We revealed tht this involved not only histone deacetylation, as with cyclooxygenase-2 repression, but also histone H3 hypermethylation, as a result of decreased recruitment of histone acetyltransferases and increased presence of histone deacetylase (HDAC)-contg. repressor complexes, histone methyltransferases G9a and SUV39H1, and heterochromatin protein 1 at the IP-10 promoter, leading to reduced transcription factor binding.  More importantly, treatment of diseased cells with HDAC or G9a inhibitors similarly reversed the repressive histone deacetylation and hypermethylation and restored IP-10 expression.  These findings strongly suggest that epigenetic dysregulation involving interactions between histone deacetylation and hypermethylation is responsible for targeted repression of IP-10 and potentially other antifibrotic genes in fibrotic lung disease and that this is amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriNpAI5yLEcrVg90H21EOLACvtfcHk0lj6JlW9aDmRnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotFGqsrk%253D&md5=a809c233f0819967db4dfaadb0493207</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FMCB.01527-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01527-09%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DW.%2BR.%26aulast%3DWatts%26aufirst%3DK.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%2BA.%26aulast%3DJenkins%26aufirst%3DG.%26aulast%3DPang%26aufirst%3DL.%26atitle%3DRepression%2520of%2520IP-10%2520by%2520interactions%2520between%2520histone%2520deacetylation%2520and%2520hypermethylation%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D2874%26epage%3D2886%26doi%3D10.1128%2FMCB.01527-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagood, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambalavanan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1183/09031936.00095113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1183%2F09031936.00095113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=24603818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKnu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=1448-1458&author=Y.+Y.+Sandersauthor=J.+S.+Hagoodauthor=H.+Liuauthor=W.+Zhangauthor=N.+Ambalavananauthor=V.+J.+Thannickal&title=Histone+deacetylase+inhibition+promotes+fibroblast+apoptosis+and+ameliorates+pulmonary+fibrosis+in+mice&doi=10.1183%2F09031936.00095113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice</span></div><div class="casAuthors">Sanders, Yan Y.; Hagood, James S.; Liu, Hui; Zhang, Wei; Ambalavanan, Namasivayam; Thannickal, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1448-1458</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a fatal disease, and therapeutic agents have shown only modest efficacy.  Epigenetic alterations contribute to the pathogenesis of IPF.  The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has been approved for clin. use in cancer; however, its potential efficacy in modulating fibroblast survival and lung fibrosis has not been extensively investigated.  We investigated the effects of SAHA on apoptosis of primary IPF myofibroblasts and on injury-induced lung fibrosis in a murine model.  SAHA-induced apoptosis of IPF myofibroblasts, an effect that was mediated, at least in part, by upregulation of the pro-apoptotic gene Bak and downregulation of the anti-apoptotic gene Bcl-xL.  Alterations in the expression of these apoptosis-related genes were assocd. with histone modifications and changes in DNA methylation.  In addn. to the expected higher levels of histone acetylation in treated cells, we also detected changes in other histone modifications, such as histone methylation.  In a murine model of bleomycin-induced pulmonary fibrosis, SAHA-treated mice displayed decreased lung fibrosis and improved lung function compared to the bleomycin only group.  These results suggest that histone deacetylase inhibitors may offer a new therapeutic strategy in IPF by modulating myofibroblast susceptibility to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruyks7TCWdMbVg90H21EOLACvtfcHk0lj6JlW9aDmRnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKnu73J&md5=86f2617a181392acfc8040c9449d8102</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1183%2F09031936.00095113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00095113%26sid%3Dliteratum%253Aachs%26aulast%3DSanders%26aufirst%3DY.%2BY.%26aulast%3DHagood%26aufirst%3DJ.%2BS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DAmbalavanan%26aufirst%3DN.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520promotes%2520fibroblast%2520apoptosis%2520and%2520ameliorates%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2014%26volume%3D43%26spage%3D1448%26epage%3D1458%26doi%3D10.1183%2F09031936.00095113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scruggs, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaghy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslona, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters-Golden, M.</span></span> <span> </span><span class="NLM_article-title">Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e621</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fcddis.2013.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=23640463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e621&author=S.+K.+Huangauthor=A.+M.+Scruggsauthor=J.+Donaghyauthor=J.+C.+Horowitzauthor=Z.+Zaslonaauthor=S.+Przybranowskiauthor=E.+S.+Whiteauthor=M.+Peters-Golden&title=Histone+modifications+are+responsible+for+decreased+Fas+expression+and+apoptosis+resistance+in+fibrotic+lung+fibroblasts&doi=10.1038%2Fcddis.2013.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts</span></div><div class="casAuthors">Huang, S. K.; Scruggs, A. M.; Donaghy, J.; Horowitz, J. C.; Zaslona, Z.; Przybranowski, S.; White, E. S.; Peters-Golden, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">e621</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the recruitment of fibroblasts to areas of injury is crit. for wound healing, their subsequent apoptosis is necessary in order to prevent excessive scarring.  Fibroproliferative diseases, such as pulmonary fibrosis, are often characterized by fibroblast resistance to apoptosis, but the mechanism(s) for this resistance remains elusive.  Here, we employed a murine model of pulmonary fibrosis and cells from patients with idiopathic pulmonary fibrosis (IPF) to explore epigenetic mechanisms that may be responsible for the decreased expression of Fas, a cell surface death receptor whose expression has been obsd. to be decreased in pulmonary fibrosis.  Murine pulmonary fibrosis was elicited by intratracheal injection of bleomycin.  Fibroblasts cultured from bleomycin-treated mice exhibited decreased Fas expression and resistance to Fas-mediated apoptosis compared with cells from saline-treated control mice.  Although there were no differences in DNA methylation, the Fas promoter in fibroblasts from bleomycin-treated mice exhibited decreased histone acetylation and increased histone 3 lysine 9 trimethylation (H3K9Me3).  This was assocd. with increased histone deacetylase (HDAC)-2 and HDAC4 expression.  Treatment with HDAC inhibitors increased Fas expression and restored susceptibility to Fas-mediated apoptosis.  Fibroblasts from patients with IPF likewise exhibited decreased histone acetylation and increased H3K9Me3 at the Fas promoter and increased their expression of Fas in the presence of an HDAC inhibitor.  These findings demonstrate the crit. role of histone modifications in the development of fibroblast resistance to apoptosis in both a murine model and in patients with pulmonary fibrosis and suggest novel approaches to therapy for progressive fibroproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolF98lz1dAMLVg90H21EOLACvtfcHk0lj6JlW9aDmRnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrsL%252FF&md5=4a37654e2f02707d65643f2d2829c781</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.146%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BK.%26aulast%3DScruggs%26aufirst%3DA.%2BM.%26aulast%3DDonaghy%26aufirst%3DJ.%26aulast%3DHorowitz%26aufirst%3DJ.%2BC.%26aulast%3DZaslona%26aufirst%3DZ.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DE.%2BS.%26aulast%3DPeters-Golden%26aufirst%3DM.%26atitle%3DHistone%2520modifications%2520are%2520responsible%2520for%2520decreased%2520Fas%2520expression%2520and%2520apoptosis%2520resistance%2520in%2520fibrotic%2520lung%2520fibroblasts%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De621%26doi%3D10.1038%2Fcddis.2013.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henneke, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Beck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellusci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2014-206411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fthoraxjnl-2014-206411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26359372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1022-1032&author=M.+Korfeiauthor=S.+Skwarnaauthor=I.+Hennekeauthor=B.+MacKenzieauthor=O.+Klymenkoauthor=S.+Saitoauthor=C.+Ruppertauthor=D.+von+der%0ABeckauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=S.+Bellusciauthor=B.+Crestaniauthor=S.+S.+Pullamsettiauthor=L.+Finkauthor=W.+Seegerauthor=O.+H.+Kramerauthor=A.+Guenther&title=Aberrant+expression+and+activity+of+histone+deacetylases+in+sporadic+idiopathic+pulmonary+fibrosis&doi=10.1136%2Fthoraxjnl-2014-206411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei Martina; Skwarna Sylwia; Henneke Ingrid; MacKenzie BreAnne; Klymenko Oleksiy; von der Beck Daniel; Mahavadi Poornima; Saito Shigeki; Ruppert Clemens; Bellusci Saverio; Seeger Werner; Klepetko Walter; Crestani Bruno; Pullamsetti Soni Savai; Fink Ludger; Kramer Oliver Holger; Guenther Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thorax</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1022-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activation and differentiation of fibroblasts into contractile protein-expressing myofibroblasts and their acquired apoptosis-resistant phenotype are critical factors towards the development of idiopathic pulmonary fibrosis (IPF), a fatal disease characterised by distorted pulmonary structure and excessive extracellular matrix (ECM) deposition.  The molecular mechanisms underlying these processes in IPF remain incompletely understood.  We investigated the possible implication of aberrant overexpression and activity of histone deacetylases (HDACs) in IPF.  METHODS:  We analysed lung tissues from patients with sporadic IPF (n=26) and non-diseased control lungs (n=16) for expression of class I and II HDACs.  Primary IPF fibroblasts were treated with HDAC inhibitors (HDACi) LBH589 or valproic acid (VPA).  RESULTS:  Compared to control lungs, protein levels of class I (HDAC1, HDAC2, HDAC3, HDAC8) and class II HDACs (HDAC4, HDAC 5, HDAC 7, HDAC 9) were significantly elevated in IPF lungs.  Using immunohistochemistry, strong induction of nearly all HDAC enzymes was observed in myofibroblasts of fibroblast foci and in abnormal bronchiolar basal cells at sites of aberrant re-epithelialisation in IPF lungs, but not in controls.  Treatment of primary IPF fibroblasts with the pan-HDACi LBH589 resulted in significantly reduced expression of genes associated with ECM synthesis, proliferation and cell survival, as well as in suppression of HDAC7, and was paralleled by induction of endoplasmic reticulum stress and apoptosis.  The profibrotic and apoptosis-resistant phenotype of IPF fibroblasts was also partly attenuated by the class I HDACi VPA.  CONCLUSIONS:  Aberrant overexpression of HDACs in basal cells of IPF lungs may contribute to the bronchiolisation process in this disease.  Similarly, generation and apoptosis resistance of IPF fibroblasts are mediated by enhanced activity of HDAC enzymes.  Therefore, pan-HDAC inhibition by LBH589 may present a novel therapeutic option for patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJNhSDZx9hyjKfW6udTcc2eayMNjYbWVcoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D&md5=621f4bd5c66ff41ed4c4cbf894644a4a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2014-206411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2014-206411%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DHenneke%26aufirst%3DI.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DKlymenko%26aufirst%3DO.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3Dvon%2Bder%2BBeck%26aufirst%3DD.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DBellusci%26aufirst%3DS.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DAberrant%2520expression%2520and%2520activity%2520of%2520histone%2520deacetylases%2520in%2520sporadic%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DThorax%26date%3D2015%26volume%3D70%26spage%3D1022%26epage%3D1032%26doi%3D10.1136%2Fthoraxjnl-2014-206411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelmaszek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillappagari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0207915</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0207915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0207915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=30481203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFSis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0207915&author=M.+Korfeiauthor=D.+Stelmaszekauthor=B.+MacKenzieauthor=S.+Skwarnaauthor=S.+Chillappagariauthor=A.+C.+Bachauthor=C.+Ruppertauthor=S.+Saitoauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=L.+Finkauthor=W.+Seegerauthor=J.+A.+Laskyauthor=S.+S.+Pullamsettiauthor=O.+H.+Kramerauthor=A.+Guenther&title=Comparison+of+the+antifibrotic+effects+of+the+pan-histone+deacetylase-inhibitor+panobinostat+versus+the+IPF-drug+pirfenidone+in+fibroblasts+from+patients+with+idiopathic+pulmonary+fibrosis&doi=10.1371%2Fjournal.pone.0207915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei, Martina; Stelmaszek, Daniel; MacKenzie, BreAnne; Skwarna, Sylwia; Chillappagari, Shashipavan; Bach, Anna C.; Ruppert, Clemens; Saito, Shigeki; Mahavadi, Poornima; Klepetko, Walter; Fink, Ludger; Seeger, Werner; Lasky, Joseph A.; Pullamsetti, Soni S.; Kraemer, Oliver H.; Guenther, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0207915/1-e0207915/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a poor prognosis.  Pirfenidone is the first antifibrotic agent to be approved for IPF-treatment as it is able to slow down disease progression.  However, there is no curative treatment other than lung transplantation.  Because epigenetic alterations are assocd. with IPF, histone deacetylase (HDAC)-inhibitors have recently been proven to attenuate fibrotic remodeling in vitro and in vivo.  This study compared the effects of pirfenidone with the pan-HDAC-inhibitor panobinostat/LBH589, a FDA-approved drug for the treatment of multiple myeloma, head-to-head on survival, fibrotic activity and proliferation of primary IPF-fibroblasts in vitro.  Methods Primary fibroblasts from six IPF-patients were incubated for 24h with vehicle (0.25% DMSO), panobinostat (LBH589, 85 nM) or pirfenidone (2.7 mM), followed by assessment of proliferation and expression analyses for profibrotic and anti-apoptosis genes, as well as for ER stress and apoptosis-markers.  In addn., the expression status of all HDAC enzymes was examd.  Results Treatment of IPF-fibroblasts with panobinostat or pirfenidone resulted in a downregulated expression of various extracellular matrix (ECM)-assocd. genes, as compared to vehicle-treated cells.  In agreement, both drugs decreased protein level of phosphorylated (p)-STAT3, a transcription factor mediating profibrotic responses, in treated IPF-fibroblasts.  Further, an increase in histone acetylation was obsd. in response to both treatments, but was much more pronounced and excessive in panobinostat-treated IPF-fibroblasts.  Panobinostat, but not pirfenidone, led to a significant suppression of proliferation in IPF-fibroblasts, as indicated by WST1- and BrdU assay and markedly diminished levels of cyclin-D1 and p-histone H3.  Furthermore, panobinostat-treatment enhanced α-tubulin-acetylation, decreased the expression of survival-related genes Bcl-XL and BIRC5/survivin, and was assocd. with induction of ER stress and apoptosis in IPF-fibroblasts.  In contrast, pirfenidone-treatment maintained Bcl-XL expression, and was neither assocd. with ER stress-induction nor any apoptotic signaling.  Pirfenidone also led to increased expression of HDAC6 and sirtuin-2, and enhanced α-tubulin-deacetylation.  But in line with its ability to increase histone acetylation, pirfenidone reduced the expression of HDAC enzymes HDAC1, -2 and -9.  Conclusions We conclude that, beside other antifibrotic mechanisms, pirfenidone reduces profibrotic signaling also through STAT3 inactivation and weak epigenetic alterations in IPF-fibroblasts, and permits survival of (altered) fibroblasts.  The pan-HDAC-inhibitor panobinostat reduces profibrotic phenotypes while inducing cell cycle arrest and apoptosis in IPF-fibroblasts, thus indicating more efficiency than pirfenidone in inactivating IPF-fibroblasts.  We therefore believe that HDAC-inhibitors such as panobinostat can present a novel therapeutic strategy for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotQcZ-wK8eKbVg90H21EOLACvtfcHk0lhipRgPWsH_uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFSis7Y%253D&md5=1c7323ccf2557580915815b69bd62fc9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0207915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0207915%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DStelmaszek%26aufirst%3DD.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DChillappagari%26aufirst%3DS.%26aulast%3DBach%26aufirst%3DA.%2BC.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DComparison%2520of%2520the%2520antifibrotic%2520effects%2520of%2520the%2520pan-histone%2520deacetylase-inhibitor%2520panobinostat%2520versus%2520the%2520IPF-drug%2520pirfenidone%2520in%2520fibroblasts%2520from%2520patients%2520with%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0207915%26doi%3D10.1371%2Fjournal.pone.0207915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haitchi, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottmann, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2011-0040OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1165%2Frcmb.2011-0040OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=22246864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=687-694&author=E.+R.+Daviesauthor=H.+M.+Haitchiauthor=T.+H.+Thatcherauthor=P.+J.+Simeauthor=R.+M.+Kottmannauthor=A.+Ganesanauthor=G.+Packhamauthor=K.+M.+O%E2%80%99Reillyauthor=D.+E.+Davies&title=Spiruchostatin+A+inhibits+proliferation+and+differentiation+of+fibroblasts+from+patients+with+pulmonary+fibrosis&doi=10.1165%2Frcmb.2011-0040OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis</span></div><div class="casAuthors">Davies, Elizabeth R.; Haitchi, Hans Michael; Thatcher, Thomas H.; Sime, Patricia J.; Kottmann, R. Matthew; Ganesan, Arasu; Packham, Graham; O'Reilly, Katherine M. A.; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">687-694</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disorder characterized by the proliferation of interstitial fibroblasts and the deposition of extracellular matrix causing impaired gas exchange.  Spiruchostatin A (SpA) is a histone deacetylase inhibitor (HDI) with selectivity toward Class I enzymes, which distinguishes it from other nonspecific HDIs that are reported to inhibit (myo)fibroblast proliferation and differentiation.  Because the selectivity of HDIs may be important clin., we postulated that SpA inhibits the proliferation and differentiation of IPF fibroblasts.  Primary fibroblasts were grown from lung biopsy explants obtained from patients with IPF or from normal control subjects, using two-dimensional or three-dimensional culture models.  The effect of SpA on fibroproliferation in serum-contg. medium ± transforming growth factor (TGF)-β1 was quantified by methylene blue binding.  The acetylation of histone H3, the expression of the cell-cycle inhibitor p21waf1, and the myofibroblast markers α-smooth muscle actin (α-SMA) and collagens I and III were detd. by Western blotting, quant. RT-PCR, immunofluorescent staining, or colorimetry.  SpA inhibited the proliferation of IPF or normal fibroblasts in a time-dependent and concn.-dependent manner (concn. required to achieve 50% inhibition = 3.8 ± 0.4 nM vs. 7.8 ± 0.2 nM, resp.; P < 0.05), with little cytotoxicity.  Western blot analyses revealed that SpA caused a concn.-dependent increase in histone H3 acetylation, paralleling its antiproliferative effect.  SpA also increased p21waf1 expression, suggesting that direct cell-cycle regulation was the mechanism of inhibiting proliferation.  Although treatment with TGF-β1 induced myofibroblast differentiation assocd. with increased expression of α-SMA, collagen I and collagen III and sol. collagen release, these responses were potently inhibited by SpA.  These data support the concept that bicyclic tetrapeptide HDIs merit further investigation as potential treatments for IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopyBhe4I9WE7Vg90H21EOLACvtfcHk0lhipRgPWsH_uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyjtLg%253D&md5=a2591a60860a08499af17ce2eef116fa</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0040OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0040OC%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DE.%2BR.%26aulast%3DHaitchi%26aufirst%3DH.%2BM.%26aulast%3DThatcher%26aufirst%3DT.%2BH.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DKottmann%26aufirst%3DR.%2BM.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BM.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DSpiruchostatin%2520A%2520inhibits%2520proliferation%2520and%2520differentiation%2520of%2520fibroblasts%2520from%2520patients%2520with%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D687%26epage%3D694%26doi%3D10.1165%2Frcmb.2011-0040OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conforti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzetani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molyneaux, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorley, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetley, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skipp, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richeldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sime, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, K. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span> <span> </span><span class="NLM_article-title">The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">48737</span>– <span class="NLM_lpage">48754</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.18632%2Foncotarget.17114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28467787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1crjs1CjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=48737-48754&author=F.+Confortiauthor=E.+R.+Daviesauthor=C.+J.+Calderwoodauthor=T.+H.+Thatcherauthor=M.+G.+Jonesauthor=D.+E.+Smartauthor=S.+Mahajanauthor=A.+Alzetaniauthor=T.+Havelockauthor=T.+M.+Maherauthor=P.+L.+Molyneauxauthor=A.+J.+Thorleyauthor=T.+D.+Tetleyauthor=J.+A.+Warnerauthor=G.+Packhamauthor=A.+Ganesanauthor=P.+J.+Skippauthor=B.+J.+Marshallauthor=L.+Richeldiauthor=P.+J.+Simeauthor=K.+M.+A.+O%E2%80%99Reillyauthor=D.+E.+Davies&title=The+histone+deacetylase+inhibitor%2C+romidepsin%2C+as+a+potential+treatment+for+pulmonary+fibrosis&doi=10.18632%2Foncotarget.17114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis</span></div><div class="casAuthors">Conforti Franco; Davies Elizabeth R; Calderwood Claire J; Jones Mark G; Smart David E; Warner Jane A; Richeldi Luca; Davies Donna E; Conforti Franco; Davies Elizabeth R; Jones Mark G; Smart David E; Havelock Tom; Warner Jane A; Richeldi Luca; O'Reilly Katherine M A; Davies Donna E; Thatcher Thomas H; Sime Patricia J; Mahajan Sumeet; Warner Jane A; Skipp Paul J; Davies Donna E; Alzetani Aiman; Havelock Tom; Marshall Benjamin J; Richeldi Luca; Maher Toby M; Molyneaux Philip L; Maher Toby M; Molyneaux Philip L; Thorley Andrew J; Tetley Teresa D; Packham Graham; Ganesan A; O'Reilly Katherine M A; O'Reilly Katherine M A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">48737-48754</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive disease that usually affects elderly people.  It has a poor prognosis and there are limited therapies.  Since epigenetic alterations are associated with IPF, histone deacetylase (HDAC) inhibitors offer a novel therapeutic strategy to address the unmet medical need.  This study investigated the potential of romidepsin, an FDA-approved HDAC inhibitor, as an anti-fibrotic treatment and evaluated biomarkers of target engagement that may have utility in future clinical trials.  The anti-fibrotic effects of romidepsin were evaluated both in vitro and in vivo together with any harmful effect on alveolar type II cells (ATII).  Bronchoalveolar lavage fluid (BALF) from IPF or control donors was analyzed for the presence of lysyl oxidase (LOX).  In parallel with an increase in histone acetylation, romidepsin potently inhibited fibroblast proliferation, myofibroblast differentiation and LOX expression.  ATII cell numbers and their lamellar bodies were unaffected.  In vivo, romidepsin inhibited bleomycin-induced pulmonary fibrosis in association with suppression of LOX expression.  LOX was significantly elevated in BALF of IPF patients compared to controls.  These data show the anti-fibrotic effects of romidepsin, supporting its potential use as novel treatment for IPF with LOX as a companion biomarker for evaluation of early on-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVn-pfX7PHl-RS7coPn-RtfW6udTcc2ea3GYXy5WI2Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjs1CjtA%253D%253D&md5=f30248c911d1fda219d521496d346b2b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17114%26sid%3Dliteratum%253Aachs%26aulast%3DConforti%26aufirst%3DF.%26aulast%3DDavies%26aufirst%3DE.%2BR.%26aulast%3DCalderwood%26aufirst%3DC.%2BJ.%26aulast%3DThatcher%26aufirst%3DT.%2BH.%26aulast%3DJones%26aufirst%3DM.%2BG.%26aulast%3DSmart%26aufirst%3DD.%2BE.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DAlzetani%26aufirst%3DA.%26aulast%3DHavelock%26aufirst%3DT.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DMolyneaux%26aufirst%3DP.%2BL.%26aulast%3DThorley%26aufirst%3DA.%2BJ.%26aulast%3DTetley%26aufirst%3DT.%2BD.%26aulast%3DWarner%26aufirst%3DJ.%2BA.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26aulast%3DSkipp%26aufirst%3DP.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BJ.%26aulast%3DRicheldi%26aufirst%3DL.%26aulast%3DSime%26aufirst%3DP.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BM.%2BA.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%252C%2520romidepsin%252C%2520as%2520a%2520potential%2520treatment%2520for%2520pulmonary%2520fibrosis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D48737%26epage%3D48754%26doi%3D10.18632%2Foncotarget.17114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skwarna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henneke, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Beck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahavadi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetko, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellusci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullamsetti, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span> <span> </span><span class="NLM_article-title">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2014-206411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1136%2Fthoraxjnl-2014-206411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26359372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1022-1032&author=M.+Korfeiauthor=S.+Skwarnaauthor=I.+Hennekeauthor=B.+MacKenzieauthor=O.+Klymenkoauthor=S.+Saitoauthor=C.+Ruppertauthor=D.+von+der%0ABeckauthor=P.+Mahavadiauthor=W.+Klepetkoauthor=S.+Bellusciauthor=B.+Crestaniauthor=S.+S.+Pullamsettiauthor=L.+Finkauthor=W.+Seegerauthor=O.+H.+Kramerauthor=A.+Guenther&title=Aberrant+expression+and+activity+of+histone+deacetylases+in+sporadic+idiopathic+pulmonary+fibrosis&doi=10.1136%2Fthoraxjnl-2014-206411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Korfei Martina; Skwarna Sylwia; Henneke Ingrid; MacKenzie BreAnne; Klymenko Oleksiy; von der Beck Daniel; Mahavadi Poornima; Saito Shigeki; Ruppert Clemens; Bellusci Saverio; Seeger Werner; Klepetko Walter; Crestani Bruno; Pullamsetti Soni Savai; Fink Ludger; Kramer Oliver Holger; Guenther Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thorax</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1022-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activation and differentiation of fibroblasts into contractile protein-expressing myofibroblasts and their acquired apoptosis-resistant phenotype are critical factors towards the development of idiopathic pulmonary fibrosis (IPF), a fatal disease characterised by distorted pulmonary structure and excessive extracellular matrix (ECM) deposition.  The molecular mechanisms underlying these processes in IPF remain incompletely understood.  We investigated the possible implication of aberrant overexpression and activity of histone deacetylases (HDACs) in IPF.  METHODS:  We analysed lung tissues from patients with sporadic IPF (n=26) and non-diseased control lungs (n=16) for expression of class I and II HDACs.  Primary IPF fibroblasts were treated with HDAC inhibitors (HDACi) LBH589 or valproic acid (VPA).  RESULTS:  Compared to control lungs, protein levels of class I (HDAC1, HDAC2, HDAC3, HDAC8) and class II HDACs (HDAC4, HDAC 5, HDAC 7, HDAC 9) were significantly elevated in IPF lungs.  Using immunohistochemistry, strong induction of nearly all HDAC enzymes was observed in myofibroblasts of fibroblast foci and in abnormal bronchiolar basal cells at sites of aberrant re-epithelialisation in IPF lungs, but not in controls.  Treatment of primary IPF fibroblasts with the pan-HDACi LBH589 resulted in significantly reduced expression of genes associated with ECM synthesis, proliferation and cell survival, as well as in suppression of HDAC7, and was paralleled by induction of endoplasmic reticulum stress and apoptosis.  The profibrotic and apoptosis-resistant phenotype of IPF fibroblasts was also partly attenuated by the class I HDACi VPA.  CONCLUSIONS:  Aberrant overexpression of HDACs in basal cells of IPF lungs may contribute to the bronchiolisation process in this disease.  Similarly, generation and apoptosis resistance of IPF fibroblasts are mediated by enhanced activity of HDAC enzymes.  Therefore, pan-HDAC inhibition by LBH589 may present a novel therapeutic option for patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJNhSDZx9hyjKfW6udTcc2ea3GYXy5WI2Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFemsQ%253D%253D&md5=621f4bd5c66ff41ed4c4cbf894644a4a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2014-206411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2014-206411%26sid%3Dliteratum%253Aachs%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DSkwarna%26aufirst%3DS.%26aulast%3DHenneke%26aufirst%3DI.%26aulast%3DMacKenzie%26aufirst%3DB.%26aulast%3DKlymenko%26aufirst%3DO.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DRuppert%26aufirst%3DC.%26aulast%3Dvon%2Bder%2BBeck%26aufirst%3DD.%26aulast%3DMahavadi%26aufirst%3DP.%26aulast%3DKlepetko%26aufirst%3DW.%26aulast%3DBellusci%26aufirst%3DS.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DPullamsetti%26aufirst%3DS.%2BS.%26aulast%3DFink%26aufirst%3DL.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DKramer%26aufirst%3DO.%2BH.%26aulast%3DGuenther%26aufirst%3DA.%26atitle%3DAberrant%2520expression%2520and%2520activity%2520of%2520histone%2520deacetylases%2520in%2520sporadic%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DThorax%26date%3D2015%26volume%3D70%26spage%3D1022%26epage%3D1032%26doi%3D10.1136%2Fthoraxjnl-2014-206411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inomata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishijima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokuho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, A.</span></span> <span> </span><span class="NLM_article-title">XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1016%2Fj.pupt.2017.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=28315487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=61-69&author=K.+Kamioauthor=A.+Azumaauthor=J.+Usukiauthor=K.+Matsudaauthor=M.+Inomataauthor=N.+Nishijimaauthor=S.+Itakuraauthor=H.+Hayashiauthor=T.+Kashiwadaauthor=N.+Kokuhoauthor=K.+Atsumiauthor=T.+Yamaguchiauthor=K.+Fujitaauthor=Y.+Saitoauthor=S.+Abeauthor=K.+Kubotaauthor=A.+Gemma&title=XPLN+is+modulated+by+HDAC+inhibitors+and+negatively+regulates+SPARC+expression+by+targeting+mTORC2+in+human+lung+fibroblasts&doi=10.1016%2Fj.pupt.2017.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts</span></div><div class="casAuthors">Kamio, Koichiro; Azuma, Arata; Usuki, Jiro; Matsuda, Kuniko; Inomata, Minoru; Nishijima, Nobuhiko; Itakura, Shioto; Hayashi, Hiroki; Kashiwada, Takeru; Kokuho, Nariaki; Atsumi, Kenichiro; Yamaguchi, Tomoyoshi; Fujita, Kazue; Saito, Yoshinobu; Abe, Shinji; Kubota, Kaoru; Gemma, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unclear.  Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that participates in the assembly and turnover of the extracellular matrix, whose expression is regulated by transforming growth factor (TGF)-β1 through activation of mammalian target of rapamycin complex 2 (mTORC2).  Exchange factor found in platelets, leukemic, and neuronal tissues (XPLN) is an endogenous inhibitor of mTORC2.  However, whether XPLN modulates SPARC expression remains unknown.  Herein, we investigated the regulatory mechanisms of XPLN in human lung fibroblasts.  Effect of XPLN on mTORC2 activity was evaluated by silencing XPLN in human fetal lung fibroblasts (HFL-1 cells), using small interfering RNA.  SPARC expression was quantified by quant. real-time RT-PCR and western blotting.  Fibroblasts were treated with TGF-β1, histone deacetylase (HDAC) inhibitors, entinostat, or vorinostat, to assess their effects on XPLN expression.  Moreover, the effect of mTORC1 inhibition on SPARC and XPLN was examd.  XPLN depletion stimulated SPARC expression and Akt phosphorylation on Ser473.  TGF-β1 treatment down-regulated XPLN via Smad 2/3.  XPLN mRNA expression was up-regulated upon treatment with HDAC inhibitors in a concn.-dependent manner, and TGF-β1-induced SPARC expression was reversed by entinostat treatment. mTORC1 inhibition by rapamycin and Raptor depletion stimulated SPARC expression.  In conclusion, this is the first study describing the involvement of XPLN in the regulation of SPARC.  These findings may help uncover the regulatory mechanisms of the mTORC2-SPARC axis.  The up-regulation of XPLN by HDAC inhibitors may be a novel therapeutic approach in patients with IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3owvooqDmErVg90H21EOLACvtfcHk0lje9CrLmHHk3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWnt7s%253D&md5=d68c0ba0b3dcb8d493898a7e03f689be</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKamio%26aufirst%3DK.%26aulast%3DAzuma%26aufirst%3DA.%26aulast%3DUsuki%26aufirst%3DJ.%26aulast%3DMatsuda%26aufirst%3DK.%26aulast%3DInomata%26aufirst%3DM.%26aulast%3DNishijima%26aufirst%3DN.%26aulast%3DItakura%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKashiwada%26aufirst%3DT.%26aulast%3DKokuho%26aufirst%3DN.%26aulast%3DAtsumi%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DS.%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DGemma%26aufirst%3DA.%26atitle%3DXPLN%2520is%2520modulated%2520by%2520HDAC%2520inhibitors%2520and%2520negatively%2520regulates%2520SPARC%2520expression%2520by%2520targeting%2520mTORC2%2520in%2520human%2520lung%2520fibroblasts%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D44%26spage%3D61%26epage%3D69%26doi%3D10.1016%2Fj.pupt.2017.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasky, J. A.</span></span> <span> </span><span class="NLM_article-title">Tubastatin ameliorates pulmonary fibrosis by targeting the TGF-beta-PI3K-Akt pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0186615</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0186615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1371%2Fjournal.pone.0186615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29045477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0186615&author=S.+Saitoauthor=Y.+Zhuangauthor=B.+Shanauthor=S.+Danchukauthor=F.+Luoauthor=M.+Korfeiauthor=A.+Guentherauthor=J.+A.+Lasky&title=Tubastatin+ameliorates+pulmonary+fibrosis+by+targeting+the+TGF-beta-PI3K-Akt+pathway&doi=10.1371%2Fjournal.pone.0186615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway</span></div><div class="casAuthors">Saito, Shigeki; Zhuang, Yan; Shan, Bin; Danchuk, Svitlana; Luo, Fayong; Korfei, Martina; Guenther, Andreas; Lasky, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0186615/1-e0186615/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease.  Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition).  However, the role of HDAC6 in pulmonary fibrosis is unknown.  Methods HDAC6 expression in IPF and control lungs was assessed by quant. real-time PCR (qRT-PCR) and immunoblots.  Lung fibroblasts were treated with TGF-β1 ± HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots.  Mice were treated with bleomycin (oropharyngeal aspiration; single dose) ± Tubastatin (i.p. injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining.  In a sep. expt., HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner.  Results HDAC6 expression was deregulated in IPF lungs.  Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-β1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) assocn.  Tubastatin repressed TGF-β1-induced S6K phosphorylation, HIF-1α expression, and VEGF expression.  Tubastatin also repressed TGF-β1-induced inhibition of LC3B-II (a marker of autophagosome formation).  In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression.  However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice.  Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-β1-induced collagen expression in lung fibroblasts.  Conclusions HDAC6 expression is altered during lung fibrogenesis.  Tubastatin represses TGF-β1-induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1α-VEGF axis and autophagy.  Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not.  Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGFβ-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorEUu1wcAKXLVg90H21EOLACvtfcHk0lje9CrLmHHk3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KktrfO&md5=67dfcd8dfe9baac9d5273163c2cf3543</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0186615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0186615%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DDanchuk%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DLasky%26aufirst%3DJ.%2BA.%26atitle%3DTubastatin%2520ameliorates%2520pulmonary%2520fibrosis%2520by%2520targeting%2520the%2520TGF-beta-PI3K-Akt%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0186615%26doi%3D10.1371%2Fjournal.pone.0186615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X. H.</span></span> <span> </span><span class="NLM_article-title">Loss of alpha-tubulin acetylation is associated with TGF-beta-induced epithelial-mesenchymal transition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5405</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.713123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1074%2Fjbc.M115.713123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=26763233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1GjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=5396-5405&author=S.+Guauthor=Y.+Liuauthor=B.+Zhuauthor=K.+Dingauthor=T.+P.+Yaoauthor=F.+Chenauthor=L.+Zhanauthor=P.+Xuauthor=M.+Ehrlichauthor=T.+Liangauthor=X.+Linauthor=X.+H.+Feng&title=Loss+of+alpha-tubulin+acetylation+is+associated+with+TGF-beta-induced+epithelial-mesenchymal+transition&doi=10.1074%2Fjbc.M115.713123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition</span></div><div class="casAuthors">Gu, Shuchen; Liu, Yanjing; Zhu, Bowen; Ding, Ke; Yao, Tso-Pang; Chen, Fenfang; Zhan, Lixing; Xu, Pinglong; Ehrlich, Marcelo; Liang, Tingbo; Lin, Xia; Feng, Xin-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5396-5405</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The epithelial-to-mesenchymal transition (EMT) is a process by which differentiated epithelial cells reprogram gene expression, lose their junctions and polarity, reorganize their cytoskeleton, increase cell motility and assume a mesenchymal morphol.  Despite the crit. functions of the microtubule (MT) in cytoskeletal organization, how it participates in EMT induction and maintenance remains poorly understood.  Here we report that acetylated α-tubulin, which plays an important role in microtubule (MT) stabilization and cell morphol., can serve as a novel regulator and marker of EMT.  A high level of acetylated α-tubulin was correlated with epithelial morphol. and it profoundly decreased during TGF-β-induced EMT.  We found that TGF-β increased the activity of HDAC6, a major deacetylase of α-tubulin, without affecting its expression levels.  Treatment with HDAC6 inhibitor tubacin or TGF-β type I receptor inhibitor SB431542 restored the level of acetylated α-tubulin and consequently blocked EMT.  Our results demonstrate that acetylated α-tubulin can serve as a marker of EMT and that HDAC6 represents an important regulator during EMT process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqboOMmwm08rVg90H21EOLACvtfcHk0liUYMb3GMlk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1GjtLw%253D&md5=4462779365b48d0b9a65440fef03ba11</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.713123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.713123%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DT.%2BP.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DZhan%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DEhrlich%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%2BH.%26atitle%3DLoss%2520of%2520alpha-tubulin%2520acetylation%2520is%2520associated%2520with%2520TGF-beta-induced%2520epithelial-mesenchymal%2520transition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D5396%26epage%3D5405%26doi%3D10.1074%2Fjbc.M115.713123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roach, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutcliffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradding, P.</span></span> <span> </span><span class="NLM_article-title">A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">342</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-18555-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=10.1038%2Fs41598-017-18555-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=29321510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A280%3ADC%252BC1MzpsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=342&author=K.+M.+Roachauthor=A.+Sutcliffeauthor=L.+Matthewsauthor=G.+Elliottauthor=C.+Newbyauthor=Y.+Amraniauthor=P.+Bradding&title=A+model+of+human+lung+fibrogenesis+for+the+assessment+of+anti-fibrotic+strategies+in+idiopathic+pulmonary+fibrosis&doi=10.1038%2Fs41598-017-18555-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Roach Katy M; Sutcliffe Amanda; Matthews Laura; Elliott Gill; Newby Chris; Amrani Yassine; Bradding Peter</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with limited therapeutic options.  KCa3.1 ion channels play a critical role in TGFβ1-dependent pro-fibrotic responses in human lung myofibroblasts.  We aimed to develop a human lung parenchymal model of fibrogenesis and test the efficacy of the selective KCa3.1 blocker senicapoc. 2 mm(3) pieces of human lung parenchyma were cultured for 7 days in DMEM ± TGFβ1 (10 ng/ml) and pro-fibrotic pathways examined by RT-PCR, immunohistochemistry and collagen secretion.  Following 7 days of culture with TGFβ1, 41 IPF- and fibrosis-associated genes were significantly upregulated.  Immunohistochemical staining demonstrated increased expression of ECM proteins and fibroblast-specific protein after TGFβ1-stimulation.  Collagen secretion was significantly increased following TGFβ1-stimulation.  These pro-fibrotic responses were attenuated by senicapoc, but not by dexamethasone.  This 7 day ex vivo model of human lung fibrogenesis recapitulates pro-fibrotic events evident in IPF and is sensitive to KCa3.1 channel inhibition.  By maintaining the complex cell-cell and cell-matrix interactions of human tissue, and removing cross-species heterogeneity, this model may better predict drug efficacy in clinical trials and accelerate drug development in IPF.  KCa3.1 channels are a promising target for the treatment of IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHd2NrbcVPpmBAiYWy6n3SfW6udTcc2eb3EdxSHh6ferntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzpsVylsg%253D%253D&md5=5c6c2186e0bbd6d2d9614b757e8f01f2</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-18555-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-18555-9%26sid%3Dliteratum%253Aachs%26aulast%3DRoach%26aufirst%3DK.%2BM.%26aulast%3DSutcliffe%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DG.%26aulast%3DNewby%26aufirst%3DC.%26aulast%3DAmrani%26aufirst%3DY.%26aulast%3DBradding%26aufirst%3DP.%26atitle%3DA%2520model%2520of%2520human%2520lung%2520fibrogenesis%2520for%2520the%2520assessment%2520of%2520anti-fibrotic%2520strategies%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D342%26doi%3D10.1038%2Fs41598-017-18555-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVWqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1817-1828&author=W.+Luauthor=X.+Yaoauthor=P.+Ouyangauthor=N.+Dongauthor=D.+Wuauthor=X.+Jiangauthor=Z.+Wuauthor=C.+Zhangauthor=Z.+Xuauthor=Y.+Tangauthor=S.+Zouauthor=M.+Liuauthor=J.+Liauthor=M.+Zengauthor=P.+Linauthor=F.+Chengauthor=J.+Huang&title=Drug+repurposing+of+histone+deacetylase+inhibitors+that+alleviate+neutrophilic+inflammation+in+acute+lung+injury+and+idiopathic+pulmonary+fibrosis+via+inhibiting+leukotriene+A4+hydrolase+and+blocking+LTB4+biosynthesis&doi=10.1021%2Facs.jmedchem.6b01507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis</span></div><div class="casAuthors">Lu, Weiqiang; Yao, Xue; Ouyang, Ping; Dong, Ningning; Wu, Dang; Jiang, Xingwu; Wu, Zengrui; Zhang, Chen; Xu, Zhongyu; Tang, Yun; Zou, Shien; Liu, Mingyao; Li, Jian; Zeng, Minghua; Lin, Ping; Cheng, Feixiong; Huang, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-1828</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) and idiopathic pulmonary fibrosis (IPF) are both serious public health problems with high incidence and mortality rate in adults, and with few drugs available for the efficient treatment in clinic.  In this study, the authors identified that two known histone deacetylase (HDAC) inhibitors, suberanilohydroxamic acid (SAHA, 1) and its analog 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide (2), are effective inhibitors of Leukotriene A4 hydrolase (LTA4H), a key enzyme in the biosynthesis of leukotriene B4 (LTB4), across a panel of 18 HDAC inhibitors, using enzymic assay, thermofluor assay, and x-ray Crystallog. investigation.  Importantly, both 1 and 2 markedly diminish early neutrophilic inflammation in mouse models of ALI and IPF under a clin. safety dose.  Detailed mechanisms of down-regulation of proinflammatory cytokines by 1 or 2 were detd. in vivo.  Collectively, 1 and 2 would provide promising agents with well-known clin. safety for potential treatment in patients with ALI and IPF via pharmacol. inhibiting LAT4H and blocking LTB4 biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZIoiPhzUZBrVg90H21EOLACvtfcHk0liUYMb3GMlk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVWqurk%253D&md5=a94045bbbe5514eb48b1468b54cac0b5</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01507%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DOuyang%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DDrug%2520repurposing%2520of%2520histone%2520deacetylase%2520inhibitors%2520that%2520alleviate%2520neutrophilic%2520inflammation%2520in%2520acute%2520lung%2520injury%2520and%2520idiopathic%2520pulmonary%2520fibrosis%2520via%2520inhibiting%2520leukotriene%2520A4%2520hydrolase%2520and%2520blocking%2520LTB4%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1817%26epage%3D1828%26doi%3D10.1021%2Facs.jmedchem.6b01507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00924%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00924" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b39a06f0622d8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
